1	SARS-CoV-2
2	coronavirus
3	evolution
4	mutation
5	MD simulations
6	SARS-CoV
7	coronaviruses
8	human infection
9	molecular mechanism
10	protein docking
11	Epidemic
12	Novel coronavirus
13	Public health
14	Respiratory disease
15	COVID-19
16	ORF8
17	natural selection
18	phylogeny
19	vaccines
20	codon usage bias
21	host adaptation
22	mutational bias
23	CoVID-19
24	biodefense
25	pandemic
26	N protein
27	Nsp1
28	positive selection
29	spike protein
30	viral evolution
31	SARS
32	immune evasion
33	immunoglobulin
34	pathogenesis
35	Emergence
36	Prevention
37	Transmission
38	Treatment
39	entry receptor
40	evolutionary adaptation
41	glycosylation
42	hemagglutinin-esterase
43	sialic acid O-acetylation
44	virus–host interaction
45	CpG depletion
46	cytosine deamination
47	mutation bias
48	2019 novel coronavirus
49	2019-nCoV
50	interactome
51	protein-protein interactions
52	structural genomics
53	PHEIC
54	alignment-free phylogeny
55	bioinformatics
56	genomics
57	ACE2
58	Furin
59	Coronavirus
60	Genomic diversity
61	Mutations
62	RNA virus
63	human genetics
64	molecular dynamics
65	molecular evolution
66	post-translational modification (PTM)
67	protein structure
68	receptor structure-function
69	severe acute respiratory coronavirus 2 (SARS-CoV-2)
70	virus entry
71	Comparative genomics
72	Drug target
73	Molecular basis of pathogenesis
74	Molecular evolution
75	HCoV-19
76	Human-to-human transmission
77	Novel pneumonia outbreak
78	Phyloepidemiology
79	Multiorgan failure
80	Secondary bacterial infection
81	Severe acute respiratory syndrome coronavirus 2
82	coexistence
83	viral perspective
84	bat coronavirus
85	disease-X
86	population genetics
87	virus bioinformatics
88	Evolutionary analysis
89	Nigeria
90	preventive measures
91	severe acute respiratory syndrome coronavirus 2
92	transmission chain
93	Host genome interaction - phylogeny - RNA sequence - SARS-CoV-2 - viral type coronavirus
94	Infection follow-up
95	Minority variants
96	NGS
97	Quasispecies
98	Emerging infectious diseases
99	Genomic surveillance
100	Hybrid capture
101	Metatranscriptomic sequencing
102	Multiplex PCR
103	Virus evolution
104	iSNV
105	Bioinformatics
106	Pathogenesis
107	Bat
108	Host
109	pneumonia
110	Genotyping
111	Single-nucleotide polymorphism
112	Animal coronaviruses
113	Genetic plasticity
114	Host switch
115	Novel human coronavirus
116	Tissue tropism
117	coronavirus disease-19
118	severe acute respiratory syndrome coronavirus-2 isolates
119	transmission
120	virulence
121	Drug interactions
122	Intéractions médicamenteuses
123	Psychotropes
124	Psychotropics
125	nucleocapsid
126	pathogenicity
127	broadly neutralizing antivirals
128	docking
129	protein evolution
130	sequence analysis
131	genes
132	SARS‐CoV‐2 evolution
133	primary literature
134	teaching of evolution
135	 India
136	 Kerala
137	 genomes
138	 next-generation sequencing
139	 phylogeny
140	 real-time reverse transcription-polymerase chain reaction
141	 severe acute respiratory syndrome coronavirus 2
142	Epitope
143	RT-qPCR
144	WGS data
145	bioinformatics tool
146	detection
147	diagnosis
148	in silico specificity evaluation
149	mismatches
150	primers and probes
151	Tissue host tropism
152	Viral evolution
153	Zoonotic coronavirus
154	SARS-CoV-2 evolution
155	ancestral type
156	subtype
157	Autophagy
158	Bio-informatic
159	adaptation
160	Coronaviridae
161	FISH
162	HAE
163	NCoV-2019
164	human airway epithelium
165	model
166	Wuhan
167	pp1ab protein
168	virus
169	TMRCA
170	cross-species transmission
171	evolutionary rate
172	potential intermediate animal host
173	Gene
174	Infection
175	Mutation
176	Natural selection
177	coronavirus evolution
178	protein–protein complex
179	virus–host interactions
180	SARS-CoV-2 Spike protein
181	adaptive evolution
182	therapeutic peptides
183	CpG motifs
184	evolution of synonymous mutations
185	pathogen-associated molecular patterns (PAMPs)
186	pattern recognition receptors (PRRs)
187	ssRNA viruses
188	viral host mimicry
189	Gompertz model
190	Italy
191	Logistic model
192	Model calibration
193	Non linear differential equations
194	Sars-Cov-2
195	APOBEC
196	SARS coronavirus 2
197	hypermutation
198	Cardiovascular disease
199	Cytokine storm
200	Myocardial injury
201	Venous thromboembolism
202	IL-6
203	T lymphocyte
204	cytokine storm
205	immune response
206	prognostic factor
207	PCR cycle threshold
208	Spike
209	antibody
210	diversity
211	infectivity
212	neutralization
213	pseudovirus
214	Drug resistance
215	Europe
216	Pneumonia
217	RNA-dependent-RNA-polymerase
218	RdRp
219	Viral mutagenesis
220	Education
221	Policy
222	phylodynamic analysis
223	super-spreader
224	Coding potential
225	Coronaviruses
226	Functional RNA elements
227	SARS CoV-2
228	antiviral drugs
229	cytokines
230	nonstructural proteins
231	severe acute respiratory syndrome
232	viremia
233	ORF7a
234	COVID-2019
235	asymptomatic
236	paucisymptomatic
237	CoV-2
238	intrahost variant
239	microbiota
240	covid-19
241	genetics
242	genome
243	infectious disease
244	phylogenetics
245	sars-cov-2
246	sequence
247	tracing
248	tracking
249	Phylodynamic analyses
250	SARS-CoV2 circulation in Italy
251	molecular tracing
252	whole genome sequencing
253	Mutation rate
254	RNA-dependent RNA polymerase
255	cleavage sites
256	Genome
257	Genomics
258	Pandemic
259	Viral disease
260	Whole genome sequence
261	phylogenetic analysis
262	Evolution
263	Sequence
264	Hemophagocytic syndrome
265	Storm cytokine syndrome
266	ACE-2
267	Feline coronavirus
268	conservation
269	ncRNA
270	secondary structure
271	structurome
272	Active site
273	Homology modeling
274	Molecular Docking
275	Phylogenetic tree
276	evolutionary dynamics
277	reproductive number
278	RNA synthesis
279	cofactors
280	cryo-EM
281	non-structural proteins
282	polymerase
283	Betacoronavirus
284	Homoplasies
285	Phylogenetics
286	immunosuppression
287	incidence
288	inflammatory bowel disease
289	MERS
290	emerging diseases
291	BBIBP-CorV
292	inactivated vaccine
293	ORF8 deletion
294	Phylogeny
295	genome sequencing
296	application
297	molecular assays
298	quality assurance
299	serological assays
300	Southeast Asia
301	genetic variation
302	homology
303	nucleotide
304	reference sequence
305	variation
306	RNA-seq
307	coronavirus disease 2019 (COVID-19)
308	global health
309	loop-mediated isothermal amplification (LAMP)
310	next-generation sequencing (NGS)
311	quantitative reverse transcription polymerase chain reaction (qRT-PCR)
312	severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
313	Homology-based protein-protein docking
314	Variants
315	Viral spike receptor binding domain
316	Coronaviridae
317	MERS-CoV
318	bats
319	ecology
320	phylogenetic
321	receptor-binding domain
322	sequencing
323	deletion mutation
324	replication kinetics
325	B cell epitopes
326	T cell epitopes
327	vaccine
328	Coronavirus Disease 2019 (COVID-19)
329	Race
330	Socioeconomic
331	reverse-transcription-polymerase-chain-reaction (RT-PCR)
332	2109-nCoV
333	Asymptomatic
334	Quarantine
335	coalescent
336	coronavirus disease
337	full genome sequence
338	phylogenetic tree
339	respiratory infections
340	viruses
341	ACE2, angiotensin receptor 2
342	BCoV, bovine coronavirus
343	COVID-19, Coronavirus Disease 2019
344	IBV, avian infectious bronchitis viruses
345	Origin
346	Phylogenetic analysis
347	SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
348	TGEV, transmissible gastroenteritis virus
349	Variations
350	WHO, World Health Organization
351	Burgers' equation
352	Riccatti equation
353	integrable systems
354	inverse problems
355	mathematical modelling of epidemics
356	Multiple sequence alignment
357	Point mutation
358	SNPs
359	epidemiology
360	laboratory diagnostics
361	SARS-COV-2
362	genomic epidemiology
363	real-time disease surveillance
364	virus evolution
365	Animals
366	Pets
367	SARS-CoV-2 entry inhibitors
368	TMPRSS2
369	cathepsins
370	peptides inhibitors
371	small molecules inhibitors
372	spike
373	deconfinement
374	seroprevalence
375	statistical model
376	pangolins
377	Saliva
378	nCoV-2019
379	host interactions
380	nonsense-mediated decay
381	proteomics
382	risk factors
383	transcriptomics
384	viral-induced genetics
385	RNA secondary structure
386	conserved mutation
387	miRNA
388	Lockdown
389	NO(2)
390	Ozone
391	Particulate matter
392	SO(2)
393	Africa
394	Low-income countries
395	Free energy
396	Phylogenetic
397	SARs-CoV-2
398	Simulation
399	Virtual screening
400	Molecular docking
401	Network pharmacology
402	ENaC
403	acute respiratory distress syndrome
404	computational biology
405	human
406	human biology
407	medicine
408	molecular mimicry
409	mouse
410	systems biology
411	SEIR modeling
412	stochastic modeling
413	swarm intelligence
414	2019 novel coronavirus pneumonia
415	Computed tomography
416	Ground glass opacification
417	Imaging features
418	D614G
419	S-Protein
420	comparative genomics
421	species conservation
422	outbreak surveillance
423	virus genomics
424	Care
425	Immunity
426	Older adults
427	SARS-CoV-2 spike protein (S)
428	angiotensin-converting enzyme 2 (ACE2)
429	receptor-binding domain (RBD) of coronavirus
430	Natural Vector method
431	transmission path
432	S1/S2 cleavage site
433	MinION sequencing
434	travel risk
435	CTD
436	crystal structure
437	immunogenicity
438	receptor
439	receptor binding domain
440	Clinical features
441	Diagnosis
442	Epidemiology
443	Managements strategies
444	Treatments
445	genome sequence
446	CRISPR
447	Cas13
448	IAV
449	RdRP
450	antiviral
451	influenza
452	LAMP
453	POCT
454	origin
455	pangolin
456	2019 Coronavirus disease (COVID-19)
457	Genetic evolution
458	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
459	Structural protein
460	 Coronavirus
461	 Directed Evolution
462	 Radiation Dosage
463	 Respiratory Distress Syndrome
464	 Selective Pressure
465	 X-Rays
466	amplicon sequencing
467	bait capture
468	Clinical cure
469	Evidence
470	Infectious disease
471	Treatment options
472	Virological cure
473	Immunoinformatics
474	One-health
475	Personalized medicine
476	Angiotensin converting enzyme 2 (ACE2)
477	Receptor utilization
478	Molecular oncology
479	diagnostic imaging
480	thoracic oncology
481	Outbreak
482	infection
483	secondary effects
484	migration rate
485	multitype bearth-death
486	number of introductions
487	reverse genetics
488	Mutational bias
489	Population genetics
490	Positive selection
491	WCA
492	codon usage analysis
493	serology
494	MPro
495	SARS-CoV-2 virus
496	hACE-2
497	multi-target-directed ligand
498	protease inhibitor
499	Amino acid replacements
500	G- S- and V-clades
501	co-evolved mutations
502	coronavirus disease 2019
503	european countries
504	Arthropod borne viruses
505	Phlebomotus
506	Phlebovirus
507	COVDI-19
508	Imported
509	Indigenous
510	Taiwan
511	antiviral therapeutic
512	peptide
513	inflammation
514	outcome and process assessment, health care
515	SARS coronavirus
516	drug design
517	evolutionary analysis
518	ligand tracking approach
519	molecular dynamics simulations
520	small-molecule inhibitors
521	MERS CoV
522	SARS CoV
523	drugs
524	spillover
525	control
526	public health
527	serial interval
528	2019 Novel Coronavirus
529	Culture
530	Korea
531	Microscopy, Electron
532	protein-protein interaction
533	viral infectivity
534	genomic analysis
535	recombinant virus
536	recombination
537	zoonoses
538	Infection cluster
539	Phylogenetic divergence
540	Sampling bias
541	Coronavirus disease 2019
542	Intrinsically disordered proteins
543	Molecular recognition features
544	Nucleotide-binding regions
545	Anthropocene
546	Bats
547	cross-species
548	adoptive cell-based therapy
549	anti-neoplastic regimen
550	extracellular vesicles
551	immunomodulatory drugs
552	mesenchymal stem cells
553	Covid-19
554	Sewage sludge
555	Soil
556	Viruses
557	Wastewater
558	Water
559	COVID 19
560	Confinement
561	Habitudes de sommeil
562	Sleep
563	Sleep habits
564	Social jet-lag
565	Sommeil
566	« Jet-lag » social
567	infections
568	lung diseases other than asthma and COPD
569	Sarbecovirus
570	Traditional Chinese Medicine
571	epidemic
572	whole-genome comparison
573	zoonosis
574	microbial
575	Codon bias
576	Corona virus
577	Dog
578	Selection pressure
579	host range
580	Serodiagnosis
581	Vaccination
582	Evolution disease
583	HLA class I
584	Viral peptide-MHC class I binding affinity
585	Genealogy
586	Recombination
587	Spike glycoprotein
588	genome evolution
589	canine intestine
590	zinc finger antiviral protein
591	3D modeling
592	Spike protein
593	glycoprotein
594	mass spectrometry
595	Batch chemical reactor
596	Infection dynamics
597	Non-linear regression
598	Pandemic mathematical model
599	Predictive model
600	Australia
601	climate
602	humidity
603	meteorological factors
604	time series analysis
605	C-TAK1
606	Nucleocapsid protein
607	Phosphorylation dependent binding and sequestration
608	Protein 14-3-3
609	Protein kinases
610	Abruzzo
611	naso-pharyngeal swab
612	qPCR
613	viral shedding
614	pregnancy
615	vertical transmission
616	Indian geographical area
617	Nsp12
618	RNA-dependent RNA polymerases (RdRp)
619	Bangladesh
620	Descriptive epidemiology
621	Temperature
622	3D-modeling
623	Antibody
624	Antigen
625	Avian influenza virus
626	Pseudovirus
627	Pseudovirus system
628	acute inflammatory demyelinating polyneuropathy
629	guillain barre syndrome
630	miller fisher variant
631	Endomyocardial biopsy
632	Heart failure
633	Myocarditis
634	SARS-CoV-2-infection
635	SARS‐CoV‐2
636	purifying selection
637	South America
638	genetic variants
639	France
640	Aerosol vaporization and nebulization
641	Alcoholic gargle
642	IL-1/IL-6
643	Monoclonal antibody
644	Povidone-iodine gargle and eye drop
645	Remdesivir
646	Viral pneumonia
647	molecular epidemiology
648	virus variant detection
649	antigenicity
650	Genetic variability
651	Pandemics
652	Virus classification
653	Cystic fibrosis
654	Health Surveillance
655	PCR
656	Virus
657	ACE1
658	Asia
659	Death toll difference
660	Resistance gene mutation
661	Social behaviors
662	Virulent viruses
663	Hydroxychloroquine
664	Immunosuppression
665	Lopinavir
666	Low-dose CT scan
667	COVID-19 infection
668	kidney transplantation
669	clinical study
670	oxygen-ozone
671	protocol
672	Novel proteins
673	Phylogenetic profile
674	          ORF8 gene
675	genotyping method
676	Chlorpromazine
677	Clinical trial
678	Essai clinique
679	Repositionnement de molécules
680	Repurposing of drugs
681	Children
682	Viral load
683	RNA-dependent-RNA polymerase
684	inhibitor
685	nsp12
686	vitamin B12
687	HIF-1alpha
688	diabetes
689	glycolysis
690	interferon
691	metabolism
692	mitochondria
693	monocyte
694	Infarction
695	MR perfusion
696	SARS-Cov2
697	Visual loss
698	liver transplantation
699	postoperative period
700	Non-meteorological factors
701	Spatio-temporal model
702	Weather conditions
703	Codon usage
704	Genetic variability < Evolution
705	Mutation < Genetics
706	SARS coronavirus < Virus classification
707	Zhejiang province
708	SARS-Cov-2
709	encephalitis
710	immunotherapy
711	natural history
712	post-infectious
713	covid
714	dialysis
715	mortality
716	registry
717	Human and SARS-CoV2
718	ORF3a
719	Pangolin
720	Shannon entropy
721	BEAST
722	Bayesian inference
723	Phylogeographic
724	Porcine Deltacoronavirus
725	T cells
726	immune dysfunction
727	cluster infection
728	novel coronavirus
729	systematic review
730	COVID-19, Genetic mutations, Next generation sequencing, SARS-CoV-2, South Asian.
731	cluster
732	Immune evasion
733	Immunoglobin
734	Pathogenicity
735	Unexplained pneumonia
736	molecular
737	biological markers
738	medical biology
739	animal reservoir
740	Ancestral reading frame
741	Apoptin
742	Computer simulation
743	De novo reading Frame
744	Homologs
745	Multivariate statistics
746	Therapeutic proteins
747	HLA
748	MHC
749	Changing epidemiology
750	Cholecystitis
751	Gallbladder
752	Histopathology
753	Immunohistochemistry
754	Computed Tomography
755	Coronavirus Disease 2019(COVID-19)
756	Ground Glass Opacity
757	SARS coronavir
758	biostatistics & bioinformatics
759	genetic mapping
760	genetic variabili
761	virus classification
762	Coevolution
763	Host susceptibility
764	Immune system
765	Phylodynamics
766	Italian Regions
767	Model
768	Outbreak Progression
769	Peak
770	Diffuse alveolar damage
771	Interstitial pneumonia
772	Post-mortem
773	Antioxidants
774	Hypoxia
775	NF-κB
776	Nrf-2
777	Sepsis
778	Sars-CoV-2
779	atherosclerosis
780	cytokine
781	pathogenesis of Sars-CoV-2
782	Gastroenterology
783	endoscopy
784	immunology
785	antisera
786	furin-like cleavage site
787	plaque phenotype
788	Cross-species infection
789	Machine learning
790	Chilblain-like lesions
791	Chilblains
792	Cutaneous manifestations
793	Pernio
794	Influenza virus
795	Mortality
796	Respiratory viruses
797	RT-PCR
798	clinical features
799	dexamethasone
800	life cycle
801	remdesivir
802	therapeutics
803	Anakinra
804	Convalescent plasma
805	Corticosteroids
806	Vaccine
807	Emergent infections
808	Sars-cov-2
809	Skin
810	Urticaria
811	COVID-19 pandemic
812	Environment stability
813	External environment
814	Host body environment
815	Molecular genetic evolution
816	autoantibodies
817	autoimmune diseases
818	dermatomyositis
819	
820	2019 Novel coronavirus disease
821	Colitis
822	Respiratory diseases
823	Spain
824	Cancer
825	Oncology
826	Evolutionary medicine
827	Host-pathogen interaction
828	ASTM
829	Alcohol-based hand rub
830	Disinfection
831	HIV
832	Handwashing
833	Hepatitis
834	Infection control
835	N95
836	Negative pressure
837	SHEA
838	Sterilization
839	Tuberculosis
840	UV-C
841	WHO
842	international instructions
843	neonate
844	outbreak
845	perinatal period
846	building operations
847	built environment
848	betacoronaviruses
849	renin-angiotensin
850	transcatheter aortic valve replacement
851	Cell membrane
852	G-protein coupled receptors
853	GPCR
854	Ligand-receptor
855	Lipid rafts
856	Mechanobiology
857	Structured deformations
858	Satellite imagery
859	Sentinel-2
860	Suspended sediments
861	Vessel traffic
862	Water transparency
863	hemodialysis
864	clinical signs
865	diagnostic tests
866	public health measures
867	contributing factors
868	immune system
869	toxic mixture
870	Blood groups ABO
871	Factor de von Willebrand
872	Factores de riesgo
873	Grupos sanguíneos ABO
874	Risk factors
875	Von Willebrand factor
876	Emerging infections
877	Cell
878	Prokaryotes
879	Protists
880	Classification of Proteins
881	Evolutionary Mechanisms
882	Virology
883	pathogenic coronaviruses
884	 Coronavirus Infections
885	 Health Personnel
886	 Occupational Health
887	 Peru (Source: MeSH)
888	Bayesian statistics
889	Disease dynamics
890	Mixture theory
891	Model inference
892	macromolecular design
893	CT
894	CXR
895	X-ray
896	computed tomography
897	COVID19
898	Genome signature
899	Yak
900	Flavonoids
901	furin cleavage PRRA motif
902	viral variants
903	head and neck surgery
904	otolaryngology
905	review
906	ACE Inhibitors
907	angiotensin
908	ace2
909	ards
910	chloroquine
911	lopinavir and ritonavir
912	mrna-1273 vaccine
913	remdesivir (gs-5734)
914	severe acute respiratory infection
915	sARS-CoV-2
916	Emergency surgery
917	Fatal outcome
918	Pandemic outbreak
919	guideline
920	Nantong
921	SARS-CoV2
922	clinical characteristics
923	symptom
924	Phylogenesis
925	Protein modeling
926	Real-time polymerase chain reaction
927	familial clustering
928	virology
929	Chest CT
930	Convolutional neural networks
931	Differential evolution
932	Multi-objective
933	Cumulative distribution function
934	Cirugía reconstructiva
935	Estenosis uretra
936	Pandemia
937	Reconstructive surgery
938	Urethral stricture
939	Urology
940	Urología
941	Tomography, X-ray computed
942	AGP: Aerosol Generating Procedure
943	CoViD-19: Coronavirus Disease 2019
944	DGP: Droplet Generating Procedure
945	Digestive endoscopy
946	Healthcare workers
947	PPE: Personal Protective Equipment
948	SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2
949	Safety
950	case fatality rate
951	social behavior
952	clinical presentation
953	Lombardy region
954	fatality rate
955	swab tests
956	Cholangiocytes
957	Chronic liver disease
958	characteristics of lesion evolution
959	pulmonary CT imaging performance
960	health planning
961	intensive care unit
962	pandemics
963	 SARS-CoV-2
964	 coronavirus
965	 critical care
966	 lung ultrasound
967	 point-of-care ultrasound
968	Tomography
969	diffuse alveolar damage
970	immunohistochemistry
971	lung histopathology
972	next generation sequencing
973	thrombi
974	viral pneumonia
975	traveller
976	Bronchoalveolar lavage fluid
977	Chemokines
978	Hypercytokinemia
979	Innate immune response
980	Interferon response
981	Interferon-stimulated genes
982	Accès aux soins
983	Complications
984	Electroconvulsive therapy
985	Health care access
986	Pandémie
987	Électro-convulsivo-thérapie
988	Épidémiologie
989	Block direct sequential simulation
990	Disease mapping
991	Infection risk maps
992	Critical patient
993	Intensive care unit
994	Paciente crítico
995	Recomendaciones
996	Recommendations
997	Unidad de cuidados intensivos
998	Autopsy
999	Capillaritis
1000	Lung
1001	Microthrombosis
1002	Clinical physic
1003	Contingency plan
1004	Medical physic
1005	community detection
1006	network analysis
1007	Chemosensory loss
1008	Psychophysical test
1009	ARIMA Models
1010	Data analysis
1011	Statistics
1012	Gene sequence
1013	LSTM model
1014	Neural Network
1015	Antiviral agents
1016	Biosensors
1017	Herbal
1018	Alemtuzumab
1019	Multiple sclerosis
1020	cerebrovascular disease
1021	endotheliopathy
1022	stroke
1023	prevention
1024	therapeutic advances
1025	Acute lymphoblastic leukemia-children-adolescents
1026	Animal health
1027	Cross-species
1028	One health
1029	Trio coronaviruses
1030	adult intensive care
1031	mechanical ventilation
1032	obstetrics and gynaecology
1033	pneumonia (infectious disease)
1034	 Anti-Inflammatory Responses
1035	 COVID-19
1036	 Convalescent Plasma
1037	 Immune System
1038	 Low Dose Radiation
1039	 Mutations
1040	 Radiotherapy
1041	 phylogenetic
1042	 reverse transcription-polymerase chain reaction
1043	Hidden Markov Model
1044	growth curve analysis
1045	mathematical modeling
1046	moving regression
1047	emerging infectious disease
1048	epidemic containment
1049	epidemic control
1050	travel screening
1051	cystic fibrosis
1052	lung transplant
1053	Neutrophil
1054	Traps
1055	circulating DNA
1056	Broader tissue tropism
1057	GI-19 lineage
1058	High pathogenicity
1059	Infectious bronchitis virus
1060	Multiple recombination events
1061	FK506-binding protein
1062	genome mining
1063	natural products
1064	Indian patients
1065	Missense mutations and genetic variations
1066	SARS-CoV2 genomes
1067	Therapeutic target
1068	HLA population genetics
1069	Indigenous Americans
1070	peptide-binding predictions
1071	HIV & AIDS
1072	medical history
1073	COVID
1074	health system
1075	tele-ICU
1076	telecritical care
1077	telemedicine
1078	Wuhan pneumonia
1079	metagenomic next-generation sequencing
1080	phylogenetic analyses
1081	Aesthetic surgery
1082	COVID-19 PCR test
1083	COVID-19 prophylaxis
1084	Clinical care protocol
1085	Contamination management
1086	Elective surgery
1087	IGM/IGG antibody rapid testing
1088	Patient safety
1089	Patient selection
1090	Procedure flow
1091	Anti-body
1092	Anti-gene
1093	Bottle-neck
1094	Comorbidities
1095	Depression
1096	Economy
1097	Epidemics
1098	Ethics
1099	Home isolation
1100	Individual outcomes
1101	Laboratory medicine
1102	Multi-professional expertise
1103	Policymaking
1104	Population screening
1105	Predictive preventive personalised (3P) medicine
1106	Psychotic attitude
1107	Related mortality
1108	Salami-tactic
1109	Strategy
1110	Suicide
1111	Suppressed immune defence
1112	Targeted protective measures
1113	Test
1114	Titanic
1115	Triage
1116	Violence
1117	“Real-time” monitoring
1118	epidemics
1119	mobile-tracing
1120	emerging
1121	respiratory
1122	TSG-6
1123	bikunin
1124	chondroitin sulfate
1125	extracellular matrix
1126	glycosaminoglycan
1127	heavy chain
1128	inter-α inhibitor proteins
1129	inter-α-trypsin inhibitor
1130	proteoglycan
1131	Anosmia
1132	Dysgeusia
1133	Symptoms
1134	ECMO
1135	Spanish perspective
1136	Disease
1137	Human
1138	FDG
1139	PET
1140	coronaviridae
1141	alphacoronavirus
1142	host sharing
1143	molecular Epidemiology
1144	3C-like proteinase
1145	Coronavirus disease (COVID-19)
1146	Non-structural protein 8
1147	Vaccinomics
1148	coronavirus infected disease
1149	disease classification
1150	lymphocyte subsets
1151	pulmonary inflammatory index
1152	Coinfección
1153	Diagnóstico
1154	S. pneumoniae
1155	Tratamiento
1156	co-infection
1157	convalescent plasma
1158	plasma
1159	epidemic model
1160	placenta
1161	Adrenaline
1162	Autonomic
1163	Catecholamines
1164	Dyshomeostasis
1165	Homeostasis
1166	Stress
1167	Sympathetic
1168	Data mining and web-base
1169	Geographical dimensions
1170	Health geography
1171	Interdisciplinary correlation
1172	Spatiotemporal analyst
1173	Imaging protocol
1174	Management
1175	Radiology
1176	Association of Program Directors in Radiology
1177	Program director
1178	Radiology resident
1179	Well-being
1180	Cardiovascular diseases
1181	Laser-based methods
1182	Microvascular endothelial dysfunction
1183	Neurosurgery
1184	Residency
1185	Survey
1186	Virus spread
1187	CT manifestations
1188	Laboratory
1189	Meta-analysis
1190	arthroplasty education
1191	fellowship
1192	residency
1193	virtual learning
1194	web-based learning
1195	novel coronavirus pneumonia
1196	intervention
1197	intervention measures
1198	modeling
1199	multiple waves
1200	pandemic response index
1201	simulations
1202	collective resilience
1203	effective mobilization
1204	emergent solidarity
1205	health behaviour
1206	public action
1207	social crisis
1208	groin
1209	hospitalization
1210	thrombectomy
1211	cancer
1212	head and neck
1213	survivorship
1214	treatment effects
1215	COVID-19 coronavirus pandemic
1216	modularity optimization algorithm
1217	prediction
1218	regression splines
1219	Bayesian brain
1220	Belief
1221	Biais cognitif
1222	Cerveau bayésie
1223	Codage prédictif
1224	Cognitive biases
1225	Croyance
1226	Perceived risk
1227	Perception du risque
1228	Predictive coding
1229	Terror management theory
1230	Théorie de la gestion de la terreur
1231	communication
1232	digital health
1233	digital technology
1234	eHealth
1235	health care
1236	infodemiology
1237	surveillance
1238	Compensation
1239	Dose totale
1240	Radiotherapy
1241	Radiothérapie
1242	Total dose
1243	Treatment duration
1244	Étalement
1245	Cirugía
1246	Consultas
1247	Consultations
1248	Functional urology
1249	Surgery
1250	Urología funcional
1251	COVID-19 pneumonia
1252	Lung cancer
1253	Oncological patient
1254	nursing education
1255	school epidemic prevention
1256	student counseling
1257	Critical care
1258	Prioritisation
1259	air transport
1260	aviation
1261	risk assessment
1262	spatial analysis
1263	DE
1264	PSO
1265	artificial intelligence
1266	feature selection
1267	sustainable development
1268	dynamic change
1269	tomography, X-ray computed
1270	 epidemiology
1271	 mathematical models
1272	2019nCoVR
1273	China National Center for Bioinformation (CNCB)
1274	National Genomics Data Center (NGDC)
1275	genomic data sharing
1276	Acute coronary syndrome
1277	Infarctus du myocarde
1278	Myocardial infarction
1279	2019 Novel Coronavirus (2019-nCoV)
1280	Demographic features
1281	Pathogenic molecularmechanism.
1282	Critical pathways
1283	Neuropsychology
1284	Physical therapy modalities
1285	Rehabilitation
1286	Telemedicine
1287	Middle East Respiratory Syndrome CoV
1288	Public Health Emergency
1289	Severe Acute Respiratory Syndrome CoV
1290	genetic analyses
1291	reservoir host
1292	Bat-hCoV
1293	Pangolin-hCoV
1294	Synonymous and non-synonymous substitutions
1295	Host tRNA genes
1296	Host-specific slow codons
1297	CLUSTAL analysis
1298	data visualization
1299	Wuhan city
1300	phylogenetic cluster
1301	time to most recent common ancestor
1302	transmission cluster
1303	engineering and technology
1304	Genomic sequence analysis
1305	Molecular epidemiology
1306	Bangkok
1307	angiotensin-converting enzyme 2
1308	human-to-human transmission
1309	Biosecurity
1310	Interceptions
1311	International policy
1312	Invasions
1313	Port of entry
1314	COVID-19, bats
1315	cardiovascular diseases
1316	myocardial injury
1317	older patients
1318	United States
1319	bottlenose dolphin
1320	genetic characterization
1321	EMS
1322	emergency
1323	personnel protection equipment
1324	providers’ contamination
1325	delay
1326	diagnostics
1327	oncology
1328	survival
1329	anosmia
1330	epidemiological surveillance
1331	self-assessment
1332	symptoms
1333	web application
1334	Bushmeat
1335	Cameroon
1336	Illegal wildlife trade
1337	Microsatellite loci
1338	Pangolins
1339	Phataginus tricuspis
1340	plague
1341	RTqPCR
1342	SARS-CoV-2 interacting proteins
1343	USP13
1344	Ubiquitin Specific Peptidase 13
1345	Biochemistry
1346	Cell biology
1347	Genetics
1348	Microbiology
1349	Molecular biology
1350	Host-viral interactome
1351	Integrative network biology
1352	Network centrality
1353	Pathway enrichment
1354	Probabilistic modeling
1355	Regulatory circuitry
1356	SARS-CoV-2 pathogenicity
1357	Topological clustering
1358	genome structure
1359	treatment
1360	laboratory utilization
1361	negative predictive value
1362	sensitivity
1363	BLAST, Basic Local Alignment Search Tool
1364	CDC, Centers of Disease Control and Prevention
1365	COVID-19, Coronavirus disease 2019
1366	EMBOSS, The European Molecular Biology Open Software Suite
1367	Genomic characterization
1368	MERS, Middle East Respiratory Syndrome
1369	NCBI, National Center for Biotechnology Information
1370	NGDC, National Genomics Data Center
1371	NMDC, National Microbiology Data Center
1372	NSP, nonstructural protein
1373	ORF, Open Reading Frame
1374	UTR, Untranslated region
1375	Acute respiratory distress syndrome (ARDS)
1376	Angiotensin-converting enzyme 2 (ACE-2)
1377	Coronavirus disease 2019 (COVID-19)
1378	Methyltransferase
1379	N7-MTase
1380	RNA capping
1381	TCM
1382	ensemble sampling
1383	nsp14
1384	AutoDock Vina
1385	luteolin
1386	ribavirin
1387	drug repurposing
1388	protease
1389	target
1390	Biological sciences
1391	Drug repurposing
1392	Molecular docking simulation
1393	Pharmaceutical science
1394	RNA Dependent RNA polymerase
1395	Sensitivity
1396	Chloroquine
1397	Ganglioside
1398	In silico
1399	Indole chalcones
1400	Phytochemicals
1401	Fusion inhibitors
1402	Molecular dynamics
1403	Sequence alignment
1404	COVID‐19
1405	SARS‐COV‐2
1406	molecular dynamics simulation
1407	spike glycoprotein
1408	Antiviral
1409	protein–protein interaction
1410	relative free energy of binding
1411	Molecular diagnosis
1412	Molecular pathology
1413	EndoU family
1414	NendoU
1415	Nsp15
1416	endoribonuclease
1417	SARS-CoV-1
1418	pregnancy vertical transmisssion
1419	scRNA-seq
1420	viral receptors
1421	Apoptosis
1422	autophagy flux
1423	drug targeting
1424	macroautophagy
1425	nanomedicine
1426	nanoparticles
1427	Reverse vaccinology
1428	theaflavin
1429	traditional Chinese medicinal compounds
1430	Docking
1431	ACE-2 receptor protein
1432	Epitope designing and screening
1433	SARS CoV-2 (COVID 19)
1434	Severe global outbreak-Dec 2019
1435	AXL
1436	CDK
1437	MAPK
1438	PIKFYVE
1439	casein kinase II
1440	p38
1441	phosphoproteomics
1442	Reproductive Biology
1443	microbiology
1444	quantitative biology
1445	nanotechnology
1446	point-of-use
1447	rapid detection of virus
1448	ACE2 gene
1449	Immunohistochemistry (IHC)
1450	RNA-sequencing
1451	Testis
1452	Prediction of sialic acid binding
1453	S1-NTD
1454	Sialic acid
1455	Sugar binding
1456	HLA antigens
1457	computers
1458	immunogenetics
1459	SARS-CoV-2 spike protein
1460	computational alanine-scanning mutagenesis
1461	free energy of binding
1462	molecular mechanics/Poisson−Boltzmann surface area
1463	HIV-1 protease clinical trial drugs
1464	SARS-COV-2Mpro 
1465	binding free energy
1466	molecular docking
1467	epitopes
1468	immunoinformatics
1469	Molecular Diagnostics
1470	Point of Care
1471	alternative splicing
1472	splice-switching oligos
1473	N-terminal domain
1474	TLR7
1475	TLR8
1476	bottleneck
1477	logistics
1478	quality control
1479	supply chain
1480	universal tranport medium
1481	viral transport medium
1482	Molecular simulation calculations
1483	SARS-CoV-2 M(pro)
1484	Tetracyclines
1485	Molecular
1486	RT-LAMP
1487	gastrointestinal tract
1488	favipiravir
1489	nsp8
1490	Pathogen host interaction
1491	SARS-CoV-2-Spike Glycoprotein
1492	Small Molecules
1493	ACE2 receptor
1494	Synthetic peptides
1495	COVID qPCR analyzer
1496	COVID-19 detection assay
1497	Diagnostics
1498	Graphical user interface (GUI)
1499	Microbial genomics
1500	Real-time RT- PCR
1501	ELISA
1502	Fab
1503	IgG
1504	electron microscopy
1505	Epitopes
1506	Immune-informatics
1507	3 chymotrypsin like protease
1508	RNA dependent RNA polymerase
1509	tetracycline
1510	cardiology
1511	cardiomyocytes
1512	cardiovascular biology
1513	heart
1514	induced pluripotent stem cells
1515	stem cell
1516	viral myocarditis
1517	Liver
1518	Liver impairment
1519	Mpro
1520	microbial natural products
1521	molecular dynamic simulation
1522	Interferon
1523	Interferon-stimulated gene
1524	Calorie restriction
1525	Immune responses
1526	ACE2 variants
1527	susceptibility
1528	Exonuclease
1529	Nucleotide analogue
1530	RNA-Dependent RNA polymerase
1531	Resistance
1532	HRV3C protease
1533	biotinylated probe
1534	single-chain Fc
1535	structurebased design
1536	RNA genomes
1537	Coronavirus infection
1538	Virus–host interactome
1539	(+) ssRNA
1540	RNA
1541	RNA structure
1542	mRNA pseudoknot
1543	programmed −1 ribosomal frameshifting (−1 PRF)
1544	small molecule inhibitor
1545	translation
1546	CoV
1547	Intrinsically disordered protein
1548	Membrane
1549	Nucleocapsid
1550	Spread
1551	Assay
1552	Evaluation
1553	PRNT
1554	3C-like protease
1555	HCV
1556	Hepatitis C virus
1557	drug repurpose
1558	ledipasvir
1559	molecular modelling
1560	velpatasvir
1561	virtual screening
1562	Accessory proteins
1563	Structural proteins
1564	IFN
1565	ISGs
1566	human intestinal epithelial cells
1567	interferon lambda
1568	interferon stimulted genes
1569	intrinsic immunity
1570	organoids
1571	Covid19-NMR
1572	Non-structural protein
1573	Nucleic acid-binding domain
1574	Protein drugability
1575	Solution NMR-spectroscopy
1576	Nuclear factor-κB
1577	Off label drugs
1578	Proteasome, Lipoxin
1579	Serine protease.
1580	Viral entry pathways
1581	allergenicity
1582	multi-epitopes
1583	deep learning
1584	main protease (MPro)
1585	natural compounds
1586	Detection
1587	Mechanism
1588	anti-SARS-CoV-2 antibodies
1589	plasma donation
1590	3CLpro
1591	drug-repurposing
1592	monoclonal antibody
1593	neutralizing antibody
1594	single B cell analysis
1595	crude drug
1596	homology modeling
1597	cross-reactive antibodies
1598	alpha cells
1599	beta cells
1600	human pluripotent stem cells
1601	liver organoids
1602	pancreatic endocrine cells
1603	Cross-neutralization
1604	Neutralizing monoclonal antibodies
1605	Receptor-binding domain
1606	ACE2 expression
1607	aging
1608	olfactory epithelium
1609	cross-neutralizing antibody
1610	receptor binding motif
1611	substitution mutation
1612	ISG
1613	non-human primate
1614	high-throughput screening
1615	magnetic bead RNA purification
1616	Marine drugs
1617	dock
1618	interactions
1619	cardiovascular disease (CVD)
1620	cardiovascular system
1621	hydroxychloroquine
1622	Antiviral therapeutics
1623	Neutralizing antibodies
1624	Host–virus interaction
1625	MicroRNA
1626	clearance
1627	hammer and dance strategy
1628	herd immunity
1629	clinical isolates
1630	furin cleavage
1631	APILIMOD
1632	Vacuolin-1
1633	ZEBOV
1634	CSF
1635	infectious diseases
1636	subarachnoid haemorrhage
1637	SARS-CoV-2 IgG and SARS-CoV-2 IgM antibodies
1638	chemiluminescent
1639	evaluation
1640	immunoassay
1641	molecular modeling
1642	non-structural protein 1
1643	MAPK signaling
1644	RAAS
1645	cardiovascular burden
1646	severe COVID-19
1647	signaling pathways
1648	Iran
1649	Veteran
1650	mustard gas
1651	clinical trial
1652	drug targets
1653	2019-nCoV coronavirus
1654	Automatic browser
1655	Peptidomimetic
1656	Q-UEL language
1657	Retroinverso
1658	Synthetic vaccine
1659	Wuhan seafood market coronavirus
1660	MHC class I epitopes
1661	antigen presentation
1662	in silico analysis
1663	structural biology
1664	vaccine development
1665	viral peptides
1666	Animal modelling
1667	Drosophila melanogaster
1668	Interactome
1669	Antibodies
1670	Receptor-Binding-Domain
1671	Structural Biology
1672	Anti-cytokine therapeutics
1673	Cytokine release syndrome
1674	anti-virals
1675	molecular targets
1676	proteases
1677	Molecular dynamics simulation
1678	Immuno-informatics
1679	Multi-epitope peptide vaccine construct
1680	Main protease
1681	ISM
1682	main protease Mpro
1683	acetylcholine receptors
1684	nicotine
1685	nicotinic cholinergic system
1686	smoking
1687	3D Reconstruction of Protein
1688	Protein Structure Aspects
1689	mRNA vaccine
1690	Chloroquine derivatives
1691	Flow cytometry
1692	Focus-forming assay
1693	Plaque assay
1694	Titration
1695	Virus inactivation
1696	1-Methoxyphaseollidin.
1697	Glyasperin
1698	Glycyrrhizic acid
1699	Isoliquiritin apioside
1700	Liquiritin
1701	Antiviral testing
1702	Drug screening
1703	In-cell ELISA
1704	Neutralization
1705	Seroprevalence
1706	Drug repositioning
1707	Structural bioinformatics
1708	RT-PCR-RFLP
1709	coronavirus disease: SARS-CoV-2
1710	ACE2-B0AT1
1711	SLC6A19
1712	drug discovery
1713	nimesulide
1714	ACE2 and ACE inhibitors
1715	Comparative modeling
1716	Fold recognition tools
1717	Receptor binding domain
1718	Spike post-fusion conformation
1719	n-CoV19
1720	COVID-19 receptor blockers
1721	Medicinal herbal compounds
1722	Therapeutic targets
1723	miRNAs
1724	Andrographis paniculata
1725	RNA-directed RNA polymerase
1726	andrographolide
1727	neoandrographolide
1728	CpG Island
1729	Motif
1730	Promoter
1731	Transcription factor
1732	MD simulation
1733	PCA
1734	covalent docking
1735	CRISPR-Cas12
1736	Nucleic acid detection
1737	Binding interactions
1738	Glycosaminoglycans
1739	Heparin
1740	Chinese medicine
1741	G-quadruplex
1742	PQSs
1743	helicase inhibitor
1744	viral helicase nsp13
1745	enveloped viruses
1746	liquid-liquid phase separation
1747	low-complexity domain
1748	stress granule
1749	viral capsid
1750	ACE2 binding
1751	allosteric drugs
1752	binding patch softness
1753	elastic networks modeling
1754	protein contact networks
1755	glyasperin
1756	glycyrrhizic acid
1757	liquiritin
1758	liquorice
1759	inverted repeats
1760	longitudinal dynamics
1761	neutralizing antibodies
1762	serological immune response
1763	angiotensin converting enzyme 2
1764	immunity
1765	MHC presentation
1766	memory T cell
1767	RNA-dependent RNA-polymerase
1768	main-protease (3CLpro)
1769	quinoline based-drugs
1770	spike-ACE2 complex
1771	RNA binding
1772	phase separation
1773	Frequent mutation
1774	Hot-spot mutations
1775	Protein stability
1776	Ferret (Mustela putorius furo)
1777	biophysics
1778	computational biology and chemistry
1779	conformational change
1780	non-covalent molecular recognition
1781	protein entropy
1782	protein inhibition
1783	structure-based drug design
1784	COPD
1785	COVID-19 children
1786	SARS receptor
1787	asthma
1788	hypertension
1789	obesity
1790	airport
1791	decontamination
1792	fomites
1793	ultraviolet light
1794	bat coronaviruses
1795	intermediate host
1796	zoonotic infection
1797	spike (S) protein
1798	2019 -nCoV
1799	deep mutational scanning
1800	AFB
1801	BCG
1802	Envelope protein
1803	COVID19-NMR
1804	Macrodomain
1805	In vitro assay
1806	N-substituted isatin compounds
1807	SARS-CoV-2 3C-like protease
1808	Structure-activity relationship
1809	Chemical informatics
1810	Computer-aided drug design
1811	Drug discovery
1812	Structure activity relationship
1813	Toxicology
1814	Zoonosis
1815	Zoonotic model
1816	animal modeling
1817	interspecies transmission
1818	pets
1819	viral zoonosis
1820	zoo animals
1821	antibodies
1822	antivirals
1823	CR3022
1824	X-ray crystallography
1825	cryo-electron microscopy
1826	epitope
1827	therapeutic
1828	nucleoprotein
1829	ISG15
1830	papain-like protease
1831	ubiquitin
1832	Antiviral drug
1833	Treatment strategy
1834	UPR
1835	miRNA sponges
1836	AF, Amniotic fluid
1837	Abortion
1838	BMI, Body mass index
1839	BP, Blood pressure
1840	CS, Cesarean section
1841	ED, Emergency department
1842	FHR, Fetal heart rate
1843	Fetal death
1844	GA, Gestational age
1845	HR, Heart rate
1846	Infectious disease transmission
1847	RR, respiratory rate
1848	SpO2, Oxygen saturation
1849	Spontaneous
1850	Stillbirth
1851	US, Ultrasound
1852	Vertical
1853	Z-STORCH, Zika, syphillis, toxoplasmosis, rubella, cytomegalovirus, herpes
1854	Group testing
1855	Infectious diseases
1856	commercial nucleotide production
1857	contamination
1858	delayed laboratory response
1859	molecular diagnostics
1860	primers
1861	probes
1862	ADME
1863	GC‐MS
1864	Ipomoea Obscura (L.)
1865	attenuate
1866	disorder
1867	immune
1868	intrinsic
1869	matrix
1870	protein
1871	shell
1872	Antiretroviral
1873	Data science
1874	Healthcare
1875	Coronavirus < Virus classification
1876	Public policy < Social Science
1877	Controlled Human Infection
1878	Human Challenge Trial
1879	Vaccine evaluation
1880	JAK
1881	senescence
1882	stat3
1883	Biological techniques
1884	3CL, 3C-like proteinase
1885	ACE2, angiotensin converting enzyme II
1886	COVID-19, corona virus disease-2019
1887	E, envelope
1888	M, membrane
1889	N, nucleocapsid
1890	Network Pharmacology
1891	New coronavirus pneumonia
1892	PPI, protein-protein interaction network
1893	RdRp, RNA dependent RNA polymerase
1894	Rhizoma Polygonati
1895	S, spike protein
1896	SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
1897	diagnostic techniques and procedures
1898	molecular biology
1899	salivary glands
1900	Laser irradiated phenothiazines
1901	human transporter associated with antigen processing (TAP)
1902	molecular docking, molecular dynamics simulation
1903	multiepitope vaccine
1904	toll-like receptor (TLR)
1905	Angiotensin
1906	Apelin
1907	Bradykinin
1908	Human cardiomyocytes
1909	Oxypurinol
1910	Pentoxifylline
1911	cytokine release syndrome.
1912	pro-inflammatory cytokines
1913	serine/threonine phosphatase PP2A
1914	systemic inflammatoryresponse
1915	Anti-viral
1916	lysophagy
1917	plaquenil
1918	virophagy
1919	pooling strategy
1920	whole-genome sequencing
1921	HERV
1922	HHV-6
1923	MTHFR
1924	RNASeq
1925	endometrial analysis
1926	reproduction
1927	principles
1928	host pathogen interactions
1929	nutritional status
1930	quality of health care
1931	RdRp inhibitors
1932	corticosteroids
1933	eculizumab
1934	immunomodulators
1935	nCOVID-19
1936	computational screening
1937	methylation
1938	methyltransferases
1939	DNA
1940	gastrointestinal microflora
1941	niacin
1942	nicotinamide adenine dinucleotide
1943	oocyte quality
1944	oxidative stress
1945	FURIN
1946	host
1947	liver
1948	single-cell transcriptomics
1949	Cathepsin
1950	Elastase
1951	Polymorphisms
1952	TMPRSS11A
1953	active-site ligand
1954	Mesenchymal stem cells
1955	autoimmunity
1956	exosomes
1957	disinfection
1958	droplets
1959	light microscopy
1960	physical distancing
1961	Epidemiological study
1962	Follow-up studies
1963	Health assessment
1964	Recovered patients
1965	IL-1β
1966	TNF-α
1967	corona virus disease 2019
1968	Acute myocardial injury
1969	Aging
1970	Cardiovascular system
1971	Frailty
1972	bradykinin
1973	hyaluronic acid
1974	renin-angiotensin system
1975	Ebola
1976	Niemann-Pick disease
1977	cholesterol
1978	cholesterol trafficking
1979	dyslipidemias
1980	lysosomal storage disease
1981	nanobody
1982	Fusion peptide
1983	Middle east respiratory syndrome
1984	Severe acute respiratory syndrome
1985	incubation period
1986	chemiluminescence immunoassay
1987	serological test
1988	endocytosis
1989	lipid metabolism
1990	sphingolipid
1991	Fluorescent detection
1992	Highly sensitive
1993	Bionformatics
1994	ANPEP
1995	EGFR
1996	IGF2R
1997	RAS
1998	immune system genes
1999	CADD
2000	Zoonotic diseases
2001	Angiotensin-converting enzyme 2 (ACE2)
2002	Genetic susceptibility
2003	MS2 phage
2004	respirator
2005	reuse
2006	sterilization
2007	autophagy
2008	canonical autophagy
2009	noncanonical autophagy
2010	Cysteine protease
2011	Lung inflammation
2012	Organoselenium compounds
2013	 COVID 19 
2014	 Pandemia
2015	 SARS
2016	2 
2017	Coronavirus 
2018	resistance
2019	coagulation
2020	heparan sulfate
2021	heparin
2022	3c
2023	ORF3c
2024	overlapping gene
2025	sarbecovirus
2026	complement proteins
2027	lectin pathway
2028	Grazoprevir
2029	Helicase
2030	Rimantadine
2031	Adaptive immunity
2032	S1 domain
2033	S2 domain
2034	corona vaccine
2035	animal model
2036	respiratory syndrome
2037	vaccine and drug discovery
2038	COVID-19 comorbidity
2039	COVID-19 immunity
2040	COVID-19 multi-morbidity
2041	COVID-19 prevention
2042	COVID-19 treatment
2043	SARS-CoV-2 receptors
2044	Acute lung injury
2045	Angiotensin-converting enzyme 2
2046	B cell repertoire
2047	SARS-CoV-2-specific antibody
2048	T cell compartments
2049	T cell receptor clusters
2050	T cell repertoire
2051	cytokine profile
2052	immunoglobulin heavy chain
2053	age-based susceptibility
2054	children
2055	pediatric lung
2056	comorbidity
2057	fibrinolysis
2058	plasmin(ogen)
2059	coagulopathy
2060	thrombosis
2061	Indian traditional medicine
2062	Mechanism of action
2063	Therapeutic approach
2064	cytokine storm syndrome
2065	baricitinib
2066	interferons
2067	lopinavir
2068	antiviral activities
2069	medicinal plants
2070	natural therapeutics/alternative medicine
2071	secondary metabolites
2072	Nervous system
2073	Neuroinvasion
2074	Neurological symptoms
2075	clinical trials
2076	Entry inhibitor
2077	Middle East respiratory syndrome
2078	innate immunity
2079	Senescence
2080	SARS-CoV-2 neuroinvasion
2081	neurodegenerative disorders
2082	neuroinflammation
2083	olfactory bulb dysfunction
2084	ACEI
2085	ARBs
2086	angiotensin-renin system
2087	malaria
2088	plasmodium
2089	DNA synthesis
2090	Platelets
2091	Thrombocytopenia
2092	antiviral agents
2093	cell fusion
2094	cellular effect
2095	entry inhibitors
2096	fusion protein
2097	glycoproteins
2098	Emerging
2099	RNA polymerase
2100	cellular immune response
2101	endoplasmic reticulum
2102	plus-stranded RNA virus
2103	viral replication
2104	Binding
2105	Molecular dynamic simulations
2106	S-protein
2107	Thermodynamic stability
2108	Antibiotics
2109	Coronavirus diseases 2019
2110	Inflammation
2111	Septic shock
2112	cobicistat
2113	drug hits
2114	icatibant
2115	main protease enzyme
2116	nafarelin
2117	Arg-Gly-Asp (RGD) peptide
2118	L-thyroxine (T4)
2119	clotting risk
2120	nonthyroidal illness syndrome (NTIS)
2121	porcine epidemic diarrhea α-coronavirus (PEDV)
2122	serum reverse T3 (3,3ʹ5ʹ-triiodo-L-thyronine, rT3)
2123	Death rate
2124	Latitude
2125	cardio-metabolic disease
2126	differential pathogenesis
2127	Academia
2128	Bibliometric analysis
2129	Emerging infectious disease
2130	RBD
2131	S protein
2132	SARS-CoV-
2133	Global pandemic
2134	Restriction factors
2135	Viral receptors
2136	Aspergillosis
2137	Candidiasis
2138	Fungal co-infection
2139	ADP-ribosylhydrolase
2140	Biochemistry & Chemical Biology
2141	MHV
2142	Microbiology & Infectious Disease
2143	PARP
2144	SDOH
2145	economy
2146	education
2147	food
2148	social inequality
2149	biomarkers
2150	disease progression
2151	antiviral therapy
2152	kinase inhibitors
2153	pharmacokinetics
2154	Men
2155	endothelial dysfunction
2156	vascular biology
2157	Air pollution
2158	alopecia
2159	androgens
2160	anti-androgen
2161	Early warning
2162	Models
2163	Rapid assessment
2164	SARS CoV-2 virus
2165	coronavirus disease in pregnancy
2166	lower respiratory infections in pregnancy
2167	maternal death
2168	maternal mortality
2169	maternal respiratory morbidity
2170	respiratory failure with COVID-19
2171	epitope prediction
2172	disposal
2173	Blood cells
2174	Contact killing
2175	Copper
2176	Cu-deficiency
2177	CuONPs
2178	Cupric chloride
2179	ROS
2180	Th1/Th2 cells
2181	Viral infection
2182	transferrin
2183	adjuvant
2184	epitope-based peptide vaccine design
2185	allergen immunotherapy (AIT)
2186	allergy clinic
2187	anaphylaxis
2188	position paper
2189	psychological COVID
2190	S1 subunit
2191	Spike (S) transmembrane glycoprotein
2192	subcutaneous
2193	tocilizumab
2194	Point-of-Care test
2195	Immune
2196	Paediatrics
2197	ARDS
2198	Nebulised heparin
2199	Unfractionated heparin
2200	heme
2201	heme oxygenase
2202	toll-like receptor
2203	dysbiosis
2204	gut permeability
2205	gut-lung axis
2206	2019 nCoV
2207	MERS- and SARS-CoV
2208	adeno-associate virus
2209	coronavirus (CoV)
2210	passive immunization strategy
2211	bleeding
2212	fibrin(ogen)
2213	pathology
2214	specific T cells
2215	Neurodegeneration
2216	Proteasome
2217	Proteasome inhibitors
2218	Germany
2219	Sweden
2220	strategy
2221	complement
2222	contact system
2223	serpins
2224	B-factor
2225	Drug Design
2226	Molecular modeling
2227	Protein flexibility
2228	gene network
2229	Influenza
2230	Ketone bodies
2231	Ketones
2232	exogenous ketone
2233	ketone ester
2234	ketone salt
2235	β-hydroxybutyrate
2236	Melatonin
2237	CRISPR-Cas9
2238	hospitalist
2239	nucleic acid
2240	EB
2241	Mendelian disorders
2242	epidermolysis bullosa
2243	Pannexin 1
2244	endothelium
2245	CD26
2246	receptor binding
2247	SWATH-MS
2248	antiviral immune response
2249	clinical classifiers
2250	high-throughput proteomics
2251	Fanconi syndrome
2252	acute kidney injury
2253	acute proximal tubule injury
2254	hypophosphataemia
2255	Manifestations
2256	RNA viruses
2257	eIF4A
2258	energy metabolism
2259	immune modulation
2260	rocaglate
2261	age-associated diseases
2262	bioavailability
2263	metabolic disorders
2264	nicotinamide riboside
2265	safety
2266	supplementation
2267	Colombia
2268	coronavirus infections
2269	epidemiological monitoring
2270	serologic tests
2271	Publishing ethics
2272	Scientific articles
2273	liver disease
2274	liver enzymes
2275	liver injury
2276	Dengue
2277	Host factor
2278	Positive stranded RNA viruses
2279	Topoisomerase III-ß (TOP3B)
2280	follow-up
2281	lymphocyte
2282	neutrophil
2283	recovery
2284	total protein
2285	Aptamer
2286	Probe
2287	Therapy
2288	anti-cytokine
2289	anti-viral
2290	case series
2291	COVID 2019
2292	Coronavirus (CoV)
2293	SARS—CoV-2
2294	healthcare worker protection
2295	Amino acid metabolism
2296	Intermediary metabolism
2297	Metabolism
2298	Imiquimod (IMQ)
2299	SARS - CoV-2
2300	immune activation
2301	angiotensin-converting enzyme-2
2302	enzyme inhibition
2303	furin
2304	point-of-care tests
2305	reverse transcription loop-mediated isothermal amplification
2306	polymorphism
2307	rs4588
2308	rs7041
2309	vitamin D binding protein
2310	Analytical Chemistry
2311	Diagnostic Equipment
2312	Infection Control in Health Technology
2313	Genome sequencing
2314	Hotspot
2315	nCoV2019
2316	dysfunctional neutrophils
2317	emergency myelopoiesis
2318	immune profiling
2319	mass cytometry
2320	monocytes
2321	neutrophils
2322	clot
2323	disease severity
2324	serum
2325	influenza pandemic
2326	nanomaterials
2327	quantum dots
2328	Careers
2329	COVID-19 mothers
2330	Clinical outcomes
2331	Preterm infants
2332	Health Sciences
2333	Medicine
2334	Brazil
2335	Oxidation
2336	Renin-angiotensin system
2337	Vitamin D
2338	Etiology
2339	Swine acute diarrhea syndrome coronavirus (SADS-CoV)
2340	Swine enteric alphacoronavirus (SeACoV)
2341	Acute respiratory distress syndrome
2342	Barrier function
2343	LMWF5A
2344	Anti-inflammatory Drug
2345	Antiviral Drug
2346	pathogenesis and diagnosis
2347	viral sepsis
2348	coronavirus 2019
2349	severe acute respiratory syndrome–coronavirus-2
2350	hyperuricemia
2351	Adjuvant
2352	Immune response
2353	Multi-epitope
2354	preexisting liver disease
2355	angiotensin receptor blocker
2356	angiotensin-converting enzyme inhibitor
2357	adverse outcome
2358	Infections
2359	Vitamin D supplementation
2360	cardiac injury
2361	cardiac markers
2362	meta-analysis
2363	outcome
2364	C-reactive protein
2365	interlukin-6
2366	lymphocytes
2367	lymphopenia
2368	procalcitonin
2369	prognosis
2370	viral load
2371	liver function
2372	antitumor agents
2373	phagocytosis
2374	reactive halogen species
2375	reactive nitrogen species
2376	reactive oxygen species
2377	respiratory burst
2378	signaling
2379	protease inhibitors
2380	Clinical practice guideline
2381	Evidence-based medicine
2382	Rapid advice guideline
2383	H1N1
2384	Lung disease
2385	Immunomodulation
2386	MSC priming
2387	NAT
2388	Arab league
2389	Middle East
2390	pandemic preparedness and response
2391	cytokine release syndrome
2392	intravenous immunoglobulin
2393	intravenous immunoglobulins
2394	kidney
2395	neurological disorders
2396	neurological manifestations
2397	Imiquimod
2398	Efficiency
2399	Operating room
2400	Orthopaedic trauma
2401	Performance indicators
2402	Immunoglobulins
2403	Cytopathic effects
2404	Immune reactions
2405	Viral accessory proteins
2406	Hospital stay
2407	Mortality rate
2408	Nucleotide inhibitors
2409	Sofosbuvir
2410	Wuhan coronavirus
2411	Anti-viral drugs
2412	Master regulator
2413	Regulatory networks
2414	type 2 taste receptors (TAS2Rs)
2415	Antibody fragments
2416	Biopharmaceuticals
2417	Viral infections
2418	Viral targets
2419	economic recession
2420	global health responses
2421	health care systems
2422	strategies
2423	Active component
2424	Pharmacological mechanism
2425	Severe acute respiratory coronavirus-2
2426	Signaling pathway
2427	Traditional Chinese medicine
2428	international cooperation
2429	prevention and control
2430	research and development
2431	traditional medicines
2432	viral infection susceptibility
2433	Health systems
2434	Personal protective equipment
2435	Thoracic oncology
2436	eosinophil infiltration
2437	recombinant protein
2438	spices
2439	epigenetic clock
2440	Biofilm
2441	Monitoring tool
2442	Nanofiber
2443	Surveillance
2444	Wastewater treatment
2445	Honey bees
2446	economics
2447	honey bee importation
2448	queen breeding
2449	elderly
2450	leukocyte count
2451	RNA-FISH
2452	click chemistry
2453	fluorescence probes
2454	mRNA detection
2455	viral infection
2456	Pakistan
2457	awareness
2458	preparedness
2459	Neutrophil extracellular traps
2460	P2Y12 inhibitor, Ticagrelor
2461	Platelets – Neutrophils aggregates
2462	Sepsis-induced coagulopathy
2463	Vascular leakage
2464	effective
2465	measures
2466	spread
2467	Antiviral medication
2468	Diet
2469	Herbs
2470	Lifestyle
2471	Nutrition
2472	SARS-CoV-II
2473	Smoking
2474	International
2475	Lost
2476	Unreported
2477	Cell therapy
2478	Therapeutic approaches
2479	CareDose 4D
2480	Image quality
2481	Radiation dose
2482	drug therapy
2483	novel coronavirus (2019-nCoV)
2484	research progress
2485	COVID-19, pilgrimage: travel
2486	border crossings
2487	travel restrictions: Qom
2488	COVID- 19
2489	Cancer patients
2490	Lymphopenia
2491	Angiotensin II
2492	Anti–PD-1 therapy
2493	Erythema multiforme
2494	Urticarial
2495	Vasculitis
2496	Angiotensin II receptor type 1 blockers
2497	Angiotensin II-converting enzyme inhibitors
2498	RAAS inhibitors
2499	cardiovascular disease
2500	biomarker
2501	bis(monoacylglyero)phosphates
2502	lipidomics
2503	metabolomics
2504	monosialodihexosyl gangliosides
2505	phosphatidylserines
2506	B-cells
2507	T-cell exhaustion
2508	interferons (IFNs)
2509	macrophages
2510	chemistry optimization
2511	ARDS (acute respiratory distress syndrome)
2512	conferences
2513	early-career researchers
2514	research assessment
2515	science funding
2516	travel
2517	Wuhan-2019-nCoV
2518	membrane protein
2519	nucleocapsid protein
2520	protein intrinsic disorder
2521	shell disorder
2522	endothelial cell dysfunction
2523	endotheliitis
2524	Parkinson’s disease
2525	neurodegenerative diseases
2526	neurological alterations
2527	Akt/mTOR/HIF-1
2528	MK-2206
2529	inflammatory response
2530	peptides
2531	viral protein detection
2532	Adverse events
2533	Demographic characteristic
2534	China
2535	Global transmission
2536	mice
2537	host response
2538	infection kinetics
2539	Human tissues
2540	in silico drug design
2541	viral replication inhibition
2542	repurposed drugs
2543	AT1R blockers
2544	COVID-19 epidemic
2545	losartan
2546	medicinal chemistry
2547	theranostic strategies
2548	laboratory medicine
2549	patient safety
2550	PM2.5
2551	aryl hydrocarbon receptor
2552	xenobiotic response element
2553	Fungal metabolites
2554	Main protease (M(pro))
2555	SARS-CoV-2 novel corona virus
2556	Brain
2557	Diabetes mellitus
2558	Therapeutics
2559	Automated immunoassays
2560	Lateral flow immunoassay
2561	Performance
2562	Crystal structure
2563	Primase
2564	Caveolin
2565	Epithelial barrier
2566	Placenta
2567	Syncytium
2568	antibody-dependent enhancement
2569	CLIA
2570	Immunoassays
2571	Lateral flow assays
2572	UPR response
2573	endoplasmic stress
2574	proteasome inhibitors
2575	viral genomics
2576	viral receptor
2577	SARS-CoV-2 antibody
2578	health care workers
2579	Biomarkers
2580	Patients
2581	Inflammatory bowel disease
2582	allostery
2583	drug development
2584	protein dynamics
2585	correlates
2586	humoral immunity
2587	vesicular stomatitis virus
2588	central nervous system
2589	neuroinvasive
2590	Acute respiratory syndrome
2591	Carbonic anhydrases (CAs)
2592	Neprilysin
2593	Renin angiotensin system (RAS)
2594	Respiratory acidosis
2595	ACE-2 receptor
2596	human TLRs
2597	therapeutic intervention
2598	binding site
2599	inhibitors
2600	trimer cavity
2601	variability
2602	blood-brain barrier
2603	glia
2604	neurogenic inflammation
2605	neurons
2606	neurovascular unit
2607	immune responses
2608	public policy
2609	social science
2610	Lateral flow assay
2611	Immunogenic epitopes
2612	Peptide vaccine
2613	Subunit vaccine
2614	Animal model
2615	SARS-CoV-2 / HCoV-19
2616	Susceptibility
2617	Tree shrews
2618	biochemistry
2619	pharmacology
2620	allosteric inhibition
2621	enzyme-substrate complex
2622	main protease
2623	native mass spectrometry
2624	Genetic diagnosis
2625	RNA extraction
2626	axonal transport
2627	multiple organ failure
2628	neurological symptoms
2629	neurotropic infection
2630	peripheral nerves
2631	Romania
2632	WGS
2633	mutations
2634	RNA aptamer
2635	Repurposing
2636	PatchDock
2637	SARS-CoV-2 or COVID-19
2638	pandemic global outbreak
2639	tea flavonoids
2640	deletions
2641	quasispecies
2642	respiratory virus
2643	3CL protease
2644	GC-376
2645	boceprevir
2646	calpain inhibitors
2647	avidity
2648	urea dissociation
2649	HCQ
2650	Protease inhibitor
2651	Vaccines
2652	Non-human Primates
2653	Rodents
2654	Transgenic Animals
2655	Nonsynonymous Mutations
2656	S Protein
2657	Kawasaki disease
2658	MIS-C
2659	case report
2660	VSV
2661	neutralization assay
2662	surrogate
2663	neutralizing
2664	surrogate assay
2665	antibody detection
2666	point of care
2667	rapid tests
2668	covalent inhibitors
2669	paritaprevir
2670	simeprevir
2671	B cells
2672	antigen receptors
2673	nanoparticle
2674	nonhuman primates
2675	replicon
2676	293T-ACE2
2677	ALAYT
2678	cytoplasmic tail
2679	lentiviral pseudotype
2680	luciferase
2681	Antiviral phytochemicals
2682	Neutralization Assay
2683	coronavirus spike
2684	DETECTR
2685	betacoronavirus
2686	diagnostic testing
2687	isothermal amplification
2688	lateral flow
2689	molecular testing
2690	zoonotic
2691	immunologic tests
2692	immunopathology
2693	West Nile
2694	Cobicistat
2695	High-intensity exercise
2696	Moderate-intensity exercise
2697	Obesity
2698	SARS- CoV-2 (COVID-19)
2699	Infectious Disease
2700	antiviral miRNA
2701	antiviral peptides
2702	Immunology
2703	Muti-target
2704	Natural compounds
2705	BCG vaccine
2706	trained immunity
2707	Protease inhibitors
2708	binding modes
2709	phytochemicals
2710	flavonoids and non-flavonoids
2711	Pseudotyping
2712	Newborns
2713	Pregnancy
2714	IgM
2715	rapid test
2716	sars-CoV-2
2717	bias
2718	clinical studies
2719	diagnostic error
2720	GS-5734
2721	biosensors
2722	Oropharyngeal sampling
2723	Polymerase chain reaction
2724	Pragmatic trial
2725	Protocol
2726	Randomized controlled trial
2727	ACE2, Angiotensin converting enzyme
2728	ARDS, Acute respiratory distress syndrome
2729	ARF, Acute respiratory failure
2730	COPD, Chronic obstructive pulmonary disease
2731	CRP, C reactive protein
2732	IFN, Interferon
2733	Lung microbiome
2734	PAMP, Pathogen associated molecular patterns
2735	PRR, Pattern recognition receptor
2736	RSV, Respiratory syncytial virus
2737	TLR, Toll like receptor
2738	TNF, Tumour necrosis factor
2739	rRNA, Ribosomal RNA
2740	H2S
2741	lung
2742	OMICS
2743	respiratory system
2744	ACE
2745	Arthropod
2746	Cat
2747	Flea
2748	Proteomics
2749	IVF
2750	fertility
2751	ovary
2752	testis
2753	Convalescent Serum
2754	Immunotherapy
2755	broad-spectrum antiviral agents
2756	dimerization
2757	homodimer
2758	main protease (Mpro)
2759	angiotensin-converting enzyme
2760	therapy
2761	Nucleotide analogues
2762	Anti-viral responses
2763	Asthma
2764	Basigin
2765	Cellular therapy
2766	EMMPRIN
2767	Invasion
2768	Lung stem cells
2769	immunoassays
2770	anisocytosis
2771	hematology
2772	red blood cells
2773	validation
2774	N-acetylcysteine
2775	Oxidative stress
2776	Epidemic.
2777	bioactive compounds
2778	malnutrition
2779	nutrition
2780	nutritional support
2781	Epidemic disease
2782	database
2783	prospective cohort
2784	Central nervous system
2785	Neuroprotection
2786	Cold environment
2787	Acute respiratory disease
2788	Drug development targets
2789	Molecular pathogenesis
2790	Protein engineering
2791	Ct value
2792	point-of-care devices
2793	biochemical monitoring
2794	serology testing
2795	ADCC
2796	Fc receptors
2797	immune therapy
2798	monoclonal antibodies
2799	DNA vaccine
2800	Nucleic acid based vaccines
2801	RNA vaccine
2802	Stem cell based vaccine
2803	Protease
2804	reverse transcription polymerase chain reaction (RT-PCR)
2805	laboratory tests
2806	retinopathy
2807	screening
2808	STAT
2809	interleukin-6
2810	SARS–CoV-2
2811	compassionate use
2812	mesenchymal stem cell therapy
2813	Lactobacillus gasseri
2814	nutritional intervention.
2815	purine
2816	Troponin
2817	analytes
2818	cardiac troponin I
2819	cardiac troponin T
2820	biohazard
2821	biosafety
2822	laboratory management
2823	Androgens
2824	Diabetes
2825	Hypertension
2826	PCOS
2827	Polycystic ovary syndrome
2828	Severe acute respiratory syndrome coronavirus-2
2829	Health System Preparedness
2830	biochemical alterations
2831	laboratory
2832	cellular and humoral immunity
2833	polymerase chain reaction
2834	real time reverse transciptase
2835	hACE2
2836	pyrimidine derivatives
2837	enzyme
2838	curcuminoids
2839	pulmonary fibrosis
2840	Blood science testing
2841	Hospital laboratories
2842	Monitoring and management
2843	Gut-lung axis
2844	Probiotics
2845	Current scenario
2846	Sudan
2847	Antiviral drugs
2848	Immunochromatographic assay and Drug discovery
2849	Hcv glycoproteins E1 and E2
2850	Iron oxide nanoparticles (IONPs)
2851	Reactive oxygen species (ROS)
2852	Repurposing medication
2853	Cholesterol
2854	Immune cells
2855	Isopentenyladenosine
2856	LDL
2857	Statins
2858	repurposed therapeutics
2859	gene expression network
2860	molecular docking and dynamics simulation
2861	Plasmodium
2862	renin angiotensin system
2863	side effect
2864	viral invasion
2865	humoral immune response
2866	protective immunity
2867	receptor-binding protein
2868	serology test
2869	pathobiology
2870	Anti-viral activity
2871	Hesperidin
2872	Prophylaxis
2873	Viral entry
2874	Gastrointestinal Symptoms
2875	Multiomics
2876	coronavirus 3CLpro
2877	natural product
2878	challenges
2879	Coagulation
2880	Endothelial dysfunction
2881	Thrombosis
2882	EGCG
2883	JAK/STAT
2884	antiviral activity
2885	green tea extract
2886	inflammatory bowel diseases
2887	multiple sclerosis
2888	rheumatoid arthritis
2889	Angiotensin converting enzyme
2890	RNA-dependent
2891	Angiotensin converting enzyme 2
2892	Coronavirus-2
2893	Renin-angiotensin-aldosterone-system
2894	Transmembrane protease serine-2, Mesenchymal Stem Cell
2895	Neonate
2896	Vertical transmission
2897	detection kits
2898	false negative
2899	false positive
2900	point-of-care testing (POCT)
2901	specificity
2902	TMPRSS4
2903	nitric oxide
2904	albumin
2905	lactate dehydrogenase
2906	6LU7
2907	statins
2908	Structure
2909	polyprotein processing
2910	structural virology
2911	Laboratory parameters
2912	Parámetros de laboratorio
2913	ENT
2914	Gustatory
2915	Hyposmia
2916	Loss
2917	Olfaction
2918	Olfactory
2919	Smell
2920	Taste
2921	Clinical chemistry
2922	Pediatrics
2923	Sodium
2924	calcium
2925	chloride
2926	potassium
2927	neoplasms
2928	histone deacetylases
2929	NAD
2930	sirtuins
2931	Senescent cell
2932	Inflammaging
2933	Longevity
2934	NK cells
2935	Acute Respiratory Distress Syndrome (ARDS)
2936	Anti-inflammatory phenotype
2937	Hormesis
2938	Low dose radiotherapy
2939	KEAP1
2940	anti-inflammatory ARDS
2941	bardoxolone methyl
2942	sulforaphane
2943	Healthcare staff
2944	Israel
2945	SARS-CoV-2 vaccine
2946	Vaccine hesitancy
2947	Vaccine safety
2948	Egypt
2949	SARS-CoV-2 RNA
2950	biochemical markers
2951	clinical data
2952	hematological parameters
2953	severity
2954	biologic
2955	immunosuppressive
2956	psoriasis
2957	critical illness
2958	predictors
2959	Rift Valley fever virus
2960	West Nile virus
2961	avian influenza
2962	dengue
2963	hemorrhagic fever
2964	influenza A virus
2965	monkeypox
2966	one health
2967	rabies
2968	re-emerging
2969	simian immunodeficiency
2970	vector-borne
2971	biochemical biomarkers
2972	biomarkers of disease progression
2973	hematological biomarkers
2974	immunological biomarkers
2975	inflammatory biomarkers
2976	neutrophil–lymphocyte ratio (NLR)
2977	HSPGs
2978	iron
2979	lactoferrin
2980	membrane receptors
2981	phytoconstituents
2982	smoke water
2983	Immunogenetics
2984	Biochemistry; blood cell count
2985	Reverse Transcriptase Polymerase Chain Reaction
2986	traditional Chinese medicine
2987	hospital
2988	test
2989	demographics
2990	outcomes
2991	SARS–Cov-2
2992	antioxidants
2993	exercise
2994	fasting
2995	free radicals
2996	surfactant protein A
2997	Acute decompensation
2998	Hepatic failure
2999	Liver function tests
3000	 Acute-on-chronic liver failure
3001	Correlation
3002	COX‐2 inhibitors
3003	interleukin‐6
3004	Zimbabwe
3005	medical tourism
3006	personalized medicine
3007	precision herbal medicine
3008	Cytokine
3009	Laboratory findings
3010	Lymphocyte subsets
3011	Antibiotic stewardship
3012	PCT
3013	Procalcitonin
3014	CHIP
3015	DNMT3A
3016	TET2
3017	clonal hematopoiesis
3018	Neonatal outcomes
3019	Pregnant women
3020	Systematic review
3021	neutrophil extracellular traps
3022	neutrophilia
3023	Age
3024	Curcuma longa
3025	antibiotic resistance
3026	antimicrobial resistance
3027	Angiogenic factors
3028	PlGF
3029	pre-eclampsia
3030	pre-eclampsia-like syndrome
3031	sFlt-1
3032	antiretrovirals (ARVs)
3033	azithromycin
3034	type I interferon
3035	biochemical characteristics
3036	systemic review
3037	DPP-4 inhibitors
3038	fibrosis
3039	multi-organ injury
3040	health policy
3041	health services administration & management
3042	mental health
3043	neurological
3044	psychological
3045	germicidal
3046	photobiology
3047	photobiomodulation
3048	photodynamic
3049	photoinactivation
3050	ultraviolet
3051	virucidal
3052	ASCT2
3053	Amino acid
3054	B0AT1
3055	Protein expression
3056	SLC
3057	Flavivirus
3058	Inhibitor
3059	Renin-angiotensin-aldosterone system
3060	endocrine
3061	renin angiotensin aldosterone system
3062	nomogram
3063	marine natural products
3064	marine organisms
3065	inflammation.
3066	fluorescence
3067	nucleotides
3068	real-time PCR
3069	NETs
3070	antioxidant
3071	ergothioneine
3072	COVID-19 virus
3073	Exosomes
3074	Extracellular vesicles
3075	Allium sativum
3076	Covid-19 infection
3077	Garlic
3078	Leptin
3079	Natural killer cells
3080	T lymphocytes
3081	gender
3082	plantaricin
3083	probiotics
3084	spike proteins
3085	India
3086	cross-immunity
3087	drug repositioning
3088	electronic health records (EHR)
3089	Colon Capsule Endoscopy
3090	colonoscopy
3091	elastic fibers
3092	factor II
3093	matrix Gla protein
3094	protein S
3095	vitamin K
3096	calcineurin inhibitors
3097	rheumatic diseases
3098	solid organ transplantation
3099	Pharmacology
3100	Laboratory features
3101	estrogen
3102	immunomodulation
3103	progesterone
3104	sex difference
3105	sex differences
3106	sex hormones
3107	testosterone
3108	anaemia
3109	patient blood management
3110	active distance learning
3111	audience response system
3112	medical education continuity
3113	online interactive pedagogy tools
3114	Favipiravir
3115	Healthcare systems
3116	Orthopaedic surgery
3117	Diarrhea
3118	Nausea
3119	Vomiting
3120	diet
3121	endotoxin
3122	gut bacteria
3123	intestine
3124	Data mining
3125	Optimization algorithm
3126	Synthetic repurposing
3127	Respiratory problem
3128	Treatment approach
3129	COVID-19 vaccine
3130	Respiratory tract infections
3131	Myasthenia
3132	receptors
3133	signal transduction
3134	Research
3135	Society
3136	hypercoagulability
3137	pulmonary embolism
3138	thromboembolic
3139	Lighthouse Lab
3140	collaboration
3141	teamwork
3142	volunteers
3143	Cognition
3144	Science fiction
3145	Coronavirus Disease 2019
3146	Information
3147	Periodicals as Topic
3148	Publishing
3149	Social Media
3150	Cigarette
3151	Coronavirus, COVID-19
3152	CD8+: T lymphocyte subsets
3153	T-Cells (or lymphocytes)
3154	viral (or virus)
3155	angiotensin receptor antagonists
3156	angiotensin-converting enzyme inhibitors
3157	clinical review
3158	Chronic obstructive pulmonary disease
3159	Cerebrovascular disease
3160	clinical chemistry
3161	Clinical trials
3162	Immunomodulatory
3163	Mesenchymal stem cell
3164	Stem cell therapy
3165	polyphenols
3166	real-life risk simulation
3167	Contact tracing
3168	containment
3169	healthcare worker
3170	hospital outbreak
3171	serological Ab tests
3172	widespread testing
3173	Biomarker
3174	Prognosis
3175	Social Media, Pakistan, Coronavirus, Facebook, WHO, Global health, Mental health, Lockdown.
3176	health
3177	No Keywords
3178	Collaboration
3179	Complex problems
3180	Interdisciplinarity
3181	biological age
3182	biomarkers of biological age
3183	Angiotensin converting enzyme inhibitors
3184	Angiotensin receptor antagonists
3185	Novel coronavirus disease 2019 (COVID-19)
3186	ACE 2
3187	Interleukin-6
3188	Diamond Princess
3189	haplotypes
3190	non-synonymous mutation
3191	Drug development
3192	Genetic diversity
3193	Gut microbiome
3194	SARS-CoV-2 genome
3195	evolutionary strategies
3196	genomic structure
3197	recombination or reassortment
3198	Bat SARS-CoV
3199	Bat-CoV
3200	Evolutionary imprints
3201	Pangolin-CoV
3202	Multiple alignment
3203	Pairwise alignment
3204	Reference
3205	Surface spike glycoprotein
3206	complete genomes
3207	multiple sequence alignment
3208	severe acute respiratory syndrome coronavirus-2
3209	druggable protein
3210	envelope protein
3211	ligand
3212	nucleocapsid phosphoprotein
3213	Genetic manipulation
3214	Plant-based drugs
3215	Genomic variants
3216	RT-PCR performance
3217	SARS-CoV-2 coronavirus
3218	drugs and medicinal substance repurposing
3219	eriodictyol
3220	estradiol
3221	mitigation approaches
3222	quercetin
3223	vitamin D
3224	Genomic
3225	Homology
3226	ORF
3227	Boltzmann function
3228	Modeling studies
3229	Traditional Chinese Medicine (TCM)
3230	coronavirus pneumonia
3231	SARS-nCoV-2
3232	metagenomics
3233	brain-gut-lung axis
3234	lung disease
3235	pulmonary hypertension
3236	COVID-19 data
3237	Drug Discovery Programmes
3238	Molecular Dynamics Simulation Study
3239	Protein Conformations
3240	SARS-CoV-2 coronavirus; genomics; mitigation approaches; drugs & medicinal substances repurposing
3241	cytotoxic T lymphocyte epitopes
3242	epitope mapping techniques
3243	helper T lymphocytes
3244	immune response modulation
3245	vaccine candidate protein
3246	vaccine database
3247	Neutralizing antibody
3248	Variant gene
3249	Ashwagandha
3250	Withaferin-A
3251	Withanone
3252	binding
3253	caffeic acid phenethyl ester
3254	honeybee propolis
3255	VeroE6
3256	Illumina
3257	protocols
3258	interstitial pneumonia
3259	offlabel drug use
3260	RNA dependent RNApolymerase
3261	helicase
3262	infection cycle
3263	nucleosides.
3264	structural proteins
3265	N-glycosylation
3266	hemagglutinin
3267	lectin
3268	fast protocols
3269	sample treatment
3270	APEX-seq
3271	COX4
3272	double-membrane vesicle
3273	hypothesis generation
3274	machine learning model
3275	proximity labelling
3276	viral RNA localization
3277	NOA
3278	adult
3279	fetal
3280	normal
3281	testis cells
3282	VDA
3283	VDA-KATZ
3284	Antiviral peptides
3285	nCoV-19
3286	peptide design
3287	COVID-19-nsp2 assay
3288	GolayMetaMiner
3289	clinical evaluation
3290	genome subtraction
3291	nsp2
3292	real-time RT-PCR
3293	Vietnam
3294	Peri-implantation
3295	antagonists
3296	peptidomimetics
3297	viral entry
3298	antiviral drug combinations
3299	broad-spectrum antivirals
3300	heart failure
3301	Allele frequencies
3302	Functional prediction
3303	Gene variants
3304	Host genomics
3305	Population genomics
3306	Susceptibility and resistance
3307	cruise ship
3308	genome epidemiology
3309	haplotype network
3310	imported case
3311	single-nucleotide variations
3312	high-throughput nucleotide sequencing
3313	ORF8ab
3314	accessory protein
3315	Acetaminophen
3316	Hepatocyte
3317	Medications
3318	Metformin
3319	Nsaids
3320	Biosafety/Biosecurity
3321	Dual-use
3322	Engineering SARS-CoV-2 virus
3323	Regulation
3324	Risk
3325	Proteomic analysis
3326	Populations
3327	SARS-CoV-2 binding
3328	Single nucleotide variants
3329	barcoding
3330	genetic surveillance
3331	genome variation
3332	Genomic rearrangements
3333	Intra-host variability
3334	Molecular diagnostics
3335	Cerebrovascular disorders
3336	Intracranial haemorrhage
3337	Neurological complications
3338	Stroke
3339	Venous thrombosis
3340	hormones
3341	morbidity
3342	sex bias
3343	False negatives
3344	Solution comparisons
3345	B cell
3346	CDR3
3347	convalescent patient
3348	single-cell sequencing
3349	Care homes
3350	Occupational risk
3351	immunodominant epitope
3352	vaccine target
3353	Cardiac dysfunction
3354	Single-cell sequence
3355	angiotensins
3356	population
3357	consensus
3358	simulation
3359	deoxyribonuclease I
3360	flagellin
3361	toll-like receptor 5
3362	Case series
3363	Mechanical ventilation
3364	Mesenchymal stromal cells
3365	Transgenic mouse
3366	PA28γ
3367	Protein degradation
3368	nCoV N
3369	DHA
3370	EPA
3371	SPMs
3372	ACDC
3373	GISAID
3374	Genomic hubs
3375	Alveolar macrophage
3376	Pathology
3377	Antibody-dependent enhancement
3378	Innate immunity
3379	Repurposing of molecules
3380	AAAAI, American Academy of Allergy, Asthma and Immunology
3381	ACAAI, American College of Allergy, Asthma and Immunology
3382	ACE2, Angiotensin-converting enzyme 2
3383	ADCC, Antibody-Dependent Cell-mediated Cytotoxicity
3384	AEs, Adverse events
3385	BTS, British Thoracic Society
3386	Biologics
3387	DNA, Deoxyribonucleic acid
3388	EBM, Evidence Based Medicine
3389	ELF, European Lung Foundation
3390	ERS, European Respiratory Society
3391	FDA, Food and Drug Administration
3392	GINA, Global Initiative for Asthma
3393	GSK, Glaxo Smith Kline
3394	ICS, inhaled corticosteroids
3395	ICU, Intensive Care Unit
3396	IL13, Interleukin 13
3397	IL4, Interleukin 4
3398	IL5, Interleukin 5
3399	IL5Ra, Interleukin 5 alfa receptor
3400	IL5r, Interleukin 5 receptor
3401	IL6, Interleukin 6
3402	IgE, Immunoglobulin E
3403	NHLBI, National Heart, Lung, and Blood Institute
3404	OCS, Oral corticosteroids
3405	PDGFRA, Platelet-Derived Growth Factor Receptor A
3406	PROSE study, Preventative Omalizumab or Step-up therapy for fall Exacerbations study
3407	RCTs, Randomized Controlled Trials
3408	SAEs, Serious Adverse Events
3409	SARP, Severe Asthma Research Programme
3410	SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2
3411	SC, Subcutaneous
3412	SIAAIC, Italian Society of Allergy, Asthma and Clinical Immunology
3413	Severe
3414	T2, Type 2 inflammation
3415	TMPRSS2, Transmembrane Protease Serine 2 Enzyme
3416	USA, United States of America
3417	mAb, Monoclonal antibody
3418	Alignment
3419	Annotation
3420	Epigenetic
3421	Endoplasmic reticulum
3422	IRE1
3423	PERK
3424	Spliced XBP1
3425	Unfolded protein response
3426	Genomic analysis
3427	kinin
3428	Environment
3429	Environmental impacts
3430	Pollutants
3431	insilico
3432	patient transcriptomics
3433	pharmacogenomics
3434	conjunctiva
3435	conjunctivitis
3436	eye
3437	KDM5B
3438	adult-onset
3439	genetic analysis
3440	magnetic resonance imaging
3441	white matter disease
3442	white matter hyperintensities
3443	CD47
3444	immune checkpoint
3445	pathogen recognition receptors
3446	Immunosenescence
3447	Sex differences
3448	machine learning
3449	Coronavirus, 2019-nCoV, SARS-CoV-2, 2019nCoV, Clinical Trial, Asia.
3450	control and therapeutic strategies
3451	evidence-based medicine
3452	BRCA genes
3453	COVID-19 pandemic in Italy
3454	Germline BRCA testing
3455	HLA class II transgenic mice
3456	JAK inhibitor
3457	multiple organ dysfucntion
3458	superantigens
3459	D-dimers
3460	circulating endothelial cells
3461	contact tracing
3462	CRISPR/Cas9
3463	Gene editing
3464	Gene therapy
3465	HIV and SARS-Cov-2 infection
3466	Human-induced pluripotent stem cells (hiPSCs)
3467	Dicer
3468	mTOR
3469	nCOVID19 SARS-CoV
3470	p53
3471	Israeli population study
3472	low plasma 25(OH) vitamin D level
3473	risk of infection
3474	Mechanisms of disease
3475	Diseases
3476	Pollution
3477	RStudio Shiny framework
3478	Spatio-temporal analysis
3479	Weather variables
3480	age
3481	length of hospital stay
3482	respiratory support
3483	sex
3484	breast cancer
3485	low- and middle-income countries
3486	Mycobacterium tuberculosis vaccine
3487	TBC
3488	tuberculosis
3489	Coronavirus-19 (COVID-19)
3490	Human Immunodeficiency Virus (HIV)
3491	ICU-acquired weakness
3492	chronic pain
3493	critical care
3494	post-intensive care syndrome
3495	rehabilitation
3496	survivor
3497	LINCS
3498	Oxytocin
3499	Transcriptomic signature
3500	blood
3501	immune cells
3502	Coagulopathy
3503	Hypercoagulability
3504	LMWH
3505	Autoimmunity
3506	fatality
3507	infection rate
3508	arthritis, rheumatoid
3509	lupus erythematosus, systemic
3510	methotrexate
3511	tumor necrosis factor inhibitors
3512	ethics
3513	cost benefit
3514	health services research
3515	myeloma therapy
3516	SEIR model
3517	estimate
3518	healthcare personnel
3519	Clinical guideline
3520	Literature review
3521	Literature survey
3522	Review
3523	pilot project
3524	treatment outcome
3525	Virus-host relationship system
3526	Genetic variant
3527	TLRs
3528	GeneSoC
3529	antigenic drift
3530	diversifying selection
3531	Acute Stroke
3532	Stroke protocol
3533	organ involvement
3534	pathophysiology
3535	renin-angiotensin-aldosterone system (RAAS)
3536	Immunological assay
3537	Lab diagnosis
3538	2019 novel coronavirus diseases(SARS-CoV-2)
3539	determination methods
3540	CpG motif
3541	Phosphorothioate oligonucleotides
3542	Cesarean delivery
3543	Neonatal outcome
3544	Vaginal delivery
3545	antibody response
3546	high titre
3547	neutralising antibodies
3548	symptomatic infection
3549	sputum specimens
3550	throat swabs
3551	early childhood caries
3552	infection control
3553	minimally invasive
3554	gene editing
3555	laboratory diagnosis
3556	laboratory testing
3557	complete blood count
3558	emergency department
3559	swab test
3560	ABO
3561	isoagglutinins
3562	natural products library
3563	cancer/malignancy/neoplasia
3564	clinical decision-making
3565	clinical research/practice
3566	diagnostic techniques and imaging
3567	infection and infectious agents - viral
3568	liver transplantation/hepatology
3569	organ procurement and allocation
3570	risk assessment/risk stratification
3571	Coronavirus management algorithm
3572	Precision medicine
3573	medical education
3574	otolaryngology residency
3575	residency applicant
3576	 Tinospora cordifolia 
3577	berberine
3578	β-sitosterol
3579	influenza vaccination
3580	nasopharyngeal swab testing
3581	pneumococcal vaccination
3582	web-based survey
3583	ACOG, American College of Obstetrics and Gynecology
3584	AFPS, American foundation for patient safety
3585	AGP, Aerosol generating procedures
3586	ASA, American Society of Anesthesiology
3587	CDH, Congenital diaphragmatic hernia
3588	COVID-19, Coronavirus 2019
3589	FETO, Fetoscopic endoluminal tracheal occlusion
3590	Fetal intervention
3591	GA, General anesthesia
3592	IFMSS, International Fetal Medicine and Surgery society
3593	LUTO, lower urinary tract obstruction
3594	MAC, Monitored anesthesia care
3595	NAFTNet, North American Fetal Therapy Network
3596	OR, Operating room
3597	SMFM, Society for Maternal and Fetal Medicine
3598	TAPS, Twin anemia polycythemia sequence
3599	TTTS, Twin to twin transfusion syndrome
3600	WHO, World health organization
3601	fetal anomalies
3602	qRT-PCR, Quantitative real time polymerase chain reaction
3603	artificial feeding
3604	birth
3605	breast-feeding
3606	caesarean
3607	disambiguation
3608	duplicate publication
3609	isolation
3610	neonatal infection
3611	3CL hydrolase
3612	multiepitope
3613	peptide vaccine
3614	donors and donation: donor evaluation
3615	health services and outcomes research
3616	organ allocation
3617	organ transplantation in general
3618	waitlist management
3619	beneficial microbes
3620	immunobiotics
3621	respiratory viral infections
3622	Pharmacodynamics
3623	Pharmacokinetics
3624	2019-Novel Coronavirus
3625	research ethics
3626	research on special populations
3627	coronavirus-2
3628	molecular diagnostic techniques
3629	real-time polymerase chain reaction
3630	Accessibility
3631	Accès
3632	Guidelines
3633	Recommandations
3634	Électroconvulsivothérapie
3635	Response
3636	protein-protein interaction analysis
3637	research and analysis methods
3638	Intrauterine fetal demise
3639	Maternal morbidity
3640	Maternal mortality
3641	Miscarriage
3642	Neonatal morbidity
3643	Neonatal mortality
3644	Preterm birth
3645	Chemiluminescence immunoassay (CLIA)
3646	Convalescent serum
3647	Enzyme-linked immunosorbent assay (ELISA)
3648	Lateral flow immunoassay (LFIA)
3649	Plaque reduction neutralization test (PRNT)
3650	Serology
3651	macrolide
3652	gastrointestinal symptoms
3653	heat
3654	thermal inactivation
3655	Antiviral treatment
3656	Fetal safety
3657	New coronavirus disease
3658	Virus susceptibility
3659	pre existing immunity
3660	Coronavirus infections
3661	Pneumonia, viral
3662	Radiomics, nomograms
3663	Thorax
3664	Tomography, x-ray computed
3665	Adult
3666	Epilepsy
3667	Pediatric
3668	Teleneurology
3669	Transcriptome
3670	Treatment drugs
3671	Virus-host co-adaptation
3672	PRT
3673	Pathogen reduction
3674	anticoagulation
3675	ethnicity
3676	race
3677	biological safety
3678	handheld system
3679	modular hospital
3680	Endoscopy
3681	Filtering mask
3682	Filtration
3683	Medical face mask
3684	Virus SARS-COV-2
3685	Blood transcriptomics
3686	Immune monitoring
3687	Repositioning
3688	Artificial Intelligence
3689	Biological Data Mining
3690	Machine Learning
3691	Lymphatic
3692	Vascular
3693	Vascular anomalies
3694	Vascular malformations
3695	Venous
3696	Head and neck oncology
3697	Head and neck surgery
3698	healthcare
3699	medical stuff
3700	Efficacy
3701	Lopinavir/ritonavir
3702	Randomized controlled clinical study
3703	Cytokine storm syndrome
3704	Hemophagocytic lymphohistiocytosis
3705	Macrophage activation syndrome
3706	tracheotomy
3707	Hospital preparation
3708	Trauma
3709	COVID-19
3710	airway
3711	time-out
3712	tracheostomy
3713	adult volunteers
3714	challenge model
3715	experimental challenge
3716	maternal outcomes
3717	neonatal outcomes
3718	obstetric outcomes
3719	Anosmia/hyposmia
3720	Olfactory dysfunction
3721	NMOSD
3722	Neuromyelitis optica spectrum disorder
3723	Laboratory diagnosis
3724	arbidol
3725	health professional
3726	primary prevention
3727	CNS
3728	cerebrovascular
3729	scoping review
3730	colonic microflora
3731	diarrhoeal disease
3732	Extracorporeal membrane oxygenation
3733	Intracranial hemorrhage
3734	Intraparenchymal hemorrhage
3735	Resource allocation
3736	Leukoaraiosis
3737	Leukoencephalopathy
3738	Microangiopathy
3739	Neurologic
3740	Respiratory protection
3741	exposure modeling
3742	personal protective equipment
3743	quantitative microbial risk assessment
3744	viral aerosol
3745	Antibody production
3746	Blood plasma
3747	Cross reactivity
3748	Proteins
3749	Specificity
3750	cancer intervention
3751	healthcare improvement and patient safety
3752	orthopaedic and trauma surgery
3753	paediatric oncology
3754	surgical oncology
3755	Hypothesis
3756	Loss of taste
3757	chemosensory dysfunction
3758	dysgeusia
3759	loss of smell
3760	COVID-19 [Supplementary Concept]  
3761	Lithotripsy
3762	spike protein, SARS-CoV-2 [Supplementary Concept]
3763	CAPR
3764	PAPR
3765	aerosol generating
3766	aerosol-generating procedures
3767	controlled air-purifying respirator
3768	elastomeric respirator
3769	high risk
3770	powered air-purifying respirator
3771	protection
3772	Cancer history, Independent risk factor
3773	Hydroxychloroquine + Lopinavir/Ritonavir
3774	Interferon-β 1a
3775	Interferon-β 1b
3776	COVID-19, SARS-CoV-2, Biosafety, Personal protective equipment.
3777	clonal haematopoiesis
3778	coronavirus 2
3779	economic
3780	ethical challenge
3781	orthopaedic
3782	revision arthroplasty
3783	total hip arthroplasty
3784	total knee arthroplasty
3785	Laparoscopic viral transmission
3786	Robotic surgery
3787	Smoke evacuation
3788	Viral transmission
3789	MCS
3790	thoracic transplant
3791	Business
3792	Industry
3793	pediatric otolaryngology
3794	Tracheostomy
3795	DNA-encoded chemical library
3796	focused DECL
3797	Algorithm
3798	personal protection equipment
3799	skull base surgery
3800	PPE
3801	cathlab readiness
3802	Immune plasma
3803	Accreditation Council for Graduate Medical Education Telehealth
3804	Competency
3805	Fellowship Program
3806	Pain Management
3807	Wellness
3808	aerosol
3809	bacteria
3810	debonding
3811	mouth rinse
3812	ultrasonic scaling
3813	head neck
3814	palliative care
3815	aerosols
3816	cloth filtration efficiency
3817	face masks
3818	facial coverings
3819	triboelectricity
3820	aerosol-generating procedure
3821	air changes per hour
3822	air handling
3823	environmental control
3824	environmental safety
3825	eye protection
3826	high-risk aerosol
3827	oropharyngeal swab
3828	planning
3829	respiratory protection
3830	rhinologic
3831	rhinology
3832	testing
3833	visit planning
3834	lymphatic
3835	triage
3836	vascular
3837	vascular anomalies
3838	vascular malformations  
3839	venous
3840	head and neck cancer
3841	patient management
3842	Convolutional neural network
3843	Deep learning
3844	Ensemble
3845	Iterative pruning
3846	case selection
3847	pediatric cardiology
3848	bedside cannulation
3849	perfusion
3850	IL6
3851	Tocilizumab
3852	interleukin
3853	Critical Care
3854	Multidisciplinary Team
3855	Personal Protective Equipment
3856	treatment delay / IVF / live birth outcomes / COVID-19 / SARS-CoV-2 / coronavirus / outcomes / diminished ovarian reserve / treatment cycle suspension / cycle cancellation
3857	N95 respirators
3858	masks
3859	Phase 1
3860	Corona
3861	Optimization
3862	Population kinetics
3863	Prediction
3864	clinical outcomes
3865	disparity
3866	male
3867	Epidemiological investigation
3868	Knowledge graph
3869	Platform
3870	 Ascorbic Acid
3871	 Coronavirus disease
3872	 Severe Acute Respiratory Syndrome Coronavirus 2
3873	 Systematic Review
3874	 Vitamin C
3875	Clostridioides difficile infection
3876	Shiga toxin–producing Escherichia coli
3877	fecal microbiota transplant
3878	microbiome
3879	crisis
3880	drug costs
3881	drugs, generic
3882	off-label use
3883	anticoagulants
3884	sepsis
3885	thromboembolism
3886	fair participant selection
3887	human subjects research
3888	lottery Iyer
3889	Medical research
3890	Research management
3891	clinical practice guidelines
3892	new case
3893	predictor
3894	social media
3895	CT scan image
3896	Fused feature vector
3897	KNN classifier
3898	Segmentation and detection accuracy
3899	Antimicrobial resistance
3900	Global health
3901	Targeted hygiene
3902	key interacting residues
3903	pharmacophore modeling
3904	Chimeric antigen receptor T cells
3905	heart transplantation
3906	pediatrics
3907	minimally invasive surgeries (MIS)
3908	pneumoperitoneum
3909	Antivirals
3910	Generative Topographic Mapping
3911	Structure-Activity Relationships
3912	chemography
3913	cardiovascular anti-inflammatory therapy
3914	cardiovascular impairment
3915	assessment
3916	change
3917	innovation
3918	resilience
3919	selection
3920	teaching and learning
3921	technology
3922	workplace learning
3923	Undergraduate
3924	staff workload
3925	Laparoscopic surgery
3926	MIS
3927	Seraph-100
3928	extracorporeal sorbent hemoperfusion
3929	vasopressor
3930	Bonferroni mean operator
3931	antivirus mask selection
3932	multi-criteria decision-making
3933	spherical normal fuzzy set
3934	meningitis
3935	neurology
3936	seizure
3937	Aerosol exposure
3938	Electrocautery
3939	Laparoendoscopy
3940	Surgery protocols
3941	public health ethics
3942	right to healthcare
3943	surgery
3944	family medicine
3945	general practice
3946	health care costs
3947	rural health
3948	Hospital
3949	Wastes
3950	mass production
3951	Hypersensitivity pneumonitis
3952	influenza virus
3953	admissions
3954	enrollment management
3955	graduation
3956	orientation
3957	pharmacy recruitment
3958	Daily readout
3959	Residents
3960	Cholesteatoma
3961	Safety precautions
3962	Breast cancer
3963	Coronavirus pandemic
3964	Racial disparities
3965	Hand sanitizer
3966	Surface disinfectant
3967	High priority
3968	Major cancer surgery
3969	2019 novel coronavirus disease (COVID-19)
3970	artificial intelligence (AI)
3971	big data
3972	nature-inspired computing (NIC)
3973	Adult Psychiatry
3974	Adults
3975	Mental Health
3976	Public Health Nursing
3977	Young
3978	adult psychiatry
3979	Gastrointestinal and Liver Manifestations
3980	viral disease
3981	Childbirth
3982	Systematic scoping review
3983	chronic lymphocytic leukemia
3984	Poor outcome
3985	Radiomics
3986	ADHD
3987	Bien-être
3988	Enfants
3989	Famille
3990	Family
3991	School
3992	TDAH
3993	École
3994	Angiosuite
3995	Interventional radiology
3996	anaesthesia
3997	difficult airway
3998	intubation
3999	 Antivirals
4000	 Lopinavir
4001	 Lopinavir/ritonavir
4002	 Severe acute respiratory syndrome coronavirus 2
4003	 Systematic review
4004	laryngoscopy
4005	Lopinavir/ritonavir and Lianhua Qingwen
4006	Ribavirin
4007	Umifenovir
4008	evidence-based Chinese medicine
4009	methodology
4010	new public health emergencies
4011	Novel coronavirus; Coronavirus disease 2019 (COVID-19); 2019 novel coronavirus (2019-nCoV); Disinfection; Gastrointestinal endoscopy; Infection prevention and control
4012	compliance to guidelines
4013	crisis management
4014	economical threat
4015	online survey
4016	perception
4017	risk
4018	source of information credibility
4019	spokesperson credibility
4020	 MERS, ARDS
4021	 anxiety
4022	 depression
4023	 exercise tolerance
4024	 fatigue
4025	 follow-up
4026	 follow-up studies
4027	 lung function
4028	 post-traumatic stress disorder
4029	 prevalence
4030	 quality of life
4031	coronavirus infection
4032	healthcare workers
4033	silent carrier
4034	Diagnosis and treatment strategy
4035	Esophageal neoplasms
4036	continuous renal replacement therapy
4037	renal failure
4038	Covid-19 epidemic
4039	resources
4040	epidemic logistics
4041	epidemic outbreak
4042	medical waste
4043	network design
4044	operations research
4045	reverse logistics
4046	arrhythmia management
4047	cardiac electrophysiology
4048	General surgery
4049	Impact of COVID-19 on training programs
4050	Surgical oncology
4051	Virtual interviews
4052	Medical ethics
4053	Rationing
4054	Spine surgery
4055	CD3(+) T cells
4056	CD4(+) T cells
4057	CD8(+) T cells
4058	decision making
4059	extracorporeal membrane oxygenation
4060	ventilation
4061	Sézary syndrome
4062	cutaneous lymphoma
4063	high-risk
4064	mycosis fungoides
4065	Chemotherapy
4066	Rectal cancer
4067	Bariatric surgery
4068	hematopoietic stem cell transplantation
4069	oncologist
4070	online testing
4071	participants
4072	developing countries
4073	plasmapheresis
4074	Clinical Research
4075	Clinical Trials
4076	External Validity
4077	Underserved Minorities
4078	reperfusion
4079	workflow
4080	medical ethics
4081	resource allocation
4082	Covid-19 vascular guidelines
4083	arteriovenous fistula
4084	catheters
4085	dialysis access
4086	economics and health services
4087	ethics and end-of-life issues
4088	pre-dialysis patients
4089	clotting factor concentrates
4090	direct oral anticoagulants
4091	emicizumab
4092	hemophilia
4093	Controlled human infection model
4094	Public consultation
4095	SARSCoV2
4096	Cancer care
4097	Oncological surgery
4098	ACLF
4099	APASL
4100	CLD
4101	DDLT
4102	Guidance
4103	Hepatology
4104	LDLT
4105	Liver injury
4106	clinical care
4107	imaging/CT MRI etc
4108	Liver transplantation
4109	donors and donation: donor-derived infections
4110	Patient surge
4111	Sharing a ventilator
4112	Affinity column prepared immunoglobulins
4113	COVID 19 antibodies
4114	Convalescent plasma derived preparation
4115	Cryoppt-depleted plasma sup
4116	Pathogen inactivation
4117	Plasmapheresis FFP
4118	QT interval
4119	sudden cardiac death
4120	Anaesthesia
4121	Mechanical ventilators
4122	thyroid cancer
4123	thyroid surgery and surveillance
4124	Aortic stenosis
4125	Surgical aortic valve replacement
4126	Transcatheter aortic valve replacement
4127	MitraClip
4128	TAVR
4129	structural heart disease
4130	health care delivery
4131	hemangiomas/vascular tumors
4132	therapy-systemic
4133	Beliefs
4134	Facebook
4135	Knowledge
4136	Methodology
4137	Practices
4138	Social media
4139	COVID-19, SARS-CoV2, oncology, clinical trials
4140	Survey reliability
4141	online surveys
4142	Biological protection
4143	Cardiologie nucléaire
4144	Médecine nucléaire
4145	Nuclear cardiology
4146	Nuclear medicine
4147	Protection biologique
4148	interleukin-1
4149	pneumonia, viral
4150	Neonates
4151	Protection
4152	Recommendation
4153	Surgical management
4154	ABCDEF bundle
4155	agitation
4156	delirium
4157	intensive care
4158	ischemic
4159	neurointervention
4160	Arogya Setu app
4161	combined content analysis
4162	mHealth
4163	technology acceptance
4164	asymptomatic course
4165	comorbidities
4166	population adaptation
4167	viral co-infections
4168	Herd immunity
4169	Human population adaptation
4170	Lung remodeling
4171	UV
4172	exaggerated information
4173	healthcare system stress
4174	misallocation of resources
4175	social panic
4176	host antiviral response
4177	ACC, Auto Cross-Covariance
4178	Allergenicity
4179	CAI, Codon Adaptation Index
4180	Epitopic vaccine
4181	Inflammatory response
4182	NMA, Normal Mode Analysis
4183	TLR, Toll-like receptor
4184	coronavirus disease (COVID-19)
4185	stress
4186	evolutions
4187	seroepidemiologic
4188	study design
4189	Acute respiratory distress
4190	High-altitude hypoxia
4191	Hypoxic acclimatization
4192	Respiratory system
4193	Silent hypoxemia
4194	Molecular divergence
4195	Spillover
4196	Zoonotic transmission
4197	Performance assays
4198	Serological assays
4199	Embryos
4200	Human reproductive system
4201	Ovary
4202	Semen
4203	Testes
4204	Uterus
4205	Ageusia
4206	Ear nose and throat [MeSH]
4207	Cirugía electiva
4208	Cirugía oncológica
4209	Oncologic surgery
4210	Bone tumor
4211	Orthopedic department
4212	Traumatology
4213	IVF laboratory
4214	new adaptations
4215	Facemask
4216	Gloves
4217	Heat-health warning system
4218	Heat-stress
4219	ECT
4220	Healthcare system
4221	Impacto socioeconómico
4222	Pandemias
4223	Salud pública
4224	Sistema de Salud
4225	Socioeconomic impact
4226	low-resource health care settings
4227	planetary health
4228	Polysomnography
4229	Sleep medicine
4230	Sleep-related respiratory disorders
4231	antiviral treatment
4232	low-dose corticosteroid
4233	risk-adapted treatment strategy
4234	Carcinoma decélulas renales
4235	Clear cell carcinoma
4236	Cáncer renal
4237	Renal cancer
4238	adaptability to change
4239	design
4240	general population
4241	Loss adaptation
4242	Loss and grief
4243	Mental and physical health
4244	prolonged grief disorder (PGD)
4245	Clinical trials unit
4246	Surgical Research
4247	older individuals
4248	Adolescents
4249	Behaviors
4250	Physical activity
4251	Screens
4252	Sedentary lifestyle
4253	Institutional psychotherapy
4254	Teleconsultation
4255	Therapeutic setting
4256	Neuromuscular
4257	HIV care continuum
4258	PEPFAR
4259	readiness
4260	response
4261	Emergency care
4262	Hygiene control measures
4263	Maximum care clinics
4264	SARS-CoV-2 pandemic
4265	Standard operating procedures (SOP)
4266	clinical pathway
4267	risk management
4268	Malaysia
4269	community health
4270	emerging infectious diseases
4271	homelessness
4272	public health practice
4273	minimally invasive surgery
4274	paediatrics, paediatric emergency medicine
4275	haemoglobinopathies
4276	thalassaemia
4277	dentistry
4278	Breast surgery
4279	Radiation therapy
4280	Colorectal disease
4281	Colorectal surgery
4282	COVID-19/SARS-CoV-2
4283	high-risk groups
4284	patient-centered approach
4285	Adolescent
4286	Allergy
4287	Child
4288	Immunologic disease
4289	orthopedics
4290	Aerosols
4291	Surgical smoke evacuation
4292	Burnout
4293	Grief
4294	Mindfulness
4295	Physician wellness
4296	Social distancing
4297	alcohol
4298	mentoring
4299	research lab
4300	social distancing
4301	Organ failure
4302	Respiration, artificial
4303	SARS-CoV‑2
4304	Food safety
4305	Foodborne diseases
4306	Resilience
4307	Second wave
4308	Coronavirus 2 (SARS-CoV-2)
4309	Food security
4310	Acceptance
4311	Contingent valuation
4312	Health economics
4313	Laparoscopy
4314	Viral contamination
4315	adolescents
4316	digital
4317	digital medicine
4318	interventions
4319	mobile health
4320	pediatric
4321	telehealth
4322	3D printing
4323	allergy
4324	biologics
4325	immunodeficiency
4326	Dementia
4327	Demenz
4328	Pandemie
4329	caregivers
4330	pflegende Angehörige
4331	Autism
4332	Equity
4333	Health services
4334	Telehealth
4335	care safety
4336	nursing homes
4337	detraining
4338	injury
4339	performance
4340	powerlifting
4341	resistance training
4342	weightlifting
4343	radiology
4344	guidelines as topic
4345	athletes
4346	team sports
4347	training
4348	Gastrointestinal
4349	Risk-mitigation
4350	psychological support strategies
4351	self-help strategies
4352	gero-pandemic
4353	géro-pandémie
4354	older adults
4355	personnes âgées
4356	résilience
4357	vieillissement
4358	vulnerability
4359	vulnérabilité
4360	Resuscitation
4361	Stroke code
4362	Systems of care
4363	COVID-19 diagnostic testing [Supplementary Concept]
4364	Outpatients
4365	ISOPP
4366	oncology pharmacy
4367	pharmacist
4368	OAT
4369	Opioid agonist therapy
4370	Opioid user
4371	Remote health
4372	clinical skills
4373	healthcare providers
4374	implementation
4375	interpersonal skills
4376	qualitative research
4377	video consultation
4378	Drug–drug interactions
4379	Psychiatric comorbidity
4380	Psychopharmacology
4381	frailty
4382	polypharmacy
4383	remote consultation
4384	workload
4385	anxiety
4386	coronavirus disease-2019 (COVID-19)
4387	mindfulness meditation
4388	Community-hospital-community transmission
4389	Fomite transmission
4390	Traffic control bundling
4391	eTCB
4392	bioethics
4393	end of life
4394	principle of justice
4395	Alcohol use
4396	Heavy drinking episodes
4397	Mental health
4398	Negative coping styles
4399	Post-traumatic stress disorder
4400	Mental wellbeing applications
4401	PTSD
4402	Netflix
4403	coping
4404	infodemic
4405	information and communication technologies
4406	media
4407	social network
4408	survey
4409	Older people
4410	Sub-Saharan Africa
4411	cognitive coping
4412	emotional distress
4413	stress perception
4414	ageism
4415	intergenerational solidarity
4416	older persons’ rights
4417	policy
4418	access to care
4419	body image
4420	eating disorders
4421	risk and protective factors
4422	Outcome-based
4423	postgraduate
4424	Bereavement
4425	death and dying
4426	infectious disease outbreak
4427	psychosocial responses
4428	2019 novel coronavirus disease
4429	Exposure
4430	Medical and nursing staff
4431	Mental healthcare
4432	entrepreneurial intention
4433	optimism
4434	proactiveness
4435	psychological need satisfaction
4436	well-being
4437	employment
4438	food access
4439	food security
4440	physical activity
4441	psychosocial competences
4442	teaching
4443	university students
4444	COVID-19 impact
4445	surgeons
4446	education & training (see medical education & training)
4447	quality in health care
4448	experiential education
4449	compulsive sexual behaviors
4450	pornography
4451	gaming disorder
4452	psychological impact
4453	spiritual care
4454	lockdown
4455	LGBT
4456	health belief
4457	sexual minority
4458	Coping strategies
4459	Psychological impact
4460	confidence
4461	information
4462	internet
4463	online health information
4464	cross-sectional survey
4465	medical staff
4466	psychology
4467	Anxiety
4468	Anxiété
4469	Dépression
4470	Health personnel
4471	Professionnels de santé
4472	Santé mentale
4473	Trouble de stress post-traumatique
4474	Epidemic outbreak
4475	Nurse
4476	Psychological experience
4477	Qualitative study
4478	determinants
4479	health crisis
4480	panic buying
4481	purchasing behaviour
4482	emerging adulthood
4483	youth
4484	behavior
4485	cyberchondria
4486	information overload
4487	protection motivation theory
4488	self-isolation
4489	Post-Traumatic Stress Symptoms (PTSS)
4490	depression
4491	insomnia
4492	2019 Novel coronavirus
4493	health workers
4494	addiction
4495	screen time
4496	e-learning
4497	wellbeing
4498	COVID -19
4499	Online survey
4500	headache
4501	trainees
4502	Surface water
4503	Suspended particulate matter
4504	Turbidity
4505	Water quality
4506	cell signalling pathways
4507	comorbidities.
4508	microRNAs (miRs 8066, 5197, 3611, 3934-3p, 1307-3p, 3691-3p, 1468-5p)
4509	viral pathogenesis
4510	nanopore sequencing
4511	targeted amplification
4512	primer design
4513	quantitative nucleic acid testing
4514	virus genome
4515	FFPE
4516	Molecular testing
4517	SARS-CoV-2; Coronavirus
4518	Viral sequencing
4519	nCov-19
4520	2019-nCov
4521	3CL-pro
4522	M-pro
4523	chymotrypsin-like protease
4524	Angiotensin-converting enzyme 2
4525	Monitoring/mutations
4526	Neutralization tests
4527	Nucleic acid amplification techniques
4528	angiotensin-converting enzyme-II
4529	CD147
4530	lung cancer
4531	Russia
4532	next generation sequencing (NGS)
4533	staff
4534	Cross-reactivity
4535	Cytokines
4536	Disease association
4537	MHC binding
4538	Peptides
4539	T-cells
4540	Viral variants
4541	live-attenuated vaccine
4542	combinatorial optimization
4543	haplotype
4544	major histocompatibility complex
4545	population coverage
4546	vaccine augmentation
4547	vaccine evaluation
4548	E protein Inhibitors
4549	envelope protein (E)
4550	therapeutic targets
4551	Founder effect
4552	SNVs
4553	Viral genetic drift
4554	SARS-CoV-2 Spike
4555	Superantigen
4556	Toxic shock syndrome
4557	Spike S1/S2 mutant
4558	Spike mutant
4559	gene expression
4560	genetic networks
4561	genetic variability
4562	ethnic variation
4563	diarrhoea
4564	Pan-Family Assays
4565	Viral Screening
4566	PRRT2 mutations
4567	afebrile seizures
4568	benign familial infantile epilepsy
4569	non-febrile seizures
4570	pediatric COVID-19
4571	Treatment strategies
4572	Reverse transcription-polymerase chain reaction
4573	Specific primer
4574	conserved high free energy sites
4575	spike glycoprotein backbones
4576	animal
4577	Incidence
4578	autopsy
4579	COVID-19 Mpro 
4580	calendula officinals
4581	molecular simulation
4582	Porcine epidemic diarrhea virus
4583	RNA methylation
4584	AGEs
4585	Glycolysis
4586	omeprazole
4587	triosephosphate isomerase
4588	Asian Indian
4589	Ethnicity
4590	South Asia
4591	4,4′-diaminodiphenyl sulfone (dapsone)
4592	AD
4593	Alzheimer’s disease
4594	DDS
4595	LL
4596	MADDS
4597	MPO
4598	NACHT, LRR and PYD domains-containing protein 3
4599	NLRP3
4600	TLR
4601	lepromatous leprosy (also known as Hansen’s disease)
4602	monoacetyldapsone
4603	myeloperoxidase
4604	vaccination
4605	bioterrorism
4606	plasma proteins
4607	RNA 3′-terminal adenylyltransferase
4608	replication
4609	E protein
4610	Golgi
4611	oligomers
4612	pH
4613	viroporin
4614	CO(2) and NO(2) emissions
4615	Environmental regeneration
4616	Pollution and wildlife
4617	Self nurturing nature
4618	Social lockdown
4619	Clinical characteristics
4620	Liver function
4621	Risk factor
4622	RNA virus infections
4623	Virus diseases
4624	Human coronaviruses
4625	Interferons
4626	Interleukin
4627	management
4628	puerperium
4629	mouse model
4630	receptor-binding domain (RBD)
4631	Avian coronaviruses
4632	mammalian coronaviruses
4633	poultry
4634	wild birds
4635	food safety
4636	meat
4637	(+) ssRNA viruses
4638	Key-words: replicon systems
4639	direct-acting antivirals
4640	cryo-TEM
4641	gene therapy
4642	lipid nanoparticles
4643	mRNA delivery
4644	Uganda
4645	codon bias
4646	genomic diversity
4647	Chile
4648	Clinical Manifestations
4649	Genomic Epidemiology
4650	Latin America
4651	COVID-19 diagnostic testing
4652	Next-generation sequencing
4653	asymptomatic SARS-CoV-2 infection
4654	community-based SARS-CoV-2 testing
4655	ethnic disparities
4656	shelter-in-place
4657	gene E
4658	gene N
4659	gene RdRp
4660	molecular diagnosis
4661	DNA methylation
4662	X-linked genes
4663	histone PTMs
4664	virus infection
4665	infectious clone
4666	nasal infection
4667	primary cells
4668	reporter virus
4669	respiratory tropism
4670	case/control studies
4671	disease association
4672	disease association studies
4673	histocompatibility
4674	human leucocyte antigens
4675	MHC class I
4676	Data privacy
4677	Fecal-oral transmission
4678	Health management
4679	Wastewater surveillance
4680	Abbott ID NOW
4681	EUA
4682	nasopharyngeal
4683	COVID-19; SARS-CoV-2; Transmission; Therapeutic options; Antiviral therapies
4684	nomenclature
4685	Nucleic acid test
4686	Positive rate
4687	differential diagnosis
4688	rapid molecular assay
4689	respiratory pathogens
4690	patient isolation
4691	review literature as topic
4692	survival analysis
4693	host entry machinery
4694	Psychiatric
4695	Computational biology
4696	HLA-I binding prediction
4697	HLA-II binding prediction
4698	SARS-CoV-2 T cell epitopes
4699	T cell assay
4700	Vaccine design
4701	lung development
4702	ARBs (angiotensin II receptor blockers)
4703	NSAIDs (non-steroidal anti-inflammatory drugs)
4704	PheWAS
4705	real-time fluorescence PCR
4706	reverse transcription
4707	bioinformatic analysis
4708	eQTLs
4709	Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pathogenesis; Epidemiology; Prevention and management
4710	genetic
4711	respiratory tract infection
4712	single nucleotide polymorphism
4713	Bolivia
4714	Real-time RT-PCR
4715	severe acute respiratory syndrome-related coronavirus 2
4716	prediction model
4717	Hub
4718	Public Health England
4719	UK Biobank
4720	bugbank
4721	database linkage
4722	Protein–protein interactions
4723	Virus-host interactions
4724	nested RT-PCR
4725	novel coronavirus 2019
4726	Mexico
4727	health literacy
4728	Diagnostic
4729	Loop mediated isothermal amplification (LAMP)
4730	Polymerase chain reaction (PCR)
4731	preventive strategies
4732	psychological distress
4733	psychiatry
4734	psychopathological symptoms
4735	adipose-derived mesenchymal stem/stromal cells
4736	Arrhythmia
4737	ECG
4738	QT
4739	Torsades de pointes
4740	Geographic distribution
4741	Incidence and case-fatality rates
4742	Texas
4743	Han population
4744	allele frequency
4745	coronavirus disease-2019
4746	Body mass index
4747	Central obesity
4748	GWAS
4749	Hospitalization
4750	Polygenic risk score
4751	Fibrinolysis
4752	Lipoprotein(a)
4753	HCT
4754	Pharmacist
4755	Pharmacy
4756	quarantine
4757	Absolute humidity
4758	Ambient temperature
4759	Diurnal temperature range
4760	Population migration
4761	clinical decision support
4762	cloud system
4763	medical informatics
4764	stakeholders involvement
4765	syndromic surveillance
4766	adolescent
4767	athletic injuries
4768	brain concussion
4769	child
4770	sports injuries
4771	birth defects
4772	birth defects registry
4773	Google Trends
4774	infoveillance
4775	internet activity
4776	airborne
4777	cross-species spread
4778	live animal markets
4779	Japan
4780	corona
4781	algorithm
4782	hybridization chain reaction
4783	in silico
4784	lagomorphs
4785	virus–receptor complex
4786	B-cell epitopes
4787	T-cell epitopes
4788	gene structure
4789	pathogenic mechanisms
4790	potential therapeutic targets
4791	protein function
4792	lopinavir/ritonavir
4793	Düsseldorf
4794	Heinsberg
4795	artic
4796	nanopore
4797	superspreading
4798	Nsp9 replicase
4799	drug designing
4800	fusion inhibitor
4801	lipopeptide
4802	membrane fusion
4803	FDA approved drugs
4804	Main protease (Mpro) inhibitor
4805	UCSF Chimera
4806	structure-based drug design (SBDD)
4807	blind docking
4808	docking simulations
4809	pocket druggability
4810	pocket search
4811	marine natural product
4812	3CL(pro) inhibitor
4813	Antiviral targeting site
4814	RNA binding domain
4815	principal component analysis
4816	quantitative structure-activity relationship
4817	2-O-methyltransferase
4818	NSP12-NSP7-NSP8
4819	drug candidates
4820	Peptidomimetics
4821	Formulation
4822	Physicochemical properties
4823	serine protease
4824	Antigenicity
4825	SAXS
4826	Structure and function
4827	Chemical reactivity
4828	Coumarin derivative
4829	Interaction SARS-CoV-2/Mpro-LTA
4830	Thermodynamic properties
4831	global reactivity
4832	molecular dynamincs simulation
4833	Cardiovascular complications
4834	hematopathologic effect
4835	immune therapy
4836	HCV protease inhibitors
4837	a-thrombin inhibitors
4838	RNA replication
4839	Host range
4840	Chinese herbal medicines
4841	Therapeutic agents
4842	Biological characteristics
4843	Spike protein Pro330-Leu650
4844	DRUDIT web service
4845	HIV-protease
4846	NADH
4847	SARS-CoV-2 main protease
4848	SARS-CoV-2 (2019-nCoV)
4849	nucleic acid testing
4850	serological testing
4851	specimen collection
4852	Blocking peptide
4853	Missense
4854	peptide inhibitors
4855	ADMET
4856	anthocyanin derivatives
4857	docking workflow
4858	Aerosol generating procedure
4859	Aerosolisation
4860	Bronchoscopy
4861	Cell fusion
4862	Fusion protein
4863	Angiotensin Converting Enzyme 2 (ACE2)
4864	network topology
4865	scale-free network
4866	virus interactome
4867	Attachment inhibitor
4868	Ayurveda
4869	CAM (Complementary and Alternative Medicine)
4870	Natural products
4871	C30 endopeptidase
4872	Pharmacophore
4873	Therapeutic
4874	protein structures
4875	signaling pathway
4876	antivirus drugs
4877	fusion inhibitors; host proteases inhibitors
4878	Molecular dynamics simulations
4879	dynamics simulation
4880	immune simulation
4881	multi-epitope vaccine
4882	B-cell and T-cell epitopes
4883	ARB
4884	SARI
4885	laboratory infection
4886	3a protein
4887	nonsynonymous mutations
4888	antibody/cryogenic electron microscopy structure/crystal structures/epitope prediction/glycopeptide/SARS-CoV-2
4889	▪▪▪
4890	Editorial
4891	SARS-CoV spike glycoprotein
4892	binding sites
4893	bio-interface
4894	quartz crystal microbalance
4895	self-assembled monolayers
4896	surface modification
4897	therapeutic strategies
4898	single nucleotide polymorphisms
4899	3CLpro, 3-chymotrypsin-like protease
4900	M, membrane protein
4901	N, nucleocapsid protein
4902	Nsp, non-structure protein
4903	ORF, open reading frame
4904	PDB, protein data bank
4905	RdRp, RNA-Dependence RNA polymerase
4906	S, Spike
4907	SUD, SARS unique domain
4908	UB, ubiquitin-like domain
4909	Drug targets
4910	Re-purposing
4911	contact plot
4912	energetic mappings
4913	latch
4914	Coronavirus SARS-CoV-2
4915	Protein structure
4916	Viral fusion protein
4917	Drug design
4918	MolPort database
4919	E-pharmacophore
4920	Envelope
4921	bibliometrics
4922	scientometrics
4923	Silkworm-BmNPV expression system
4924	RBD and HR1 domain
4925	SARS-CoV-2 spike glycoprotein
4926	deleterious mutations
4927	time-varying reproduction number
4928	Homology modelling
4929	Molecular modelling
4930	Serine protease
4931	in silico molecular docking.
4932	Biosensor
4933	Electrochemical biosensor
4934	Optical biosensor
4935	Virus detection
4936	ORF1ab polyprotein
4937	United States of America
4938	mutational spectra
4939	SARS-CoV-2 
4940	anti-NCP
4941	Ritonavir
4942	3CLpro 
4943	cryptic pockets
4944	repurposing
4945	SARS-CoV-2 Mpro inhibition
4946	furoxan
4947	release
4948	self-assemble
4949	virus-like particles
4950	COVID-19, SARS-CoV-2
4951	Consensus Scoring
4952	Drug Repurposing
4953	Quantum Mechanical Scoring
4954	SARS-CoV-2 inhibitors
4955	quantum chemical calculations
4956	repositioning antiviral drugs
4957	specific antiviral drugs
4958	Conjunctivitis
4959	Coronavirus Infections
4960	Eye Diseases
4961	Ophthalmology
4962	GRP78
4963	Sequence analysis
4964	Behaviour Change Wheel
4965	rapid response
4966	corona virus disease-2019 (COVID-19
4967	novel coronavirus (nCoV)
4968	novel coronavirus main protease (SARS-CoV-2 Mpro)
4969	antiretroviral agents
4970	clinically approved drugs
4971	3D-QSAR
4972	pyridine N-oxide
4973	Spike Protein
4974	Corona virus disease 2019
4975	Phase III clinical trial
4976	Crystallography
4977	Molecular Structure
4978	3D Structures
4979	Cavity Search
4980	hydrolysable tannins
4981	main 3-chymotrypsin-like cysteine protease
4982	structural-relationship activity
4983	epitope switch
4984	unfolded protein response
4985	structure-guided drug discovery
4986	viral proteases
4987	Food
4988	Lactoferrin
4989	Protein
4990	immuno-informatics
4991	interferon - gamma and lymphocytes
4992	Novel Coronavirus
4993	hotspots
4994	molecular dynamic simulations
4995	protein interactions
4996	Alanine scanning
4997	DCCM
4998	Free energy calculations
4999	Nucleocapsid Phosphoprotein
5000	Repurposing drugs
5001	Spike proteins
5002	Zoonotic origin
5003	Computational drug repurposing
5004	encephalopathy
5005	neuroinvasive property
5006	MERS-CoV S1
5007	Microneedle array
5008	Subunit vaccines
5009	Trimerization
5010	FDA approved drug
5011	structural–activity relationship
5012	Binding energy
5013	Ethnomedicine
5014	Endolysosome
5015	de-acidification
5016	disease outbreaks
5017	pandemia
5018	surge capacity
5019	case fatality
5020	dipeptidyl-peptidase IV inhibitors
5021	metabolic syndrome
5022	严重急性呼吸综合征冠状病毒2型
5023	二肽基肽酶IV抑制剂
5024	代谢综合征
5025	新冠肺炎
5026	病例死亡
5027	Point-of-care testing
5028	acute respiratory distress syndrome (ARDS)
5029	coronavirus disease; COVID-19; SARS
5030	Lichen COMPOUNDS
5031	SARS-2-CoV
5032	computational chemistry
5033	arterial stiffness
5034	biosurfactants
5035	cleaning products
5036	drug delivery
5037	handwash
5038	soap
5039	RNA genome
5040	S-adenosylmethionine
5041	methioninase
5042	methionine restriction
5043	methyltransferase
5044	Malayan pangolins
5045	metagenome assembly
5046	Echocardiography
5047	Mechanical
5048	Ultrasonography
5049	Ventilators
5050	Protein homology modelling
5051	Anti-Viral drugs
5052	Drug Repositioning
5053	Virtual Screening
5054	Computational Drug Discovery
5055	Target Proteins
5056	mask
5057	Theophylline
5058	main protease enzyme coronavirus
5059	noscapine conjugates
5060	double hit effect
5061	hybrid drugs
5062	oleanolic acid
5063	D3Targets-2019-nCoV
5064	Multi-conformation
5065	Multi-site
5066	Target prediction
5067	African Americans
5068	novel SARS-CoV-2
5069	Amazonia
5070	Indigenous people
5071	Metapopulation dynamics
5072	One-Ecohealth
5073	SIR model
5074	anthraquinone
5075	flavonoids
5076	peptide mass fingerprinting
5077	Foam
5078	Gel
5079	Hand hygiene
5080	UVC
5081	inactivation
5082	irradiation
5083	antiviral therapies
5084	Limonoids
5085	Triterpenoids
5086	BCG vaccination
5087	correlation data
5088	severity variation
5089	Vitamins
5090	MD Simulations
5091	translational science
5092	2D-QSAR
5093	3CLpro enzyme
5094	MLR
5095	docking and virtual screening
5096	AML, acute myeloid leukemia
5097	CCC, cut countercurrent chromatography
5098	CD11b, integrin alpha M
5099	CD14, cluster of differentiation 14
5100	CD86, cluster of differentiation 86
5101	COVID-19, coronavirus disease
5102	Cancer therapy
5103	CoREST, RE1-silencing transcription factor co-repressor
5104	EMT, epithelial–mesenchymal transition
5105	EVOO, extra virgin olive oil
5106	EdU, 5-ethynyl-20-deoxyuridine
5107	Epigenetic regulation
5108	FAD, flavin adenine dinucleotide
5109	FDA, U.S. Food and Drug Administration
5110	GGA, geranylgeranoic acid
5111	H3K4, histone H3 lysine 4
5112	H3K9, histone H3 lysine 9
5113	HDAC, histone deacetylase
5114	HRP, horseradish peroxidase
5115	Histone demethylase
5116	Kt, competitive inhibition constant
5117	LSD1 inhibitors
5118	LSD1, lysine-specific histone demethylase 1A
5119	MAO-A, monoamine oxidase A
5120	MHC, myosin heavy chain
5121	MMA, methylmalonic acid
5122	NAD, nicotinamide adenine dinucleotide
5123	NTRK2, neurotrophic receptor tyrosine kinase 2
5124	PDX, patient-derived xenograft
5125	SARs, structure–activity relationship studies
5126	SIRT1, sirtuin 1
5127	SOX2, sex determining region Y-box 2
5128	SPR, surface plasmon resonance
5129	TCP, tranylcypromine
5130	THF, tetrahydrofolate
5131	Tm, melting temperature
5132	iPS, induced pluripotent stem
5133	mRNA, messenger RNA
5134	siRNA, small interfering RNA
5135	ΔΨm, mitochondrial transmembrane potential
5136	α-MG, α-mangostin
5137	Severe Acute Respiratory Syndrome Coronavirus 2
5138	essential oils
5139	herbal medicines
5140	Built environment
5141	Exploratory Spatial Data Analysis (ESDA)
5142	GIS
5143	Socioeconomic status
5144	Mpro protease
5145	molecular docking analysis
5146	Middle East respiratory syndrome (MERS)
5147	Severe acute respiratory syndrome (SARS)
5148	Traditional medicine
5149	Community quarantine
5150	Traffic injury
5151	coronavirus pandemic
5152	epidemic safety
5153	organizational changes
5154	treatment in an infectious hospital
5155	Orthopaedic
5156	Pathways
5157	CTC
5158	South Korea
5159	community treatment center
5160	quarantine facility
5161	SEIR models
5162	disease outbreak scenarios
5163	social contact restrictions
5164	spatially explicit epidemiology
5165	computational simulation
5166	coronavirus Spike
5167	prediction of lead compounds
5168	structure-based docking
5169	cilia
5170	smell loss
5171	dental care
5172	cardiac critical care
5173	Endoribonuclease
5174	NSP15 inhibitors
5175	SAR
5176	biological applications
5177	chemistry
5178	quinoxaline
5179	Corona Virus
5180	Exponential Growth Model
5181	QSAR
5182	peptide-type compounds
5183	Graphene
5184	Nanocomposite
5185	ADAM10
5186	Adipose tissue
5187	Irisin
5188	TRIB3
5189	2019-nCoV or COVID-19 or SARS-CoV-2
5190	etiology
5191	antimicrobials
5192	SARS-CoV 2
5193	respiratory failure
5194	Docking simulation
5195	Interfering ligands
5196	Quaternary disassembly
5197	S glycoprotein
5198	Middle-East respiratory syndrome
5199	outbreaks
5200	Real-time PCR
5201	swine diarrhea virus
5202	BiP
5203	COVID-19 spike
5204	Pep42
5205	Protein-protein docking
5206	trophectoderm
5207	rapid review
5208	Active site prediction and MD simulation
5209	Phytocompounds
5210	RNA binding domain of nucleocapsid phosphoprotein
5211	antiviral and toxicity
5212	Repurpose
5213	Simeprevir
5214	combination therapy
5215	modelling
5216	viral cell cycle
5217	respiratory tract
5218	Airborne pathogens
5219	Biomicroscope
5220	Droplet projection
5221	Fluid-structure system
5222	3C- like protease
5223	Anti-viral agent.
5224	Anti-viral agent.Coronavirus
5225	Molecular Modelling
5226	Non-pharmaceutical interventions
5227	Physical distancing
5228	Infection prevention
5229	Obstetrical care
5230	CEACAM7
5231	CSF3
5232	DNAH7
5233	Respiratory cilia
5234	SARS-CoV(2)
5235	c8orf4
5236	Bayesian Optimization
5237	Deep Learning
5238	Rapid Diagnosis of COVID-19
5239	Laryngology
5240	Video visit
5241	Gargles
5242	Nasal spray
5243	Povidone iodine
5244	SARS CoV 2
5245	SARS Cov
5246	chest computed tomography
5247	chest radiograph
5248	lung ultrasound
5249	Genotype
5250	Phenotype
5251	Pathophysiology
5252	Host–pathogen interactions
5253	Lipid biosynthesis
5254	Membrane organization
5255	Virulence-associated lipids
5256	guidelines
5257	primary eye care
5258	vision cente
5259	Capacity
5260	Chest pain unit
5261	Closed pattern mining
5262	Nettree
5263	Nonoverlapping sequence pattern
5264	Periodic wildcard gaps
5265	Sequential pattern mining
5266	COVID-19 coronavirus infection
5267	medical rehabilitation
5268	physical methods
5269	combination drug delivery
5270	repurposed nanotechnology
5271	severe acute respiratory syndrome coronavirus 2 structure
5272	targeted therapeutics
5273	vaccine adjuvant nanoparticles
5274	vaccine nanocarriers
5275	age structure
5276	demography
5277	Age structure
5278	Hong kong
5279	Singapore
5280	BCG vaccination policy
5281	COVID-19 coronavirus
5282	cross-protection
5283	COVID-19, 2019-nCoV
5284	Wuhan Coronavirus
5285	psychometrics
5286	Mathematical modeling
5287	System dynamics
5288	pneumothorax
5289	respiratory medicine
5290	tropical medicine (infectious disease)
5291	geriatrics
5292	veteran
5293	chronic illness
5294	e-health
5295	Bio-based membranes
5296	Electrospinning
5297	Facemasks
5298	Gluten
5299	COVID-19 Federal Guidelines
5300	assisted living
5301	long-term care facilities
5302	new referrals
5303	outpatient consultation
5304	triaging
5305	characteristic
5306	content analysis
5307	health information dissemination
5308	official account
5309	regression model
5310	users’ information behavior
5311	B-lymphocytes
5312	adjuvants, immunologic
5313	interferon inducers
5314	urinary bladder neoplasms
5315	Medical Task Force
5316	Puerto Rico
5317	academic alliance
5318	self-efficacy
5319	assisted living facility
5320	long-term care
5321	CiteSpace
5322	visual analysis
5323	circadian disruption
5324	shiftwork
5325	sleep deprivation
5326	 Coronavirus, Signs, Symptoms, Diagnosis, Outpatient care.
5327	Health systems response
5328	Indigenous populations
5329	Minimally invasive autopsy
5330	Pathological conditions,anatomical
5331	Brescia
5332	nephrology
5333	transplants
5334	City lockdown
5335	Governmental action
5336	Individual reaction
5337	Mathematical modelling
5338	SWOT analysis
5339	 biosafety
5340	 designated health facility
5341	 infection prevention and control
5342	Biocontainment
5343	coresidence
5344	intergenerational contacts
5345	intergenerational relationships
5346	glycocalyx
5347	systemic disease
5348	filtering facepiece respirator
5349	gamma irradiation
5350	re-sterilization
5351	gene silencing
5352	microRNA
5353	pathways
5354	antibody test
5355	rapid diagnostic test (RDT)
5356	5-α reductase
5357	androgen receptor
5358	androgenetic alopecia
5359	antiandrogen therapy
5360	dutasteride
5361	finasteride
5362	human skin
5363	retinoids
5364	transmembrane protease serine 2
5365	Minas Gerais
5366	genomic surveillance
5367	southeast Brazil
5368	Quencher
5369	Vero
5370	complete genome sequencing
5371	NTNG1 gene
5372	haloperidol
5373	orf1b gene
5374	the UCSC Genome Browser
5375	kidney involvement; severe acute respiratory syndrome coronavirus 2; humen ACE2; genetic perspective
5376	nsp1
5377	External quality assessment
5378	Molecular test
5379	Standardisation
5380	coronavirus SARS-CoV-2
5381	polymerase chain reaction (PCR)
5382	primer–template mismatch
5383	sequence variation
5384	ORF1b gene
5385	massively parallel sequencing
5386	nasopharyngeal swab
5387	viral genome
5388	Saxifraga spinulosa
5389	medicinal herb
5390	pyrogallol-enriched fraction
5391	virus disinfectant
5392	molecular diagnostic testing
5393	serological diagnostic testing
5394	E-gene
5395	N2
5396	primer
5397	probe
5398	clinical manifestations
5399	genomic comparison
5400	pathogenic mechanism
5401	proteomic comparison
5402	antigen
5403	genome-wide association study (GWAS)
5404	human leukocyte antigen (HLA)
5405	polyomavirus
5406	transcriptome-wide association study (TWAS)
5407	Antiviral biomolecules
5408	Plant-based vaccines
5409	Synergistic effect
5410	antisense oligonucleotide
5411	gold nanoparticle
5412	hyperspectral imaging
5413	naked-eye detection
5414	replicase
5415	cats
5416	luminex
5417	next-generation sequencing
5418	Quantitative microbial risk assessment (QMRA)
5419	Virus detection method
5420	Wastewater-based epidemiology (WBE)
5421	Airborne
5422	Tehran
5423	nonstructural protein
5424	preferred codons
5425	gain-of-function
5426	serial passage
5427	coronavirus-infected pneumonia
5428	zoonotic pathogen
5429	Conjonctivite
5430	Larmes
5431	Ocular surface
5432	Surface oculaire
5433	Tears
5434	urine
5435	virus isolation
5436	Data stream
5437	Respiratory infection
5438	CGR
5439	mink
5440	Acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
5441	Fecal specimens
5442	Novel coronavirus disease 19 (COVID-19)
5443	Respiratory specimens
5444	SARS-CoV-2 viral RNA
5445	Aptima
5446	TMA
5447	Transcription mediated amplification
5448	alleles
5449	genome-wide association study
5450	polymorphisms
5451	single nucleotide
5452	IL-8
5453	NKRF
5454	nsp10
5455	human ACE2 transgenic mouse
5456	immunofluorescence assay
5457	microneutralisation test
5458	western blotting
5459	RNA modification
5460	direct RNA sequencing
5461	discontinuous transcription
5462	epitranscriptome
5463	poly(A) tail
5464	transcriptome
5465	India - next-generation sequencing - RT-PCR - replication cycle - SARS-CoV-2 - transcriptome
5466	emerging pathogens
5467	occupational health
5468	Drugs
5469	Entry
5470	Proteases
5471	diagnostic test
5472	3Clpro
5473	Camostat
5474	α-Ketoamides
5475	Sewage
5476	Chaos game representation
5477	Coordinate series
5478	Nonlinear analysis
5479	Recurrence quantification analysis
5480	Cytochrome P450 (CYP)
5481	Epigenetics
5482	Pharmacogenetics
5483	Retinopathy
5484	Diagnostic capacity building
5485	Laboratory surveillance
5486	Public health preparedness/response
5487	quantified virus
5488	direct multiplex qRT-PCR
5489	multiplex qRT-PCR
5490	qRT-PCR
5491	biology
5492	clinical symptoms
5493	therapeutic treatment
5494	diagnostic virology
5495	gut inflammation
5496	Indicator
5497	Particulate Matter
5498	Relapse
5499	characterization
5500	ACE1 I/D polymorphism
5501	ACE1 II genotype
5502	Prevalence
5503	Heilongjiang
5504	asymptomatic transmission
5505	Ace2
5506	Alzheimer's disease
5507	Genome-wide association study
5508	lung innate immunity
5509	serine protease inhibitors
5510	Capillary electrophoresis
5511	Quantitative PCR
5512	Viral genome detection
5513	gene expression profiling
5514	translational medical research
5515	tumor microenvironment
5516	N-CTD
5517	Nsp3
5518	Infectivity
5519	Milano
5520	T cell immunity
5521	consensus sequence
5522	overlapping peptides set
5523	dynamics simulations
5524	promiscuous
5525	Re-positive
5526	Jordan
5527	Cepheid GeneXpert
5528	Panther Fusion
5529	False negative results
5530	Internal reference
5531	Kinetics
5532	PALS1
5533	PDZ
5534	SARS-CoV
5535	SARS-CoV-2
5536	angiotensin converting enzyme 2 (ACE2)
5537	coronavirus
5538	host range
5539	interspecies transmission
5540	receptor utilization
5541	Laboratory testing
5542	Serological test
5543	Cerebrospinal fluid
5544	Clinically isolated syndrome
5545	androgen
5546	Molecular characterization
5547	Next generation sequencing
5548	Veterinarians
5549	Human coronavirus
5550	Medicinal plants
5551	Functional sequence
5552	RNA stability
5553	Prolixin
5554	sinigrin
5555	culturability
5556	genome copy
5557	genome integrity
5558	re-infection
5559	Feces
5560	Mild
5561	Non-steroidal anti-inflammatory drugs
5562	SARS-CoV-2/COVID-19
5563	T and B cell epitopes prediction
5564	allergic rhinitis
5565	BLASTn
5566	Docking tools
5567	Ligands
5568	Polymerase inhibitors
5569	SMART BLAST and WebDSV 2.0
5570	Flu
5571	Human to human transmission
5572	Pyroptosis
5573	Huashi Baidu formula
5574	network pharmacology
5575	adjunctive therapy
5576	anti-parasite
5577	molecular immune response
5578	risk factor
5579	whole genome
5580	Protein-protein interactions
5581	Nucleic Acid
5582	rRT-PCR
5583	EZH2
5584	H3.3
5585	Bronchoalveolar-lavage fluid
5586	Tracheoscopy
5587	Nullomers
5588	Peptide-HLA
5589	Self/Non-Self
5590	Viral genomes
5591	COVID-19 testing
5592	Sparse recovery algorithms
5593	data sharing
5594	metabolic associated fatty liver disease (MAFLD)
5595	Toxicity
5596	3CLpro, chymotrypsin-like protease
5597	ACE2, angiotensin-converting enzyme 2
5598	BALF, bronchoalveolar lavage fluid
5599	COVID-19, coronavirus disease 2019
5600	CoVs, coronaviruses
5601	DAT, desaminotyrosine
5602	ER, endoplasmic reticulum
5603	ERGIC, endoplasmic reticulum–Golgi intermediate compartment
5604	HCoVs, human coronaviruses
5605	HLH, hemophagocytic lymphohistiocytosis
5606	HR, heptad repeats
5607	HSV, herpes simplex virus
5608	IL, interleukin
5609	LHQWC, Lian-Hua-Qing-Wen Capsule
5610	MAPK, mitogen-activated protein kinase
5611	MERS, Middle East respiratory syndrome
5612	MERS-CoV, Middle East respiratory syndrome coronavirus
5613	N protein, nucleocapsid protein
5614	NCIP, novel coronavirus-infected pneumonia
5615	NF-κB, nuclear factor-κB
5616	PI3K, phosphoinositide 3-kinases
5617	PLpro, papain-like protease
5618	RNA-Virus
5619	RTC, replication transcription complex
5620	RdRp, RNA-dependent RNA polymerase
5621	S protein, spike protein
5622	SARS, severe acute respiratory syndrome
5623	SARS-CoV, severe acute respiratory syndrome coronavirus
5624	STAT, signal transducer and activator of transcription
5625	TCM, traditional Chinese medicine
5626	B-cell
5627	Genome editing
5628	NSPs
5629	Accessory genes
5630	Circular code motifs
5631	ORF prediction
5632	host-pathogen protein interaction
5633	protein interaction prediction
5634	Nucleoprotein
5635	Quantitative proteomics
5636	Shotgun proteomics
5637	anti-viral drugs
5638	siRNA
5639	docking studies
5640	Maturation protease
5641	Biotechnology
5642	Research data
5643	APOL1
5644	collapsing glomerulopathy
5645	kidney biopsy
5646	nephrotic
5647	Adjuvants
5648	Antigens
5649	Coronavirus disease vaccine
5650	Hospitalist
5651	Nosocomial
5652	FilmArray
5653	host genetic factors
5654	Ethnic
5655	real-time-reverse transcription-polymerase chain-reaction
5656	Gel mobility assay
5657	LDH
5658	Plasmid
5659	XRD
5660	shRNA
5661	metatranscriptomics
5662	genomic drift
5663	immune escape
5664	variant
5665	2019- nCoV
5666	MERS- CoV
5667	SARS-CoV- 2
5668	Acute kidney injury
5669	Continuous renal replacement therapy
5670	Disease X
5671	Air surface nitrogen dioxide (NO(2))
5672	Air surface ozone (O(3))
5673	Climate variables
5674	Coronavirus COVID-19
5675	NOAA satellite data
5676	Planetary Boundary Layer (PBL)
5677	interactome prediction
5678	ligand receptor signalling
5679	neuroimmunology
5680	pulmonary immunology
5681	respiratory neurobiology
5682	Diagnostic testing
5683	Emergency use authorization
5684	disease symptoms
5685	health effects
5686	point-of-care testing
5687	microarray
5688	Arrhythmias
5689	Fulminant myocarditis
5690	Interleukin 6
5691	Drug classification
5692	Pharmaceutical agents
5693	Possible treatments
5694	unbiased metagenomics
5695	Bioanalytical chemistry * Genetic circuit* Primer exchange reaction* Electrochemistry * CRISPR
5696	Data Science
5697	Decision tree classifier
5698	X-ray images
5699	 In situ hybridization
5700	H&E
5701	microenvironment
5702	spatial transcriptomics
5703	special stains
5704	Ghana
5705	Innovation
5706	Technology
5707	Testing
5708	Nidovirales
5709	Positive-sense RNA viruses
5710	Live attenuated vaccine
5711	Reverse genetics
5712	emerging viruses
5713	novel CoV
5714	ageusia
5715	ACE inhibitors
5716	Drug treatment
5717	HLA-A*24:02
5718	HLA-DPA1*02:02
5719	HLA-DPB1*05:01
5720	Human Leukocyte Antigen (HLA)
5721	RNA-Seq
5722	bronchoalveolar lavage fluid
5723	DNA Synthesis
5724	DNA electrophoresis
5725	COVID-19, Mental Health, Stress, Anxiety, Synchronicity. 
5726	nsp7–10
5727	polyprotein 1a/ab
5728	polyprotein conformation
5729	posttranslational control
5730	Checkpoint inhibitors
5731	Pneumonitis
5732	IFITM3
5733	rs12252
5734	severe pneumonia
5735	Throat swab
5736	Viral nucleic acid testing
5737	Mobile application rating scale
5738	Smartphone application
5739	Paediatric
5740	Resources
5741	liver-type fatty acid-binding protein
5742	urinary biomarker
5743	β2-microglobulin
5744	Artificial intelligence
5745	Computational Biology
5746	Drug therapy
5747	COVD19
5748	B cell epitope
5749	T cell epitope
5750	sequence conservation
5751	Essential oils
5752	Crohn disease
5753	ulcerative colitis
5754	IFN response
5755	bronchial epithelial
5756	gene expressions
5757	lncRNAs
5758	pathway analysis
5759	ACE2 transcriptome
5760	drug target
5761	immune infiltration
5762	COVID-19 (SARS-CoV-2) Mpro 
5763	ayurveda
5764	drug-likeness
5765	HIV-1
5766	data mining
5767	text mining
5768	mitochondrial DNA
5769	viomycin
5770	Conservation
5771	Knowledge management
5772	Macro domain
5773	X domain
5774	biological networks
5775	data integration
5776	metabolome
5777	Andrographolide
5778	SWISS-bioinformatics
5779	in silico studies
5780	plant compound
5781	gene network analysis
5782	semen
5783	Coronavirus vaccine
5784	S1 S2 Glycosylation
5785	SARS-CoV-2 glycosylation
5786	coronavirus disease 2019(COVID-19)
5787	pharmacodynamic prediction
5788	co-expression network analysis
5789	Faeces
5790	age-specific infectiousness
5791	mobility data
5792	SARS-CoV-2 main protease (Mpro)
5793	Asian population
5794	azurin
5795	p28
5796	oral rinses
5797	suspension test
5798	MM-PBSA
5799	cyanobacterial metabolites
5800	deoxycylindrospermopsin
5801	Clerodendrum spp
5802	MM-GBSA
5803	taraxerol
5804	bioactive molecules
5805	spermatogonia
5806	HLA-Alleles
5807	Biological Database
5808	Angiotensin receptor blockers
5809	Renin–angiotensin–aldosterone system
5810	burden
5811	nurses
5812	Disease control
5813	Statistical inference < Biostatistics & Bioinformatics
5814	Cluster of differentiation 26 (CD26)
5815	Coronavirus disease 19 (COVID-19)
5816	Dipeptidyl peptidase-4 (DPP-4)
5817	Middle-East-respiratory-syndrome-related-coronavirus (MERS-CoV)
5818	Severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2)
5819	T-helper type 1 (T(h)1)
5820	T-helper type 2 (T(h)2)
5821	molecular pathways
5822	tiotropium
5823	angiotensin I-converting enzyme 2
5824	drug-modifying ACE2 expression
5825	E gene
5826	RdRp gene
5827	Vitamin A
5828	mechanism
5829	drug combination
5830	systems pharmacology analysis
5831	virus knowledgebase
5832	Glucocorticoids
5833	BASIGIN
5834	CD 147
5835	Oral cancer
5836	Oral potentially malignant disorder
5837	non-structural protein 3
5838	reverse vaccinology
5839	vaxign
5840	vaxign-ML
5841	Immune-therapy
5842	Therapeutic strategies
5843	Traditional Chinese medicines
5844	Stilbenoids
5845	Chest X-ray images
5846	Coronavirus (COVID-19)
5847	Radiology images
5848	Lung diseases
5849	Fuzzy color technique
5850	Social mimic
5851	Stacking technique
5852	Agent-based modeling
5853	Transmission models
5854	Viral-Track
5855	single-cell RNA-seq
5856	virus host interactions
5857	Outcomes
5858	pulmonary viruses
5859	secondary bacterial infection
5860	Coronavirus disease
5861	acute lung injury
5862	clinical phenome
5863	SARS-CoV2 infection
5864	S100A8
5865	S100A9
5866	calprotectin
5867	monocyte subsets
5868	carvacrol
5869	ursolic acid
5870	NEUROCOVID
5871	Neurological manifestations
5872	Observational study
5873	MMP9
5874	PPI-CPI network
5875	Emerging virus
5876	Human-infecting virus
5877	Receptor
5878	Virome
5879	Molecularmechanism. 
5880	TCM formulations
5881	water-borne epidemics
5882	Business and industry
5883	Scientific community
5884	biostatistics and bioinformatics
5885	data processing
5886	test statistics
5887	drug-induced heart injury
5888	pharmacovigilance
5889	rational administration of drug
5890	Expression
5891	literature mining
5892	topic inference
5893	Critical
5894	Febrile
5895	Fever
5896	phage endolysins
5897	phage therapy
5898	Dental healthcare
5899	N95 masks
5900	saliva
5901	basic reproduction number
5902	mathematical modelling
5903	optimal control
5904	sensitivity analysis
5905	Anesthesia work area
5906	Bacterial transmission
5907	Nosocomial infections
5908	Surgical site infection
5909	Nigella sativa
5910	dithymoquinone
5911	pandemic dynamics, transmission rates, death toll, non-pharmaceutical interventions, epidemic mitigation, regional differences
5912	Behavioral changes
5913	Data sharing initiative
5914	Open-source
5915	Social contact data
5916	Transmission dynamics
5917	User interface
5918	ICU
5919	Antidiabetic treatment
5920	Elderly
5921	Type-2 diabetes
5922	Health policy
5923	Anti-CD20 antibody
5924	Rituximab
5925	VVM
5926	Vaccine logistics
5927	Vaccine target profile
5928	Vaccine vial monitor
5929	Wuhan virus
5930	Evidence-based messaging
5931	Health disparities
5932	Vaccine acceptance
5933	acceptance
5934	clinical ethics
5935	distributive justice
5936	Epitope display
5937	HAdV vectors
5938	Immunomodulatory prediction
5939	Vaccine strategy
5940	Convalescent Plasma Therapy
5941	Monoclonal Antibodies
5942	COVID-19 vaccination
5943	health belief model
5944	intention
5945	willingness to pay
5946	mucosal vaccination
5947	route of administration
5948	Community engagement
5949	Epidemic management/response
5950	Vaccine confidence
5951	Vaccine uptake
5952	CTL Vaccine
5953	Controller
5954	Ebola Zaire vaccine
5955	Flow Focusing
5956	YQVNNLEEI
5957	Human challenge study
5958	severe acute respiratory syndrome-CoV-2
5959	technologies
5960	vaccines development
5961	YouTube
5962	SARS & MERS
5963	Vaccine candidate
5964	Vaccine development
5965	Covid19
5966	Innovative financing mechanisms
5967	Manufacturing capacity
5968	Research and development
5969	innovation speed
5970	regulation
5971	Advance market commitment
5972	Costs and spending
5973	Incentives
5974	Manufacturing
5975	Markets
5976	Pharmaceutical innovation
5977	Pharmaceuticals
5978	Prescription drug costs
5979	CD20
5980	ocrelizumab
5981	rituximab
5982	immunization
5983	vaccine testing
5984	Animal models
5985	Enhanced disease
5986	MERS-CoV vaccine
5987	SARS-CoV-1 vaccine
5988	Vaccine adjuvants
5989	vaccine trials
5990	Greece
5991	attitudes and practices
5992	health care professionals
5993	knowledge
5994	human challenge studies
5995	randomized controlled trials
5996	risk-taking
5997	animal models
5998	ADE, Antibody-Dependent Enhancement
5999	CEPI, Coalition for Epidemic Preparedness Innovations
6000	MERS-CoV, Middle East Respiratory Syndrome Coronavirus
6001	MHC, Major Histocompatibility Complex
6002	platform technology clinical trials
6003	Computable statistical analysis
6004	biomanufacturing
6005	mucosal immunization
6006	plantibody
6007	Matrix
6008	Research translation
6009	Time-lags
6010	Timescales
6011	Trials
6012	World Health Organization
6013	Eosinophil
6014	Immunopathology
6015	COVID-19 vaccines
6016	Human challenge studies
6017	Randomized clinical trials
6018	Risk taking
6019	Trust in science
6020	Trust in vaccine
6021	Vaccine effectiveness
6022	Non-pharmaceutical intervention
6023	Disease-modifying therapies
6024	D)
6025	research and development (R&amp
6026	newcastle disease virus
6027	recombinant vaccine
6028	medium-throughput screening
6029	microneutralization
6030	Newcastle disease virus (NDV)
6031	viral vector and viral respiratory infection
6032	ISAC Biosafety Committee
6033	SARS-CoV-2 cell sorting procedure
6034	biosafety and cell sorting
6035	infectious cell sorting
6036	sars-cov-2, vaccine, pandemic
6037	philosophical ethics
6038	next-generation vaccine
6039	Influenza, SARS-CoV-2, vaccine, respiratory, air-borne infections, viral infections, influenza
6040	severe acute respiratory syndrome – SARS, influenza virus, biosafety, vaccines and immunisation, laboratory
6041	Immunization
6042	community protection
6043	B cell precursors
6044	mimotope
6045	cervix uteri
6046	Funding
6047	Government
6048	public trust
6049	clinical development
6050	eosinophils
6051	immunopotentiation
6052	Human immune system
6053	Pharmacological treatments
6054	Rapid test
6055	SARS-Cov-2 infection
6056	antivax
6057	vaccine hesitancy
6058	attenuated live vaccine
6059	nucleic acid vaccine
6060	recombinant protein vaccine
6061	Developing world
6062	prevention strategies
6063	CD4
6064	CD8
6065	cross-reactivity
6066	diagnosis and interventions
6067	features
6068	biomaterials
6069	filtration
6070	gist
6071	risk communication
6072	risky decision making
6073	ethics committees/consultation
6074	informed consent
6075	policy guidelines/Inst
6076	review boards/review Cttes
6077	Fatality rate
6078	Gender difference
6079	Sex difference
6080	Coronaviruses, SARS-CoV- 2, Respiratory Infections, Receptor Binding Domains, Angiotensin Converting Enzyme 2, Pandemic.
6081	Information technology
6082	Media
6083	NIPTE
6084	manufacturing
6085	pharmaceuticals
6086	re-shoring
6087	shortages
6088	Polyclonal hyperimmune globulin
6089	Benefit-risk
6090	Brighton Collaboration
6091	CEPI
6092	Peptide
6093	Recombinant
6094	Template
6095	Health-seeking behavior
6096	Influenza vaccine
6097	Infodemiology
6098	Online health information
6099	Patient education
6100	Pneumococcal vaccine
6101	Nucleic acid
6102	Lung Cleansing and Detoxifying Decoction
6103	Polysaccharide
6104	Qing Fei Pai Du Tang
6105	risk taking
6106	ACE2 blocker
6107	Antimalaria
6108	Antiviral: Chinese traditional medicine
6109	Immunoenhancer
6110	repurposed therapies
6111	and animal model
6112	SPIKE protein
6113	Communication
6114	Economics
6115	Congenital infection
6116	SARS-CoV-2 vaccines
6117	TORCH infection
6118	Heterologous vaccine
6119	subunit vaccine
6120	cross-neutralization
6121	viral inhibitor
6122	Emerging coronavirus
6123	rapalog
6124	sirolimus
6125	Epidemic prevention and control
6126	bioengineering
6127	preclinical testing
6128	drug delivery systems
6129	theranostic nanoparticles
6130	Structural biology
6131	tissue engineering
6132	viral
6133	2019-CoV
6134	potential interventions
6135	Envelope (E) protein
6136	In-silico
6137	Middle East respiratory syndrome coronavirus
6138	coronavirus vaccines
6139	severe acute respiratory syndrome coronavirus (SARS-CoV)
6140	virological diagnosis
6141	SARS-Co-V-2
6142	Viral dynamics
6143	vaccine readiness
6144	Coronavirus disease-19
6145	severe acute respiratory syndrome-coronavirus-2
6146	Biological products
6147	T cell cross-reactivity
6148	adaptive immunity
6149	Cross-protection
6150	Diagnostic approaches
6151	AI Applications
6152	Artificial Intelligence (AI)
6153	behaviour change
6154	social marketing
6155	vaccine uptake
6156	Covid 19
6157	Human trials
6158	Timeline
6159	corona pandemic
6160	corona virus
6161	TAVI
6162	valve repair/replacement
6163	Adaptive design
6164	Exponential growth
6165	Seamless trial design
6166	SIS
6167	Stochastic disease
6168	Vaccination stockpile
6169	Black seed
6170	Nagella sativa
6171	Nigellidine
6172	Thymoquinone
6173	α-hederin
6174	Twitter
6175	social networking
6176	tobacco industry
6177	Antigen specific immunity
6178	HCW
6179	Revaccination
6180	Poverty
6181	respiratory medicine (see thoracic medicine)
6182	SARSCoV
6183	epidemic SARS-CoV-2
6184	epidemiology characteristics
6185	epidemiology process
6186	links
6187	biological risk
6188	infection prevention
6189	procedures
6190	Corona Virus Disease 2019(COVID-19)
6191	Neonatal pneumonia
6192	Premature
6193	Severe Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2)
6194	Asymptomatic carrier
6195	Emerging infection
6196	SARS2
6197	Hong Kong.
6198	confirmation efficiency
6199	early outbreak
6200	IgM-IgG antibody test
6201	Severity of illness
6202	medical supplies
6203	public health emergency
6204	beta coronavirus
6205	humans and animals
6206	respiratory and gastrointestinal infections
6207	Randomised controlled trial
6208	health care worker
6209	household contact
6210	post-exposure prophylaxis
6211	Attack rate - contact testing - descriptive epidemiology - epidemic curve - positivity - SARS-CoV-2 - testing rate
6212	Basic reproduction number
6213	Incubation period
6214	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
6215	“Coronavirus disease 2019” (COVID-19)/epidemiology
6216	cities
6217	death
6218	trends
6219	group testing
6220	pooled testing
6221	postpartum
6222	SARS-CoV-2 infection
6223	presymptomatic
6224	travelers health
6225	NEWS2
6226	National Early Warning Score 2
6227	Exit strategy
6228	Service provision
6229	Cardiovascular manifestations
6230	Italy geographical circulation
6231	Neurological implications
6232	brain
6233	neurodegeneration
6234	neuropathogenesis
6235	cavitary coccidioidomycosis
6236	pulmonary coccidioidomycosis
6237	influenza B virus
6238	prevalence
6239	Antibody - COVID-19 - hotspot - SARS-CoV-2 - serial cross-sectional - seroprevalence - surveillance - trend
6240	health systems
6241	cytokine release storm
6242	CODID-19
6243	fecal-oral transmission
6244	viral RNA
6245	real-time reverse transcription polymerase chain reaction
6246	coinfection
6247	eosinophil
6248	Oncological activity
6249	Patients' perception
6250	Risk containing measures
6251	neonatal intensive & critical care
6252	perinatology
6253	community transmission
6254	public health response
6255	respiratory disease
6256	Laboratory infection
6257	Laboratory safety
6258	Attaque de panique
6259	Panic attack
6260	Panic disorder
6261	Trouble panique
6262	Mathematical model
6263	Reproductive number
6264	Risk estimation
6265	Stochastic simulation
6266	National crisis
6267	lymphocyte function
6268	viral excretion
6269	clustering
6270	positive cases
6271	animal coronaviruses
6272	history of coronaviruses
6273	Type-2 low
6274	viral response
6275	Long-term infection
6276	COVID-19 - diagnosis - ELISA - human - IgG antibodies - microneutralization test - SARS-CoV-2 - standardization
6277	Contacts
6278	diagnostic potential
6279	paediatric patients
6280	Dose-response relationship - healthcare workers - hydroxychloroquine prophylaxis - personal risk management - rapid evidence generation - SARS-CoV-2
6281	Co-infection
6282	Influenza viruses
6283	Chest
6284	Household
6285	Indirect transmission
6286	Novel coronavirus disease
6287	Snot-oral transmission
6288	COVID-19, anti-SARS-CoV-2 IgG seroprevalence in Germany
6289	Hunan
6290	Abbott
6291	Idaho
6292	coronavirus disease (covid-19)
6293	sars-cov-2 (severe acute respiratory syndrome coronavirus -2)
6294	SARS-Co2 infection
6295	hospitalized children
6296	Characteristics
6297	CT imaging
6298	IgA
6299	commercial
6300	androgen-deprivation therapy
6301	prostate cancer
6302	infection dynamics
6303	ozone
6304	viral outbreak
6305	early warning system
6306	wastewater
6307	wastewater-based epidemiology
6308	 SARS coronavirus 2
6309	asymptomatic infection
6310	Neurotropic
6311	River water
6312	Wastewater-based epidemiology
6313	RNA-PCR
6314	diagnostic
6315	Radiography
6316	Pulmonary embolism
6317	Venous thromboembolic disease
6318	Asymptomatic infection
6319	Colonization
6320	Contamination
6321	Circulatory system
6322	Digestive system
6323	Urogenital system
6324	infection fatality ratio
6325	external quality assessment (EQA)
6326	laboratory preparedness
6327	molecular detection
6328	outbreak control
6329	Radiation oncology
6330	Screening
6331	Database
6332	anorexia
6333	gut-brain axis
6334	Case spread
6335	Emergency preparedness
6336	Human immunity
6337	Season
6338	air pollution
6339	climatic zones
6340	epidemic forecasting
6341	pandemic geographical distribution
6342	population median age
6343	weather conditions
6344	Containment policies
6345	Diagnostic tests
6346	Contact precaution
6347	Surface contamination
6348	high altitude
6349	hypoxia
6350	comorbidity analysis
6351	demographic analysis
6352	web interface development
6353	Hematologic
6354	Peripheral blood
6355	Peripheral smear
6356	nosocomial infection
6357	aerosolization
6358	face-to-face contact
6359	handshake
6360	CoViD-19
6361	health workers (HWs), screening
6362	Lodi Red Zone
6363	SARS-CoV-2 seroprevalence
6364	microneutralization assay
6365	Guangdong
6366	persistence
6367	household contacts
6368	Minipools
6369	United Kingdom
6370	mortality rate
6371	paradox
6372	Enveloped viruses
6373	Human health risks
6374	WBE
6375	Concentration method
6376	Enveloped virus
6377	Murine hepatitis virus
6378	Recovery
6379	Untreated wastewater
6380	KIT D816V
6381	Mast cells
6382	mast cell activation syndrome
6383	mastocytosis
6384	tryptase
6385	inoculum
6386	Botulinum toxin
6387	Dystonia
6388	Hemifacial spasms
6389	Pain conditions
6390	Patient rights
6391	Perception
6392	Quality of life
6393	Spasticity
6394	colostrum
6395	manual extraction
6396	newborn
6397	neurological disorder
6398	neuroscience
6399	neurotropic behaviour
6400	Contact - COVID-19 - India - SARS-CoV-2 - transmission
6401	basic reproductive number
6402	doubling time
6403	epidemic growth rate
6404	Community Acquired Pneumonia
6405	gastric diseases
6406	gastrointestinal pathology
6407	age-specific
6408	confirmed cases
6409	infection spread
6410	isolation and quarantine
6411	pakistan
6412	retrospective
6413	ACE-inhibitors
6414	PM-10
6415	PM-2.5
6416	SARS-CoV-2 IgG antibodies
6417	serosurvey
6418	descriptive epidemiology
6419	virus transmission
6420	HCWs
6421	IG
6422	Bayesian multilevel model
6423	generation interval
6424	Health inequality
6425	Inequality
6426	Social factors
6427	Enfermedades neurodegenerativas
6428	Enfermedades neuropsiquiátricas
6429	Neurodegenerative diseases
6430	Neuroinflamación
6431	Neuroinflammation
6432	Neuropsychiatric diseases
6433	Tormenta de citoquinas
6434	antirheumatic agents
6435	patient care team
6436	quality indicators, health care
6437	Care home
6438	Nursing home
6439	HEPA
6440	MPPS
6441	Male fertility
6442	Semen cryopreservation
6443	dietitians
6444	wellbeing at work
6445	Fecal specimen
6446	Cell culture
6447	Suckling baby
6448	eosinophilic myocarditis
6449	severe respiratory syndrome coronavirus 2
6450	Surge capacity
6451	lethality
6452	EEG
6453	Neurophysiology
6454	Health care workers
6455	SARS-CoV-2 detection
6456	device
6457	instrument
6458	portable
6459	2019-nCoV disease
6460	T cell
6461	Romanian population
6462	prevalence study
6463	predictive values
6464	serological tests
6465	Nested case–control study
6466	Occupational health
6467	Quality improvement
6468	Questionnaire
6469	Therapies
6470	Aerosol
6471	HVAC
6472	Ventilation
6473	Hospital environmental contamination
6474	host immune response
6475	Antiviral properties
6476	Binding affinity
6477	Ang (1–7)
6478	intracerebral hemorrhage
6479	virus-laden particles
6480	CARES Act
6481	advocacy
6482	intermediate hosts
6483	wild animals
6484	mass screening
6485	household transmission
6486	school closure
6487	southern Italy
6488	MT-PCR
6489	Inmunidad
6490	Arbidol
6491	blood coagulation
6492	HPV testing
6493	abnormal screening results
6494	cervical cancer prevention
6495	cervical cytology
6496	selfsampling
6497	Autopsia
6498	Daño alveolar difuso
6499	España
6500	Registro
6501	Registry
6502	Renal replacement therapies
6503	Sociedad Española de Nefrología
6504	Spanish Society of Nephrology
6505	Tratamiento renal sustitutivo
6506	CRP (C- reactive protein)
6507	COVID-19 disease
6508	Medical staffs
6509	Person-to-person transmission
6510	Protective measures
6511	collateral damage
6512	neurological diseases
6513	neurological services
6514	neurological signs
6515	Environmental contamination
6516	Healthcare-associated infection
6517	Central Nervous System
6518	Cerebrospinal Fluid
6519	Neuroinvasive
6520	Neuron
6521	Transcribrial
6522	hand eczema
6523	irritant contact dermatitis
6524	occupational
6525	prevention measure
6526	RAS-pathway
6527	lung shut-down
6528	prognostic molecular/genetic markers
6529	sex/gender-gap
6530	prophylaxis
6531	retina
6532	cross-sectional study
6533	disease control
6534	pandemic outbreak
6535	perception of risk
6536	olfaction
6537	sinonasal outcomes
6538	taste loss
6539	2019 n-CoV
6540	Host-directed therapies
6541	Inflamm-aging
6542	app
6543	smartphone app
6544	smoking cessation
6545	Professional burnout
6546	Psychological stress
6547	Antibody detection
6548	clinical treatment and prevention
6549	Household contacts
6550	Smell and taste loss
6551	underlying health conditions
6552	Cardiovascular disease treatment
6553	Diabetes Mellitus tipo 2
6554	Enfermedad cardiovascular
6555	Type 2 diabetes mellitus
6556	Hemodialysis
6557	Hemodiálisis
6558	Immunosuppressed
6559	Inmunodeprimido
6560	Kidney transplantation
6561	Trasplante renal
6562	brain imaging
6563	cerebrospinal fluid
6564	molecular mechanisms
6565	neuroinvasion
6566	neurotropism
6567	neurovirulence
6568	recommended learning list
6569	NCP
6570	COVID-19 outbreak
6571	Waste Based Epidemiology
6572	 Anesthesiology
6573	communicable diseases
6574	Epidemic infection
6575	Pandemic infection
6576	SARS – CoV-2
6577	Toxoids
6578	Repair
6579	Severe acute respiratory coronavirus 2
6580	Stem cells
6581	Communicable disease control
6582	Epidemiological monitoring
6583	Medical informatics applications
6584	biobanking
6585	hyperinflammatory
6586	Fecal-to-Oral Transmission
6587	PRISMA
6588	Viral Persistence
6589	Nitrogen dioxide
6590	Sentinel-5P
6591	coronavirus pregnancy
6592	QT prolongation
6593	antibody testing
6594	chronic kidney disease (CKD)
6595	dialysis unit
6596	disease surveillance
6597	end-stage kidney disease (ESKD)
6598	infection detection
6599	nucleic acid testing (NAT)
6600	subclinical infection
6601	Quality Control (QC)
6602	Wastewater-Based Epidemiology (WBE)
6603	multiplex
6604	Delirium
6605	PICS
6606	Pain
6607	Sedation
6608	Epidemy
6609	Pandemy
6610	Psychiatrie
6611	Psychiatry
6612	Épidémie
6613	Cellular senescence
6614	Neurotropism
6615	Environmental context
6616	Modes of transmission
6617	Solid waste
6618	infection and infectious agents
6619	infection and infectious agents-viral
6620	immunosuppressive regimens-maintenance
6621	kidney transplantation/nephrology
6622	clinical research
6623	Glucose
6624	aircraft
6625	Modeling
6626	COVID-19 patients
6627	SARS-CoV-2-specific T cells
6628	Angiotensin-converting-enzyme inhibitors
6629	biological monitoring
6630	health and safety
6631	Asymptomatic carriers
6632	Nasal swab
6633	UNICORN
6634	Viral RNA
6635	Atmospheric pollution
6636	bioconjugate
6637	clinical samples
6638	column agglutination test
6639	inpatient consults
6640	Determinants
6641	Dynamics
6642	Health Care Workers
6643	SSEs
6644	behavioral factors
6645	environmental factors
6646	host factors
6647	pathogen-specific factors
6648	response factors
6649	superspreading events
6650	Guangdong Province
6651	CV disease
6652	Nutritionist
6653	Sleep disturbance
6654	Sleep quality
6655	Smart-working
6656	clinical epidemiology
6657	transmission potential
6658	Asymptomatic infections
6659	travel-related illness
6660	acute kidney failure
6661	renal pathology
6662	chronic carrier
6663	COVID-19 indicators
6664	cubic model
6665	nonlinear estimation
6666	Survival
6667	Immunoassay
6668	Droplet
6669	Mask
6670	angiotensin-converting enzyme II
6671	hACE2-KI/NIFDC
6672	clinical research/ practice
6673	complication: infectious
6674	horizontal transmission
6675	CAP
6676	Influenza-like Illness (ILI)
6677	Spike S1
6678	endemic coronavirus
6679	multiplex bead-based immune assay
6680	lysosomes
6681	proximal tubule cells
6682	Italian outbreak
6683	phylogenetic inference
6684	Heart injury
6685	Coronavirus-2019
6686	Severe acute respiratory disease coronavirus 2
6687	GeneXpert
6688	developing country
6689	Crohn-betegség
6690	Crohn’s disease
6691	SARS-koronavírus
6692	biological therapy
6693	biológiai terápia
6694	colitis ulcerosa
6695	immunosuppressive agents
6696	immunszuppresszív szerek
6697	Mother
6698	Neonatal resuscitation
6699	Newborn
6700	Therapeutic antibodies
6701	Extended use N95 respirator
6702	COVID-19 app
6703	ICU organisation
6704	Picardy
6705	Inflammatory cytokine
6706	Immune checkpoint inhibition
6707	Oral–faecal transmission
6708	Viral pandemic
6709	Waterborne infection
6710	CMC
6711	Controlled human infection models
6712	2019 novel coronavirus infection
6713	COVID-19 virus disease
6714	Cáncer
6715	Predictive factors
6716	Respiratory distress syndrome
6717	Severity
6718	Organization and reorganization
6719	Patient flow
6720	Pregnant
6721	Women
6722	Neonatal
6723	BSL-2
6724	Biosafety
6725	Environmental risk
6726	Lab safety
6727	GS-441524
6728	ritonavir
6729	Healthcare operators
6730	Nasopharyngeal swab
6731	Nosocomial transmission
6732	ELISpot
6733	Interferon-gamma release assay
6734	T-cell response
6735	Long-term conditions
6736	family clusters
6737	biosafety & biosecurity
6738	current scenario
6739	Death
6740	Décès
6741	Nourrisson
6742	clinical laboratory
6743	epigenetics
6744	polycomb
6745	ACE2: venous thromboembolism
6746	gender differences
6747	vitamin D deficiency
6748	pharmacoepidemiology
6749	Urological surgery
6750	digestive tract route
6751	mode of transmission
6752	 Virus Research and Diagnostic Laboratory
6753	 diagnosis
6754	 preparedness
6755	 quality control
6756	 quarantine
6757	 severe acute respiratory syndrome-CoV-2
6758	bronchoscopy and interventional techniques
6759	endobronchial ultrasound
6760	infectious disease transmission
6761	Arterail blood gas
6762	CT volumetry
6763	Emergency department
6764	Emergency medicine
6765	environmental sampling
6766	Clinical
6767	CD4+ T lymphocyte count
6768	clinical patterns
6769	allergic diseases
6770	COVID-19 incidence
6771	meteorology
6772	outdoor relative humidity
6773	outdoor temperature
6774	Epidemiological
6775	Imaging findings
6776	SRAS-CoV-2
6777	public health emergency of international concern
6778	Obstetrics
6779	disease severity, epidemiology
6780	genotype
6781	Life-threatening COVID-19
6782	Multisystem organ failure
6783	Therapeutic plasma exchange
6784	Acute appendicitis
6785	Apendicectomía
6786	Apendicitis aguda
6787	Appendectomy
6788	Complicaciones postquirúrgicas
6789	Paciente pediátrico
6790	Paediatric patient
6791	Post-surgical complications
6792	Research ethics
6793	SOLIDARITY
6794	recommendations
6795	Coronavirus 2
6796	European Milk Banking Association
6797	Human Milk Banking Association of North America
6798	Severe Acute Respiratory Syndrome Coronavirus-2
6799	breastfeeding
6800	donor milk
6801	donor milk banking
6802	 infrastructure
6803	 laboratories
6804	 novel coronavirus
6805	Biorisk
6806	Case Fatality Rates
6807	Novel coronavirus COVID-19
6808	SARS-CoV-19
6809	genomic
6810	Lupus anticoagulant
6811	Atención primaria
6812	Enfermeras
6813	General practitioner
6814	Médicos
6815	Nurses
6816	Prevalencia
6817	Primary care
6818	Residencias de ancianos
6819	Lung fibrosis
6820	Capacity building
6821	equipment
6822	human resource
6823	networks
6824	reverse transcription polymerase chain reaction
6825	Seroepidemiologic studies
6826	critical care; mortality
6827	reporting
6828	resource utilization
6829	Angiotensin-Converting Enzyme 2
6830	leukopenia
6831	ogyEpidemiologyPandemicsVirus classification
6832	Digestive surgery
6833	SARS-cov-2
6834	viral RNA shedding
6835	Food Safety
6836	One Health
6837	neglected route
6838	Hemoglobinopathies
6839	Thalassemia
6840	ACE-Inhibitors
6841	Angiotensin-receptor-blockers
6842	ABO blood groups
6843	markers
6844	Hypoxemia
6845	SARS-CoV-2 pneumonia
6846	Shunt
6847	Venous admixture
6848	temperature and humidity
6849	therapeutics strategies
6850	Atención Primaria
6851	Contact study
6852	Epidemiological surveillance
6853	Estudio de contactos
6854	Salud Pública
6855	Vigilancia epidemiológica
6856	Cholera
6857	RNA persistence
6858	gastrointestinal
6859	México
6860	Administrative wards
6861	data triangulation
6862	effectuation theory
6863	policy entrepreneurship
6864	testing rate
6865	Coronavirus. COVID-19. Estado nutricional.
6866	ultrasound examination
6867	Bibliometrics
6868	WHO COVID-19 database
6869	ambulatory treatment
6870	anti-inflammatory
6871	anticoagulant
6872	Healthcare worker
6873	in-hospital mortality
6874	Autonomous communities
6875	Comunidades autónomas
6876	Death cases
6877	density
6878	spatial polarization
6879	urbanization
6880	Azithromycin
6881	Azitromicina
6882	Cloroquina
6883	Long QT syndrome
6884	Síndrome de QT largo
6885	Tratamiento COVID-19
6886	Community acquired pneumonia
6887	Multiplex RT-PCR
6888	Respiratory pathogens
6889	Biodata mining
6890	ORF1ab
6891	Protein Modelling
6892	Generalized Gamma model
6893	Prediction model
6894	Serbia
6895	troponin
6896	Sludge
6897	Enfermedades infecciosas
6898	Healthcare personnel
6899	Personal sanitario
6900	Environmental surveillance
6901	Pandemic monitoring
6902	Wastewater based epidemiology
6903	Clinic symptoms
6904	respiratory infection
6905	home testing
6906	pilot study
6907	Shenzhen
6908	epidemiologic
6909	Death rates
6910	Regression
6911	Blood < Epidemiology
6912	Immunoglobulin < Immune responses
6913	nursing home
6914	temperature
6915	Ivermectin
6916	Mild covid-19
6917	SARS coronavirus < virus classification
6918	coronavirus < virus classification
6919	immunity/immunization < epidemiology
6920	persistent infection < infection
6921	outbreak analyses
6922	FURIN
6923	Human Cell Atlas
6924	epithelial differentiation
6925	emergency care
6926	quality improvement
6927	AGEING
6928	BIOSTATISTICS
6929	CHRONIC DI
6930	Cohort studies
6931	Epidemiology of chronic diseases
6932	HEARThermo
6933	Thermal screening
6934	Wearable device
6935	2019 novel coronavirus diseases
6936	head and neck tumor
6937	medical protection
6938	colloidal gold rapid test
6939	immunochromatographic rapid test
6940	preanalytics
6941	whole blood
6942	Air
6943	Air-conditioning system
6944	Ship
6945	Surfaces
6946	Ventilation system
6947	Waste
6948	health informatics
6949	Coronavirus-19
6950	Ecuador
6951	Rural setting
6952	SARS virus
6953	longitudinal studies
6954	Interferonᵧ
6955	disease enhancement
6956	vaccine safety
6957	Metabolically Benign
6958	body mass index
6959	mortality determinants
6960	COBAS 6800
6961	preoperative testing
6962	metastatic triple-negative breast cancer
6963	Burns
6964	Exposure risk
6965	Healthcare-associated infections
6966	COVID-19 prevalence
6967	PMMoV
6968	viral titers
6969	Rural communities
6970	Social determinants of health
6971	Population study
6972	maternal
6973	neonatal
6974	D-dimer
6975	inflammatory cytokine
6976	IL-6 inhibitors
6977	settings
6978	HBV
6979	Liver Injury
6980	SARS-CoV-2 RT-PCR
6981	test characteristics
6982	Neutropenia
6983	home
6984	Pseudovirus neutralisation assay
6985	Recombinant immunofluorescence assay
6986	Serological testing strategy
6987	oncology patients
6988	air travel
6989	cardiac catheterization
6990	congenital heart disease
6991	ICU beds
6992	ethical and organizational issues
6993	intermediate respiratory care
6994	prostate
6995	dental practice
6996	home assessment
6997	Aerosol-generating procedures
6998	Control de infección
6999	High-flow nasal therapy
7000	Non-invasive mechanical ventilation
7001	Procedimientos generadores de aerosoles
7002	Terapia nasal de alto flujo
7003	Ventilación mecánica no invasiva
7004	Biomedical databases
7005	Natural Language Processing
7006	Medical Education
7007	Medical students
7008	remote work
7009	TCM advantages
7010	epidemiology dynamics
7011	national healthcare system capacity
7012	novel Coronavirus Infection
7013	renal transplantation
7014	end-stage kidney disease
7015	haemodialysis
7016	dental
7017	endodontics
7018	NEWS
7019	Outcome
7020	epicentre
7021	healthcare resource availability
7022	repeat exposure
7023	severity of disease
7024	RNA PCR
7025	management practices
7026	testing algorithm
7027	online learning
7028	ARDS, acute respiratory distress syndrome
7029	CFR, case fatality rate
7030	COVID-19, coronavirus disease-2019
7031	CoV, coronavirus
7032	DIC, disseminated intravascular coagulation
7033	ICU, intensive care unit
7034	SARS-CoV, severe acute respiratory syndrome-coronavirus
7035	SOFA, sequential organ failure assessment
7036	TMPRSS2, transmembrane serine protease 2
7037	cardiovascular
7038	hsCRP, high-sensitivity C-reactive protein
7039	treatments
7040	Organ injury
7041	RT-ddPCR
7042	Renal tumors
7043	Therapeutic targeting
7044	Disaster response
7045	Hospital emergency plan
7046	Mass critical care
7047	Inflammatory Bowel disease
7048	coronarovirus 2 (SARS-CoV-2)
7049	gustatory dysfunction
7050	olfactory dysfunction
7051	smell
7052	taste
7053	RT-PCR test
7054	anesthesia
7055	labor
7056	severe acute respiratory syndrome 
7057	China; ACE2
7058	ICS
7059	Mechanisms
7060	relationship
7061	Hospital wastewater
7062	Municipal wastewater
7063	Lung resection
7064	Perioperative period
7065	Dysregulated repair
7066	E-cig exposure
7067	Extracellular matrix
7068	nAChRα7
7069	Dental care
7070	Dental health services
7071	Acute Kidney Injury
7072	Proteinuria
7073	Corona Virus Disease 2019 (COVID-19)
7074	clustered regularly interspaced short palindromic repeats (CRISPR)
7075	reverse transcription loop-mediated isothermal amplification (RT-LAMP)
7076	severe acute respiratory syndrome coronavirus 2 (2019 Novel Coronavirus SARS-CoV-2)
7077	Community testing
7078	Neoplasm
7079	CT-scan
7080	Chest imaging
7081	Radiation
7082	Allergic diseases
7083	Type 2 immune response
7084	Down syndrome
7085	obstructive sleep apnea
7086	head and neck cancer treatment
7087	microvascular reconstruction
7088	practice patterns
7089	Gansu province
7090	severe acute respiratory syndrome coronavirus 2 (SARSCoV-2)
7091	Global warming
7092	myocarditis
7093	post-infectious disease
7094	Outdoor activities
7095	acute respiratory disease
7096	case definition
7097	Clinical phenotyping
7098	Patient registry
7099	Cross-sectional
7100	Hungary
7101	Nationwide
7102	hospital epidemiology
7103	novel corona virus
7104	sars-cov-2 (severe acute respiratory syndrome coronavirus-2)
7105	renin-angiotensin system (RAS)
7106	Anthropology
7107	Compliance
7108	Representations
7109	special population
7110	oral medicine
7111	personal protective equipment (PPE)
7112	ACE inhibitor
7113	ACEIs
7114	angiotensin-converting enzyme-1
7115	arterial hypertension
7116	renin-angiotensin-aldosterone system
7117	ACE, angiotensin-converting enzyme
7118	AT1R, angiotensin II type 1 receptor
7119	CI, confidence interval
7120	IFN, interferon
7121	IQR, interquartile range
7122	RAS, renin-angiotensin system
7123	RNA, ribonucleic acid
7124	SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2
7125	TMPRSS2, transmembrane protease serine 2
7126	renin angiotensin system
7127	sACE2, soluble angiotensin-converting enzyme 2
7128	Endothelial damage
7129	antibody-mediated cell-mediated cytotoxicity
7130	Cytokine release synddrome
7131	Hemofagocítico
7132	Hemophagocytic
7133	Síndrome de liberación de citocinas
7134	delivery
7135	intensive care units
7136	FFP2 mask
7137	N95 mask
7138	Respiratory droplets
7139	Coronavirus Disease-19
7140	False negative
7141	dissemination
7142	preparation
7143	smartphone
7144	Blood safety
7145	Pathogen inactivation technology
7146	Infectious Diseases
7147	SARS-COV 2
7148	Dynamic profile
7149	Encephalitis
7150	Meningitis
7151	Myositis
7152	oxygen therapy
7153	Disease transmission, infectious
7154	acute coronary syndromes
7155	pericardial effusion
7156	thromboembolic pulmonary vascular disease
7157	Cycle Threshold values
7158	Reverse Transcription PCR
7159	Patient care
7160	Hepatobiliary
7161	neonatal outcome
7162	pregnancy outcome
7163	IPC
7164	PPI
7165	environmental contamination
7166	Mother-to-child vertical transmission
7167	Pregnant woman
7168	Clinical Symptoms
7169	Gansu Province
7170	cancer care
7171	patient guidance
7172	cancer patients
7173	Cross-sectional Study
7174	E2
7175	Female Hormones
7176	Menstrual Status
7177	immunosuppressive therapy
7178	Chest X-ray
7179	Scoring system
7180	Zoonotic
7181	Fighting
7182	International health regulation
7183	Preparedness
7184	Angiotensin II Receptor Blockers
7185	administrative data
7186	ocular surface
7187	sars CoV-2
7188	infectious disease medicine
7189	naming
7190	fever
7191	maternal morbidity
7192	neonatal morbidity
7193	neonatal mortality
7194	respiratory distress syndrome
7195	Mycoplasma pneumonia
7196	asymptomatic infections
7197	data analysis
7198	visualization
7199	cruise ship quarantine
7200	infectious control
7201	virological testing
7202	Convalescent plasma therapy
7203	Fatality
7204	Survival rate
7205	Viral shedding
7206	perceptions
7207	rapid online surveys
7208	Tumor
7209	Chronic kidney failure
7210	Co-infections
7211	Community-acquired
7212	Respiratory viral infections
7213	Neutrophil extracellular traps (NETs)
7214	accuracy
7215	clinical diagnosis
7216	multiple regression model
7217	Extra-respiratory manifestations
7218	nonalcoholic steatohepatitis (NASH); clinical trials
7219	FilmArray™ Respiratory Panel
7220	SARS-CO-V-2
7221	SARS-CoV-2 symptoms
7222	nervous system
7223	air quality
7224	Cuidados intensivos
7225	Intensive care
7226	Triaje
7227	antiplatelet
7228	antithrombotic therapy
7229	Secondary attack rate
7230	Transmissibility
7231	Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Zhejiang Province; Wuhan
7232	Características clínicas
7233	Comorbidity
7234	Comorbilidades
7235	Emergency health services
7236	Servicios de urgencias
7237	Severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2)
7238	contagion
7239	UPSIT
7240	chronic rhinosinusitis
7241	olfactory disorders
7242	olfactory test
7243	IDD
7244	intellectual and developmental disability
7245	Heart failure unit
7246	Cribado
7247	rapid-diagnostic test (RDT)
7248	COVID-19 [Supplementary Concept]
7249	Kidney Transplantation
7250	health Worker
7251	Chicago
7252	Geography
7253	Hot spot
7254	New York
7255	renin-angiotensin system)
7256	two hits
7257	Biobanking
7258	Translational medicine
7259	Disease Transmission
7260	Meta-MUMS
7261	Intervention
7262	Lupus
7263	Methylation
7264	Next generation matrix
7265	Coronavirus disease 19
7266	Face masks
7267	Universal masking
7268	Chronic diseases
7269	NCD
7270	SARS-coV-2
7271	ARV
7272	Contact
7273	Medical mask
7274	N95 respirator
7275	diabetes mellitus
7276	Adult-onset Still’s disease
7277	Catastrophic antiphospholipid syndrome
7278	Deferoxamine
7279	Hyperferritinemic
7280	Iron
7281	Iron depletion therapy
7282	Epidemiological features
7283	Family clusters
7284	senior dwellers
7285	face mask
7286	Human immunodeficiency virus < Virus classification
7287	Pandemics < Epidemiology
7288	Kidney
7289	Riñón
7290	Transplantation
7291	Trasplante
7292	Cyprus
7293	control measures
7294	Coronavirus disease-2019
7295	Droplet-based transmission
7296	Personal protective equipment (PPE)
7297	Clinical management
7298	Endemic
7299	Prevention and control
7300	Cluster of youngsters
7301	Outside Wuhan
7302	Prospective contact-tracing study
7303	Rapid transmission
7304	Reproductive health
7305	Axillary artery
7306	Brachial plexus
7307	Consensus
7308	Deep venous thrombosis
7309	Endovascular treatment
7310	Hospital resources
7311	Neurogenic
7312	Subclavian artery
7313	Subclavian vein
7314	Surgical treatment
7315	Teleconference
7316	Thromboembolism
7317	Upper extremity
7318	Critically ill
7319	Human resources for health
7320	Infection control, mental health
7321	Diagnostic accuracy
7322	 MERS-CoV
7323	 epidemic
7324	 pandemic
7325	 transmission
7326	arrhythmia
7327	myocardial damage
7328	Transplant programs
7329	COVID-19 diagnosis
7330	COVID-19 management
7331	Risk Factors
7332	 Emergencies
7333	Primary Health Care
7334	spike protein, SARS-CoV-2 [Supplementary Concept] 
7335	SARS-CoV-2 viral infection
7336	anterior skull base
7337	endoscopic endonasal surgery
7338	sinonasal malignancy
7339	Jilin
7340	clinical characteristic
7341	Peritoneal dialysis
7342	Renal transplant
7343	Immune deficiency
7344	Xenobiotics
7345	Otolaryngological manifestations
7346	emerging coronavirus
7347	Cirugíamínimamente invasiva
7348	Cirugía laparoscópica
7349	Cirugía robótica
7350	Minimallyinvasive surgery
7351	Roboticsurgery
7352	corticosteroid
7353	renal transplant
7354	Pulmonary function testing
7355	respiratory center
7356	Oral and maxillofacial surgery
7357	ANG II
7358	Basic Reproduction Number
7359	Disease Outbreak
7360	Fitness Centers
7361	cyclophilin A
7362	cyclosporin A
7363	Cardiovascular surgery
7364	Hub-and-spoke
7365	CDC
7366	Ministry of Health
7367	Arachidonic acid
7368	Lipoxin A4
7369	Polyunsaturated fatty acids
7370	Prostaglandins
7371	Protectins and maresins
7372	Resolvins
7373	IL-13
7374	airway epithelial cells
7375	nasal epithelial cells
7376	type 2 inflammation
7377	nucleic acid-negative
7378	nucleic acid-positive
7379	Clinique
7380	Nouveau coronavirus
7381	illness severity
7382	serial testing
7383	viral transmission
7384	home isolation
7385	information systems
7386	privacy
7387	symptom monitoring
7388	Family cluster
7389	Prolonged quarantine
7390	Saudi Arabia
7391	occupational hygiene
7392	workers’ health
7393	moxifloxacin
7394	geroscience
7395	Cluster analysis
7396	Comorbidités
7397	Diabète
7398	Obésité
7399	Pneumonie
7400	CoVs
7401	Bone marrow transplantation
7402	Hematopoietic cell transplantation
7403	Immunocompromise
7404	Macrophages
7405	Medical statistics
7406	Pulmonology
7407	echocardiography
7408	pulmonary vascular disease
7409	cardiac rehabilitation
7410	cardiac risk factors and prevention
7411	electronic medical records
7412	COVIDUrology
7413	COVIDUrología
7414	COVID19 cirugía
7415	COVID19 surgery
7416	Urgencia
7417	Infección
7418	Multiple myeloma
7419	Smoldering multiple myeloma
7420	COVID-19, SARS-CoV-2, 2019-nCov
7421	swab
7422	Brote COVID-19
7423	Contigencia sanitaria
7424	Health contingency
7425	Síndrome coronario agudo
7426	Ferritins
7427	Lymphocytes
7428	MeSH repository (3-10)
7429	Colitis ulcerosa
7430	Crohn's disease
7431	Enfermedad de Crohn
7432	Enfermedad inflamatoria intestinal
7433	Ulcerative colitis
7434	Henan Province
7435	Shaanxi Province
7436	anti-viral efficacy
7437	clinical course
7438	Angiotensin-converting enzyme-2
7439	hand hygiene
7440	Coronavirus disease 2019 (COVID-19); SARS-CoV-2; Emergency department
7441	Disease outbreaks
7442	Severe acute respiratory syndrome coronavirus 2 [Supplementary Concept]
7443	Universal precautions
7444	Pregnancy outcomes
7445	Acromegaly
7446	Cushing’s disease
7447	Pituitary disease and surgery
7448	Prolactinomas
7449	Cerebellar ataxia
7450	Cerebellum
7451	endoscopic sinus surgery
7452	endoscopic skull base surgery
7453	intracranial dura
7454	paranasal sinuses
7455	sinus surgery
7456	skull base
7457	frontline health care staff
7458	respirator mask
7459	DPP4
7460	Diabetes therapy
7461	Bilirubin
7462	Liver tests
7463	cohort isolation
7464	end-stage renal disease
7465	hemodialysis units
7466	Inflammatory Bowel Diseases
7467	epidemiological pattern
7468	geospatial pattern
7469	hotspot
7470	biosafety guidelines
7471	cytology
7472	fine-needle aspiration
7473	histology
7474	Health worker infection
7475	gustatory function
7476	hyposmia
7477	nasal obstruction
7478	olfactory function
7479	rhinorrhea
7480	diarrhea
7481	end-stage renal disease (ESRD)
7482	geospatial
7483	mobility
7484	Correlation analysis
7485	Prognostic indicator
7486	Viral respiratory infections
7487	Arthritis
7488	Behcet Syndrome
7489	Juvenile
7490	Systemic vasculitis
7491	Olfactory loss
7492	Multiorgan dysfunction
7493	Severe pneumonia
7494	SEIR
7495	data fitting
7496	data simulation
7497	effective reproductive number
7498	effectiveness
7499	surgeries
7500	transplantations
7501	childbearing age
7502	health information
7503	women
7504	Healthcare management
7505	Southeast European (SEE) countries
7506	Sina Weibo
7507	help
7508	Breastfeeding
7509	Infant
7510	Coronavirus disease-2019 (COVID-19)
7511	Asymptomatic Person
7512	Clinical Manifestation
7513	Acute respiratory infections
7514	Coinfection
7515	Disease surveillance
7516	Virus-virus interactions
7517	cardiac
7518	coronary artery bypass grafting
7519	Infants
7520	companion animals
7521	livestock
7522	immune system diseases
7523	communicable diseases, imported
7524	neonatology
7525	chemosis
7526	conjunctival hyperemia
7527	UAE
7528	human coronavirus
7529	indoor and outdoor climate
7530	post-lockdown period
7531	pre-existing conditions
7532	public health strategy
7533	Chloroquine (CQ)
7534	hydroxychloroquine (HCQ)
7535	inapparent infection
7536	virus classification|taste disorder |olfactory disorder
7537	T cell receptors
7538	TCR repertoire
7539	TCR-seq
7540	radiation oncology
7541	radiotherapy
7542	dental public health
7543	infectious disease(s)
7544	Morbidity
7545	Rendesivir.
7546	digital contact tracking
7547	mobile geopositioning
7548	precision public health
7549	proximity tracing
7550	2019-nCOV
7551	dietary fiber
7552	functional foods
7553	gut microbiota
7554	innate immune response
7555	probiotic
7556	short-chain fatty acids (SCFAs)
7557	synbiotic
7558	otolaryngologists
7559	upper airway
7560	apoptosis
7561	anti-inflammatory effects
7562	gut-lung microbiota aixs
7563	high-fibre diet
7564	Challenges
7565	emergent cardiovascular diseases
7566	pacemaker
7567	virus pneumonia
7568	Early treatment
7569	Paucisymptomatic
7570	Randomized controlled clinical trial
7571	mathematical model
7572	scleroderma
7573	systemic
7574	Chronic kidney disease
7575	Severe acute respiratory syndrome-CoV-2
7576	CD4+ counts
7577	Neutrophil-lymphocyte ratio
7578	RT-PCR-CT values
7579	family aggregation
7580	disease importation
7581	ICD
7582	LSTM
7583	RNN
7584	community disease
7585	correlation
7586	hypothesis test
7587	keras
7588	measurable sensor data
7589	python
7590	regression
7591	spread factor
7592	statistics
7593	transmission rate
7594	containment delay
7595	secondary attack rate
7596	corona 2019
7597	health care provider
7598	laparoscopy
7599	physician
7600	surgical procedures, operative
7601	California
7602	Coronavirus diseases
7603	respiratory diseases
7604	Ablation therapy
7605	tumor
7606	risk map
7607	Fangcang Hospital
7608	Non-critically ill patients
7609	Hemiarthroplasty
7610	Hip fracture
7611	Readmissions
7612	Total hip arthroplasty
7613	Cáncer de próstata
7614	Prostate Cancer
7615	SARSCoV-2
7616	Children, COVID-19, SARS-CoV-2, Pandemic, Paediatrician, Pakistan
7617	proton pump inhibition
7618	SARS-coronavirus 2
7619	host immune defenses
7620	primary immunodeficiency
7621	whole exome sequencing
7622	COVID-19, MERS-CoV
7623	Rheumatic immune disease
7624	 COVID-19, Glucovigilance, Prognosis, Diabetologists, Social distancing, Type 1 diabetes, Type 2 diabetes.
7625	Powered air-purifying respirator
7626	chronic conditions
7627	complications
7628	population-based estimates
7629	coagulation parameters
7630	disseminated intravascular coagulation
7631	low-molecular-weight heparin
7632	Isolation
7633	severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)
7634	state of emergency
7635	urology
7636	Drug shortage
7637	Employee screening
7638	Risk assessment
7639	Risk mitigation
7640	Supply chain
7641	venous thromboembolism
7642	gastrointestinal manifestation
7643	Fatality or mortality
7644	assisted reproduction
7645	Cardiovascular implications
7646	Canada
7647	best practices
7648	G6PD deficiency
7649	haemolysis
7650	Medical personnel
7651	Respirator
7652	Self-isolation
7653	Sexual activity
7654	UK
7655	attitudes
7656	dental practitioners
7657	risk perception
7658	Novel coronavirus disease (COVID-19)
7659	Epidemiologic
7660	SARS CoV-2, Mechanical management, ARDS, Pandemic, Coronavirus.
7661	odor identification
7662	2019 coronavirus disease
7663	antenatal care
7664	health care management
7665	maternal health
7666	pregnant
7667	Percutaneous
7668	medical news
7669	Head and neck cancer
7670	Engagement in care
7671	Substance use
7672	FFP3 masks
7673	surgical care
7674	Epidemiologic Measurements
7675	Generation Interval
7676	Serial Interval
7677	Poland
7678	health professionals
7679	Gender
7680	GI bleeding
7681	Urgent endoscopy
7682	appropriateness
7683	disease transmission
7684	nonpharmaceutical interventions
7685	social distancing interventions
7686	epidemiological characteristics
7687	Wuhan, SARS, SARS-CoV-2
7688	automatic integrated gene detection system
7689	rapid detection
7690	coronavirus quarantine
7691	covid-19 isolation
7692	covid-19 prevention
7693	lock-down
7694	nepal
7695	nepal covid-19
7696	sars-cov-2 testing
7697	Cohort study
7698	viral inoculum
7699	diagnostic indicator
7700	fever clinic
7701	Surgical outcomes
7702	isolation ward
7703	suspected COVID-19
7704	ENT endoscopy
7705	Endoscopic nasopharyngoscopy
7706	Risk of contamination
7707	Multi-organ failure and immunopathology
7708	Loss of smell
7709	Gustatory disorders
7710	Olfactory disorders
7711	C-reactive protein (CRP)
7712	myxovirus resistance protein A (MxA)
7713	point-of-care test
7714	rapid diagnostic tests
7715	COVID-19 neurological complications
7716	Endotheliitis
7717	Environmental neurology, MERS
7718	Neuroepidemiology
7719	Neuropathology
7720	Viral neurotropism
7721	Academic research
7722	Social impacts
7723	low-grade inflammation
7724	type 2 diabetes
7725	surgical smoke
7726	ultrasonic scalpel
7727	Craniosynostosis
7728	Pediatric neurosurgery
7729	SARS-CoV-2 COVID-19
7730	Hyperimmune globulin
7731	Intravenous immunoglobulin
7732	Burkitt lymphoma
7733	Hodgkin lymphoma
7734	WHO Global Initiative on Childhood Cancer
7735	Wilms tumor
7736	acute lymphoblastic leukemia
7737	childhood cancer
7738	low-grade glioma
7739	nephroblastoma
7740	retinoblastoma
7741	infection control precautions
7742	coronavirus disease 19
7743	infant
7744	paediatric
7745	viral infections
7746	Communicable diseases
7747	Conflict
7748	Syria
7749	cardiac disease
7750	cerebrovascular disease/stroke
7751	vascular disease
7752	High-risk bladder
7753	Neurourology
7754	Neurourología
7755	Vejiga de riesgo
7756	Immunité
7757	Physiopathologie
7758	Thromboses
7759	Milieu pénitentiaire
7760	Prison
7761	antibiotic: antiviral
7762	immunosuppression/immune modulation
7763	Atención oftalmológica
7764	Eye care
7765	Oftalmología
7766	Mucosal squamous cell carcinoma
7767	Multilevel risk
7768	Risk stratification
7769	Surgical barriers
7770	Surgical risk
7771	Treatment paradigms
7772	importation
7773	Phoniatrics
7774	Swallowing
7775	Arthroplasty
7776	Arthroscopy
7777	Health-care
7778	Ligament reconstruction
7779	Rotator cuff
7780	Bias analysis
7781	Uncertainty
7782	Under-diagnosis
7783	Ozono
7784	Vitamin C
7785	Vitamina C
7786	Original research
7787	Preprint
7788	Immunosuppressive agents
7789	call center
7790	Intravenous immunoglobulins
7791	immunological characteristics
7792	inflammatory cytokine storm
7793	Clinical decision-making
7794	Endoscopia
7795	Toma de decisiones clínicas
7796	Chronic exposure
7797	Viral diffusion
7798	generalized linear model
7799	thrombocytopenia
7800	Corona virus: market hazard
7801	breath test
7802	manometry
7803	pH impedance monitoring
7804	Infant and young child feeding in emergencies
7805	Policy development
7806	Prevention of mother-to-child-transmission
7807	Blood gas analysis
7808	Tracheal intubation
7809	Consensus methods
7810	De-escalation
7811	Desescalada
7812	Métodos de consenso
7813	Priorización
7814	Priorization
7815	Anesthesia management
7816	Type I interferons
7817	Climate effect
7818	Local transmission rate
7819	cardiomyopathies
7820	NT-proBNT
7821	migration scale index
7822	COVID-19; Lockdown; Exit Strategy; Nepal
7823	Children - clinical features - COVID-2019 - epidemiology - prevention - SARS-CoV-2 - severity of illness - treatment
7824	infection control measures
7825	leukocytosis
7826	preventive medicine
7827	cardiac magnetic resonance
7828	chest x-ray
7829	multimodality imaging
7830	Forecast
7831	Locally advanced
7832	Non–small cell lung cancer
7833	 drugs
7834	 host-based
7835	 repurposing
7836	 virus-based
7837	Metabolic Syndrome
7838	atherothrombotic disease
7839	cardiometabolic health
7840	cardiometabolic risk
7841	cardiometabolic syndrome
7842	Artificial feeding
7843	Critical illness
7844	Mortalidad
7845	Servicio de urgencias
7846	pneumonia outbreak
7847	human immunodeficiency virus
7848	anti-aging
7849	hallmarks of aging
7850	associated factors
7851	Practice Patterns, Physicians’
7852	Novel Cornonavirus
7853	Pulmonary CT scan
7854	Elevated hs-crp
7855	Eosinopenia
7856	Global surgery
7857	ALP
7858	Diabetic ketoacidosis
7859	Length of stay
7860	patient outcomes
7861	Control measures
7862	Travel restrictions
7863	Quirófano
7864	Recomendación
7865	Burden of Disease
7866	Disability-Adjusted Life Years
7867	Years of Life Lost
7868	SARSCoV-2
7869	coronavirus secondary transmission
7870	droplet transmission
7871	family cluster
7872	restaurant
7873	myocardial infarction
7874	thrombolysis
7875	transshipment
7876	Hong Kong
7877	Acute care surgery
7878	long-acting β-agonist
7879	rhinosinusitis
7880	COVID-19 wastewater based epidemiology
7881	Electronegative membrane filtration
7882	PEG-based separation
7883	Precondition
7884	Primary concentration
7885	Ultrafiltration
7886	Urothelial cancer
7887	Disruption
7888	Health care
7889	Total joint arthroplasty
7890	gynecology
7891	Risk Factor
7892	cell susceptibility
7893	SARS-CoV-2 RDT kits
7894	Trend of infection
7895	admission
7896	IBD
7897	Endocrine emergencies
7898	Endocrine surgery
7899	Thyroid cancer
7900	anticoagulant therapy
7901	Clostridiodes difficile
7902	IFN-γ
7903	IL-12
7904	enteric infections
7905	3D-printing
7906	Health care workers protection
7907	community
7908	evidence-based practice
7909	source control
7910	surgical mask
7911	COVID-19-infected patients COVID-19 patients
7912	asymptomatic carriers
7913	familial outbreaks
7914	air conditioning
7915	airborne transmission
7916	airborne viral spread
7917	indoor air conditioning
7918	Angiography
7919	Bronchial arteries
7920	contingency planning
7921	novel severe acute respiratory syndrome coronavirus 2
7922	Nutraceuticals
7923	Repurposing approved drugs
7924	incubation
7925	Coronavirus infections/epidemiology
7926	Enzyme-linked Immunosorbent assay
7927	Geographic information systems
7928	Models, economic
7929	Panel study
7930	Socio-economic factors
7931	Spatial analysis
7932	Stress, psychological
7933	infectiousness
7934	public health policy
7935	address-based sampling
7936	convenience sampling
7937	aesthetic
7938	dermatology
7939	skin
7940	acute symptomatic seizures
7941	epilepsy
7942	ACEi/ARB
7943	statin
7944	 lopinavir/ritonavir
7945	 treatment outcome
7946	antibodies against SARS-CoV-2
7947	national health insurance
7948	universal health care
7949	treatment other
7950	Cytokine Release Syndrom (CRS)
7951	SARS-CoV-2 (virus)
7952	cholinergic anti-inflammatory pathway
7953	case-fatality risk
7954	CFR
7955	Hubei
7956	case-fatality ratio
7957	Wenzhou
7958	Ictus
7959	Google trends
7960	Internal Medicine
7961	Respirology
7962	Acute respiratory distress syndrome - ARDS
7963	Lungs
7964	Nicotine
7965	α4/α7 Nicotinic Ach receptors - nAChRs
7966	Encephalopathy
7967	MRI
7968	Respiratory failure
7969	coagulation parameter
7970	Social Distancing
7971	MSC
7972	bone marrow
7973	exosome
7974	Emerging viruses
7975	Surveillance Sentinel Network, influenza-like illness
7976	Cancer du sein
7977	Recommandation
7978	SARS-CoV-2; COVID-19; Therapeutics; Pandemics
7979	Therapeutics repurposing
7980	effect
7981	animal models of human disease
7982	canine respiratory coronavirus
7983	dogs
7984	tracheal cultures
7985	gerontology
7986	Screening strategies
7987	Cellphone
7988	Time trend
7989	Tracheotomy
7990	Neurosurgical residents
7991	outpatients
7992	pediatric critical care
7993	veno-venous extracorporeal membrane oxygenation
7994	immune checkpoint inhibitors
7995	immune-related Pneumonitis
7996	Cardiac CT
7997	Cardiac MRI
7998	Cardiovascular imaging
7999	Emergency
8000	Health Public
8001	healthcare-associated
8002	surgical
8003	EMG
8004	Hygiene
8005	Neurophysiological test
8006	Risky Sexual Behavior
8007	Sexual Activities
8008	Sexual Frequency
8009	Neurology
8010	Thin-section CT
8011	Covid
8012	ophthalmologist
8013	Case Fatality Rate
8014	IRAN
8015	Nepal
8016	The COVID-19
8017	impacts
8018	visual disabilities
8019	bacteremia
8020	blood culture
8021	Asymptom
8022	Cardiac impact
8023	Gestion des thérapeutiques
8024	Impact cardiaque
8025	Therapeutics management
8026	histopathology
8027	alcohol use
8028	dietary habits
8029	Coronavirus 2019
8030	Facteurs de risque
8031	Tabagisme
8032	infection fatality rate
8033	GI
8034	LFT
8035	Early characteristics
8036	Epidemic size
8037	Ischemic Stroke
8038	Hyperimmune plasma
8039	Plasmapheresis
8040	Health emergency
8041	cohort study
8042	hyperglycemia
8043	impaired fasting glucose
8044	immunological mechanisms
8045	immunotherapies
8046	heart injury
8047	laboratory indicators
8048	patient education
8049	quality of information
8050	youtube
8051	overlapping
8052	syndemic
8053	Angiotensin-converting enzyme
8054	Angiotensin-converting enzyme inhibitors
8055	reproduction number
8056	Impoverished area
8057	Telomeres
8058	Lung damage
8059	hip fractures
8060	trauma
8061	Non-hospitalized
8062	Outpatient
8063	Economic
8064	chronic disease
8065	Angiotensin receptor blocker
8066	Angiotensin-converting enzyme inhibitor
8067	Bricitinib
8068	JAK inhibitors
8069	JAK-STAT pathway
8070	Methotrexate
8071	Cirrhosis
8072	Cirrosis
8073	Hígado
8074	Antibody tests
8075	droplet
8076	nasal endoscopy
8077	splatter
8078	chest CT
8079	covid-19 pneumonia
8080	rt-PCR
8081	Covid-19 outcomes
8082	Respiratory infections
8083	organ acceptance
8084	organ procurement
8085	Inhalers and Drugs
8086	Nebulizers
8087	Coronavirus 19
8088	contact lens
8089	lens care
8090	lens wear
8091	SAR-CoV-2
8092	Syndrome
8093	Deep vein thrombosis
8094	Doppler ultrasound
8095	 COVID-19, Radiology, Chest X-ray, CT scan, Ultrasound, Artificial intelligence, Sub-pleural consolidation, Ground glass opacification.
8096	 COVID-19, Cardiology, Pulmonology, Rehabilitation, Physical examination.
8097	geriatric
8098	inpatient rehabilitation
8099	patient outcome
8100	subacute care
8101	improvisation
8102	new research reality
8103	medical workers
8104	Cardiologist
8105	Mitigation
8106	Respiratory Virus
8107	Orthopaedic and Trauma
8108	Pancreatic Injury
8109	eye care
8110	oseltamivir
8111	primary care
8112	randomised controlled trial
8113	Long-term care facilicity
8114	questionnaire
8115	SARS-CoV-2, COVID-19, coronavirus disease
8116	coronavirus, EU/EEA, United Kingdom, Europe
8117	Cardiac events
8118	weather
8119	concern
8120	cross-sectional
8121	health disparity
8122	inequality
8123	adaptive clinical trials
8124	clinical trials as a topic
8125	medical record systems, computerized
8126	primary health care
8127	public health surveillance
8128	sentinel surveillance
8129	elderly people
8130	risk interaction
8131	Geographical information systems
8132	Cardiovascular risk
8133	Diabetes management
8134	caregiving
8135	neurocognitive disorder
8136	Obesidad
8137	Overweight
8138	Sobrepeso
8139	Cluster distribution
8140	Reporting delay
8141	Reproduction number
8142	Transmission heterogeneity
8143	Transmission potential
8144	cardiovascular risk factors
8145	gynecologic surgical procedures
8146	laparoscopes
8147	postoperative complications
8148	Limited resources
8149	kidney (allograft) function/dysfunction
8150	SARS -CoV-2
8151	continuous glucose monitoring
8152	glucose variability
8153	health data
8154	global surveillance
8155	science forum
8156	DISCERN instrument
8157	HONcode
8158	JAMA benchmarks
8159	health information seeking
8160	information quality
8161	misinformation
8162	nCoV
8163	Otolaryngology
8164	Indonesia
8165	Northern Italy
8166	interprofessional education
8167	obstetrics
8168	patient simulation
8169	simulation training
8170	Mycoplasma pneumoniae
8171	Centers for disease control
8172	Donald Trump
8173	Environmental Protection Agency
8174	clinical character
8175	AQI
8176	Ambient air pollutant
8177	Coexistent disease
8178	South Africa
8179	burial ceremony
8180	religion
8181	tradition
8182	Aspergillus
8183	aspergillosis
8184	fungal superinfection
8185	fungi
8186	Severe acute respiratory syndrome-related coronavirus 2
8187	Virulence
8188	Autonomic nervous system
8189	Autonomic units
8190	Cardiovascular autonomic testing
8191	Electrocardiography
8192	Heart
8193	availability
8194	medical professional
8195	haematological malignancies
8196	Orthopaedic hospital
8197	Outbreak management
8198	Elevated liver enzymes
8199	HME
8200	Laryngectomy
8201	Olfactory bulb
8202	Respiratory
8203	Laboratory tests
8204	electronic health record
8205	neural networks
8206	Effective reproduction number
8207	Intervention strategy
8208	cross infection
8209	health personnel
8210	equity
8211	rationing
8212	Oman
8213	health care worker (HCW)
8214	preexamination
8215	Clinic management
8216	Crude fatality ratio
8217	interventive measures
8218	HLS-EU-Q
8219	adult population
8220	Gastrointestinal symptom
8221	Subtype
8222	Time Series models
8223	mARIMA Prediction Model
8224	Gynecologic Oncology
8225	Rheumatic diseases
8226	BTC
8227	HCC
8228	liver cancer
8229	Epidemic model
8230	Infection Control
8231	Patient Isolation
8232	IL-2R/lymphocyte ratio
8233	clinical progression
8234	CT scan
8235	Gender effect
8236	General population
8237	Personality
8238	Stress response
8239	Laboratory factors
8240	Renal impairment
8241	oncological care
8242	Anticoagulation therapy
8243	Thromboembolic events
8244	Novel Coronavirus SARS-CoV-2
8245	COVID-19, epidemic, Hungary, under-ascertainment, SARS-CoV-2, compartmental model, reproduction number, intervention, case fatality rate
8246	Skin cancer
8247	Skin malignancies
8248	Distance to the epicenter
8249	Ripple effect
8250	Typhoon eye effect
8251	Occurrence
8252	Reporting criteria
8253	Predictor
8254	Radiographic findings
8255	pandemic preparedness
8256	countermeasures
8257	principles of aetiology
8258	Weibo
8259	remote
8260	remote learning
8261	video conference
8262	virtual
8263	virtual conference
8264	virtual tumor board
8265	Austria
8266	exported cases
8267	tourism
8268	biological hazard
8269	decision-making
8270	Pandemic, corona virus disease
8271	severe acute respiratory syndrome coronavirus
8272	world
8273	Respiratory syndrome
8274	computerized
8275	medical record systems
8276	records as topic
8277	Lombardy outbreak
8278	seriousness of disease
8279	angiotensin receptor blockers
8280	arrhythmias
8281	cardiovascular imaging
8282	organ transplant
8283	infection clearance
8284	organ shortage
8285	transplant activity
8286	CPAP
8287	acute respiratory failure
8288	high flow nasal oxygen therapy
8289	non-invasive mechanical ventilation
8290	ventilatory support
8291	Analgesia
8292	Obstetric
8293	Care organization
8294	Epidemia
8295	Organización asistencial
8296	Hematology
8297	Viral encephalitis
8298	Shoulder
8299	fracture
8300	humerus
8301	early treatment
8302	Evacuation
8303	Incubation time
8304	Isolation and quarantine
8305	Systemic sclerosis
8306	Addictions
8307	Harm-reduction
8308	Stigma
8309	Substance use disorder
8310	COVID-19 face masks
8311	transmission route
8312	Disease outcome
8313	SARS COV-2
8314	ophthalmologists
8315	Global health emergency
8316	Organ donation
8317	Virus tests
8318	cardiac biomarkers
8319	cardiac manifestations
8320	clinical presentations
8321	insulin
8322	COVID-19, Cardiovascular disease
8323	Plenatery health
8324	Diabetic foot ulcer
8325	Public Health Crisis
8326	CBT-I
8327	acute insomnia
8328	brief intervention
8329	online intervention
8330	short-term insomnia
8331	critical governance
8332	epistemic democracy
8333	political theory
8334	identification
8335	robotics
8336	DCR
8337	lacrimal
8338	nasolacrimal duct
8339	Hepatocelluar carcinoma
8340	Liver cirrhosis
8341	Oral
8342	Ovarian cancer
8343	Targeted therapy
8344	arthroplasty
8345	complexity science
8346	globalization
8347	ncov
8348	precautionary principle
8349	emotion understanding
8350	health communication
8351	opinion mining
8352	sentiment analysis
8353	respiratory viruses
8354	cross-sectional studies
8355	false positive and false negative probabilities
8356	molecular, serological and medical imaging diagnostics
8357	number of infections
8358	policy-making and testing campaigns
8359	prevalence ratio
8360	sensitivity and specificity
8361	stem cell-therapy
8362	Cataract
8363	Phacoemulsification
8364	COVID-19 endemic
8365	Surgery guidelines
8366	funds
8367	research
8368	trials
8369	adults
8370	hospitalized
8371	mechanical ventilator
8372	gustatory
8373	olfactory
8374	Patient concerns inventory
8375	Crohn’s Disease
8376	Ulcerative Colitis
8377	case cancellations
8378	emergency response
8379	staged management
8380	surgical subspecialties
8381	nutrition support
8382	Contraception
8383	family planning
8384	reproductive health
8385	Authorship
8386	Lab life
8387	Denmark;
8388	Management guidelines
8389	Economic impact
8390	In-hospital mortality
8391	qSOFA
8392	Coronary artery disease
8393	Case report
8394	Doubling time
8395	Seeding time
8396	negativization
8397	professionals
8398	Endourology
8399	Endourología
8400	LEOC
8401	Lithiasis
8402	Litiasis
8403	SWL
8404	BladderCáncer
8405	Cáncer de vejiga
8406	Guías clínicas
8407	School closure
8408	Convalescence period
8409	Health system
8410	Hospitalisation
8411	Organisation des soins
8412	cardiac surgery
8413	Chirurgie gynécologique
8414	Cœlioscopie
8415	Gynecological surgery
8416	Public awareness
8417	delay in diagnosis
8418	referral
8419	Hotel
8420	Outbreak control
8421	Rapid response
8422	Households
8423	Metropolitan-wide quarantine
8424	Public space
8425	COVID-19, SARS-CoV-2.
8426	Multidetector computed tomography
8427	neuro-oncology
8428	Asian Americans
8429	allocation of scarce resources
8430	bias in medicine
8431	disability
8432	novel coronavirus SARS-CoV-2
8433	OneHealth
8434	Acoustic neuroma
8435	Brain metastasis
8436	Endoscopic endonasal
8437	Glioblastoma
8438	Glioma
8439	Meningioma
8440	Neuro-oncology
8441	Skull base
8442	evacuation
8443	incubation time
8444	duration of stay
8445	 SARS-CoV-2, COVID-19, Pandemic, Conjunctivitis, Ophthalmologist.
8446	 SARS-CoV-2, Disaster response, Coronavirus, Quarantine, PPE, Pakistan.
8447	lessons learned
8448	Advance care planning
8449	advance directives
8450	shared decision making
8451	Nursing homes
8452	confidentiality and privacy
8453	FFP2
8454	Personal protection equipment
8455	Reprocessing
8456	Respirators
8457	Georgia
8458	geographic distribution
8459	social determinants
8460	New-born
8461	Walk-through
8462	critical care need
8463	Non-communicable diseases
8464	COVID–19
8465	fej-nyak régió
8466	fogászat
8467	head and neck region
8468	koronavírus
8469	oral surgery
8470	szájsebészet
8471	coronavirus, COVID-19
8472	Health financing, equity
8473	clinical management
8474	continuing medical education
8475	amyloidosis
8476	national statistics
8477	Anti–IL-6R
8478	Anti–PD-1
8479	Pembrolizumab
8480	angiotensin II
8481	septic shock
8482	Allergic rhinitis
8483	Allergy immunotherapy
8484	Anaphylaxis
8485	Cost-effectiveness analysis
8486	Economic outcomes
8487	Epinephrine
8488	Epinephrine autoinjectors
8489	Quality-adjusted life-years
8490	Systemic reaction to immunotherapy
8491	Venom immunotherapy
8492	neurosurgery
8493	bronchoalveolar lavage (BAL)
8494	critical care/intensive care management
8495	Practical health vigilance recommendations
8496	Country healthcare resources
8497	Daily cumulative index
8498	Disease incidence
8499	clinical impact
8500	inflammatory bowel disease centre
8501	organisational impact
8502	Philippines
8503	infection cluster
8504	person-to-person transmission
8505	pre-symptomatic transmission
8506	Anticancer
8507	Global Health
8508	Population health
8509	Autodock
8510	Aerosol generating procedures
8511	Changsha
8512	Calcitriol
8513	Cholecalciferol
8514	proactive planning
8515	prognostication
8516	Headache disorders, secondary
8517	Mortality, laboratory parameters
8518	Nervous system diseases
8519	micronutrient
8520	selenoprotein P
8521	trace element
8522	GLP-1RAs
8523	Hyperglycemia
8524	Insulin
8525	Type 2 diabetes
8526	capacity planning
8527	electronic health records
8528	surge models
8529	esophageal manometry
8530	pH monitoring
8531	Emergencia mundial
8532	Geriatrics
8533	Geriatría
8534	Worldwide emergency
8535	Headache
8536	Coagulation and Fibrinolysis
8537	fibrinogen-to-Albumin Ratio (FAR)
8538	non-Severe Survival (NSS)
8539	platelet count (PLT)
8540	2019-New coronavirus
8541	lipid nanoparticle
8542	mouse-adapted strain
8543	Covid-19 serology
8544	Immunofluorescence assay
8545	grey Verhulst model
8546	grey prediction
8547	rolling mechanism
8548	Northeast China
8549	infection location
8550	Cyberchondria
8551	Emotion regulation
8552	Health anxiety
8553	Virus anxiety
8554	Emergency response
8555	Hospital management
8556	Infection prevention and control
8557	Department
8558	Organisation
8559	Organization
8560	Patient
8561	Service
8562	ILD
8563	Androgen
8564	Chromosome
8565	Estrogen
8566	Hormone
8567	Peer review
8568	30-day mortality
8569	Advanced age
8570	Impact
8571	CD4 +
8572	CD8+
8573	Lymphocyte subset counts
8574	Anhui province
8575	Expressed prostatic secretion
8576	Prostate
8577	Acute coronary syndromes
8578	Acute myocardial infarction
8579	Physical Distancing
8580	Public Health
8581	Trust
8582	dentist
8583	protective measures
8584	AGES
8585	hysteroscopy
8586	Causes
8587	Preventions
8588	cytokine storms
8589	Risk communication
8590	Propagation
8591	Superspreader
8592	Superspreading
8593	Anti-diabetic agents
8594	clinical sequelae
8595	consequences of infection
8596	global pandemic
8597	innate and adaptive immune response
8598	Colorectal
8599	Oncological
8600	Orthopaedics
8601	catastrophe
8602	healthcare demand
8603	hospital bed capacity
8604	COVID-19, 2019 Novel Coronavirus 2
8605	Facemask shortage
8606	Novel coronavirus-infected pneumonia
8607	Public health intervention
8608	Universal facemask wearing policy
8609	Retrospective study
8610	age-dependent lethality
8611	economic recovery
8612	lockdown termination
8613	antiretroviral therapy
8614	 COVID-19 
8615	 delay in diagnosis 
8616	 dynamic model 
8617	 hospital resources 
8618	Computerized tomography
8619	cardiovascular pathology
8620	new normal
8621	valvular surgery
8622	Cohort
8623	Florence
8624	Community Treatment Center
8625	Medical Resources
8626	Incidental findings
8627	Multidetector
8628	Comparison
8629	cardiovascular manifestations
8630	critical status
8631	hypotension
8632	Spleen
8633	Acute kidney injury (AKI)
8634	citrates
8635	continuous renal replacement therapy (CRRT)
8636	coronavirus 19 disease (COVID-19)
8637	dialysis solutions
8638	kidney failure
8639	nursing staff
8640	resource management
8641	trend
8642	Female urology
8643	Prioritization
8644	aesthetic clinic
8645	aesthetic medicine
8646	consensus guidelines
8647	COVID-19 patient management
8648	Coronavirus infection control
8649	Health workers
8650	Interventional radiologist safety
8651	Interventional radiology staff safety
8652	Interventional suite infection control
8653	Prevention of infection control
8654	Adenoma
8655	Endonasal
8656	Endoscopic
8657	Hotspots
8658	Epidemic curves
8659	Impact of mitigation measures
8660	Peak magnitude and timing
8661	Total infections
8662	Clinical progression
8663	Viral clearance
8664	climate change
8665	environmental public health
8666	the Anthropocene
8667	ear, nose and throat/otolaryngology
8668	decision criteria
8669	renal cell carcinoma
8670	treatment pattern
8671	CHD
8672	perioperative care
8673	health-care workers
8674	global policy analysis
8675	infectious disease spread
8676	paid sick leave
8677	workplace
8678	elective surgery
8679	Intervention strategies
8680	Psychiatric disorders
8681	Stress vulnerability
8682	Adherence
8683	Paediatric vaccination coverage
8684	Paediatricians
8685	occupational dentistry
8686	psychosocial factors
8687	subjective overload
8688	precautions
8689	CGM
8690	inpatient
8691	type 2
8692	Chest radiography
8693	Coronavirus pneumonia
8694	Mass population tests
8695	pediatric pulmonology
8696	laryngeal evaluation
8697	laryngeal ultrasound
8698	vocal cord paralysis
8699	vocal cord paresis
8700	health policies and all other topics
8701	health systems evaluation
8702	hygiene
8703	infections, diseases, disorders, injuries
8704	portable health clinic
8705	remote healthcare system
8706	unreached communities
8707	child abuse
8708	child protection
8709	school
8710	unemployment
8711	Policy responses
8712	Policy-making
8713	Protective face shield
8714	Three-dimensional printing
8715	drainage
8716	head and neck neoplasms
8717	neck dissection
8718	covid19
8719	risk of contamination
8720	algorithms
8721	 Pandemics
8722	 Practice Guideline
8723	Atherosclerosis
8724	Autoantibodies
8725	Early rheumatoid arthritis
8726	Rheumatoid arthritis
8727	Sjøgren’s syndrome
8728	infection - viral
8729	inflammatory disorders
8730	therapy - systemic
8731	acute respiratory infections
8732	surgical masks
8733	infodemiology, infodemic monikers, Italy
8734	novel coronavirus, COVID-19, Google search
8735	online search
8736	exit strategy
8737	uncertainty
8738	stress disorder
8739	boncolás
8740	forensic pathology
8741	igazságügyi orvostan
8742	patológia
8743	cell death
8744	chemokine
8745	cytoskeleton
8746	epithelium
8747	innate immune system
8748	tight junction
8749	psychosomatic
8750	therapeutic drug monitoring
8751	voriconazole
8752	whole blood inactivation
8753	maladie infectieuse
8754	pandémie
8755	Atención de enfermería
8756	Nursing care
8757	Prevención y control
8758	Prevención y mitigación
8759	Prevention and mitigation
8760	Kazakhstan
8761	Anti-platelets
8762	Anticoagulantes
8763	Anticoagulants
8764	Antitrombóticos
8765	Complicaciones del embarazo
8766	Heparina de bajo peso molecular
8767	Infecciones por coronavirus
8768	Low-molecular-weight heparin
8769	Pregnancy complications
8770	Trombosis
8771	Brote
8772	Infecciones
8773	Telemedicina
8774	Cardiovascular Computed Tomography
8775	sarcopenia
8776	Diabetes, Intensive Care Unit
8777	Enhanced surveillance
8778	offline drug delivery
8779	online outpatient visit
8780	pandemic management
8781	remote diagnosis and treatment
8782	Cuarentena
8783	Content-analysis
8784	coverage
8785	newspapers
8786	Diagnostic imaging
8787	Mass chest X-ray
8788	transplantation
8789	Basilisk algorithm
8790	Correlation Explanation (CorEx)
8791	Patient Health Questionnaire (PHQ)
8792	social media data mining
8793	Epidemiology and outcomes
8794	transplant outcomes
8795	semiology
8796	symptomatology
8797	particulate matter
8798	Glycemic control
8799	Hybrid closed loop
8800	Time in range
8801	vulnerable populations
8802	herd immunology
8803	Aerosolization
8804	Radiology department
8805	zoonotic disease
8806	Antibody dependent enhancement
8807	Collaborations
8808	Interventions
8809	Severe acute respiratory disease
8810	emergency and trauma radiology
8811	severe respiratory failure
8812	Cardiovascular
8813	Complications, and treatment
8814	Lymphocytopenia
8815	Neutrophilia
8816	White blood cells
8817	Bioethics
8818	Importing
8819	Outbreaks
8820	Spreading
8821	cardiac care
8822	heart failure unit
8823	COVID-19 questionnaire
8824	atopic dermatitis
8825	hidradenitis suppurativa
8826	Eyam
8827	History of epidemiology
8828	History of medicine
8829	Plague
8830	Public health ethics
8831	colon cancer
8832	esetismertetés
8833	tüdőgyulladás
8834	vastagbéldaganat
8835	Climate
8836	Sensitivity analysis
8837	Virus surveillance
8838	CVD
8839	prognostic symptoms
8840	preview and triage
8841	Clinical research
8842	Imagerie cardiovasculaire
8843	Maladies cardiovasculaires
8844	Recherche clinique
8845	Close contacts
8846	Jiangsu
8847	Wartime control measures
8848	Bladder cancer
8849	kindey cancer
8850	open surgery
8851	penile cancer
8852	robotic surgery
8853	testicular tumor
8854	urooncology
8855	Epidemiología
8856	Humanism
8857	Humanismo
8858	Resiliencia
8859	health care worker protection
8860	Chloroquine - contact lens - coronavirus - eye donation - eye shields - hydroxychloroquine - ophthalmologist
8861	Hengyang
8862	Novel coronavirus pneumonia
8863	optimization
8864	family-based transmission
8865	migration index
8866	measles
8867	COVID-19-related death
8868	Demographic factors
8869	Mortality displacement
8870	Surveillance system
8871	Total excess mortality
8872	Theoretical
8873	Case fatality rate
8874	Flattening the curve
8875	Sars cov-2
8876	New York City
8877	False positive
8878	Bacillus Calmette–Guérin
8879	ecological study
8880	series of cases
8881	signs
8882	Orthopedic surgeons
8883	Orthopedic surgery
8884	Origen
8885	Patología
8886	chronic gastrointestinal disorders
8887	Human Aging
8888	Air Pollution
8889	Emissions
8890	PM(2.5)
8891	global child health
8892	health emergency
8893	stigma
8894	Access and use
8895	Bundled charges
8896	Jail-involved population
8897	Socioeconomic determinants of health
8898	health disparities
8899	prison health care
8900	head and neck examination
8901	practical guide
8902	Coagulation disorder
8903	esophageal cancer
8904	postoperative
8905	Covid-19 pandemic
8906	Google Forms
8907	e-survey
8908	score
8909	SARS-CoV-2 Infection
8910	zinc
8911	Acute Myocardial Infarction
8912	Cardiogenic Shock
8913	African American
8914	Latino
8915	black
8916	minorities
8917	racial disparity
8918	Benign prostatic hyperplasia
8919	Cirugía endourológica
8920	Endourologic surgery
8921	Hiperplasia benigna de próstata
8922	blood tests
8923	brainstem involvement
8924	Bronx
8925	nosocomial infections
8926	outcome SARS-CoV-2
8927	Airway management
8928	foreign born
8929	health determinants
8930	health inequities
8931	immigrants
8932	migrant workers
8933	refugees
8934	Environmental factors
8935	Humidity
8936	carnosine
8937	Sars - CoV - 2 infection
8938	ESMO adapted recommendations
8939	blood glucose control
8940	Adrenal Gland
8941	Cortisol
8942	Hypothalamo-Pituitary-Adrenal Axis
8943	ART
8944	Dolutegravir
8945	differentiated service delivery
8946	multi-month dispensing
8947	stable
8948	stock out
8949	Healthcare professional
8950	Infection transmission route
8951	Psychosocial status
8952	Intensive care medicine
8953	Angiotensin conversion enzyme type 2
8954	Coronavirus SARS- CoV-2 2019
8955	Coronavirus SARS-CoV-2 2019
8956	Enzima de conversión de angiotensina-2
8957	Sistema renina angiotensina aldosterona
8958	acute coronary syndrome
8959	anti-coagulation
8960	anti-platelet
8961	left ventricular assist device
8962	peripheral arterial disease
8963	X chromosome
8964	Y chromosome
8965	End-stage renal disease
8966	Hemofiltration
8967	Kidney impairment
8968	Renal replacement therapy
8969	Invasive aspergillosis
8970	Pediatric rheumatology
8971	Targeted disease modifying anti-rheumatic drugs
8972	emergency preparedness
8973	Adrenal insufficiency
8974	Endocrine system diseases
8975	Endocrinologists
8976	Ferroptosis
8977	Hyper-ferritinemia
8978	Iron homeostasis
8979	Mitochondria
8980	diabetic ketoacidosis
8981	pancreatic and gastrointestinal hormones
8982	Neutrophil-to-Lymphocyte Ratio
8983	extracorporeal cytokine elimination
8984	vasoplegic shock
8985	Hospital epidemiology
8986	Doxycycline
8987	Hydroxy-chloroquine
8988	Quercetin
8989	Rapamycin
8990	antibiotic
8991	senolytic drug therapy
8992	 SARI
8993	 sentinel
8994	 surveillance
8995	Containment
8996	community-based long-term care
8997	multimorbidities
8998	Mitigation impact
8999	Risk mitigation measures
9000	bereavement
9001	family management
9002	holistic care
9003	palliative medicine
9004	symptom management
9005	test data
9006	Anti-PD-1 monoclonal antibody
9007	immune-checkpoint inhibitors
9008	Antirheumatic medications
9009	IgM/IgG serology
9010	immunofluorescence
9011	Open ward
9012	Baidu
9013	Washington
9014	regional anesthesia
9015	hazard ratio
9016	retrospective cohort
9017	Respiratory virus
9018	Zinc
9019	Contact Trace
9020	Screening Testing
9021	Editorials
9022	case reports
9023	inflammation mediators
9024	SaTScan
9025	Space-time clusters
9026	Ethical dilemma
9027	Hydroxychloroquine treatment
9028	Responsibilities
9029	Rights
9030	home infusion
9031	antibody rapid diagnostic test
9032	sample pooling
9033	Acute respiratory disease syndrome
9034	B-Lines
9035	Interstitial syndrome
9036	Lung ultrasound
9037	pediatric HIV
9038	perinatal HIV
9039	study retention
9040	young adults
9041	asymptomatic infection rate
9042	error-contaminated data
9043	Clinical diagnostic criteria
9044	Evaluation of the intervention effect
9045	Extended SEIR+Q dynamics model
9046	Universal symptom survey
9047	bat
9048	drought
9049	exposure
9050	green light
9051	red light
9052	wildlife
9053	cervical cancer
9054	endometrial cancer
9055	ovarian cancer
9056	value-based priorities
9057	2019-novel coronavirus
9058	Computer science
9059	Mathematics and computing
9060	aged care
9061	older people
9062	endothelial activation
9063	endothelial glycocalyx
9064	severe acute respiratory syndrome corona virus-2
9065	type 2 diabetes mellitus
9066	critically ill
9067	novel coronavirus disease 2019 (COVID-19)
9068	Lactobacillus
9069	cabbage
9070	fermented vegetable
9071	kimchi
9072	ecologic study
9073	Antimalarial
9074	Patient blood management
9075	Transfusion strategy
9076	Politics
9077	Pseudoscientific beliefs
9078	Psychotic disorders
9079	Psychotic phenotype
9080	infectivity of asymptomatic
9081	proportion of asymptomatic
9082	Olfactory disorder
9083	Invasive pulmonary aspergillosis
9084	Multimorbidity
9085	coronavirus; pregnancy outcome; vertical infectious disease transmission.
9086	copathogen
9087	eosinophilopenia
9088	fatal cases
9089	Misclassification
9090	Probabilistic bias analysis
9091	effort/reward imbalance
9092	occupational disease
9093	occupational epidemiology
9094	occupational stress
9095	organizational justice
9096	sleep quality
9097	precautionary measures
9098	psychological effects
9099	quality of life
9100	fetal death
9101	fetus
9102	perinatal infection
9103	preterm birth
9104	D-Dimers
9105	thromboprophylaxis
9106	venous thrombosis
9107	emergency management
9108	infection prevention and control
9109	Cohort Study
9110	Estrategias
9111	Mitigación
9112	Strategies
9113	Shelter-in-place
9114	Agriculture
9115	Emergency medical system
9116	Emergency medical system organization
9117	emergency medical service
9118	pulse oximetry
9119	treatment delays
9120	wellness
9121	5-alpha reductase
9122	Code of Federal Regulations
9123	Infection fatality rate
9124	Patient testing
9125	care algorithm
9126	hospital organization
9127	Health care reorganization
9128	Thoracic surgery
9129	UroSoMe
9130	Urological service
9131	policymaking
9132	health care surveys
9133	hospice care
9134	hospices
9135	palliative care end-of-life care
9136	corona Virus Disease 2019
9137	epidemiological features
9138	Clinical stage
9139	Disease progress
9140	Gastrointestinal intubation
9141	Daytime sleepiness
9142	Sex
9143	Sleep impairment
9144	Physical symptoms
9145	Biologic
9146	Disease activity
9147	Hospitalized
9148	Immunosuppressive
9149	Rheumatology
9150	RALE score
9151	Austere conditions
9152	Burn surgery
9153	SARS-COV2
9154	Brief Severity Scoring System
9155	Facility Isolation
9156	Telephone
9157	Therapeutic Living Center
9158	Chronic
9159	Kidney Failure
9160	renal dialysis
9161	exacerbation prediction
9162	Remote consultation
9163	ophthalmology
9164	Forensic medicine
9165	Coronavirus humano
9166	Infecciones del tracto respiratorio
9167	Virus respiratorios
9168	outbreak dynamics
9169	Burden of disease
9170	Prognostic factors
9171	orthopaedic surgeons
9172	surveys and questionnaires
9173	health economics
9174	Systemic anticancer therapy
9175	Race factors
9176	Neuro-imaging
9177	HPB surgeons
9178	respinse
9179	Transmission routes
9180	infection countermeasures
9181	military appreciation process
9182	pandemic planning
9183	mortalityolder patientsrisk factors
9184	 Subject Terms: Epidemiology
9185	Emergency Medical Services
9186	emergency medical services
9187	prehospital
9188	mental wellness
9189	psychiatric distress
9190	Conferences and meetings
9191	Practice management
9192	immunisation
9193	paediatric hospital surveillance
9194	pandemic influenza
9195	syndromic conditions
9196	vaccine-preventable disease
9197	Malaria
9198	Climate sciences
9199	Asymptomatic transmission
9200	laryngectomy
9201	otolaryngology-head and neck surgery
9202	seasons
9203	Databases
9204	High-flow nasal cannula
9205	Prone positioning
9206	computational social sciences
9207	DRESS syndrome
9208	SARS-2
9209	Stevens-Johnson syndrome
9210	Sweet syndrome
9211	acute generalized exanthematous pustulosis
9212	drug rash
9213	erythema multiforme
9214	figurate erythema
9215	toxic epidermal necrolysis
9216	urticaria
9217	Angioedema
9218	Atopic dermatitis
9219	Food allergy
9220	Primary immunodeficiency
9221	Venom allergy
9222	E-health
9223	Asistencia neurológica
9224	Departamento de neurología
9225	Gestión sanitaria
9226	Neurological care
9227	Neurology department
9228	SARS2-CoV
9229	HE method
9230	HEPA filter
9231	SHE-bougie method
9232	airway management
9233	clincial management
9234	infectious diseases, SARS
9235	tracheal intubation
9236	AGMP
9237	Aerosol generating medical procedure
9238	Airway
9239	Ventilator
9240	Renal Replacement Therapy
9241	intensive care medicine
9242	kidney replacement
9243	peritoneal dialysis
9244	Disease Outbreaks
9245	Records
9246	chronic dialysis
9247	ambulatory care facilities
9248	chronic
9249	visitors to patients
9250	Manila
9251	X-ray computed
9252	CBC
9253	Continuity of patient care
9254	Metastatic cancer
9255	Demography
9256	Infertility
9257	Medical workers
9258	Pressure
9259	Sleep disturbances
9260	cellular therapy
9261	hematopoietic cell transplan
9262	COVID-19. Nutrición. Nutrición enteral. Cuidados críticos. Energía.
9263	coronary heart disease
9264	coronary intervention
9265	ischaemic heart disease
9266	Posttraumatic stress disease
9267	Insomnia
9268	Occupational health mental health
9269	Workers
9270	Workforce
9271	Longitudinal
9272	Precaution
9273	mothers
9274	post-traumatic stress disorder
9275	prenatal
9276	Patients' perspective
9277	Botswana
9278	contributions
9279	Republic of Korea
9280	antihypertensive agents
9281	Depressive symptoms
9282	Disparities
9283	Multivariable model
9284	Gynecological Malignancies
9285	Severe acute respiratory syndrome coronavirus
9286	editorial/personal viewpoint
9287	patient survival
9288	Decision-making
9289	citizen preparedness
9290	disaster
9291	epidemic risk
9292	online health
9293	oral health
9294	tweet
9295	tertiary care hospital
9296	Computational epidemiology
9297	Higher education
9298	Post-secondary education
9299	National Institute for Communicable Diseases (NICD)
9300	World Health Organization (WHO)
9301	nasal
9302	oropharyngeal
9303	person under investigation (PUI).
9304	everolimus
9305	mycophenolate
9306	standardized incidence
9307	standardized mortality
9308	tacrolimus
9309	MMR vaccine
9310	multivariable regression
9311	cancer patient
9312	GGT
9313	Metabolic syndrome
9314	Assortative
9315	Masks
9316	Mixing
9317	Symptom
9318	Psychological distress
9319	Meta-Analysis
9320	Computer Model
9321	SIRD
9322	Global Polio Eradication Initiative
9323	polio
9324	disease management
9325	environment
9326	internal medicine
9327	OVID-19
9328	maintenance hemodialysis
9329	Novel coronavirus (COVID-19)
9330	Older patients
9331	1918–1919 influenza pandemic
9332	Bacteriology
9333	Ecology of knowledge
9334	Emerging and re-emerging infections
9335	Networks
9336	Parasitology
9337	Population ecology
9338	Tropical medicine
9339	case fatality ratio
9340	alternatives
9341	ash
9342	hand wash
9343	low-resource settings
9344	sand
9345	soda ash
9346	Enfermedad por coronavirus 19
9347	Infección quirúrgica
9348	Medidas preventivas
9349	Preventative measures
9350	Surgical infection
9351	Environmental sciences
9352	Infection Prevention
9353	Costs and Cost Analysis
9354	Insurance
9355	Laboratory characteristics
9356	health burden
9357	Travelers
9358	TIA
9359	chronic inflammation
9360	Ageing
9361	Health inequalities
9362	Inequalities
9363	Life course epidemiology
9364	Longitudinal studies
9365	Social epidemiology
9366	Social inequalities
9367	Fracture
9368	Anticoagulation
9369	General wards
9370	Practice
9371	Volume
9372	doctors
9373	physicians
9374	CRISP-DM
9375	Czech Republic
9376	epidemiological overview
9377	interactive reporting
9378	web app
9379	Femoral neck fracture
9380	Neck of femur fracture
9381	Predictors
9382	Iron overload
9383	Influenza A
9384	Health system transformation
9385	Maternal health
9386	NCD pregnancy complications
9387	systemic inflammatory diseases
9388	AFO-202 beta glucan
9389	chronic kidney disease
9390	co-morbidity
9391	immuno-compromised
9392	nutritional supplement
9393	epidemic evaluation
9394	epidemic peak
9395	moving average
9396	novel coronavirus COVID-19
9397	maternal anxiety
9398	Meaning response
9399	Psychoneuroimmunology
9400	symptom variation
9401	Delphi consensus
9402	brain ischemia
9403	premature baby
9404	Corona virus disease 2019 (COVID-19)
9405	Population
9406	Psychology
9407	Psychopathology
9408	Mass-media
9409	Periprosthetic joint infections
9410	Surgical site infections
9411	Fear
9412	Medical staff
9413	Behavior changes
9414	Phobia
9415	Public psychological status
9416	 remote physical therapy
9417	 tele-medicine
9418	telerehabilitation
9419	oral candidiasis
9420	oropharyngeal candidiasis
9421	Clinical decision making
9422	Urological surgical procedures
9423	Bias
9424	checklist
9425	system
9426	epidemiologic study
9427	home-based primary care
9428	open
9429	percutaneous
9430	conservation of PPE
9431	novel approach
9432	LMIC
9433	Vulnerable populations
9434	Wellbeing
9435	precaution
9436	respiratory symptoms
9437	EPIDEMIOLOGY
9438	MENTAL HEALTH
9439	PSYCHOSOCIAL FACTORS
9440	PUBLIC HEALTH
9441	Digital health management
9442	IT/ICT applications for coronavirus disease 2019
9443	digital management of pandemic
9444	Zoonotic Risk
9445	ethnographic
9446	qualitative
9447	rural communities
9448	southern China
9449	Pythagorean means
9450	global health security risk
9451	numerical rankings
9452	ordinal rankings
9453	Renin angiotensin aldosterone system
9454	cardiovascular therapy
9455	manifestations
9456	oral
9457	Sexual and reproductive health
9458	CRC and COVID-19
9459	colorectal cancer patients during COVID19 pandemic
9460	colorectal cancer patients recommendetions
9461	HIT
9462	computational health
9463	health information technology
9464	interface
9465	monitoring
9466	real-time analytics
9467	real-world data
9468	Angiotensin-receptor blockers
9469	anxiety disorder
9470	medical students
9471	personal protective measures
9472	Cluster
9473	Control
9474	Angioplastia
9475	Angioplasty
9476	Fibrinólisis
9477	NSTEMI
9478	STEMI
9479	one health surveillance
9480	platelet count
9481	Computed tomographic
9482	UVB
9483	ascorbic acid
9484	cathelicidin
9485	observational
9486	solar radiation
9487	vitamin C
9488	Anti-rheumatic drugs
9489	Autoimmune diseases
9490	Respiratory viral infection
9491	Seasonality
9492	mindfulness and well-being
9493	misinfodemics
9494	psychological problems
9495	psychosocial issues
9496	social and behavioral epidemiology
9497	London
9498	endoscopic ultrasound
9499	Joinpoint
9500	Times series
9501	symptom assessment
9502	Reporting
9503	Statistical model
9504	Shanghai
9505	organ procurement organization
9506	Clustering
9507	Turkey
9508	percutaneous coronary intervention
9509	Distancing
9510	population health
9511	virus outbreak
9512	immune-epidemiology
9513	disease cognition
9514	internet hospital
9515	novel coronavirus disease
9516	psychological burden
9517	hepatology
9518	obstetric decisions
9519	prenatal anxiety
9520	Heterogeneity
9521	Mitigation strategies
9522	Network model
9523	B-cell depleting therapies
9524	DMTs
9525	Multiple Sclerosis
9526	depressive disorder
9527	major
9528	 mathematical model
9529	 public health
9530	distress
9531	income losses
9532	COVID-19 and shoulder trauma
9533	COVID-19 and traumatology
9534	COVID-19 shoulder impact
9535	proximal humerus fractures
9536	radial head fractures
9537	shoulder and elbow trauma
9538	Conjunctival congestion
9539	Smartphone addiction
9540	Major Trauma Centre
9541	healthcare professionals
9542	students
9543	TB
9544	syndemics
9545	GSTM1
9546	GSTT1
9547	Polymorphism
9548	Super-spreading
9549	Transmission clusters
9550	Edinburgh Postnatal Depression Scale
9551	perinatal anxiety
9552	perinatal depression
9553	2008 MSC: R181.2
9554	Infectious kinetics
9555	Nonpharmaceutical interventions
9556	Statistical models
9557	Time series analysis
9558	COVID-19 - epidemiology - high-flow nasal cannula - intensive care unit - lactate - mechanical ventilation - mortality
9559	Henan province
9560	perceived COVID-19 test availability
9561	perceived health condition
9562	psychiatric screening
9563	dementia
9564	employees
9565	job satisfaction
9566	resume work
9567	turnover intention
9568	work attitudes
9569	work engagement
9570	Emerging and re-emerging diseases
9571	Multi-sectorial approaches
9572	Neglected tropical diseases
9573	patient health questionnaire
9574	sleep wake disorders
9575	Chest pain
9576	Cardiac rehabilitation
9577	Secondary prevention
9578	Lassa fever
9579	Brugada syndrome
9580	Cardiomyopathy
9581	Catecholaminergic polymorphic ventricular tachycardia
9582	Genetic heart disease
9583	care homes
9584	residents
9585	imaging features
9586	systematical review
9587	lung disease: infectious
9588	outpatient care
9589	 mathematics
9590	 models
9591	life expectancy
9592	social determinants of disease
9593	SarsCoV2
9594	eating behaviours
9595	emotional eating
9596	lifestyle
9597	Anxiety symptoms
9598	Family members of health care workers
9599	leadership
9600	policing
9601	procedural justice
9602	shared social identity
9603	social disorder
9604	social order
9605	Coronavirus Act 2020
9606	ICU capability
9607	NHS cancels routine surgery and therapies
9608	PPE supply chain
9609	death toll
9610	debt burden
9611	impact on public welfare
9612	indefinite lockdown
9613	is the cure worse than the disease
9614	jobs and business suffer
9615	medical and legal practices
9616	not the Plague
9617	online working
9618	rapid spread
9619	relaxation of research rules
9620	remote education
9621	slowing infection spread
9622	staying home
9623	trialling new therapies
9624	up-skilling clinicians
9625	Cardiac services
9626	Remote monitoring
9627	Rural
9628	Psychological barriers
9629	Epidemic history
9630	Logistic growth model
9631	Non-linear least squares
9632	physiology
9633	Exercise
9634	alcohol intake
9635	health behaviors
9636	delivery of health care
9637	thoracic surgery
9638	drug-resistant epilepsy
9639	stress status
9640	ST elevation myocardial infarction
9641	lung neoplasms
9642	Communicable diseases/epidemiology
9643	Forecasting/methods
9644	SARS coronavirus-2
9645	Statistical
9646	adverse childhood experiences
9647	childhood resilience
9648	children's fears
9649	opioid use disorder (OUD)
9650	 face mask
9651	itch
9652	emotion analysis
9653	public engagement
9654	public health authorities
9655	Loss of Smell
9656	Loss of Taste
9657	disparities
9658	involuntary hospitalization
9659	mental illness
9660	New York Ventilator Allocation Guidelines
9661	Plague of Athens
9662	Thucydides
9663	2019 novel coronavirus (2019-nCoV)
9664	COVID-19; CoronaVirus
9665	Pandemic Disease
9666	Symptomology
9667	coronavirus Wuhan
9668	digital epidemiology
9669	machine learning in public health
9670	modeling disease outbreaks
9671	Pacific islands
9672	Wuhan coronavirus outbreak
9673	emerging infection
9674	pregnancy complications
9675	SEIRD-model
9676	Enzyme-linked immunosorbent assay
9677	Seroepidemiologic Studies
9678	Dynamic interventions
9679	Prediction modelling
9680	Population cohort
9681	Gay
9682	MSM
9683	SARS-COVID-2
9684	Preventive measures
9685	Public anxiety
9686	STAI-6
9687	traffic control bundling
9688	ARDS, Acute Respiratory Distress Syndrome
9689	COVID-19, Coronavirus Disease-2019
9690	SARS-CoV, Severe Acute Respiratory Syndrome Coronavirus
9691	Thymus
9692	pp1ab, Polyprotein 1ab
9693	guidance
9694	severe acute respiratory syndrome coronavirus 2 infection
9695	XMRV
9696	endogenous retroviruses
9697	Dentistry
9698	infection risk
9699	Comprehensive stroke center
9700	Quality research
9701	anticancer treatment
9702	systemic therapy
9703	Distanciation sociale
9704	Emergency ophthalmology
9705	Teleophthalmology
9706	Téléophtalmologie
9707	Urgences ophtalmologiques
9708	drug administration
9709	end of life care
9710	home care
9711	nursing home care
9712	supportive care
9713	terminal care
9714	ACEI or ARB
9715	ARIMA
9716	Forecasting
9717	Infection disease
9718	Time series
9719	Sir William Osler
9720	global public health
9721	Clinical practice recommendations
9722	Head and neck cancers
9723	severe disease
9724	Interventional oncology
9725	Patient care protocol
9726	Acute ischemic stroke
9727	Interventional neuroradiology
9728	Thrombolysis
9729	aneurysm
9730	standards
9731	multimorbidity
9732	odds ratio
9733	Cardiac electrophysiology
9734	Cardiac implantable electronic devices
9735	Pacemakers
9736	clinical
9737	epidemiological
9738	patients
9739	Network
9740	Front-line nurses
9741	General public
9742	Non-front-line nurses
9743	Vicarious traumatization
9744	informatics
9745	Generation time
9746	Illness onset
9747	surfaces
9748	Antibody Test
9749	Daegu
9750	Hospital Visitors
9751	information management
9752	information science
9753	haematology (incl blood transfusion)
9754	racial and ethnic disparities
9755	social determinants of health
9756	web search
9757	blood glucose
9758	blood glucose meter
9759	contagious
9760	self-monitoring of blood glucose
9761	diabetes technology
9762	sex workers
9763	Childhood obesity
9764	Microsimulation
9765	humans
9766	CT angiography
9767	infectious diseases, viral
9768	poisoning
9769	poisoning, mass incidents
9770	toxicology
9771	Kyphoplasty
9772	Novel Coronavirus 2019
9773	Spine
9774	emergency medicine
9775	opioid epidemic
9776	doulas
9777	freebirth
9778	homebirth
9779	maternity care
9780	midwives
9781	obstetricians
9782	Glytec
9783	glucose
9784	length of stay
9785	allocation of health care resources
9786	capacity
9787	acute stroke
9788	ischemic stroke
9789	mechanical thrombectomy
9790	electromyography
9791	neurophysiology
9792	neve conduction studies
9793	solutions
9794	Morocco
9795	self-management
9796	Chronic Diseases
9797	Mortality Risk
9798	cornea guidelines
9799	eye banking
9800	preferred practice
9801	prognostic factors
9802	glycemia
9803	Regular practice
9804	Vascular surgery
9805	patient satisfaction
9806	telehealth usability questionnaire
9807	troponin I
9808	Information Technology
9809	Outpatient Psychiatry
9810	Telepsychiatry
9811	health promotion
9812	legal aspects
9813	standard of care
9814	Acute cardiomyopathy
9815	High sensitivity troponin
9816	Screening algorithm
9817	Targeted transthoracic echocardiogram
9818	ethnic groups
9819	health status disparities
9820	healthcare disparities
9821	Immunopsychiatry
9822	Psychiatric illness
9823	Alzheimer's disease and related disorders
9824	Drug administration
9825	Drug delivery
9826	Hospital medicine
9827	Opioid addiction
9828	Opioids
9829	Research laboratories
9830	retrospective case study
9831	severe clinical events
9832	Integrated management
9833	Parkinson disease
9834	impact of COVID-19 lockdown
9835	psycholinguistic analysis
9836	psychological states
9837	public health emergencies
9838	Deprivation
9839	England
9840	Hospital capacity
9841	Local
9842	NHS
9843	Population density
9844	Regional
9845	Wales
9846	metropolitan areas
9847	rural or nonmetropolitan
9848	spatial disparities
9849	Mitral regurgitation
9850	Transcatheter aortic valve implantation
9851	behavioral addiction
9852	gambling disorder
9853	problem gambling
9854	catheter laboratory
9855	interventional cardiology
9856	structural interventions
9857	Antiplatelet therapy
9858	Carotid endarterectomy
9859	Field hospital
9860	Military
9861	Cancer care delivery
9862	Health care organisation
9863	Breast surgery services
9864	Emergency preparedness and response
9865	Health professionals
9866	Psychic exhaustion
9867	Gastrointestinal disorder
9868	Real-time reverse-transcriptase polymerase chain reaction
9869	pulmonary lesions
9870	systemic inflammation
9871	commercial media
9872	media exposure
9873	media vicarious traumatization
9874	official media
9875	Alliance against Cancer
9876	Acute heart failure
9877	National Heart Failure Audit
9878	Patient risk assessment
9879	Timely management
9880	Tele-medicine
9881	Tele-neurology
9882	atrioventricular block
9883	bradycardia
9884	Digestive cancer
9885	French Clinical Practice Guidelines
9886	Lombardy
9887	Psychiatric services
9888	Haiti
9889	Cardiac surgery
9890	Immune-modulation
9891	Obese subjects
9892	Effective reproduction numbers
9893	Acute Respiratory Disease
9894	duty to care
9895	ethics consultation
9896	patient noncompliance
9897	scarce resources
9898	COVID-19, Coronavirus, Diarrhoea, Digestive symptoms.
9899	2019 novel coronavirus diseases (COVID-19)
9900	lifestyle restrictions
9901	Cardio-oncology
9902	mitigation strategies
9903	COVID-19 Crisis
9904	Nosocomial Transmission
9905	Revised Triage
9906	Surveillance Protocol
9907	Temporary ED Closure
9908	computer simulation
9909	Chinese people
9910	Berlin criteria
9911	Cardiac injury
9912	Cardiovascular metabolic diseases
9913	Congo
9914	PEN-3
9915	trust
9916	adverse effects
9917	Beijing
9918	Alcohol
9919	Autonomy
9920	Harm minimisation
9921	Prohibition
9922	Internet
9923	PR
9924	home-based exercise
9925	mild cognitive impairment
9926	Mental Health Act
9927	Public health law
9928	Seclusion
9929	Cribado de infecciones
9930	Effectiveness
9931	Equipos deprotección individual
9932	Programa de Prevención y Control de Infecciones
9933	Surgical mask
9934	Trabajador sanitario
9935	confinement
9936	neuropsychiatric symptoms
9937	Economic stress
9938	accident under-reporting
9939	emotional contagion
9940	workplace injuries
9941	Urological care
9942	importation risk
9943	travel ban
9944	Common variable immunodeficiencies
9945	General Health Questionnaire
9946	Health-related quality of life
9947	Remote assistance
9948	Clinical characteristic
9949	Different exposure histories
9950	Dynamic change
9951	Ethnic minority
9952	structural racism
9953	Community care
9954	General practice
9955	Public policy
9956	Health behavior
9957	Dynamic transmission model
9958	Psychosocial burdens
9959	Syndemic
9960	Migration
9961	Scale-free network
9962	Harm reduction
9963	Homelessness
9964	Incarceration
9965	People who use drugs
9966	Substance abuse disorders
9967	Treatment for opioid use disorders
9968	Admission
9969	Ocrelizumab
9970	sedentary lifestyle
9971	International communication
9972	Thailand
9973	Generalized linear mixed models
9974	R-INLA
9975	Elimination
9976	Large-scale case-screening
9977	Parameter estimation
9978	SEIQR model
9979	Subarachnoid hemorrhage
9980	Travel
9981	Voronoi treemap
9982	secondary prevention
9983	Preprint manuscripts
9984	Rapid publications
9985	Bed occupancy
9986	Kaplan–Meier analysis
9987	fixed cohort
9988	severe acute respiratory illness
9989	Antiviral therapy
9990	Case control studies
9991	Otorhinolaryngology, COVID-19, Aerosol generating procedures, Universal precautions.
9992	Contact survey
9993	Disease outbreak
9994	nCov
9995	age groups
9996	older adolescents
9997	younger adults
9998	Mass panic
9999	mass media
10000	public crisis
10001	topic modeling
10002	Drug-induced pulmonary injury
10003	Neoplasms
10004	Pulmonary infiltrates
10005	Epidemic forecasting
10006	SEIR(+CAQ) dynamic model
10007	Generation interval
10008	Health Information Exchange
10009	Hospital Mortality
10010	Epidemiological characteristics
10011	2019 novel Coronavirus
10012	diseases
10013	travelers
10014	health system reform
10015	national response
10016	triage and quarantine
10017	acute respiratory distress
10018	syndrome (ARDS)
10019	Competing risks
10020	Multistate model
10021	food insecurity
10022	social-distancing
10023	stay-at-home orders
10024	disease mitigation
10025	Psychobehavioural
10026	Temporal changes
10027	ABO blood group
10028	disease
10029	epidemic doubling time
10030	Implications
10031	Indicators
10032	Types
10033	observational study
10034	Cordon sanitaire
10035	Delay
10036	Mobility
10037	Modelling
10038	Renal
10039	codes
10040	Obstetrical anaesthesia
10041	Regional anaesthesia
10042	ASRM
10043	HFEA
10044	live birth
10045	Antihypertension
10046	PrEP
10047	sexual health
10048	Quality
10049	Single-arm trials
10050	law/legislation
10051	high-flow nasal cannula
10052	Injection drug use
10053	Non-injection drug use
10054	non-pharmaceutical interventions
10055	public attitudes
10056	branching process
10057	overdispersion
10058	meta-Analysis
10059	Dermatology
10060	Emergency Consultations
10061	Emergency Department
10062	Analytical performance
10063	Clinical performance
10064	Medical tests
10065	minority ethnic groups
10066	rapalogs
10067	senolytics
10068	Cohort Studies
10069	Dyspnea
10070	Nonparametric
10071	creatinine
10072	Out-of-hospital cardiac arrest
10073	epidemiologic characteristics
10074	Health Policy
10075	Lock Down
10076	Clinical knowledge mining
10077	Early prognosis
10078	Generalized additive mixed model (GAMM)
10079	Platelet count
10080	Predictive preventive personalized medicine (PPPM)
10081	Gastrointestinal Bleeding
10082	estimation
10083	methylprednisolone
10084	biological indicators
10085	chemical indicators
10086	filtering facepiece respirators
10087	hydrogen peroxide vapor
10088	food cravings
10089	cardiac procedures and therapy
10090	optical imaging
10091	optimum management
10092	Olfaction disorders
10093	COVID-19 and diabetes
10094	Diabetes complications
10095	awake proning
10096	prone positioning
10097	prone positioning in obese
10098	proning
10099	proning in non-intubated
10100	shape matching
10101	surgical history
10102	Health services research
10103	FiY1
10104	foundation training
10105	junior doctor
10106	redeployment
10107	cosmetics
10108	disinfectants
10109	handwashing
10110	hygienic habits
10111	Breakpoint
10112	Disease transmission
10113	Association
10114	Priority
10115	Palestine
10116	conflict settings
10117	systemic anti-cancer treatments
10118	Medical abortion
10119	Self-determination
10120	Intermediate care
10121	Pulmonary rehabilitation
10122	health behavior
10123	health education
10124	health equity
10125	DOAC
10126	Oral anticoagulants
10127	Warfarin
10128	occupational health practice
10129	Malnutrition
10130	Nutritional care
10131	Merkel cell carcinoma
10132	Mohs surgery
10133	basal cell carcinoma
10134	cutaneous squamous cell carcinoma
10135	melanoma
10136	skin cancer
10137	Clinical feature
10138	Out-patient
10139	carotid artery thrombosis
10140	Centers for Disease Control and Prevention
10141	population-based management
10142	culture
10143	lung separation
10144	thoracic anesthesia
10145	AIRO (Italian Association of Radiotherapy and Clinical Oncology)
10146	collaboration intersectorielle
10147	communication savante
10148	interdisciplinary research
10149	interprofessional relations
10150	intersectoral collaboration
10151	recherche interdisciplinaire
10152	relations interprofessionnelles
10153	scholarly communication
10154	Environmental pollution
10155	PM 10
10156	PM 2.5
10157	Infection control nursing
10158	Infection prevention practice
10159	Nursing taskforce
10160	acute myocardial infarction
10161	global healthcare delivery
10162	healthcare delivery
10163	heath care worker protection
10164	Effective strategies
10165	Oncology services
10166	criminal justice
10167	homeless
10168	research incentives
10169	Online treatment
10170	Face mask
10171	Influenza activity
10172	Social responsibility
10173	Tropics
10174	Multiscale GWR
10175	Spatial non-stationarity
10176	Rainfall
10177	US
10178	Weather
10179	Dew point
10180	Wind speed
10181	population movement
10182	Hematology index
10183	Influenza B
10184	Laboratory data
10185	Fang Cang Shelter Hospital
10186	PCCM
10187	Probability modeling
10188	family
10189	imaging
10190	Health-EDRM
10191	NCD management
10192	early phase of pandemic
10193	non-communicable disease
10194	self-care
10195	Cellular immunity
10196	Humoral immunity
10197	structured population
10198	surge
10199	African american
10200	Maternal health services
10201	Surgery anesthesiology Covid19
10202	Excessive inflammatory response
10203	crowding
10204	emergency care systems
10205	FSFI
10206	Quality of Life
10207	Sexual Function
10208	Capacity management
10209	Operations research
10210	COVID 19 pandemic
10211	epidemiological techniques
10212	geocoding
10213	health information systems
10214	Individual behaviour change
10215	Media report
10216	SEIR-type model
10217	Post-traumatic stress
10218	Sleep disorders
10219	risk modelling
10220	unprecedented
10221	graduate medical education
10222	surgical training
10223	Osteoarthritis, hip
10224	Osteoarthritis, knee
10225	Physical functional performance
10226	Effective reproductive number
10227	Intervention timing
10228	Mobile devices
10229	Oral self-examination
10230	Remote intervention
10231	Google community mobility reports
10232	Interrupted time series analysis
10233	Social distance
10234	aortic stenosis
10235	transcatheter valve interventions
10236	valve disease surgery
10237	mass incarceration
10238	policy advocacy
10239	Acute phase reactants
10240	Episcleritis
10241	Eye
10242	Neutrophil to lymphocyte ratio
10243	Psychosocial effects
10244	quarantined
10245	Telerheumatology
10246	Video consultation
10247	Quantile-on-quantile approach
10248	Medical management
10249	Preventive management
10250	AANEM
10251	electrodiagnosis
10252	electrodiagnostic testing
10253	nerve conduction study
10254	roadway safety
10255	truck drivers
10256	amyotrophic lateral sclerosis
10257	gender mainstreaming
10258	Continuous positive airways pressure
10259	Hypoxemic respiratory failure
10260	Non-invasive ventilation
10261	cyberspace
10262	international students
10263	Coumarins
10264	Sleep duration
10265	bronchiectasis
10266	Caesarean section
10267	Labour analgesia
10268	Obstetric anaesthesia
10269	Resource management
10270	Teledermatology
10271	inpatient dermatology
10272	store-and-forward
10273	Seattle
10274	Clinical Characteristics
10275	Transmission Ddynamics
10276	myocardial disease
10277	Leadership
10278	Planning
10279	Surge
10280	Eosinophils
10281	Lymphocyte
10282	Neutrophil-Lymphocyte ratio
10283	Curve fitting
10284	Recurrent neural network
10285	Gastric bypass
10286	emergency medical system
10287	operating room
10288	Differential diagnosis
10289	Interstitial lung disease
10290	Angiotensin-Converting Enzyme Inhibitors
10291	Renin-Angiotensin System
10292	Coronavirus outbreak
10293	Public reporting
10294	and recovered (SEIR)
10295	exposed
10296	infectious
10297	movement
10298	susceptible
10299	absolute humidity
10300	morbidity rate
10301	Cardiovascular Disease
10302	Health Equity
10303	Physical Activity
10304	Children and adolescents
10305	High School
10306	control strategies
10307	Instagram
10308	engagement
10309	health media
10310	social networks
10311	data-driven
10312	modified auto-encoder
10313	time series prediction
10314	Statistical modelling
10315	Absenteeism
10316	Child care
10317	Geographic disparities
10318	Geospatial
10319	School closures
10320	Simulation study
10321	small businesses
10322	social support
10323	Geographic location of epidemics
10324	Pathway of spread
10325	Severity of epidemics
10326	Northern Territory
10327	Theatre utilisation and staffing / Teamwork and communication / Service improvement / Risk management / Leadership / Infection control / Operating theatre
10328	determinant
10329	ordinal logistic regression
10330	non invasive ventilation
10331	respiratory Infection
10332	Handheld echocardiography
10333	Limited echocardiography
10334	Retrospective analysis
10335	Remote monitoring technologies
10336	Coronary artery aneurysm
10337	IVUS
10338	teleconsultation
10339	teleophthalmology
10340	Corneal preservation medium
10341	cryopreservation
10342	gamma irradiated cornea
10343	glycerol preservation
10344	respiratory physiology
10345	departmental procedures
10346	health care protections
10347	Control strategy
10348	Droplet transmission
10349	Elder Index
10350	cost of living
10351	economic downturn
10352	economic security
10353	ERISA
10354	Pensions
10355	annuities
10356	electronic disclosures
10357	retirement
10358	rural population
10359	Decision tree analysis
10360	Parental perceived capability
10361	Screen time
10362	hand & wrist
10363	limb reconstruction
10364	plastic & reconstructive surgery
10365	Area agencies on aging
10366	COVID-19 response
10367	cross-sectoral partnerships
10368	integrated care
10369	antiarrhythmic drug
10370	atrial fibrillation
10371	gum disease
10372	periodontitis
10373	Social care
10374	care needs
10375	family care
10376	chronic illness management, challenges in healthcare
10377	Families
10378	multigenerational households
10379	blood glucose testing
10380	self-monitoring
10381	ambulatory electrocardiography
10382	cardiac arrhythmias
10383	electrocardiography
10384	long QT syndrome
10385	Psychological
10386	Business administration
10387	Elective plastic surgery
10388	Plastic surgery ethics
10389	Social-distancing
10390	glucose control
10391	airway team
10392	renal insufficiency
10393	renal replacement therapy
10394	disaster planning and response
10395	emergency departments
10396	Healthcare professionals (HCPs)
10397	National Health Service (NHS)
10398	FMAP
10399	Medicaid
10400	dual eligibles
10401	home and community-based care
10402	long-term services and supports
10403	Brain mets
10404	Brain tumor
10405	Marche
10406	Projections
10407	Serial interval
10408	medical oncology departments
10409	oncological centresoncological patients
10410	risk reduction
10411	history
10412	Operating in pandemic
10413	Pandemic management
10414	Physician collaboration
10415	Surgeon's role
10416	Surgical unit
10417	Generations
10418	Mainland China
10419	Mobile device data
10420	q statistic
10421	Cervical cancer
10422	Early stage
10423	Hysterectomy
10424	Wait time
10425	Allocation
10426	disabilities
10427	health policies
10428	lessons
10429	artificial Intelligence
10430	home care workers
10431	respiratory illnesses
10432	seniors
10433	social isolation
10434	Traffic level
10435	VDS
10436	Generalized additive model
10437	B-cell lymphoproliferative disorder
10438	autoimmune hemolytic anemia
10439	paediatric healthcare workers
10440	sleep disturbance
10441	hip
10442	knee
10443	total joint replacements
10444	Adrenal
10445	Endocrinology
10446	Pituitary diseases
10447	Thyroid diseases
10448	Disaster
10449	Pandemic response
10450	Team dynamics
10451	Control and treatment of major epidemic diseases
10452	Suggestions
10453	ambulatory care
10454	remote patient monitoring
10455	atypical presentation
10456	medical education & training
10457	fatal outcome
10458	AMSTAR-2
10459	evidence
10460	methodological quality
10461	gastroenterology
10462	HMGB-1 (high mobility group box 1)
10463	RAGE (receptor for advanced glycation end products)
10464	coagulation disorders
10465	clinical courses
10466	Social determinants
10467	Life Changing Events
10468	distance
10469	nursing
10470	schools
10471	Suceava County
10472	consumer
10473	local producers
10474	short food supply chains
10475	Multifunctional sampling station
10476	municipal waste
10477	pollution
10478	waste management
10479	dietary intake
10480	gestational weight gain
10481	pregnant women
10482	news frame
10483	Pacific Small Island Development States
10484	Pacific region
10485	economic impact
10486	healthcare organisation
10487	dentists
10488	fear
10489	job insecurity
10490	Quantitative
10491	Health
10492	Professionals
10493	essential service
10494	eye care practitioners
10495	capacity pressures
10496	excess deaths
10497	hospital bed numbers
10498	international comparison
10499	methods
10500	population density
10501	Italy and COVID
10502	Orthopedics and COVID
10503	Padova COVID experience
10504	sleep
10505	sleep disorders
10506	healthcare professional
10507	long-term care facility
10508	nursing care
10509	environmental health
10510	Maternal
10511	Perinatal
10512	Pharmacological management
10513	cruise ship health
10514	prison medicine
10515	impulsive consumption
10516	materialism
10517	perceived control
10518	gaseous contaminants
10519	human activity
10520	temporal distribution
10521	travel behavior
10522	individual differences
10523	social norm
10524	working memory
10525	mass making
10526	public precautionary measures
10527	universal hygiene
10528	Acquired brain injury
10529	neuropsychology
10530	case isolation
10531	assisted ventilation
10532	lung physiology
10533	Middle east respiratory syndrome coronavirus
10534	compartmental models
10535	hospital mortality
10536	stroke volume
10537	algorithm bias
10538	digital divides
10539	user characteristics
10540	Super-spreader
10541	Virus features
10542	Positive
10543	Retest
10544	consumer health informatics
10545	descriptive research
10546	online fever clinic
10547	Decision making
10548	end-of-life issues
10549	rationing/resource allocation
10550	utilization
10551	volumes
10552	Diabetes care
10553	aging in place
10554	civil society organizations (CSO)
10555	live alone
10556	public leadership
10557	disaster planning
10558	organizational preparedness
10559	Corona virus pandemic
10560	Plastic Surgery
10561	civil litigation
10562	claims by NHS staff against employers
10563	clinical negligence
10564	commercial claims
10565	disciplinary standards
10566	criticism
10567	e-psychological care
10568	professional responsibility
10569	community hospital
10570	Maxillofacial emergency
10571	public health interventions
10572	Rural health
10573	economic disparities
10574	social isolation and loneliness
10575	Geo-referenced
10576	Interdisciplinary
10577	Network-theory
10578	Smallworld
10579	T2 cytokines
10580	heart ventricles
10581	information work
10582	healthy aging
10583	informal caregiving
10584	intergenerational programs
10585	choroid
10586	neoplasia
10587	contingency plan
10588	medical physics
10589	Neurosurgeons' role
10590	Quebec
10591	agenda-setting
10592	focusing events
10593	policy windows
10594	private facilities
10595	Travel restriction
10596	Zhejiang
10597	Ischemic stroke
10598	Stroke unit
10599	Maxillofacial surgery
10600	pharmacy service
10601	laryngeal stenosis
10602	laryngotracheal stenosis
10603	subglottic stenosis
10604	tracheal stenosis
10605	finances
10606	Early diagnosis
10607	Follow-up
10608	Chongqing
10609	Epidemiological and clinical characteristics
10610	Eating disorder
10611	Health care delivery
10612	Neuroendocrine tumors
10613	New Orleans Louisiana Neuroendocrine Tumor Specialists
10614	schizophrenia
10615	Treatment workflow
10616	Earthquake
10617	Mental health disorders
10618	T cell subsets
10619	COVID-19 Pandemic
10620	IT-enabled Services
10621	hospital responding strategy
10622	emergency psychiatry
10623	mental health service
10624	Survery
10625	Antipsychotics
10626	drug interactions and side-effects
10627	psychotic disorders
10628	information sources
10629	situational awareness
10630	Intensive care units
10631	Population statistics
10632	Prevention, policy, and public health
10633	Pulmonary diseases
10634	Upper respiratory tract infections
10635	Health insurance
10636	Medicare
10637	Patient advocacy
10638	Surveys
10639	Taxes
10640	SEIR compartmental model
10641	contact rate
10642	latent individuals
10643	Addiction
10644	Cancer prevention
10645	Health care providers
10646	MD’s nurses
10647	Mount Sinai
10648	Zoom
10649	kind
10650	JCPP
10651	pharmacists
10652	logistic growth model
10653	prevention measures
10654	health resources
10655	psychological burnout
10656	Case study
10657	Evidence based medicine
10658	prescreening
10659	telemonitoring
10660	Ireland
10661	active surveillance
10662	Daily
10663	Size
10664	Trend
10665	pharmacotherapies
10666	rural healthcare
10667	community resiliency
10668	county
10669	rural-urban
10670	Coronary heart disease
10671	Cognitive interviews
10672	Diversity
10673	Inclusion
10674	Online research methods
10675	Qualitative research
10676	Race/ethnicity
10677	Recruitment
10678	Video interviewing
10679	Young adults
10680	Youth
10681	Face Mask
10682	Hand Washing
10683	Micro-vascular disease
10684	Several disease
10685	NO2
10686	Tokyo
10687	exposure dose
10688	health effect
10689	infection prevention and control guidelines
10690	paediatric risk groups
10691	primary schools
10692	transmission of COVID-19 in children
10693	Academic infectious diseases
10694	Critical care echocardiography
10695	Focused cardiac ultrasound
10696	Limited transthoracic echocardiography
10697	Point-of-care ultrasound
10698	ASE
10699	Protection statement
10700	Gardening
10701	Link workers
10702	Social prescribing
10703	Attitude
10704	UT of J and K
10705	practice
10706	Chhattisgarh
10707	community health worker
10708	China and India
10709	health systems preparedness
10710	comprehensive primary health care
10711	health systems approach
10712	minority
10713	Quarantine strategies
10714	SEIRQ model
10715	Scenario analysis
10716	cardiotoxicity
10717	Congenital heart disease
10718	5G
10719	all-wireless network
10720	cabin hospital
10721	information system
10722	Breast
10723	Dépistage
10724	Sein
10725	Emergency services, medical
10726	first responders
10727	Head and neck squamous cell carcinoma
10728	Reconstructive surgical procedures, Neck
10729	Pre-preparation
10730	Hub and spoke
10731	Single center
10732	Afghanistan
10733	Internet of Things
10734	NICU
10735	Disparity
10736	Italian population
10737	Lock down
10738	2019 coronavirus disease (COVID-19)
10739	Homeless
10740	Social psychiatry
10741	ICUs
10742	Multi-source data
10743	prisoners
10744	sub-Saharan African countries
10745	critical care; COVID-19; intensive care unit; Nepal; ventilator.
10746	rural and remote
10747	rural surgery
10748	Thoracic cancer
10749	priorities
10750	concerns
10751	family stress
10752	perceived mental health
10753	social determinants of mental health
10754	epidemiological indexes
10755	infection COVID-19
10756	infection disease
10757	Antihypertensive Medication
10758	Big Data
10759	Risk Assessment
10760	Disease Activity
10761	Juvenile Idiopathic Arthritis
10762	Lupus Erythematosus
10763	Outcomes research
10764	Rheumatoid
10765	Rheumatoid Arthritis
10766	Sjogren’s Syndrome
10767	Spondyloarthritis
10768	Synovitis
10769	Systemic
10770	news on the pandemic
10771	Forecast Modeling
10772	coronasvirus disease-19
10773	epidemiological and clinical characteristics
10774	outside Wuhan
10775	treatment strategies
10776	Antiphospholipid syndrome
10777	Disseminated intravascular coagulation
10778	Thrombotic microangiopathy
10779	Experiences
10780	Perceived stress
10781	Prenatal care
10782	Self-care
10783	disease outbreak
10784	DALY
10785	YLD
10786	YLL
10787	productivity loss
10788	COVID-19 (Coronavirus)
10789	artificial neural networks
10790	multilayer perceptron
10791	Gastrointestinal symptoms
10792	public health measure
10793	Valle d’Aosta
10794	ESM
10795	digital healthcare
10796	health spending review
10797	national health system
10798	public governance
10799	Affected area
10800	Contact with confirmed and suspected patients
10801	High-risk department
10802	Infection prevention and control behaviors
10803	Outbreak risk
10804	Gastrointestinal surgery
10805	Teaching and training
10806	ANFIS
10807	GA
10808	Absorption
10809	Jinhua Qinggan
10810	Treatment outcome
10811	Perioperative
10812	Periprocedural
10813	Sonographer
10814	low-income adults
10815	Tamil Nadu
10816	decay rate
10817	growth rate
10818	Bhilwara
10819	cluster containment
10820	explosive epidemic
10821	super spreader
10822	Epistemology
10823	evidence generation
10824	traditional health knowledge systems
10825	Kerala
10826	Armed Forces
10827	reducing mortality
10828	science-based response
10829	Taiwan experience
10830	nurse
10831	nursing role
10832	professional image
10833	Anxiety sensitivity
10834	Behavioral immune system
10835	Disgust propensity
10836	Disgust sensitivity
10837	adult congenital heart disease
10838	trophozoites
10839	COVID-19 Hospital Relief Act
10840	Compensation mechanisms
10841	Diagnosis-related groups
10842	Orthopaedic and trauma surgery
10843	Oncology nursing
10844	workforce
10845	Potential Mechanism
10846	Global public health
10847	Pharmacotherapy
10848	Models, statistical
10849	ITP
10850	TPO RA
10851	platelets
10852	steroids
10853	Breast cancer surgery
10854	Arterial hypertension
10855	Hypertension artérielle
10856	Système rénine-angiotensine-aldostérone
10857	general
10858	Neurological diseases
10859	Method
10860	Méthode
10861	Preuve
10862	Santé publique
10863	Traitement
10864	Evidence-based standards
10865	Gynaecology oncology
10866	Refugees
10867	Personal protection
10868	Radiologic technologist
10869	Aggregate outbreak
10870	Network analysis
10871	Time-phased nature of epidemic
10872	Guangdong province
10873	Cardiopulmonary resuscitation
10874	Chest compression
10875	Defibrillation
10876	Infection transmission
10877	Communities of practice
10878	Genetics education
10879	Telemedicine education
10880	Administration and management
10881	Psychiatric leadership
10882	Quality and safety
10883	Service delivery systems
10884	CNGOF
10885	Hospitals
10886	ICUM
10887	Ortality
10888	Dementia day-care facility
10889	Chengdu
10890	Ordinary Chinese citizens
10891	Psychological symptoms
10892	SCL-90 level I emergency response
10893	Parents
10894	Psychological status
10895	Early evidence
10896	Exercising hours
10897	Life disruptions
10898	Physical health
10899	Latin American public healthcare systems
10900	inequalities
10901	Academic medicine
10902	Emotions
10903	Instinct
10904	heart team
10905	valve center
10906	Child health
10907	Homicide
10908	Pathogens
10909	clinical informatics
10910	discharge rate
10911	new coronavirus pneumonia
10912	new drugs
10913	intestinal epithelium
10914	intestinal gene regulation
10915	inflammatory
10916	community justice
10917	community-inclusive bioethics
10918	justice
10919	fairness
10920	sub-Saharan Africa
10921	ventilator
10922	COVID-19; Nepal; World Health Organization.
10923	Group meetings
10924	Massive infection
10925	Perspectives
10926	Prevent
10927	Religious services
10928	Colorado
10929	multiple chronic conditions
10930	Psychotherapy
10931	physical therapists
10932	super spreading
10933	transmission heterogeneity
10934	hygiene and public health
10935	pandemic response
10936	public health department
10937	Algeria
10938	Infection rate
10939	community engagement
10940	CoViD−19
10941	behaviors
10942	undergraduates
10943	Health resources
10944	Health service system
10945	Pairing assistance
10946	adoption of PARs
10947	government intervention
10948	data quality
10949	informational conformity consumer behavior
10950	need to belong
10951	perceived social support
10952	threat of death
10953	hip fracture
10954	preventive strategy
10955	Iraq
10956	Kurdistan region
10957	fake news
10958	impact
10959	panic
10960	social network analysis
10961	twitter
10962	tele-education
10963	teleteaching
10964	kinship care support
10965	social workers
10966	Growth rate
10967	cataract
10968	tears
10969	CT criteria
10970	Diagnostic performance
10971	College students
10972	airport screening
10973	geographic spread
10974	COVID-19 (coronavirus disease of 2019)
10975	neurosurgical practice
10976	health insurance
10977	prenatal care
10978	global health ethics
10979	solidarity
10980	care ethics
10981	care workers
10982	interdependence
10983	Black Lives Matter
10984	Covid narratives
10985	Covid-19 guidelines
10986	Pakistan and bioethics
10987	Chengdu Sport University
10988	new coronavirus
10989	zero infection during epidemic
10990	COVID-19; medical students; outbreak; pandemic.
10991	 Cardiovascular, Conduction defects, Coronavirus, Diabetes, Heart failure, Myocarditis.
10992	Religious belief
10993	Spearman’s rank correlation
10994	influencing factor
10995	spatial autocorrelation
10996	spatial scale
10997	SEIHR epidemic model
10998	Health-Emergency and Disaster Risk Management
10999	Hong Kong,
11000	health risks
11001	urban
11002	pediatric dentistry
11003	viral spread prevention
11004	Psycho-social issues
11005	decision support
11006	rapid evidence synthesis
11007	systematic reviews
11008	social and economic factors
11009	spatial regression analysis
11010	dental management
11011	dental procedure
11012	health care system
11013	web-based intervention
11014	border control
11015	imported cases
11016	health QR code
11017	internet-based research
11018	SEIRUS
11019	math
11020	reinfection
11021	2009 pandemic H1N1
11022	school closures
11023	Acute stroke
11024	Stroke Unit
11025	Spatial autocorrelation
11026	radiation
11027	Susceptible-Infected-Removed (SIR)
11028	pediatric infection
11029	Public Health Emergency of International Concern
11030	migration
11031	Thromboembolism risks
11032	COVID-19; ethics; public health; strategy.
11033	COVID-19; hospital preparedness; Nepal.
11034	Travel histories
11035	Disease characteristics
11036	Non-respiratory injury
11037	efficacy belief
11038	perceived risk
11039	precautionary behaviors
11040	public health emergency preparedness
11041	discrimination
11042	social exclusion
11043	COVID-19: pediatrics
11044	chatbots
11045	online questionnaire
11046	participatory surveillance
11047	social media, surveillance
11048	participatory
11049	abrupt change
11050	daily new confirmed cases
11051	geographic information science
11052	incidence rates
11053	spatial cluster
11054	spatial outlier
11055	Learning
11056	Finland
11057	data science
11058	urban informatics
11059	urban science
11060	linear regression
11061	public response
11062	Dynamic basic reproduction number
11063	Statistical prediction
11064	curative
11065	preventive
11066	rehabilitative
11067	shielding
11068	medical response actions
11069	Cardiovascular risk factors
11070	2019-nCoV-WOM
11071	epidemic protection
11072	role of E-government
11073	social presence theory
11074	moral injury
11075	physician wellbeing
11076	climate and urban parameters
11077	COVID-19 transmission
11078	Spring Festival travel rush
11079	emerging epidemic
11080	migrant population
11081	migration network
11082	Ospedale Maggiore di Lodi
11083	Comprehensive prevention and contro
11084	Influenza, human
11085	Behavior Changes
11086	Mathematical Modeling
11087	School Closures
11088	School Opening Delay
11089	control measure
11090	epidemic management
11091	Emergency management
11092	Infection control scientifically
11093	Lawful duties
11094	Liability, legal
11095	Public health emergency
11096	Epidemiological analysis
11097	Dynamical model
11098	Transmission rate
11099	Community pharmacy
11100	Macau
11101	Imported case
11102	home hemodialysis
11103	nephrology nurses
11104	citizen participation
11105	good governance
11106	humanitarian emergency
11107	emergency control measures
11108	sampling
11109	 basic reproduction number 
11110	 mathematical model 
11111	 media reporting 
11112	 sensitivity analysis 
11113	population size
11114	quasi-experimental approach
11115	social characteristics of floating population
11116	the origins of Wuhan's migrants
11117	Novel coronavirus (2019-nCoV)
11118	communications media
11119	human rights
11120	democracy
11121	Spatial-temporal distribution
11122	 compartmental modeling 
11123	medical isolation
11124	vehicle scheduling
11125	water wave optimization (WWO)
11126	Community mental health
11127	health service research
11128	quality of care
11129	college students
11130	Challenge
11131	Countermeasure
11132	symptom onset
11133	Emerging Infectious Diseases
11134	epidemic Response
11135	novel
11136	outbreak Response
11137	Emergency legislation
11138	Human rights
11139	Mental capacity law
11140	Mental health law
11141	Northern Ireland
11142	Emergency measures
11143	Mental health and capacity law
11144	Scotland
11145	Paediatric population
11146	evidence-based research
11147	Argentina
11148	Anatomía patológica
11149	Trombosis vascular
11150	Vascular thrombosis
11151	Gestión clínica
11152	Healthcare organisation
11153	Clinical manifestations
11154	Respiratory disorders
11155	Abandon
11156	Computer
11157	Domestic cats
11158	Hypoglycaemia
11159	Remission
11160	Type 1 diabetes
11161	Cochlear function
11162	Hearing loss
11163	Integrated emergency management system
11164	Self-interest
11165	Shared-interests
11166	crew
11167	cruise ship medicine
11168	passengers
11169	Olympic
11170	Sports
11171	Descalation
11172	Dual antiplatelet therapy
11173	cannabis
11174	cocaine
11175	opioids
11176	substance use disorders
11177	tobacco
11178	Equipo de protección individual (EPI)
11179	Filtering face piece (FFP)
11180	Filtering face piece (FFP) mask
11181	Mascarillas quirúrgicas
11182	Respiratory protective equipment
11183	Covid-19 lockdown
11184	Social support
11185	low- and middle-income settings
11186	medication-assisted treatment
11187	older adults with HIV
11188	Implementation science
11189	research priorities
11190	translational health research
11191	confidentiality
11192	health care reform
11193	organizational innovation
11194	patient comfort
11195	vasculitis
11196	Arrythmias
11197	Novel Corona virus
11198	Online teaching
11199	Teaching diabetes
11200	DBS withdrawal
11201	battery depletion
11202	DSME
11203	Diabetes self-care
11204	Diabetes self-management education
11205	renin–angiotensin system
11206	Simulation Training
11207	Emergency medical communication center
11208	System
11209	Child immunity
11210	Immune system development
11211	Detention
11212	Immigration
11213	Migrant health
11214	Serologic tests
11215	clinical exchanges
11216	deprivation
11217	research exchanges
11218	Inflammatory factors
11219	News media coverage
11220	Exit strategies
11221	elder abuse
11222	elder neglect
11223	housing for the elderly
11224	equipments
11225	medical devices
11226	regulatory
11227	DTaP-IPV-Hib-HBV vaccine
11228	Measles-Mumps-Rubella vaccine
11229	RFID
11230	real-time locating systems
11231	Coronavirus (2019-nCoV) outbreak
11232	One H﻿ealth approach
11233	challenge
11234	global outbreak
11235	Antenatal care
11236	Demands
11237	Remote teaching
11238	work environments
11239	 deterministic model
11240	 mitigation
11241	Airport screening
11242	pulpitis
11243	﻿coronavirus
11244	Case cluster
11245	Missing data
11246	Partial identification
11247	disease prevention and control
11248	expert consensus
11249	osteonecrosis of femoral head
11250	Apprenticeship
11251	Community specialist practice
11252	Contemporary curriculum
11253	District nurse education
11254	Quality assurance
11255	humanitarian response
11256	multi-weighted factor analysis
11257	risk evaluation
11258	Disease prevalance
11259	Mortality rates
11260	adrenal cancer
11261	chemotherapy
11262	standard operating procedures
11263	targeted therapies
11264	Emergency medical services
11265	Interrupted time series
11266	Opioid overdose
11267	Segmented regression
11268	Contact lens
11269	optical
11270	optometry
11271	Collisions
11272	Road safety
11273	Low- and middle-income countries
11274	Employee health
11275	Online collaboration
11276	Patient-care
11277	Shut-down
11278	Chronic Obstructive
11279	Pulmonary Disease
11280	motivation
11281	pulmonary rehabilitation
11282	maternity
11283	translational simulation
11284	Medical education
11285	education engagement
11286	online teaching; home-schooling
11287	student parents
11288	Emerging hazards
11289	Prevention failure
11290	medical school examinations
11291	online examinations
11292	open-book examination
11293	Spine surgeons
11294	intern
11295	food systems
11296	AROME
11297	LMICs
11298	TRONE
11299	OSHA enforcement
11300	essential workers
11301	fissured workplace
11302	hazard pay
11303	Augmented reality
11304	Plastic surgery
11305	Teaching
11306	Training
11307	cosmetic procedures
11308	Breast reconstruction
11309	Same-day
11310	childbirth
11311	non-evidence-based practice
11312	obstetric violence
11313	political
11314	acute renal failure
11315	global health security
11316	political leadership
11317	sexual and reproductive health and rights
11318	universal health coverage
11319	Management strategy
11320	Traumatic brain injury
11321	Patient perspective
11322	Uro-oncology
11323	Ablation
11324	Cryoablation
11325	Cryosurgery
11326	return to sport
11327	Total Worker Health
11328	human factors and ergonomics
11329	safety management systems
11330	critical policy studies
11331	digital transformation
11332	digitalism
11333	futures
11334	innovation policy
11335	risk and uncertainty
11336	Asynchronous readout
11337	Radiology readout
11338	Disposal
11339	immunosupression
11340	poor outcomes
11341	ACCESS TO HLTH CARE
11342	ADDICTIVE BEHAVIOUR/ADDICTION
11343	ALCOHOL
11344	DISABILITY
11345	ETHICS
11346	PREVENTION
11347	PREVENTIVE MEDICINE
11348	teledermatology
11349	Budget
11350	Consumption
11351	Income
11352	Labour market
11353	Global
11354	Surgeons
11355	Worldwide
11356	hepatobiliary disease
11357	hepatocellular carcinoma
11358	liver cirrhosis
11359	PS/QI
11360	chilblains
11361	pernio
11362	Dental public health
11363	Economic evaluation
11364	Infectious disease(s)
11365	Mathematic modelling
11366	COVID-19 screening
11367	Clinical safety
11368	Delayed surgery
11369	Perioperative complication
11370	Traumatic fracture
11371	Experience in children
11372	Indications
11373	SARS CoV2
11374	Timing
11375	duty to treat
11376	hazards
11377	adolescence
11378	peer influence
11379	early childhood development
11380	parenting
11381	Immunodeficiency
11382	Severe illness
11383	ALS
11384	eConsent
11385	telepresenter
11386	telescreening
11387	geropsychiatry
11388	human factors
11389	incarceration
11390	prison
11391	ADOLESCENTS CG
11392	EDUCATION
11393	HEALTH BEHAVIOUR
11394	HEALTH PROMOTION
11395	MEDICAL SOCIOLOGY FQ
11396	Dear Editor,
11397	Myopia
11398	Quarantine myopia
11399	Fangcang shelter hospital
11400	3D-printed adaptor
11401	anaesthesia circuit filter
11402	breathing system filter
11403	delayed diagnosis
11404	redployment
11405	Environmental effect
11406	Regulations
11407	Hospital discharge
11408	Positive RT-PCR
11409	Rectal swabs
11410	epidemics/pandemics
11411	device related pressure injury
11412	medical personnel
11413	preventive and protective measures
11414	hematological anomalies
11415	thrombo-inflammation
11416	Chronic disease
11417	Community nursing
11418	Older persons
11419	Social Cognitive Career Theory
11420	nursing human resources
11421	nursing shortages
11422	nursing workforce
11423	dietary behaviors
11424	lockdowns
11425	sleeping
11426	sociodemographics
11427	Italian COVID-19 data
11428	climate data
11429	data warehouse
11430	pollution data
11431	mass-casualty
11432	ventilator-induced lung injury
11433	‘COVID-19’
11434	‘Medical student’
11435	‘career development’
11436	‘specialty choice’
11437	‘virtual education’
11438	triage and symptoms algorithms
11439	Driving exposure
11440	Teen driving
11441	Diagnosis and treatment
11442	Spinal cord injuries
11443	Spine fracture
11444	outpatient
11445	cardiac surgical procedures
11446	cardiopulmonary bypass
11447	effective communication
11448	End-of-life care
11449	Health equity
11450	Palliative care
11451	Exodontia
11452	UDCC
11453	staff protection
11454	chronic kidney failure
11455	chronic renal failure
11456	end stage kidney disease
11457	kidney disease
11458	Migraine
11459	New York state
11460	organ donation
11461	Adverse drug reactions
11462	PD-1
11463	communications
11464	work
11465	contraceptive
11466	unmet need
11467	clinical research units
11468	clinical trials integrity
11469	patients’ safety
11470	accountability
11471	governance
11472	research integrity
11473	access
11474	anonymous
11475	body regions
11476	health care facilities
11477	health care quality
11478	manpower
11479	multivisceral transplant recipient
11480	operative
11481	services
11482	surgical procedures
11483	transplant donor
11484	Chao's lower bound
11485	Population heterogeneity
11486	Undetected cases
11487	crisis communication
11488	health communications
11489	Theoretical Domains Framework
11490	structural barriers
11491	Fellows
11492	catheterization laboratory
11493	Chronic subdural hematoma
11494	Collateral damage
11495	autoimmune disease
11496	Infection control / standards
11497	Patient isolation / instrumentation
11498	care delivery
11499	ventricular assist device
11500	Short-term outcomes
11501	Pneumoperitoneum
11502	Endometrial cancer
11503	Endometriosis
11504	Gynecology
11505	Myoma
11506	Urogynecology
11507	Vulvar cancer
11508	Non-frontline specialty
11509	Orthopedics
11510	Pandemic preparedness
11511	Clinical embryology
11512	Fertility
11513	abortion
11514	later abortion
11515	quantitative methods
11516	student health
11517	clinical assessment
11518	service evaluation
11519	preoperative
11520	Adult trauma
11521	Children fractures
11522	Dislocation
11523	Sprain
11524	cardiac catheterisation and angiography
11525	coronary artery disease
11526	EMR
11527	Counterfeit
11528	Particle filtration efficiency
11529	abortion access
11530	contraception
11531	obstetrics and gynecology
11532	women’s health
11533	medical curricula
11534	online teaching
11535	undergraduate
11536	recreational
11537	sport
11538	sports medicine
11539	Ambulatory Reflux Monitoring
11540	Esophageal Manometry
11541	humanism
11542	minimalism
11543	Namaste
11544	Air pollutants
11545	Sars virus
11546	Cochlear Implants
11547	Hearing health services
11548	Parental reactions
11549	Pediatric hearing loss
11550	critical thinking
11551	experiential learning program
11552	nurse education
11553	self-reflection
11554	attitude
11555	positive effects
11556	satisfaction
11557	sustainable tourism
11558	critical patient
11559	liver abnormality
11560	severe
11561	diabetes complications
11562	diabetes mellitus, type 2
11563	air quality forecast
11564	national holiday
11565	pollution episodes
11566	gastric function
11567	gastrointestinal function
11568	curfew
11569	epidemic curve
11570	national containment
11571	stay-at-home
11572	Clinical practice guidelines
11573	Knowledge translation
11574	Telestroke
11575	elderly patients
11576	 COVID-19 diagnostic testing [Supplementary Concept]
11577	Clinical Protocols  
11578	Reopen
11579	Comics
11580	graphic medicine
11581	Fundamental human rights
11582	Emergencies
11583	Corneal transplant
11584	fresh corneal tissue
11585	glycerol-preserved cornea
11586	keratitis
11587	therapeutic keratoplasty
11588	differential diagnosis of ocular pain
11589	ocular pain
11590	Tele-ophthalmology
11591	medicolegal
11592	tele-consultation
11593	glaucoma
11594	glaucoma guidelines
11595	preferred practice with COVID-19
11596	preferred practice patterns
11597	refractive surgery
11598	transitions
11599	Privacy
11600	home quarantine
11601	progressive COVID-19 patients
11602	quarantine management assessment
11603	telemedicine system
11604	EHR
11605	video visits
11606	Penile Neoplasms
11607	Assessment
11608	Resistance Training 
11609	Sexual Behavior  
11610	Prostatic Hyperplasia
11611	Urologic Neoplasms
11612	Carcinoma, Renal Cell
11613	Pandemics 
11614	Prostate cancer, familial [Supplementary Concept]
11615	Ageism
11616	Elder Justice Act
11617	aging stereotypes
11618	aging stigma
11619	compassionate ageism
11620	externalization
11621	internalization
11622	politicization
11623	Surgical residency program
11624	Surgical residents
11625	Community acquired infections
11626	British Society of Gastroenterology
11627	Home care aides
11628	emergency savings
11629	living wage
11630	single mothers
11631	Covid-19 and quarantine
11632	Domestic abuse
11633	hidden
11634	impact of forced isolation with an abuser
11635	prevention and detection
11636	Cancer surgery
11637	Developing countries
11638	Limited-resource countries
11639	Amputation
11640	Diabetic foot ulcers
11641	COVID-19, pandemic, infection control, PPE use
11642	information technology
11643	inpatient telemedicine
11644	technology implementation
11645	telerounding
11646	virtual rounding
11647	digitalization
11648	ethics of aging
11649	Transitional care
11650	family caregivers
11651	fellows in training
11652	anorexia nervosa
11653	eating disorder
11654	national survey
11655	Developmental disability
11656	Intellectual disability
11657	masculinities
11658	men's health
11659	pharmacy learners
11660	pharmacy preceptors
11661	Concerns
11662	Medical student
11663	Training camp
11664	Neurosurgery residents
11665	applied and professional ethics
11666	exoscope
11667	otologic surgery
11668	AGP
11669	DFL
11670	aerosol generating procedure
11671	diagnostic flexible laryngoscopy
11672	flexible laryngoscopy
11673	Delayed treatment
11674	Kidney cancer
11675	Penile cancer
11676	Prostate cancer
11677	Sstemic therapy
11678	Testicular cancer
11679	Upper tract urothelial carcinoma
11680	chronicity
11681	illness work
11682	prioritization
11683	emergencies
11684	e-Learning/computers
11685	High risk
11686	Immunocompromised
11687	Atrial fibrillation
11688	academic practice
11689	hospital employed
11690	industry partner
11691	private practice
11692	surgeon education
11693	AAHKS
11694	humanitarianism
11695	operation walk
11696	elder mistreatment
11697	surgery cancellation
11698	European Association of Urology
11699	Guidelines Office
11700	Section Offices
11701	virtual meeting
11702	Cardiovascular medicine
11703	Healthcare delivery
11704	bayesian thinking
11705	patient care
11706	audiology
11707	hearing loss
11708	business continuity
11709	clinical services
11710	access to telemedicine
11711	broadband
11712	digital communication
11713	digital divide
11714	smart phone
11715	multimedia
11716	video
11717	heart injuries
11718	respiratory insufficiency
11719	ventilators, mechanical
11720	AANS
11721	AASNS
11722	CAANS
11723	EANS
11724	FLANC
11725	WFNS
11726	diffusion of innovation
11727	education, medical
11728	policy making
11729	global health collaboration
11730	global health equity
11731	global health partnership
11732	econonomics
11733	elective orthopaedic surgery
11734	patient demand
11735	technology and innovation
11736	volume
11737	surgical safety checklist
11738	analytics
11739	applied informatics
11740	SMA
11741	health information interoperability
11742	medical economics
11743	Neutrophil-to-lymphocyte ratio
11744	Platelet-to-LYM ratio
11745	Predictive
11746	disaster preparedness
11747	scarcity of resources
11748	Microlaryngobronchoscopy
11749	Paediatric airway
11750	religious ethics
11751	Internet hospital
11752	Online medical services
11753	aerosol-generating surgery
11754	Diagnosis Criteria
11755	False Negative
11756	burnout
11757	posttraumatic stress disorder
11758	Religiosity
11759	Religious Institutions
11760	anxiety disorders
11761	depression and mood disorders
11762	statistics and research methods
11763	eating habits
11764	boredom
11765	self-control
11766	GNSS/GPS
11767	hot spot
11768	social networking service
11769	assumptions
11770	likelihood
11771	RIG-I
11772	STING
11773	COVID-19 dynamics
11774	Runge–Kutta method
11775	patient willingness
11776	remote communications
11777	harm reduction
11778	people who inject drugs
11779	indices of health and disease and standardisation of rates
11780	activity restrictions
11781	traffic reductions
11782	urban health
11783	acute hepatitis
11784	hepatitis
11785	liver function test
11786	elderly patient
11787	Surgical Procedures, Operative
11788	Burnout, Psychological
11789	Occupational Health Stress Disorders, Post-Traumatic
11790	Surgical Procedures, Operative 
11791	E-therapies
11792	face-to-face therapies
11793	paediatric psychology
11794	psychological support
11795	remote therapies
11796	telemental health
11797	telepsychology
11798	Foundation interim year 1
11799	medical apps
11800	prescribing
11801	physician perspectives
11802	restarting services
11803	paediatric ophthalmology
11804	strabismus
11805	Barriers of tele-ophthalmology
11806	tele-ophthalmology
11807	telemedicine guidelines
11808	neuro-ophthalmology
11809	ophthalmology practice
11810	pediatric ophthalmology
11811	COVID-19 guidelines
11812	ocular malignancies
11813	ocular oncology
11814	ocular tumors
11815	Clinical competence
11816	Curriculum
11817	Education, medical
11818	Female
11819	Testicular Neoplasms
11820	paediatric intensive care
11821	paediatrics
11822	Information Dissemination
11823	Primary Prevention
11824	Robotic Surgical Procedures
11825	 COVID-19 [Supplementary Concept]  
11826	BCG Vaccine
11827	Urinary Bladder Neoplasms
11828	Covid-19, decision-making
11829	behavior change
11830	health management
11831	Guideline
11832	Global health crises
11833	digital inequality
11834	eHealth literacy
11835	lifelong learning
11836	social interaction
11837	Disability
11838	Hormone menopause therapy
11839	Venous thromboembolism prophylaxis
11840	QAPI
11841	care quality
11842	SGLT2 inhibitors
11843	 risk/benefit analysis
11844	international/global health
11845	BGM
11846	CORONA
11847	smart insulin pen
11848	Medicaid LTSS
11849	Medicaid waivers
11850	program eligibility
11851	state budgets
11852	head and neck advocacy
11853	head and neck cancer support
11854	not-for-profit
11855	European Society of Cardiology
11856	ST-elevation myocardial infarction
11857	Operatory room
11858	Evidence-Based Medicine
11859	Virus Diseases
11860	Battle Plan
11861	Case variety
11862	Caseload
11863	Neurosurgical practice
11864	continuing
11865	Long-term care
11866	Infographics
11867	Pandemic network
11868	Visualization
11869	pediatrician survey
11870	dupilumab
11871	Clinic
11872	Neurologic examination
11873	Behavior change
11874	codes of/position statements on professional ethics
11875	digital orthopaedics
11876	future
11877	virtual visits
11878	health care for specific diseases/groups
11879	professional - professional relationship
11880	Oral Radiology
11881	audit
11882	otology
11883	apremilast
11884	multispecialty
11885	Prevention measures
11886	Telesurgery
11887	differential lung ventilation
11888	shared ventilation
11889	hip artthroplasty
11890	knee arthroplasty
11891	Disaster triage
11892	implementation science
11893	epistaxis
11894	Broncoscopia
11895	Consenso
11896	bronchoscopy
11897	esophagoscopy
11898	high-risk procedures
11899	perioperative protocols
11900	disaster medicine
11901	ventilator modes
11902	hip and knee arthroplasty
11903	doctor-patient relationship
11904	moral distress
11905	consortium
11906	resident education
11907	emotional wellbeing
11908	people with diabetes
11909	consensus statement
11910	lung cancer screening
11911	lung nodule
11912	BMD
11913	DMD
11914	muscular dystrophy
11915	Bioactive lipids
11916	OEA
11917	Oleoylethanolamide
11918	Invasive mechanic ventilation
11919	frontline
11920	Disaster management
11921	chronic inflammatory demyelinating polyneuropathy
11922	dysimmune
11923	multifocal motor neuropathy
11924	paraproteinemic neuropathy
11925	Endoscopic surgery
11926	Extended endoscopic skull base surgery
11927	Powered air purifying respirators (PAPR)
11928	Physical Therapy
11929	Physiotherapy
11930	Causative sources
11931	Susceptible population
11932	privatization
11933	continuity of operations
11934	emergency operations
11935	academia
11936	Affordability
11937	Cost
11938	SOR model
11939	lockdown measures
11940	pandemic COVID-19
11941	Catheter-directed thrombolysis
11942	Chilling
11943	Risk factor: symptom aggravation
11944	Cardiomyopathies
11945	Channellopathies
11946	Inherited and rare heart disease
11947	Biomedical research
11948	Capacity-building
11949	Evidence-based practice
11950	Health ministries
11951	Health research systems
11952	Priority-setting
11953	Research utilisation
11954	Sustainable Development Goals
11955	Translational medical research
11956	Pulmonary infection
11957	X-ray computed tomography
11958	access to information
11959	evidence synthesis
11960	information literacy
11961	information-seeking behavior
11962	knowledge translation
11963	message amplification
11964	Lavage des mains
11965	Masques
11966	Acontecimientos
11967	Catastrophe
11968	Catástrofe
11969	Diosa Salud
11970	Events
11971	Health Goddess
11972	Sucesos
11973	Carcinoma urotelial
11974	Nefroureterectomía
11975	Nephroureterectomy
11976	Urothelial carcinoma
11977	COVID warriors
11978	Concerns of doctors
11979	frontline doctors
11980	Nightingale
11981	epidemic prevention
11982	scientific response
11983	health information exchange
11984	online
11985	Cataract training
11986	post-graduation
11987	residency training
11988	resident
11989	virtual reality
11990	Alcohol-based hand rubs
11991	sanitizer aerosol-driven ocular surface disease
11992	Uveitis
11993	Vitreoretina
11994	retinopathy of premat
11995	Deconfinement
11996	Déconfinement
11997	Gynecologic surgery
11998	Chest tightness
11999	Corticosteroid use
12000	public drug information
12001	hand
12002	microsurgery
12003	needs
12004	psychological homeostasis
12005	self-esteem
12006	Ang-(1-7)
12007	female reproductive system
12008	Demoralization
12009	Urological cancer
12010	Liver cancer
12011	Junior doctors
12012	Service improvement
12013	teleoncology
12014	Eye care practitioners
12015	OMFS
12016	TRAUMA
12017	salivary gland cancer
12018	salivary gland disease
12019	salivary gland imaging
12020	salivary gland neoplasm
12021	FPMRS
12022	Virtual visit
12023	health workforce
12024	multidisciplinary
12025	teleconference
12026	Climate change
12027	Persons with disabilities
12028	Emergency room
12029	Patient allocation
12030	Sars-CoV‑2
12031	Throat-swab
12032	Disaster mental health
12033	Emergency responders
12034	medical errors
12035	Regular prevention and control
12036	Pneumonia epidemic
12037	People experiencing homelessness
12038	IBD clinical
12039	Infection prevention and protection
12040	Non-invasive positive airway pressure
12041	Sleep study
12042	patient portal
12043	self-triage
12044	symptom checker
12045	gender-based violence
12046	Gynaecological cancer
12047	Behavior
12048	Communication in health care
12049	General practitioners
12050	Health care quality
12051	Health surveys
12052	Motivation
12053	Natural disasters
12054	Safety equipment
12055	Hyperlipidemia
12056	Intubation
12057	Noninvasive ventilation
12058	Oxygen
12059	Elderly patients
12060	Young and middle-aged patients
12061	Novel virus
12062	clinical service
12063	trauma-informed practice
12064	faculty
12065	faculty development
12066	tripartite mission
12067	student
12068	accreditation
12069	pharmacy education
12070	quality
12071	adaptability
12072	sustainability
12073	teaching delivery
12074	lactate dehydrogenase (LDH)
12075	lung injury
12076	epigenetic aging
12077	immune senescence
12078	thymic hormones
12079	thymus
12080	Barriers
12081	Facilitators
12082	Solutions
12083	logistic regression
12084	prediction scoring system
12085	severity pneumonia
12086	antibody-dependent enhancement (ADE)
12087	social activities
12088	suicidal thoughts
12089	BMJ health informatics
12090	COVID-19
12091	Formación
12092	Residencia
12093	Covid-19 en urología pediátrica
12094	Covid-19 in pediatric urology
12095	De-escalation phase
12096	Fase de desescalada
12097	Andology
12098	Andrología
12099	Cáncer de pene
12100	Penile prothesis
12101	Peyronie
12102	Peyronie disease
12103	Prótesis de pene
12104	Cancer de testiculo
12105	Orchidectomy
12106	Orquiectomia
12107	Testicular neoplasm
12108	Urologia
12109	Aprendizaje inteligente
12110	Recursos virtuales
12111	Remoteclinics
12112	Smart learning
12113	Tele-medicina
12114	Teleconsulta
12115	Virtuallearning
12116	Gestion
12117	Gestión
12118	design thinking
12119	patient
12120	user experience
12121	Eating habits
12122	Mediterranean diet
12123	home confinement
12124	wearable activity trackers
12125	wearables
12126	Dentist
12127	Redeployment
12128	Transferable skills
12129	diffusion innovation theory
12130	post-COVID world
12131	technology adoption
12132	responsiveness
12133	pandemic prevention
12134	HIIT
12135	cardiorespiratory fitness
12136	high intensity intermittent exercise
12137	muscle strength
12138	physical inactivity
12139	hospital information system
12140	mobile app
12141	Crise économique
12142	Déconnexion sociale
12143	Economic crisis
12144	Prévention
12145	Social disconnection
12146	Suicidal behavior
12147	Suicidal vulnerability
12148	Suicide prevention
12149	Vulnérabilité suicidaire
12150	Blepharoplasty
12151	botox
12152	dacryocystorhinostomy
12153	eyelid surgery
12154	orbital surgery
12155	ptosis
12156	digital determinants of health
12157	digital health equity
12158	social
12159	virtual health
12160	arthritis, infectious
12161	Maternal isolation
12162	Post-Partum depression
12163	Psychological vulnerability
12164	chronic lymphocytic leukaemia
12165	lymphoma
12166	myeloma
12167	Fibrosis
12168	Haematological malignancies
12169	Hémopathies malignes
12170	Historiography
12171	Nursing
12172	Nursing History
12173	Health care disparities
12174	New-onset type 1 diabetes
12175	compliance
12176	nonessential businesses
12177	vape shops
12178	disaster research
12179	social sciences
12180	cardiac computed tomography
12181	cardiac magnetic resonance imaging
12182	cardiovascular procedures
12183	cardiovascular surgery
12184	electrophysiology
12185	nuclear cardiac imaging
12186	Education, distance
12187	Education, graduate
12188	Health Care Index
12189	Healthcare Access and Quality Index
12190	preoperative period
12191	endovascular procedures
12192	Anterior eye segment
12193	Contact lenses
12194	Evidence based healthcare
12195	Teleoptometry
12196	Covid-19 disease
12197	SARS Covid-19
12198	financial toxicity
12199	Collegiate mental health
12200	Global neurosurgery
12201	Human Factors
12202	Operating
12203	Head & neck cancer
12204	Multidisciplinary team
12205	CT imaging findings
12206	ground glass opacities
12207	thin-section chest CT
12208	health care workers’ safety
12209	new coronavirus disease 19
12210	NPI
12211	librarianship, health science
12212	public health, Pakistan
12213	EMTALA
12214	medical screening exam
12215	autocratic regimes
12216	pregnant mothers
12217	COVID-19 research
12218	HIPAA
12219	health privacy
12220	Cancer chemotherapy
12221	Cancer treatment
12222	Drug delivery system preparation
12223	Hereditary nonpolyposis colorectal cancer
12224	Respiratory system procedures
12225	disaster management
12226	sustainability, coronavirus, COVID-19
12227	Medical societies
12228	Operative surgical procedures
12229	disinformation
12230	racism
12231	structural injustice
12232	crisis standard of care
12233	reproductive ethics
12234	women's reproduction
12235	crisis standards of care
12236	pandemic ethics
12237	clinical ethics consultation
12238	clinician-family relationship
12239	end-of-life care
12240	patient-family relationship
12241	Long-Term Care
12242	older adult
12243	COVID 19, Long Term Complications, Cardiopulmonary, Glucometabolic, Neuropsychiatric
12244	 COVID-19, Infections, Social distancing.
12245	COVID-19 and the Research Community
12246	careers in science
12247	grad school
12248	postdoc
12249	DPP4 inhibitors
12250	GLP1 receptor agonists
12251	Pacific
12252	non-communicable diseases
12253	librarian
12254	Air ambulance
12255	HEMS
12256	Highly contagious patient
12257	Transport
12258	coronaSARS-CoV-2
12259	RAAS-Inhibition
12260	Infant, newborn
12261	Covid_19
12262	Grossesse
12263	Nouveau-né
12264	poverty
12265	Home respiration
12266	Respiratory therapists
12267	Ressource management
12268	barriers to care
12269	digital interventions
12270	efficacy
12271	online treatment
12272	therapeutic alliance
12273	Antirheumatic therapy
12274	Patient questionnaire
12275	Rheumatic diesease
12276	COVID-19, 2019 corona virus disease
12277	CT, computed tomography
12278	CXR, chest radiography
12279	RT-PCR, real-time fluorescence polymerase chain reaction
12280	health planning guidelines
12281	practice guideline
12282	Hospitalists
12283	Pediatric infections
12284	Ground-glass opacities
12285	statistical analysis
12286	dental education
12287	dental practice management
12288	tomography
12289	Telehealth and COVID-19
12290	telemedicine and neurosciences
12291	teleneurology and COVID-19
12292	Alasdair MacIntyre
12293	The Hastings Center
12294	bioethicists
12295	bureaucratic managers
12296	expertise
12297	virtue
12298	end-of-life planning
12299	disorientation
12300	burdensome care
12301	end-of-life
12302	decisions
12303	transparency
12304	ventilators
12305	and complicity
12306	coercion
12307	exploitation
12308	systemic injustice
12309	data privacy
12310	equality
12311	Allocation, Scarce resources, Ethical decision-making, Pandemics, Ethical dilemmas.
12312	Pandemic, Infectious disease, COVID-19, Health resources, Healthcare, Resource husbandry. 
12313	COVID-19, Personal protection, Social Distancing, Quarantine.
12314	Health impacts
12315	Misinformation
12316	LASSO
12317	spatial autoregressions
12318	stochastic cycles
12319	Healthcare digitization
12320	Medical Robots
12321	disaster risk management
12322	economic evaluation
12323	economic impact study
12324	public health policies
12325	social justice
12326	vaccine rationing
12327	preventive behavior
12328	social actors
12329	registries
12330	 constructivist learning theory
12331	 distance learning
12332	 health professions education
12333	 online pedagogy
12334	cognitivism
12335	other infection, disease, disorder, or injury
12336	mobile assessment centers
12337	optimum route planning
12338	self-organizing feature map
12339	health care workers (HCWs)
12340	psychological guidance
12341	Solution focused brief therapy
12342	Communication characteristics
12343	Latent period transmission
12344	colorectal cancer
12345	management model
12346	interferon type I
12347	ground-glass opacity
12348	radiological features
12349	Inflammatory rheumatic diseases
12350	Digital health
12351	Digital triage
12352	Delivery of Health Care
12353	Cryptogenic Organizing Pneumonia
12354	X-Ray Computed
12355	Cancer disparities
12356	advertising and promotion
12357	health services
12358	covid-19 pandemic
12359	geriatric Health policy
12360	geriatric care
12361	inclusion of geriatric care
12362	Advisory
12363	Belgium
12364	data application
12365	epidemic situation
12366	mixed research
12367	Individualized treatment
12368	Lung neoplasms
12369	epidemiological modelling
12370	non-pharmaceutical
12371	dental hygienists
12372	psychological factors
12373	collective action
12374	moral obligation
12375	abnormal returns
12376	investor sentiment
12377	stock market indices
12378	az egészségügyi dolgozók személyi védelme
12379	coronavirus epidemy
12380	intenzív terápia
12381	koronavírus-járvány
12382	personal protection of healthcare workers
12383	GDPR
12384	General Data Protection Regulation
12385	Nigeria’s National Data Protection Regulation
12386	Endoscopy, selective
12387	new coronavirus infection
12388	MOOC
12389	OpenWHO
12390	Covid-19, Post Intensive Care Syndrome, Rehabilitation
12391	Stomatological practice
12392	Cabin hospital
12393	Pharmaceutical care
12394	Pharmacists
12395	Pharmacy service
12396	Cancer de la prostate
12397	Cancer de la vessie
12398	Cancer du penis
12399	Cancer du rein
12400	Cancer du testicule
12401	Cross infection
12402	Genital neoplasms, female
12403	Patient care management
12404	Infección respiratoria
12405	Niños
12406	Diagnostic and therapeutic strategy
12407	Breast neoplasms
12408	Health management outside the hospital
12409	classified protection
12410	epidemic prevention materials
12411	inbound and outbound management
12412	targeted use
12413	low and middle income countries
12414	low income countries
12415	middle income countries
12416	ageing
12417	care prevention
12418	help organization
12419	CMR
12420	oral and maxillofacial
12421	mask-wearing behavior
12422	primary school student
12423	COVID–19-fertőzött beteg
12424	anesztézia
12425	műtét
12426	operation
12427	perioperatív ellátás
12428	reverse transcriptase polymerase chain reaction
12429	reverztranszkriptáz polimeráz-láncreakció
12430	tesztelés
12431	viral pandemics
12432	viral vaccines
12433	víruspandémiák
12434	vírusvakcinák
12435	Reallocation
12436	Urgent surgery
12437	Bluetooth
12438	data protection
12439	Aged (Mesh)
12440	Nursing Homes
12441	Prise en charge
12442	Sarcoma
12443	Sarcome
12444	Fractionation
12445	Tandem-teams
12446	Criticalities
12447	Mass casualties
12448	WSES
12449	Cancers génito-urinaires
12450	Genitourinary cancers
12451	mobile phone
12452	peer-to-peer
12453	personal data
12454	construction
12455	epidemic prevention and control
12456	public hospital
12457	Medical team
12458	Oral emergency
12459	Oral health management
12460	cognition
12461	emotion
12462	word frequency analysis
12463	medical hardware
12464	open hardware
12465	open source
12466	crazy-paving sign
12467	halo sign
12468	IES
12469	 Sina-microblog 
12470	 prediction 
12471	First case
12472	Hepatobiliary system
12473	Traffic restriction
12474	Patient management
12475	swabs
12476	preventio
12477	Expert witness
12478	Forensic mental telehealth assessment (FMTA)
12479	Forensic psychiatry
12480	Forensic psychology
12481	Domestic violence
12482	Intimate partner violence
12483	Geriatric
12484	Resource-allocation
12485	Cardiología nuclear
12486	Echocardiography Cardiac tomography
12487	Ecocardiografía
12488	Equipo de protección personal
12489	Magnetic resonance
12490	Resonancia magnética
12491	Tomografía cardiaca
12492	COVID19 infection
12493	mortality risk
12494	nursing facilities
12495	Critical care medicine
12496	Position paper
12497	Pulmonary medicine
12498	Brachytherapy
12499	Novel coronavirus 2019
12500	Uterine cancer
12501	Traqueotomía
12502	Emerging epidemic diseases
12503	Enfermedades epidémicas emergentes
12504	2019 novel corona virus
12505	Emergency Committee
12506	International Health Regulations
12507	Hajj
12508	Mass gatherings
12509	Umra
12510	surgical treatment
12511	anticoagulant drugs
12512	neutrophil to lymphocyte ratio
12513	organizational climate
12514	working conditions
12515	Asistencia sanitaria
12516	Cefalea
12517	Transtornos do olfato
12518	High-risk
12519	Cancérologie
12520	Multidisciplinary team meeting
12521	Quality of Care
12522	Qualité de la prise en charge
12523	Réunion de concertation pluridisciplinaire
12524	Tumor board
12525	Non-invasive brain stimulation
12526	Transcranial alternating current stimulation
12527	Transcranial direct current stimulation
12528	Transcranial electrical stimulation
12529	Transcranial magnetic stimulation
12530	New coronavirus
12531	Nuevo coronavirus
12532	cruise
12533	guest
12534	Non-small cell lung cancer
12535	Small cell lung cancer
12536	Meteorological factors
12537	Time-series analysis
12538	infectious agents-viral
12539	psychobehavioral
12540	All-cause mortality
12541	EuroMOMO
12542	Self-quarantine
12543	NeuroCOVID
12544	Peripheral nervous system
12545	EU/EEA
12546	age mortality rates
12547	historical
12548	demographic factors
12549	surveillance system
12550	Compartmental model
12551	angiotensin II receptor blocker
12552	angiotensin‐converting enzyme inhibitor
12553	Cancer incidence
12554	alcohol policy
12555	methanol poisoning
12556	public health models
12557	COVID-19-associated aspergillosis
12558	ICU admission
12559	invasive aspergillosis
12560	Tobacco Use Disorder
12561	nicotine dependence
12562	people with HIV
12563	radiology department
12564	reconfiguration
12565	Racial/ethnic disparities
12566	Bacterial infections
12567	Living review
12568	Secondary infection
12569	Bayesian analysis
12570	Pediatric ARDS
12571	pediatric respiratory failure
12572	pediatric viral sepsis
12573	Clinical manifestation
12574	Laboratory examination
12575	Acute cardiac care
12576	Insuffisance cardiaque
12577	Soins aigus cardiaque
12578	Syndrome coronarien aigu
12579	Unité de soins intensifs
12580	NSCLC
12581	adverse outcomes
12582	nationwide study
12583	nonsteroidal anti-inflammatory drugs
12584	pharmacoepidemiologic study
12585	Research agenda
12586	Disease progression
12587	Severe patients
12588	Associated factors
12589	Critical outcomes
12590	Renin–angiotensin system inhibitors
12591	STROKE
12592	epidemiologic methods
12593	population surveillance
12594	Gaza
12595	Severe Acute Respiratory Syndrome
12596	Nonpharmaceutical intervention
12597	Alzheimer’s dementia
12598	Chronic lung disease
12599	occupational segregation
12600	racial/ethnic disparities
12601	Air humidity
12602	COVID-19 mortality
12603	Habitat
12604	Negative correlation
12605	Plaquenil
12606	exacerbation
12607	induction
12608	relapse
12609	community-based participatory research
12610	capitalism
12611	fundamental causes
12612	Religious mass gathering
12613	Kessler 6-item psychological distress scale
12614	Severe psychological distress
12615	CRP
12616	Lipoprotein apheresis
12617	Average high temperature
12618	Average low temperature
12619	Daylight hours
12620	Regional climate
12621	Central Asia
12622	Diagnostic-therapeutic protocols
12623	heart disease
12624	general terms
12625	neighborhood
12626	place
12627	population groups
12628	risk and crisis communication
12629	cohort study, type 2 diabetes
12630	Cure rate
12631	Tomography, spiral computed
12632	Ethnic inequalities
12633	: Infrared
12634	airports
12635	thermal
12636	thermography
12637	all-cause mortality
12638	Hendra virus
12639	Nipah virus
12640	henipavirus
12641	paramyxovirus
12642	surveillance studies
12643	zoonotic infections
12644	access facility
12645	clinical pathways
12646	organization and administration
12647	Radiographer
12648	LTSS
12649	Overdose
12650	COVID-19 & mental health
12651	COVID-19 suicide
12652	Coronavirus suicide
12653	Economic recession
12654	Poverty and suicide
12655	Suicides in Pakistan
12656	masking
12657	influenza A
12658	2020
12659	Peru
12660	risk of death
12661	time-delay adjusted CFR
12662	practice transformation
12663	cognitive appraisal
12664	public health concerns
12665	international governance
12666	public anthropology
12667	urgency
12668	Pediatric pneumonia
12669	CoViD-19 associated complications
12670	Corona infection
12671	Governance
12672	Online
12673	Poisoning
12674	Videoconference
12675	deep vein thrombosis
12676	adult orthopaedics
12677	diagnostic radiology
12678	orthopaedic & trauma surgery
12679	trauma management
12680	cutaneous manifestations
12681	skin involvement
12682	risk factors outcome
12683	Staging
12684	musculoskeletal
12685	factor VIII
12686	von Willebrand factor
12687	Disease severity
12688	DMARDs (biologic)
12689	DMARDs (synthetic)
12690	Anesthesia ventilators
12691	ICU shortage
12692	Ventilator deployment
12693	Ventilator shortage
12694	late adolescents
12695	Democracy
12696	COVID-19 (SARS-COV2)
12697	race/ethnicity
12698	Contingency Plans
12699	Coronavirus Infections Gastroenterology
12700	Learning Health System
12701	Public Reporting of Healthcare Data
12702	dietary behaviours
12703	fried foods
12704	fruits
12705	legumes
12706	olive oil
12707	snacking
12708	vegetables
12709	Cardiac care units
12710	post-acute care
12711	ACEI/ARB
12712	multiple lung lobe involvement
12713	pleural effusion
12714	preventive behaviors
12715	risk awareness
12716	Angiotensin receptor blockers (ARBs)
12717	Angiotensin-converting enzyme inhibitors (ACEIs)
12718	Antihypertensive regimen
12719	Adolescence
12720	Childhood
12721	Enfance
12722	Re-opening
12723	patients' voice
12724	skilled nursing facilities
12725	unimprovement
12726	Community hospital
12727	Preventive strategies
12728	radiological imaging
12729	abdominal pain
12730	infectious diarrhoea
12731	citizen science
12732	smartphones
12733	Viral Pneumonia
12734	X-Ray Computed Tomography
12735	nurse-patient-family relationship
12736	nursing ethics
12737	safety of nurses
12738	alcohol drinking
12739	Infectious disease outbreaks
12740	Aged
12741	Expert consensus
12742	major psychiatric disorders
12743	online mental health service
12744	blinding
12745	interventional
12746	randomized
12747	Coronavirus, Pakistan, Pandemic, Awareness, Preparedness, COVID-19. 
12748	Disease spreading
12749	WhatsApp
12750	community dentistry
12751	teledentistry
12752	Ethical guidance
12753	Professional guidance
12754	Public fear
12755	Social and economic implications
12756	Tomography scanners
12757	patient outcome assessment
12758	x-ray computed
12759	Emilia Romagna
12760	Piacenza
12761	kidneys
12762	nephropatic patients
12763	2019 Novel coronavirus pneumonia
12764	Clinical diagnosis
12765	Nucleic acid amplification test
12766	pathological autopsy
12767	sociability
12768	radiology management
12769	psychiatric disorders
12770	and COVID-2019
12771	point-of-care
12772	severe acute respiratory syndrome (SERS-CoV)
12773	Lung occupying lesions
12774	Preventive
12775	Conservation biology
12776	Embolia de pulmón
12777	Hospital emergency department
12778	Cough
12779	Virus shedding
12780	nosocomial infection prevention and control﻿ ﻿
12781	﻿coronavirus disease 2019 (COVID-19)
12782	multisystem organ failure
12783	pathophysiolog
12784	Respiratory distress syndrome, acute
12785	mechanical circulatory support
12786	shock
12787	Disease attributes
12788	Fluid volume status
12789	Nephrology
12790	POCUS
12791	Point of care ultrasound
12792	Intervention Effect
12793	mobile technology
12794	notification system
12795	imported
12796	outcome assessment
12797	arthritis
12798	critical type
12799	immuno-neuroendocrine interface
12800	Medical–religious partnerships
12801	Ambulatory
12802	Double-blind
12803	Moderate disease
12804	Placebo-controlled
12805	Case fatality ratio
12806	Migrants
12807	Sequelae
12808	Hepatitis B
12809	Interferon Beta-1a
12810	media coverage
12811	Cardiac arrest
12812	CURB-65
12813	Outpatient care
12814	Relative humidity
12815	Diesel particulate matter
12816	Hazardous waste sites
12817	prognosis, China
12818	web-based data
12819	ACE inh/ARBs
12820	Cerebrovascular
12821	Coronavirus disease-19 (COVID-19)
12822	Human umbilical cord mesenchymal stem cells
12823	Antihypertensive
12824	Social, environmental and health risk factors
12825	Vulnerability
12826	Hepatic encephalopathy
12827	Hepatocellular carcinoma
12828	Liver disease
12829	Varices
12830	trial
12831	Asymptomatic patients
12832	hyperinflammation
12833	anticoagulant treatment
12834	Inpatient
12835	Normal distribution
12836	cigar
12837	quitting
12838	Postmortem examinations
12839	Renin angiotensin system
12840	collective behaviour
12841	crowds
12842	disasters
12843	spondylitis, ankylosing
12844	dead body management
12845	disinfectant
12846	sodium hypochlorite
12847	Ruxolitinib
12848	randomized controlled trial
12849	SVM
12850	critical/severe symptom
12851	complete remission
12852	interlerleukin 6
12853	public Health
12854	chronic diseases
12855	cohort
12856	Supplementation
12857	Vitamin B
12858	Vitamin E
12859	global
12860	households
12861	Direct oral anticoagulants
12862	Terror management
12863	terror management health model
12864	Hunger
12865	World food program
12866	intensive & critical care
12867	Medication discontinuation
12868	Hematologic indices
12869	immunologic responses
12870	cancer patients and COVID-19
12871	darunavir
12872	infection and cancer
12873	oncology and coronavirus
12874	corticosteroid treatment
12875	early career
12876	investigators
12877	Clinical course
12878	Discharge
12879	Procedures
12880	Process
12881	European association of psychosomatic medicine
12882	Nosology
12883	Somatic symptom disorders
12884	Compartmentalization
12885	Enhanced traffic control bundling
12886	Long-term care facility
12887	child health
12888	network scenarios
12889	pandemic spread
12890	Comorbidites
12891	Demographics
12892	Epidemiological trends
12893	Health care system
12894	Community health
12895	Informal settlements
12896	Slums
12897	Polymerase Chain Reaction
12898	HbA1c
12899	Acute Kidney Failure
12900	Hematuria
12901	proteinuria
12902	In-hospital cardiac arrest
12903	ROSC
12904	Hospital acquired
12905	duration of viral shedding
12906	prognosis of disease
12907	geriatric assessment
12908	predictive biomarkers
12909	mental disorder
12910	Advanced heart failure
12911	heart transplant
12912	clinical medicine
12913	communicable disease control
12914	close contact
12915	in-hospital death
12916	IL-6R
12917	low molecular weight heparin
12918	Novel coronavirus diseases 2019
12919	case fatality risk
12920	adult diabetes
12921	fibrin degradation product
12922	          R          0        
12923	Epidemic potential
12924	Public health emergency of international concern
12925	Medication for opioid use disorder
12926	 laboratory
12927	 real-time reverse transcription-polymerase chain reaction test
12928	saline nasal irrigations
12929	general workers
12930	buprenorphine
12931	methadone
12932	opioid use disorder
12933	regulations
12934	Novel coronavirus disease 19
12935	Rennin-angiotensin-aldosterone system blockade
12936	Viral sepsis
12937	Liver dysfunction
12938	SARS-Coronavirus-2
12939	Hope brings light into dark places!
12940	Time-varying reproduction number
12941	attack rate
12942	casual contact
12943	social gathering
12944	delivery of healthcare
12945	healthcare quality, access, and evaluation
12946	socioeconomic factors
12947	jal-neti
12948	nasal irrigation
12949	nasal wash
12950	oral gargles
12951	immunomodulatory therapy
12952	Ebola virus
12953	Lassa virus
12954	RNA-dependent RNA polymerase (RdRp)
12955	drug action
12956	sofosbuvir
12957	Gene expression
12958	Immune signatures
12959	SARS-CoV-2 cell receptor
12960	covid 19
12961	idiopathic hypertension
12962	ischemic heart disease
12963	PM(2.5).
12964	Tropical countries
12965	IMD-0354
12966	VeroE6/TMPRSS2
12967	mycophenolic acid
12968	IL-22
12969	SARS-CoV-2 (COVID-19)
12970	human bronchial epithelial cell line (16HBE)
12971	SARS-CoV-2 3CL hydrolytic enzyme
12972	angiotensin converting enzyme II
12973	acute respiratory syndrome
12974	anti-cytokine antibodies
12975	human immunoglobulin for intravenous use
12976	immune system targeting in COVID-19
12977	TMPRSS2 expression
12978	respiratory epithelium
12979	viral brain infection
12980	Keap1/Nrf2/ARE pathway
12981	NF-κ B
12982	Nrf2
12983	ozone therapy 1
12984	Angiotensin-converting enzyme 2 (ACE2) receptor
12985	CoV-19
12986	Hartnup's disease
12987	miRNA-5197
12988	single stranded RNA (ssRNA)
12989	Markov state model
12990	random forest
12991	transition path theory
12992	Raccoons
12993	Spillback
12994	Waste water treatment plants
12995	Endothelialitis
12996	Molecular chaperones
12997	Molecular mimicry
12998	SARS‐CoV2
12999	congestion
13000	nose
13001	paranasal sinus
13002	sinonasal
13003	          ex vivo        
13004	coronavirus outbreak
13005	medical consequences
13006	western China
13007	ACE-2, angiotensin-converting enzyme-2
13008	ATM, azithromycin
13009	CLQ, chloroquine
13010	CLQ-OH, hydroxychloroquine
13011	COVID-19, coronavirus disease 19
13012	NTD, N-terminal domain
13013	RBD, receptor binding domain
13014	SARS-CoV-2, SARS-coronavirus-2
13015	host mechanism
13016	miRNA targets
13017	ECM proteins
13018	HSPG
13019	Molecular ophthalmology
13020	Picornavirus
13021	Pink eye
13022	agent-based modelling
13023	causal inference
13024	difference-making evidence
13025	mechanistic evidence
13026	Microarray
13027	peptide inhibitor
13028	polybasic cleavage sites
13029	Long noncoding RNAs
13030	ceRNA network
13031	miR-124-3p
13032	SARS COV 2
13033	immune regulation
13034	miRNA-microRNA
13035	18F-FDG-PET
13036	Brainstem
13037	Functional disorders
13038	Limbic system
13039	Demyelinating disease
13040	MHV-59
13041	Optic neuritis
13042	community prevention and control
13043	emergency response mechanism
13044	prevention and treatment system
13045	Seminal vesicles
13046	Cenicriviroc
13047	Chemokine receptor antagonist
13048	male reproductive
13049	Molecular Dynamics
13050	SARS-CoV-2 3CLpro
13051	membrane trafficking
13052	3CL main protease
13053	disulfiram
13054	thiol-reacting drugs
13055	breast milk
13056	human milk
13057	3CL-protease
13058	Activity inhibition
13059	Adsorption
13060	Meteorological parameters
13061	Guillain-Barre syndrome
13062	neurovirology
13063	EPAC
13064	PKA
13065	cAMP
13066	soluble adenylyl cyclase
13067	Domestic pets
13068	Farm animals
13069	Non-human primates
13070	Transgenic models
13071	Vaccine studies
13072	Nasal cavity
13073	Traditional Chinese herbs
13074	Demyelination
13075	Neuropathy
13076	mechanism of action
13077	Adult distress respiratory syndrome
13078	Hyperinflammatory state
13079	Hypertension arterial
13080	neuro-trauma
13081	biomedical
13082	drug
13083	network algorithm
13084	ranking
13085	Spontaneous Pneumomediastinum
13086	Macrophage
13087	Monocyte
13088	antioxidant therapy
13089	3CL pro
13090	Action mechanism
13091	Baicalein (PubChem CID: 5281605)
13092	Isorhamnetin (PubChem CID: 5281654)
13093	Kaempferol (PubChem CID: 5280863)
13094	Luteolin (PubChem CID: 5280445)
13095	Naringenin (PubChem CID: 932)
13096	Quercetin (PubChem CID: 5280343)
13097	Rutin (PubChem CID: 5280805)
13098	Ursolic acid (PubChem CID: 64945)
13099	Wogonin (PubChem CID: 5281703)
13100	β-Sitosterol (PubChem CID: 222284)
13101	cytokine treatment
13102	respiratory distress
13103	Hemoglobin
13104	ACE, angiotensin converting enzyme
13105	ACE2, angiotensin converting enzyme-2
13106	AT(1–7), angiotensin (1–7)
13107	AT1, angiotensin 1
13108	AT2, angiotensin 2
13109	Angiotensin converting enzyme 2 receptor
13110	SARS CoV, severe acute respiratory syndrome coronavirus
13111	SARS CoV-2, severe acute respiratory syndrome coronavirus-2
13112	V-ATPase
13113	eNHEs
13114	Heme
13115	Iron chelator
13116	Pulmonary fibrosis
13117	inflammatory markers
13118	therapeutic inference
13119	digital tracking
13120	do-it-yourself
13121	pandemic policy
13122	rapid testing
13123	Brain infection
13124	Olfactory epithelium
13125	antiviral agent
13126	antiviral mechanism
13127	therapeutic approaches
13128	viral mechanism of entry
13129	animals
13130	veterinary
13131	CD209L
13132	L-SIGN
13133	endothelial cell injury
13134	Ang II
13135	VEGF
13136	brain inflammation
13137	therapeutic target
13138	drug metabolism
13139	pulmonary delivery
13140	Clinical pharmacology
13141	Drug interaction 
13142	1,25(OH)2D3
13143	25(OH)D
13144	Extra-renal
13145	NF-kB
13146	NGF
13147	TNF
13148	Protein-homeostasis-system hypothesis
13149	Hemorrhagic stroke
13150	Intracerebral hemorrhage
13151	Case Series
13152	ACE2, Angiotensin Converting Enzyme-2
13153	CFR, Case-fatality rate
13154	CK-MB, Creatine Kinase Myocardial Band
13155	CPVT, Catecholaminergic polymorphic ventricular tachycardia
13156	CVD, Cardiovascular disease
13157	DIC, Disseminated intravascular coagulation
13158	FDP, Fibrin degradation products
13159	Hs-cTnI, High-sensitive cardiac troponin I
13160	LV, Left Ventricle
13161	MI, Myocardial Infarction
13162	NT-proBNP, N-terminal prohormone of brain natriuretic peptide
13163	PCI, Percutaneous coronary intervention
13164	TnT, Troponin T
13165	VTE, Venous thromboembolism
13166	Sinus bradycardia
13167	Sinus tachycardia
13168	Torsade de pointes
13169	Ventricular arrhythmias
13170	Ventricular fibrillation
13171	Ventricular tachycardia
13172	Therapeutic molecule
13173	expression
13174	Nitric oxide
13175	RRx-001
13176	Conditionally reprogrammed cells (CRCs)
13177	Kidney proximal tubule epithelial cells (KPTECs)
13178	Organoids
13179	SARS-CoVs
13180	disseminated intravascular coagulation (DIC)
13181	Ionophore
13182	systemic lupus erythematosus (SLE)
13183	acute kidney injury (AKI)
13184	arterial thrombi
13185	computed tomography (CT)
13186	kidney infarction
13187	renal complications of COVID-19
13188	thrombotic events
13189	exercise therapy
13190	Bayesian
13191	Master protocol
13192	Phase I/II
13193	Platform study
13194	ER stress
13195	pharmacological chaperone
13196	proteostasis
13197	unfolded protein response (UPR)
13198	Anti-inflammatory
13199	Colchicine
13200	Colchicine-tubulin complex
13201	ABCB1
13202	ACEIs/ARBs inhibitors
13203	Ethanolamine
13204	SARS-CoV-2. 
13205	coagulation factors
13206	cornea
13207	corneal epithelial cells
13208	acute cardiac injury
13209	acute myocardial injury
13210	troponins
13211	Drugs for COVID-19
13212	Airborne Transmission
13213	Airborne disease
13214	Coronavirus Infection
13215	Epidemic Outbreak
13216	Lung Disease
13217	Opportunistic pathogen
13218	SARS Coronavirus
13219	Transmission Dynamics
13220	Viral infectivity
13221	Virus Pneumonia
13222	Virus Transmission
13223	AAV
13224	TLR9
13225	adeno-associated virus
13226	cGAS
13227	Cannabis
13228	Endocannabinoid
13229	c reactive protein
13230	chest tube
13231	renin-angiotensin-aldosterone inhibitors
13232	solid organ transplant
13233	Antiviral activity
13234	Polysaccharides
13235	Cold‒Damp Plague Formula (CDPF)
13236	Molecular mechanism
13237	compounding
13238	dietary supplement
13239	immunological
13240	Camostat mesylate
13241	Cathepsin L
13242	Nafamostat mesylate
13243	Protease inhibitor cocktail
13244	Beta-adrenergic blockers
13245	Septic Shock
13246	CP
13247	CQ
13248	Cov
13249	NK
13250	convalescent plasma therapy
13251	ivermectin
13252	natural killer cell therapy
13253	folic acid
13254	p38 MAPK
13255	Haemodialysis
13256	Angiotensin-converting enzyme-2 receptor (ACE2-R)
13257	Central Nervous System (CNS)
13258	Corona Virus Disease 2019 (CoViD-19)
13259	Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2)
13260	transmembrane protease serine-2 (TMPRSS2)
13261	rhesus macaque model
13262	Pioglitazone
13263	oxLDL
13264	Blood routine analysis
13265	Convalescent COVID-19 patients
13266	Immunity response
13267	Self-reported depression
13268	Cerebrovascular stroke
13269	adipose tissue
13270	corpus callosum
13271	microbleeds
13272	Ebola virus (EBOV)
13273	Middle East respiratory syndrome coronavirus (MERS–CoV)
13274	RNA chain termination
13275	antiviral drug
13276	enzyme inhibitor
13277	nucleoside/nucleotide analog
13278	positive-sense RNA virus
13279	viral polymerase
13280	viral replicase
13281	chemokines
13282	cerebral vascular disease
13283	Platelet
13284	Alzheimer’s Disease
13285	West Nile Virus
13286	granulocyte-macrophage colony-stimulating factor
13287	mesenchymal stem cells (MSCs)
13288	natural killer (NK) cells
13289	platelet lysate
13290	Chinese medicine (CM)
13291	Convalescence
13292	Low-grade fever
13293	cerebrovascular diseases
13294	neuro-invasive mechanism
13295	SARS-CoV-2.
13296	mesenchymal stromal/stem cells
13297	regenerative medicine
13298	Siglec
13299	sialic acid
13300	leukotrienes
13301	vascular leak
13302	MSCs' immunomodulatory properties
13303	Mesenchymal stem cells (MSCs)
13304	Bacillus Calmette-Guerin (BCG) vaccine
13305	nonspecific effects
13306	trained innate immunity
13307	Nitrate
13308	Nitrite
13309	Neuroinvasive mechanism
13310	splenic infarction
13311	brain injury
13312	indoleamine 2,3-dioxygenase
13313	multiple organ injury
13314	physical exercise
13315	systemic AhR activation syndrome (SAAS)
13316	vitamin E
13317	clinical practice and basic research integration
13318	formula screening
13319	Immune reconstitution
13320	T cell exhaustion
13321	Thymosin alpha 1
13322	genetic polymorphism
13323	laboratory findings
13324	Dayuanyin
13325	Mechanism research
13326	AMI - Acute myocardial infarction
13327	CAD - Coronary Artery Disease
13328	Porphyrin
13329	heme pathway
13330	serum analysis
13331	hyponatremia
13332	hypovolemia
13333	inappropriate adh syndrome
13334	sars virus
13335	Xuanfei Baidu Tang(XFBD)
13336	hepatic and biliary metabolism
13337	immunity and inflammation
13338	adult atopic dermatitis
13339	ALT
13340	AST
13341	Hepatic regeneration
13342	Novel coronavirus pneumonia (NCP)
13343	HIV protease inhibitors
13344	birth outcomes
13345	decidualization
13346	drug safety
13347	spiral artery remodeling
13348	trophoblasts
13349	uterine natural killer cells
13350	Imported scale
13351	Meteorology
13352	Monalizumab
13353	NKG2A
13354	Amygdalin (PubChem CID: 656516)
13355	Baicalin (PubChem CID: 64982)
13356	Ephedrine (PubChem CID: 9294)
13357	Glycyrrhizic acid (PubChem CID: 14982)
13358	Hesperidin (PubChem CID: 10621)
13359	Ma Xing Shi Gan Decoction
13360	Narirutin (PubChem CID: 442431)
13361	Neohesperidin (PubChem CID: 442439)
13362	Qingfei Paidu Decoction
13363	cyclodextrin
13364	SARS- CoV-2
13365	azithromycin (AZM)
13366	Endosome
13367	Lysosomotropic agents
13368	angiotensinconverting enzyme inhibitors
13369	Characteristic
13370	autonomic nervous system
13371	sympathoactivation
13372	Prostaglandin D(2)
13373	Ramatroban
13374	Tp-e interval
13375	Tp-e/QT ratio
13376	Ventricular arrhythmia
13377	Gustatory dysfunction
13378	acute pulmonary embolism
13379	covid coagulopathy
13380	pulmonary embolism (pe)
13381	molecular dynamics (MD) simulations
13382	Artesunate
13383	Choroquine
13384	dual ocular route
13385	Percutaneous Coronary Intervention
13386	STEMI (ST-Elevation Myocardial Infarction)
13387	severe acute respiratory syndrome 2 (SARS-Cov-2)
13388	cell surface enzyme
13389	proteolytic enzyme
13390	transmembrane domain
13391	Corticosteroid
13392	Confined space
13393	Correction coefficient
13394	Invasion process
13395	Optimal value
13396	Penetration factor
13397	Virus-containing aerosols
13398	Liver transplant
13399	Furosemide
13400	Amino acids
13401	Gastrointestinal disturbances
13402	Hartnup disease
13403	Interpersonal violence
13404	endothelial cells
13405	microcirculation
13406	thromboxane (TxB2)
13407	Decompression illness
13408	Red blood cells
13409	Seizures
13410	Status epilepticus
13411	BAME
13412	Insulin resistance
13413	Visceral fat
13414	Aminoquinolines
13415	Anti-viral mechanism
13416	Small intestine
13417	PM(10)
13418	Chinese patent medicines
13419	Current evidence
13420	Guillain Barre syndrome
13421	Collapsing glomerulopathy
13422	Nephrotic syndrome
13423	Podocytopathy
13424	Apremilast
13425	Crisaborole
13426	Cyclic adenosine monophosphate
13427	Phosphodiesterase 4 inhibitor
13428	Psoriasis
13429	Roflumilast
13430	Dynamic panel
13431	Human mobility
13432	pneumomediastinum
13433	surgical emphysema
13434	tracheal injury
13435	consumer health information
13436	infectious disease outbreaks
13437	Dynamical analysis
13438	Kinetic modelling
13439	MCMC analysis
13440	Numerical simulations
13441	Chinese classical prescriptions
13442	TCMATCOV platform
13443	adult palliative care
13444	adult intensive & critical care
13445	Kv1.3-channels
13446	light
13447	Tumor necrosis factor-alpha
13448	ALI
13449	GTS-21
13450	HMGB1
13451	Hyperoxia
13452	RAGE
13453	TLR4
13454	Vagus nerve stimulation
13455	nurse in international medical center
13456	Oral disease
13457	Oral public health system
13458	Public health administration
13459	acute sedentary lifestyle
13460	insulin resistance
13461	metabolic consequences
13462	positive energy balance
13463	step reduction
13464	GSK3β
13465	Lung-toxin Dispelling Formula No. 1
13466	Meridian tropism
13467	forensic pathology; radiology; virtual autopsy; infectious diseases; corona virus disease 2019
13468	anti-infectives
13469	eliminating pathogens and strengthening healthy energy
13470	holistic view of traditional Chinese medicine
13471	host-directed therapy(HDT)
13472	Lung injury
13473	Non-epidemic area
13474	Respiratory function tests
13475	Work suggestion
13476	Galectin-3
13477	organ function support
13478	severe and critical type
13479	IgY
13480	Passive immunotherapy
13481	Phage display
13482	Spike protein (S)
13483	Receptor binding-motif
13484	Bioconjugation
13485	Immunosensing
13486	Protein-surface interaction
13487	United residue model
13488	artemisinin
13489	JACOM
13490	Kabasura Kudineer
13491	cd16
13492	sACE2
13493	sACE2-Anti-CD16
13494	Bovidae
13495	Cricetidae
13496	Homology Modeling
13497	Surface plasmon resonance
13498	Virtual drug design
13499	Cardiac failure
13500	master protocol
13501	phase II
13502	platform study
13503	randomised
13504	single-domain antibody
13505	trimeric interface
13506	ANCHOR and MD simulation
13507	Caulerpin
13508	exanthem
13509	viral diseases
13510	FET
13511	biosensor
13512	Macrophage Activation Syndrome (MAS)
13513	RAS system
13514	mRNA-LNP
13515	nucleoside-modified mRNA
13516	Auger
13517	Molecular Imaging
13518	Radiopharmaceuticals
13519	passive immunization
13520	ACE2, Angiotensin converting enzyme 2
13521	ACEI, ACE inhibitor
13522	COVID-19, Coronavirus Infectious Disease-19
13523	CVD, cardiovascular disease
13524	Coronavirus Infectious Disease-19
13525	Health disparity
13526	PAH, pulmonary artery hypertension
13527	R0, Reproductive number
13528	RAS, Renin-angiotensin system
13529	RBD, Receptor binding domain
13530	S, Spike: TMPRSS2, Transmembrane protease, serine 2
13531	SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus −2 SARS-CoV-2, Middle East Respiratory Syndrome 2: MERS-2
13532	SNP, Single Nucleotide Polymorphism
13533	Severe Acute Respiratory Syndrome Coronavirus −2
13534	Single Nucleotide Polymorphism
13535	Underlying diseases
13536	Lactobacillus plantarum (L. plantarum)
13537	Hematopoietic stem cells
13538	Nlrp3 inflammasome
13539	VSELs
13540	immunoglobulin fragment
13541	Protein production
13542	protein production
13543	COVID−19
13544	Antibody development
13545	Antigenic analysis
13546	Electrostatic interactions
13547	Protein-protein interaction
13548	pH effect
13549	bi-specific antibody
13550	humanized antibody
13551	llama antibody
13552	tri-specific antibody
13553	Withaferin a
13554	Withanolides
13555	defense
13556	reservoir
13557	antibody dependent enhancement (ADE)
13558	antigenic sin
13559	protecting IgG
13560	receptor binding protein
13561	protein expression
13562	serological assay
13563	Antibody-dependent enhancement (ADE)
13564	Fc receptors (FcR)
13565	camostat
13566	coronavirus 229E
13567	nafamostat
13568	type II transmembrane protease
13569	Antibody testing
13570	Geometry-matching principle
13571	cellular membrane coating
13572	spiky nanostructures
13573	virus binding and inhibition
13574	nanobodies
13575	human sialome
13576	pathogen susceptibility
13577	sialoquake
13578	Visual
13579	NLRP3 inflammasome
13580	viroporins
13581	Bioelectric Recognition Assay (BERA)
13582	Point-of-Care (POC)
13583	S1 spike protein
13584	membrane engineering
13585	severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)
13586	proprotein convertase furin
13587	S1/S2
13588	cleavage
13589	entry
13590	blood vessels
13591	human organoids
13592	spike glycoproteins
13593	Biparatopic
13594	antibody-ACE2 fusion
13595	Approved drugs
13596	Canine respiratory coronavirus
13597	COVID-19 diagnostic testing [Supplementary Concept]   
13598	Review [Publication Type]
13599	Diminazene aceturate (PubChem CID: 5284544)
13600	Resorcinolnaphthalein (PubChem CID: 337218)
13601	Xanthenone (PubChem CID: 7020)
13602	citronellol
13603	geranium essential oil
13604	lemon essential oil
13605	limonene
13606	alveolar
13607	bronchial
13608	nasal epithelium
13609	Drug by docking
13610	Inhibitors of RBD
13611	reproductive disorder
13612	testicular cells
13613	Spironolactone
13614	TMPRS22
13615	Non-diseased tissues
13616	Solid tumors
13617	receptor ACE2
13618	TMPRSS2, preterm birth
13619	decidua
13620	gestation-age dependent gene expression
13621	term pregnancies
13622	host susceptibility
13623	isoform
13624	angiotensin converting enzyme II (ACE2)
13625	liver hepatocellular carcinoma (LIHC)
13626	ACE2 closed state
13627	ACE2 polymorphism
13628	Iranian ethnic groups
13629	adaptive biasing force
13630	binding affinity
13631	Extracellular Vesicles
13632	competitive inhibition therapy
13633	Conjunctiva
13634	Cornea
13635	priming
13636	5-fluorouracil
13637	ADAM-17
13638	Antiandrogens
13639	Calmodulin antagonists
13640	Inhaled corticosteroids
13641	SERMs
13642	ADAM17
13643	human islets
13644	STATs
13645	enhancer
13646	mammary alveolar cells
13647	epithelial cells
13648	Brincidofovir
13649	familial multiple sclerosis
13650	whole-exome sequencing
13651	Kallikrein-kinin system
13652	Head Neck
13653	nutrigenetics
13654	nutrigenomics
13655	human conjunctiva
13656	angiotensin II converting enzyme inhibitors
13657	angiotensin II type 1 receptor blockers
13658	Multi-organ injury
13659	ACE2, angiotensin converting enzyme 2
13660	ARB, angiotensin receptor blocker
13661	BNP, B-type natriuretic peptide
13662	EmBx, endomyocardial biopsies
13663	F/NDC, nonischemic dilated cardiomyopathy with heart failure
13664	HFrEF, heart failure with reduced (<0.50) left ventricular ejection fraction
13665	LOCF, last observation carried forward
13666	LV, left ventricle (ventricular)
13667	LVEF, left ventricular ejection fraction
13668	NF, nonfailing
13669	NR, nonresponder
13670	PCR, polymerase chain reaction
13671	R, responder
13672	RGD, arginine-glycine-aspartic acid
13673	RNA-Seq, ribonucleic acid sequencing
13674	RV, right ventricle (ventricular)
13675	integrins
13676	mRNA, messenger ribonucleic acid
13677	ventricular remodeling
13678	ACEI/ARB therapy
13679	angiotensin II receptor blockers
13680	mineralocorticoid receptor antagonist
13681	diminazene
13682	Olink
13683	endometrial transcriptomics
13684	TMPRSS-2
13685	Age-related diseases
13686	Gut microbiota dysbiosis
13687	Poor outcomes
13688	Ibuprofen
13689	Angiotensin II type-1 receptor
13690	Renin-angiotensin inhibitors
13691	alveolar type II cells
13692	ciliated cells
13693	Oral squamous cell carcinoma
13694	protein levels
13695	virus attachment
13696	virus infections
13697	virus internalization
13698	Transcription
13699	Myopathy
13700	Respiration
13701	Skeletal muscle
13702	neurotropic virus
13703	infertility
13704	electronic cigarettes
13705	vaping
13706	mammals
13707	COVID-19 (2019-nCoV)
13708	GapmeR
13709	nasal delivery
13710	Ig-like proteins
13711	tmprss2
13712	oral cavity
13713	taste cell
13714	tongue coating
13715	Gastrointestinal tract
13716	Gut–lung axis
13717	Ang (1-7)
13718	Immunomodulators
13719	protein-protein docking
13720	Alveolar epithelial type II cell
13721	Pulmonary surfactant
13722	GLP-1
13723	inflammatory cytokines
13724	vascular inflammation
13725	vasculopathy
13726	IL-10
13727	Mas receptor
13728	cardiac dysfunction
13729	lung fibrosis
13730	ACE2 receptors
13731	Vitamin D3
13732	thymoquinone
13733	ADAR
13734	APOBEC3
13735	ACEi
13736	dipeptidyl peptidase 4
13737	gliptins
13738	fetal organs
13739	Blood-brain barrier
13740	Endothelial cells
13741	Microglia
13742	Neurons
13743	Baricitinib
13744	JAK-STAT
13745	VeroE6 Cells
13746	in vitro studies
13747	therapies
13748	Lung Cancer
13749	Angiotensin 2
13750	Angiotensin-(1–7)
13751	Glycoprotein spikes
13752	RAAS system
13753	COVID-19 cutaneous manifestations
13754	Infecciones virales de la piel
13755	Manifestaciones cutáneas de COVID-19
13756	Viral skin infections
13757	Aprotinin
13758	Icatibant
13759	SARS Coronaviruses
13760	male fertility
13761	syncytium
13762	Angiotensin-converting enzymes 2
13763	Male infertility
13764	Reproductive tissues
13765	RaTg13
13766	SCFAs
13767	Diabetes mellitus (DM)
13768	Faecal-oral route
13769	PARP14
13770	de-MARylation
13771	interferon-stimulated gene
13772	angiotensin-converting enzyme-2 (ACE2)
13773	lipid rafts
13774	lysosomal storage diseases
13775	Antiseptic
13776	Oral health
13777	andrology
13778	endocrinology
13779	male infertility
13780	ACE2, Angiotensin Receptor 2
13781	CI, Confidence Interval
13782	COVID-19, Coronavirus Disease-19
13783	GI, Gastrointestinal
13784	RNA, Ribonucleic Acid
13785	RT-PCR, Real-time Polymerase Chain Reaction
13786	TMPRSS, Transmembrane Serine Protease
13787	IFITM
13788	SARS-like coronavirus WIV1
13789	Angiotensin-(1-7)
13790	Emmprin
13791	BSL-4
13792	MERS virus
13793	bat virus
13794	biological agents
13795	vaccine and antibody against SARS-CoV-2
13796	Modes
13797	Routes
13798	neuron
13799	neurotropic
13800	transcribrial
13801	herbal medicines, HMGB1, coronaviruses, SARS-CoV, respiratory system
13802	Fat
13803	ACEIs/ARBs
13804	SARS coronavirus (CoV)-2
13805	ultra-processed foods
13806	Angiotensin Converting Enzyme 2
13807	Mice
13808	Transmembrane protease/serine subfamily member 2
13809	Molecular tropism
13810	design drugs
13811	Reproduction
13812	Clinical proteomics
13813	Label-free quantification
13814	Mass Spectrometry
13815	Parallel reaction monitoring
13816	Stable-isotope labeling
13817	Targeted mass spectrometry
13818	Vero E6
13819	Endocrine
13820	Electronic cigarettes
13821	Heat-Not-Burn
13822	IQOS
13823	Vaping
13824	GLP-1 agonists
13825	Mineralocorticoid receptor inhibitors
13826	ANG1-7
13827	Gastrointestinal Infection
13828	Oral-Fecal Transmission
13829	Retina
13830	Hydroxychloroquine aerosol
13831	Hypertransaminasemia
13832	Ocular viral infections.
13833	Protein-Protein Interaction
13834	ACE2 protein
13835	Angiotensinogen
13836	Renin
13837	polycystic ovary syndrome
13838	androgen signaling
13839	galectin
13840	ganglioside
13841	integrin
13842	Co-receptor
13843	immunohistochemistry   
13844	microphysiological systems  
13845	organoids  
13846	 COVID-19
13847	binding inhibition
13848	Codeine
13849	Morphine
13850	rhACE2
13851	Mouse models
13852	Renin–angiotensin system
13853	MEM
13854	Organ culture
13855	Gene set enrichment analysis
13856	Triglycerides
13857	azithromycin, SARS-CoV-2, COVID-19, TMPRSS2, TMPRSS11D, INSIG-1, IL-1, IL-6, NDST1, Cholesterol
13858	display technologies
13859	human monoclonal antibody
13860	human scFv
13861	neutralizing assays
13862	SARS-CoV-2 in the semen
13863	drug induced liver injury
13864	microthromboses
13865	viral damage
13866	RAS inhibitors
13867	heart damage
13868	pulmonary damage
13869	seminal fluid
13870	spermatozoa
13871	Receptores celulares de SARS-CoV-2
13872	SARS-CoV-2 cell receptors
13873	Virus ARN
13874	ADAM metallopeptidase domain 17, ADAM17
13875	C1 inhibitor, C1–INH
13876	Complement system
13877	Contact system
13878	Coronavirus disease 2019, COVID-19
13879	Hereditary angioedema
13880	Middle East respiratory syndrome coronavirus, MERS-CoV
13881	acute respiratory distress syndrome, ARDS
13882	angiotensin-converting enzyme, ACE
13883	bradykinin receptor B1, B1R
13884	bradykinin receptor B2, B2R
13885	bradykinin, BK
13886	des-Arg(9)-bradykinin, DABK
13887	granulocyte-colony stimulating factor, GCSF
13888	granulocyte-macrophage colony stimulating factor, GM-CSF
13889	hereditary angioedema, HAE
13890	high-molecular-weight kininogen, HMWK
13891	interleukin-1, IL-1
13892	macrophage inflammatory protein, MIP
13893	mannose-binding lectin associated serine protease, MASP
13894	mannose-binding lectin, MBL
13895	severe acute respiratory syndrome coronavirus 2, SARS-CoV-2
13896	transforming growth factor-β, TGF-β
13897	transmembrane serine protease, TMPRSS2
13898	tumor necrosis factor γ, TNF-γ
13899	renal Fanconi syndrome
13900	Immune function
13901	Virus receptor
13902	6VSB
13903	6W01
13904	Saikosaponins
13905	Chlorogenic acid
13906	Mongolian medicine
13907	Phillyrin
13908	E-cigarettes
13909	angiotensin-(1-7)
13910	Leydig cells
13911	cytokines and infertility
13912	CoVid-19
13913	human angiotensin-converting enzyme 2 (ACE2)
13914	adipocyte
13915	bisphosphonates
13916	inflammatory monocytes
13917	kallikrein-kinin system
13918	RAAS inhibitor
13919	heart rate
13920	sex characteristics
13921	IgG1
13922	mAb
13923	phage display
13924	scFv
13925	Dysfunctional coagulation
13926	Kallikrein
13927	Kinin
13928	healthcare in COVID-19
13929	neurovirulence SARS-CoV-2
13930	kinin-kallikrein system
13931	snake-derived bradykinin-potentiating peptide
13932	Downregulation
13933	Kawasaki-like disease
13934	TNF- α
13935	Cardiac
13936	Endothelium
13937	Microvascular
13938	Mas receptors
13939	neuropsychiatric disorders
13940	estrogens
13941	tamoxifen
13942	Angiotension converting enzyme 2
13943	PPAR-ɤ agonist
13944	Dysbiosis
13945	Lung microbiota
13946	Botox
13947	viral fusion
13948	ADEM, acute disseminated encephalomyelitis
13949	ANHE, acute necrotizing hemorrhagic encephalopathy
13950	BBE, Bickerstaff’s encephalitis
13951	DPP4, dipeptidil peptidase 4
13952	G-CSF, granulocyte colony stimulating factor (G-CSF)
13953	GBS, Guillain-Barré syndrome
13954	GM-CSF, granulocyte-macrophage colony-stimulating factor
13955	HCoV, Human coronavirus
13956	HCoV-229E, Human coronavirus 229E
13957	HCoV-OC43, Human coronavirus OC43
13958	MCP-1, monocyte chemoattractant protein-1
13959	Neurologic manifestations
13960	PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses
13961	SARS‐CoV, severe acute respiratory syndrome coronavirus
13962	βCoV, betacoronavírus
13963	central nervous system (CNS)
13964	Liver diseases
13965	Neutralizing Antibodies
13966	Male genital system
13967	BMI
13968	anti-hypertensive
13969	disease susceptibility
13970	endogamy
13971	Alzheimer’s disease risk
13972	neuroinvasivness
13973	IL-6 pathway
13974	adipokines
13975	renin–angiotensin system (RAS) pathway
13976	Hemodynamics
13977	Vasculopathy
13978	telmisartan
13979	Biological activity
13980	Computational Chemistry
13981	Melaleuca cajuputi oil
13982	PDB6LU7
13983	Bromhexine
13984	Prophylactic
13985	Non-steroidal anti-inflammatory agents
13986	enteric symptoms
13987	gastrointestinal infection
13988	cardiovascular complications
13989	inflammatory factor storm
13990	online consultation
13991	Placental barrier
13992	Indian population
13993	killer cell immunoglobulin-like receptors
13994	lipid-lowering therapy
13995	cefuroxime
13996	ACP, acute cor pulmonale
13997	CI, cardiac index
13998	COVID-19, coronavirus disease-19
13999	Fio2, fraction of inspired oxygen
14000	Pao2, partial pressure of oxygen
14001	RV, right ventricle
14002	RVSWI, right ventricular stroke work index
14003	TEE, transesophageal echocardiography
14004	acute cor pulmonale
14005	almitrine
14006	acute pancreatitis
14007	amylase
14008	lipase
14009	Heart transplantation
14010	Antiviral research
14011	Clinical efficacy
14012	clinical pharmacy
14013	vascular medicine
14014	Angiotensin-II receptor blockers
14015	natural language processing
14016	single cell RNA-seq
14017	ACE2 tissue distribution
14018	host−virus interaction
14019	Blood vessels
14020	Injury
14021	Ammoides verticillata
14022	isothymol
14023	molcular docking
14024	cholangiocyte injury
14025	gamma‐glutamyltransferase
14026	allosteric modulators
14027	nAChR
14028	Glycyrrhizin
14029	Converting enzymes
14030	Diastolic dysfunction
14031	Renal function
14032	Covid-19 treatment
14033	Diacerein
14034	Rhein
14035	assisted reproductive technologies
14036	NSAIDs
14037	non-steroidal anti-inflammatory drugs
14038	Neurological disorders
14039	PNS
14040	Phylogenetic perspective
14041	Mannose-binding lectin
14042	Monocytes
14043	A1AT
14044	hypercytokinemia
14045	Glucose-lowering medications
14046	Insulin therapy
14047	acutely ill
14048	obstetric management
14049	Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)
14050	plants
14051	CXCL10
14052	HDAC5
14053	LIF
14054	NFE2L2
14055	ethnic minorities
14056	ibuprofen
14057	hemorrhagic stroke
14058	type II cells
14059	CKD
14060	cardiorenal syndrome
14061	Cardiovascular drugs
14062	SARS-Cov 2
14063	AT1
14064	Contact System
14065	COVID-19 planet
14066	endothelitis
14067	flavonoids and their derivatives
14068	phytomedicine
14069	smart nanoparticles
14070	faecal-oral transmission
14071	gallbladder
14072	hypercoagulopathy
14073	Cardiac complication
14074	Myocardial damage
14075	ACE inhibitors/angiotensin receptor blockers (ACEIs/ARBs)
14076	renin-angiotensin system blockers (RAS blockers)
14077	Angiotensin II type‑1 receptor blocker
14078	Severe acute respiratory syndrome coronavirus 2
14079	Dysrhythmia
14080	SARS-CoV-2-ACE2
14081	Coronavirus, covid-19, anosmia, olfaction, olfactory, gustatory, smell, taste, loss, SARS-CoV-2, ACE2, infection
14082	(Bcl10), mucosa-associated lymphoid tissue lymphoma translocation protein 1
14083	(MALT1), CBM
14084	Angiotensin converting enzyme-2, ACE2
14085	CARMA, B-cell lymphoma protein 10
14086	G protein-coupled receptor, GPCR
14087	Janus kinase, JAK
14088	MALT1
14089	NFκB
14090	adherens junctions, AJ
14091	angiotensin II type 1 receptor, AT1: domain-containing protein
14092	arrestins
14093	coronavirus disease of 2019, COVID-19
14094	endosomes
14095	endothelial
14096	fibroblast-growth-factor, FGF
14097	inhibitor of NFκB kinase, IKK
14098	mitogen-activated protein kinase, MAPK
14099	neural precursor cell expressed developmentally down-regulated protein 4, NEDD4
14100	nuclear factor kappa-light-chain-enhancer of activated B cells, NFκB
14101	platelet activating factor, PAF
14102	protease-activated receptor-1, PAR1
14103	signal transducer and activator of transcription, STAT
14104	transforming growth factor-α-activated kinase binding protein-1, TAB1
14105	ACLF, acute-on-chronic liver failure
14106	ERC, endoscopic retrograde cholangiography
14107	HCC, hepatocellular carcinoma
14108	IL-6, interleukin-6
14109	LT, liver transplant
14110	MELD, model for end-stage liver disease
14111	NAFLD
14112	NAFLD, non-alcoholic fatty liver disease
14113	NASH, non-alcoholic steatohepatitis
14114	OGD, oesophagogastroduodenoscopy
14115	ULN, upper limit of normal
14116	ACE-I, angiotensin-converting enzyme inhibitor
14117	ALT, alanine aminotransferase
14118	AST, aspartate aminotransferase
14119	EGD, esophagogastroduodenoscopy
14120	NUC, nucleoside analogue
14121	PIs, protease inhibitors
14122	AT1R
14123	New coronavirus (COVID-19)
14124	SARS coronavirus (SARS-CoV)
14125	gastrointestinal manifestations
14126	gi societies
14127	pre-existing gi diseases
14128	dipeptidyl peptidase-4
14129	Angiotensin converting enzyme inhibitor
14130	Carvedilol
14131	Verapamil
14132	ATF4
14133	SOD3
14134	single-cell RNA sequencing
14135	Vaccines.
14136	ApoE gene complex
14137	apoE
14138	olfactory sensory neurons (OSNs)
14139	Extended Interval Dosing
14140	Natalizumab
14141	Relapsing remitting multiple sclerosis
14142	T1DM
14143	T2DM
14144	Bioaerosols
14145	Standing potential of the eye
14146	Renin Angiotensin System
14147	Neurological
14148	Angiotensin II type-1 receptor blockers
14149	Antihypertensive drugs
14150	neuroinfection
14151	neurological sequelae
14152	Sodium hydrogen exchanger
14153	Nrf2 activators
14154	RIG-1
14155	AT2R
14156	MASR
14157	MRGD
14158	physical training
14159	AKI
14160	Angiotensin II receptor blockers
14161	soluble ACE2
14162	COVID-19 retinal microangiopathy
14163	COVID-19 retinopathy
14164	COVID-19 vascular risk
14165	Angiotensin receptors
14166	Complement
14167	immune cell
14168	dural puncture
14169	neuraxial anaesthesia
14170	neurological complications
14171	spinal anaesthesia
14172	DIZE
14173	Diminazene aceturate
14174	angiotensin-converting enzyme (ACE)
14175	glutathione
14176	glycine
14177	paracetamol
14178	Cerebral hemorrhage
14179	Immunoglobulin
14180	renin
14181	Cardiac Valves
14182	Haemodynamics
14183	Alveolar cells
14184	Nanomedicine
14185	Immunological shift
14186	Cytokine Storm
14187	Diabetes Mellitus
14188	Insulin Resistance
14189	 Mortality
14190	Clinical severity
14191	RAS inhibition
14192	Circadian rhythms
14193	Host response
14194	Organotypic models
14195	generic drugs
14196	host response treatment
14197	cardiomyopathy
14198	Covid-19 during pregnancy
14199	fetal development
14200	long-term maternal vascular health
14201	maternal immunity
14202	placental function
14203	angiotensin-converting enzyme-related carboxypeptidase 2
14204	extravillous trophoblasts
14205	middle east respiratory syndrome
14206	severe acute respiratory syndrome coronavirus-
14207	syncytiotrophoblasts
14208	Adenosine monophosphate kinase (AMPK)
14209	Mechanistic target of Rapamycin (mTOR)
14210	Imaging
14211	nuclear medicine
14212	positron emission tomography
14213	single photon emission computed tomography
14214	anti-retroviral agents
14215	anti-viral immunity
14216	ardiovascular
14217	hronic obstructive pulmonary disease
14218	iabetes mellitus
14219	ypertension
14220	Carotid Body
14221	Chemosensitivity
14222	Nervous System
14223	Vagus
14224	Sodium balance
14225	Basic reproduction number (R(0))
14226	Novel coronavirus infection
14227	Continuous veno-venous hemofiltration
14228	mers
14229	sars
14230	sars-cov2
14231	wuhan-hu-1-cov
14232	Severe acute respiratory syndrome-coronavirus2 (SARS-CoV2)
14233	carbohydrate
14234	inflammatory neuropathy
14235	monoclonal gammopathy
14236	macronutrients
14237	nuclear factors
14238	nutrient
14239	protein intake
14240	trace elements
14241	transcription factors
14242	Bupleurum chinense
14243	Cinnamomum cassia
14244	Ephedra sinica
14245	Glycyrrhiza uralensis
14246	Pogostemon cablin
14247	QFPDT
14248	Scutellaria baicalensis
14249	Therapeutic Targets
14250	Antiviral targets
14251	Astrocyte
14252	Glial cells
14253	Cardiac manifestation
14254	Inflammasomes
14255	tissue regeneration
14256	antiviral immunity
14257	interferon-induced transmembrane proteins
14258	valproic acid
14259	drug development/discovery
14260	approved active compounds
14261	cathepsin L
14262	lysosome
14263	lysosomotropic compounds
14264	lysosomotropism
14265	viral host cell entry
14266	SARS-CoV-2 3CL protease
14267	Structural stability
14268	small-molecule therapeutics
14269	Differentially expressed genes
14270	Enrichment analysis
14271	RNAseq
14272	2′-O-ribose methyltransferase
14273	endocytic pathway
14274	Indian Ayurveda
14275	Indian Rasayana
14276	Withania somnifera
14277	in-silico
14278	molecular docking and dynamics
14279	pandemic infection
14280	olfactory bulb
14281	arsenical drug
14282	darinaparsin
14283	novel-corona virus
14284	cyclosporine A
14285	in silico study
14286	micronutrient Clinical trial
14287	protein interaction
14288	Chymotrypsin-like protease
14289	Drug repurposing.
14290	Papain-like protease
14291	Polymerase
14292	Spikeprotein
14293	RdRP assays
14294	RdRP inhibitors
14295	Ribosomal proteins
14296	Viral translation
14297	Anti-malarial drugs
14298	Antiviral compounds
14299	Simulations
14300	Drug
14301	Inflammasome
14302	A recent update
14303	Pharmacological therapy
14304	Pipeline drugs
14305	IL‐6
14306	medications
14307	NETosis
14308	extracellular vesicles (EVs)
14309	peptidylarginine deiminases (PADs)
14310	protein deimination
14311	Naringenin
14312	SARS - CoV
14313	endo-lysosomal dysfunction
14314	two-pore channel (TPC)
14315	Gene enrichment
14316	Gene prioritization
14317	Neurological damage
14318	Bacterial dysbiosis
14319	Microbiota
14320	Vomit
14321	microvascular
14322	thrombotic microangiopathy
14323	tissue factor
14324	N-glycans
14325	glyco-conjugate
14326	oligomannoses
14327	virus-neutralizing antibody
14328	Interferon stimulating genes
14329	Network biology
14330	IL1
14331	early immune response
14332	transcriptomic profiling
14333	Inflammatory storm
14334	PDE
14335	cGMP
14336	pan-selective inhibitors
14337	Eculizumab
14338	HIF-1-alpha
14339	Imatinib
14340	H5N1 influenza
14341	Haematopoietic cells
14342	IL-1
14343	Anticancer drugs
14344	Health emergencies
14345	Extracellular mitochondria
14346	Hyper-inflammation
14347	Platelet mitochondria
14348	morphoproteomics
14349	pulmonary COVID-19
14350	TCMIP V2.0
14351	recommended prescription
14352	traditional Chinese medicine syndromes
14353	Gas exchange
14354	DAMP
14355	HIF-α
14356	Mitochondrial dysfunction
14357	Sirtuins
14358	Viral replication
14359	Actin cytoskeleton
14360	Cdc42
14361	Rho GTPases
14362	Tunneling nanotubes
14363	immunological products and vaccines
14364	association analysis
14365	medication regularity
14366	lung protective ventilation
14367	splitting
14368	traditional Chinese herbal medicines (traditional CHM)
14369	"""cytokine storm"""
14370	arachidonic acid metabolic pathway
14371	disease outcomes
14372	microbial dysbiosis
14373	ACE-2-r
14374	Alveoli
14375	SARS-CoV-2 epitopes
14376	peptide sharing
14377	CD39
14378	CD73
14379	cytotoxic lymphocytes
14380	granzyme B
14381	perforin
14382	purinergic signaling
14383	Protein reliability
14384	herbs
14385	mushrooms
14386	ERAP2
14387	ERAP2/Iso3
14388	host cell response
14389	microbial infections
14390	Pooling
14391	CT-guided biopsy
14392	diagnostic yield
14393	pleural lesions
14394	ultrasound-guided biopsy
14395	antimalarial drugs
14396	Dissemination
14397	Bisubstrate
14398	Nucleoside
14399	RNA methyltransferase
14400	SAM analogs
14401	JAK/STAT pathway
14402	Immune Enhancement
14403	Pathogenic priming
14404	Ankylosing spondylitis
14405	Biological drugs
14406	Interleukin-17
14407	Secukinumab
14408	Aerosol Box
14409	Aerosol-generating medical procedures
14410	AMP activated protein kinase(AMPK)
14411	Akt
14412	interleukins
14413	mTOR Complex 1 (mTORC1)
14414	mTOR Complex 2 (mTORC2)
14415	macrophage inflammatory protein 1-α(MIP-1α)
14416	mechanistic target of rapamycin(mTOR)
14417	metformin
14418	monocyte chemoattractant protein 1 (MCP-1)
14419	tumor necrosis factor-α
14420	virion
14421	Lab-on-chip
14422	disease modifying therapies
14423	Atazanavir
14424	MT-DTI
14425	nucleotide analogues
14426	SARS-corona virus-2
14427	target structures
14428	cockroaches
14429	novel antivirals
14430	ADME analysis
14431	Main protease proteins
14432	Plant metabolites
14433	cobas
14434	cobas 6800
14435	Nanotherapeutics
14436	Anti-virals
14437	Bacterial assays
14438	catalytic triad
14439	conserved water molecule
14440	adjuvant treatment
14441	antiviral environment
14442	fenretinide
14443	Complement activation
14444	Low-molecular weight heparin
14445	Methylprednisolone
14446	SARS-CoV-2 Pneumonia
14447	SARS-CoV-2 and RNA‐dependent RNA polymerase (RdRp)
14448	natural polyphenols
14449	International Health Security
14450	global impact
14451	LSPR
14452	nuclei acids
14453	plasmonic photothermal effect
14454	IL-17 target therapy
14455	 Broussonetia papyrifera polyphenols
14456	SARS CoV-2 main protease
14457	6lu7
14458	Lopinavir.
14459	Clinical dose
14460	Indomethacin
14461	Model-based
14462	Translational model
14463	IC50
14464	endonuclease
14465	Shuanghuanglian oral liquid
14466	baicalein
14467	baicalin
14468	traditional Chinese medicines
14469	CoV-Mpro
14470	CoV-Nsp12 polymerase
14471	CoV-Nsp13 helicase
14472	off-label drug use
14473	honey bee
14474	inhibition
14475	propolis
14476	transmembrane protease serine 2 (TMPRSS2)
14477	in-silico drug discovery
14478	GC376
14479	M protease
14480	Mpro
14481	antiviral research
14482	Virion
14483	green tea polyphenols/catechins
14484	DHODH inhibitors
14485	de novo pyrimidine biosynthesis
14486	immuno-regulation
14487	influenza viruses
14488	virus replication
14489	 Withania somnifera 
14490	Acute myocarditis
14491	Multisystem inflammatory syndrome
14492	Shock
14493	activity-based protein profiling
14494	enzymes
14495	fluorescent probes
14496	2019-nCov/SARS-CoV-2
14497	Endoplasmic reticulum stress
14498	Transgenic cell vaccination
14499	GM-CSF
14500	mavrilimumab
14501	JAK2 inhibitor
14502	TH17
14503	Anti-HCoV agent
14504	Target based screening
14505	25-hydroxycholesterol
14506	AM580
14507	Notch
14508	DFT calculations
14509	N-heterocycles
14510	graphene oxide
14511	nanovaccines
14512	Antiviral target
14513	NTPase
14514	Nsp13
14515	SARS-coronavirus-2 (SARS-CoV-2)
14516	fragment-based drug discovery
14517	Monte Carlo based optimization
14518	QSAR based virtual screening
14519	SARS-CoV PLpro
14520	T-Lymphocytes
14521	pentoxifylline
14522	Cancer-targeting
14523	Peptide inhibitors
14524	critically ill patient
14525	heat shock response
14526	          de novo drug design
14527	GCGR
14528	Sars-CoV-2 virus
14529	Ankaferd hemostat
14530	Oestrogen
14531	PAR-1
14532	EPO
14533	SARS-CoV-2; recombinant human erythropoietin
14534	clinical trial design
14535	neuroprotection
14536	respiratory function
14537	side effects
14538	small molecule inhibitors
14539	tsDMARDs
14540	Thromboinflammation
14541	Coronaviral main protease
14542	Dihydroergotamine
14543	Ergotamine
14544	biguanides
14545	buformin
14546	inhaled
14547	mammalian target of rapamycin
14548	Enoxaparin
14549	necroinflammation
14550	Asparagus racemosus
14551	Pandemic disease
14552	Shatavari; Molecular docking
14553	nCov-2019
14554	Ca(2+) current
14555	Hyperpolarization-activated cation current
14556	K(+) current
14557	Membrane potential
14558	Pirfenidone
14559	Pituitary cell
14560	Voltage hysteresis
14561	Chloroquine phosphate
14562	Hydroxychloroquine sulfate
14563	entry inhibitor
14564	Blood purification therapies
14565	ventilator support
14566	Pneumocytes
14567	Zinc transporter
14568	COVID-19 complications
14569	aging resilience
14570	antiaging drug cocktail
14571	interactive cytokines
14572	Closed-loop
14573	Continuous glucose monitoring
14574	Diabetes pregnancy
14575	Gestational diabetes
14576	Insulin pump therapy
14577	Type 1diabetes
14578	cancer drugs
14579	growth factors
14580	tyrosine kinase
14581	pneumonitis
14582	Drug-drug interaction
14583	Microdosing
14584	Midazolam
14585	Pantoprazole
14586	Trial protocol
14587	Yohimbine
14588	N terminal domain
14589	bradykinin receptor
14590	Blood glucose level
14591	Blood glucose monitoring
14592	Inpatient glycemic control
14593	Asinex BioDesign
14594	3-D printing
14595	Assistive technologies
14596	Industry 4.0
14597	Medical
14598	drug interaction
14599	immunosuppressive regimens
14600	pharmacokinetics/pharmacodynamics
14601	Patients management
14602	Bradykinins
14603	Endothelin-1
14604	GRP
14605	fMLP
14606	Secondary opportunistic infection
14607	COVID-19 therapy
14608	DUBs
14609	PLP inhibitors
14610	Clinical trials as topic
14611	blood glucose meter (BGM)
14612	continuous glucose monitor (CGM)
14613	smartpen
14614	type 1 diabetes
14615	SARS Cov 2
14616	nigella.
14617	scleroderma, systemic
14618	repositioning
14619	pre-emptive therapy
14620	acute on chronic liver failure
14621	CNS infection
14622	Spike protein and therapeutics
14623	Bleeding disorders
14624	Haemophilia A
14625	VV-ECMO
14626	takotsubo
14627	immunonutrition
14628	China's COVID-19 Guide
14629	IL-6 inhibitor
14630	Xuebijing
14631	athlete
14632	sports cardiology
14633	burn surgery
14634	false-negative
14635	patient under investigation
14636	rt-pcr
14637	sjs/ten
14638	antiviral therapeutics
14639	ferrets
14640	serum neutralization
14641	alkaloids
14642	anti-herpesvirus drugs
14643	herpesviruses
14644	Anti-SARS-CoV-2 plasma
14645	Convalescent Plasma
14646	Respiratory Failure
14647	stroke management
14648	Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Propensity score match; Interferon (IFN)
14649	Vero E6 cells
14650	virus shedding
14651	Cesarean section
14652	COVID-19 clinical trial
14653	IFN-β-1a
14654	Esclerosis múltiple
14655	Immunosuppressants
14656	Inmunosupresores
14657	Tratamientos
14658	heart transplantation/cardiology
14659	immunosuppressant - calcineurin inhibitor: tacrolimus
14660	Rheumatic disease
14661	IVIg
14662	leukocyte
14663	ICU cases
14664	Guillain-Barré syndrome
14665	Sudden sensorineural hearing loss
14666	viraemia
14667	Virus pneumonia
14668	immunity, cellular
14669	immunity, humoral
14670	immunotherapy, adoptive
14671	receptors, chimeric antigen
14672	dermatologic treatments
14673	immunosuppressants
14674	skin disease
14675	therapy systemic
14676	In vitro techniques
14677	heat treatment
14678	molecular methods
14679	nasopharyngeal samples
14680	rt-Real time PCR
14681	Standard of care
14682	immunomodulatory
14683	transmission-blocking
14684	Update
14685	economic reason
14686	ADME/T
14687	suramin
14688	Syrian hamsters
14689	countermeasure
14690	SARS-CoV-2 re-positive
14691	erythrocyte
14692	long-term follow-up
14693	recovered patients
14694	infection (neurology)
14695	mood disorders (including depression)
14696	psychotic disorders (incl schizophrenia)
14697	Innate immune
14698	lung acute embolism
14699	severe acute respiratory syndrome-Coronavirus-2
14700	antibody content
14701	plaque assay
14702	virus quantification
14703	Active Surveillance
14704	EIDD-2801
14705	N-acetylcysteine (NAC)
14706	copper
14707	remdesivir (RDV)
14708	VKA
14709	subacute thyroiditis
14710	thyroid
14711	Chloroquine/hydroxychloroquine
14712	Liu Shen capsule
14713	Anal swab
14714	Baby
14715	Bat coronavirus
14716	Expanding host range
14717	respiratory sampling
14718	Darunavir
14719	In vitro
14720	melatonin
14721	FRET
14722	SARS-CoV 3CL protease
14723	flavonoid
14724	inhibitory compounds
14725	feces
14726	Anestesia
14727	Infecção por SARS‐CoV‐2 (COVID‐19)
14728	Pituitary tumor
14729	SARS‐CoV‐2 infection (COVID‐19)
14730	Tumor pituitário
14731	ANCA vasculitis
14732	Idiopathic inflammatory myopathies
14733	Systemic lupus erythematosus
14734	HAN
14735	HEN
14736	Home enteral nutrition
14737	Home medical nutritition
14738	Home parenteral nutrition
14739	PRES
14740	human metapneumovirus
14741	kidney transplant
14742	nutraceuticals
14743	FDA-approved drug
14744	sputum
14745	stool
14746	pathogen reduction
14747	riboflavin
14748	COVID-19 mechanisms
14749	viral resistance
14750	Drug regulation
14751	Inflammatory diseases
14752	Therapy Management
14753	fomite
14754	half-life
14755	COVID-19 drug treatment
14756	Serine proteases
14757	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
14758	Presepsin
14759	SARS-CoV-2 patients
14760	Mesenteric ischaemia
14761	Pneumatosis intestinalis
14762	human coronaviruses
14763	acute haematological malignancies
14764	social distancing measures
14765	COVID-19 (SARS-CoV-2)
14766	G6PD
14767	oxidative injury
14768	ocular manifestations
14769	side-effects
14770	CD8+ T cells
14771	cytotoxic cells
14772	SARS-CoV-2 Mpro
14773	alliin
14774	Cranial polyneuritis
14775	Miller Fisher syndrome
14776	Severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus, SARS-CoV-2)
14777	Rheumatic musculoskeletal diseases (RMDs)
14778	donors and donation: deceased
14779	ethics and public policy
14780	generalized rash
14781	maculopapular rash
14782	morbilliform
14783	rash
14784	sepsis, COVID-19, Thrombosis, Coagulopathy
14785	Bioactivity scores
14786	In silico ADMET properties
14787	Lipinski’s parameters
14788	Antimalarial drug
14789	in vitro
14790	Chronic intestinal failure
14791	environmental surface
14792	Recurrence
14793	IL-6 levels
14794	endoscopic laboratory
14795	ABSTRACT
14796	Emetine
14797	Homoharringtonine
14798	perinatal
14799	treatment safety
14800	viral clearance
14801	Betamethasone
14802	pharmacophore model
14803	biological treatment
14804	Betweenness
14805	M(pro)
14806	high flow nasal cannula
14807	sinusitis
14808	human antibodies
14809	mouse hepatitis virus (MHV)
14810	Nucleic acid extraction
14811	Proteinase K
14812	Auranofin
14813	Maternal-fetal transmission
14814	Transmission materno-fœtale
14815	AURI, Acute upper respiratory infection
14816	COVID-19, Coronavirus disease
14817	Ct, Cycle threshold
14818	Indoor Air Environment
14819	NP, Nucleocapsid protein
14820	ORF1ab, Open reading frame
14821	QRT-PCR, Quantitative real-time polymerase chain reaction
14822	RP, Re-detectable positive patients
14823	Re-detectable Positive
14824	Ready-for-discharge Patient
14825	alisporivir
14826	cyclophilin
14827	dental office management
14828	heat inactivation
14829	virus neutralization test
14830	Chemiluminescence microparticle immunoassay
14831	Real -Time RT-PCR
14832	Autobio
14833	Serologic rapid tests
14834	weak positive bands
14835	lumbar
14836	Long-term consequence
14837	Brain hemorrhage
14838	Imaging finding
14839	HIV cure-related trials
14840	analytical treatment interruptions
14841	risk mitigation
14842	viral protease
14843	viral protein N
14844	haematological malignancy
14845	SARS-CoV-2 antibodies
14846	point of care tests
14847	Lianhuaqingwen
14848	Lipoprotein A
14849	Livedoid vasculitis
14850	checkpoint inhibitor
14851	pembrolizumab
14852	cell ultrastructure remodeling
14853	diltiazem
14854	 influence
14855	nucleic acid detection
14856	storage
14857	throat swab
14858	Environmental SARS-CoV-2 contamination
14859	Intestinal infection
14860	Viral excretion of SARS-CoV-2
14861	immunotherapeutic
14862	Citokynes
14863	intravitreous injection
14864	control precautions
14865	therapeutic regimens
14866	lung transplantation/pulmonology
14867	Xuzhou
14868	familial cluster
14869	nosocomial transmission
14870	innate immune
14871	bacterial co-infection
14872	stem cell therapy
14873	common touch surfaces
14874	environmental conditions
14875	inanimate surfaces
14876	stability
14877	survivability
14878	virus survival
14879	detection rate
14880	faecal specimen
14881	Fertilidad masculina
14882	Orchitis
14883	Orquitis
14884	Glutathione
14885	NAC
14886	Redox potential
14887	Redox status
14888	T Cell Exhaustion
14889	TNF-ɑ
14890	Dental clinics
14891	thyroidvirus
14892	imaging characteristics
14893	intracranial hemorrhage
14894	chronic renal disease
14895	experience
14896	gynecologist
14897	obstetrician
14898	age-related immune response
14899	childhood COVID-19
14900	donors and donation
14901	neonatal sepsis
14902	ferret
14903	virus-host interactions
14904	Diabetes mellitus: SARS-CoV-2
14905	in vitro diagnostic tests
14906	serology immunoassays
14907	challenging questions
14908	Systemic autoimmune diseases
14909	Renal transplantation
14910	immune milk
14911	Kawasaki Disease
14912	hemophagocytic lymphohistiocytosis
14913	macrophage activation syndrome
14914	multisystem inflammatory syndrome in children (MIS-C)
14915	toxic shock syndrome
14916	Discharge standard
14917	Turn positive
14918	Diagnostic test
14919	SARS-CoV-2 hepatitis
14920	acute rejection
14921	copy number
14922	digital PCR
14923	Natural compound
14924	SARS-CoV-2 IgG antibody
14925	sexual discrepancy
14926	plateau
14927	anti-fungals
14928	Atypical symptoms
14929	Ground-glass opacity
14930	Bridge therapy
14931	Congestion
14932	resuscitation
14933	alcohols
14934	CNS penetration
14935	drug treatment
14936	log P
14937	convalescent
14938	2019-ncov
14939	acei
14940	arb
14941	transplant
14942	Tormenta de citocinas
14943	SARS-CoV-2; Breastfeeding; Pregnant woman; Pathogenesis; Maternal-fetal transmission
14944	Short QT syndrome
14945	ineffective clearance
14946	antiretroviral therapy/coinfection
14947	 PICS
14948	 PTSD
14949	 delirium
14950	 pain
14951	 sedation
14952	Recipients
14953	Fibrotic
14954	cytopathic effect
14955	carrier
14956	characteristics
14957	reverse transcription-polymerase chain reaction
14958	serum antibodies
14959	Adverse drug reaction
14960	Alergia a medicamento
14961	Drug allergy
14962	Reacción adversa a medicamento
14963	Ciclesonide
14964	Iguratimod
14965	immune-mediated disease
14966	lung-gut axis
14967	Aerosolized inhalation
14968	Lopinavir/Ritonavir
14969	Novaferon
14970	occupational exposure
14971	Gynecological malignancy
14972	brain infection
14973	human neural progenitor cell
14974	iPSCs
14975	neurosphere
14976	organoid
14977	T Cells
14978	adoptive cell therapy
14979	Prone position ventilation
14980	Biological therapy
14981	Immunsuppression
14982	Positive antibody status SARS-CoV2
14983	Environmental surface
14984	Hospital-associated infection
14985	broad spectrum
14986	cell membrane
14987	nanosponge
14988	intestinal flora
14989	Dimethyl Sulfoxide
14990	Viral Infection
14991	Zinc Iodide
14992	CCBs
14993	Ca2+
14994	SARS-CoV S-mediated fusion
14995	acute disseminated encephalomyelitis
14996	glycolipid antibody
14997	natural antioxidants
14998	 in silico ADMET screening
14999	acridine
15000	oxazine
15001	FFR
15002	viability
15003	Dornase alfa
15004	COVID-19, Stroke
15005	Clinical pathology
15006	DMT
15007	Disease modifying therapies
15008	MS
15009	NET
15010	reactivation
15011	Lopinavir/ritonavir (LPV/r)
15012	Shedding
15013	Lower GI endoscopy
15014	Upper GI endoscopy
15015	Diagnostic yield
15016	Long QT
15017	QT long médicamenteux
15018	QT prolonging drugs
15019	Torsades de pointe
15020	ddPCR
15021	Faecal shedding
15022	blue-green inclusions
15023	lactic acid
15024	diagnostic challenges
15025	Autoimmune hepatitis
15026	Hepatitis autoinmune
15027	Inmunosupresión
15028	Trasplante hepático
15029	immunosuppressant
15030	kidney disease: infectious
15031	kidney transplantation / nephrology
15032	Clinical treatment
15033	Prevention and management
15034	Social impact
15035	NSP10/NSP16 methyltransferase
15036	anti-viral/anti-infectious/anti-protease drugs
15037	protease complex
15038	Bloqueo
15039	Infiltración
15040	Infiltration
15041	Migraña
15042	Nerve block
15043	Onabotulinumtoxina
15044	Fingolimod
15045	2-propanol
15046	ethanol
15047	hand sanitizer
15048	medical error
15049	medical malpractice
15050	negligence
15051	otorhinolaryngology
15052	Coronavirus (2019-nCoV)
15053	lung injuries
15054	arteriovenous malformation
15055	hemorrhage
15056	ERT
15057	Gaucher Disease
15058	Home therapy
15059	Fibrose
15060	Plethysmography
15061	Pléthysmographie
15062	Scanner
15063	Suivi
15064	AIDP
15065	autonomic dysfunction
15066	COVID-19; SARS-COV-2
15067	Subacute thyroiditis
15068	Viral thyroiditis
15069	SARS-CoV-2 (Covid-19) pandemic
15070	ototoxicity
15071	Cytomegalovirus Infections
15072	Patient Care
15073	Physical Exertion
15074	SARS Virus
15075	Maternal feacal contamination
15076	Mode of delivery
15077	Pregnancy outcome
15078	Vaginal
15079	Community
15080	Lung injuries
15081	e-cigarettes
15082	clinical treatment
15083	drugs.
15084	virological characteristics
15085	Co-culture
15086	coronavirus 19
15087	immunity cytokine
15088	Coronavirus infant infection
15089	SARS-CoV-2 
15090	C-reactive protein.
15091	CytoSorb
15092	SARS-COV-2-19
15093	myocardial stunning
15094	pre-exposure prophylaxis
15095	CPT, convalescent plasma therapy
15096	CQ, chloroquine
15097	EC50, half maximal effective concentration
15098	HCQ, hydroxychloroquine
15099	IL6, interleukin 6
15100	LPV/RTV, lopinavir/ritonavir
15101	RCT, randomized controlled trial
15102	SARS, systemic acute respiratory syndrome
15103	SARS-CoV-2, systemic acute respiratory syndrome coronavirus-2
15104	Colon Cancer
15105	liver transplant
15106	Contagious routes
15107	Waste management
15108	Elevated procalcitonin
15109	Infant infection
15110	SARS-CoV-2 systemic infection
15111	Dexamethasone
15112	Emapalumab
15113	EGID (Eosinophilic gastrointestinal disease)
15114	eosinophilic esophagitis
15115	steroid
15116	coronavirus disease-19 (COVID-19)
15117	COVID-19: Human Milk Banking Association of North America
15118	breast pump
15119	milk expression
15120	neonatal intensive care unit
15121	surface contamination
15122	Demyelinating lesions
15123	Neuro-COVID
15124	Janapadodhwamsa
15125	Sudarsana churna
15126	Talisadi churna
15127	Vata-kaphaja-sannipataja jwara
15128	pediatric malignancy
15129	Lipid-based nanocarriers
15130	Silver bullet
15131	Tat-peptide
15132	azoospermia
15133	opinion
15134	semen analysis
15135	sperm banking
15136	systemic auto-immune diseases
15137	Clathrin-mediated endocytosis
15138	Sedative medication
15139	Deep throat saliva
15140	Lower respiratory tract specimens
15141	Non-validated specimen types
15142	Xpert Xpress SARS-CoV-2 assay
15143	Cardiac involvement
15144	Coronary aneurysm
15145	Multisystem inflammatory syndrome in children
15146	Myocardial dysfunction
15147	Polytrauma management
15148	Severe trauma
15149	Trauma bay management
15150	Bilateral facial diplegia
15151	Guillain–Barré syndrome
15152	IL17
15153	IL23
15154	mAbs
15155	3-chymotrypsin-like protease
15156	Pyridone drugs
15157	α-ketoamide
15158	disease evaluation
15159	multi-epitopes fusion protein
15160	time-resolved fluorescence immunoassay
15161	anal swab
15162	Serum SARS-CoV-2 RNA
15163	Severe respiratory failure
15164	asymptomatic patients
15165	eyes-oral transmission
15166	transmission routes
15167	Municipal solid waste
15168	Occupational safety
15169	Selective collection
15170	Cyclodextrins
15171	Rings
15172	Post-pandemic outbreaks
15173	SARS-CoV-2 inactivation
15174	Sewage-borne transmission
15175	Underprivileged societies
15176	Virus-laden aerosols
15177	Coronavirus transmission
15178	Wastewater reuse
15179	IL-6R antagonist
15180	sarilumab
15181	therapeutic option
15182	conocimiento
15183	endoscopia
15184	gastroenterología
15185	knowledge.
15186	Minocycline
15187	cardiovascular medicine
15188	Thoracic CT-scan
15189	fat embolism
15190	Digestive System Surgical Procedures
15191	Procedimientos quirúrgicos del aparato digestivo
15192	Systemic Inflammatory Response Syndrome
15193	Síndrome de respuesta inflamatoria sistémica
15194	Urgencias
15195	Nasopharyngeal
15196	Oropharyngeal
15197	Sputum
15198	18F-FDG PET
15199	PET/CT
15200	Niemann-Pick C1
15201	infection.
15202	modifier gene
15203	high infection rate
15204	route of transmission
15205	co-morbidities
15206	Kawasaki
15207	Mastoidectomy
15208	Otitis media
15209	Ventilation tube
15210	altered mental status
15211	Protease of SARS-CoV-2
15212	noscapine
15213	Pulmonary ventilation
15214	Speech therapy
15215	Voice
15216	laboratory examinations
15217	Africasouth of Sahara
15218	imaging finding
15219	Antagonistas del receptor de angiotensina II
15220	High blood pressure
15221	Hipertensión arterial
15222	Inhibidores de la enzima convertidora de angiotensina
15223	Sistema renina-angiotensina-aldosterona
15224	Neuromuscular disorder centres
15225	Neuromuscular disorders
15226	Ventilatory support
15227	Berberine
15228	Diltiazem
15229	Drug combination
15230	Ligand docking
15231	Clinical practice
15232	drug therapeutics
15233	treatment choices
15234	Control de infección.
15235	HBOT
15236	oxygen saturation
15237	SARS-CoV-2 virus infection
15238	fingerstick blood
15239	lateral flow immunoassay
15240	rapid IgM-IgG combined test
15241	Cardiogenic shock
15242	Heart ultrasound
15243	Pneumonia due to SARS-CoV-2
15244	Thromboembolic risk
15245	Treatment management
15246	Bathing waters
15247	Fecal-oral route
15248	Infection risk
15249	Sanitation
15250	Waterborne illness
15251	computational
15252	brain MRI
15253	imaging patterns
15254	Antiviral intervention
15255	Early pulmonary
15256	Prednisone
15257	bacillus Calmette-Guerin
15258	N95 respiratory masks
15259	adult respiratory distress syndrome
15260	Teicoplanin
15261	primary PCI
15262	agglutination
15263	anti–spike protein
15264	liquid handling
15265	SASP inhibitors
15266	cellular senescence
15267	senoptotics
15268	Andean rivers
15269	HAdV
15270	Viral dissemination
15271	Fractures
15272	Chemiluminescence immunoassay
15273	IgM and IgG
15274	Serological testing
15275	radiation therapy
15276	IFN-α/β
15277	Anesthesia
15278	Anticancer chemotherapy
15279	RNAaemia
15280	critically ill patients
15281	COVID 19 infection
15282	Therapeutic drug monitoring
15283	β lactam
15284	passive antibody transfer
15285	Diagnostic techniques and procedures
15286	IVIG
15287	passive immunity
15288	plasma therapy
15289	pediatric infectious diseases
15290	respiratory viral pathogens
15291	Decompression sickness
15292	Fitness for diving
15293	Hyperbaric oxygen treatment
15294	Pulmonary barotrauma
15295	chest drain
15296	pleural
15297	De Quervain’s thyroiditis
15298	Post-viral thyroiditis
15299	RCT
15300	Inmunomodulación
15301	atorvastatin
15302	microparticles
15303	knowledge graph
15304	representation learning
15305	differentiation
15306	endoderm
15307	lung organoid
15308	pulmonary disease modeling
15309	smooth muscle
15310	surfactant
15311	type 1 alveolar cells
15312	type 2 alveolar cells
15313	autoimmune encephalitis
15314	myoclonus
15315	Immun plasma
15316	Sars-Cov-2 infection
15317	B-Lymphocytes
15318	prolonged qt
15319	risk-benefit
15320	Drug-induced prolonged QT
15321	Covid -19
15322	ards, human
15323	lung inflammation
15324	sars coronavirus
15325	vascular endothelial cells
15326	vaccine interventions
15327	body composition
15328	fat
15329	lean
15330	liver attenuation
15331	muscle wasting
15332	re-purposed
15333	Education in resuscitation
15334	Paediatric resuscitation
15335	Resuscitation guidelines
15336	ATN
15337	Renal involvement
15338	Medical staff safety
15339	cytochrome P450
15340	renal
15341	Subconjunctival hemorrhage
15342	clinical outcome
15343	Open-label nonrandomized control study
15344	DMARDs
15345	Immunosuppressant. IL-1
15346	Rheumatic
15347	tDMARDs
15348	Anti-inflammatory and anti-viral prostaglandin
15349	Immuno-pathology
15350	COVID-19, COrona VIrus Disease - 2019
15351	CQ, Chloroquine
15352	HCQ, Hydroxychloroquine
15353	IL-6, Interleukin-6
15354	INF, Interferon
15355	LPV/TRV, Lopinavir/ritonavir
15356	TCZ, Tocilizumab
15357	Early stage symptom
15358	canakinumab
15359	Apnea test
15360	Brain death
15361	Coronavirus, SARS-CoV-2, COVID-19, Conjunctivitis, Cytokine surge
15362	Randomized Controlled Trial
15363	aminotransferases
15364	hepatic injury
15365	1α, 25(OH)2D or 1α, 25-dihydroxyvitamin D or calcitriol
15366	Calcifediol or 25-hydroxyvitamin D3
15367	Vitamin D, vitamin D3 or cholecalciferol
15368	esophageal surgery
15369	gastric cancer
15370	TLR tolerance
15371	TLR-7
15372	X-chromosome inactivation
15373	inflammaging
15374	nanoantiviral
15375	silver
15376	BPS
15377	CPOT
15378	arthralgia
15379	myalgia
15380	neuropathy
15381	antimalarial agents
15382	immunoregulation
15383	levels
15384	lopinavir-ritonavir
15385	intellectual disabilities
15386	learning disabilities
15387	neurodevelopmental disorders
15388	immunomodulatory agents
15389	interferon alpha
15390	phytocannabinoids
15391	thimerosal
15392	OPAT
15393	Clostridioides difficile
15394	Wheelchairs
15395	cytokine release syndrome (CRS)
15396	adjunct therapy
15397	butyrate
15398	Biologicals
15399	Digital medicine service
15400	Home delivery
15401	Fibrin
15402	pharmacotherapy
15403	MSC-therapy
15404	Family Cluster
15405	chloroquine/hydroxychloroquine
15406	neutrophil degranulation
15407	saquinavir, ribavirin
15408	Dietary therapy
15409	Herbal medicine
15410	SARS-CoV-2 PCR
15411	CT image
15412	abdominal viscera
15413	infarction
15414	enteral nutrition
15415	nutrition therapy
15416	parenteral nutrition
15417	eye drop
15418	dental emergencies
15419	cell therapy
15420	COVID-19 , SARS-CoV-2, Endocrine glands, Endocrine vigilance.
15421	Dialysis
15422	feasibility
15423	jaktinib hydrochloride
15424	Pediatric inflammatory bowel disease
15425	discharge standard
15426	positive RT-PCR
15427	readmission
15428	Kidneys
15429	Myocardium
15430	Colorectal cancer
15431	Gastric cancer
15432	Hepatobiliary cancer
15433	Pancreatic cancer
15434	Hazard ratio
15435	Negative conversion
15436	orbital cellulitis
15437	atrial arrhythmias
15438	atrial flutter
15439	Lymphocyte count
15440	Viral prophylaxis
15441	Cord blood
15442	Host transcriptome
15443	MERS-CoV,morbidity
15444	black seed
15445	phytotherapy
15446	severe acute respiratory syndrome (SARS)
15447	Dipeptidyl peptidase-4
15448	Glucagon-like peptide-1
15449	S1P analogs
15450	immuno-modulators
15451	Autoinflammatory diseases
15452	Biologic drug
15453	antiretroviral treatment (ART)
15454	double-blinded
15455	pre-exposure
15456	PIMS-TS
15457	medical management
15458	pneumonia (respiratory medicine)
15459	Wharton's Jelly
15460	Ocular manifestation
15461	conjunctival swab
15462	tears sample
15463	aspirin
15464	computed tomography angiography
15465	fibrinogen
15466	budesonide
15467	rotocol
15468	aryl hydrocarbon receptor activation
15469	lung basal cells
15470	Extra-corporeal membrane oxygenation
15471	Remdesivir treatment
15472	Mycobacterium tuberculosis
15473	Fecal shedding
15474	Pediatric patient
15475	glomerulonephritis
15476	lupus
15477	renal vasculitis
15478	diagnostic testing high-risk patient
15479	diagnosztika
15480	járvány
15481	magas rizikójú beteg
15482	pandémia
15483	prognózis
15484	új koronavírus
15485	Acute liver injury
15486	Adamantanes
15487	Amantadine
15488	Cognitive impairment
15489	Memantine
15490	PD
15491	Intestinal flora
15492	Clinical management - corticosteroids - COVID-19 - hydroxychloroquine - lopinavir - remdesivir - risk groups - SARS-CoV-2
15493	trehalose
15494	Acute respiratory failure
15495	Lung protective ventilation
15496	Dysphagia management
15497	early
15498	Chemoprophylaxis
15499	Healthcare professionals
15500	D-Dimer
15501	cesarean section
15502	Dual therapy
15503	nitazoxanide
15504	treatment regimen
15505	glioblastoma
15506	high-grade glioma
15507	QTc
15508	hERG
15509	Minimally invasive surgery
15510	Surgical
15511	smoke
15512	community assessment
15513	interferon antagonist
15514	nsp15
15515	nsp16
15516	porcine epidemic diarrhea virus
15517	noncommunicable diseases
15518	postviral
15519	upper respiratory infection
15520	rheumatology
15521	antiinflammatory
15522	Quercetin 
15523	‘Ayurveda’
15524	‘COVID 19’
15525	‘Phytochemical’
15526	‘Traditional medicine’
15527	allograft biopsy
15528	coronavirus 2019 (COVID-19)
15529	Orthopaedic and trauma
15530	Telemedicine pandemic
15531	Corona-Virus-Disease-19
15532	wuhan coronavirus
15533	Cerebrospinal fluid leak
15534	Endoscopic skull base surgery
15535	Nasoseptal flap necrosis
15536	Pituitary adenoma
15537	Transsphenoidal
15538	Extend isolation time
15539	New corona virus
15540	Protective antibodies
15541	therapeutic options
15542	risk stratification
15543	suspected cases
15544	Artificial respiration
15545	Multiple organ failure
15546	Systemic inflammatory response syndrome
15547	Lung strain
15548	P-SILI
15549	Work of breathing
15550	cov
15551	multifocal
15552	wuhan
15553	Clinical outcome
15554	Cml
15555	Cold agglutinin
15556	Hyponatremia
15557	Interleukin-6 (IL-6)
15558	PaO2/FiO2 ratio
15559	medication therapy
15560	Myocardial inflammation
15561	veterinarian
15562	Case reports
15563	SARS-CoV-2 viral load
15564	IV-RTPA
15565	Infectious
15566	Reactive
15567	Enzyme replacement therapy
15568	Fabry disease
15569	Pulmonary involvement
15570	bacterial overgrowth
15571	clinical decision making
15572	colonic diseases
15573	BAL fluid
15574	Nasopharyngeal swabs
15575	SARS CoV2 pneumonia
15576	 acuterespiratory distress syndrome (ARDS)
15577	 acute pneumonia
15578	 infection
15579	coenzyme Q10
15580	micronutrients
15581	nutritional
15582	selenium
15583	vitamin A
15584	Severe trauma, critical care
15585	People living with HIV
15586	cirrhosis
15587	Inpatient care
15588	Ophthalmological emergencies
15589	Autoimmune
15590	Neuroimmunology
15591	Polyradiculopathy
15592	Nitazoxanide
15593	Medical treatment
15594	New drug research and development
15595	current evidences
15596	current recommendations
15597	early phase
15598	Ataxia
15599	Cerebellitis
15600	Magnetic resonance imaging
15601	Vertigo
15602	Polyneuropathy
15603	Zinc supplementation
15604	Exosome
15605	monoclonal antibody therapy
15606	immunszuppresszió
15607	májátültetés
15608	veseátültetés
15609	neonates
15610	AOSC
15611	Acute obstructive suppurative cholangitis
15612	Refractory hypoxemia
15613	Genetic Susceptibility
15614	Immune Dysregulation
15615	Brain bank
15616	Brain pathology
15617	Brain stem
15618	Cardiorespiratory centre
15619	Cognitive dysfunction
15620	Movement disorders
15621	Neurological symptoms/disorders
15622	Parkinsonism
15623	Postmortem studies
15624	SARS-CoV-2 brain disorders
15625	psoriatic arthritis
15626	Nanoparticles
15627	Virus-like particles
15628	PENTAGLOBIN
15629	atypical
15630	fall
15631	Dental hygiene protocol
15632	Dental treatment protocol
15633	Cycle threshold
15634	Adjunctive therapy
15635	investigational antiviral agents
15636	potential pharmacological agents
15637	perniosis
15638	toes
15639	Neurologic Manifestations
15640	Tumor Necrosis Factor-alpha
15641	acute respiratory distress syndrome
15642	caries
15643	minimally invasive treatment
15644	non-invasive treatment
15645	paediatric dentistry
15646	northeast Chongqing
15647	MODS
15648	SOFA
15649	CRP, C-reactive protein
15650	CT, computerized tomography
15651	IFN-β, interferon-β
15652	IMV, invasive mechanical ventilation
15653	IV, intravenous
15654	LPV/r, lopinavir/ritonavir
15655	RT-PCR, reverse transcription polymerase chain reaction
15656	TCZ, tocilizumab
15657	URTI, upper respiratory tract infection
15658	ePaO2/FiO2, estimated arterial oxygen/fraction of inspired oxygen ratio
15659	Abiraterone
15660	Abiraterone acetate (PubChem CID: 9821849)
15661	Bexarotene
15662	Bexarotene (PubChem CID: 82146)
15663	Cetilistat
15664	Cetilistat (PubChem CID: 9952916)
15665	Diiodohydroxyquinoline
15666	Diiodohydroxyquinoline (PubChem CID: 3728)
15667	Library
15668	Musculoskeletal tumor
15669	Diarrhoea
15670	Plasma exchange
15671	effectiveness and safety
15672	interferon-alpha
15673	mild to moderate COVID-19
15674	Hospital admission
15675	digestive system
15676	Coronavirus disease 2019 (COVID-19); Internet-based integrated intervention; Depression; Anxiety
15677	Cytokine storms
15678	Eicosanoid storm
15679	Inflammation resolution
15680	Docking studies
15681	plasma level
15682	Insuficiencia respiratoria
15683	Ventilación mecánica
15684	Pneumonia, Latent class analysis
15685	androgen deprivation therapy
15686	Microorganism
15687	Neuroscience
15688	convalescent patients
15689	LFTs
15690	cholangiocyte
15691	hemoglobin
15692	hypoxemia
15693	packed red blood cell transfusion
15694	rbc
15695	General and visceral surgery
15696	German healthcare system
15697	Quality of care
15698	Restructuring
15699	University medicine
15700	Cholinergic anti-inflammatory pathway
15701	Vagus nerve
15702	α7 nicotinic acetylcholine receptor
15703	Fish oil
15704	Refeeding syndrome
15705	B-cell lymphoma
15706	high-grade
15707	anti-interleukin-6 receptor antibody
15708	individual patient data
15709	hyperpyrexia
15710	lung infection
15711	Multidisciplinary therapeutic approach
15712	psychotherapy
15713	telepsychiatry
15714	Dipyridamole
15715	Severe cases
15716	Nazla-e-wabaiya
15717	Unani medicine
15718	Waba
15719	β-glucan
15720	DIC
15721	plasma exchange
15722	Multi-triazole resistance
15723	guideline. pulmonary rehabilitation
15724	Abdominal wall
15725	Cirugías no esenciales
15726	Hernia
15727	Non-essential surgeries
15728	Pared abdominal
15729	Janus kinases
15730	Molecular targeted therapy
15731	Tumor necrosis factor
15732	Compassionate use
15733	vasoconstriction
15734	Antiplatelet
15735	bilateral patchy ground-glass opacity
15736	pulmonary thromboembolism
15737	Respiratory support
15738	overview
15739	post-exposure
15740	NSAID
15741	prostaglandin
15742	Early precautions
15743	ADEM
15744	Neurological manifestation
15745	CRS
15746	ammonium chloride
15747	antiseptic
15748	cetylpyridinium chloride
15749	Maternal outcome
15750	Obstetric outcomes
15751	literature review
15752	Interleukin-15
15753	Pulmonary inflammation
15754	MDRO
15755	Gastrointestinal endoscopy
15756	Gastrointestinal manifestations
15757	Liver function test
15758	PCI
15759	extremely preterm
15760	tuberous sclerosis
15761	paucisymptomatic case
15762	breathing
15763	cardiopulmonary resuscitation
15764	chest compression
15765	Immune escape
15766	Negative conversion time
15767	Neutrophil to CD4+ lymphocyte ratio
15768	continuous renal replacement therapy (crrt)
15769	coronavirus disease 2019 (covid-19)
15770	severe acute respiratory syndrome coronavirus-2 (sars-cov-2)
15771	Recombinant tissue plasminogen activator
15772	Acute rhinosinusitis
15773	Smell and taste dysfunction
15774	acral ischemia
15775	chilblain
15776	dermoscopy
15777	diabetes: type 2
15778	graft survival
15779	immunosuppressive regimens - minimization/withdrawal
15780	Olfactory detection
15781	Scent detection dogs
15782	Volatile organic compounds
15783	infection in dentistry
15784	prevention procedures
15785	preventive dentistry
15786	SARS Coronavirus 2 and Covid-19 immunity
15787	SARS-CoV-2 immunity
15788	antibody protection for Covid-19
15789	antibody therapy for Covid-19
15790	convalescent plasma for Covid-19 therapy
15791	gamma globulin for Covid-19 protection
15792	human volunteer testing for Covid-19 protection
15793	vaccine and therapeutics testing for Covid-19
15794	health impact assessment
15795	Immuno-modulation
15796	Nano-formulation
15797	myeloid cells
15798	natural killer cells
15799	Oxidation-reduction
15800	TRPV4
15801	TRPV4 inhibitor
15802	pulmonary edema
15803	Adipocyte secreted exosomal microRNA
15804	adipose derived stem cells
15805	antenatal
15806	convenience
15807	online education
15808	online prenatal education
15809	Familial Mediterranean fever
15810	laboratory features
15811	sharing data
15812	B-cell-depleting therapy
15813	Multiple sclerosis (MS)
15814	cellular immune responses
15815	Dental triage flowchart
15816	Infection-control
15817	Nosocormial infection
15818	COVID-19, Dexamethasone, Acute Respiratory Distress Syndrome, Randomised controlled trial, protocol, Steroids
15819	CXCL8
15820	FDA-approved drugs
15821	host-directed therapy
15822	pathogen-directed therapy
15823	clinical interpretation
15824	positive predictive value
15825	test parameters
15826	blood groups
15827	sickle cell disease
15828	human immunodeficiency virus (HIV)
15829	idiopathic pulmonary fibrosis
15830	severe sepsis
15831	orthopaedic oncology
15832	sarcoma
15833	Nutritional Risk Screening 2002
15834	inflammatory marker
15835	  COVID-19
15836	  Chloroquine
15837	  Hydroxychloroquine
15838	  SARS-CoV-2
15839	  chest CT
15840	  compassionate use
15841	  repurposed agent
15842	Early
15843	Eradication
15844	Takotsubo syndrome
15845	rheumatoid
15846	Epoprostenol
15847	Oseltamivir
15848	Sarilumab
15849	Sirolimus
15850	ESKD
15851	Pharmacological treatment
15852	Transplant
15853	coagulation/clotting/thrombosis
15854	coronavirus-induced disease 2019 (COVID19)
15855	hemocompatibility testing
15856	intensive care unit (ICU)
15857	intravascular and intravenous infusion
15858	mesenchymal stromal cells (MSC)
15859	severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2)
15860	tissue factor (TF/CD142)
15861	chronic liver disease
15862	orthotopic liver transplantation
15863	Tea polyphenols
15864	Theaflavin
15865	T-cell immunity
15866	human immunome
15867	complement system
15868	Diagnosis and treatment recommendations
15869	Otorhinolaryngology
15870	altered mental state
15871	basal ganglia
15872	gene delivery
15873	HCoV-229E
15874	NRTIs
15875	rhabdomyolysis
15876	Randomised placebo controlled trial
15877	viral PCR
15878	arachidonic acid
15879	lipoxin A4
15880	prostaglandin E2
15881	smell impairment
15882	d-dimer
15883	sequelae
15884	92-02
15885	92B99
15886	Lyapunov’s function
15887	Drug hypersensitivity
15888	reverse transcription PCR
15889	Acute pancreatitis
15890	Atlanta classification
15891	internet of things
15892	transmission and clinical characteristics
15893	 anti-CTLA-4
15894	anti-PD-1
15895	anti-PD-L1
15896	Rapid review
15897	Respiratory tract infection
15898	AMR, antibody-mediated rejection
15899	COVID-19, coronavirus 2019
15900	LVAD, left ventricular assist device
15901	Post-viral neuropsychiatric sequelae
15902	Public mental health
15903	corona virus disease
15904	cytokine release syndrome (crs)
15905	prone position
15906	thoracoscopy
15907	severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2)
15908	adaptive
15909	multi-center
15910	randomization
15911	sHLH
15912	severe COVID
15913	supplement
15914	vitamin
15915	Antiphospholipid antibodies
15916	blood clots
15917	Autoimmune disease
15918	Immune-Mediated Inflammatory Diseases
15919	cough
15920	dyspnea
15921	rna virus
15922	Hematologic neoplasms
15923	Pulmonary contusion
15924	Hyperinflammation
15925	F(ab')2 fragments
15926	hyperimmune horse sera
15927	Isolation precautions
15928	Real world data
15929	Bacteria
15930	Fecal Nucleic Acid
15931	Gut Microbiome
15932	Japanese case
15933	CPK
15934	myopathy
15935	myositis
15936	Idiopathic multicentric Castleman disease
15937	Severe acute respiratory syndrome coronavirus −2 (SARS-CoV-2)
15938	Renal and cardiac side effects
15939	Zika virus
15940	broad antiviral agents
15941	flavivirus
15942	human adenovirus
15943	niclosamide
15944	IFN-I
15945	virus clearance
15946	TNFα
15947	Panton-Valentine leukocidin
15948	Staphylococcus aureus
15949	necrotizing pneumonia
15950	Ultomiris
15951	acute pneumonia
15952	complement inhibitor
15953	humanized
15954	monoclonal
15955	randomized controlled study
15956	ravulizumab
15957	severe acute respiratory distress syndrome coronavirus 2
15958	AML
15959	mobile cabin hospital
15960	Colorectal neoplasms
15961	Cross-sectional study
15962	Plasma donation
15963	JAK-inhibitor
15964	Janus-associated kinase inhibitor
15965	coronary aneurysm
15966	kawasaki disease
15967	anesthetic management
15968	aortic dissection
15969	clinical specimens
15970	nucleic acid test
15971	positive detection rate
15972	Acute Lymphoid Leukemia
15973	Acute Myeloid Leukemia
15974	Colon cancer
15975	Point of care
15976	Serological tests
15977	Caregivers
15978	End-stage kidney disease
15979	early life adversity
15980	health inequalities
15981	immune exhaustion
15982	immunosenescence
15983	psychosocial stress
15984	socioeconomic status
15985	Combination therapy
15986	Corona Virus Disease 2019
15987	lopinavir and ritonavir tablets
15988	severe respiratory syndrome
15989	immunometabolism
15990	Sequencing
15991	Virus concentration
15992	FDG-PET/CT
15993	GSK-3β
15994	glycogen synthase kinase 3-beta
15995	lithium
15996	lithium carbonate
15997	lithium orotate
15998	Breathing
15999	Angiotensin receptor blocker (ARB)
16000	Angiotensin-converting enzyme inhibitor (ACEI)
16001	Hypertention
16002	Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
16003	Interleukin 10
16004	Recreational water
16005	Dermatologic Therapy
16006	autoimmune bullous disease
16007	Pulmonary
16008	Demyelinating
16009	Infarct
16010	White matter
16011	 ARDS 
16012	 SARS-CoV-2 
16013	 UHMS position 
16014	 hyperbaric oxygen therapy 
16015	 hyperbaric treatment of COVID-19 
16016	 hypoxemia 
16017	 hypoxia 
16018	 novel corona virus 
16019	 pneumonia 
16020	 pulmonary inflammation 
16021	 viral infections 
16022	Traditional Chinese herbal medicine
16023	Clinical pathway
16024	SARS-CoV-2/COVID–19
16025	felső légúti szűkület
16026	prolonged mechanical ventilation
16027	tartós lélegeztetés
16028	tracheotomia
16029	upper airway stenosis
16030	cyclosporine
16031	immunosuppressant - fusion proteins and monoclonal antibodies
16032	ATII-RB
16033	Anti-hypertensive drugs
16034	GLP1
16035	incretins
16036	IL-6-Rezeptor blockade
16037	Ventilator free days
16038	Rapid detection
16039	Chimeric antigen receptor T-cells
16040	Relapsed/refractory hematological malignancies
16041	serological diagnostic test
16042	HbSC
16043	acute chest syndrome
16044	mild
16045	dermatology-rheumatology
16046	medical dermatology
16047	hemoglobinopathies
16048	iron chelation therapy
16049	sickle cell diseases
16050	thalassemia
16051	disseminated intravascular coagulopathy
16052	sanitizer
16053	toxicity
16054	carnivores
16055	clustering analysis
16056	drivers
16057	expert elicitation
16058	CARDIOLOGY
16059	plasma concentration
16060	sarcoidosis
16061	CVVHDF
16062	Chronic renal failure
16063	Gastrointestinal neoplasms
16064	COVID-19 Infection
16065	Tobacco Smoking
16066	Viral Transmission
16067	Herbal treatment
16068	Plasma transfusion
16069	Biological therapies
16070	Dmards
16071	Paediatric rheumatology
16072	1,8‐cineole
16073	asymptomatic COVID‐19
16074	lung elimination
16075	monoterpenes
16076	volatile drugs
16077	Adsorptive hemofilter
16078	oXiris
16079	recognition
16080	Coronavirus disease SARS-CoV-2 (COVID-19)
16081	Drug-interactions
16082	public emergency
16083	convalescent plasma transfusion (CPT)
16084	Aerosol inhalation
16085	IFN-κ
16086	Safety and efficacy
16087	TFF2
16088	immunocompromised
16089	Hubei province
16090	Otolaryngology healthcare workers
16091	C5 inhibition
16092	complement activation
16093	complement terminal pathway
16094	kidney injury
16095	vascular injury
16096	Adverse drug reactions (ADR)
16097	Drug safety
16098	Aspergillus
16099	respiratory samples
16100	Inflammatory Bowel Disease
16101	Integrated traditional Chinese and Western medicine
16102	pericarditis
16103	tamponade
16104	fingolimod
16105	genetic predisposition to disease
16106	respiratory distress syndrome–adult
16107	TSH
16108	euthyroid sick syndrome
16109	thyroid hormone
16110	ARDS-CoV-2
16111	UCI
16112	AI assisted diagnosis
16113	Biosensors for virus detection
16114	Lateral flow immunochromatographic strip
16115	extended care facilities
16116	Operation room
16117	Scheduling
16118	Viral exposure
16119	Antithrombotics
16120	(Hydroxy)chloroquine
16121	hyperimmune globulin
16122	passive immunotherapy
16123	Immune dysregulation
16124	Inflammatory receptors
16125	Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)
16126	colorectal cancer (CRC)
16127	COVID-1
16128	H2S-donor
16129	hydrogen sulfide
16130	thromboxane
16131	Gastroenterology departments
16132	Restablecimiento
16133	Resumption
16134	Servicios de Digestivo
16135	Severe acute pancreatitis
16136	Viral pancreatitis
16137	 Fangcang Shelter Hospital
16138	occupational protection
16139	Oral healthcare
16140	Oral treatment
16141	Community protection
16142	Controlled infection
16143	SARS Cov-2
16144	COVID-19 symptoms
16145	Famotidine
16146	PROMs
16147	bacteriotherapy
16148	gut
16149	lactobacillus
16150	Pancytopenia
16151	Transfusion
16152	Biologic treatment
16153	ACE-2R
16154	CYP2D6
16155	Cytochrome P450
16156	Genetic polymorphisms
16157	HO-1
16158	mitochondrial dysfunction
16159	white adipose tissue
16160	Acute limb ischemia
16161	lasers
16162	Clozapine
16163	Schizophrenia
16164	computer tomography
16165	Ozone therapy
16166	anti-COVID-19 drugs
16167	glucocorticoid
16168	testosterone replacement therapy
16169	Moral courage
16170	Moral distress
16171	Nursing ethics
16172	RdRP inhibitor
16173	Remdesivir (GS-5734)
16174	amlodipine
16175	calcium channel blockers
16176	covid-2019
16177	high altitude pulmonary edema
16178	nifedipine
16179	pulmonary artery hypertension
16180	pulmonary vasoconstriction
16181	pulmonary vasodilation
16182	2019 novel coronavirus (COVID-19)
16183	severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
16184	Non-communicable disease
16185	Vitamin
16186	mesenchymal stem cell
16187	stem cell therapeutics
16188	vaccines.
16189	AIDS
16190	Antiretroviral therapy
16191	HIV infection
16192	Inhalation
16193	civil liberties
16194	Perforin
16195	HScore
16196	ferritin
16197	hemophagocytic lymphohistocytosis
16198	Para-infectious Guillain-Barré syndrome
16199	SARS-CoV-2 neurological complications
16200	Fomite
16201	Microbes
16202	Mobile phone
16203	Cytology
16204	Pathology education
16205	Respiratory complications
16206	macaque
16207	Antioxidant
16208	COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
16209	Korean medicine
16210	nCoV-2
16211	host resistance
16212	Acupuncture therapy
16213	Application scheme
16214	Feasibility
16215	Anti-CD6
16216	Itolizumab
16217	plaque psoriasis
16218	inhalational nitric oxide
16219	inhalált nitrogén-oxid
16220	intensive therapy
16221	intenzív kezelés
16222	Anti-inflammation
16223	Entecavir
16224	Entercavir: PubChem CID 135398508
16225	Imipenem
16226	Imipenem: PubChem CID 104838
16227	Growth hormone
16228	Coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Real-time polymerase chain reaction (RT-PCR)
16229	Viral RNA shedding
16230	post kidney transplant
16231	immunotherapeutics
16232	lymphocyte subset
16233	treatment workflow
16234	Imaging diagnosis
16235	X-ray imaging
16236	Social Isolation
16237	Socioeconomic Impact
16238	Virus Shedding
16239	liver transplantation/ hepatology
16240	Immune thrombocytopenia
16241	Allogeneic stem cell transplantation
16242	Graft-versus-host disease
16243	immunosensor
16244	precision medicine
16245	rapid diagnostic test
16246	Chemical drugs
16247	intravenous melatonin
16248	pluripotent stem cell
16249	respiratory infectious diseases
16250	Fluoroquinolone
16251	Levofloxacin
16252	Moxifloxacin
16253	hypoxemic respiratory failure
16254	interleukin (il)-6
16255	advance care planning
16256	web-based tool
16257	CTA, computed tomography angiography
16258	ECMO, extracorporeal membrane oxygenation
16259	PE, pulmonary embolism
16260	PERT, pulmonary embolism response team
16261	PPE, personal protective equipment
16262	Pao2, partial arterial pressure of oxygen
16263	TTE, transthoracic echocardiography
16264	VTE, venous thromboembolism
16265	clot in transit
16266	right ventricle
16267	tPA, tissue plasminogen activator
16268	thrombus
16269	controversies
16270	data
16271	mouth
16272	Therapeutic Temperature Modulation
16273	Government response
16274	Influenza A viruses
16275	Anti-cytokine therapy
16276	antiphospholipid syndrome
16277	disease-modifying treatment
16278	systemic lupus erythematosus
16279	AVIFAVIR
16280	Acute stroke therapy
16281	Ischaemic stroke
16282	Stroke teams
16283	Nafamostat
16284	Oxygen treatment
16285	medical countermeasures
16286	primate
16287	SRAS‐CoV‐2
16288	Tregs
16289	 mortality
16290	COVID-19,
16291	2019-Coronavirus disease
16292	respiratory virus infections
16293	Manic-like symptoms
16294	Antiviral strategies
16295	Immunological approaches
16296	Administrative information
16297	Steroids
16298	Free radicals
16299	Superoxide
16300	Anti-IL-17
16301	secukinumab
16302	discharge
16303	re-positive
16304	Anti-SSA/Ro antibodies
16305	skin findings
16306	anti-SARS-CoV-2 agents
16307	therapeutic drugs
16308	Artemisia annua
16309	bioactive compound
16310	coronavirus: antiviral agents: COVID-19
16311	Multi-system inflammatory syndrome [MIS-C]
16312	ADAM17/TACE inhibitor
16313	TACE
16314	sgp130Fc
16315	glycans
16316	immunoglobulin M
16317	Delivery of healthcare
16318	Antiviral Immune Response
16319	Beta Interferon
16320	Mucosal treatments
16321	Type I Interferons
16322	Fetal anomaly
16323	Fetal medicine
16324	Fetal surgery
16325	Fetoscopy
16326	Coronary artery bypass surgery
16327	Open heart surgery
16328	ABL kinase inhibitor
16329	SARS-CoV-2 (Severe Acute Respiratory Syndrome Voronavirus 2)
16330	Intrauterine infection
16331	erythroderma
16332	Reproductive failure
16333	AIDS, acquired immunodeficiency syndrome
16334	ART, antiretroviral therapy
16335	HIV, human immunodeficiency virus
16336	HIV/AIDS
16337	LVAD
16338	burning sensations
16339	watering
16340	patient-to-professional infectious disease transmission
16341	Cholecystectomy
16342	Gallstone disease
16343	nervous system diseases
16344	aminoquinoline
16345	Brain metastases
16346	Gamma Knife
16347	Radiosurgery
16348	Monocyte distribution width
16349	Hematological parameters
16350	Immunological parameters
16351	Extracorporeal Membrane Oxygenation (ECMO)
16352	assay
16353	marker
16354	Integrins
16355	coagulation abnormalities
16356	pathological changes
16357	Dietary supplements
16358	Duchenne muscular dystrophy
16359	Lung monitoring
16360	antimicrobial stewardship
16361	Citrox
16362	mouthrinse
16363	β-cyclodextrins
16364	Cerebral venous thrombosis (CVT)
16365	Stroke in young
16366	Venous thrombotic events (VTE)
16367	pulmonary cavity
16368	COVID-19, Acute respiratory distress syndrome, Pneumonia, SARS-CoV-2.
16369	TV
16370	news
16371	Anti-Bacterial Agents
16372	Primary health care
16373	Novel coronavirus infected pneumonia
16374	Troponin I
16375	Parkinson's disease
16376	antiviral-activity
16377	multiple scleorsis (MS)
16378	type I IFN
16379	polyadenylation
16380	cholecalciferol
16381	Natural product
16382	chromones
16383	mast cells
16384	aerosol generating procedures
16385	bioaerosol dispersion
16386	filters
16387	medical aerosol
16388	Renin-angiotensin-aldosterone system inhibitors
16389	Angiotensin II type-I receptor blockers
16390	Bloqueadores tipo I de angiotensina-II
16391	Hipertensión
16392	socioeconomic impact
16393	inflammatory disease
16394	endogenous adjuvant activity
16395	distributed manufacturing
16396	drug supply chain
16397	oral solid dosage forms
16398	three-dimensional printing
16399	whole body vibration exercise
16400	Long-term care hospital
16401	Post-exposure prophylaxis
16402	gynecologic cancer
16403	Novel Corona Virus
16404	chiral switch
16405	Covid-19 clinical trials
16406	inclusion of pregnant women in trials
16407	maternal-fetal ethics
16408	pregnant research participants
16409	research with pregnant women
16410	bleach
16411	environmental disinfection
16412	Robot Assisted Surgery
16413	acute respiratory distress syndromes (ARDSs) and acute lung injury
16414	right ventricle function and dysfunction
16415	COVID-19 main protease
16416	Docking study
16417	Druggability
16418	Herbal remedies
16419	Pump head thrombosis
16420	Thrombotic complications
16421	V-V ECMO
16422	Occult infection
16423	Legionella pneumonia, COVID-19 epidemic
16424	YouTube quality
16425	Health-care workers
16426	Nefrología
16427	Profesionales sanitarios
16428	Coronavirus disease 2019 (COVID-19); Chest computed tomography (CT); Viral pneumonia; Lymphopenia
16429	Biological Drugs
16430	Hemodialysis units
16431	Practice guideline
16432	transplant safety
16433	Candida glabrata
16434	Candidemia
16435	SARS-CV-2
16436	Extracorporeal blood purification
16437	Precise prevention and control
16438	Diagnostic X-ray radiology
16439	cytometry
16440	adult onset Still's disease
16441	catastrophic anti-phospholipid syndrome
16442	haemophagocytic lymphohistiocytosis
16443	hyper-inflammation
16444	hyperferritinaemic syndrome
16445	hyperferritinemia
16446	human-primate conflict
16447	provisioning
16448	Chinese herbal medicine
16449	anesthesia management
16450	scenario design
16451	general surgery
16452	oncological emergencies
16453	European Confederation of Medical Mycology
16454	expert statement
16455	superinfection
16456	anti-GM-CSF
16457	monocyte/macrophage
16458	microvesicles
16459	secretome
16460	Ischemia-reperfusion damage
16461	Liver damage
16462	Nonalcoholic fatty liver disease
16463	Toll-like receptors
16464	Critically ill patients
16465	Respiratory rehabilitation
16466	Acute Respiratory Distress Syndrome
16467	Critical ultrasonography
16468	retrospective study
16469	Contingency plans
16470	Spinal cord injury
16471	evidence-based
16472	expert opinion
16473	antiplatelets
16474	clinical parameters
16475	radiological parameters
16476	antimalarial
16477	Delivery
16478	Pregnancy management
16479	TOCILIZUMAB
16480	invasive mechanical ventilation
16481	immunobiology
16482	immunosuppressant - other
16483	translational research/science
16484	Breast milk
16485	Donor breast milk, infant formula
16486	Diamond Princess cruise ship
16487	pulse therapy
16488	co-ventilation
16489	patient portals
16490	Viral inactivation
16491	coronovirus
16492	microbe
16493	yeast
16494	multi-disciplinary tele-rehabilitation
16495	Forecasting tool
16496	Hospital bed capacity
16497	Monte Carlo simulation
16498	designated Hospital in Beijing
16499	Human umbilical cord Wharton’s jelly-derived MSCs
16500	Coronavirus Disease-2019
16501	Diagnosis and Treatment Program for Coronavirus Disease-2019
16502	Traditional Chinese Medicine Diagnosis and Treatment Strategies
16503	Bell's palsy
16504	Sudden hearing loss
16505	treatment delay
16506	COVID19, Wuhan virus, hydroxychloroquine, remedesevir, antihelminth, anti-cytokine therapy, antiviral.
16507	 COVID-19 pneumonia 
16508	disease control policy
16509	immunity passports
16510	neoplasm
16511	targeted therapy
16512	Low-dose radiation therapy
16513	Nocturnal oxygen therapy
16514	Anti IL-17 inhibitor
16515	Biologic therapy
16516	Interleukin 17 (IL-17)
16517	endocarditis
16518	time to diagnosis and treatment
16519	time to disease resolution
16520	hematologic
16521	 nursing management in COVID-19, SARS-CoV-2, nursing care of patient with COVID-19
16522	Pneumothorax
16523	Subcutaneous emphysema
16524	duration
16525	first line
16526	Broad spectrum antiviral
16527	Bronchodilation
16528	Repurposed nitazoxanide
16529	Expert recommendations
16530	preparatory response
16531	ward reconstruction
16532	WHO formulation
16533	alcohol-based hand rub
16534	glycerol
16535	modified
16536	surgical hand preparation
16537	Spiral CT scan
16538	Bariatric
16539	Bypass
16540	Internal hernia
16541	Operation
16542	Staff
16543	HNC-LL
16544	Isolation room
16545	Severe COVID-19
16546	Shenhuang granule
16547	“Truncation and Reversion” strategy
16548	Neurosurgical procedures
16549	convalescent plasma for COVID-19 therapy
16550	coronavirus (2019-nCoV)
16551	neutralizing antibody titers (NAT)
16552	transfusion safety
16553	convalescens plazma
16554	PBMC
16555	Gamma-globulin
16556	IVIG, intravenous immune globulin
16557	Organizing pneumonia
16558	HLH
16559	IRIS
16560	cytokine release
16561	hyperimmune response
16562	Treg
16563	continuous positive airway pressure
16564	helmet
16565	positive end-expiratory pressure
16566	Ebola virus disease
16567	environmental stress
16568	geospatial care path (GCP)
16569	geospatial science
16570	global emergency
16571	global strategies
16572	government failure
16573	newdemic
16574	novel Coronavirus pneumonia (NCP)
16575	panepidemic
16576	point of risk
16577	public health crisis
16578	safe spacing
16579	severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)
16580	small-world network (SWN)
16581	spatial care path (SCP)
16582	temporal
16583	Nutritional support
16584	Vasoconstrictor drugs
16585	medicines
16586	chest distress
16587	heat-sensitive moxibustion
16588	impaired appetite
16589	moxibustion
16590	negative emotion
16591	H1N1, influenza A virus subtype H1N1
16592	SARS, Severe acute respiratory syndrome
16593	Health Economics
16594	Relative Value Unit
16595	Ground glass Opacity
16596	SARS-CoV-2PCR test
16597	bone marrow transplantation
16598	conditioning
16599	post transplant cyclophosphamide
16600	tissue plasminogen activator
16601	tranexamic acid
16602	MitoQ
16603	COVID-19 Serotherapy
16604	Immunization, Passive
16605	Transfusion Reaction
16606	Transfusion-Related Acute Lung Injury
16607	neurologic
16608	vision loss
16609	small molecules
16610	systemic medical treatment
16611	Hyperimmune anti-CMV globulin
16612	practice management
16613	consultation-liaison psychiatry
16614	neuropsychiatry
16615	psychopharmacology
16616	hematological malignancies
16617	pattern of prescriptions and syndromes
16618	characteristics of medicinal properties
16619	efficacy distribution
16620	prevention and treatment of traditional Chinese medicine
16621	Acute coronavirus epidemic
16622	Professional patient relations
16623	Shared decision making
16624	Shared traumatic stress
16625	Therapeutic alliance
16626	Trauma and stressor-related disorders
16627	Mesenchymal stromal cell
16628	atezolizumab
16629	durvalumab
16630	extended-interval dosage
16631	nivolumab
16632	CMS
16633	Health Insurance Policy
16634	coronavirus disease COVID-19
16635	proven efficacy of drugs
16636	treatment methods
16637	Operative
16638	Surgical procedures
16639	consolidations
16640	ultrasound
16641	Antimalarials
16642	Field Research
16643	blood test
16644	hospital stay
16645	Respiratory distress syndrome, adult
16646	Sedation and analgesia
16647	ribavirin.
16648	Acute and Transient Psychotic Episode
16649	Bouffée Délirante
16650	Brief Psychotic Episodes
16651	Reactive Psychosis
16652	SARS–CoV–2
16653	chorionic villous sampling
16654	fetal cell-free DNA
16655	non-invasive prenatal screening
16656	nuchal translucency
16657	prenatal screening diagnosis
16658	quantitative reverse transcription polymerase chain reaction
16659	COVID-19 virus infection
16660	Thymosin α1
16661	Common bio-medical waste treatment facility
16662	Disinfection technology
16663	Disease-modifying therapy
16664	Health behaviors
16665	Neurologist
16666	arrhythmias, cardiac
16667	drug effects
16668	drug-related side effects and adverse reactions
16669	Thyroid surgery
16670	Accufuser
16671	Elastomeric device
16672	Flucloxacillin
16673	Outpatient parenteral antibiotic therapy
16674	Patient contact
16675	sports and exercise medicine
16676	transfusion
16677	Estatinas
16678	Ezetimiba
16679	Ezetimibe
16680	Fármacos hipolipemiantes
16681	Hipercolesterolemia
16682	Hypercholesterolemia
16683	Hypolipidemic drugs
16684	Inhibidores de PCSK9
16685	PCSK9 inhibitors
16686	CPAP (Continuous Positive Airway Pressure)
16687	Mandibular advancement device (MAD)
16688	OSAS (Obstructive Sleep Apnea Syndrome)
16689	Organisation of treatment
16690	Polygraph
16691	Sleep apnoea
16692	Sleep endoscopy
16693	checkpoints inhibitors
16694	nasopharynx
16695	desensitization
16696	drug hypersensitivity reactions
16697	pressure sore
16698	rh-aFGF
16699	Viral diseases
16700	rivaroxaban
16701	safety measures
16702	electrophysiology laboratory
16703	Lifeguards
16704	Reanimation
16705	Rescue
16706	AI
16707	automated diagnosis
16708	prognosis analysis
16709	Influenza season
16710	Influenza vaccination
16711	adaptive immune enhancement
16712	alive vaccines
16713	mucosal immunity
16714	type III hypersensitivity
16715	Seguridad
16716	Inflammatory
16717	Scurvy
16718	Xylitol, SARS-Cov-2
16719	Xylose
16720	noncoding RNA
16721	therapeutic candidate
16722	Diethyl carbamazine DEC
16723	CLUE
16724	Remote care
16725	False-negative
16726	hepatobiliary
16727	pharmacology and therapeutics
16728	renal medicine
16729	(MeSH): Disabled Persons
16730	COVID-19, Corona Virus Disease 2019
16731	PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analysis
16732	Vulnerable Populations
16733	wD, People with Disabilities
16734	Obstructive sleep apnea
16735	Sleep-disordered breathing
16736	Citocina
16737	Clinically diagnose
16738	Confirmado
16739	Confirmed
16740	Diagnóstico clínico
16741	Leucocito
16742	Leucocyte
16743	Pronóstico
16744	Carcinoma hepatocelular
16745	EHGNA
16746	MAFLD
16747	Loop mediated isothermal amplification
16748	Reverse transcriptase PCR
16749	Bedside blood purification treatment
16750	Isolation ward
16751	ACTT-1
16752	Immuno-oncology
16753	Malignancy
16754	neutrophil-to-lymphocyte ratio
16755	Alcohol-based-hand-rubs
16756	Methanol toxicity
16757	IFN-α2b
16758	BSI
16759	Immune-inflammatory parameters
16760	MDT
16761	paramedic
16762	After death
16763	Cause of death
16764	Post mortal
16765	Post-mortal
16766	Postmortem
16767	Occupational exposure
16768	ACT Accelerator
16769	Dr Tedros
16770	global coordination
16771	cancelation
16772	Azvudine
16773	marketing communication
16774	segmentation
16775	Barrier to treatment
16776	Pulmonary emboli
16777	non-COVID-19 designated hospitals
16778	post-epidemic period
16779	TeleHealth
16780	bulimia nervosa
16781	eating disorders treatment
16782	family-based treatment (FBT)
16783	videoconferencing
16784	Traditional
16785	Acute distress respiratory syndrome
16786	Anticoagulant therapy
16787	multi-organ dysfunction
16788	triiodothyronine
16789	Adjunctive treatment
16790	Lopinavir-ritonavir
16791	Dysphagia
16792	Acute abdomen
16793	Non-operative management
16794	Open surgery
16795	ADT
16796	hormonal therapy
16797	prostatectomy
16798	urologic
16799	Hospital architecture
16800	Hospital wards
16801	Gastrointestinal tumor, treatment strategy
16802	Multidisciplinary therapy
16803	medical worker
16804	Anti-coagulant therapy
16805	comprehensive stroke center
16806	acute kidney insufficiency
16807	tissue plasminogen activator (tPA)
16808	cloth mask
16809	medical mask
16810	Mass gathering
16811	Olympics
16812	Umrah
16813	Heat
16814	N-95 respirators, Mask
16815	Reuse
16816	Ultraviolet Irradiation
16817	liver function tests
16818	Data
16819	Digitalisation
16820	Infrastructure
16821	latitude hypothesis
16822	respiratory tract diseases
16823	particle
16824	biological therapies
16825	Cardiovascular health
16826	Erectile dysfunction
16827	Male hypogonadism
16828	Sexual dysfunction
16829	digestive tract
16830	gastrointestinal symptom
16831	HLA-DR
16832	dysregulation
16833	macrophage activation
16834	haematology
16835	DNA therapeutics
16836	antibody cocktail
16837	electroporation
16838	gene transfer
16839	angiotensin I-converting enzyme
16840	SARS-CoV-2 Virus
16841	Patients’ characteristics
16842	Sickle cell disease
16843	β-thalassemia
16844	target cell-limited model
16845	deprescribing
16846	potentially inappropriate medications
16847	IFN-α
16848	adverse drug reaction
16849	Angiotensina
16850	Inflamación
16851	Renina
16852	Remdisivir
16853	Iron metabolism
16854	severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)
16855	haemophilia
16856	Anluohuaxian
16857	Diagnosis and treatment protocol
16858	 Tanacetum parthenium 
16859	feverfew
16860	parthenolide
16861	Ultra-shortwave diathermy; COVID-19; evidence-based practice
16862	Recommendations for diagnosis and treatment
16863	Convalescent
16864	Myelodysplastic
16865	Yemen
16866	clinical practice
16867	manual therapy
16868	Peplomer
16869	Surfactants
16870	care at home
16871	healthcare innovation
16872	patient centered care
16873	fire needling therapy
16874	prevention program
16875	small-molecule drugs
16876	malignancy
16877	Metabolic complications
16878	acupuncture and moxibustion
16879	epidemic disease
16880	Development
16881	arterial thrombosis
16882	revascularization
16883	neuromodulation
16884	non-invasive vagus nerve stimulation
16885	Blood purification treatment
16886	point-of-care ultrasound
16887	aortic root abscess
16888	infectious endocarditis
16889	mssa bacteremia
16890	health classification
16891	health information management
16892	health information manager
16893	hospitals
16894	privacy: data security
16895	dental care for children
16896	 heart failure
16897	Drug-induced QTc prolongation
16898	fertility preservation
16899	gonadotoxicity
16900	DEMATEL
16901	Public health and social (PHS) measures
16902	dysphagia
16903	covid-19 india
16904	emergency surgery
16905	spinal surgery
16906	spinal tuberculosis
16907	vertebral fracture
16908	Small molecule
16909	clinical trials of nicotine patches
16910	nicotinic receptors
16911	coagulopatthy
16912	covid-19 outbreak
16913	deep vein thrombosis (dvt)
16914	right ventricular thrombus
16915	systemic anticoagulation
16916	cerebral venous sinus thrombosis
16917	biomedical engineering
16918	diagnosis and treatment plan
16919	ultra-low-dose chest CT
16920	Inhibidor de la proteasa
16921	Interacciones medicamentosas potenciales
16922	Potential drug-drug interactions
16923	antimicrobial photodynamic therapy
16924	Work stress
16925	mind-body intervention
16926	resiliency
16927	yoga
16928	Antibacterial soaps
16929	Antibiotics in environment
16930	Antimicrobial resistance (AMR)
16931	Wastewater contamination
16932	IL-17 blocking agents
16933	brodalumab
16934	ixekizumab
16935	Recovering positive
16936	LDRT
16937	Critical ill
16938	Hazard group
16939	Infectious disease protocols
16940	Homemade mask
16941	Medical disposable face mask
16942	OMV
16943	Reused masks
16944	ROSE
16945	clinical classification
16946	antiviral polysaccharide
16947	green chemistry
16948	layer-by-layer nanocoating
16949	protective masks
16950	work surfaces
16951	breastfeeding promotion
16952	antiviral surfaces
16953	nickel
16954	palladium
16955	platinum
16956	rhodium
16957	ruthenium
16958	single wall carbon nanotubes
16959	Fat embolism syndrome
16960	airway rapid response
16961	Acute care medicine
16962	Employees
16963	Qigong
16964	Anticoagulación
16965	Coagulación intravascular diseminada
16966	Dímero D
16967	trichology
16968	medication
16969	HRCT
16970	Severe COVID-19 pneumonia
16971	Shufeng Jiedu Capsule
16972	TSA
16973	endoscopic surgery
16974	pituitary
16975	transsphenoidal
16976	Accuracy
16977	MxA
16978	Point of care testing
16979	Department of otolaryngology head and neck surgery
16980	guiding opinion
16981	health protection
16982	TRPV1
16983	resiniferatoxin
16984	Progression
16985	MSCs
16986	Mesenchymal Stem Cells
16987	Mesenchymal Stromal Cells
16988	   doctor 
16989	   statute 
16990	  epidemic 
16991	  infectious disease 
16992	  information 
16993	 coercion
16994	 hospitalization
16995	hyperthyroidism
16996	thyroid disease
16997	Ultra short-wave diathermy
16998	Medical systems
16999	Remote treatment
17000	Virtual care
17001	glomerular filtration rate
17002	retrospective cohort study
17003	High mobility group box-1 (HMGB1)
17004	clinical trial.
17005	herbal medicinal products
17006	Lithium
17007	Arteether (PubChem CID: 3000469)
17008	Artemether (PubChem CID: 68911)
17009	Artemisinin
17010	Artemisitene (PubChem CID: 11000442)
17011	Artesunate (PubChem CID:156252)
17012	Cell proliferation
17013	Chemical compounds studied in this article Artemisinin (PubChem CID: 68827)
17014	Dihydroartemisinin (PubChem CID: 139073990)
17015	IL-6 blockade
17016	IL-6 receptor antagonists
17017	Inhibitors
17018	Model prediction
17019	Antibodies*
17020	Array analysis
17021	Protein array
17022	Serum/Plasma*
17023	home blood pressure monitoring
17024	SARC-CoV-2
17025	N-acetyl-L-cysteine
17026	Coronavirus disease 19 outbreak
17027	endodontic emergency
17028	epidemiologic investigation
17029	verbal numerical rating scale
17030	vital pulp therapy
17031	mrna-based vaccine
17032	first manifestation
17033	non-respiratory symptoms
17034	novel coronavirus disease 2019
17035	morbid obesity
17036	Breast diseases
17037	Coronavirus infected diseases
17038	heated air
17039	prototype
17040	Pegylated interferon alfa 2a
17041	perinatal outcome
17042	Coagulation dysfunction
17043	hydroxychloroquine and azithromycin
17044	kidney and liver transplantation
17045	nonpathogen-specifc immune parameters
17046	Sequential analysis
17047	association rules
17048	clustering algorithm
17049	Mediterranean east respiratory syndrome
17050	Pandemic control
17051	MERS-coronavirus
17052	i301
17053	lumazine synthase
17054	rabbit
17055	spytag-spycatcher
17056	CTLA-4 Antigen
17057	programmed cell death 1 receptor
17058	ST-elevation myocardialinfarction
17059	Cardiac magnetic resonance
17060	Cardiovascular computed tomography
17061	Budd-Chiari syndrome
17062	Critical cases
17063	ACQ-6
17064	ACT
17065	IL-5
17066	IL-5R
17067	asthma control
17068	asthma control questionnaire 6-item scale
17069	asthma control test
17070	nail disorders
17071	nail psoriasis
17072	pathogenicity model
17073	poikilosis
17074	progression prediction
17075	chronic migraine
17076	onabotulinumtoxinA
17077	Corona pandemic
17078	Psychological burden
17079	Social isolation
17080	Virtual contact options
17081	immunosuppressive drugs
17082	rare skin diseases
17083	Anesthesia and intensive care
17084	Traditional Medicine
17085	Continues renal replacement therapy
17086	Hemoperfusion
17087	Viral
17088	Immunomodulatory therapy
17089	Thymosin a1
17090	Ulinastatin
17091	forensic pathology; forensic toxicology; chloroquine; corona virus disease 2019; review
17092	Anticoagulant
17093	Duplex ultrasonography
17094	Esophageal motility disorders
17095	Gastrointestinal diseases
17096	Gastrointestinal motility
17097	D‐dimer
17098	activated protein C
17099	Crisis intervention
17100	Data visualization
17101	HLA-E-restricted CD8 T cells
17102	T-cell immunotherapy
17103	Compartment syndrome
17104	carbon monoxide poisoning
17105	Nosocomial infection
17106	Pancreatic disease
17107	Prevention of infection
17108	solid tumor
17109	LOTUS China
17110	Children/young
17111	Infection and cardiovascular disease
17112	Systematic literature review
17113	Non ST-Segment elevation acute coronary syndrome
17114	ST-Segment elevation myocardial infarction
17115	Anti-inflammation treatment
17116	essential newborn care
17117	newborn health outcomes
17118	cognitive-behavioral therapy
17119	Early intervention
17120	Very severe hypoxemia events
17121	Janus kinase
17122	IL-1 inhibitors
17123	Mast cell stabilizers
17124	cancer immunology
17125	human immune monitoring
17126	rhinovirus
17127	single cell
17128	spectral flow cytometry
17129	systems immunology
17130	clinical efficacy
17131	Forest bathing
17132	Laurus nobilis
17133	Mediterranean vegetation
17134	Mpro inhibitors
17135	Plant therapeutics
17136	Plant toxicity
17137	Original disease
17138	Siltuximab
17139	hypoxic respiratory failure
17140	interleukin 1 blockade
17141	interleukin 6 blockade
17142	systemic cytokine release syndrome
17143	Exacerbation
17144	Infectious risk
17145	Inhalers
17146	MDI, Metered dose inhaler
17147	MgSO4, Magnesium sulphate
17148	SABA, Short acting beta-2-agonist/s
17149	SAMA, Short acting anti-muscarinic agent/s
17150	Leflunomide
17151	Viral shedding time
17152	patient-centered care
17153	acute exacerbation
17154	interstitial lung disease
17155	Coronavirus disease 2019 (COVID-19); Pregnancy; Postpartum; Psychological intervention; Dialectical behavior therapy
17156	consumption
17157	lopinavir–ritonavir
17158	recommendation
17159	bio-labeling
17160	gold nanoparticles
17161	protein nanoparticles
17162	silver nanoparticles
17163	transmissible gastroenteritis virus
17164	vaccine nanotechnology
17165	lung failure
17166	uterine cancer
17167	vulvar and vaginal cancer
17168	clinical trials as topic
17169	virus diseases
17170	Coronavirus disease SARS-CoV-2
17171	Drug interaction
17172	Hormonal therapy
17173	Pharmaco-invasive therapy
17174	ST-segment elevation myocardial infarction (STEMI)
17175	Black seeds
17176	erythropoietin
17177	Hepatitis B Reactivation
17178	Liver Function
17179	Acid acetic
17180	RNA interference
17181	viral vectors
17182	intervention effect
17183	Non-Invasive ventilation
17184	Positive end expiratory pressure
17185	Prone position
17186	Curcumin
17187	botulinum toxin
17188	tissue fillers
17189	Vinorelbine
17190	chronic myeloid leukaemia
17191	Drug-drug interactions
17192	Drug-related problems
17193	Herb-Drug interactions
17194	Immune depression
17195	system barriers
17196	HMG-CoA reductase inhibitor
17197	Matrine and Sodium Chloride Injection
17198	Real-Time Reverse-Transcriptase Polymerase Chain Reaction
17199	Tertiary Infection
17200	Viral Load
17201	Cytosorb
17202	blood purification
17203	COVID-19 convalescent plasma (CCP)
17204	Blood purification
17205	Critically ill COVID-19
17206	Clinical Study
17207	Nature Herbal Medicine (NHM)
17208	Treatment Approach
17209	Ecotoxicity
17210	Meiobenthic nematodes
17211	Hydroxychloroquine/ chloroquine
17212	Cause analysis
17213	Discharge from hospital
17214	escin
17215	real-world evidence
17216	safety and efficacy
17217	Aneurysm
17218	SarsCov2
17219	patent
17220	B-DMARDs
17221	Ts-DMARDs
17222	Cardiac arrhythmia
17223	antidiabetic medications
17224	严重急性呼吸综合征冠状病毒2
17225	糖尿病
17226	羟基氯喹
17227	降糖药物
17228	l-Glutamine
17229	high-flow nasal oxygen
17230	oxygen inhalation therapy
17231	Renal Replacement Therapy (RRT)
17232	Corona virus, covid-19 disease, nutritional management, medical nutrition therapy, nutritional support, food safety, recommendations, diabetes, hypertension.
17233	Azithromycine
17234	Syndrome du QT long
17235	Torsade de Pointes
17236	Respiratory therapy
17237	Severe and critical infections
17238	cerebral infarction
17239	Triazavirin
17240	Medicine, Chinese traditional
17241	Protocol interpretation
17242	oncology department
17243	Controlled multiple imputation
17244	Estimands
17245	Randomised trials
17246	organ transplantation
17247	British Medical Association
17248	ethical guidance
17249	withdrawal of treatment
17250	oncology service
17251	systemic anticancer therapy
17252	high dose intravenous immunoglobulin
17253	thalidomide
17254	adverse drug events
17255	medication safety
17256	Collection
17257	Re-use
17258	Disease management
17259	Infection control and prevention
17260	Mandatory Programs/legislation & jurisprudence
17261	Patient Isolation/legislation & jurisprudence
17262	Personal Autonomy
17263	Portugal
17264	adverse event
17265	glucose-6-phosphate dehydrogenase (G6PD) deficiency
17266	Swiss
17267	COVID-19/drug therapy
17268	Coronavirus Infections/drug therapy
17269	renal transplant recipient
17270	myocaritis
17271	Vulvar neoplasms
17272	Workflow
17273	post-mortem examination
17274	Severe coronavirus disease-19
17275	Clinical guidelines
17276	myasthenia gravis
17277	neuromuscular disorders
17278	ventricular thrombus
17279	COVID-19 disease severity
17280	Chronic immunosuppressive therapy
17281	Rheumatologic disease
17282	multiple myeloma
17283	systemic antic-cancer therapy
17284	Sudden death
17285	Kidney stones
17286	Nephrolithiasis
17287	Urolithiasis
17288	Adsorptive granulocyte and monocyte apheresis
17289	Lectin pathway
17290	MASP2
17291	Mucous membrane pemphigoid
17292	drug-drug interaction
17293	STEMI therapy
17294	Kidney transplant recipient
17295	Conventional therapy
17296	Liu-zi-jue
17297	clinical evidence
17298	corona virus disease 2019 (COVID-19)
17299	Novel corona virus
17300	Traditional Chinese herbal medicine emerging infectious diseases
17301	clinical Chinese pharmacist
17302	pharmaceutical care
17303	phasmaceutical mornitoring
17304	Lymphadenopathy
17305	overweight
17306	severe complications
17307	low-dose
17308	short-course
17309	Adaptive trial
17310	Ambrisentan
17311	Dapagliflozin
17312	EDP1815
17313	Experimental drugs
17314	Open-label
17315	solid organ transplant recipient
17316	Ophthalmic artery occlusion
17317	CT perfusion
17318	Perforating artery stroke
17319	Thalamic stroke
17320	medical oncology
17321	fibrin
17322	plasminogen activator inhibitor 1
17323	respiratory distress syndrome (adult)
17324	haemophilia A
17325	rare bleeding disorders
17326	von Willebrand disease
17327	gyógyszer
17328	kezelés
17329	immunoparalysis
17330	Vertebrate fracture
17331	oral lichen planus
17332	recurrent aphthous ulcers
17333	stress response﻿﻿
17334	﻿cheilitis
17335	obsessive-compulsive disorder
17336	Extended prophylaxis
17337	Thromboprophylaxis
17338	feline coronavirus
17339	feline infectious peritonitis
17340	Enteral feeding
17341	Cytokine-release syndrome
17342	Interleukin-1 receptor antagonist
17343	Tomography, X‑ray computed
17344	Ventilation, mechanical
17345	Chest physiotherapy
17346	Oscillation
17347	prevention & control
17348	treatment-drug
17349	ICU treatment
17350	complicated grief
17351	natural disaster
17352	ICU-bed occupancy
17353	lifting
17354	acetazolamide
17355	high-altitude pulmonary edema
17356	shock, cardiogenic
17357	Daily-dosing
17358	Placebo
17359	Weekly-dosing
17360	Ocular
17361	Vague neurostimulation
17362	clinical oncology
17363	young oncologists
17364	patient benefit
17365	treatment decisions
17366	ATS/IDSA CAP guidelines
17367	CAP severity assessment scores
17368	New antibiotics
17369	Severe community acquired pneumonia
17370	Site of care
17371	Hip fractures
17372	immunosuppression management
17373	kidney transplant recipient
17374	Oxidative Stress
17375	pulmonary heart disease
17376	mild course
17377	primary myelofibrosis
17378	ruxolitinib
17379	catheter-directed thrombolysis
17380	interventional radiology
17381	pulmonary embolus
17382	Extended Screening Criteria
17383	Nosocomial Infection
17384	Markov
17385	Pulmonary failure
17386	Tissue plasminogen activator (tPA)
17387	Angiotensin converting enzyme2
17388	care
17389	psychosocial impact
17390	post-pandemic
17391	cell senescence
17392	protocol registration
17393	University of Pennsylvania Smell Identification Test (UPSIT)
17394	anosmia treatment
17395	olfactory neuritis
17396	Geriatric oncology
17397	Dynamic
17398	Routine blood parameters
17399	Complication
17400	collagen vascular disorder
17401	cosmetic procedure
17402	cutaneous
17403	cutaneous manifestation
17404	dermatitis
17405	drug reaction
17406	eczema
17407	health care staff
17408	immunobullous
17409	immunomodulator
17410	immunosupressant
17411	immunosupressive
17412	novel human coronavirus (SARS-CoV-2)
17413	pandemic considerations
17414	papulosquamous
17415	pemphigus
17416	skin manifestation
17417	skin rheumatologic disorder
17418	special
17419	specific skin diseases
17420	surgical procedure
17421	systemic treatment
17422	visits
17423	RNA-induced silencing complex
17424	airway host defense
17425	airway surface liquid
17426	chronic obstructive pulmonary disease
17427	ion channels
17428	miRNA-mRNA interaction
17429	Low-medium intensity of care
17430	Acute aortic syndrome
17431	Disease mitigation
17432	Medicinal mushroom
17433	β-Glucans
17434	oxygen
17435	Antiviral immunity
17436	Reactive oxygen species
17437	neuromuscular disease
17438	A-a gradient
17439	PF ratio
17440	alveolar macrophage
17441	hypoxic failure
17442	inflammatory monocyte
17443	leukine®
17444	oxygenation
17445	sargramostim
17446	NADPH oxidase
17447	Progressive muscle relaxation
17448	crohn's disease
17449	acute gouty arthritis
17450	Psychological therapy
17451	Rehabilitative therapy
17452	Respiratory airway care
17453	High flow nasal cannula
17454	Non invasive ventilation
17455	Pronation
17456	left ventricular ejection fraction
17457	CKRT
17458	mechanisms
17459	mechanistic reasoning
17460	Prophylactic anticoagulation
17461	Crisis
17462	Humanitarian
17463	Multipurpose
17464	Venezuela
17465	nonoperative treatment
17466	Chinese Medicine
17467	Integrative Medicine
17468	Non–small-cell lung cancer
17469	Acidosis
17470	Bhramari Pranayam
17471	Cinnamon
17472	Coagulopathies
17473	Coronavirus (SARS-CoV-2)
17474	Ginger
17475	Liquorice
17476	Metabolic
17477	RNA respiratory VIRUS
17478	Coronary angiography
17479	Percutaneous coronary intervention
17480	castrate resistant
17481	hormone sensitive
17482	metastatic
17483	vitamin D-hydroxyderivatives
17484	antimalarials
17485	Country response
17486	Disaster medicine
17487	Drug addiction
17488	Mental health Services
17489	Opiate substitution treatment
17490	Substance-related disorders
17491	Embolism
17492	metalloenzyme
17493	zinc ejecting drug
17494	zinc finger
17495	creatine kinase
17496	creatine phosphokinase
17497	sars-cov-2 (severe acute respiratory syndrome corona virus 2)
17498	clinical pharmacology
17499	gap analysis
17500	Adverse effects
17501	Coronavirus infectious disease-2019 (COVID-19)
17502	concomitant
17503	concurrent
17504	manifestation
17505	pemphigoid
17506	simultaneous
17507	specific skin disease
17508	systemic drug
17509	Heart transplant
17510	digital ischemia
17511	drug-induced liver injury
17512	hepatotoxicity
17513	Dental Care
17514	Guideline Development
17515	emergency dental treatment
17516	urgent dental care
17517	Endonasal treatment
17518	Nasal lavages
17519	Nasopharynx
17520	Rhinology
17521	Sinonasal polyposis
17522	Sinus
17523	CBRN
17524	difficult airway management
17525	Aspergillus fumigatus
17526	CAPA
17527	TR34L98H
17528	azole-resistant Aspergillus
17529	pulmonary aspergillosis
17530	ethnomedicine
17531	preventing and treating program
17532	transplant recipients
17533	Screening Clinic
17534	infants
17535	lebanon
17536	middle east
17537	Audit
17538	Standard treatment
17539	Endovascular
17540	Vasospasm
17541	COVID-19 and breastfeeding
17542	COVID-19 and pregnancy
17543	coronavirus and pregnancy
17544	antiandrogen
17545	dental emergency treatment
17546	patient questionnaire
17547	patient triage
17548	Dutasteride
17549	Finasteride
17550	Gabrin sign
17551	anti-androgen therapy
17552	ERP
17553	Exposure therapy
17554	OCD
17555	Steroid treatment
17556	acute infectious disease
17557	pulmonary infection
17558	Herpes simplex-1
17559	Valproic acid
17560	epidemy
17561	head & neck
17562	Taiwan CECC
17563	domestic family clusters infections
17564	Disease modifying therapy
17565	allergy treatment
17566	immunotherapy clinical
17567	immunotherapy vaccines and mechanisms
17568	Direct muscle stimulation
17569	spine surgery
17570	Social network analysis
17571	Super-factors
17572	Tyrosine kinase inhibitors
17573	chronic myeloid leukemia
17574	severe patients
17575	short-term outcomes
17576	foreign body
17577	torsade des pointes
17578	ventricular fibrillation
17579	ventricular tachycardia
17580	host-directed
17581	Brasil
17582	Pediatria
17583	Pediatric intensive care
17584	Terapia intensiva pediátrica
17585	Fecal samples
17586	Microorganisms
17587	Ventilator-associated pneumonia
17588	Midwives, World Health Organization, Healthcare-associated infection
17589	blood-brain barrier (BBB)
17590	hypothalamic–pituitary–adrenal (HPA) axis
17591	substance use disorder (SUD)
17592	Refractory Myasthenia Gravis
17593	granulocyte-colony stimulating factor
17594	immune reconstitution inflammatory syndrome
17595	health care disparity
17596	antibiotic use
17597	coinfections
17598	Macrolides
17599	ADE effect
17600	Infection stage
17601	Serum antibody quantitative detection
17602	CT scores
17603	Bowel perforation
17604	Colonic perforation
17605	Saliva biomarkers
17606	thromboembolic complications
17607	Central America
17608	Insomnia severity index (ISI)
17609	Subjective sleep
17610	Severe acute respiratory distress syndrome
17611	Medical hydrology
17612	Spa centers
17613	Clinical Frailty Scale
17614	Hyper-inflammatory host response
17615	adverse drug reactions
17616	potential drug–drug interactions
17617	prone ventilation
17618	Adult CHD
17619	tetralogy of Fallot
17620	deceased
17621	Anti-inflammatories
17622	Cytokine-storm
17623	Lidocaine
17624	development
17625	cerebrovascular accidents
17626	cva
17627	ischemic cva
17628	mca
17629	stroke systems of care
17630	epidemiological characteristic
17631	Adverse childhood experiences
17632	Domestic violence family
17633	Economic hardship
17634	Recession
17635	liposome
17636	telestroke
17637	COVID-19 cardiac disease
17638	Haemorrhage
17639	Appendicitis
17640	pregnant mother
17641	Cytopenia
17642	Tomography, X-ray Computed
17643	pulmonary
17644	COVID-19 serotherapy
17645	blood donors
17646	blood transfusion
17647	hypertensive patients
17648	angiotensin II type1 receptor blockers
17649	BiPAP
17650	high flow oxygen
17651	high velocity nasal insufflation
17652	non‐invasive ventilation
17653	personal protection
17654	radiology operations
17655	Torsades de Pointes
17656	e-Health
17657	multidisciplinary collaboration
17658	online management
17659	cholangiocytes
17660	Capnocytophaga canimorsus
17661	hospital departments
17662	inpatients
17663	 hyperbaric oxygen therapy clinical trials for COVID-19 
17664	Actemra
17665	Advil
17666	Kaletra
17667	Kevzara
17668	Motrin
17669	Tylenol
17670	acetaminophen
17671	antiretrovirals
17672	Ganlu Xiaodu Decoction
17673	association
17674	combined medication
17675	right ventricular function
17676	speckle tracking echocardiography
17677	strain
17678	intranasal
17679	neurological manifestation
17680	Antimicrobial stewardship
17681	Aerosol-generating procedure
17682	Surgical drapes
17683	Transoral robot surgery
17684	Airway assessment
17685	Preoperative assessment
17686	Preoperative assessment clinic
17687	glomerular disease
17688	kidney diseases
17689	adrenal
17690	civil defense
17691	pharmacy services, hospital
17692	adult management
17693	Extracorporeal membrane oxygenation (ECMO)
17694	CT angiography (CTA)
17695	Heparin induced thrombocytopenia (HIT)
17696	Pulmonary thrombus
17697	Cerebral venous thrombosis
17698	Electroencephalography
17699	Intracerebral hematoma
17700	Advanced maternal age
17701	Oncology patients
17702	Poor-prognosis patients
17703	Reduced ovarian reserve
17704	Immunomodulation , immunopathology , CD8+ T cells , viral pneumonia , inducible epithelial resistance
17705	Korean Medicine Center
17706	Pandemic outbreaks
17707	Antiviral interactions
17708	Drug-induced long QT syndrome
17709	calcineurin inhibitor
17710	crohn's colitis
17711	Orotracheal tube
17712	hospitalization time
17713	CVDs
17714	ESC Guidelines
17715	containment measures
17716	Clot formation
17717	Dialysis membrane
17718	Fluid management
17719	essential services
17720	speech language therapy
17721	swallowing.
17722	COVID-19 drug treatment [Supplementary Concept]
17723	Drug Eruptions
17724	Drug-Related Side Effects and Adverse Reactions
17725	ECMO complications
17726	intracranial hemorrhage on heparin
17727	Blood type
17728	T-lymphocytes
17729	immune evation
17730	tumor escape
17731	Biliary atresia
17732	Liver graft
17733	clinical haematology
17734	immune thrombocytopenia
17735	peripheral nerve disease
17736	colchicine
17737	Retinal disease
17738	Vision Academy
17739	Acute cholecystitis
17740	COVID-19 pandemic
17741	fibroblast growth factor receptor
17742	traditional Chinese medicine formula
17743	vascular endothelial growth factor receptor
17744	Intensive care ventilators
17745	Ventilators’ essential technical requirements
17746	Ancianos
17747	Care Homes
17748	Older
17749	Residencias
17750	Enfermedad renal crónica
17751	Morbilidad
17752	Energy target
17753	Enteral nutrition
17754	Protein target
17755	SARS-Cov2 virus
17756	Supplemental parenteral nutrition
17757	Adult respiratory distress syndrome
17758	Antimicrobial therapy
17759	Bovine coronavirus
17760	Coinfections
17761	Ferritin
17762	Human immunodeficiency virus (HIV)
17763	Interleukin-1
17764	Oral candidiasis
17765	Pneumocystis jiroveci pneumonia
17766	Soluble urokinase-type plasminogen activator receptor
17767	viscoelastic tests
17768	Immunotherapies
17769	Infections risk
17770	RSV
17771	controlled human infection model
17772	human viral challenge model
17773	AIP
17774	cancer center
17775	Intravenous thrombolysis
17776	rt-PA
17777	IgG4-related disease
17778	Risk of infection
17779	granulomatosis with polyangiitis
17780	Huoxiang Zhengqi Oral Liquid
17781	Jinhao Jiere Granules
17782	Critical quality attributes
17783	IV and SC medicines
17784	early infection
17785	viral carriage
17786	COVID-19 and coagulopathy
17787	DIC-syndrome
17788	complement system activation
17789	prothrombotic state in pregnancy
17790	thrombotic microangiopathy and COVID-19
17791	ground-glass opacity (GGO)
17792	pregnant women with COVID-19 pneumonia
17793	reverse transcription–polymerase chain reaction (RT-PCR)
17794	PCR test negative
17795	alternative medicine
17796	antibody test positive
17797	prolonged symptoms
17798	Drug shortages
17799	Rheumatologists
17800	Cellular immune response
17801	Respiratory-related disorders
17802	bedside testing
17803	commercial point-of-care tests
17804	innovative approaches
17805	virus diagnostics
17806	Chinese traditional patent medicine
17807	SARTs-Co-V-2 virus
17808	burns
17809	cytomegalovirus
17810	herpes simplex virus
17811	varicella zoster virus
17812	novel infectious disease
17813	Plasma therapy
17814	clinkical trial
17815	collateral
17816	Advanced non-small cell lung cancer
17817	TB and other respiratory infections
17818	Cerebral infarction
17819	Thrombectomy
17820	Cardiovascular comorbidities
17821	Coagulopatía
17822	Enfermedad tromboembólica venosa
17823	Pediatric population
17824	Población pediátrica
17825	Antiviral antibodies
17826	Viral immunity
17827	Integrated Traditional Chinese and Western Medicine
17828	Antithrombotic therapy
17829	Computed tomography pulmonary angiography
17830	Hypercoagulable state
17831	Couples Therapy
17832	Relationship Education
17833	Terapia de pareja
17834	capacitación en relaciones
17835	伴侣治疗
17836	关系教育
17837	high-flow nasal oxygenation
17838	preoxygenation
17839	infection-bacterial/fungal/viral
17840	skin signs of systemic disease
17841	therapy-topical
17842	Connected health
17843	Personalized healthcare devices
17844	Wearable devices
17845	antenatal steroids
17846	delivery mode
17847	fetal neuroprotection
17848	Begelomab
17849	GVHD
17850	MAS
17851	TKIs
17852	Takotsubo cardiomyopathy
17853	stress cardiomyopathy
17854	mother and neonate
17855	emergent disease
17856	medication information
17857	MOG
17858	disease modifying therapy
17859	autonomy
17860	Cross-infection
17861	Treatment and diagnosis
17862	Bioprospection
17863	Pressurized liquids
17864	Subcritical water
17865	Supercritical fluids
17866	social disparities
17867	Reinfection
17868	Broad-spectrum antiviral agents
17869	Fragmentation
17870	Herpes viruses
17871	Neuraminidase inhibitors
17872	Nucleoside analogues
17873	Protein inhibitors
17874	Tandem mass spectrometry
17875	CCB
17876	Calcium channels
17877	Calcium homeostasis
17878	SARs
17879	Electrostatic filtration
17880	Fabric pore size
17881	Filtration efficiency
17882	Mechanical filtration
17883	Neutrophils
17884	mobile apps
17885	biological aspects
17886	blood morphology
17887	Endocarditis
17888	mitral valve
17889	occupational groups
17890	Sars-COV2
17891	vitamin D supplementation
17892	acute care surgery
17893	Dental general practice
17894	CVID-19
17895	infection-associated glomerulonephritis
17896	menstrual toxic shock syndrome
17897	methicillin-resistant Staphylococcus aureus
17898	Oral & maxillofacial surgery
17899	Surgeon's perspective
17900	Clinico-epidemiologic - cough - COVID-19 - north India - outcome - prospective
17901	dry district
17902	withdrawal
17903	World health organization
17904	HCoV-OC43
17905	LC3
17906	MRC-5 cell
17907	kurarinone
17908	p62/SQSTM1 protein
17909	Endoscopic endonasal surgery
17910	Pituitary surgery
17911	amoeba
17912	leishmania
17913	Kawasaki Disease Shock Syndrome
17914	Multisystem Inflammatory Syndrome
17915	cancer management
17916	multidisciplinary cancer
17917	Electrical muscle stimulation
17918	carcinoma
17919	Biological agents
17920	Biológicos
17921	Resident
17922	Residente
17923	Reumatólogos
17924	antibody biology
17925	hematologic malignancies
17926	cranial polyneuritis
17927	polyradiculonevritis
17928	Clothing
17929	Fomites
17930	Fómites
17931	Higiene de la piel
17932	Protective clothing
17933	Ropa de protección
17934	Skin care
17935	Vestuario
17936	Virus del SARS
17937	Flow-chart
17938	Small molecules
17939	bDMARDs
17940	emergency general surgery
17941	perioperative protocol
17942	follicular conjunctivitis
17943	hemodialysis center
17944	 Health Policy 
17945	 Novel coronavirus 
17946	 Public health 
17947	Health Services for the Elderly
17948	Health Vulnerability
17949	Institutional policy
17950	Social services
17951	Immune modulator
17952	FMT
17953	cryoconservation
17954	fecal microbiota transplantation
17955	fecal samples
17956	stool banks
17957	psychotropic
17958	Brain edema
17959	Focal seizure
17960	HLH/MAS
17961	Chest X-Ray image
17962	Deep neural network
17963	Faster R–CNN
17964	Neumonía intersticial
17965	storm
17966	multidisciplinary team
17967	fractionation
17968	Angiotensin II receptor blockers (ARBs)
17969	Sildenafil
17970	pulmonary arterial hypertension (PAH)
17971	thalassemic syndromes
17972	human intestinal enteroid
17973	toll-like receptors
17974	viral-host interactions
17975	Decannulation
17976	Peak cough flow
17977	complement inhibition
17978	pharmacological treatment
17979	clinical service delivery
17980	toolkit
17981	influenza B
17982	Sars‐CoV‐2
17983	NKG2C
17984	nestRPA
17985	Klebsiella
17986	ECMO (extracorporeal membrane oxygenation)
17987	early diagnosis
17988	Prognostic Factor
17989	Severe Disease
17990	ESPEN
17991	Feeding intolerance
17992	Gastric residuals
17993	hazard control measures
17994	cardiac arrhythmia
17995	prolonged QTc
17996	torsade de pointes
17997	Antiepileptic drug
17998	Interaction
17999	Seizure
18000	Contact-tracing
18001	Face-mask
18002	Macrolide
18003	Trial
18004	Outpatient management
18005	 child
18006	 coronavirus infections
18007	 pediatrics
18008	 perú
18009	Ion channel
18010	Muscarinic receptor
18011	Sars-CoV2
18012	Type-I interferon
18013	dietary supplements
18014	elderberry and silver
18015	infection (gastroenterology)
18016	infection control in hospital
18017	Ravulizumab
18018	Repurposed drugs
18019	Oxygenation
18020	Amyotrophic Lateral Sclerosis
18021	Covid-19 Pandemic
18022	limited resource settings
18023	oncofertility
18024	Internet of things
18025	IoT applications
18026	post-COVID syndrome
18027	Exercise therapy
18028	Physical therapy specialty
18029	Telerehabilitation
18030	Reverse transcriptase–polymerase chain reaction
18031	Coronavirus disease 2019 (COVID-19); Clinical characteristics; Intensive care unit (ICU); Mechanical ventilation
18032	case discussion
18033	patient information
18034	family physicians
18035	risk/benefit
18036	Immune complexes
18037	Health protection
18038	Indoor stadium
18039	Mobile cabin hospital
18040	Hypercoagulation status
18041	adiponectin
18042	diet therapies
18043	lung infections
18044	ω-3 PUFAs
18045	overdose
18046	Lupus erythematosus
18047	Metastasis
18048	Transtheoretical Model
18049	smoking cessation interventions
18050	Chronic wound
18051	Corona-virus disease 2019
18052	Wound healing
18053	geriatric medicine
18054	comfort care at the end of life
18055	communication skills curriculum
18056	narrative communication
18057	primary palliative care
18058	Implementation
18059	Musculoskeletal
18060	support
18061	mechanical ventilators
18062	multidisciplinary critical care
18063	Physical therapy
18064	acute care
18065	emergency department operations
18066	management, HR management
18067	protection barrier
18068	airway response team
18069	tracheal perforation
18070	consensus recommendations
18071	tracheal extubation
18072	equipment evaluation
18073	ventilation, invasive
18074	Israel national guidelines
18075	percutaneous tracheostomy
18076	peri-operative
18077	aerosolisation
18078	antiretroviral
18079	Blood flow
18080	Virchow’s triad
18081	Global Palliative Care
18082	Nursing Policy
18083	Palliative Care
18084	Palliative Nursing
18085	Primary Palliative Care
18086	Universal Health Coverage
18087	Acute respiratory distress sendrom
18088	Physical function
18089	altitude
18090	hypertension, pulmonary
18091	Psychological state
18092	Pulmonary function
18093	Dead space ventilation
18094	Hyperinflation
18095	Lung compliance
18096	Positive end-expiratory pressure
18097	non-invasive ventilation
18098	Fragility fractures
18099	Proximal femur fractures
18100	mechanical thrombolysis
18101	Heat stress
18102	balneotherapy
18103	hyperthermia
18104	sauna
18105	steam inhalation
18106	cardiopulmonary arrest
18107	keringés- és légzésleállás
18108	újraélesztés
18109	gépi lélegeztetés
18110	légzési elégtelenség
18111	légzéstámogatás
18112	High-flow Nasal Cannula
18113	Bronchoscope-guided
18114	Endotracheal intubation
18115	Positive pressure protective hood
18116	Candesartan
18117	Pandemic crisis
18118	Wound infection
18119	scoring system
18120	Janus Kinase Inhibitors
18121	biologic agents
18122	ciclosporin
18123	dermatolology
18124	systemic steroids
18125	Compound Qinlan Oral Liquid
18126	pestilence attacking the lung syndrome
18127	anti-viral drug
18128	Expanded access
18129	Off-label prescribing
18130	Drug-related side effects and adverse reactions
18131	Chikungunya
18132	pediatric surgery
18133	Ischemic muscle
18134	Lysosomal inhibition
18135	Oxidative phosphorylation
18136	Netherlands
18137	Old-age psychiatry
18138	Gastrointestinal bleeding
18139	Antiviral prophylaxis
18140	Telemonitoring
18141	Subclinical infection
18142	Health Care Quality, Access, and Evaluation
18143	Chiropractic
18144	Spinal manipulation
18145	Ergonomy
18146	Exoskeleton
18147	continuous glucose monitor
18148	virtual visit
18149	International Diabetes Center
18150	insulin start
18151	remote care
18152	Bisphosphonate
18153	Bone mineral density
18154	Denosumab
18155	Osteoporosis
18156	protected code blue
18157	videolaryngoscopy
18158	Ambulatory Care
18159	Critical Illness
18160	Post-Intensive Care Syndrome
18161	editorial
18162	Inpatient medicine
18163	Intensive Care Unit
18164	World Stroke Organization
18165	healthcare systems
18166	Clinical and epidemiological parameters
18167	Neuro-rehabilitation, COVID-19, Pandemic, Leadership, UK, Coronavirus.
18168	Assisted reproductive technology
18169	In vitro fertilization
18170	Intracytoplasmic sperm injection
18171	Poseidon criteria
18172	Viewpoint
18173	angiotensin converting enzyme inhibitors
18174	angiotensin converting enzyme‐2
18175	severe acute respiratory syndrome coronavirus‐2
18176	behavioral intent
18177	entertainment-education
18178	list experiment
18179	Diabetes mellitus, type 1
18180	Diabetes mellitus, type 2
18181	diabetes self-management
18182	insulin supply
18183	drug interactions
18184	population mental health
18185	psychiatric patients
18186	psychiatric service
18187	psychopharmacotherapy
18188	Consolidation
18189	Quantitative analysis
18190	B-lines
18191	Derrame pleural
18192	Ecografía
18193	Líneas-B
18194	Neumonía
18195	Pleura
18196	Pleural effussion
18197	Ultrasound
18198	Co-morbidity
18199	ethical review
18200	5Ts
18201	Maxillofacial
18202	REDCap
18203	email
18204	patient monitoring
18205	technological innovation
18206	transdisciplinary
18207	usability
18208	user-centered
18209	Retrospective cohort study
18210	Drug-induced disorder
18211	Neurological complication
18212	Serotonin syndrome
18213	Acute disseminated encephalomyelitis
18214	Asari Radix et Rhizoma
18215	dosage
18216	intestinal microbiota
18217	anatomical learning
18218	anatomy
18219	Medical oncology
18220	investigation
18221	Immune-mediate Inflammatory Disease
18222	Immunosuppressive drugs
18223	Particular contacting
18224	paroxysmal nocturnal haemoglobinuria
18225	Interventional trial
18226	Registered clinical trial
18227	Aerobic capacity
18228	Type 2 myocardial infarction
18229	TNFα inhibitor
18230	etanercept
18231	neuropathology, virology
18232	Clinical typing
18233	Hypohepatia
18234	deterioration
18235	Advanced chronic liver disease
18236	PIMS
18237	Respiratory Distress Syndrome, Adult
18238	Viral myocarditis
18239	Blood routine test
18240	Lymphocytes subsets
18241	Peripheral blood inflammatory cells (PBICs)
18242	Severe type
18243	Dengue fever
18244	Mechanical thrombectomy
18245	migraine
18246	mycoplasma
18247	respiratory tract infections
18248	FAERS
18249	adverse events
18250	Oral psychosomatic disorder
18251	diagnosis and treatment process
18252	oral and maxillofacial surgery
18253	bone tumour surgery
18254	sarcoma treatment
18255	acute lymphoblastic leukaemia
18256	COX
18257	COX-2
18258	Atypical infection
18259	Familial cluster
18260	Shedding duration
18261	Ethylene oxide
18262	Hydrogen peroxide
18263	Steam
18264	Sterilisation
18265	Ultra-violet
18266	sirtuin
18267	OUD
18268	Opioid Use Disorder
18269	Volatile anesthetics
18270	Professional liability
18271	Sunlight
18272	community health planning
18273	personal experience
18274	antibody-synthesising lymphocytes
18275	full blood count
18276	hospital preparedness
18277	Payment parity
18278	Reimbursement
18279	Telehealth expansion
18280	Telemedicine billing
18281	water trap
18282	egalitarianism
18283	utilitarianism
18284	Emergency operations
18285	clinical guidelines
18286	evidence based medicine
18287	Ethical obligations
18288	physician safety
18289	mobile field hospital
18290	frameshifting
18291	professional ethics in obstetrics
18292	professional virtue of integrity
18293	roles
18294	catecholamines
18295	heart failure
18296	influenza, human
18297	antibodies, antiphospholipid
18298	sleep apnoea
18299	1918 Influenza Pandemic
18300	Antiviral Drugs
18301	Stem Cells
18302	interstitial syndrome
18303	Retrospective
18304	Novel coronavirus disease 2019
18305	asymptomatic patient
18306	enoxaparin
18307	heparin-induced thrombocytopenia
18308	incidental detection
18309	serum amyloid A
18310	Acute necrotizing encephalopathy
18311	Adult onset Still’s disease
18312	Diffuse hemorrhagic encephalopathy
18313	Diagnosis, differential
18314	Tomography, X-Ray computed
18315	pulmonary complications
18316	volume scanning
18317	CT features
18318	mild/moderate type
18319	recovery stage
18320	severe/critical type
18321	Convexity subarachnoid hemorrhage
18322	Coronavirus,
18323	Reversible cerebral vasoconstriction syndrome
18324	Vertebral artery dissection
18325	allergic contact dermatitis
18326	isocyanate
18327	polyurethane
18328	elastase
18329	plasmin
18330	Outpatient treatment
18331	cyclooxygenase 1
18332	disease monitoring
18333	Medication shortages
18334	impaired immune system
18335	zinc deficiency
18336	challenge studies
18337	Prescription drug shortages
18338	Drug industry
18339	Drugs, generic
18340	Medicine, traditional
18341	Policy, drugs and alcohol
18342	Inflammatory bowel diseases
18343	health care personnel
18344	population risk classification
18345	thyrotoxicosis
18346	FESUM
18347	Hand infection
18348	Hand trauma
18349	glucocorticoids
18350	IL-17
18351	Immune therapy
18352	hidroxiklorokin
18353	hosszú-QT-szindróma
18354	proarrhythmia
18355	proarrhythmic effect
18356	syncope
18357	torsade de pointes kamrai tachycardia
18358	torsade de pointes ventricular tachycardia
18359	IAPM
18360	laboratories
18361	GI-stents
18362	bird flu
18363	pancreas and biliary tract
18364	Delphi technique
18365	esophageal neoplasms
18366	Identity processes
18367	collective actions
18368	social identities
18369	social norms
18370	societal inequality
18371	empathy
18372	non-pharmaceutical intervention
18373	Position statement
18374	Consultation liaison psychiatry
18375	Interactions
18376	Psychodrug
18377	Physicians
18378	Care planning
18379	Convulsive
18380	Nonconvulsive
18381	combined hormonal contraception
18382	postmenopausal hormone therapy
18383	progesterone; testosterone
18384	Digital technology
18385	computerized tomography
18386	Departmental transformation
18387	Standards of care
18388	Practice standards
18389	protocols & guidelines
18390	rehabilitation medicine
18391	Valve in valve
18392	closed-loop
18393	remote healthcare
18394	Severe respiratory distress syndrome
18395	diabetes technologies
18396	medication distribution
18397	video conferencing
18398	community screening
18399	diabetic retinopathy
18400	sickle cell anaemia
18401	clinical deterioration
18402	thrombolytic therapy
18403	Health care disparities mental health
18404	Non-profit organizations
18405	Virtual clinic
18406	Virtual
18407	depression & mood disorders
18408	schizophrenia & psychotic disorders
18409	suicide & self-harm
18410	Pulmonary disease, chronic obstructive
18411	  Critical care
18412	  clinical governance
18413	  interdisciplinary intensive therapy
18414	  pandemic 
18415	 medical education
18416	Mental disorder
18417	Mental health legislation
18418	Migrant
18419	Self management
18420	dental operating microscope
18421	Chest CT scan
18422	Orthopaedic patients and COVID-19
18423	PCR test
18424	Pandemic COVID-19
18425	Thoracic CT scan
18426	Trauma patients and COVID-19
18427	Medical image analysis
18428	Texture
18429	On-site testing
18430	Mobile
18431	Intensive-care unit
18432	RSI
18433	aerosol box
18434	barrier device
18435	rapid sequence induction
18436	Health knowledge, Attitudes, Practice
18437	Travel medicine
18438	VFR travellers
18439	Midwives
18440	copresence
18441	remote monitoring
18442	hypofractionation
18443	non melanoma skin cancer
18444	CNN
18445	LSTM networks
18446	image processing
18447	Real-time reverse transcription polymerase chain reaction
18448	fear of infection
18449	remote psychotherapy
18450	Resource utilization
18451	Sustainability
18452	1,25-dihydroxyvitamin D
18453	25-hydroxyvitamin D
18454	autoimmune disorders
18455	endothelial membrane stability
18456	immune function
18457	Blood urea nitrogen
18458	protein C
18459	severe COVID-19 prediction
18460	Disabled persons
18461	Neurological rehabilitation
18462	Individualism
18463	collectivism
18464	conspiracy theories
18465	powerlessness
18466	accident & emergency
18467	mycobacterium bovis
18468	PICC
18469	central venous catheter
18470	midline
18471	tip location
18472	ultrasound guidance
18473	venous access device
18474	Sign Language
18475	Hypofractionation
18476	Reusable
18477	general anaesthesia
18478	oral cancer
18479	oral dysplasia
18480	oral leukoplakia
18481	oral potentially malignant disorders
18482	flexibilities
18483	policies
18484	waivers
18485	Laryngoscopy
18486	Pediatric airway
18487	Suspension
18488	extubation
18489	Laboratory markers
18490	Mild and severe COVID-19
18491	Computed tomography imaging
18492	Serum amyloid A
18493	BCG-vaccine
18494	Health-Care Workers
18495	Registration
18496	Veterinary vaccine
18497	 COVID-19 pandemic
18498	birth center
18499	birth location
18500	counseling
18501	home birth
18502	Outpatient clinic
18503	MMR
18504	live attenuated vaccines
18505	myeloid-derived suppressor cells
18506	clinical organization
18507	CABG
18508	positive detection
18509	post-discharge surveillance
18510	COVID-19, Dental guidelines, Aerosol, Pandemic.
18511	Immunologlobulin M
18512	Artificial intellingence
18513	Computer tomography
18514	Placental pathology
18515	Corona virus disease 2019 (COVID-19); Aerosol; Infection control
18516	embolic
18517	Reyanning Mixture
18518	Blood test
18519	Primary screening
18520	Suspected cases
18521	Educational institutions
18522	health economics and outcome research
18523	real-world evidence studies
18524	control and prevention of nosocomial infection
18525	imaging diagnosis
18526	imaging examination
18527	hospital staffing
18528	medical rescue
18529	trans-regional
18530	aggravation
18531	acute leukaemia
18532	haemophagocytic syndrome
18533	BTK inhibitors
18534	CLL
18535	Endoscopic drainage
18536	Pancreatic pseudocyst
18537	Cardiac Surgery policies
18538	Access to care
18539	Service organisation
18540	drive-through
18541	high-volume testing
18542	underserved population
18543	EDTA
18544	pseudothrombocytopenia
18545	Fat mass
18546	PNI
18547	Steatosis
18548	SAD
18549	cardiorespiratory
18550	temporary tracheostomy
18551	tracheostomy tube
18552	Blood banking
18553	Blood donation
18554	Therapeutic apheresis
18555	imaging-based diagnosis
18556	ultrashort echo time MRI
18557	hygiene / occupational hygiene
18558	Mixed-method
18559	Peripheral inflammation
18560	syndrome of inappropriate antidiuretic hormone secretion
18561	SIADH
18562	positive pressure ventilation
18563	"""babysitter"" tissue expander/implant"
18564	breast cancer management
18565	breast reconstruction
18566	epipectoral breast reconstruction
18567	therapeutic mammaplasty
18568	hospitalizations
18569	fibreoptic tracheal intubation
18570	apnoeic oxygenation
18571	Carbon ion radiotherapy
18572	negative pressure room
18573	transport
18574	personal narrative
18575	mind–body intervention
18576	new-normal
18577	Hallucinations
18578	TSPT
18579	Health-care worker
18580	HCPAP
18581	Helmet
18582	NIV
18583	Assisted reproduction safety
18584	Assisted reproduction urgency
18585	Deferred pregnancy
18586	Doppler
18587	vaccine-preventable diseases
18588	community-acquired infections
18589	primary healthcare
18590	Chest radiology
18591	Dual-source CT
18592	Low-dose CT
18593	Spectral shaping
18594	OCT
18595	spontaneous coronary artery dissection
18596	Endothelial barrier
18597	Inflammation-associated haemostasis
18598	acute COVID-19 cardiovascular syndrome
18599	enterocyte biology
18600	Cardiology
18601	adult cardiology
18602	Adolescente
18603	Coronavírus
18604	Criança
18605	Infecções por Coronavírus
18606	Obesidade
18607	Thoracic anaesthesia
18608	Quarantine inspection procedures (QIPs)
18609	South korea
18610	N95 cleaning
18611	hydrogen peroxide sterilization
18612	Intracerebral biopsy
18613	hyponatraemia
18614	Fellowship
18615	Pediatric otolaryngology
18616	field
18617	acceptability
18618	augmented reality
18619	headset
18620	mixed reality
18621	pilot
18622	friendship
18623	loneliness
18624	mass isolation
18625	social boycott
18626	social brain
18627	Reusability
18628	2-bromo-2-nitropropane-1,3-diol
18629	bronopol
18630	formaldehyde
18631	medical device
18632	rosacea
18633	Pneumonia, Viral
18634	government regulations
18635	infectious disease modeling
18636	spread control
18637	Pediatric radiology
18638	nurse staffing
18639	CT/MRI
18640	efficiency
18641	emergency care systems, efficiency
18642	Measures
18643	face shield
18644	flexible endoscopy
18645	Exposure investigation
18646	Health care worker
18647	health care cost
18648	COVID-19 era
18649	Cerebrospinal fluid leakage
18650	Endonasal endoscopic repair
18651	Fat-on-fascia graft
18652	Fluorescein
18653	Skull base defect
18654	Traumatic nonmissile penetrating transnasal skull base fracture
18655	respiratory protective devices
18656	Cohorting
18657	Cotton mask
18658	Micro environment
18659	Respiratory droplet
18660	N95 face mask
18661	Resident education
18662	Virtual teleconferencing
18663	Aerosolization reduction
18664	COVID-19 infection prevention
18665	Endonasal surgery
18666	Ventilated mask
18667	colpotomy
18668	Financial risk
18669	Neurosurgeons
18670	performance measurement
18671	attitude networks
18672	identity
18673	opinion-based groups
18674	political polarization
18675	interview
18676	psychological issues
18677	transdisciplinary nurses
18678	vocational problems
18679	containment policies
18680	intergroup relations
18681	moral emotions
18682	norm deviation
18683	Cardiac surgical procedures
18684	Attend Anywhere
18685	Surgical Education
18686	ehealth
18687	hand trauma
18688	injury assessment
18689	isolating surgical trainee
18690	protecting health care workers
18691	surgical training during COVID-19
18692	telemedicine in COVID-19
18693	telephone appointment
18694	telephonic triage
18695	trauma assessment
18696	virtual clinic
18697	virtual trauma clinic
18698	vulnerable health care worker
18699	vulnerable trainee
18700	Anti-Lunch Shaming Act
18701	NURSE Act
18702	National Association of School Nurses
18703	The Protecting American Lungs and Reversing Youth Tobacco Epidemic Act of 2020
18704	online research
18705	research methods
18706	Routine
18707	occupational health services
18708	occupational physicians
18709	orthopaedics
18710	total joint arthroplasty
18711	Checklist
18712	self-rated health
18713	Health education
18714	Health promotion
18715	comparison
18716	exponential growth bias
18717	statistical literacy
18718	Human values
18719	Prosocial behaviour
18720	Value similarity
18721	Data collection
18722	Mobile applications
18723	Atmospheric pollutants
18724	high-volume suction
18725	pre-procedural mouthwash
18726	Consensus statement
18727	CPD
18728	Webinars
18729	Pandemic well-being
18730	Surgeon wellness
18731	Pandemic policy
18732	Research of policy
18733	THA
18734	TKA
18735	international
18736	negative-pressure
18737	surgical helmet systems
18738	allied health/nursing
18739	patient characteristics
18740	quality of care/care delivery
18741	contact
18742	cytokines/cytokine receptors
18743	HSR
18744	cleaning
18745	door handle cleaning
18746	human service robot
18747	object detection
18748	Healthcare Funding
18749	International Council of Nurses
18750	Nursing Care
18751	State of the World’s Nursing
18752	critical heath literacy
18753	information appraisal
18754	rural-urban health disparities
18755	structural equation modeling
18756	theory of reasoned action
18757	mobile sensing
18758	phone usage
18759	sedentary
18760	cognitive functioning
18761	multinational survey
18762	rational
18763	KOH
18764	hydrophobic
18765	membrane
18766	nanopores
18767	reusable mask
18768	Intracranial
18769	Resection
18770	Respirator masks
18771	Suits
18772	Surgeon
18773	Infrared Imaging
18774	protective face masks
18775	evidence-informed policy-making
18776	systems
18777	Awareness
18778	Dental Auxiliaries
18779	Dentists
18780	Oral health care workers
18781	presenteeism
18782	protective equipment
18783	filtration efficiency
18784	Eye protection
18785	Filtered eye mask (FEM)
18786	healthcare supplies
18787	radiation oncologists
18788	head and neck oncology
18789	patient-physician communication
18790	paper towel
18791	anesthesiology
18792	coronary angiography
18793	Otolaryngology-head and neck surgery
18794	cross-infection
18795	Hajj, Umrah
18796	mass gatherings
18797	pilgrims
18798	Coronavirus disease 2019 (COVID-19); Lung Transplantation; ST-segment elevation myocardial infarction; Percutaneous coronary revascularization
18799	IoT
18800	blockchain
18801	cloud
18802	federation
18803	smart contract
18804	travellers
18805	Cancer gynécologique
18806	Conjunctivitis, viral
18807	Bus
18808	Public transportation
18809	Medical organization
18810	Public transport
18811	Key places
18812	authorship
18813	digital media
18814	official public health organizations
18815	Enterprise
18816	Conference designated hotels
18817	Preventive health services
18818	laboratory investigations
18819	2019 Novel Coronavirus infection
18820	Prevention and protection
18821	Sampling
18822	Containment strategy
18823	Core measures
18824	public health centers
18825	Doença ORL
18826	ENT disease
18827	Otolaryngologist
18828	Otorrinolaringologista
18829	Fitness
18830	Splatter
18831	COVID-19 and cancer surgery
18832	cancer and COVID-19
18833	preoperative COVID testing
18834	immune characteristics
18835	serum potassium
18836	Post-exposure
18837	Sri Lanka
18838	immune complex diseases
18839	lupus erythematosus systemic
18840	heart transplantation/ cardiology
18841	immunosuppression/ immune modulation
18842	Mesenteric thrombosis
18843	social work
18844	Corona virus cycle
18845	Targets
18846	lupus erythematosus
18847	CAD, cationic amphiphilic drug
18848	amiodarone
18849	Zero mortality
18850	dermatological therapies
18851	antiphospholipid antibody
18852	coronavirus 2019 (covid-19)
18853	covid-19 respiratory failure high altitude pulmonary edema high flow nasal cannula acute respiratory distress syndrome
18854	key words corona
18855	sars cov-2
18856	tube impaction
18857	diffuse st elevation
18858	myopericarditis
18859	RNA-dependent RNA polymerase inhibitors
18860	autoimmune
18861	camostat mesylate
18862	high altitude pulmonary edema (HAPE)
18863	ECG, electrocardiography
18864	LDH, lactate dehydrogenase
18865	RR, reference range
18866	TTC, takotsubo cardiomyopathy
18867	cTnI, cardiac troponin I
18868	takotsubo cardiomyopathy
18869	intubated
18870	Hospitalizados
18871	investigational medication
18872	ecuador
18873	Centralized procedure (CP)
18874	Chenodeoxycholic acid
18875	Decentralized procedure (DCP)
18876	Drug rediscovery
18877	Magistral compounding
18878	Market Authorization Application (MAA)
18879	Mexiletine
18880	Mutual recognition procedure (MRP)
18881	Orphan drugs
18882	Pharmaceutical compounding
18883	Reference Member State (RMS)
18884	Thalidomide
18885	Thioguanine
18886	alkaloid
18887	broad-spectrum antiviral
18888	Cytopathic effect
18889	Drug repurpose
18890	DNN
18891	abidol
18892	chloroquine phosphate
18893	lopinavir/ ritonavir
18894	plasma.
18895	in silico comparison
18896	Public heath
18897	Autoimmune systemic diseases
18898	Connective tissue diseases
18899	Fragment molecular orbital method
18900	Interaction analysis
18901	Template-primer RNA
18902	acute lymphoblastic leukaemia (ALL)
18903	Septic
18904	drug allergy
18905	drug hypersensitivity
18906	phosphoramidates
18907	prodrugs
18908	Serologic Responses
18909	Serological assay
18910	IgG antibodies
18911	COVID-19 convalescent plasma
18912	SARS-CoV-2 antibody quantification
18913	Virus neutralization test
18914	Concordance
18915	Concordancia
18916	HCoV
18917	serologic analysis
18918	COVID-19, ELISA
18919	kinetics
18920	immunoanalysis
18921	immune globulin
18922	IgG-antibodies
18923	anti-Gal antibodies
18924	immune complex
18925	Antibody test
18926	Glycoprotein
18927	hACE2 transgenic mice
18928	respiratory droplets
18929	Neutralisation
18930	Denmark
18931	Faroe Islands
18932	Anti-SARS-CoV-2 IgM/IgG, rRT-PCR
18933	Antibody response
18934	Disease course
18935	COVID-19 pandemia
18936	COVID–19-pandémia
18937	SARS-CoV-2 novel coronavirus
18938	SARS-CoV-2 vírus
18939	gyorsteszt
18940	’real-time’ PCR
18941	Seroepidemiology
18942	LIPS
18943	luciferase immunoprecipitation
18944	mild COVID-19
18945	persistent infection
18946	virus-specific antibody response
18947	Alltest
18948	Serologic rapid test
18949	coronavirus disease -19 (COVID-19)
18950	Immunochromatographic assay
18951	Lateral flow method
18952	Immunochromatographic strip assay
18953	Lateral flow immunoassays
18954	Point-of-care test
18955	Rapid diagnostic test
18956	Convalescent patient
18957	Health-care professionals
18958	interpretation of laboratory results
18959	Colloidal gold-based
18960	Immunochromatographic strip
18961	COVID IgG and IgM
18962	analytical performances
18963	antibody kinetics
18964	ECLIA
18965	Seroconversion
18966	evacuees
18967	IgM/IgG gyorstesztek COVID–19-kimutatásra
18968	egészségügyi dolgozók
18969	rapid antibody tests for COVID-19
18970	világjárvány
18971	Blood donors
18972	Blood groups
18973	Seroneutralisation
18974	home-testing
18975	primary- and secondary-care physicians
18976	point-of-care diagnostics
18977	systematic review and meta-analysis
18978	enzyme-linked immunosorbent assay
18979	false-positive
18980	gold immunochromatography assay
18981	urea
18982	diagnostic pathway
18983	external quality assurance
18984	Clinical performances
18985	pseudoviral particles
18986	nucleic acids detection
18987	COVID-19 units
18988	Carriage
18989	Hospital staff
18990	Assay validation
18991	Virus neutralization
18992	t-cell immunity
18993	SAR-CoV-2 antibodies
18994	original antigenic sin
18995	ESHRE
18996	cohort studies
18997	nucleic acids
18998	patient discharge
18999	IFA
19000	antibody tests
19001	IgG/IgM
19002	Rapid Antibody Test
19003	Abbott IgG
19004	cross-reacting antibody
19005	Anti-SARS-CoV-2
19006	Method comparison
19007	Roche
19008	Serologic assay
19009	Nucleic acid test (NAT)
19010	Real-time polymerase chain reaction (RT-PCT)
19011	Serologic test
19012	immunoglobulin (Ig)G
19013	molecular farming
19014	transgenic plants
19015	transient expression
19016	qualitative results
19017	quantitative results
19018	standardization
19019	z-scores
19020	Heat-inactivation
19021	Autoinflammatory syndrome
19022	CAPs
19023	Capillary leak-like syndrome
19024	antibody assay
19025	mutants
19026	pseudotyped virus
19027	variants
19028	Chinese
19029	drug resistance
19030	viral escape
19031	IgA antibodies
19032	virus neutralization
19033	hemato-oncological diseases
19034	acro-ischemia
19035	pernio-like lesions
19036	seroconversion
19037	diagnostic value
19038	functional antibody
19039	Anti-GD1b
19040	The second trimester
19041	Cyclophosphamide
19042	antistress proteins
19043	cell stress
19044	crossreactive antibodies
19045	molecular chaperones
19046	laboratory automation
19047	micro-array
19048	T cell immune response
19049	acute infection
19050	dendritic cell
19051	Neonatal intensive care unit
19052	Neonatology
19053	Newborn infant
19054	Preterm infant
19055	Very low birth weight infant
19056	FDA-EUA
19057	Point-of-care
19058	Contact persons
19059	SARS-CoV-2-IgG
19060	ct values
19061	GI endoscopy
19062	immunoglobulin G
19063	chemiluminescent tests
19064	enzyme-linked ELISA
19065	immunochromatographic tests
19066	Immunochemistry
19067	breastmilk
19068	maternal woman
19069	clinical performances
19070	GICA
19071	IgM antibody
19072	delayed
19073	Covid-19 diagnosis laboratory test
19074	maglum
19075	Immunoglobulin G
19076	Immunoglobulin M
19077	ICU patient
19078	spectrum
19079	Sensitivity and specificity
19080	Serum amyloid a
19081	Antikörper
19082	Negative predictive value
19083	Negativer prädiktiver Wert
19084	Positive predictive value
19085	Positiver prädiktiver Wert
19086	Pre-test probability
19087	Vortestwahrscheinlichkeit
19088	Anticardiolipin
19089	Coronarvirus
19090	Peripheral arterial disease
19091	Warp Speed
19092	lateral flow assay
19093	external quality assessment scheme
19094	proficiency testing
19095	ring trial
19096	immunosuppressant-fusion proteins and monoclonal antibodies: belatacept
19097	Cells
19098	Infectious disease immunology
19099	Nucleic acids
19100	False-positive
19101	Metrics
19102	BALT
19103	MVA
19104	Maternal breastfeeding
19105	Scoping review
19106	Anti-SARS-CoV-2 antibody
19107	Real-time reverse transcription PCR
19108	biological technology
19109	Immune complex disease
19110	Type III hypersensitivity
19111	immunoserology
19112	cleaning personnel
19113	cleaning staff
19114	hospital hygiene
19115	immunochromatographic test
19116	Luminex
19117	serum antibody of SARS-CoV-2
19118	antiphospholipid
19119	lupus anticoagulant
19120	Hypertensive encephalopathy
19121	Posterior reversible encephalopathy syndrome
19122	Reversible posterior leukoencephalopathy syndrome
19123	nucleic acid tests
19124	Autologous stem cell transplantation (ASCT)
19125	Lymphoma
19126	Antibody dynamics
19127	smoldering multiple myeloma
19128	molecular interaction assay
19129	protective antibodies
19130	Hemostasis
19131	Spike protein S
19132	Emerging diseases
19133	COVID-19 patient
19134	Non-specific Test
19135	glycan
19136	Immunity Certificates
19137	Law
19138	Low molecular weight heparin
19139	qualitative rapid chromatographic immunoassays
19140	Tissue factor
19141	nebulized triamcinolone
19142	Cladribine
19143	Mycoplasma IgM
19144	border quarantine
19145	antibodies to SARS-CoV-2
19146	Mandatory quarantine
19147	Traffic ban
19148	Cross-Sectional Study
19149	False-positive Rate
19150	SARSCov-2
19151	Seroprevalence and Specificity
19152	Detection ratio
19153	blood group serology
19154	MSc secretome
19155	Novel strategy
19156	Bio-threat
19157	Electrochemical
19158	Medical diagnostics
19159	Pathogen quantification
19160	Water safety
19161	deaths
19162	West Africa
19163	Zero tolerance
19164	complacency
19165	government
19166	pyroptosis
19167	environmental phagocyte
19168	model organism.
19169	Sars-CoV
19170	Coagulase
19171	Fibrinogen
19172	Anti–SARS-CoV-2 immunity
19173	COVID-19 pathogenesis
19174	viral immune evasion
19175	gut virome
19176	steatosis
19177	systemic low-level inflammation
19178	Long-term viral shedding
19179	Novel coronavirus (SARS-CoV-2)
19180	cannabinoid receptor type 2
19181	endocannabinoids system
19182	molecular target
19183	Citrus sinensis
19184	citrus fruits
19185	hesperidin
19186	sweet orange
19187	virus and oxidative stress
19188	Macaques
19189	Food hygiene
19190	Foodborne viruses
19191	Nanotechnology
19192	Mouse hepatitis virus
19193	Sistema nervioso central
19194	Síntomas neurológicos
19195	Virus murino de la hepatitis
19196	229E
19197	HKU1
19198	NL63
19199	OC43
19200	Neurocovid
19201	Psychosocial support
19202	Guillain–Barré
19203	neuromuscular diseases
19204	syndrome
19205	MDMs
19206	dendritic cells
19207	moDCs
19208	CNS in COVID-19
19209	Neurological signs and symptoms in COVID-19
19210	immune privilege
19211	re-detectable positive
19212	IEDB
19213	Vaxigen
19214	vaccine design
19215	Additive manufacturing
19216	Isothermal amplification
19217	Viral detection
19218	HPA axis
19219	Innate immune system
19220	Bisphosphonates
19221	Glycoproteins
19222	lymphocyte subsets and cytokines
19223	third-trimester
19224	Bronchial epithelial cells
19225	Gene ontology
19226	Immunological regulations
19227	Reactome pathways
19228	Signaling pathways
19229	Transcriptomics
19230	Covid-19 lethality
19231	Main text
19232	hypothalamic−pituitary−adrenal axis
19233	nucleus tractus solitarius
19234	olfactory sensory neurons
19235	Viral clearance kinetics
19236	Potential cardiotoxicity
19237	Astrocytes
19238	Diabetic complications
19239	Hyperglycaemia
19240	exposome
19241	oxidative phosphorylation
19242	viral culture
19243	vascular endothelium
19244	venous thromboembolism (VTE)
19245	male hypogonadism
19246	lipoprotein a
19247	livedoid vasculitis
19248	transcriptome profiling
19249	Neurologic disease
19250	cerebrovascular injury
19251	hypoxic injury
19252	immune-mediated injury
19253	immunothrombosis
19254	Adenosine
19255	Cerebral toxoplasmosis, Zika, SARS-CoV-2
19256	Neuroinfections
19257	P2 receptor
19258	Vitamin D deficiency
19259	carbon nanoparticles
19260	cathelicidin/LL37
19261	citrullination of peptide
19262	tobacco smoke
19263	phototherapy
19264	surface chemistry
19265	Forensic autopsy
19266	Laboratory Staffs
19267	Pathologists
19268	T cell reduction
19269	cytokine strom
19270	GLP
19271	Standardization
19272	T cell memory
19273	T cell response
19274	antiemetic prophylaxis
19275	Complementary therapies
19276	Evidence map
19277	Integrative medicine
19278	similarities
19279	hemolysis
19280	WBC
19281	aspartate aminotransferase
19282	Pathologic processes
19283	Punctures
19284	Sitagliptin
19285	neurogenic stress cardiomyopathy
19286	thromboinflammation
19287	caesarean section
19288	Blood tests
19289	cytotoxic T lymphocyte
19290	natural killer
19291	perforinopathies
19292	Glymphatic system
19293	Lymphatic drainage
19294	Lymphocytic endothelitis
19295	Saccharomyces
19296	co-infections
19297	fungaemia
19298	Diagnostic value
19299	Laboratory index
19300	Inhaled corticosteroid
19301	Oral corticosteroid
19302	ERVE Nairovirus vOTU
19303	LFA-1
19304	SARS-CoV-2/COVID-19 PL(pro)
19305	foot and mouth disease virus Lb(pro)
19306	influenza B NS1
19307	interferon-α/β
19308	interferon-γ
19309	acute hepatic injury
19310	acute neurologic syndrome
19311	central neurogenic respiratory failure
19312	severe acute respiratory syndrome coronavirus 1
19313	Gliptins
19314	Loneliness
19315	immune-mediated neurological syndromes
19316	interleukin-6 (IL-6)
19317	Immuno-inflammatory
19318	Acute phase protein (APP)
19319	Lactate dehydrogenase (LDH)
19320	Serum amyloid A (SAA)
19321	White blood cells (WBC)
19322	COVID toes
19323	macular erythema
19324	retiform purpura
19325	urticarial
19326	vesicular
19327	air-liquid interface
19328	conditional reprogramming
19329	functional models
19330	normal cells
19331	physiological conditions
19332	electron
19333	microscopy
19334	Contraction
19335	Cytotoxic T cell
19336	Granzyme B
19337	Granzyme
19338	CD4+T
19339	CD4/CD8 ratio
19340	CD8+T
19341	T-cell subset
19342	flow cytometry
19343	immunophenotyping
19344	circulating plasma cells
19345	high fluorescent lymphocytes
19346	CD4 lymphocyte
19347	CD8 lymphocyte
19348	Serum cytokines
19349	bone marrow morph
19350	eosinopenia
19351	lymphocyte count
19352	neutrophil count
19353	NLR
19354	travel medicine
19355	neutrophil/lymphocyte ratio
19356	warning signal
19357	favourable
19358	limphocytosis
19359	Immune suppression
19360	mHLA-DR
19361	bovine respiratory coronavirus
19362	porcine respiratory coronavirus
19363	simultaneous heart-kidney transplant
19364	Citoquinas
19365	Inmunomoduladores
19366	Clinical protocols
19367	Enfermedad renal
19368	Hemodialysis, Kidney transplantation
19369	Kidney diseases
19370	Protocolos clínicos
19371	Acetyl-cholin receptor
19372	PCR testing
19373	SARSCo-V-2
19374	Lung transplantation
19375	enterocolitis
19376	neutropenic enterocolitis
19377	superficial fungal infections
19378	Modifiable risk factors
19379	end-stage liver disease
19380	Bioactive peptide
19381	Cell-penetrating peptide
19382	dental safety
19383	oral rinse
19384	povidone-iodine
19385	cytokine action
19386	interferon-alpha/beta
19387	interferon-lambda
19388	antiviral efficacy
19389	contact transmission
19390	deep-UV LED
19391	fomite infection
19392	natural-product-inspired
19393	potential anti-SARSCoV-2 agents
19394	Non-human primate animal model
19395	hydrogen peroxide
19396	27-Hydroxycholesterol
19397	Oxysterols
19398	protease‐activated receptor
19399	Antivirial Drugs
19400	Modes of Action
19401	B-cell epitope
19402	T-cell epitope
19403	immune-informatics
19404	PLpro
19405	Chikungunya virus
19406	Picornaviruses
19407	Prohibitin
19408	Cepharanthine
19409	non-covalent interactions
19410	phytochemical inhibitors
19411	Endocytosis
19412	Salinomycin
19413	autodock
19414	anti-inflammatory drugs
19415	direct acting antivirals
19416	host-targeted approaches
19417	Cellulose acetate
19418	Polylactic acid
19419	Niclosamide
19420	Pandemic 2020
19421	Seaweed compounds
19422	Sulphated polysaccharides
19423	nanoclays
19424	silica nanoparticles
19425	Aspergillus versicolor
19426	ECD calculation
19427	diketopiperazines
19428	enantiomers
19429	endophyte fungus
19430	main protease inhibitors
19431	Ayush
19432	SARS-CoV Mpro
19433	SPCI analysis
19434	ZINC database
19435	telomerase reverse transcriptase
19436	dermatologic medications
19437	cardiac MRI
19438	echocardiogram
19439	Dendritic cells
19440	antiviral plants
19441	emodin
19442	lycorine
19443	coronavirus disease 2019; severe acute respiratory syndrome-coronavirus-2
19444	characteristics analysis
19445	clinical trial registration
19446	Idasanutlin
19447	MDM2
19448	new therapeutic approach
19449	estrogen receptor
19450	selective estrogen receptor modulators
19451	Anti-viral mechanisms
19452	Emerging respiratory viruses
19453	Resveratrol
19454	CCD-RSM
19455	Soxhlet extraction
19456	composite fibers
19457	electrical properties
19458	mechanical properties
19459	water interface
19460	Immunochromatography
19461	diagnostic tool
19462	Brugada pattern
19463	myocardial ion channels
19464	Myalgia
19465	DFT
19466	GIPAW
19467	NMR crystallography
19468	solid-state NMR
19469	valinomycin
19470	thrombotic complications
19471	orf6
19472	amyloid
19473	amantadine
19474	memantine
19475	Drugs persistence
19476	DrugBank molecules
19477	QSAR Modeling
19478	Indoor
19479	SARS-CoV-2 (CoVID19)
19480	Virus airborne transmission
19481	aerosol and surface stability
19482	aerosol decay
19483	aerosol persistence
19484	relative humidity
19485	sunlight
19486	hematological diseases
19487	hemoperfusion
19488	exposure risk
19489	hospital-associated infection
19490	medical staff protection
19491	exhaled aerosols
19492	PBS
19493	refrigeration
19494	specimen stability
19495	transport media
19496	VTM
19497	PL-protease
19498	anti-HIV drugs
19499	epirubicin
19500	saquinavir
19501	vapreotida
19502	active pharmaceutical ingredients
19503	manufacturing industry
19504	medicine access
19505	pharmaceutical industry
19506	regulatory agency
19507	SGLT2i
19508	euDKA
19509	euglycaemic diabetic ketoacidosis
19510	type 1 diabetes mellitus
19511	H5N1
19512	Drug Discovery
19513	Lead Drug Design
19514	Main Protease Mpro
19515	Protein Solvation
19516	Rational Modification
19517	Solvation Thermodynamics
19518	lymphopénie
19519	CoV-2019
19520	crocin
19521	digitoxigenin
19522	natural herbal
19523	β-eudesmol
19524	Mers-CoV
19525	DMARD
19526	common hits approach
19527	docking consensus approach
19528	IL-6 trans-signaling
19529	SGP130Fc
19530	Hospital-acquired infection
19531	Toxic epidermal necrolysis
19532	Azafluorene
19533	Antifungal drugs
19534	Azoles
19535	Mucorales
19536	Nebulization
19537	Polyenes
19538	Inanimate surface
19539	field disinfection
19540	practical experience
19541	scientific disinfection
19542	NAATs
19543	anti-hypertensive medication
19544	compassionate
19545	off-label
19546	Biologic drugs
19547	Korea centers for disease control and prevention (KCDC) classification
19548	angiotensin II receptor blockers (ARB)
19549	disease prevention during dental care
19550	﻿aerosol
19551	﻿ventilation
19552	Glucocorticoid
19553	C-reactive protein, [CRP]
19554	Coronavirus Disease 2019, [COVID-19]
19555	Length of stay, [LOS]
19556	abnormal liver chemistries
19557	alanine aminotransferase, [ALT]
19558	aminotransaminase
19559	angiotensin receptor blocker, [ARB]
19560	angiotensin-converting enzyme 2, [ACE-2]
19561	angiotensin-converting enzyme inhibitor, [ACEI]
19562	aspartate aminotransferase, [AST]
19563	body mass index, [BMI]
19564	chronic obstructive pulmonary disease, [COPD]
19565	coronary artery disease, [CAD]
19566	creatine phosphokinase, [CPK]
19567	gastrointestinal, [GI]
19568	international normalized ratio, [INR]
19569	interquartile range, [IQR]
19570	lactate dehydrogenase, [LDH]
19571	nonsteroidal anti-inflammatory drugs, [NSAIDs]
19572	severe acute respiratory syndrome corona virus-2, [SARS-CoV-2]
19573	white blood cell count, [WBC]
19574	adulterants
19575	immunocompromise
19576	high-volume evacuator (HVE)
19577	suction
19578	Colon
19579	Fecal
19580	Viral pneumonia 
19581	Efavirenz
19582	NNRTI
19583	Pharmaceutical chemistry
19584	Theoretical chemistry
19585	Infection prevention of influenza virus
19586	Wearing masks
19587	disease tracking and monitoring
19588	emerging space-time pattern
19589	infectious disease surveillance
19590	emergency use authorization
19591	expanded access
19592	expedited drug development
19593	Intensive Care
19594	Rational Use
19595	Depletive drugs
19596	Immunomodulating
19597	Myelin
19598	Sclerosis
19599	cloth masks
19600	pharmacology and pharmacogenomics
19601	epitope-based vaccine
19602	oral vaccines
19603	Angiotensin Ⅱ receptor antagonist
19604	Post-coronavirus Stress Syndrome - PCSS
19605	WHO Guidelines
19606	antithrombotic
19607	mesenchymal stromal cells
19608	DAD, Diffuse Alveolar Damage
19609	MERS, Middle-East Respiratory Syndrome
19610	PCR, Polymerase Chain Reaction
19611	SARS, Severe Acute Respiratory Syndrome
19612	paediatrics (drugs and medicines)
19613	acute pain
19614	analgesia
19615	pain management
19616	verification
19617	adenovirus
19618	clinical diagnostics
19619	pathology and laboratory medicine
19620	digital contact tracing
19621	long term care
19622	Biocidal agents
19623	Chemical inactivation
19624	Inanimate surfaces
19625	Persistence
19626	Food and Drug Administration
19627	M protein
19628	serologic test
19629	viral genes
19630	Sensing
19631	preclinical pharmacokinetics
19632	COVI-19
19633	Phase I (drug development)
19634	ISG5
19635	severe acute respiratory syndrome 2
19636	Cobas
19637	VIASURE
19638	Haritaki
19639	tea
19640	Crude specimen
19641	Direct RT-qPCR
19642	No RNA extraction
19643	Respiratory materials
19644	ACE-2 ectodomain
19645	Opsonin
19646	Phagocytosis
19647	alveolo-capillary barrier
19648	lung edema
19649	atypical hemolytic-uremic syndrome
19650	thrombotic microangiopathies
19651	heat inhibition
19652	temperature sensitivity
19653	weather-dependent virulence
19654	Chinese herbals
19655	Endothelial pathogenicity
19656	Ion channel inhibitors
19657	Polybasic cleavage site
19658	Laboratory Diagnostics
19659	Molecular Testing
19660	Real-Time PCR
19661	concentrations
19662	deficiency
19663	Concentration protocol
19664	Influent water
19665	Reclaimed water
19666	Micro-thrombosis
19667	Morphology
19668	Birmingham
19669	VIASURE qRT-PCR
19670	West Midlands
19671	Molecular point of care test
19672	Intensive care unit admissions
19673	Interrupted time-series
19674	   SARS-CoV-2  
19675	  SARS 
19676	  adrenocorticotrophic axis  
19677	  prolactin  
19678	  transmission  
19679	 detection  
19680	 liver injury
19681	 pneumonia
19682	Communicable diseases, emerging
19683	SARS-CoV-2 outbreak
19684	international risk areas
19685	testing strategy
19686	endarterectomy
19687	Prejudice
19688	Xenophobia
19689	Ecological niche modelling
19690	Maximum entropy
19691	Federation of Orthopaedic and Trauma Trainees in Europe
19692	Orthopaedic training
19693	access to services
19694	Reproductive tissue
19695	Medical staff protection
19696	Air quality
19697	Particulate matter (PM2.5 and PM10)
19698	seasonal influenza vaccination
19699	vaccination-associated virus interference
19700	liver recipient
19701	pediatric transplantation
19702	post-transplant management
19703	young and adolescents
19704	the American continents
19705	COronaVIrus disease 19
19706	Swabs
19707	Symptomatic/paucisymptomaticpatients
19708	forecasting
19709	marine predators algorithm (MPA)
19710	department organization
19711	sub-intensive respiratory unit
19712	control strategy
19713	travel history
19714	Selenium
19715	redox status
19716	classroom
19717	teacher
19718	Continuity of operations plan
19719	Medical face masks
19720	Non-medical face masks
19721	Novel coronavirus SARS-CoV-2
19722	Optical particle counter
19723	TNT
19724	Carbon footprint
19725	Energy
19726	Greenhouse gas (GHG)
19727	Sars-Cov-2 virus
19728	Almaty
19729	Point-of-care diagnostics
19730	Suicidio
19731	Trastornos psicóticos
19732	Rapid testing
19733	Air monitoring
19734	CoViD
19735	Co-ordination
19736	Nitrogen dioxide (NO(2))
19737	Rhythm
19738	Macroplastic
19739	Single-use-plastics
19740	Adriatic Sea
19741	Marine environment
19742	Maritime traffic
19743	Weight
19744	Bioplastics
19745	Environmental sustainability
19746	Plastic pollution
19747	Plastic waste
19748	abnormal liver tests
19749	in-hospital aggravation
19750	Facilitations
19751	Rule out
19752	Malta
19753	Coronavirus 2019 (COVID-19)
19754	psychological well-being
19755	isavuconazole
19756	Mayotte; coinfection
19757	Western Europe
19758	pandemic; dengue fever
19759	tropical diseases
19760	COVID + zone
19761	coronavirus obstetrics
19762	delivery and COVID
19763	tips in COVID
19764	Fragile States Index
19765	outbreak resurgence
19766	policy changes
19767	adaptive immune cells
19768	dilated cardiomyopathy viral myocarditis
19769	innate immune cells
19770	Bayesian (SIR)
19771	Kalman filter
19772	Anhedonia
19773	Postpartum period
19774	Purple air
19775	IBEX
19776	Short-term forecast
19777	SutteARIMA
19778	NO(2) emissions
19779	Continuous professional development
19780	international occupational health
19781	Covid-19 new daily cases
19782	Precipitation
19783	anger
19784	paranoia
19785	violence
19786	kidney transplantation: living donor
19787	Norway
19788	Gastrointestinal cancer
19789	ovarian diseases
19790	sample size
19791	oncology staff
19792	Crazy-paving
19793	Enlarged pulmonary vessels
19794	Ground glass opacities
19795	BD Max platform
19796	co-detection
19797	Nasopharyngeal Swab
19798	Oropharyngeal Swab
19799	Luminex NxTAG
19800	Multicentre evaluation
19801	RT-RAA
19802	CPCB-AQI
19803	Gujarat
19804	Isolation Ward
19805	SARS-CoV-2 incidence rate
19806	Burning incense
19807	Hot climate
19808	Indoor environments
19809	Middle Eastern countries
19810	Conjunctival swab
19811	Ocularsurface
19812	Reverse-transcriptase-polymerase-chain-reaction
19813	Transmission route
19814	RT-PCR testing
19815	local infection/replication/spread
19816	sewerage
19817	psychobehavioural
19818	          Legionella pneumophila        
19819	Legionnaires’ disease
19820	SARA-CoV-2
19821	the basic reproduction number (R0)
19822	PTB
19823	ascending infection
19824	pregnancy outcomes
19825	spontaneous PTB
19826	spontaneous abortion
19827	spontaneous preterm birth
19828	Abdominal Pain, Gastrointestinal Symptom
19829	Clinical impact
19830	corona virus diseases-19 (COVID-19)
19831	Himawari-8
19832	smokeless tobacco
19833	Epidemic modeling
19834	Generalized logistic model
19835	Richards model
19836	case fatality rate (CFR)
19837	self-protection for health care workers
19838	suggest
19839	the new coronavirus
19840	Kampo
19841	facial nerve palsy
19842	multiple peripheral neuropathies
19843	olfactory disturbance
19844	global health emergency
19845	severity of illness index
19846	Inflammatory markers
19847	Female sexual function index (FSFI)
19848	Sexual behavior
19849	Lactate dehydrogenase
19850	Disability-adjusted Life Years
19851	Years Lived with Disability
19852	real-time reverse transcription-polymerase chain reaction (RT-PCR) assay
19853	the novel corona virus (SARS-CoV-2)
19854	Drive-through
19855	forensic pathology; autopsy; SARS-CoV-2; corona virus disease 2019 （COVID-19）; guide
19856	cardiac arrest
19857	Maternal-fetal interface
19858	COVID-19 hazard
19859	airborne infection isolation rooms
19860	health care–associated infections
19861	negative pressure
19862	Evidence gap map
19863	medical care
19864	community outbreaks
19865	epidemic preparedness
19866	Learning habits
19867	Occupational Aspiration
19868	Secondary school
19869	Numerical simulation
19870	Testing capacity
19871	adherence
19872	government perception
19873	COVID-19, provincial updates
19874	Heavy metal
19875	Lockdown, Tuticorin, India
19876	Organic pollutant
19877	Medical waste
19878	indirect infection
19879	management principles
19880	Yangtze River Delta
19881	Industrial emissions
19882	Traffic emissions
19883	Partial and Multiple Wavelet Coherence
19884	RMB exchange rate
19885	China's megacities
19886	Early forecasting
19887	Ecological niche model
19888	Risk zones
19889	Corona19
19890	incivility
19891	social grooming
19892	endothelial cell adhesion molecules
19893	fractalkine
19894	Neurosurgery service
19895	Concentration of particulate matter
19896	Environmental components
19897	Noise pollution
19898	River water quality
19899	Surface temperature
19900	Change of air quality
19901	Megacity Delhi
19902	National Air quality Index
19903	Epidemiological history
19904	Air pollutant index
19905	Fine particulate matter
19906	Movement control order
19907	NO(2) emission
19908	AERMOD
19909	Population size
19910	ROC
19911	community health services
19912	factor analysis
19913	postmodern education theories
19914	disaster relief fund
19915	pride
19916	sense of belonging
19917	Ischemia
19918	Pleural effusion
19919	COVID -19; health care professionals; knowledge.
19920	spread and decay durations
19921	“dandelion sign”
19922	“feather sign”
19923	“pomegranate sign”
19924	“rime sign”
19925	hypochondriasis
19926	intention of continuous participation
19927	type of sports activity
19928	Lebanon
19929	use
19930	collective quarantine for medical observation
19931	Epidemic peak
19932	Psychiatric screening
19933	presymptomatic carriers
19934	dental professionals
19935	COVID-19 pneumonia; chest X-ray; CT scan.
19936	Pre-symptomatic
19937	academic year
19938	fear of COVID-19
19939	lifestyles
19940	psychological health
19941	health technology assessment
19942	priority setting
19943	perioperative clinical characteristics
19944	Multidisciplinary
19945	Psychosocial Support
19946	PCR tests
19947	narrative information
19948	Corona virus-related conjunctivitis
19949	Lipid
19950	Odds ratio
19951	clinical neurology
19952	Asymptomatic and pre-symptomatic cases
19953	Infectiousness
19954	CT findings
19955	bed and breakfast (B&B)
19956	importance–performance analysis (IPA)
19957	tourism resumption
19958	tourist satisfaction
19959	Preventive medicine
19960	System construction
19961	Ground-glass
19962	Solitary pulmonary nodule
19963	Relative transmissibility
19964	immnopathology
19965	knowledge-attitude-behavior (KAB)
19966	risk aversion attitude
19967	risk knowledge
19968	rural tourism
19969	tourism risk perception
19970	Likelihood ratio
19971	rheumatoid factor
19972	High-resolution computed tomography
19973	Pure ground-glass opacity
19974	Arabic people
19975	Information storage and retrieval
19976	Intelligence
19977	Air travel data
19978	Ascertainment rate
19979	Retrospective cohort
19980	dental clinic
19981	nosocomial infection control
19982	Evolvement
19983	The chest
19984	Fiscal value of human lives
19985	Non-health gross domestic product
19986	Program evaluation
19987	Outside Hubei
19988	Disease control and prevention
19989	Modernization
19990	nursing interns
19991	Antiscience
19992	china
19993	college
19994	Thyroid
19995	EIA
19996	lateral flow diagnostics
19997	real-time reverse transcription PCR
19998	coronavirus disease 19 (COVID-19)
19999	high throughput
20000	platform
20001	reverse transcription-PCR (RT-PCR)
20002	silent transmission
20003	High-throughput assay
20004	Nonhuman primate
20005	Xpert
20006	BAL
20007	Specimen type
20008	Disability disparities
20009	Healthcare disparities
20010	Non-institutionalized disabled population
20011	Population-based analysis Ecological study.
20012	Racial disparity
20013	Socioeconomic factors
20014	turnaround time
20015	transmission rates
20016	CLIA ‘88
20017	Proficiency testing
20018	in vitro diagnostic
20019	nucleic acid amplification
20020	LDT
20021	Multiplex
20022	Triplex
20023	Cu2O
20024	coating
20025	cuprous oxide
20026	SARS−COV-2
20027	facility
20028	skilled nursing
20029	skilled nursing facility
20030	Louisiana
20031	New Orleans
20032	convalescence
20033	seroepidemiologic studies
20034	San Francisco Bay area
20035	encephalomyelitis
20036	SARS-CoV-2 infection (COVID-19)
20037	acute respiratory illness
20038	Prediction tool
20039	HB pathway
20040	IRF5
20041	2019-novel coronavirus (2019-nCoV)
20042	novel coronavirus disease (COVID-19)
20043	universal screening
20044	coronavirus diseases
20045	Microglial nodules
20046	Neuronophagia
20047	n-CoV
20048	Meningoencephalitis
20049	In Situ Hybridization
20050	Placental Pathology
20051	Pregnancy Trimester
20052	Third
20053	Glandular Cells
20054	Transmission of Infection
20055	Basic science
20056	breast feeding
20057	Abbott ID Now
20058	nasopharyngeal and nasal swabs
20059	Pulmonary pathology
20060	androgen receptor antagonist
20061	spironolactone
20062	daylight
20063	First responders
20064	COVID-2019 epidemic
20065	Guillain-Barré Syndrome
20066	acute myocardial infarction/STEMI
20067	angiography, coronary
20068	epileptiform discharges
20069	seizures
20070	Prion disease
20071	stillbirth
20072	Loss of Appetite
20073	covid-19 in neonates
20074	transmission in neonatal covid-19
20075	lateral flow immunoassay (LFIA)
20076	point-of-care (POC)
20077	real-time reverse transcriptase polymerase chain (RT-PCR)
20078	Extrapulmonary manifestation
20079	Gastrointestinal complications
20080	Pericardial effusion
20081	Renal dysfunction
20082	Akinetic mutism
20083	Elevated creatinine kinase
20084	Rhabdomyolysis
20085	ID NOW
20086	Point-of-Care
20087	Flatten the curve
20088	cycle threshold values
20089	SCD
20090	asthma & early wheeze
20091	antimicrobial
20092	biocide
20093	mitigation
20094	biopreparedness
20095	AOD, aerosol optical depth
20096	AQI, air quality index
20097	CO, carbon monoxide
20098	CO2, carbon dioxide
20099	EPA, Environmental Protection Agency
20100	ER, excess risk
20101	ESA, European Space Agency
20102	Emission switch-off
20103	GEV, generalized extreme value
20104	GoI, Government of India
20105	HB, health burden
20106	Health and economic impacts
20107	MODIS, moderate resolution imaging spectroradiometer
20108	MSL, mean sea level
20109	NASA, National Aeronautics and Space Administration
20110	NH3, ammonia
20111	NO2, nitrogen dioxide
20112	O3, ozone
20113	PDF, probability density function
20114	PM, particulate matter
20115	PM10, PM with aerodynamic diameter of ≤ 10 μm
20116	PM2.5 concentration
20117	PM2.5, PM with aerodynamic diameter of ≤ 2.5 μm
20118	RH, relative humidity
20119	RR, relative risk
20120	SO2, sulphur dioxide
20121	SSEC, Space Science and Engineering Centre
20122	TROPOMI, TROPOspheric monitoring instrument
20123	UK, United Kingdom
20124	USD, United States Dollar
20125	VSL, value of statistical life
20126	Decidual arteriopathy
20127	Intervillous thrombi
20128	Maternal vascular malperfusion
20129	Maternal vascular underperfusion
20130	Perinatal outcomes
20131	ACR, American College of Radiology
20132	COVNet, COVID-19 detection neural network
20133	DAD, diffuse alveolar damage
20134	GGO, ground-glass opacity
20135	SARS-CoV-1 infection, severe acute respiratory syndrome coronavirus from the 2003 outbreak
20136	SARS-CoV-2 infection, severe acute respiratory syndrome coronavirus 2
20137	SDU, step down unit
20138	rRT-PCR, real-time reverse transcriptase polymerase chain reaction
20139	intrauterine infection
20140	Cornea donation
20141	Penetrating keratoplasty
20142	Tissue donation
20143	Hispanic
20144	Latinx
20145	Hispanics/Latinos
20146	non-Hispanic Whites
20147	Atlanta
20148	meningitis/encephalitis
20149	isolation precautions
20150	intimate contact
20151	biomolecular corona
20152	magnetic levitation
20153	sensor array
20154	Arizona
20155	mobile device
20156	worker well-being
20157	Detroit
20158	Michigan
20159	antibiotics
20160	antimicrobial drug resistance
20161	bacterial infections
20162	Altitude
20163	mass surveillance
20164	population screening
20165	employee health
20166	COVID, SARS-CoV-2
20167	bitter taste receptors
20168	solitary chemosensory cells
20169	immunopathogenesis
20170	Biobank
20171	Repository
20172	Hyperosmolar hyperglycemic state
20173	Silent hypoxia
20174	Droplet Transmission
20175	Respiratory Protection
20176	Adult infections
20177	crowdsource
20178	post code map
20179	congenital, hereditary, and neonatal diseases and abnormalities
20180	infectious disease transmission, vertical
20181	Big Data Analytics
20182	Unsupervised Machine Learning
20183	Health sciences
20184	Pre-hospital care
20185	pediatric transplant
20186	return to school
20187	school reopening
20188	Circadian delay
20189	Recall bias
20190	Adverse event following immunization (AEFI)
20191	Adverse event of special interest (AESI)
20192	Global Vaccine Safety Blueprint
20193	multisystem inflammatory syndrome in children
20194	pulseless electrical activity
20195	torsades de pointes
20196	CAD, coronary artery disease
20197	COPD, chronic obstructive pulmonary diseases
20198	CRP, c-reactive protein
20199	DM, diabetes
20200	HTN, hypertension
20201	NT-proBNP, NT-pro brain natriuretic peptide
20202	OR, odds ratio
20203	SMD, standard mean difference
20204	education technology
20205	Dynamic Model
20206	Mathematical Model
20207	Projection
20208	Statistical Model
20209	transportation
20210	Marginalized Communities
20211	Racial Disparities
20212	emergency ultrasound
20213	point of care ultrasound
20214	thoracic ultrasound
20215	RT‐PCR
20216	unextracted
20217	Decline
20218	Systemic inflammation
20219	ataxia
20220	cerebellum
20221	Indoor air pollution
20222	: Public Health Informatics
20223	Health Education
20224	Population Health
20225	crops
20226	plant made SARS-CoV-2 antigens
20227	plant made pharmaceuticals
20228	ASO, antistreptolysin O
20229	BNP, brain-natriuretic peptide
20230	CBC, complete blood count
20231	CDC, Center for Disease Control
20232	COVID-19, severe viral respiratory infection caused by SARS-CoV-2
20233	CSS, cytokine storm syndrome
20234	GI, gastrointestinal
20235	IVIG, intravenous immunoglobulin
20236	KD, Kawasaki disease
20237	LFTs, liver function tests
20238	MAS, macrophage activation syndrome
20239	MIS-C, Multisystem Inflammatory Syndrome in Children
20240	PCAID, Pediatric COVID-19 Associated Inflammatory Disorder
20241	PMIS, Pediatric Multisystem Inflammatory Syndrome
20242	PT, prothrombin Time
20243	PTT, partial Thromboplastin Time
20244	TNF, tumor necrosis factor
20245	VA, veno-arterial
20246	VTE, venous thromboembolic events
20247	indirect influence
20248	transmission
20249	Airborne transmission
20250	Coronavirus Disease
20251	Governing board
20252	Licensure
20253	Social control
20254	Black Race
20255	Environmental temperature
20256	Best practice
20257	Open access
20258	Scientific collaborations
20259	Publications
20260	Age identity
20261	Multilevel Modeling
20262	Acute respiratory syndrome associated with COVID-19
20263	Transesophageal echocardiography
20264	ppe
20265	stop transmission
20266	moral reasoning
20267	novel coronavirus pandemic
20268	reasonable person standard
20269	ENDS
20270	Electronic Cigarettes
20271	VALI
20272	appraisal
20273	perioperative management
20274	obstetric anaesthesia
20275	management reasoning
20276	Convection
20277	Cooling centers
20278	Evaporation
20279	Fan-use
20280	Heat balance
20281	computer systems
20282	medical informatics computing
20283	pathology, surgical
20284	Oncologists
20285	FERPA
20286	school nursing
20287	underserved care
20288	underserved populations
20289	sepsis-related cardiomyopathy
20290	stress-induced cardiomyopathy
20291	public droplet safety
20292	respiratory pandemic
20293	spray simulation model
20294	textiles
20295	High-risk patients
20296	Breathability
20297	Cloth face covering
20298	Droplet blocking
20299	Parkinson's disease (PD)
20300	interleukin-1 receptor antagonist (IL-1 ra)
20301	geovisualization
20302	medical geography
20303	multiscale model
20304	social-health determinants
20305	Dental
20306	Neuroinfectious diseases
20307	immunohaematology
20308	liver chemistries
20309	liver tests
20310	SARS-CoV-2 testing
20311	Bioaerosolization
20312	Face shield
20313	Patient transport
20314	Post-operative
20315	Low-resource ventilator
20316	Lung Injury
20317	Organizing Pneumonia
20318	Radiology-Pathology Correlation
20319	Neurological surgery
20320	Patient’s chief complaint
20321	Signs and symptoms
20322	acute grief
20323	prolonged grief disorder
20324	multitargeting
20325	Ischemic colitis
20326	focal segmental glomerulosclerosis
20327	oncology practice
20328	Visceral adipose tissue (VAT)
20329	COVID-19 morbidity
20330	Distributed lag non-linear model
20331	Time-stratified case-crossover
20332	virioplankton
20333	virome
20334	Charged phospholipids
20335	HSPA5
20336	Hsp70
20337	Liposomes
20338	Membranes
20339	viral diagnostics
20340	Kidney transplant recipients
20341	Socio-economic effects
20342	Strategies to take care
20343	Healthcare policy
20344	EVALI
20345	MCT
20346	VEA
20347	barrier dysfunction
20348	phone app
20349	Case Fatality Ratio
20350	SIR Model
20351	Survival Probability
20352	ACLS
20353	CPR
20354	Prehospital intubation
20355	Monitoring
20356	aguesia
20357	olfaction Disorders
20358	search Engine
20359	Hurricane Katrina
20360	physical health
20361	operations
20362	imaging volume
20363	modality types
20364	patient service locations
20365	indoor air
20366	eLearning
20367	coronavirus in pregnancy
20368	large health system
20369	Children’s Hospitals
20370	hospital intensive care
20371	organizational resilience
20372	staff retention
20373	worker psychological safety
20374	community outreach
20375	physician leadership
20376	public health education
20377	Long short-term memory (LSTM)
20378	Mitigation measures
20379	SARS Co-V-2
20380	chikungunya
20381	co-endemic
20382	zika
20383	COVID-19 in pregnancy
20384	critical care in pregnancy
20385	critical care obstetrics
20386	infectious disease in pregnancy
20387	management of COVID-19
20388	laboratory test
20389	Coronaphobia
20390	Death anxiety
20391	control of breathing
20392	Hypercoagulable
20393	curriculum
20394	education, medical, undergraduate
20395	medical school
20396	mental health services
20397	Surgical care
20398	Chest computed tomography
20399	Community-Partnered Participatory Research
20400	Team Science
20401	generation intervals
20402	infection network
20403	markov chain monte carlo
20404	getmeppe
20405	getusppe
20406	Health Care Rationing
20407	drug abuse
20408	biosecurity
20409	employers' responsibilities
20410	false-negative diagnoses
20411	negligence liability
20412	occupational health and safety obligations
20413	research culture
20414	scientific community
20415	scientific meetings and conferences
20416	Dietary inorganic nitrate
20417	Druggable targets
20418	Pediatric burns
20419	School-age children
20420	Ethiopia
20421	PANDEMICS
20422	Livestock
20423	Social
20424	POC
20425	nosocomial
20426	environmental influences
20427	seasonality
20428	Sperm
20429	community education
20430	lecturers
20431	western Uganda
20432	Contagion
20433	Infectious illness
20434	COVID-19 attributable deaths
20435	COVID-19 confirmed cases
20436	Spatial variation
20437	System GMM
20438	COVID-19 preparedness
20439	Public health control measures
20440	Serological
20441	Test kits
20442	biological invasions
20443	invasion science
20444	novel pathogens
20445	Infertility, male
20446	postgraduate medical education
20447	Countries of the world
20448	Gene expression programming (GEP)
20449	Time series forecasting
20450	Athletes
20451	Lockdown impact
20452	Return to sport
20453	Africa response to COVID-19
20454	COVID-19 in Uganda
20455	information on COVID-19
20456	market-vendors
20457	rural community
20458	discomfort
20459	Norms
20460	africa
20461	neuro-COVID-19 Africa
20462	aesthetic practice
20463	eye surgery
20464	medical liability
20465	ocular surgery
20466	Backward bifurcation
20467	Imperfect lockdown
20468	Sub-Saharan African
20469	Heart Rhythm Society
20470	catheter ablation
20471	defibrillators
20472	pacemakers
20473	Cape Town
20474	geographic data
20475	informal settlements
20476	low-resource setting
20477	mother
20478	neonatal resuscitation
20479	Indirect effects
20480	Low-middle income countries
20481	Phase based model
20482	adoption
20483	integration
20484	Disasters
20485	Waste Management
20486	Human milk
20487	Self-collection
20488	Airborne infection spread
20489	Infections transmission
20490	clinical microbiology
20491	Exhaled breath
20492	nasopharyngeal swabs
20493	universal transport media
20494	Holder pasteurisation
20495	pasteurised donor human milk
20496	viral inactivation
20497	Schools
20498	cybernetics
20499	gas exchange
20500	inflammatory mediators
20501	pressure difference
20502	thermostat
20503	LAMP, RPA, NEAR
20504	point of care testing
20505	gestational diabetes mellitus
20506	macrosomia
20507	Sports medicine
20508	neutralisation
20509	boarder closure
20510	immunity password
20511	outbreak response
20512	travel restrictions
20513	vaginal secretions
20514	Adult congenital heart disease
20515	Childhood heart disease
20516	Electrocardiogram
20517	Attitudes
20518	Behaviours
20519	Employer support
20520	Household surveys
20521	Longitudinal study
20522	Travel activity
20523	Working from home (WFH)
20524	control of diseases
20525	specialties, surgical
20526	salivary bioaerosols transmission
20527	salivary diagnostics
20528	Bacille Calmette-Guérin
20529	non-specific effects
20530	off-target effects
20531	COVID-19 and dermatology
20532	histopathology laboratory
20533	histotechnology
20534	vertical
20535	units
20536	vaginal delivery
20537	Aeromedical transport
20538	Helicopter emergency medical service
20539	Retrieval
20540	Allergen bans
20541	Americans with Disabilities Act
20542	Hand washing
20543	Rehabilitation Act of 1973
20544	Stock epinephrine
20545	ultrasound; PPE
20546	Community sport
20547	Elite athlete
20548	High performance sport
20549	Injury and illness prevention
20550	Sport and exercise
20551	Sport medicine
20552	Sport safety
20553	Youth athletes
20554	Background risk
20555	Research Ethics
20556	mother-infant separation
20557	Partnered charting
20558	Psychological trauma
20559	Guidelines.
20560	Pulmonary function test
20561	Spirometry
20562	Junior doctor health
20563	Junior doctor wellbeing
20564	Nosocomial spread
20565	Sick leave availability
20566	surgical specialties
20567	Evidence synthesis
20568	complexity theory
20569	crisis theory
20570	situational assessment
20571	ProctoLock2020
20572	Proctology
20573	Genetic programming
20574	attachment
20575	child neglect
20576	infant and young child feeding in emergencies
20577	infant mental health
20578	maternal caregiving capacity
20579	maternal proximity
20580	rooming-in
20581	skin-to-skin contact
20582	airborne infection spread
20583	advanced therapies
20584	global markets
20585	movement disorders
20586	general paediatrics
20587	respiration
20588	Face masks: Plastic pollution
20589	Microfibers
20590	Microplastics
20591	Single-use plastics
20592	Multi-institutional systems
20593	Detraining
20594	Elite athletes
20595	Injury prevention
20596	Injury risk
20597	nonalcoholic steatohepatitis
20598	Covidiots
20599	moralization
20600	shaming
20601	group processes
20602	health risk perception
20603	Contact tracking
20604	Symptom monitoring
20605	Web-app
20606	conspiracy
20607	psychiatric identification
20608	registered report
20609	scientific research
20610	scientific review
20611	environmental modification
20612	safe community
20613	 online tutorial
20614	 peer learning
20615	 small group learning
20616	 social constructionism
20617	 social constructivism
20618	distance learning
20619	 online lecture
20620	Gilles de la Tourette syndrome
20621	tics
20622	biofluids
20623	placental pathology
20624	postpartum complications
20625	geography
20626	temporality
20627	hyperinflammatory syndrome
20628	near-patient testing
20629	Hospitalized Patients
20630	Artificial Neural Network (ANN)
20631	Full blood count
20632	Leukocytes
20633	COVID19 and pregnancy, maternal leave policies
20634	asymptomatic COVID19
20635	Acute and chronic neurological diseases
20636	Human respiratory virus
20637	ACS
20638	coronary artery bypass
20639	B.1
20640	lineage
20641	NeuMoDx
20642	industrial hygiene
20643	gradient boosted decision tree
20644	routine laboratory tests
20645	COVID-19 diagnostics
20646	gender parity
20647	medical genetics
20648	women in science
20649	Choral performance
20650	Singing
20651	ABM
20652	EMS, emergency medical services
20653	LAD, left anterior descending artery
20654	LV, left ventricular
20655	MI, myocardial infarction
20656	PCI, percutaneous coronary intervention
20657	STEMI, ST-segment elevation myocardial infarction
20658	complication
20659	Multisystem Inflammatory Syndrome in children
20660	SARS-CoV-2 in children
20661	Distúrbios do olfato
20662	Distúrbios do paladar
20663	Distúrbios olfativos
20664	Taste disorders
20665	Cardiac conduction system
20666	Heart disease
20667	Transient AV block
20668	kidney pathology
20669	DVT
20670	cardiac troponin
20671	Endoscopy Operations
20672	Cloth mask
20673	endemic coronaviruses
20674	repeated endemic coronavirus infection
20675	waning immunity to endemic coronavirus
20676	early discharge
20677	Creatine kinase
20678	immunosuppesive
20679	stool PCR
20680	acute tubular injury
20681	air purifier
20682	high-efficiency particulate air filter
20683	ACE-2, Angiotensin converting enzyme-2
20684	AKI, Acute kidney injury
20685	CKD, Chronic kidney disease
20686	Covid-19, Coronavirus disease 2019
20687	SARS-CoV-2, Severe acute respiratory syndrome coronavirus-2
20688	MODS, multiorgan dysfunction syndrome
20689	PEA, pulseless electrical activity
20690	Arterial thrombosis
20691	hospice
20692	Middle East Respiratory Syndrome Coronavirus
20693	abdominal CT
20694	ACS, acute coronary syndrome
20695	CCL, catheterization laboratory
20696	ICD, implantable cardioverter defibrillator
20697	NSTE, non– ST-segment elevation
20698	PPCI, primary percutaneous coronary intervention
20699	ST-segment elevation myocardial infarction
20700	primary percutaneous coronary intervention
20701	biopsy
20702	BAS, balloon atrial septostomy
20703	D-transposition of the great arteries
20704	ICCU, infant cardiac care unit
20705	TGA, d-transposition of the great arteries
20706	av nodal blockers
20707	brash syndrome
20708	hyperkalemia
20709	Analytic parametrization
20710	Global COVID19 model
20711	Outbreak modelling
20712	Pandemic modelling
20713	Neurosurgery residency
20714	Residency training
20715	community and hospital pharmacists
20716	history of pharmacies and pharmacists
20717	HELLP
20718	overlapping conditions
20719	families
20720	human development
20721	psychological science
20722	stroke prevalence
20723	vascular events
20724	multi-agent simulations
20725	second wave
20726	berlin criteria
20727	AST, aspartate transaminase
20728	cyanotic heart disease
20729	tricuspid valve
20730	DKA
20731	DM
20732	sinus
20733	public health intervention
20734	resurgence
20735	physician assistants
20736	Counseling
20737	COVID-19; SARS-CoV-2; sialadenitis
20738	parotid gland
20739	parotitis
20740	submandibular gland
20741	geratrics
20742	house call
20743	3-way video conferencing
20744	barriers in patient care
20745	deaf
20746	hard of hearing
20747	sign language interpreter
20748	telecommunication relay services
20749	jewelry
20750	rings
20751	wristwatches
20752	naïve T cells
20753	intubation box
20754	vacuum filtration
20755	people living with HIV
20756	pancreas transplant
20757	open surgical tracheostomy
20758	percutaneous dilatational tracheostomy
20759	Histamine-2 Receptor Antagonists
20760	sample quality
20761	Arterial thromboembolism
20762	medical screening
20763	Outcome prediction
20764	CDT, catheter-directed thrombolysis
20765	PUI, patient under investigation
20766	RV, right ventricular
20767	RV/LV, right ventricular to left ventricular diameter ratio
20768	UFH, unfractionated heparin
20769	pulmonary circulation
20770	2D echocardiography
20771	embolism
20772	pulmonary artery
20773	right atrial thrombus
20774	“Happy hypoxemia”
20775	Caesarean delivery
20776	spinal anesthesia
20777	Classification
20778	Quantitative evaluation
20779	Mechanical Turk
20780	Siracusa Principles
20781	state obligations
20782	virtual intervention
20783	CAP, community-acquired pneumonia
20784	CRP, C-Reactive Protein
20785	CT chest
20786	SARSCoV-2, severe acute respiratory syndrome coronavirus 2
20787	Airway team
20788	European laryngological society
20789	Intubation injuries
20790	Laryngotracheal stenosis
20791	Disinfection by-products
20792	Real-time RT-RAA
20793	exposure-based risk classification
20794	nosocomial SARS-CoV-2 outbreak
20795	black swan
20796	chest
20797	Nanopore sequencing
20798	Routine RT-PCR
20799	Virus variation
20800	surface
20801	Fecal–oral transmission
20802	Mode of transmission
20803	Route of transmission
20804	PCR1100
20805	ultra-rapid real-time RT-PCR
20806	Viral Load Kinetics
20807	Open reading frame 1b
20808	Vero cell lines
20809	False-negative of pharyngeal swab
20810	False-negative results
20811	Severe progression
20812	Rapid antigen detection
20813	Viral culture
20814	vaginal fluid
20815	Realtime reverse transcription PCR
20816	LOD
20817	Household transmission
20818	Second infection rate (SIR)
20819	discharge criteria
20820	virus nucleic acid test
20821	returnees
20822	   SARS-CoV-2
20823	   digestive system  
20824	  endoscopy  
20825	suspected then confirmed SARS-CoV-2-negative pneumonia
20826	Cytopathy
20827	Liver enzyme abnormality
20828	Transaminase
20829	ARIMA model
20830	Least square support vector machine
20831	SARS-COV-2 cases
20832	Autopsy investigation
20833	Postmortem diagnosis
20834	Virological diagnosis
20835	GNRI
20836	Indoor air quality
20837	Viral air quality
20838	bocavirus
20839	parainfluenza virus
20840	respiratory syncytial virus
20841	polyradiculoneuropathy
20842	Reactivation
20843	Respiratory tract
20844	real time PCR
20845	clinical detection
20846	droplet digital PCR
20847	single-tube nested
20848	LightMix E-gene
20849	Viability
20850	Xpert Xpress SARS-CoV-2
20851	mild disease
20852	subgenomic RNA
20853	viral RNA load
20854	virus culture
20855	Computed axial tomography
20856	Viral transmission and infection
20857	HCoV-19 / SARS-CoV-2
20858	Natural Reservoir
20859	Zoonotic origins
20860	N gene
20861	ORF1a gene
20862	fluorescence real-time quantitative PCR
20863	Age-specific dynamics
20864	Occupational exposure risk
20865	DNA nanoscaffold
20866	DNA self-Assembly
20867	RNA detection
20868	deep throat saliva
20869	specimens
20870	S1
20871	SARS-CoV-2 subunit vaccine
20872	Freeze-drying
20873	Corona virus disease 19
20874	Ocular transmission
20875	dynamic changes
20876	false‐negative
20877	rRT‐PCR
20878	commercial kits
20879	Evolutionary rate
20880	Re
20881	Huanan Seafood Market
20882	Influenza patients
20883	Novel coronavirus pneumonia patients
20884	natural-like product
20885	Clinical symptoms
20886	lgM/lgG antibody detection
20887	predict
20888	score model
20889	young Italians
20890	Hepatitis B Virus
20891	Mask-wearing
20892	imaging findings
20893	Animal
20894	Reservoir
20895	Infectious strongly
20896	Rapid transmission among humans
20897	Survived
20898	The first critical case in Gansu
20899	The novel coronavirus (SARS-CoV-2)
20900	SARS-Cov-2 IgM/IgG antibody
20901	colloidal gold immunochromatography assay
20902	immunoglobulin M/immunoglobulin G
20903	rapid diagnosis
20904	blood index
20905	Body Composition
20906	Visceral Obesity
20907	peptide-protein docking
20908	Absorción viral por nervios periféricos
20909	Central respiratory control
20910	Central respiratory failure
20911	Control central de la respiración
20912	Insuficiencia respiratoria central
20913	Invasión transináptica
20914	Peripheral nerve viral uptake
20915	Trans-synaptic invasion
20916	RT-PCR assay
20917	blood donations
20918	Ultraviolet light
20919	ISO 15189
20920	intussusception
20921	microaspiration
20922	oral care
20923	oral microbiome
20924	microbial composition
20925	next generation sequencing; NGS
20926	RNAemia
20927	organ damage
20928	menstrual cycle
20929	intestinal infection rectal cancer
20930	Laboratory environment
20931	Nucleic acid residue
20932	diagnostic efficacy
20933	Dynamics profile
20934	angiotensin‐converting enzyme 2
20935	Full-term pregnant patients
20936	multidetector computed tomography
20937	dry eye
20938	Air travel
20939	Outbreak investigation
20940	Travel-associated infections
20941	Inflammatory mediators
20942	community-acquired pneumonia
20943	nucleic acid conversion
20944	fecal–oral transmission
20945	false negative SARS-CoV-2 nucleic acid
20946	mild-to-moderate COVID-19
20947	railway journey
20948	ecological niche
20949	relative synonymous codon usage
20950	rodent
20951	RGD
20952	drug screening
20953	Case-Fatality Rate
20954	Medical Supplies
20955	Antigen detection
20956	Product design
20957	SAR-Cov-2
20958	Blood
20959	Discrimination
20960	epidemic control experience
20961	rural areas
20962	3D-T1WI, 3 Dimensional T1-weighted Images
20963	AAL-3, Automated Anatomical Labelling Atlas-3
20964	ACE-2, Angiotensin Converting Enzyme-2
20965	AD, Axial Diffusivity
20966	CNS, Central Nervous System
20967	COVID-19, Coronavirus Disease
20968	CR, Corona Radiata
20969	CSF, Cerebral Spinal Fluid
20970	Central Nervous System Diseases
20971	DICOM, Digital Imaging and Communications in Medicine
20972	DTI, Diffusion Tensor Imaging
20973	Diffusion Tensor Imaging
20974	EC, External Capsule
20975	FA, Fractional Anisotropy
20976	FOV, Field of View
20977	GM, Gray Matter
20978	GMV, Gray Matter Volume
20979	HIV, Human Immunodeficiency Virus
20980	HSV, Herpes Simplex Virus
20981	JEV, Japanese Encephalitis Virus
20982	LDH, Lactate Dehydrogenase
20983	MD, Mean Diffusivity
20984	MPRAGE, Magnetization Prepared Rapid Gradient Echo
20985	Neuroimaging
20986	OB, Olfactory Bulb
20987	Prospective studies
20988	RD, Radial Diffusivity
20989	SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus-2
20990	SFF, Superior Frontal-occipital Fasciculus
20991	TBSS, Track-based Spatial Statistics
20992	TE, Echo Time
20993	TR, Repetition Time
20994	UF, Uncinate Fasciculus
20995	URTI, Upper Respiratory Tract Infection
20996	VBM, Voxel-based Morphometry
20997	WBC, White Blood Cell
20998	WM, White Matter
20999	WMV, White Matter Volume
21000	asymptomatic child
21001	Postmortem needle autopsy
21002	Dispersal
21003	antibody responses
21004	viral nucleic acid
21005	Anesthesia machines
21006	traumatic brain injury
21007	result interpretation
21008	specimen type
21009	Tropic
21010	conjunctival congestion
21011	hand-eye contact
21012	The elderly
21013	Agent-based models
21014	Multi-scale modelling
21015	elimination
21016	Susceptible-Exposed-Infectious-Removed (SEIR)
21017	healthcare worker infection
21018	nurses death from COVID-19
21019	Postmortem Inspection
21020	Standard Operating Procedure
21021	healthcare impact
21022	hospital admission
21023	operating theatre
21024	orthopaedic department
21025	seasonal influenza
21026	subsistence
21027	pulmonary tuberculosis
21028	tuberculosis and other mycobacteria
21029	mental health response
21030	psychosocial support
21031	clinical feature
21032	High-resolution CT (HRCT)
21033	extrapulmonary manifestations
21034	pediatric outpatient department
21035	prevention and control of infection
21036	Glycobiology
21037	Severe acute respiratory syndrome corona virus 2
21038	Lateral flow biosensor
21039	Multiplex reverse transcription loop-mediated isothermal amplification
21040	Rapid diagnosis
21041	Th17 cells
21042	Treg cells
21043	male gonadal function
21044	sex-related hormones
21045	Neutrophil lymphocyte ratio (NLR)
21046	combination parameter
21047	linear discriminant analysis
21048	novel coronavirus (SARS-CoV-2)
21049	receiver operating characteristic
21050	red cell volume distribution width-standard deviation (RDW-SD)
21051	maternal-infant infection
21052	severe acute respiratory syndrome-associated coronavirus
21053	Fecal‐oral transmission
21054	dandelion clock-like
21055	hematological patient
21056	immunocompromised state
21057	Carrier
21058	Charge
21059	Deposition
21060	Particulate
21061	Laboratory workers
21062	covid-19 in children
21063	sars-cov-2 in pediatric patients
21064	nasopharyngeal virus RNA load
21065	incidence risk
21066	clinical significance
21067	Adoption and benefits
21068	One health approach
21069	hiv
21070	immune deficiency
21071	remdesavir
21072	Bayesian probability
21073	Change point analysis
21074	Voronoi diagram
21075	dvt
21076	hypercoagulable
21077	prothrombotic
21078	venous thromboembolsim
21079	infection control strategy
21080	gastroenterological surgery
21081	novel coronavirus disease-2019
21082	2019 Coronavirus disease
21083	Cluster-onset families
21084	Solitary-onset families
21085	Orthopaedic surgeons
21086	Work characteristics
21087	Qualitative real-time RT-PCR
21088	Recovery efficiency
21089	urine biochemical parameters
21090	Brain–lung–brain axis
21091	transplacental transmission
21092	Smell loss
21093	Taste disorder
21094	Necessity
21095	Crossed infections
21096	Flapless procedure
21097	Rubber dam
21098	Sinus lift
21099	implant placement
21100	dizziness
21101	lymphocytopenia
21102	cross infections
21103	dental environment
21104	brain disorders
21105	coronaviral infections
21106	neurological & psychiatric symptoms
21107	neurological infection and inflammation
21108	kindergarten
21109	cns complications
21110	guillian barre syndrome
21111	SARS-CoV-2 positive pregnant women
21112	maternal-fetal outcomes
21113	COVID-19, SARS, COV-2-
21114	Household transmissionCOVID-19Novel coronavirus pneumoniaSARS-CoV-2
21115	Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
21116	Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
21117	Wuhan - China
21118	ADC, apparent diffusion coefficient
21119	CNS, central nervous system
21120	Covid-19, coronavirus
21121	DWI, diffusion weighted imaging
21122	ED, emergency department
21123	FLAIR, fluid attenuated inversion recovery
21124	GCS, Glasgow Coma Scale
21125	HRCT, high-resolution computed tomography
21126	MRI, magnetic resonance imaging
21127	SARS-Cov-2, severe acute respiratory syndrome coronavirus 2
21128	Out-patients
21129	Taste loss
21130	Biological features
21131	Illness
21132	Carcinoembryonic antigen
21133	Gastrointestinal damage
21134	Black carbon
21135	Southern China
21136	active packaging
21137	food package
21138	sanitation
21139	infant outcome
21140	maternal outcome
21141	Hip
21142	Knee
21143	Second phase
21144	Verhulst
21145	forecast
21146	Kidney injury
21147	Urine
21148	2019 novel coronavirus (SARS-CoV-2)
21149	macrophage
21150	Acute-on-chronic liver failure
21151	Chronic liver diseases
21152	18F-FDG PET/CT
21153	Consolidative opacities
21154	θ-SEIHRD model
21155	SOFA score
21156	disease progression pattern
21157	COVID-19 resurgence
21158	work resuming
21159	close contacts
21160	administrative and logistics departments
21161	psychological intervention
21162	Ontario
21163	Clinical symptoms period
21164	Convalescent period
21165	hand washing
21166	COVID-19 infected mothers
21167	newborns
21168	Qinghai model
21169	dental school
21170	dairy
21171	small ruminants
21172	Follow-up study
21173	Serum marker
21174	Epidemic curve
21175	RT-PCR detection
21176	recurrently positive
21177	Bleeding episodes
21178	Coronavirus-19 disease
21179	Pulmonary intravascular coagulopathy
21180	air passengers
21181	acute SARS-CoV-2
21182	SARS-CoV 2003 infection
21183	Smokers
21184	Squamous cell metaplasia
21185	discharge surveillance
21186	post-discharge quarantine
21187	regulatory agencies
21188	autopsy pathology
21189	Dead body management
21190	dead body disposal
21191	funeral guidelines
21192	Biomass burning
21193	COVID-19 casualties cases
21194	Discrete wavelet decomposition
21195	Hybrid model
21196	COVID-19 health impacts
21197	STD
21198	STI
21199	sexually transmitted disease
21200	sexually transmitted infection
21201	critical
21202	mother-to-child transmission
21203	Cardiac marker
21204	pregnant woman
21205	preterm delivery
21206	case‐control studies
21207	anaesthetic management
21208	neutrophil-to-lymphocyte ratio (NLR)
21209	prognostic
21210	Health care professionals
21211	Water demand
21212	therapeutic anticoagulation
21213	2019-novel Coronaviruses (2019-nCoV)
21214	Computed Tomography (CT)
21215	differentiation of pneumonia
21216	ground glass opacity (GGO)
21217	superimposed infections
21218	HDL-c
21219	LDL-c
21220	Kansas
21221	health guidelines
21222	Computed tomography (CT)
21223	chest radiography (CXR)
21224	Administration and health services
21225	Public and environmental health
21226	discharged patients
21227	Salivary glands
21228	long-term exposure
21229	Cruise
21230	Pityriasis rosea
21231	biochemical parameters
21232	blood routine parameters
21233	intracity travel intensity
21234	Coronaviruses infection
21235	Customs inspection
21236	Guangzhou
21237	Imported cases
21238	fluorescent microsphere
21239	immunochromatographic
21240	serodiagnosis
21241	flight
21242	passenger
21243	complete clinical course
21244	non-survivor
21245	Stool
21246	HLA‐G
21247	peripheral immune cells
21248	automation
21249	microfluidics
21250	sample-to-answer
21251	Concurrent infection
21252	Host responses
21253	Metatranscriptomics
21254	pulmonary CT screening
21255	laryngopharyngeal reflux disease
21256	ESR
21257	UA
21258	hs-CRP
21259	urine protein
21260	critical ill patient with COVID-19
21261	herpes simplex Ⅰ (HSV Ⅰ)
21262	reactivation of human herpesvirus alpha subfamily
21263	secondary infection
21264	varicella-zoster virus (VZV)
21265	Orphanage
21266	Retrospective review
21267	IgM/IgG antibody
21268	discharged patient with reoccurring positive nucleic acid test (RPNAT)
21269	Asymptomatic patient
21270	Cluster epidemic
21271	Community transmission
21272	PICU
21273	general anesthesia
21274	Neonatal death
21275	digestive endoscopy
21276	endoscopic retrograde cholangio-pancreatography
21277	breath
21278	sensor
21279	Aging kidney
21280	co-travel time
21281	spatial distance
21282	train
21283	Hepatic
21284	Emotional well-being
21285	Happiness
21286	Psychological well-being
21287	symptomatic
21288	Baidu index
21289	Big data
21290	female
21291	Forensic sciences
21292	guide
21293	Precautions
21294	Suggestion
21295	Oral manifestations
21296	Extubation
21297	acute ischemic stroke
21298	lacunar infarct
21299	Decontamination
21300	Filtering facepiece respirators
21301	Exposure history
21302	Tears SARS COVID-19
21303	Framing pandemic
21304	Media and coronavirus
21305	psycho-oncology
21306	Atypical CT manifestation
21307	Acute renal failure
21308	acute respiratuary distress syndrome
21309	fatty liver
21310	nitrosative stress
21311	effective reproduction number
21312	mechanistic-statistical model
21313	Generalized growth model
21314	Glucose control
21315	case-fatality rate
21316	digestive disease
21317	hospital-acquired infection
21318	nosocomial SARS-CoV-2
21319	Attitude and knowledge
21320	Medical and non-Medical students
21321	Agent-based model
21322	Close contact
21323	Infection spread
21324	Optimal control
21325	Pontryagin’s Maximum Principle
21326	Particulate matter pollution
21327	chest computed tomography (chest CT)
21328	reverse transcription-polymerase chain reaction (RT-PCR)
21329	Health care policy
21330	Hospital at Home
21331	Environmental benefits
21332	Technologies
21333	Nonoperative
21334	cesarean delivery
21335	cross-contamination
21336	isolation OR
21337	COVID-19-related fear
21338	generalized anxiety
21339	Convolution neural network
21340	Kannur
21341	H12
21342	I15
21343	O40
21344	children coronavirus disease 2019
21345	presymptomatic infection
21346	pediatric patients
21347	analysis of CT imaging findings
21348	novel coronavirus-infected pneumonia
21349	Blood coagulation
21350	Wells-Riley equation
21351	infection probability
21352	Government interventions
21353	Stock market
21354	Meta‐analysis
21355	Microbiological diagnosis
21356	BC‐6800plus
21357	neutrophil‐to‐lymphocyte ratio
21358	novel coronavirus (SARS‐Cov‐2)
21359	environmental persistence
21360	leucocyte
21361	electrolyte imbalance
21362	recovery time
21363	Positivity rate
21364	R0
21365	coronvirus disease 2019
21366	cancer biomarker
21367	carbohydrate antigens
21368	carcinoembryonic antigen
21369	cytokeratin-19 fragment
21370	epididymis protein 4
21371	Western Pacific Islands
21372	asymptomatic viral infections
21373	protect
21374	skin and mucous membrane barrier
21375	prevention; control 
21376	chest radiography
21377	death case report
21378	quarantine and COVID-19
21379	Nucleic acid testing
21380	Qualitative analysis
21381	RNA virus diagnoses
21382	portable systems
21383	bodily secretions
21384	severe cases
21385	Ultraviolet germicidal irradiation
21386	SF-36
21387	health-related quality of life
21388	influencing factors
21389	ABO blood group system
21390	Bibliometric
21391	Scopus
21392	laryngectomy stoma
21393	Western medicine
21394	core outcome set
21395	Isothermal nucleic acid amplification-based methods
21396	Microarray-based methods
21397	PCR-Based methods
21398	sedentary behavior
21399	Multi-view model
21400	Consistency
21401	Lung CT
21402	2019n-CoV
21403	lung diseases
21404	2019-Novel coronavirus pneumonia
21405	Dynamic evaluation
21406	Corona score
21407	laboratory markers
21408	Environmental impact
21409	GHGs
21410	Social distancing policies
21411	radiography
21412	hypoglycaemia
21413	Statistical analysis
21414	Visual data analysis
21415	Artificial intelligence (AI)
21416	Ground glass opacity (GGO)
21417	Device related pressure ulcer
21418	Facial injuries
21419	Protective devices
21420	adverse skin reaction, N95 respirator, medical mask, skin biophysical property
21421	Pathological conditions, anatomical
21422	structured report
21423	Nomogram
21424	Outcome improvement
21425	Drinking
21426	Parturient
21427	Carbon-fossil combustion
21428	Chemicals use
21429	Healthcare expenditures
21430	Panel GMM estimates
21431	Poverty headcount
21432	Comfort
21433	Positive detection rate
21434	Protective face screen
21435	Sitting position method
21436	Supine position method
21437	Clinical classification
21438	Quantitative CT
21439	Chemical composition
21440	Fine particle
21441	Random forest tree
21442	Regional transportation
21443	Source apportionment
21444	prospective meta-analysis
21445	lactose dehydrogenase
21446	Tomography, X-ray
21447	Psychological problem
21448	agonistic behaviour
21449	Wildlife
21450	diagnostic utility
21451	the severe COVID-19
21452	hypocalcemia
21453	organ injury
21454	parathyroid hormone
21455	decision support system
21456	dynamic risk stratification
21457	multiclass logistic regression
21458	telemedicine triage system
21459	Crazy-paving pattern
21460	CT imaging characteristics
21461	Atypical imaging features
21462	Hemoptysis
21463	fatal patients
21464	immune status
21465	prealbumin
21466	Florence Nightingale
21467	careful nursing
21468	modern nursing
21469	conjunctival
21470	secretion
21471	Presymptomatic transmission
21472	Source of infection
21473	forensic pathology; viral pneumonia; autopsy; children; cases analysis
21474	Gastrointestinal Viral Reservoir
21475	Profile of Viral Shedding
21476	Inflammatory cytokines
21477	forensic pathology; autopsy; coronavirus; corona virus disease 2019 （COVID-19）; severe acute respiratory syndrome （SARS）; Middle East respiratory syndrome （MERS）; review
21478	blood viral RNA
21479	pharyngeal swab
21480	computed tomographic findings
21481	Contingent valuation method
21482	Social cost
21483	Tourism impact
21484	Willingness to pay
21485	Endpoint values
21486	Pharyngeal swab
21487	Semen fluid
21488	biomass smoke
21489	Reemerging
21490	surfaces TCID
21491	(Loop-mediated isothermal amplification) LAMP assay
21492	(polymerase chain reaction) PCR
21493	Point-of-care detection
21494	Illicit Wildlife Trade
21495	atypical presentations
21496	Contagious
21497	Religious
21498	Winners
21499	SARS-CoV-12
21500	Psychological problems
21501	external quality assessment
21502	transmissibility
21503	Clinical onset serial interval
21504	Diagnostic serial interval
21505	drive-through screening system
21506	tertiary hospital
21507	Response Team
21508	Seoul
21509	nightclubs
21510	environmental sample
21511	occupational illness
21512	sick benefits
21513	sick leave
21514	work environment
21515	colorimetric detection
21516	reverse transcription-loop-mediated isothermal amplification
21517	Presymptomatic
21518	Viral kinetics
21519	SARS-related coronavirus
21520	specimen pooling
21521	infectious disease incubation period
21522	Coughing
21523	Penicillin
21524	Phosphates
21525	Serum albumin
21526	Streptomycin
21527	Lower respiratory tract infection
21528	Blood transfusion
21529	Viremia
21530	Hospital planning
21531	Mathematical modelling and simulation
21532	Resusceptibility
21533	SEIRS
21534	Time delay
21535	negative conversion
21536	Collaboration in different level
21537	Extensive partnership
21538	Medical information security
21539	Smart medical security
21540	Telecare security
21541	Telemedicine security
21542	convolutional neural networks, transfer learning
21543	neural network
21544	scan
21545	Device reuse
21546	Medical security
21547	Protective equipment
21548	Physiologically-based pharmacokinetic modeling
21549	free drug hypothesis
21550	in vitro-to-in vivo extrapolation
21551	pharmacokinetic-pharmacodynamic correlation
21552	Cu nanoparticles
21553	healthcare-associated infection
21554	orthomyxoviridae
21555	Post-mortem computed tomography
21556	Random forest
21557	Three-way
21558	Parenteral fish oil
21559	Resolution of inflammation
21560	Specialized pro-resolving mediators
21561	human immunology
21562	facemasks
21563	legislations
21564	respirators
21565	CVID
21566	common variable immunodeficiency
21567	intravenous immune globulin
21568	Aggregated neutrophil extracellular traps
21569	Immunothrombosis
21570	ANM
21571	GBS
21572	Post-infectious
21573	Blood bank
21574	Indian scenario
21575	Inventory management
21576	Transfusion service
21577	Felis silvestris catus
21578	cat
21579	reverse zoonosis
21580	respiratory protective device
21581	elective
21582	Operating procedure
21583	Report system
21584	Severe acute respiratory infections
21585	qRT-PCR detection
21586	test protocol
21587	Cluster - COVID-19 - India - SARS-CoV-2 - transmission - Uttar Pradesh
21588	Cardiovascular prevention
21589	Profesionales de la salud
21590	Salud laboral
21591	Infection prevention and control (IPC)
21592	aerosol transmission
21593	control banding
21594	hierarchy of controls
21595	occupational safety and health
21596	workplace exposure
21597	geriatric psychiatry
21598	Bacillus Calmette-Guérin vaccination
21599	alcohol-based hand sanitizer
21600	enterovirus
21601	scarlet fever
21602	diagnostic test sensitivity
21603	acute respiratory infection
21604	cross sectional studies
21605	saudi arabia
21606	social distance
21607	occupational health and safety
21608	CoViD-19 pandemic
21609	HVAC systems setting
21610	indoor air quality
21611	specific enthalpy of moist air
21612	ocular transmission
21613	ophthalmic precautions
21614	chronobiology
21615	chronodisruption
21616	circadian dysregulation
21617	circadian timing system
21618	natural experiment
21619	repeat
21620	airplane
21621	sewage
21622	Epidemic prevention policies
21623	Universal healthcare systems
21624	environmental exposure
21625	Human sexual behavior
21626	Sexually transmitted diseases
21627	Multi-objective genetic algorithm
21628	systemic vasculitis
21629	phlebotomy
21630	preanalytical phase
21631	ultrasonography
21632	disease determinants
21633	vertebrate hosts
21634	Acetazolamide
21635	Carbonic anhydrases
21636	Breath-test
21637	Desinfección
21638	Desinfection
21639	Digestive motility disorders
21640	EPI
21641	Manometry
21642	Manometría
21643	Pandemia COVID-19
21644	Reinicio de actividad
21645	Resumption of activity
21646	Test de aliento
21647	Trastornos de la motilidad digestiva
21648	pH-impedance
21649	pH-impedancia
21650	Spectroscopy
21651	hospital-onset infection
21652	Allergic contact dermatitis
21653	Irritant contact dermatitis
21654	Covid-19 prevention
21655	retrospective studies
21656	spreading factor
21657	urologists
21658	Mascarilla
21659	Streptococcus pneumoniae
21660	cns manifestations
21661	neurological signs and symptoms
21662	post-viral anosmia
21663	border measures
21664	Fatality Rate
21665	extended theory of planned behavior
21666	Public response
21667	healthcare protection
21668	protection management
21669	Anatomic Pathology
21670	Surgical pathology laboratory
21671	famciclovir
21672	herpes zoster
21673	immunocompetent
21674	immunocompetent adults
21675	varicella-zoster virus
21676	Scientific publications
21677	pandemia; outcome
21678	(5 max): COVID-19
21679	general practitioners
21680	occupational medicine
21681	Scientometrics
21682	perioperative surgical home
21683	rRT-PCR testing
21684	resumption of elective surgery
21685	Dental Education
21686	Dental Public Health
21687	Practice Management
21688	Night shift work
21689	FFP2/N95 Mask
21690	protection equipment
21691	perinatal outcomes
21692	prevention and mitigation
21693	emerging infections
21694	ADKAR
21695	change management
21696	nursing leadership
21697	team nursing
21698	Special consideration
21699	facemask
21700	personal protection equipment (PPE)
21701	COVID-19 emergency, Layout redesign, Pathways
21702	Endoscopy digestive unit
21703	European
21704	contact tracing app
21705	data donation app
21706	data security
21707	social trust
21708	anti-vaccine movement
21709	medicine and media
21710	heterologous
21711	japanese encephalitis vaccines
21712	travel certificate
21713	travel limitations
21714	travel requirements
21715	clathrin-coated vesicles
21716	multivesicular bodies
21717	taste disorders
21718	Natural Experiment
21719	circadian
21720	mood
21721	physical Distancing
21722	blood differential count
21723	hemato‐morphology
21724	peripheral blood smear
21725	public health system
21726	Air temperature
21727	Principal component analysis
21728	Elective orthopaedics
21729	Pretest probability
21730	outbreak investigation
21731	Abdominal surgery
21732	Aquatic environment
21733	Mesocricetus auratus
21734	age-related disease
21735	cellular tropism
21736	in situ hybridization
21737	evolutionary biology
21738	direct and indirect impact
21739	congenital infection
21740	Interficie web
21741	Poisson regression
21742	Regresión de Poisson
21743	Visualización de datos
21744	Web browser
21745	adrenal disorders
21746	general diabetes
21747	general endocrinology
21748	latitude
21749	ECG, electrocardiogram
21750	dilated cardiomyopathy
21751	hs-troponin I, high-sensitivity troponin I
21752	Climate indicators
21753	Economic conditions
21754	Latin America and the Caribbean
21755	Pollution indicators
21756	Mechanisms of myocardial injury
21757	predictive factors
21758	Determinantes sociales de la salud
21759	Síndrome respiratorio agudo grave por coronavirus 2
21760	Dependencia funcional
21761	Functional impairment
21762	Personas mayores
21763	Atypical CT appearance
21764	Municipalities
21765	Andrological care
21766	Assisted reproductive technologies
21767	Male
21768	Testosterone
21769	Healthcare Disparities
21770	Race/Ethnicity
21771	AF, atrial fibrillation
21772	DCCV, direct current cardioversion
21773	PMVT, polymorphic ventricular tachycardia
21774	cardioversion
21775	electrocardiogram
21776	preserved ejection fraction
21777	computerised tomography
21778	Multi-compartmental hemorrhage
21779	Subdural hematoma
21780	Liver transplant recipients
21781	Severe respiratory disease
21782	palpitations
21783	MMR Vaccine
21784	pulmonary vascular diseases
21785	vascular remodeling
21786	Headache
21787	Health burden
21788	senile amyloidosis
21789	living-donor kidney transplantation
21790	Trained immunity
21791	SARS-Cov-2 infection and liver biopsy
21792	liver histopathology
21793	liver morphology in COVID 19 disease
21794	Neuromyelitis Optica Spectrum Disorder (NMOSD)
21795	Candida auris
21796	Candida parasilopsis
21797	Candida
21798	eschar
21799	Survival probability
21800	better outcomes
21801	cell-mediated immunity
21802	complications’
21803	covid-19 in pregnancy
21804	human pathophysiology
21805	Excess mortality
21806	indicators
21807	indices
21808	.
21809	APOE
21810	Cardiopathy
21811	Cardiopatía
21812	Factores pronósticos
21813	Linear regression
21814	PM10
21815	Virus infection
21816	disaster manual
21817	obstetric
21818	Biventricular function
21819	Speckle tracking echocardiography
21820	COVID-19 outcome
21821	anemia
21822	iron metabolism
21823	Aquatic toxicity
21824	Climate conditions
21825	Abdominal pain
21826	nasal congestion
21827	pharyngodynia
21828	Thoracic
21829	Anorexia
21830	Hepatic manifestations
21831	Al-Andalus Medicine
21832	Black death
21833	Fallo multiorgánico
21834	Ibn Jatima
21835	Medicina Al-Andalus
21836	Medicina medieval
21837	Medieval Medicine
21838	Peste negra
21839	Leukemia
21840	COVID- 19 pregnancy registry
21841	Pregnancy and VTE
21842	Pregnancy and coagulopathy
21843	Thromboprophylaxis in pregnancy
21844	Basic reproductive number
21845	Recovered
21846	SIR
21847	SUQC
21848	Susceptible
21849	collapsing glomerulopathy, focal segmental glomerulosclerosis, COVID-19, acute kidney injury, proteinuria, APOL1 genotype
21850	postpartum period
21851	Critical care.
21852	Mortality.
21853	SARS- Cov-2.
21854	Venous Thromboembolism.
21855	High cholesterol
21856	alcohol-related liver disease
21857	hepatitis B and C
21858	necrosis
21859	lung pathology
21860	minimally invasive autopsy
21861	gastrointestinal tumours
21862	Case mortality rate
21863	cardiovascular death
21864	cardiovascular hospitalization
21865	refractory patients
21866	Health services accessibility
21867	Health status indicators
21868	Maternal death
21869	western countries
21870	exclusive breastfeeding
21871	infant morbidity
21872	infant mortality
21873	relactation
21874	supplementation, altruism
21875	wet nursing
21876	Appendicectomy
21877	Non-operative
21878	interstitial disease
21879	Abdominal CT
21880	acute appendicitis
21881	nonquarantine
21882	UV rays
21883	blood count
21884	intraparenchymal hemorrhage
21885	Biostatistics
21886	Healthcare reorganization
21887	Nutrients
21888	Trace elements
21889	Remote continuous glucose monitoring
21890	disaster readiness
21891	nCOV-19
21892	contrast-enhanced ultrasound
21893	ischemia
21894	pulmonary embolism.
21895	vascular biomarkers
21896	Hyperglycemic crisis
21897	Intravenous insulin
21898	Subcutaneous insulin
21899	Host factor in COVID-19
21900	Source of coronavirus
21901	Subtypes of novel coronavirus
21902	information source
21903	university student
21904	Acute
21905	Aortic
21906	Infrarenal
21907	Thromboembolic disease
21908	Humanitarian forensic action
21909	Management of the dead
21910	diabetes type 2
21911	hyperglycemic emergency
21912	hyperosmolar hyperglycaemic state
21913	type i diabetes mellitus
21914	Oldest-old
21915	Respiratory syncytial virus
21916	congenital cardiac percutaneous interventions
21917	congenital cardiac surgery
21918	chrononutrition
21919	circadian clock
21920	dinner meal timing
21921	Acceso universal
21922	Oftalmólogos
21923	Ophthalmologists
21924	Optometrists
21925	Optómetras
21926	Universal access
21927	Hospital remodeling
21928	Severe acute respiratory syndrome-coronavirus-2
21929	epidemic severe acute respiratory syndrome-coronavirus-2
21930	health-care worker
21931	angiotensin (1–7)
21932	cerebral venous thrombosis
21933	Monoclonal Gammopathy of Undetermined Significance (MGUS)
21934	AutoML Vision
21935	automated machine learning
21936	chest CT scan
21937	image classification
21938	post-operative
21939	interdisciplinary
21940	perspectives
21941	Ketosis
21942	chest computerized tomography
21943	Emerging and re-emerging infectious diseases (EIDs)
21944	Low- and middle-income countries (LMICs)
21945	Sexual and reproductive health and rights (SRHRs)
21946	Sustainable developmental goals (SDGs)
21947	Zika
21948	2019 SARS-CoV-2
21949	Kenya
21950	self-medication
21951	stool test
21952	bilateral interstitial pneumonia
21953	End-Stage Kidney Disease (ESKD)
21954	Nasopharyngeal Swabs
21955	healthcare provider
21956	knowledge mapping
21957	public health and safety
21958	computerized provider order entry
21959	health information technology implementation
21960	laboratory information system
21961	Estudio de evaluación
21962	Evaluation study
21963	Sample size
21964	concentration methods
21965	enveloped virus
21966	recovery efficiency
21967	surrogate virus
21968	tropical
21969	global environment
21970	Communal isolation
21971	Statisticals of volatility
21972	Score
21973	incidence rate
21974	Bahrain
21975	Perceived stress scale
21976	Pittsburgh Sleep Quality Index
21977	Interobserver variability
21978	plasmacytoid lymphocytes
21979	white blood cells scattergram
21980	interdisciplinary education
21981	school interruption
21982	Gynecologic surgical procedures
21983	Lymph node excision
21984	Ovarian neoplasms
21985	Uterine cervical neoplasms
21986	Uterine neoplasms
21987	Influence function
21988	Model misspecification
21989	Nonlinear regression
21990	Reference prior
21991	SARS CoV‐2 disease
21992	Scoring rules
21993	Health Belief Model
21994	blood pressure
21995	self-reporting
21996	tablet
21997	COVID-19, 2019-nCoV disease, Disease outbreak, Open Access Publishing, Periodicals, Publications.
21998	Growth factors
21999	NF-κB pathway
22000	immune defense
22001	interferon type III
22002	Hemophagocytosis
22003	paralytic ileus
22004	Heat shock response
22005	Metabolic diseases
22006	pancreas/simultaneous pancreas-kidney transplantation
22007	classical monocytes
22008	intermediate monocytes
22009	multicolor flow cytometry
22010	non-classical monocytes
22011	IL-18
22012	hospital pharmacy education
22013	mesenchymal stromal cell
22014	coronavirus disease 2019 COVID–19
22015	hemostasis
22016	severe acute respiratory syndrome coronavirus 2 SARS–CoV–2
22017	EBV
22018	Cytokine/Chemokine
22019	Pharmacokinetic
22020	Brain trigger zones
22021	Catecholamine storm
22022	Microvascular clotting
22023	Neurogenic pulmonary edema
22024	Nucleus tractus solitarius
22025	Evans syndrome
22026	SOCS1
22027	Auditory brainstem responses
22028	Brainstem dysfunction
22029	Microglia priming
22030	Neuroinflammatory mechanisms
22031	Neurologic sequelae
22032	Th2 response
22033	P2X7 receptor
22034	Autism Spectrum Disorder
22035	cytokine Storm
22036	Factor XIII deficiency
22037	interleukin-6 receptor
22038	plasminogen activator
22039	proteolytic enzymes
22040	transient hypercoagulable state
22041	Immunopathogenesis
22042	Immune-checkpoints
22043	headache pathophysiology
22044	headache symptoms
22045	“COVID-19” “OR” “SARS” “OR” “SARS – COV 2” “AND” “systemic disease”
22046	“cardiac pathology”
22047	“central nervous system”
22048	“nephropathy”
22049	IL-1ß
22050	Inflamasoma
22051	Inflamosome
22052	Síndrome de distrés respiratorio agudo
22053	Cytokine Release Syndrome
22054	microvascular damage
22055	right ventricular failure
22056	Henoch-Schönlein
22057	IgA Vasculitis
22058	postinfectious glomerulonephritis
22059	leucoerythroblastic
22060	secondary haemophagocytic lymphohistiocytosis
22061	FMN riboswitch
22062	flavin mononucleotide
22063	mucosal associated invariant T cells
22064	cancer immunotherapy
22065	cytokines storm
22066	COVID-19 Elderly patients
22067	Palliation
22068	Cerebral Pseudoaneurysm
22069	Microcirculation
22070	Neuropsychiatric symptoms
22071	IL-17A
22072	Thrombus
22073	Vascular diseases
22074	Fragmented QRS
22075	Alteraciones neurológicas
22076	Hipercoagulabilidad
22077	Ictus isquémico
22078	Respuesta hiperinflamatoria
22079	SARS-CoV-2 ;
22080	mis-c
22081	multisystem
22082	inflammasome
22083	arthritis, reactive
22084	synovitis
22085	synovial fluid
22086	Hyper-inflammatory
22087	Adult Respiratory Distress Syndrome (ARDS)
22088	Cardiovascular System
22089	Multisystem Inflammatory Syndrome in Children (MIS-C)
22090	AV, atrioventricular
22091	CHB, complete heart block
22092	complete heart block
22093	ref, reference range
22094	ventricular dysfunction
22095	BiPaP, Bilevel positive airway pressure
22096	COVID 19, Corona Virus Disease 2019
22097	CP, cerebellopontine
22098	CTA, CT angiography
22099	CXR, chest X-ray
22100	FiO2, fraction of inspired oxygen
22101	Phlebitis
22102	SARS-COV-2, severe acute respiratory syndrome coronavirus 2
22103	STAT, statum which is Latin meaning immediately
22104	Sub-occipital craniectomy
22105	t-PA, tissue plasminogen activator
22106	polymyositis
22107	oncovirus
22108	Carotid body
22109	Cranial nerves
22110	Happy hypoxemia
22111	postmortem examination
22112	T2 inflammation
22113	diurnal fasting
22114	dermatopathology
22115	direct immunofluorescence
22116	Hyper-inflammatory syndrome
22117	neck
22118	node
22119	parotid
22120	Cardiovascular consult
22121	Multidisciplinary care
22122	Cardiac troponins
22123	Fermented foods
22124	Prebiotics
22125	Body composition
22126	contrast enhanced ultrasound sonography (CEUS)
22127	Intrathecal inflammation
22128	Ischaemic stroke etiologies
22129	Multiple cerebral infarcts
22130	Multivessel cerebral infarction
22131	lung surfactant
22132	Relative bradycardia
22133	APLS
22134	brainstem encephalitis
22135	rhombencephalitis
22136	Btk
22137	platelets; thromboinflammation
22138	race and ethnicity
22139	Community level data elements
22140	Community transmission of SARS-CoV-2
22141	Family-centered
22142	Individual level data elements
22143	Maternal and child health
22144	cotton swab
22145	rayon swab
22146	COVID-19 outcomes
22147	Asymptomatic deep veins thrombosis
22148	Covid-19 pneumonia
22149	Point of care ultrasonography
22150	- Implementation research
22151	- Multidisciplinary
22152	- Outpatient management
22153	- Pandemic
22154	- Quality improvement
22155	- SARS-CoV-2
22156	- Telemedicine
22157	first trimester
22158	 Diagnosis
22159	 Testing
22160	lung sonography
22161	remote telementoring
22162	BTK
22163	X linked agammaglobulinemia
22164	immunoglobulins
22165	Invasive meningococcal disease
22166	Respiratory presentations
22167	SARS-CoV-2, COVID-19
22168	Typing
22169	Loss of sense of smell
22170	Loss of sense of taste
22171	Adenoid
22172	Adenoidectomy
22173	Otitis
22174	Tonsil
22175	label-free detection
22176	nanoplasmonics
22177	optical biosensors
22178	silicon photonics
22179	virus detection
22180	pilgrimage
22181	autopsy studies
22182	neurological symptom
22183	Dry eye
22184	Head and neck
22185	phrenic paralysis
22186	one health approach
22187	sars-cov
22188	tropism
22189	Eyewear protection
22190	preventive testing
22191	augmentation
22192	chest X-rays
22193	convolutional neural network
22194	localization
22195	Foetus
22196	Preterm delivery
22197	placental swab
22198	rhino-pharyngeal swab
22199	materno-fetal medicine
22200	Embarazo
22201	Neonato
22202	Parto
22203	Cellular tropism
22204	Fetus
22205	Maternal-infant infection
22206	Trans-placental passage
22207	trans-placental passage
22208	Amniotic fluid
22209	Líquido amniótico
22210	Transmisión vertical
22211	fetal transmission
22212	vertical transmission novel coronavirus
22213	Medical disorders in pregnancy
22214	Universal screening
22215	Middle East Respiratory Syndrome
22216	Pregnant Women
22217	decidual vasculopathy
22218	fetal vascular malperfusion
22219	maternal vascular malperfusion
22220	thrombotic vasculopathy
22221	female gender bias
22222	 SARS-Cov-2, COVID-19, Pregnancy, Labour, Personal protective equipment, Caesarean section.
22223	miscarriage
22224	risks
22225	thrombocytopaenia
22226	sexual activity
22227	sexual risk
22228	Crisis management
22229	Regional network
22230	Severe maternal morbidity
22231	case-control study
22232	intrauterine transmission
22233	maternal infection
22234	maternal and neonatal outcomes
22235	High-risk pregnancy
22236	Propensity score matching
22237	Gynaecology
22238	Obstetric ultrasound
22239	Safe measures
22240	Administrative challenges
22241	Cesarean
22242	Dedicated COVID-19 facility
22243	Maternity
22244	CT, Computed tomography
22245	ICU, Intensive care unit
22246	NICU, Neonatal intensive care unit
22247	PaO2/FiO2, Partial pressure of arterial oxygen /fraction of inspired oxygen
22248	Antimicrobial Stewardship
22249	Bacterial co-infection
22250	Aedes
22251	computer modeling
22252	human rhinovirus
22253	Parainfluenza virus
22254	buccal
22255	Switzerland
22256	ocular disease
22257	Mesa Accula
22258	laboratory-developed test
22259	household
22260	Viral load diagnostic
22261	Pediatric inflammatory multisystemic syndrome
22262	professional
22263	NAAT
22264	acral skin eruption
22265	COVID-19 and vaginal delivery
22266	Swab
22267	delivery room
22268	Rapid antigen detection test
22269	gatherings
22270	sporting events
22271	sports
22272	nasal decontamination
22273	oral decontamination
22274	BCG immunization
22275	BCG, Bacille Calmette-Guérin
22276	ICAM-1, Intracellular adhesion molecule-1
22277	IFN-γ, Interferon gamma
22278	IL-1β, Interleukin-1β
22279	Immunity and Tuberculosis
22280	LFA-1, Lymphocytes function associated antigens-1
22281	MERS-CoV, Middle East Respiratory Syndrome coronavirus
22282	NSEs, Non-specific effects
22283	SARS-CoV-2S, Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
22284	TCR, T cell receptor
22285	TNF-α, Tumor necrosis factor
22286	disease burden
22287	pathology, molecular
22288	infection-viral
22289	CCL5/RANTES
22290	CXCL9/MIG
22291	T-cell activation
22292	Closures
22293	viral exanthem
22294	 Child behaviour
22295	Child development
22296	GI symptoms
22297	nausea
22298	stool SARS-CoV-2 RNA
22299	vomiting
22300	pediatric oncology
22301	Hospitales pediátricos
22302	Internal pediatric medicine
22303	Medicina hospitalaria
22304	Pediatric hospitals
22305	Pediatría interna hospitalaria
22306	SARS-CoV-2; coronavirus
22307	Medicina pediátrica de urgencias
22308	Paediatric emergency medicine
22309	acute alcohol intoxication
22310	dual disorder
22311	hospitalizations due to behavioral/mental issues
22312	hospitalizations due to the toxic effects of alcohol
22313	psychiatric manifestations
22314	trends of hospitalization
22315	Presenting features
22316	Apnea
22317	BRUE
22318	Cyanosis
22319	rubella
22320	Hyperinflammatory response
22321	cardiogenic shock
22322	paediatric multisystem inflammatory syndrome
22323	SARS-CoV-2 School closure Transmission Children Control Social contacts
22324	dentist-patient relation
22325	Respiratory insufficiency
22326	COViD-19
22327	dermatology service
22328	Postinfectious demyelination
22329	Transverse myelitis
22330	Child and adolescent psychiatry
22331	Obsessive compulsive symptoms
22332	Somatic symptom disorder
22333	Respiratory medicine
22334	Lung Ultrasound
22335	light beam
22336	infectious disease pandemic
22337	Inflammatory syndrome
22338	Multi-organ dysfunction
22339	cerebral palsy
22340	participatory medicine
22341	Intestinal ischemia
22342	Kawasaki like
22343	Medullar aplasia
22344	Couples
22345	hospital employee
22346	skin lesions
22347	law/legal issues
22348	school health
22349	new presentation
22350	pediatric cancer
22351	Covid‐19
22352	bronchiolitis
22353	neurologic symptoms
22354	Detection bias
22355	social contact
22356	infant, newborn, diseases
22357	Pediatric anesthesia
22358	Perioperative outcomes
22359	Transmission risk
22360	mitral valve stenosis
22361	high flow extractor
22362	PSS (Perceived stress scale)
22363	Obstetrics unit
22364	Urgency
22365	prebiotics
22366	pulmonary function test
22367	acne
22368	humanitarian
22369	intersectionality
22370	power
22371	sexual and reproductive health
22372	gastrointestinal endoscopy
22373	pediatric gastroenterology
22374	autism
22375	autism spectrum condition (ASC)
22376	diagnostic criteria
22377	positive
22378	strengths
22379	viral protein detection; nasopharyngeal swab
22380	TIMS-TOF PRO
22381	mass-spectrometry
22382	comment
22383	sweat
22384	Equipment
22385	Air and water borne transmission
22386	SARS-CoV-2 survival
22387	Surface characteristics
22388	independent action hypothesis
22389	speech droplet
22390	Retina clinic
22391	CFD
22392	Large-Eddy Simulation
22393	Monte-Carlo
22394	coughing
22395	faeces
22396	optimal pooling
22397	pool testing
22398	chopsticks
22399	communal dining
22400	Skilled Nursing Facility
22401	Common cold
22402	Bio-aerosols
22403	Faecal transmission
22404	Gastrointestinal shedding
22405	clinical sample
22406	clinical specimen
22407	Pet
22408	Wild animals
22409	Sexual transmission
22410	Public Health Dentistry
22411	assisted reproductive technology
22412	sexual transmission
22413	airborne virus
22414	multi-scale model
22415	particle transport
22416	surgical suite
22417	air contamination
22418	olfaction disorders
22419	Criminal casework
22420	Forensic DNA testing
22421	Human identification
22422	superspreader
22423	superspreading event
22424	Abnormal behaviour
22425	Brain-immune axis
22426	CNS-changes
22427	Obligate parasites
22428	Social interactions
22429	Faecal-oral transmission
22430	Health communication
22431	telecommunications
22432	investigation of outbreaks of illness
22433	Sexual Transmission
22434	Viral Pandemic
22435	FMEA
22436	Model predictive control
22437	On-Off control
22438	Nosocomial infection control
22439	staff health
22440	Human respiratory problems
22441	Computational fluid-particle dynamics (CFPD)
22442	SARS-CoV-2-laden cough droplets
22443	Wind and gust
22444	Barcelona
22445	Incidence rate
22446	Time-series regression
22447	Water disinfection
22448	public
22449	mobile Diagnostic
22450	on-site screening
22451	nebulized treatments
22452	hospital infections
22453	Bronchaill challenge
22454	Inflammatory biomarkers
22455	Lung function tests
22456	Upper airways examination
22457	ocular infection
22458	personal
22459	protective
22460	Optometry
22461	Tear
22462	Respiratory Protective Devices
22463	Bariatric endoscopy
22464	Obesity surgery
22465	liquid-based cytology
22466	Eid-Ul-Adha
22467	recautionary measures
22468	zoonotic transmission
22469	After lockdown
22470	Swab tests
22471	Cross-contamination
22472	Good tissue practices
22473	IVF laboratories
22474	OtoTent
22475	barrier drape
22476	health care providers
22477	mastoidectomy
22478	neurotology
22479	Infection of healthcare workers
22480	Rapid serological test
22481	health-protective behaviour
22482	repeated cross-sectional design
22483	neurodiagnostic testing
22484	technologist safety
22485	myringotomy
22486	Tropical temperature
22487	dental facility
22488	dry mouth
22489	urgent care
22490	laser
22491	weddings
22492	North America
22493	Epidemic growth
22494	Sunshine
22495	aerosol particles
22496	endonasal drilling
22497	Hashmi-Asif Covid-19 Chart
22498	thrombopenia
22499	operation room
22500	Endoscopic Sinus Surgery
22501	Negative Pressure
22502	Transmission mitigation
22503	translational gastrointestinal research
22504	Olfactory impairment
22505	Sniff test
22506	flexible fiberoptic laryngoscopy
22507	avaps
22508	critical illness myopathy
22509	worsening obstructive sleep apnea (osa)
22510	PLTR
22511	PMSR
22512	Acute conjunctivitis
22513	Eyes
22514	SARS-CoV-2 virus pandemic
22515	URT
22516	Occupational hazard
22517	Otolaryngologists
22518	healthcare associated infection
22519	ENT surgeon
22520	transmission risk
22521	Clouds, jets, puffs
22522	Coughing, sneezing, speaking
22523	Droplets
22524	Non-pharmaceutical protection measures
22525	Respiratory emissions
22526	Hospital transmission
22527	Aerosol-generation medical interventions
22528	High-flow nasal cannula oxygen
22529	Protection gear
22530	Shield
22531	Virus transmission
22532	COVID-19 and dew/frost point
22533	COVID-19 and humidity
22534	COVID-19 and precipitation
22535	COVID-19 and temperature
22536	COVID-19 and wind speed
22537	Clinical risk management
22538	Legal
22539	HCID
22540	aeromedicine
22541	helicopter air ambulance
22542	prehospital medicine
22543	Micro-droplets
22544	mask materials
22545	sneeze velocity
22546	Economic impact of COVID-19
22547	Environmental impact of COVID-19
22548	Health impact of COVID-19
22549	Social distancing measures
22550	Hiposmia
22551	Diagnosis SRDS-CoV-2
22552	Diagnóstico de SARS-CoV-2
22553	Medidas preventivas en COVID-19
22554	Preventive measures COVID-19
22555	Serological COVID-19
22556	Serología COVID-19
22557	review, systematic
22558	Aerosol based disease transmission
22559	HEPA air filtration
22560	Covid Vulnerability Index
22561	Metro cities
22562	UN-Habitat
22563	postoperative care
22564	body donation
22565	dermatology consultation
22566	Animal behaviour
22567	Zoology
22568	or injury
22569	other infection
22570	other study design
22571	do-not-resuscitate
22572	mechanical compression device
22573	aged
22574	agile
22575	cellphone
22576	health care quality, access and evaluation
22577	public reporting of healthcare data
22578	requirements engineering
22579	Defense Production Act
22580	U.S. federal government
22581	Personal protective equipment PPE
22582	United Kingdom UK
22583	operative time
22584	medical simulation
22585	Dry heat
22586	Microwave
22587	Exoscope
22588	Laryngeal cancer
22589	Microscope
22590	VITOM
22591	Examination chair
22592	Headlight
22593	Ophthalmological surgery
22594	COVID-19 - gargle lavage - nasopharyngeal swab - oropharyngeal swab - SARS-CoV-2
22595	Healthcare workers anxiety
22596	Healthcare workers safety
22597	Surgical practice
22598	Depression in neurosurgeons
22599	Depression in surgeons
22600	Depression scale
22601	Depression/anxiety
22602	Primary joint arthroplasty
22603	cost efficiency
22604	Intensive Care Units
22605	Resource Use
22606	Displaced populations
22607	Essential workers
22608	Gender bias
22609	Humanitarian contexts
22610	Humanitarian organizations
22611	Decontamination measures
22612	N-95 mask
22613	extended use
22614	Ventilation strategies
22615	Eurotransplant Senior Program
22616	deceased donor
22617	pruritus
22618	2019
22619	consultations
22620	tier
22621	tier-based
22622	internship and residency
22623	Endoscopy Units
22624	Pre-filled syringe
22625	Vascular access
22626	EMR, electronic medical record
22627	Fit Factor
22628	frontline staff
22629	healthcare worker safety
22630	intubox
22631	Emerging Infectious Disease
22632	Global Health Security
22633	Public Health Preparedness and Response
22634	Ultraviolet-C
22635	peracetic acid
22636	Delphi process
22637	Surgical guidance
22638	Cloth gowns
22639	Coveralls
22640	PHE
22641	Surgical gowns
22642	Disposable aids
22643	Financial loss
22644	dosimetry
22645	irradiance
22646	Health planning guidelines
22647	Nose diseases
22648	Operative procedures
22649	Smell test
22650	Predictive score
22651	regulatory oversight
22652	household waste
22653	medical wastes
22654	Humanización de la atención
22655	Humanization of assistance
22656	Plan de cuidados
22657	Recruitability
22658	Respiratory mechanics
22659	Lung Recruitment
22660	Mechanical Ventilation
22661	C-ARDS
22662	airway opening pressure
22663	Electroencephalogram
22664	the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
22665	Bronchoalveolar transcriptome
22666	Hyaluronan
22667	ARI, aldose reductase inhibitor
22668	CMR, cardiac magnetic resonance
22669	LGE, late gadolinium enhancement
22670	aldose reductase inhibitor
22671	Bilateral spontaneous pneumothorax
22672	Spontaneous pneumothorax
22673	Echography
22674	Ultrasonografía
22675	Manifestation oculaire
22676	Ophtalmologie
22677	Télémédecine
22678	Euroimmun
22679	MAGLUMI
22680	sickle cell trait
22681	self proning
22682	paralysis
22683	sedation
22684	Padua prediction score
22685	d‐dimer
22686	ace-inhibitors
22687	angiotensin receptors blockers
22688	facial pressure ulcers
22689	glycocalyx shedding
22690	multiple organ failure pathophysiology
22691	protective ventilation
22692	Glioblastoma multiforme
22693	International Society on Thrombosis and Haemostasis (ISTH)
22694	 Cardiovascular disease 
22695	 Myocardial injury
22696	2019 
22697	Pericarditis
22698	Media exposure
22699	Lung, SARS-Cov-2
22700	Pneumonia (viral)
22701	Support vector machine
22702	Tomography (x-ray computed)
22703	Chronically ill patients
22704	hypoxaemia
22705	quality measures
22706	ventilator management
22707	Communicable
22708	Convergence
22709	Non-Communicable
22710	Influenza-like-illness
22711	β-coronavirus
22712	Histology
22713	Periodontal disease
22714	smell and taste
22715	structural equation model
22716	cardiovascular research
22717	Observational
22718	mediation
22719	hematological malignancy
22720	Path of infection
22721	Multi-Criteria Decision Analysis
22722	receiver operating characteristic curve
22723	physical function
22724	high-throughput PCR
22725	molecular diagnostic
22726	Random access PCR
22727	Acute disseminated encephalomyelitis (ADEM)
22728	Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
22729	Early symptoms
22730	Hypogeusia
22731	TaqMan
22732	DIRECT-PCR
22733	portable PCR
22734	Chlorhexidine
22735	Hologic® Panther System
22736	leptomeningeal enhancement
22737	Facial diplegia
22738	Facial nerve palsy
22739	Guillain Barré Syndrome
22740	Direct rRTPCR
22741	mPCR
22742	extraction buffer
22743	lysis buffer
22744	severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2)
22745	tinnitus
22746	vertigo
22747	Sugar chain-immobilized magnetic gold nanoparticle
22748	cell models
22749	High-sensitive
22750	Nares
22751	SWAB
22752	Validation
22753	Cepheid
22754	transport conditions
22755	Cognitive bias
22756	Evidence based health care
22757	Molecular diagnostic
22758	chemosensory
22759	Sars-COV-2
22760	lab testing
22761	In vitro diagnostics
22762	World Health Organisation (WHO)
22763	Cepheid Xpert Xpress SARS-CoV-2
22764	Roche cobas SARS-CoV-2 assay
22765	Laboratory-developed test
22766	Panther fusion
22767	QIAsymphony
22768	Abdomen
22769	Guillen-Barre syndrome
22770	acute necrotizing encephalopathy
22771	muscular system
22772	general practice / family medicine
22773	Coronavirus, SARS-CoV-2, COVID-19, ACE 2, Neurotoxicity, Brain, Seizures.
22774	Pancreatitis
22775	Dual-use science
22776	Export controls
22777	International coordination
22778	nasal swab
22779	Bronchial cytology
22780	Cell physiological phenomena
22781	Ciliated cell
22782	Hyperchromatic supranuclear stria
22783	Nasal cytology
22784	Aptima swabs
22785	collection device
22786	Deglutition
22787	Deglutition disorder
22788	diuretics
22789	Eye clinic
22790	Predictive value
22791	Reproducibility of Results
22792	TDM
22793	Ultra-high-resolution computed tomography
22794	Nitrogen dioxide (NO2)
22795	Ozone monitoring instrument (OMI)
22796	leukaemia
22797	lymphomas
22798	Adrenal Glands
22799	Pituitary gland
22800	pooled analysis
22801	Candida auris
22802	nasal lavages
22803	Forensic pathology
22804	Patient- and family-centered care
22805	Dental journals
22806	Cerebrovascular diseases
22807	Enfermedades cerebrovasculares
22808	Infección coronavirus
22809	acute liver failure
22810	FIB-4
22811	liver fibrosis
22812	glucose-6-phosphate dehydrogenase
22813	hemolytic anemia
22814	methemoglobinemia
22815	COVID-19: coronavirus disease 2019
22816	SARS-CoV-2: severe acute respiratory syndrome coronavirus 2
22817	computed tomography pulmonary angiography
22818	USA
22819	antibody profiles
22820	infection severity
22821	Asthme
22822	non-SARS-CoV-2 viruses
22823	depthwise separable DenseNet
22824	medical image classification
22825	Structured report
22826	AITD
22827	Thyroid autoimmune disease
22828	Bayes
22829	information dissemination
22830	chest infection
22831	postoperative joint infection
22832	tka
22833	COVID-19 detection
22834	Dyspnoea
22835	mild-to-moderate coronavirus disease
22836	relative bradycardia
22837	vibrational spectroscopy
22838	Geographic tongue
22839	Oral conditions
22840	Recurrent herpes simplex
22841	Tissue donor
22842	Tissue procurement and processing
22843	Clinically mild encephalitis
22844	Encephalopathy with a reversible splenial
22845	Lesion
22846	Anti-infective agents
22847	PVP-I
22848	Povidone-iodine
22849	R package
22850	bibliometric
22851	reference
22852	Neurologic symptoms
22853	Hypoalbuminemia
22854	Severe disease
22855	acromegaly
22856	somatostatin receptor ligands
22857	Chlamydia pneumoniae
22858	YAG
22859	compensation
22860	early-career
22861	fellows
22862	serologic testing
22863	chest X-ray
22864	képalkotás
22865	mellkasröntgen
22866	számítógépes tomográfia
22867	ultrahang-diagnosztika
22868	ultrasound diagnostics
22869	Broad beans
22870	Fatty acids
22871	Linoleic acid
22872	Vicia faba
22873	Fiebre
22874	viral myositis
22875	Anorexia nervosa
22876	Bulimia nervosa
22877	Anaesthetics
22878	Carbon monoxide
22879	Nitrogen monoxide
22880	DORSCON Scale
22881	maxillofacial surgery
22882	Mood disorder
22883	ultraviolet C
22884	false negatives
22885	QR code
22886	Kawasaki vasculitis
22887	Leukopenia
22888	OR7D4
22889	PARP9
22890	SLC12A6
22891	Vascular damage
22892	ADE
22893	dental abscess
22894	dental infection
22895	orofacial infection
22896	Lungenultraschall
22897	PoCUS
22898	bildgebende Verfahren
22899	procédés d’imagerie
22900	échographie ciblé
22901	vitamin D2
22902	vitamin D3
22903	sedentary activities
22904	lung- Contrast-enhanced ultrasound (CEUS)
22905	peripheral embolic consolidation
22906	pleural affection
22907	Source control
22908	INFECTIOUS DISEASES
22909	Emergency setting
22910	ankirin 1
22911	food intake control
22912	nausea and vomiting
22913	pulmonary thrombosis
22914	neurotrauma
22915	fees, medical
22916	health expenditures
22917	insurance, health, reimbursement
22918	Anosmia Taste
22919	Chemesthesis
22920	Chemosensory
22921	Post-viral olfactory dysfunction
22922	 Classification
22923	 Machine Learning
22924	 Prediction Model
22925	Probability-based sample
22926	SARS CoV-1
22927	dengue hemorrhagic fever
22928	hypersensitivity
22929	vaccine adverse events
22930	Elecsys assay
22931	SARS-CoV-2COVID-19
22932	advanced learning technologies
22933	blended learning
22934	intelligent personal assistant
22935	Imaging informatics
22936	Neural network
22937	Pneumonia diagnosis
22938	Transfer learning
22939	COVID-19 progression
22940	COVID-19 severity
22941	Neurological involvement
22942	PRES like syndrome
22943	analytical
22944	emergency setting
22945	postanalytical
22946	preanalytical
22947	Nitrogen oxides
22948	Dear editor
22949	covid skin disease
22950	covid skin diseases histopathology
22951	covid skin diseases pathology
22952	covid dermatopathology
22953	affinity
22954	Community health workers
22955	Safety net hospitals
22956	oropharynx
22957	Weight gain
22958	chronic inflammatory diseases
22959	diffuse alveolar hemorrhage
22960	Access
22961	field work
22962	Influenza-like illness
22963	Signs
22964	Efficiency improvement
22965	Healthcare research
22966	Workflow optimization
22967	Automatic detections
22968	 Holy Qur'an, Hadiths, Pandemic, COVID-19, Congregation, Pandemic.
22969	COVID-19, Pandemic, Healthcare delivery
22970	Dental autopsy
22971	Forensic odontology
22972	Catheterization laboratory
22973	bilirubin
22974	renin-angiotensin system inhibitor
22975	Virtual training
22976	polyneuropathy
22977	Non-methane hydrocarbons
22978	hyperkalaemia
22979	rocuronium
22980	succinylcholine
22981	sugammadex
22982	And machine learning
22983	journalism/mass media
22984	haemoglobin
22985	oxygen affinity
22986	oxygen association
22987	oxygen dissociation
22988	lung remodeling
22989	PrePARE
22990	Virtual conference
22991	Virtual meeting
22992	grief
22993	mourning
22994	open data
22995	open materials
22996	preregistered
22997	reflectiveness
22998	social cognition
22999	Low- And Middle-Income Countries
23000	Cutaneous manifestation
23001	Pins and needles sensation
23002	e-oral health
23003	health education and promotion
23004	FatMax
23005	B lines
23006	COVID-19 nephropathy
23007	COVID-19-Nephropathie
23008	acute interstitial nephritis
23009	akute Niereninsuffiezienz
23010	akute interstitielle Nephritis
23011	Autoimmune encephalitis
23012	Psychiatric disorder
23013	Hydrocolloid
23014	facial injury
23015	Smoke
23016	Health Informatics
23017	ESIR
23018	Interventional Radiology
23019	Access to medicines
23020	Pharmaceutical policy
23021	descriptors
23022	metrics
23023	noise
23024	sound
23025	soundscape
23026	otorhinolaryngologists
23027	swab: rhinopharynx
23028	patient perspectives
23029	inpatient care facility
23030	socioeconomic
23031	pleural infection
23032	accident & emergency medicine
23033	anaesthetics
23034	diagnostic microbiology
23035	allergy division
23036	training program
23037	suPAR
23038	Acute cardiac injury
23039	Cardiopathie
23040	Risque cardiovasculaire
23041	Brain-derived neurotrophic factor
23042	DDX17
23043	Dental pulp stem cells
23044	Podoplanin
23045	Premature ovarian insufficiency
23046	Hypoadrenalism
23047	Malnourishment
23048	medical protective consumables
23049	peer review
23050	preprints
23051	scientific publishing
23052	   international trade
23053	  devices and equipment 
23054	  global health 
23055	  international law 
23056	  international organizations 
23057	  international relations 
23058	  medical supplies 
23059	  public health
23060	  trade policy 
23061	dental trauma
23062	evidence-based﻿ practice
23063	NP swab
23064	irology
23065	linical pathology
23066	vaccine candidate
23067	activities of daily living
23068	electronic health literacy
23069	information seeking
23070	neuropsychological assessment
23071	novel coronovirus
23072	Floating aortic thrombus
23073	Lower limb ischemia
23074	Delphi method
23075	History
23076	phenylketonuria
23077	Anti-inflammatory medicines
23078	neprilysin inhibitors
23079	correspondence
23080	Ankle fracture
23081	Open reduction and internal fixation
23082	Transport accessibility
23083	Transportation
23084	viral respiratory infections
23085	FSGS
23086	collapsing
23087	glomerulopathy
23088	neurological effects of coronavirus
23089	psychological impacts of coronavirus
23090	Chronic lymphocytic leukaemia
23091	pseudohypoxemia
23092	open‐access
23093	chest-X-rays
23094	OA analysis.
23095	Open Access
23096	PubMed
23097	Scholarly communication
23098	PTSD differential diagnoses
23099	medical trauma
23100	nanotherapeutics
23101	Apulian Region (Italy)
23102	Artificial neural networks
23103	Calibration
23104	Mathematical programming problem
23105	Multicriteria analysis
23106	Risk of Covid-19 contagion
23107	Neural networks
23108	Pandemic influenza
23109	Pharmacist role
23110	Psychosocial well-being
23111	afebrile
23112	quantitation
23113	Altona
23114	Cobas 6800
23115	pre-analytical
23116	mid-turbinate swab
23117	Dysguageusia
23118	low viral load
23119	coronavirus inactivation
23120	viral load in matrices
23121	UVGI
23122	reverse transcription–polymerase chain reaction
23123	Cycle threshold (Ct) values
23124	Olfactory/taste disorders (OTDs)
23125	Real-time polymerase chain reaction (qPCR)
23126	SARS-CoV-2 Tunisia
23127	Sample pooling
23128	respiratory disorder
23129	universal face mask
23130	Inpatient rehabilitation
23131	Quality Improvement and Patient Safety
23132	coronavirus, pandemic
23133	Asymptomatic for coronavirus disease 2019
23134	Chest computerized tomography
23135	immunoglobulin development
23136	infection chain
23137	Lung histology
23138	cornea/external disease
23139	eyelid disease: infections/inflammations
23140	infectious diseases affecting lid/conjunctiva
23141	preventive medicine/screening
23142	Extrathoracic
23143	Healthcare Workers
23144	Incidental
23145	antigen test
23146	ground‐glass opacification
23147	Lung ultrasound (LUS)
23148	high-resolution computed tomography (HRCT)
23149	nasopharyngeal swab (NS)
23150	Exercise test
23151	cutaneous rash
23152	SARS-COv-2 infection
23153	acute on chronic liver disease
23154	adult gastroenterology
23155	hepatitis virus
23156	uae
23157	viral hepatitis b
23158	 COVID-19 and skin dermatosis
23159	 COVID-19 and skin histology
23160	 COVID-19 and skin immunohistochemistry
23161	 COVID-19 histopathology
23162	COVID-19 and skin histopathology
23163	CT Chest
23164	clinical manifestation
23165	RTPCR
23166	higher education
23167	Erythrocyte sedimentation rate
23168	c-Reactive protein
23169	Awake fiberoptic intubation
23170	Difficult airway
23171	health & safety
23172	pharmacokinetics and dynamics
23173	spectrum bias
23174	test performance
23175	anti-HIV
23176	bevirimat
23177	triterpenes
23178	microfluidic devices
23179	AIDS, Acquired Immunodeficiency Syndrome (i.e. the final stage of infection with HIV)
23180	COVID-19, COronaVirus Infectious Disease 2019
23181	Complex interconnected systems
23182	Critical public health
23183	Ecocide
23184	Ecosystem services and valuation methods
23185	HIV, Human Immunodeficiency Virus
23186	Multidimensional crisis
23187	Practical and sustainable solutions
23188	SARS-CoV-2, Severe Acute Respiratory Syndrome COronaVirus 2
23189	Acquired immune deficiency
23190	Pneumocystis jirovecii
23191	Global health justice
23192	very old age
23193	Coronavirus disease of 2019 (COVID-19)
23194	Direct viral cytopathy
23195	Potential therapies
23196	Emergency cardiological department
23197	Missing visits
23198	Allergen immunotherapy
23199	Allergoid
23200	virus biology
23201	mRNA
23202	protein biopolymer
23203	transcription
23204	IL12/13
23205	IL6 inhibitor
23206	immune-mediated diseases
23207	Immunity passport
23208	Rapid immunochromatographic antibody testing
23209	Rapid immunochromatographic antibody testing, RIAT
23210	Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2
23211	blood cell count
23212	External ocular infections
23213	disease duration
23214	hospital resources
23215	in-hospital
23216	Ocular surgery
23217	Bacillus Calmette-Guérin
23218	income
23219	dermatologic manifestations of disease
23220	sarcoid-like reactions
23221	Cardiac tamponade
23222	Early performed autopsy
23223	Samples
23224	Computed Tomography (CT)
23225	radiographic chest examination (CXR)
23226	ultrasound (US)
23227	predicting factors
23228	Chest ultrasound
23229	Point-of-care ultrasonography
23230	Thoracic ultrasound
23231	multiple organ dysfunction
23232	EF, ejection fraction
23233	EGE, early gadolinium enhancement
23234	LV, left ventricle
23235	SARS-CoV-19, severe acute respiratory syndrome-coronavirus-2019
23236	Invasive mechanical ventilation
23237	Lung volume
23238	chest ct
23239	Spontaneous pneumomediastinum
23240	olfactory loss
23241	smell disorders
23242	Coronavirus disease 2019 CXR score
23243	Pneumonia imaging features
23244	Basildon protocol
23245	COVID-19 Pneumonia
23246	Fleischner Society statement
23247	Portable Digital Radiography
23248	Radiological Society of Pakistan
23249	proposed guidelines
23250	DENV
23251	Mimicker
23252	clotting
23253	traveller's thrombosis
23254	Spiral computed
23255	progressive liver disease
23256	COVID-19, coronavirus-2019
23257	PM, pacemaker
23258	SSD, sick sinus dysfunction
23259	bradycardia-tachycardia syndrome
23260	sick sinus dysfunction
23261	sinus node dysfunction
23262	Cáncer urológico
23263	cardiac ultrasound, diaphragm ultrasound, COVID-19
23264	Endothelial dysfunction
23265	Reversible encephalopathy syndrome PRES
23266	CT-Scan
23267	Grad-CAM
23268	Chest X-rays
23269	Inception net
23270	Prognostic implication
23271	Volumetric quantitative analysis
23272	Southern Italy
23273	Aortic thrombi
23274	Lung infection
23275	Biological Agents Ordinance
23276	Deceased
23277	High risk autopsy
23278	spiral computed
23279	antidiabetic drug, database research, DPP-4 inhibitor, pharmacoepidemiology
23280	Withaferin A
23281	tinosponone
23282	xanosporic acid
23283	eQTL
23284	genetic population analysis
23285	Postviral olfactory dysfunction
23286	olfactory alterations
23287	peripheral nervous system
23288	Mucous membrane
23289	Viral tropism
23290	Personnels de santé
23291	RT-PCR screening
23292	Symptômes cliniques
23293	Test RT-PCR
23294	Gabapentin
23295	Neuralgia
23296	Neuropathic pain
23297	SARS-CoV-2 Lung ultrasonography
23298	olfactory disorder
23299	Coronavirus, COVID-19, SARS-CoV2, SARS-CoV-2, mood, depression, anxiety, anosmia, hyposmia, olfactory dysfunction, olfactory function, gustatory dysfunction, gustatory function, olfaction, smell, taste, nasal obstruction, rhinorrhea
23300	Olfactory and taste disorders
23301	Acute Myelitis
23302	Angiotensin Converting Enzyme-2
23303	Magnetic Resonance Imaging
23304	Pulmonary Embolism
23305	Diabetes-care
23306	Diabetes-management
23307	Diabetes-self-management
23308	SARS-CoV-2-virus
23309	glucose metabolism disorder
23310	Sensor
23311	Pancreatic islets
23312	atherosclerotic disease
23313	intravascular clotting
23314	large vessel occlusion
23315	Generalized Anxiety Disorder scale (GAD-7), Patient Health Questionnaire (PHQ), Insomnia Severity Index (ISI)
23316	New-onset diabetes
23317	New-onset hyperglycemia
23318	flash glucose monitoring
23319	people life with diabetes
23320	remote assistance
23321	SARS-CoV-2 | bariatric surgery
23322	Epiploic appendagitis
23323	Incidental finding
23324	Autoimmune pathogenesis
23325	skin disease/ dermatology
23326	Acute pulmonary embolism
23327	automated PCR
23328	molecular rapid testing
23329	point-of-care-testing
23330	testing comparison
23331	intrathecal synthesis
23332	Airborne particle
23333	lymphoid malignancies
23334	myeloid malignancies
23335	stem cell transplantation
23336	community mitigation
23337	Guillain Barré syndrome
23338	Miller-Fisher Syndrome
23339	neurofilament light chain
23340	Cardiovascular events
23341	Cerebrovascular events
23342	Conventional PCR
23343	Molecular diagnoses
23344	SYBR Green assay
23345	Nasal symptoms
23346	Sense of taste
23347	megakaryocytes
23348	naked megakaryocyte nuclei
23349	Tubo-ovarian cancer
23350	ablation
23351	tyrosine kinase Inhibitors
23352	cfDNA
23353	liquid biopsy
23354	Circulating Endothelial Cells
23355	Circulating Endothelial Progenitors
23356	Covid-19 pandemic; elective breast cancer surgery;
23357	Covid-19 protective cancer hubs
23358	safety;
23359	Cancer screening
23360	Cervical cytology
23361	biomimetics
23362	cardio-oncology
23363	Comprehensive approach
23364	True positives
23365	Surgical caseload
23366	dermatosurgery
23367	healthcare management
23368	mohs surgery
23369	Triaging
23370	parasites
23371	single cell level
23372	ARS, adhesive retention suture
23373	adhesive retention suture device
23374	fragile skin
23375	tension
23376	wound closure
23377	Psychological Impact
23378	Immunohistochemistry bowel
23379	rural
23380	Research quality
23381	psychosocial
23382	psychosocial interventions
23383	Media coverage
23384	digital tool
23385	bariatric surgery
23386	behaviour
23387	severe obesity
23388	weight loss
23389	mental retardation
23390	prolonged viral shedding
23391	tooth brushing
23392	health care policy
23393	common cold
23394	health practices
23395	psychological stress
23396	social integration
23397	dental services
23398	Drive-through screening
23399	Kawasaki-like
23400	Post-infective complications
23401	Ocular manifestations of Kawasaki disease
23402	Motility
23403	liver transplantation: living donor
23404	CT values
23405	Hepatology consultation
23406	Liver biochemistries
23407	clinical complications
23408	Community pharmacists
23409	Gastroenterology ward
23410	Infusion
23411	infectious complications
23412	Anemia
23413	Cold agglutinin disease
23414	Hemolytic
23415	Atrophic gastritis
23416	Crohn's disease;Ulcerative colitis
23417	Fanconi
23418	cardiorenal
23419	kidney transplantation/ nephrology
23420	thrombosis and thromboembolism
23421	brain magnetic resonance imaging
23422	microthrombi
23423	Chronic renal insufficiency
23424	SARS-Coronavirus‑2
23425	SARS‐CoV‐2 infection
23426	covid‐19
23427	lung transplantation
23428	patient survey
23429	Genetic profile
23430	MSCS
23431	stem cells
23432	lung bases
23433	Lung Transplantation
23434	COVID‐19 lung disease
23435	Cardiopulmonary pathology
23436	ocular findings
23437	DECT
23438	electron density
23439	ground-glass opacities
23440	spectral CT
23441	Health care organization
23442	Post-acute care
23443	home telemonitoring
23444	myocardial edema
23445	Myopericarditis
23446	Tamponade
23447	KL-6
23448	prognostic tool
23449	LMWH, Low molecular weight heparin
23450	PCSK, pro-protein convertase subtilizing/Kexin
23451	SARS-COV2, Severe acute respiratory syndrome coronavirus 2
23452	VTE
23453	Asthma characterization
23454	Atopic diseases
23455	inhaled corticosteroids
23456	Decision aid
23457	Decisional conflict
23458	flu
23459	influenza virus type a
23460	influenza virus type b
23461	influenza-like illness
23462	SERS
23463	SPR
23464	colorimetric
23465	electrochemiluminescence
23466	plasmonics
23467	cigarette smoking
23468	Aerosol optical depth (AOD)
23469	Criterion pollutants
23470	Most polluted cities
23471	National air quality index (NAQI)
23472	Emissions inventories
23473	Telecommunications
23474	MERV
23475	cloth
23476	ePM1
23477	filter
23478	Ambient air pollution
23479	Aerodynamics
23480	Building ventilation
23481	Filters
23482	Gym
23483	Sports club
23484	Simulation centre
23485	nutrition assessment
23486	Dental radiography
23487	process engineering
23488	O3
23489	Atmospheric chemistry
23490	Climate and Earth system modelling
23491	Climate-change mitigation
23492	Projection and prediction
23493	MCO
23494	covid-induced myocarditis
23495	st-elevation myocardial infarction (stemi)
23496	world pandemic
23497	Deformation imaging
23498	Myocardial strain
23499	Rotation
23500	Cardiac troponin
23501	proarrythmia
23502	MI
23503	microvascular dysfunction
23504	microvascular injury
23505	SARS-Cov-2, severe acute respiratory syndrome-coronavirus-2
23506	ULN, upper limit of normal value
23507	SARS- CoV-2, severe acute respiratory syndrome-coronavirus-2
23508	ASA, acetyl salicylic acid
23509	DES, drug-eluting stent
23510	LAD, left anterior descending
23511	coronary artery
23512	stent thrombosis
23513	ACE 2, angiotensin-converting enzyme 2
23514	Ischemic heart disease
23515	SPECT-MPI
23516	SARS-CoV-2 disease
23517	clinical enzymology
23518	tumors
23519	inmate population
23520	prison health
23521	vulnerable group
23522	endothelial infection
23523	Environmental sampling
23524	allogeneic transplantation
23525	immunocompromised host
23526	malignant lymphoma
23527	LR, livedo reticularis
23528	livedo reticularis
23529	Digital twin
23530	Pandemic plan
23531	Risk management
23532	ABO histo-Blood group
23533	Disease susceptibility
23534	chest computed tomogram
23535	chest tomography angiogram
23536	mou
23537	multi-organ ultrasound
23538	Clinical Validation
23539	UTLE, unilateral laterothoracic exanthem
23540	unilateral laterothoracic exanthema
23541	testing methods
23542	pooling
23543	thio-NAD cycling
23544	ultrasensitive ELISA
23545	Endoscopic retrograde cholangio-pancreatographies
23546	referral difficulties and changes
23547	urgent
23548	foreign accent syndrome
23549	language
23550	Guillain-Barrè
23551	Para-infectious
23552	ablution
23553	microbial removal
23554	one-step direct RT-PCR
23555	screening tests
23556	medical records
23557	Acidic electrolyzed water
23558	Disinfectant
23559	Free available chlorine
23560	dermatological
23561	Magnetic nanoparticle
23562	Optomagnetic sensing
23563	Rolling circle amplification
23564	complete genomes of SARS-CoV-2
23565	SNP
23566	pharmacogenetics
23567	pathology, oral
23568	exercise telehealth
23569	Americas
23570	Caribbean Region
23571	West Indies
23572	Diseases of the nervous system
23573	Enfermedades del sistema nervioso
23574	Manifestaciones neurológicas
23575	Neurología
23576	prediction-model
23577	Molecular diagnostic testing
23578	Reverse transcriptase polymerase chain reaction
23579	Coronavirus removal
23580	Human health
23581	chilblain lupus
23582	Italian SARS-CoV-2 epidemic
23583	PEG/NaCl
23584	DxH800 analyzer
23585	SARS-CoV-2 diagnosis
23586	cellular population data
23587	Decay
23588	Seasonal change
23589	Gateway-compatible
23590	TEV (tobacco etch virus) sequence
23591	coding sequence collection
23592	Male factor
23593	grey areas
23594	hospital organisation
23595	Veterinary medicine
23596	Coronavirus 2019 Disease
23597	mouthwash
23598	povidone iodine
23599	prolonged SARS-CoV-2 detection
23600	SARS-COV-19
23601	hospital visit
23602	public awareness
23603	public preparedness
23604	Scandinavia
23605	organization
23606	viral spread
23607	Atypical presentation
23608	SIADH, syndrome of inappropriate antidiuretic hormone secretion
23609	FST, Fitzpatrick skin types
23610	skin of color
23611	altmetrics
23612	publication metrics
23613	research waste
23614	recurrence
23615	dermatologist
23616	severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2)
23617	case fatality rates
23618	acute limb ischemia
23619	sars-cov-2 (severe acute respiratory syndrome coronavirus 2
23620	chilblain-like eruptions
23621	purpuric rash
23622	Research design
23623	Physical examination
23624	Safety measures
23625	Slit-lamp evaluation
23626	recommandation
23627	skin eruption
23628	RT-PCR, reverse-transcriptase polymerase chain reaction
23629	aorta
23630	aortic thrombosis
23631	Male genitalia
23632	Urinary frequency
23633	Urinary infection
23634	Viral cystitis
23635	Maculopapular eruptions
23636	muscle
23637	service provision
23638	special care dentistry
23639	Equipment reuse
23640	Microbial viability
23641	Respiratory protective devices
23642	winter
23643	Kerala (India)
23644	containment action
23645	frontline actions
23646	domestic violence
23647	dynamic
23648	Ecology
23649	Physiology
23650	ACHD, adult congenital heart disease
23651	cardiac risk
23652	congenital heart defect
23653	shortness of breath
23654	Arrhythmology
23655	Electrophysiology
23656	Arterial occlusion
23657	burials and cremation
23658	funerary practices and rituals
23659	violations and ethics
23660	Neurologic surgery
23661	SARS-CoV-2, severe acute respiratory syndrome coronavirus-2
23662	Microsurgery
23663	geographic variability
23664	Self-Isolation
23665	angioedema
23666	CPET
23667	Exercise intolerance
23668	Facial mask
23669	emergency radiology
23670	clinical sensitivity
23671	in vitro diagnostics
23672	teledermatopathology
23673	teledermoscopy
23674	Politraumatizado
23675	Trauma care
23676	Nanotoxicology
23677	Virus-host interaction
23678	pulmonary arterial hypertension
23679	Laser
23680	Plume
23681	bell's palsy
23682	guillain-barre syndrome
23683	Death Rate
23684	Health Management
23685	Hospital Beds
23686	Hospital Stress
23687	Statistical methods
23688	Surge testing
23689	Bioética
23690	Mechanical ventilator
23691	ems
23692	telerheumatology
23693	Psychological outcomes
23694	PLACE-19 Study
23695	national population-based study
23696	personal protective behaviors
23697	anatomy education, teaching
23698	cadaver
23699	dissection
23700	attendance
23701	ed attendances
23702	ed crowding
23703	PR Interval
23704	African morality
23705	cohesion
23706	sub-Saharan ethics
23707	Surgical algorithm
23708	Surgical indication
23709	Olfactory and taste disturbances
23710	Distance
23711	anesthesia machine
23712	dead space
23713	fluorescence microsphere
23714	Elective
23715	Hip arthroplasty
23716	Urgent
23717	Outpatient surgery
23718	Same day surgery
23719	Immunosenesce
23720	Mood disorders
23721	Education websites
23722	Quality of information
23723	automated detection
23724	backyard studies
23725	community science
23726	long‐term ecological/ecosystem research network
23727	multicity collaboration
23728	urban ecology
23729	Random vector functional link
23730	Wavelets
23731	AMS
23732	advanced directives
23733	Atrial Fibrillation
23734	EKG, Electrocardiogram
23735	LAD, Left anterior descending artery
23736	LDH, Lactate dehydrogenase
23737	LVEF, Left ventricular ejection fraction
23738	LVH, Left ventricular hypertrophy
23739	List: COVID-19, Coronavirus Disease-2019
23740	PCT, Procalcitonin
23741	RBBB, Right bundle branch block
23742	SARS-CoV-2, Severe Acute Respiratory Syndrome
23743	TTC, Takotsubo cardiomyopathy
23744	TTE, Transthoracic Echocardiogram
23745	cTnT, cardiac troponin T
23746	hsCRP, High sensitivity C-reactive protein
23747	Gynecological oncology
23748	CRISPR/Cas
23749	Triage strategy
23750	National Health Service
23751	PSQI
23752	actigraphy
23753	circadian Rhythm
23754	away rotation
23755	medical student
23756	subinternship
23757	facial feminization surgery
23758	facial plastic and reconstructive surgery
23759	gender-affirming care
23760	transgender
23761	transgender surgery
23762	Elective case
23763	Emergency case
23764	Priority case
23765	Personal Protection Equipment (PPE)
23766	Compartmental models
23767	Severe Acute Respiratory Syndrome Corona Virus-2
23768	Humanitarian Forensic Action
23769	Mass Fatality Response
23770	Viroporin
23771	Civil war
23772	patient-reported experience measures
23773	telephone consultation
23774	disabled people
23775	political process
23776	Family-centred care
23777	Perinatal care
23778	pulmonary intravascular coagulation
23779	Health market
23780	Pharmaceutical industry
23781	Pharmaceutical market
23782	Tele-health
23783	Blood culture-negative infective endocarditis
23784	Robotic surgical procedures
23785	noninvasive ventilation
23786	climatological factors
23787	solar irradiance
23788	BuzzSumo
23789	host immune responses
23790	microbial pathogens
23791	Agent-based simulation
23792	Epidemic models
23793	case studies
23794	nasal manifestation
23795	pharynx
23796	family-centered care
23797	otoendoscope
23798	portable otoendoscopy
23799	smartphone technology
23800	Cleavage
23801	Extreme situation
23802	Psychosis
23803	Delivery of health care
23804	Cardiac protocol
23805	chest imaging
23806	chilblain-like lesions
23807	band ligation
23808	endoscopic intervention
23809	hematemesis
23810	Communications media
23811	Information dissemination
23812	Tanzania
23813	histopathological findings
23814	hypercoagulable state
23815	micro thrombosis
23816	Medical education & training
23817	collegiality
23818	professionalism
23819	ART Pregnancies
23820	Peritonitis
23821	Nutritional status
23822	Public
23823	Faith-based
23824	Religion
23825	clinical psychiatry
23826	hospital management
23827	pandemia 
23828	organisation of health services
23829	Food Systems
23830	Food and Nutrition Security
23831	Meat
23832	NANDA-I
23833	NIC
23834	NOC
23835	standardized nursing languages
23836	Hierarchical clustering
23837	Kolmogorov complexity theory
23838	Multidimensional scaling
23839	Shannon information theory
23840	Crowd dynamics
23841	Frontliner
23842	Operational strategy
23843	Practice-Based Learning and Improvement
23844	Resident safety
23845	Resident well being
23846	Surgical residency
23847	Systems-Based Practice
23848	Fake news
23849	Community partnerships
23850	Faith
23851	Psycho-social impact
23852	Spatial
23853	bioaerosols
23854	Constrained optimization
23855	Quarantine control
23856	Health inequity
23857	Immunity passports
23858	Tracing apps
23859	midwifery
23860	sustainable development goals
23861	didactic
23862	immune passports
23863	latent infection
23864	Hemorrhage
23865	ICH
23866	Hematopoiesis
23867	Sampling methods
23868	Abbott Architect
23869	False-negative reactions
23870	Loop-mediated isothermal amplification
23871	Specificity and sensitivity
23872	Allplex 2019-nCoV (Seegene)
23873	limit of detection
23874	Antigen testing
23875	16S rRNA sequencing
23876	Bacterial community
23877	Science–Religion–Government
23878	SARS-CoV-2 serology
23879	cold agglutinin disease
23880	Réunion Island
23881	cytopathology
23882	Antisense Tethering Interactions
23883	Data Driven Analysis
23884	Host-Gene Interactions
23885	Host-Gene-Drug Interactions
23886	Systems Biology
23887	Corona Virus (COVID-19/SARS-CoV-2) outbreak
23888	Government sponsors
23889	Logistics and operations management
23890	“Bring-service-near-your-home” mobile service operations
23891	Ebolavirus
23892	Oligonucleotides
23893	PCR primer
23894	Therapeutic oligonucleotide
23895	Zoonotic virus
23896	Covid-19, SARS CoV-2
23897	Tracheostom
23898	neutralizing activity
23899	oral lesions
23900	oral symptoms
23901	sensorineural hearing loss
23902	Permethrin
23903	Scabies infestation
23904	Sémiologie
23905	nosocomial spread
23906	theatre ventilation
23907	Allergic Contact Dermatitis
23908	Patch test
23909	Blood group
23910	Biomedical Research
23911	Education, Medical
23912	Immunuglobulins
23913	Gynecologic emergency
23914	HEPA filters
23915	airborne microorganisms
23916	negative-pressure rooms
23917	route of infection
23918	Multiple sclerosis treatments
23919	Varicella zoster
23920	herpes simplex
23921	mucosal lesions
23922	oral manifestations
23923	Immune-mediated
23924	Hematological malignancies
23925	IL-1R blockade
23926	alert
23927	pathway
23928	stroke care
23929	lateral flow immunochromatography
23930	ABL
23931	CML
23932	TKI
23933	perinatal care
23934	malignant stroke
23935	Dupilumab
23936	oral mucositis
23937	Collective psychology
23938	Corona crisis
23939	Place attachment
23940	Social identity
23941	Systems thinking
23942	Transformation
23943	ENT symptoms
23944	Respiratory symptoms
23945	Neutrophil Extra-cellular Traps (NETs)
23946	major incidents
23947	Primary arthroplasty
23948	Oral vaccine
23949	intranasal vaccine
23950	mucosal adjuvant
23951	sIgA
23952	Filter
23953	Surgical smoke
23954	hypertensive encepha
23955	Nasopharyngeal swab samples
23956	Older age
23957	Acute inflammatory demyelinating polyneuropathy
23958	Cranial neuropathy
23959	Polyradiculoneuropathy
23960	Cardiorespiratory arrest
23961	correlation coefficient
23962	fast Fourier transform
23963	quantified EEG
23964	spectral entropy
23965	human resource management
23966	organisational development
23967	Point-of-care devices
23968	Serology testing
23969	 COVID-19 coagulopathy
23970	 amputation
23971	 ischaemia
23972	 rehabilitation
23973	Cuidados de enfermería
23974	Hospitalización
23975	classification
23976	galactomannan
23977	probable
23978	putative
23979	extracellular vesicle
23980	Post mortem
23981	PPE and pandemic
23982	clinical practice guideline
23983	spinal cord
23984	Intussusception
23985	Sexual satisfaction
23986	Laboratory Hematology
23987	Quarantine effectiveness
23988	Non-adaptive testing
23989	Pool testing
23990	Celiac disease
23991	autoantibody
23992	bullous disease
23993	hand dermatitis
23994	Face touching
23995	Crisis standard of care
23996	Crisis triage officer
23997	Ethics committee
23998	duplicate testing
23999	repeat testing
24000	COCATS
24001	Sniffin’ sticks
24002	smell test
24003	healthcare provisions
24004	System identification
24005	activity level
24006	implantable cardioverter defibrillator
24007	COVID-19. postinfectious parkinsonism
24008	parkinsonism
24009	enhanced contrast echocardiography
24010	intrapulmonary shunt
24011	neurointerventional
24012	SARS-CoV-2; COVID-19; ARDS; P0.1; ΔPocc; P-SILI.
24013	endoscopy unit
24014	chemoprophylaxis
24015	Fibreoptic intubation
24016	Hypoxic pulmonary vasoconstriction
24017	low-flow
24018	nasal cannula
24019	oxygen delivery
24020	barrier enclosure
24021	schlieren analysis
24022	direct laryngoscopy
24023	clinical pharmacy services
24024	hospital volunteers
24025	broncho-alveolar lavage
24026	psychosis spectrum
24027	COVID-19, Abbott ID NOW
24028	Dry nasopharyngeal swab
24029	colectomy
24030	liability protections
24031	e-education
24032	teleconsulting
24033	Nursing students
24034	Study-to-work transition
24035	Undergraduate nurses
24036	Prone
24037	face shields
24038	colostomy
24039	ileostomy
24040	ostomy
24041	stoma
24042	COVID-19 Associated Pulmonary Aspergillosis
24043	Surgical training
24044	Haematoma
24045	Spontaneous bleeding
24046	VTE prophylaxis
24047	Infectious Disorders
24048	Thrombotic Thrombocytopenic Purpura
24049	Superinfection
24050	human-animal bond
24051	welfare
24052	Clinical presentation
24053	Vein portal
24054	peritoneal
24055	Social sciences
24056	Adaptive governance
24057	Adaptivity
24058	Agile governance
24059	Agile organization
24060	Co-Infection
24061	Plasmodium vivax
24062	Satisfacción
24063	Satisfaction
24064	ENT physician
24065	Percutaneous tracheostomy
24066	mucosal viral lesion
24067	oral mucosal lesion
24068	surgeon
24069	Displacement ventilation
24070	SARS-CoV-2 spread
24071	laminar air flow
24072	mixed ventilation
24073	no ventilation
24074	Astronomy and astrophysics
24075	dental impression
24076	digital workflow
24077	intraoral scanner
24078	Orthopedic
24079	CGRP
24080	calcitonin gene-related peptide
24081	Hierarchical method
24082	Tests
24083	ionized calcium
24084	New Caledonia
24085	QTc prolongation
24086	tyrosine kinase inhibitor
24087	Throat washings
24088	Institutions
24089	MDRGNB
24090	WHO-recommended hand rub
24091	modified formulation
24092	Craniotomy box
24093	Safe alternative
24094	Cons
24095	Pros
24096	Cadaver dissection
24097	Deep-learning
24098	Explainable AI
24099	Interpretability
24100	Prototype-based models
24101	Open science
24102	Aesthetic dermatology
24103	teleneurology
24104	Adverse outcome pathway
24105	DAMPs
24106	Exposome
24107	Communication of risk and mitigation measures
24108	Effectiveness of mitigation measures
24109	Recovery from measures to mitigate infection spread
24110	Resilience management in case of pandemic
24111	Transfer crisis and resilience management concepts from natural hazards to pandemic
24112	Homologous recombination
24113	RdRp enzyme
24114	Receptor binding domain (RBD)
24115	orf1a/b
24116	dromedary camel
24117	Effective daily reproduction ratio
24118	Emerging and reemerging pathogens
24119	Inference
24120	Markov Poisson
24121	Spike Gene
24122	Modified SEIR model
24123	HLJBY strain
24124	genomic sequence
24125	open reading frame 3
24126	porcine epidemic diarrhoea virus
24127	Canine coronavirus
24128	Cutaneous
24129	Empirical study
24130	Treatment efficacy
24131	Wuhan China
24132	Control reproduction number
24133	Intervention measure
24134	Risk estimation and prediction
24135	Neural Networks
24136	Self-Organizing Maps
24137	Spatial Similarity
24138	Preferred nucleotides
24139	compartmental model
24140	Cumulative incidence
24141	dromedary camels
24142	Differential evolution algorithm
24143	Inverse problem
24144	Mathematical modeling of COVID-19
24145	Multi-objective optimization
24146	Optimal control problem
24147	Fetal echocardiography
24148	Fetal tele-echocardiography
24149	MERS-RBD
24150	bat CD26
24151	Neumonia
24152	Biology
24153	Fractional calculus
24154	Fractional derivative equation
24155	Brazilian Ministry of Health
24156	Sao Paulo
24157	Cas9
24158	Clustered regularly interspaced short palindromic repeats
24159	Mouse
24160	Fibrous stripe
24161	GGO
24162	Sequalae
24163	Beta thalassemia
24164	Respiratory distress
24165	Sardinia
24166	ARIMA-Wavelet
24167	Commodity market volatility
24168	Covid-19 spread
24169	Pandemics risks
24170	SDH
24171	COVID-19 prognosis
24172	Dynamic CT assessment
24173	Moderate COVID-19 Pneumonia
24174	ace (angiotensin-converting enzyme)
24175	angiotensin ii (agii)
24176	angiotensin receptor type 1 (at1r)
24177	angiotensin receptor type 2 (at2r)
24178	ras (renin angiotensin system)
24179	Olfactory disorders, olfactory dysfunction, COVID-19, olfactory recovery, anosmia
24180	Modeling pandemic evolution
24181	medical practice
24182	antirheumatic drugs
24183	phases
24184	Pulmonary Fibrosis
24185	Reversed halo sign
24186	41A28
24187	65D05
24188	65H10
24189	65L20
24190	65P30
24191	65P40
24192	65Z05
24193	Fractional optimal control
24194	Fractional order sidarthe model
24195	Lyapunov exponents
24196	Predictor-corrector algorithms for fractional differential equations
24197	framing
24198	public understanding
24199	disease transmission model
24200	Nonlinear dynamics
24201	Enfermedades transmisibles
24202	Environment and public health
24203	Epidemias
24204	Medio ambiente y salud pública
24205	Monitoreo epidemiológico
24206	Network inference
24207	SIR-type models
24208	Prone Positioning
24209	Green development concept
24210	Asymptomatic individuals
24211	SIR-typed model
24212	Second outbreak
24213	forensic mental health
24214	isolation units
24215	secure hospital
24216	Temporary Ark Hospital
24217	emergency planning
24218	health crisis management
24219	pandemic influenza plan
24220	Internet public opinion
24221	Latent Dirichlet Allocation (LDA)
24222	Sentiment Analysis
24223	Genome recombination
24224	Viral metagenomics
24225	SARS-HCoV-2
24226	Collective phenomena
24227	Dynamics of social systems
24228	Attenuation
24229	Cell adaptation
24230	NS7a/7b
24231	SADS-CoV
24232	Antigen capture ELISA
24233	Molecular detection
24234	infectious period
24235	the reproduction number
24236	Pathogen avoidance
24237	Social anxiety
24238	Social perception
24239	Epidemic evolution dynamic
24240	Fitting data
24241	Iterative process
24242	Mathematical models
24243	MCMC
24244	SIRU model
24245	epidemics modeling
24246	Experimental evolution
24247	Forced adaptation
24248	Host restriction
24249	Semi-permissive cell line
24250	Species barrier
24251	head and neck squamous cell carcinoma
24252	Alphacoronavirus
24253	Th1/Th2
24254	Consumers
24255	Shopping
24256	COVID-19 spreading
24257	Hidden Markov chain
24258	FDG PET/CT
24259	human coronavirus NL63
24260	new subgenotype
24261	Porcine deltacoronavirus
24262	Porcine diarrhea
24263	Swine acute diarrhea syndrome coronavirus
24264	(SIAQRD) model
24265	COVID-19 virus pandemic
24266	Disease free equilibrium stability
24267	Mathematical modeling of infection disease
24268	virus spreading
24269	Adaptive systems
24270	Geographic profiling
24271	Topological weighted centroid
24272	ablation therapies
24273	hepatic resection
24274	Approximate entropy
24275	Cryptocurrency
24276	Largest Lyapunov exponent
24277	Stock markets
24278	Mathematical epidemiology
24279	Dosage regimens
24280	Dose related toxicity
24281	Modeling and simulation
24282	AI-led innovation
24283	Business school
24284	Digital transformation
24285	National vs. regional diffusion
24286	Causality
24287	Complex networks
24288	COVID-19 impacts
24289	Home life impacts
24290	Work life impacts
24291	Work-family conflict
24292	feedback and control
24293	non-symptomatic testing
24294	group
24295	growth
24296	infection rates
24297	predictions
24298	theory
24299	Multigroup model
24300	Public-health
24301	SEIRA models
24302	Clinical clerkship
24303	Medical school administration
24304	CIEDs
24305	Pneumomediastinum
24306	Data-driven
24307	Imposed measures
24308	Infection horizon
24309	Price reaction
24310	Volatility timing
24311	Clinical spectrum
24312	Nature history
24313	SI(R) model
24314	SIRS model
24315	Laos
24316	Poultry diseases
24317	bird health
24318	chicken
24319	duck
24320	smallholders
24321	PEDV
24322	SeCoV
24323	epidemic diarrhoea
24324	porcine epidemic diarrhoea
24325	swine enteric coronavirus
24326	COVID-19, pandemic
24327	Food systems
24328	28A80
24329	92A15
24330	92D30
24331	Box-dimension
24332	Epidemic spreading
24333	Fractal interpolation
24334	faculty survey
24335	field instruction
24336	pedagogy
24337	remote teaching
24338	Interprofessional education
24339	evolving pedagogic approaches
24340	future innovation
24341	impact of virtual IPE
24342	genetic distance
24343	pigeon
24344	species
24345	taxonomy
24346	RNA sensor
24347	gene loss
24348	tolerance
24349	Emergent viral infection
24350	Microbiome
24351	Reproduction number R
24352	infectious bronchitis virus
24353	community pharmacy
24354	direct and indirect remuneration
24355	healthcare payment model
24356	pharmacist role
24357	pharmacy benefit manager
24358	pharmacy services
24359	value-based payment
24360	Swine coronavirus
24361	Ramsey
24362	bovine coronavirus
24363	geographic clustering
24364	molecular clock
24365	Neonatal Fc receptor
24366	polymeric immunoglobulin receptor
24367	chimeric virus
24368	full-length genome
24369	Mutation pressure
24370	Nature selection
24371	PDCoV
24372	Allee effect
24373	Differential equation with piecewise constant arguments
24374	Local stability analysis
24375	Neimark-Sacker Bifurcation
24376	CO2 emissions
24377	NAD worlds
24378	anthropocene
24379	deaths of despair
24380	demographic transition
24381	disease X
24382	disease transitions
24383	metabolic rift
24384	new levellers
24385	nicotinamide
24386	protonopathy
24387	Geographic region
24388	Equipoise
24389	filovirus
24390	porcine epidemic diarrhoea virus (PEDV)
24391	genotype classification
24392	Disease pyramid
24393	Ecosystem health
24394	Zoonoses
24395	behavioural immunity
24396	pathogens and extinction risk
24397	sociality
24398	virtual communication
24399	older persons
24400	          Coronaviridae        
24401	IBV
24402	avian coronavirus
24403	deltacoronavirus
24404	gammacoronavirus
24405	bacteriophage
24406	directed evolution
24407	emerging viral pathogen
24408	selective pressure
24409	general medicine (see internal medicine)
24410	history (see medical history)
24411	Chiroptera
24412	within-host model
24413	Bird Parks
24414	Gamma coronavirus
24415	Phylogenetic Analysis
24416	avian infectious bronchitis virus
24417	Canine kobuvirus
24418	Canine distemper virus
24419	Canine parvovirus
24420	Iberian wild carnivores
24421	Swine influenza virus
24422	avian-origin influenza virus
24423	influenza C virus
24424	influenza D virus
24425	DNA sequencing
24426	Nanopore
24427	metagenomic
24428	Bio-functionalization
24429	Biosensing
24430	Inflation targeting
24431	Monetary Policy Committee
24432	Monetary transmission process
24433	Unconventional monetary policy measures
24434	Crisis situation
24435	Multiagent Systems
24436	Supply Chain
24437	logistics flow
24438	modelisation
24439	optimisation
24440	Adaption and evolution
24441	Complete genome
24442	Pheasant coronavirus
24443	S1 gene
24444	vaccine spreading
24445	variant 2
24446	emerging strains
24447	spike gene
24448	16S rRNA gene
24449	colonic microbiota
24450	colonic mucosa
24451	suckling pigs
24452	cathepsin
24453	monoterpene
24454	pharmacokinetic
24455	Lung immunopathology
24456	3CLpro, 3C-like protease
24457	Bioactivity
24458	CBE, CBM, Herbal extracts from Rhizoma Cibotii
24459	CC50, 50% cytotoxicity concentration
24460	CDC, Cholesterol-dependent cytolysin
24461	CPE, Cytopathogenic effect
24462	CTH, Herbal extract from Cassiae Semen
24463	Covid-19, Coronavirus Disease 2019
24464	DBM, Herbal extract from Dioscoreae Rhizoma
24465	EC50, 50% effective concentration
24466	FA, Fatty acid
24467	FFA, Free fatty acid
24468	GCG, Gallocatechin gallate
24469	GSH, Herbal extract from Gentianae Radix
24470	IC50, 50% inhibitory concentrations
24471	MNP, Marine Natural Product
24472	MTT test, Cytotoxicity test using 3- (4,5-dimethylthiazol-2-yl) −2,5-diphenyltetrazolium bromide
24473	Mpro, The major protease
24474	PLY, Pneumolysin
24475	PLpro, The papain-like protease
24476	Plant extracts
24477	Polyphenols
24478	RNA, Ribonucleic acid
24479	SARS-CoV, Severe Acute Respiratory Syndrome coronavirus
24480	TCH, Herbal extract from Loranthi Ramus
24481	tumour
24482	Air traffic
24483	International flights
24484	postgraduate students
24485	undergraduate students
24486	virtual laboratories
24487	acute lung injury (ALI)
24488	angiotensin II (Ang II)
24489	DUB
24490	PLP2
24491	active site
24492	molecular aspects
24493	fusion
24494	fusion peptide
24495	modern Technologies
24496	supportive Care
24497	traditional Approaches
24498	Chinese herbal medicine (CHM)
24499	febrile epidemics (wenyi)
24500	traditional Chinese medicine (TCM)
24501	warm diseases (wenbing)
24502	Aanimal model
24503	hDPP4
24504	transgenic mouse
24505	cross-reactive antibody
24506	mTOR inhibitors
24507	rapamycin
24508	escape room
24509	remote-teaching
24510	Regenerative medicine
24511	Glioma and Molecular Docking
24512	TRIM25
24513	interferon-β
24514	interferon-λ1
24515	SARS-CoV unique domain (SUD), CXCL10
24516	SARS-coronavirus
24517	pulmonary inflammation
24518	Plaques inhibition
24519	Anxiety scale
24520	Psychometric properties
24521	chronic disease patients
24522	PhD education
24523	rural-urban disconnect
24524	Home based exercise
24525	IPAQ-SF
24526	PGWBI
24527	career barriers
24528	science
24529	Basque Country
24530	Cuestionario web
24531	Euskadi
24532	Online social media
24533	Redes sociales
24534	Web-based questionnaire
24535	Fatty Acid
24536	Lipotoxicity
24537	Unsaturated
24538	actin filaments
24539	host cytoskeleton
24540	intermediate filaments
24541	microtubules
24542	Attention
24543	Choline
24544	Phosphatidylcholine
24545	Anti-TNF-α
24546	Cheminformatics
24547	Immune genes
24548	Immuno-transcriptomics
24549	Interactomics
24550	Systems pharmacology
24551	Mild symptoms
24552	Recoveries
24553	healthcare capacity
24554	individual behavior
24555	individual-based modeling
24556	public health mandates
24557	acute multiorgan injury
24558	multiorgan dysfunction
24559	Hepatitis C Virus (HCV) NS3/4A protease inhibitors
24560	Human Immunodeficiency Virus 1 (HIV-1) protease inhibitors
24561	Severe Acute Respiratory Syndrome (SARS)
24562	structural bioinformatics
24563	cyclic lipopeptide
24564	surfactin
24565	Colorectal cancer resection
24566	Open data
24567	Protein S
24568	Point-of-care (POC)
24569	cryoelectron microscopy
24570	feline infectious peritonitis virus
24571	protein glycosylation
24572	fetal programming
24573	Critical & mortal COVID-19
24574	Publication bias
24575	G protein-coupled receptor
24576	Coxsackievirus B3
24577	Mineralocorticoid receptor inhibition
24578	Synthetic biology
24579	Bovine Coronavirus
24580	Immunological disorders
24581	student engagement
24582	undergraduate research
24583	IBDoc®
24584	fecal calprotectin home test
24585	anti-vimentin autoantibodies
24586	cell surface vimentin
24587	posttranslational modifications
24588	tissue damage and repair
24589	vimentin
24590	vimentin–pathogen interactions
24591	herpesvirus
24592	ubiquitin-like deconjugase
24593	virus cycle
24594	Non-coding RNAs
24595	antiviral immune responses
24596	circular RNAs
24597	rna sequencing
24598	avian metapneumovirus
24599	Cattle
24600	Dairy calves
24601	Drug Polypharmacology
24602	deep Learning
24603	drug Repurposing
24604	molecular Promiscuity
24605	multi-omics
24606	multi-targeting Design
24607	network Pharmacology
24608	off-targets
24609	gene cloning
24610	molecular characteristics
24611	novel feline interferon omega
24612	soluble expression
24613	Lateral flow dipstick
24614	Recombinase polymerase amplification
24615	Visual detection
24616	brain change
24617	brain function
24618	developmental change
24619	digital revolution
24620	mental health, well-being, mental health assessment, diagnostics, virtual therapy
24621	enteric tropism
24622	Anthocyanins
24623	Structural-relationship effects
24624	monocyte-to-lymphocyte ratio
24625	Leucomethylene blue
24626	Methylene blue
24627	Economic losses
24628	Extracorporeal life support
24629	urinary sediment
24630	Photobiomodulation
24631	Pulsed blue light
24632	Red or near infrared light
24633	immunosuppressive treatment
24634	Red blood cell distribution width
24635	anti-inflammatory drug
24636	assessment of educational activities
24637	e-OSPE
24638	formative assessment
24639	international health education in developing and developed countries
24640	Monoclonal human antibodies
24641	advisory
24642	clinical decision support system
24643	family health center
24644	hemogram
24645	serum biochemical parameters
24646	African traditional herbal medicine
24647	biodiversity
24648	Atmospheric NO2
24649	COVID-19 pandemic in India
24650	Emission from transportation
24651	Pollution and COVID-19
24652	N-acetyl cysteine
24653	biochemistry education
24654	using simulation and internet resources for teaching
24655	blood urea nitrogen
24656	Newborn health
24657	Autodock tool
24658	pkCSM tool
24659	Respiratory aerosols
24660	MERS-CoV helicase
24661	anti-MERS-CoV activity
24662	triazole derivatives
24663	Chest X-Ray Image
24664	image identification
24665	transfer learning
24666	predictive model
24667	Angiotensin-converting enzyme (ACE)-2 receptor
24668	drug.
24669	case-based learning
24670	Nicotinic agonist
24671	asymptomatic COVID-19 infection
24672	late pregnancy
24673	reverse-classroom
24674	miscommunication
24675	Case-report
24676	Reverse takotsubo cardiomyopathy
24677	DHA – 22:6n-3
24678	EPA - 20:5n-3
24679	IL-6 (Interleukin 6)
24680	DUB activity
24681	IFN antagonist
24682	PLP2 structure
24683	Endothelial glycocalyx
24684	Myocardial deformation
24685	DASS-21
24686	Home-quarantine
24687	Cases
24688	AYUSH
24689	eating behaviour
24690	CK
24691	CK-MB
24692	De Ritis ratio
24693	gestational diabetes
24694	Montenegro
24695	Albumin
24696	Liver profile
24697	In silico drug discovery
24698	boronic acid
24699	carbon quantum dots (CQDs)
24700	human coronavirus (HCoV)
24701	multivalent interactions
24702	laboratory exercises
24703	CRCoV
24704	Canine infectious respiratory disease
24705	Evolutionary genetics
24706	Kennel cough
24707	Cannabinoids
24708	COVID-19, T2DM
24709	Cyclooxygenase
24710	Prostaglandin
24711	Cytokines and chemokines
24712	Inflammatory monocyte-macrophages
24713	Broad-spectrum antiviral
24714	Coronavirus nucleocapsid
24715	Cyclophilin A/B
24716	Cyclophilin inhibitors
24717	DBS
24718	SomaScan
24719	TAP
24720	VAMS
24721	microsampling
24722	patient-centric sampling
24723	sampling device
24724	minerals
24725	omega-3 fatty acids
24726	vitamins
24727	LPS
24728	NALPR3
24729	Nifuroxazide
24730	TILR4
24731	AGE, Aged garlic extract
24732	AIV-H9N2, Avian influenza virus-H9N2
24733	ALT, Alanine aminotransferase
24734	ARVI, Acute respiratory viral infection
24735	AdV-3, Adenovirus-3
24736	AdV-41, Adenovirus-41
24737	CBV-3, Coxsackie B −3
24738	CPE, Cytopathic effect
24739	CoV, Coronavirus
24740	DADS, Diallyl disulfide
24741	DAS, Diallyl sulfide
24742	DATS, Diallyl trisulfide
24743	DDB, Dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate
24744	ECHO11, Echovirus-11
24745	ECM, Extracellular matrix
24746	ERK, Extracellular-signal-regulated kinase
24747	FDA, Food and drug administration
24748	Functional food
24749	GE, Garlic extract
24750	GLRaV‐2, Grapevine leafroll‐associated virus 2
24751	GO, Garlic oil
24752	GRAS, Generally regarded as safe
24753	HAV, Hepatitis A virus
24754	HCMV, Human cytomegalovirus
24755	HIV-1, Human immunodeficiency virus-1
24756	HPV, Influenza B virus Human papillomavirus
24757	HRV-2, Human rhinovirus type 2
24758	HSV-1, Herpes simplex virus-1
24759	HSV-2, Herpes simplex virus-2
24760	Hp, Haptoglobin
24761	IAV-H1N1, IBV Influenza A virus-H1N1
24762	IEG1, Immediate-early gene 1
24763	IEGs, Immediate-early genes
24764	LGE, Lipid garlic extract
24765	MAPK, Mitogen activated protein kinase
24766	MARS-CoV, Middle East respiratory syndrome coronavirus
24767	MDCK cells, Madin-darby canine kidney cells
24768	MeV, Measles virus
24769	NA, Not available
24770	NDV, Newcastle disease virus
24771	NK, Natural killer
24772	OSCs, Organosulfur compounds
24773	Organosulfur compounds
24774	PGE, Powdered garlic extract
24775	PIV- 3, Parainfluenza virus-3
24776	PRRSV, Porcine reproductive and respiratory syndrome virus
24777	PRV, Porcine Rotavirus
24778	PVY, Potato Virus Y
24779	RCTs, Randomized clinical trials
24780	RMCW, Recalcitrant multiple common warts
24781	RV-SA-11, Rotavirus SA-11
24782	SAC, Serum antioxidant concentration
24783	SAMC, S-allyl-mercaptocysteine
24784	SAMG, S-allyl-mercapto-glutathione
24785	SARS-CoV, Severe acute respiratory syndrome coronavirus
24786	SI, Selectivity index
24787	SRGE, Sustained release garlic extract
24788	SWV, Spotted wilt virus
24789	VSV, Vesicular stomatitis virus
24790	VV, Vaccinia virus
24791	ADAMTS13
24792	Pharmacophore modeling
24793	broad-spectrum
24794	chaperna
24795	chaperone
24796	DASS
24797	Immunometabolism
24798	Innovative training network
24799	Pneumovirus
24800	Acute emergency care
24801	Extracellular vesicle therapy
24802	Trauma and critical care medicine
24803	C5-pyrimidine ribofurano nucleosides
24804	Sonogashira reaction
24805	antiviralactivity
24806	cytotoxic activity
24807	microwave irradiation.
24808	deISGylase
24809	Cardiac diseases
24810	Cardiac metabolism
24811	Transcription factors
24812	active learning
24813	cooperative/collaborative education
24814	scholarship of teaching and learning
24815	antioxidant capacity
24816	dysmetabolism
24817	Polyunsaturated Fatty Acids
24818	2-AAPA
24819	BSO
24820	glutathione reductase
24821	neutrophil apoptosis
24822	neutrophil functions
24823	ACTN-4
24824	NS7
24825	mitochondrial localization
24826	adipokine
24827	intestinal hormones
24828	myokine
24829	Nanoemulsion
24830	Haemorrhagic enteritis virus
24831	Methionine
24832	Turkeys
24833	anti-infective surfaces
24834	carbon nanomaterials
24835	metal-organic frameworks
24836	nanostructured fibrous scaffolds
24837	osteogenic surfaces
24838	carbohydrates
24839	host-guest systems
24840	molecular recognition
24841	supramolecular chemistry
24842	Middle East respiratory syndrome human coronavirus
24843	genomic sequences
24844	growth kinetics
24845	Genomic comparison
24846	Target antigenic sites
24847	FCoV
24848	Feline infectious peritonitis (FIP)
24849	Phylogeography
24850	Alphacoronavirus 1
24851	Biocomputational method
24852	Cats
24853	Dogs
24854	Phylogenetic relationship
24855	Viral genetics
24856	6 proteins
24857	NeoCoV
24858	bioinformatics analysis
24859	evolutionary study
24860	Camel
24861	outpatient clinic
24862	Care-associated infections
24863	Hematopoietic cell transplant
24864	Phylogenetic analyses
24865	Whole genome sequencing
24866	BLAST, basic local alignment search tool
24867	ORF-8
24868	ORF-8, open reading frame 8
24869	Conference
24870	Human genetics
24871	Human genomics
24872	Full-length cDNA clone
24873	Saccharomyces cerevisiae
24874	Synthetic genomics
24875	Transformation-associated recombination (TAR) cloning
24876	ACE-inhibition
24877	angiotensin-receptor blockade
24878	angiotensinogen
24879	Rousettus bat coronavirus GCCDC1
24880	lesser dawn bat
24881	recombinant
24882	MERS-CoV carrier phenomenon
24883	Maternal morbidity/mortality
24884	Neonatal morbidity/mortality
24885	Drug repurposition
24886	IFIH1
24887	Interferon-beta
24888	insulin pump
24889	SASRS-CoV-2
24890	zebrafish
24891	multiple organ dysfunction syndrome
24892	Chimeric antigen receptor (CAR) T cell‐induced cytokine release syndrome
24893	anakinra
24894	Bipolar disorder
24895	Inositol
24896	health research
24897	healthcare policy
24898	infectious outbreaks
24899	medical disaster
24900	psychiatric guidelines
24901	psychiatric organisations
24902	consent
24903	art
24904	project
24905	FIP
24906	cell mediated immunity
24907	Sudden cardiac death
24908	Hyperglycemia in pregnancy
24909	Data sharing
24910	Health governance
24911	Bovine coronaviruses
24912	Bovine herpesvirus 1
24913	Bovine viral diarrhea viruses
24914	Genetic sequencing
24915	Influenza D virus
24916	digital resources
24917	next-generation trainee
24918	Co-detection
24919	Febrile status epilepticus
24920	Human coronavirus HKU1
24921	Human parainfluenza virus 2
24922	Influenza C virus
24923	Multiplex real-time RT-PCR
24924	Non-synonymous mutations
24925	Molecular simulations
24926	Multiscale modelling
24927	Structural genomics
24928	IL-6 inhibition
24929	Javamide-II (N-caffeoyltryptophan)
24930	macrophage-like THP-1 cells
24931	p38/ATF-2
24932	anticancer
24933	biomolecules
24934	cardiac glycosides
24935	preclinical trials
24936	viral protein translation
24937	APC-targeting
24938	BM-DC
24939	pustulan
24940	subunit vaccination
24941	GUI based automated computational analysis
24942	Linear Discriminant Analysis
24943	Principal Component Analysis
24944	Raman spectroscopy
24945	Inflection points (IPs)
24946	Numbers of the accumulative confirmed patients (NACP)
24947	Plateau phase
24948	Feature selection
24949	KNN
24950	alternative and integrative medicine
24951	complementary
24952	narrative review
24953	complementary and alternative medicine
24954	herbal medicine
24955	SAIR model
24956	latent period
24957	citizen behaviors
24958	coevolution
24959	health resilience
24960	risk communication networks
24961	stochastic actor-oriented model
24962	voluntary public health measures
24963	Dosing strategy
24964	PBPK
24965	Surgical spinal procedure
24966	Patient-relevant outcome
24967	head and neck reconstruction
24968	safety precautions
24969	General pneumonia
24970	health priorities
24971	patient selection
24972	waiting lists
24973	convalescent blood product
24974	convalescent whole blood
24975	plaque reduction neutralization test
24976	Case-based reasoning
24977	Natural language processing
24978	Ontology
24979	Peritoneal metastases
24980	Primary peritoneal tumor
24981	Antibiotic therapy
24982	older
24983	MCDM
24984	Protein biomarker
24985	SODOSM
24986	sense of control
24987	Iterative ReliefF
24988	Residual Exemplar LBP
24989	pressure injury
24990	pressure ulcer
24991	prone possition
24992	Coronary thrombosis
24993	ST-Elevation MI
24994	Donor selection
24995	Recipients selection
24996	predictive modeling
24997	bedside
24998	bedside approach
24999	peripherally inserted central catheter
25000	vascular access
25001	residents and fellow
25002	bacterium-like particle
25003	recombinant rabies virus
25004	strategies for management
25005	muscle weakness
25006	taste impairment
25007	Fluid responsiveness
25008	Heart–lung interaction
25009	Passive leg raising test
25010	coronavirus mortality overestimation
25011	sampling bias
25012	carbon tax
25013	optimal portfolio selection
25014	standard pollution tax
25015	Adverse Reactions
25016	Drug-Related Side Effects
25017	hydroxycholorquine
25018	Emergency center
25019	deep vein thromboprophylaxis
25020	Distributed manufacturing
25021	Medical face shields
25022	Micro-supply chains
25023	Repurposed manufacture
25024	Simplified design
25025	virtual education
25026	electronic learning
25027	gamification
25028	Dempster-Shafer theory
25029	Hesitant fuzzy linguistic term set
25030	Multi-criterion decision-making
25031	Z-numbers
25032	Antidepressants
25033	Anxiolytics
25034	Patient and public involvement
25035	Hidroxicloroquina
25036	Primary Care
25037	Area Under Curve
25038	Improvement Science
25039	Patient Safety
25040	Quality Improvement
25041	Team work
25042	Middle East respiratory syndrome coronavirus (MERS-CoA)
25043	RNA adjuvant
25044	intramuscular immunization
25045	intranasal immunization
25046	protein-based vaccine
25047	futility
25048	treatment pooling
25049	trial design
25050	Assessment in training
25051	Covid--19
25052	International training
25053	Specialty selection
25054	COVID-19 epidemic in Wuhan
25055	Model selection
25056	Nonidentifiability
25057	Peak time of epidemic
25058	SIR and SEIR models
25059	endoscopic nasopharyngectomy
25060	maxillary swing nasopharyngectomy
25061	recurrent nasopharyngeal carcinoma
25062	robotic nasopharyngectomy
25063	Care implications
25064	environmental justice
25065	natural experiments
25066	Thomas Jefferson University
25067	multicenter experiences
25068	Hemogram
25069	Naïve-Bayes
25070	Scarcity
25071	Atraumatic restorative treatment
25072	Biological caries treatment
25073	Non-restorative caries control
25074	Paediatric dentistry
25075	Standard care
25076	Communities of Color
25077	Contagion prevention
25078	ethical
25079	scientific
25080	artificial respiration
25081	Acupuncture
25082	External therapy
25083	Moxibustion
25084	Non-pharmaceutic measures
25085	ant colony algorithm
25086	immune tabu search algorithm
25087	path optimization
25088	transit storage
25089	Pediatric cardiology
25090	cost
25091	match
25092	recruitment
25093	Ethics and politics
25094	Interview
25095	West syndrome
25096	antiseizure drugs
25097	electroencephalography
25098	infantile spasms
25099	Actitudes ante la muerte
25100	Aislamiento de pacientes
25101	Attitudes death
25102	Farewell ritual
25103	Funeral rites
25104	Patient escort service
25105	Patient isolation
25106	Ritos fúnebres
25107	Ritual de despedida
25108	Servicio de acompañamiento de pacientes
25109	treatment integrity
25110	Covid 19 pandemic
25111	Covid negative
25112	Operating room design
25113	Orthopaedic surgeries
25114	Surgical protocols
25115	Avian
25116	Fowlpox virus
25117	Infectious bronchitis virus (IBV)
25118	Nidovirus
25119	T7 RNA polymerase
25120	Transient dominant selection (TDS)
25121	Vaccinia virus
25122	Myocardial ischemia
25123	replication complex
25124	NRT
25125	e-cigarette
25126	smokefree mental health
25127	tobacco harm reduction
25128	Animal studies
25129	Kinetic modeling
25130	Neurotransmitters
25131	Positron emission tomography
25132	Investigación en linea
25133	Netnografy
25134	Netnografía
25135	Online Research
25136	Clinicians
25137	compassion
25138	mindfulness
25139	High-consequence infections
25140	Industrial hygiene
25141	Job hazard analysis
25142	rapid recovery
25143	readmissions
25144	revision
25145	personal protection devices
25146	safety test
25147	snorkel masks
25148	resident selection
25149	undergraduate medical education
25150	Cooperation
25151	Coordination
25152	Experiments
25153	Game theory
25154	Weakest-link game
25155	Filtering efficiency
25156	Smartphone microscope
25157	AMPK
25158	feeding
25159	hypoxic pulmonary vasoconstriction
25160	hypoxic ventilatory response
25161	seep-disordered breathing
25162	Building energy
25163	Energy harvesting
25164	Photo-thermoelectric module
25165	Seebeck coefficient
25166	Semitransparent
25167	Solar energy
25168	cell biology
25169	imaging flow cytometry
25170	platelet
25171	ENC
25172	RSCU
25173	Slow codons
25174	Paris
25175	infection prevention and control policies
25176	midwifery unit management
25177	nonurgent care
25178	rescheduling
25179	Infectious disease epidemic
25180	Lockdown intervention
25181	Population mobility
25182	Life satisfaction
25183	Scale
25184	PDF2180
25185	emergence
25186	Amphetamine
25187	Cocaine
25188	Contingency management
25189	Stimulant
25190	adaptations
25191	detection probability
25192	latent prevalence
25193	Anxiety-related disorders
25194	frustration intolerance
25195	mood states
25196	Florida
25197	Health systems framework
25198	Miami-dade county
25199	rheumatic disease
25200	Medical information system
25201	Social contacts
25202	Medical care worker
25203	Posttraumatic stress disorder
25204	Psychological Adaptation
25205	Psychological and Social Coping
25206	Adaptation
25207	Digitalization
25208	Epidemic outbreaks
25209	Structured literature review
25210	geriatric syndromes
25211	Healthcare technology
25212	Inter-disciplinary teams
25213	Orthopaedic service adaptation
25214	Self-esteem
25215	Bedürfnisse
25216	Gesundheitsverhalten
25217	Pflege
25218	Coping
25219	Hyperactivité vésicale
25220	Hyperplasie bénigne de la prostate
25221	Incontinence urinaire
25222	Male LUTS
25223	Neurogenic bladder
25224	Overactive bladder
25225	Pelvic organ prolapse
25226	Prolapsus des organes pelviens
25227	Urinary incontinence
25228	Urologie fonctionnelle
25229	Vessie neurologique
25230	Active videogames
25231	Psychiatry of Later Life
25232	Active support model
25233	Parent training
25234	Clinical Pharmacist
25235	Experiential Learning
25236	Policy processes
25237	Policy sciences
25238	negative coping style
25239	youths
25240	telehospitalist
25241	disease modeling
25242	high performance computing
25243	monte-carlo
25244	population modeling
25245	Community adaptive capacity
25246	Epidemic control
25247	Local authority
25248	Complicated loss
25249	Disaster recovery
25250	Family adaptation
25251	Family belief systems
25252	Family resilience
25253	Meaning making
25254	occupational safety
25255	adaptation for low pathogenicity
25256	exponential slope
25257	random drift
25258	Medical hardware
25259	Open hardware
25260	Powered Air-Purifying Respirator
25261	RepRap
25262	life satisfaction
25263	social competence
25264	Information behavior
25265	Resource orchestration
25266	 Medical education
25267	 Simulation
25268	 Virtual education
25269	MIECHV
25270	Virtual home visiting
25271	Health care systems
25272	Hope theory
25273	Locus-of-hope
25274	State hope
25275	Specific therapeutic protocol
25276	Trouble of comportment
25277	China‐United States trade war
25278	evolutionary economic geography
25279	global production networks
25280	value
25281	COVID‐19 review
25282	Dublin
25283	Luxembourg City
25284	relational urbanisation
25285	parents
25286	xenophobia
25287	clinical supervision; tele-supervision; distance learning; telebehavioral health training; online therapy
25288	couple therapy training
25289	family therapy training
25290	Food insecurity
25291	Labor
25292	Distributive justice
25293	distance education
25294	learning
25295	Sex workers
25296	prostitution
25297	Online psychotherapy
25298	Reaction to stress
25299	Sociopathology
25300	resource constraints
25301	ventilator‐allocation
25302	Health crisis
25303	Psychiatric emergencies
25304	Antibiotic resistance
25305	Extracorporeal therapy
25306	Porcine deltacoronavirus (PDCoV)
25307	TCID50
25308	allostasis
25309	homeostasis
25310	maternal-fetal signaling
25311	neurodegenerative
25312	high fidelity simulation training
25313	virtual simulation
25314	Institutions, Pandemic
25315	Socio-technical perspective
25316	Bunkers
25317	Dread
25318	Preppers
25319	Survival Condo
25320	Underground
25321	Cyclone
25322	Disaster risk reduction
25323	Flooding
25324	Landslide
25325	Rohingya
25326	chicken diseases
25327	virus genetic variation
25328	virus population
25329	CAD/CAM
25330	facial scanning
25331	Surgical education
25332	curricula design
25333	global blueprint
25334	innovation in education
25335	Bayesian model
25336	genetic evolutionary analysis
25337	EndoU
25338	Glucose-6-phosphate deydrogenase deficiency
25339	Global initiative on sharing of all influenza data (GISAID)
25340	Triazole-resistance
25341	Ph+ acute lymphoblastic leukaemia
25342	tyrosine kinase inhibitors
25343	catalytic residue
25344	Cell-based assay
25345	Packaging signal sequence
25346	Protein-RNA interaction
25347	immunotherapy/checkpoint blockade
25348	small molecule agents
25349	Early breast cancer
25350	Hormone receptor-positive tumors
25351	7b gene reverse-transcription real-time PCR
25352	aqueous humor
25353	immunocytochemistry
25354	spike gene mutation reverse-transcription real-time PCR
25355	uveitis
25356	mouse hepatitis virus
25357	murine coronavirus (M-CoV)
25358	optic neuritis
25359	retrograde axonal transport
25360	Pathogenesis and current treatment
25361	IHC
25362	S gene
25363	Newborn piglets
25364	Porcine enteric alphacoronavirus
25365	Chicken
25366	Infectious bronchitis
25367	Feline infectious peritonitis
25368	nasal cavity
25369	rhinitis
25370	Accessory protein
25371	Recombinant virus
25372	Glycosylation
25373	Structural divergence
25374	Bacterial artificial chromosome (BAC)
25375	Infectious clone
25376	Lambda red recombination
25377	Substitutions
25378	enrichment
25379	multiorgan tropism
25380	pathotype
25381	recombinant variants
25382	serotype
25383	TGEV
25384	Reverse genetics system
25385	Chimeric S1 gene
25386	Caribbean
25387	Trinidad and Tobago
25388	Turkey coronavirus
25389	YxxØ
25390	exocytic secretion
25391	intracellular traffic
25392	Deltacoronavirus
25393	Gammacoronavirus
25394	Illumina MiSeq
25395	Pan-Coronavirus
25396	Sample collection
25397	Wild birds
25398	dromedaries
25399	Emerging viral infection
25400	Heatmap
25401	Outbreak trend
25402	Regression model
25403	Risk map
25404	Spatial modeling
25405	adverse respiratory outcomes
25406	head and neck squamous cell carcinoma (HNSCC)
25407	pulmonary comorbidities
25408	respiratory infections and complications
25409	Obsessive-compulsive disorder
25410	Y-BOCS
25411	sexual behavior
25412	evidence-based design
25413	housing built environment
25414	geographic factors
25415	social factors
25416	Detainees
25417	Health in prison
25418	supervised machine learning
25419	cancer syndromes
25420	inherited cancers
25421	BLAST algorithm
25422	sequence alignment
25423	Consensus Analysis
25424	Diterpenes
25425	Ligand
25426	Natural Products Database
25427	electronic properties
25428	Structure analysis
25429	host-pathogen interaction
25430	Bioactive Compounds
25431	Esculetin ethyl ester
25432	subunit vaccines
25433	Mental health screener
25434	structure-based virtual screening
25435	radiologist
25436	Crystallization
25437	Structure determination
25438	nsp13
25439	3CL-PRO
25440	3CL-PRO inhibitor
25441	Coronavirus main protease
25442	Binding Free Energy Calculation
25443	COVID2019
25444	MM-PBSA-WSAS
25445	drug repurposing screens
25446	Functional units of network pharmacology
25447	Metabolic programming
25448	Qingfei paidu decoction
25449	Quantile regression
25450	quantum mechanical calculations
25451	synthetic feasibility
25452	Plan-Do-Check-Act cycle (PDCA cycle)
25453	nursing management
25454	Amyloidogenesis
25455	SARS CoV E protein
25456	cardiac diseases
25457	fractal geometry
25458	gravity
25459	lung structure
25460	vascular regulation
25461	COVID-19 anxiety syndrome
25462	Coronavirus anxiety
25463	Personality traits
25464	Psychometric measure
25465	Work and social adjustment (functional impairment)
25466	behavioral change
25467	public health protection
25468	social media platforms
25469	Amphotericin B
25470	antimicrobial agents
25471	preclinical studies
25472	curriculum design
25473	flipped classroom
25474	health professions education
25475	preclinical education
25476	Arabic FCV-19S
25477	Fear of COVID-19 Scale
25478	Pre-triage
25479	Epitope mapping
25480	COVID-19 mental health response
25481	crisis intervention hotline
25482	health care service
25483	mental health hotline
25484	problem-solving
25485	Psychological resilience
25486	Somatization symptoms
25487	avoidance
25488	confirmatory factor analysis
25489	impact of event scale
25490	intrusion
25491	2008 economic crisis
25492	Economy recovery
25493	Global recession
25494	COVID-19 fear
25495	FCV-19S Malay
25496	Fear of COVID-19 scale
25497	conflict
25498	nationalism
25499	nation‐state
25500	European burden of disease network
25501	GBD
25502	Summary measures of population health
25503	FCV-19S Bangla
25504	learning health system
25505	medication supply and distribution
25506	pharmacy
25507	ENT SLT research
25508	ENT SLT services
25509	ENT SLT workforce
25510	Elderly Population
25511	HDI
25512	policy diffusion
25513	Delhi religious conference
25514	Indian states
25515	International travels
25516	Local transmission
25517	Superspreading event
25518	Neurology training
25519	infectious disease hospital
25520	isolation unit
25521	Believing COVID-19 Information Scale
25522	COVID-19 preventive behavior
25523	Preventive COVID-19 Infection Behaviors Scale
25524	BOOS, British Orthopaedic Oncology Society
25525	Bone tumour
25526	GP, General Practitioner
25527	MDT, Multi-disciplinary team
25528	NHS, National Health Service
25529	PPE, Personal Protective Equipment
25530	Virtual MDT
25531	Epidemiological model
25532	Mitigation strategy
25533	Network science
25534	Network topology
25535	Scale-free
25536	Contact-to-balloon time
25537	Key quality indicators
25538	Percutaneous coronary intervention (PCI)
25539	International Classification of Functioning, Disability and Health (ICF)
25540	deep transfer learning
25541	SARS-CoV 3CLpro
25542	LGBTQ+ health
25543	immigrant health
25544	perceived threat of disease
25545	psychometric properties
25546	interstitial fibrosis
25547	Re-structure
25548	CFA
25549	EFA
25550	face mask stigmas
25551	face mask wearing behaviors
25552	preventative behaviors
25553	scale development
25554	validity
25555	Borderline personality disorder
25556	Dialectical behavior therapies
25557	age-structured data
25558	epidemic mathematical model
25559	public closings
25560	reported and unreported cases
25561	antioxidant enzymes
25562	mitochondrial potential
25563	continuing education
25564	educational technology
25565	Intensity
25566	Light scattering
25567	Polarization
25568	Shape matrices
25569	Antiviral Therapy
25570	Competitive Intelligence
25571	Patent analysis
25572	Triazole
25573	CoVID-19, Coronavirus disease-2019
25574	Host tropism
25575	IDR, Intrinsically disordered region
25576	Intrinsic disorder
25577	N, Nucleocapsid
25578	Phosphorylation
25579	RNA-binding
25580	Ser/Arg-rich
25581	TGEV, Transmissible Gastroenteritis Virus
25582	Host cell protease
25583	Matriptase
25584	Proteolytic processing
25585	Transient transfection
25586	Virus entry
25587	Western blot
25588	coordination
25589	disaster preparedness and response
25590	incident command system
25591	Disease avoidance
25592	Pediatric surgery
25593	Surgical quality and safety
25594	compartmental epidemiological model
25595	mean-field (well mixed) approximation
25596	network theory
25597	social contact networks
25598	Sumac
25599	extract
25600	Accelerated failure time
25601	Auto-regression
25602	Proportional Hazard model
25603	University students
25604	government collaboration
25605	External cost
25606	Socially optimal lockdown
25607	Urban congestion
25608	Medical student education
25609	neurosurgery training camp
25610	T follicular helper cells
25611	germinal center
25612	Paraclinical
25613	Radiology education
25614	Remote learning
25615	Community governance systems
25616	Age distribution
25617	Sex distribution
25618	geographic disparities
25619	Exit plan
25620	Local lockdown
25621	Low and middle-income countries
25622	Non-pharmacological interventions
25623	Rolling lockdown
25624	Zonal lockdown
25625	Family Cohesion
25626	Family Conflict
25627	Family Environment
25628	Family Stress
25629	Prospective
25630	Surveys and questionnaires
25631	X-Ray computed
25632	financial crisis
25633	transmission rate (Ro)
25634	Distance learning
25635	Universal Design for Learning
25636	CORPD
25637	Reliability
25638	Validity
25639	perspective
25640	youth psychiatric care
25641	Linear regression model
25642	Perception-based questionnaire
25643	Principal component analysis (PCA)
25644	Social conflict
25645	Social panic
25646	anaesthesiology
25647	in situ simulation
25648	irish emergency department
25649	latent safety hazards
25650	system testing
25651	Biometric
25652	Contactless
25653	Cost structure transformation
25654	Level of service
25655	New revenue streams
25656	Consciousness
25657	3-Acyl-2-amino-1,4-dihydroquinolin-4(1H)-ones
25658	SAR optimization
25659	epigenetic drugs
25660	host–viral interactions
25661	clinician-patient communication/relationship
25662	continuity of care
25663	investing in relationship
25664	primary care issues
25665	relationship-centered care
25666	Airport
25667	Disruptions modelling
25668	Epidemic state
25669	Security control
25670	Simulation model
25671	health‐care access
25672	provider networks
25673	health systems science
25674	preclinical curriculum
25675	agglomeration
25676	regional economic growth
25677	satellite data
25678	Atención centrada en el paciente
25679	Autocuidado
25680	Currículo integrado
25681	Equipo interprofesional
25682	Integrated curriculum
25683	Inter-professional team
25684	Patient-centered care
25685	Responsabilidad social
25686	Social accountability
25687	blueprint
25688	Embedded systems
25689	Influenza pandemic
25690	Open source
25691	Open source medical hardware
25692	Pandemic ventilator
25693	Real-time operating system
25694	Single-limb
25695	Attachment theory
25696	Child psychotherapy
25697	Mentalization
25698	Teletherapy
25699	academic medical centers
25700	biomedical research
25701	Complement inhibition
25702	Compstatin
25703	S1-CTD
25704	alphacoronavirus spike
25705	Landfill
25706	anisotropic correlation structure
25707	factor of safety
25708	probability of failure
25709	spatial variability
25710	atomic force microscopy
25711	fluorescence microscopy
25712	Myelin water imaging
25713	Spatial pattern
25714	Epidemic threshold
25715	Markov chain
25716	Networked population
25717	Nativism
25718	Populism
25719	Radical Right
25720	Communication Technology
25721	Community of Practice
25722	Remote Collaboration
25723	Training Modernization
25724	6′-fluorohomoaristeromycin
25725	Anti-RNA virus
25726	Electrophilic fluorination
25727	S-adenosylhomocysteine hydrolase
25728	Food supply chains
25729	Market power
25730	Oligopolistic food markets
25731	FCV-19S
25732	KPK
25733	Urdu
25734	binomial analysis
25735	data envelopment analysis
25736	economic crisis
25737	private hospitals
25738	public hospitals
25739	public-private partnership
25740	Didecyldimethylammonium chloride
25741	Disinfectants
25742	Idiopathic pulmonary fibrosis
25743	Lamella body
25744	Matrix metalloproteinase-1
25745	Quaternary ammonium compounds
25746	RNA sequence
25747	alphacoronavirus nsp1
25748	cell cycle
25749	structure-function
25750	Central line teams
25751	Central venous access
25752	Iatrogenic injuries
25753	Casimir functions
25754	Dynamical systems
25755	Hamiltonian systems
25756	Poisson structures
25757	Avian influenza
25758	H9N2
25759	marketing
25760	production
25761	transboundary animal diseases
25762	PEDV 3CLpro
25763	complex
25764	functional
25765	multiparametric
25766	repeatability
25767	reproducibility
25768	Emotional contagion
25769	Value change
25770	Values
25771	(thio)semicarbazone-based benzimidazoles
25772	anti-RSV activity
25773	anti-coronavirus activity
25774	anti-influenza activity
25775	hydrazone-based benzimidazoles
25776	molecular modelling studies
25777	Balance
25778	Balance rehabilitation
25779	Postural tracking
25780	Posture
25781	Visual feedback
25782	epitope mapping
25783	insilico cloning
25784	Fc
25785	protein ligation
25786	protein trans-splicing
25787	scytovirin
25788	segmental isotopic labeling, lectibody.
25789	split intein
25790	infectious diseases nursing
25791	lived experience
25792	phenomenology
25793	qualitative study
25794	Polarimetry
25795	Ragweed pollen
25796	Scattering
25797	Scattering matrix
25798	Acute pneumonia
25799	NF‐κB
25800	Rosa rugose Thunb
25801	Rugosic acid A
25802	STAT3
25803	Automatism
25804	Hand Sanitizers
25805	Infrared Rays
25806	Motor Skills
25807	crypts
25808	infection model
25809	porcine deltacoronavirus
25810	porcine enteroids
25811	Allantoic
25812	Amniotic
25813	Embryonated egg
25814	Elderly care
25815	Stockholm
25816	Public actions
25817	Public trust
25818	benzothiazole
25819	in silico hit
25820	RNA structure/function
25821	RNA tools
25822	antiviral RNAs
25823	aptamers
25824	functional RNA domains
25825	viral RNA genome
25826	Cardiorespiratory polygraphy
25827	Sleep apnea screening
25828	biological clocks
25829	bright light therapy
25830	circadian rhythms
25831	light boxes
25832	retinal ganglion cells
25833	sleep disorder
25834	suprachiasmatic nucleus
25835	cluster-to-cluster model
25836	protein fold recognition
25837	seq-to-cluster model
25838	seq-to-seq model
25839	simulated persons
25840	virtual workshop
25841	Data incompleteness and imputation
25842	Patients’ clustering
25843	Preventive healthcare policy
25844	Anti-malarial
25845	Ototoxicity
25846	Vestibular loss
25847	Catalytic oxidation
25848	Redox properties
25849	Structure defects
25850	Synthetic routes
25851	Water resistance
25852	Adenovirus
25853	Dodecahedron
25854	Platonic solids
25855	Receptors
25856	Viral spreading.
25857	Virus Like Particles
25858	slum
25859	plpro-ubal
25860	viral classification
25861	COVID-19*
25862	Respiratory and eye protection
25863	Coronaviruse
25864	Pathogen
25865	Hybrid wavelet neuronal-fuzzification
25866	Mean absolute scaled error (mase)
25867	Symmetric mean absolute percentage error (sMAPE)
25868	Wavelet decomposition
25869	ASO
25870	ExoN
25871	NA
25872	anti-coronavirus drugs
25873	exonuclease
25874	non-structural protein 14
25875	nucleoside analog
25876	antiviral resistance
25877	nucleoside analogue
25878	microRNAs
25879	HR2 peptide
25880	Spike (S)
25881	Transfection
25882	Virus purification
25883	hospital outbreaks
25884	phylogeography
25885	Colorimetric detection
25886	MERS coronavirus (MERS-CoV)
25887	Middle East Respiratory Syndrome (MERS)
25888	Drug prediction
25889	Strobilanthes cusia
25890	indigodole B
25891	tryptanthrin
25892	Footprint
25893	Infections bronchitis virus
25894	Replicase gene
25895	sub-genomic mRNA
25896	Confocal microscopy
25897	Internalization
25898	Membrane protein
25899	Packaging signal
25900	Viral genome packaging
25901	Pteropus giganteus
25902	Pteropus medius
25903	hybrid genome assembly
25904	secondary scaffolding
25905	redox state
25906	reduced glutathione (GSH)
25907	Host factors
25908	Suppressor screening
25909	Yeast
25910	infectous clone
25911	High-throughput sequencing
25912	Anti-Viral mechanism
25913	N6-methyladenosine
25914	Posttranscriptional modification
25915	heterologous challenge
25916	Bungowannah virus
25917	ERNS
25918	foreign gene expression
25919	pestivirus
25920	viral vector
25921	virus replicon particles
25922	Betacoronavirus infection
25923	Erinaceus coronavirus (EriCoV)
25924	hedgehogs
25925	2’O-methylation
25926	Guanylate-binding proteins
25927	HRV
25928	Replication organelles
25929	viromes
25930	AAA+ ATPase
25931	BV production
25932	DNA replication
25933	LEF3
25934	ODV morphogenesis
25935	TER94
25936	baculovirus
25937	virogenic stroma
25938	LAMP-LFD
25939	Newcastle disease virus
25940	multiple pathogen detection
25941	Epidemiological survey
25942	EvaGreen-based real-time RT-PCR
25943	Feline infectious peritonitis virus
25944	Hyperglobulinemia
25945	Endotoxin
25946	Food animal worker
25947	Methicillin-resistant, Staphylococcus aureus
25948	Occupational injury
25949	Zoonotic influenza
25950	DF2
25951	NEMO
25952	nsp5
25953	VACV
25954	buffalopox
25955	orthopoxviruses
25956	smallpox
25957	Caputo fractional derivative
25958	coronavirus 2019-nCoV
25959	fractional natural decomposition method
25960	numerical behavior
25961	Biostatistics & Bioinformatics
25962	statistical inference
25963	Benzylidenechromanones
25964	SARC-CoV-2 Mpro
25965	biotarget
25966	hazard of infection
25967	super-spreading event
25968	gene co-expression network
25969	murine coronavirus
25970	Nano-sensors
25971	Personalized health care
25972	Point-of-care systems
25973	Smart diagnostics
25974	30-day prediction
25975	SIS model
25976	daily infection rate
25977	exponential model
25978	logistic model
25979	Acetylation
25980	immunoaffinity
25981	post-translational modifications
25982	Curate
25983	Downstream uses
25984	Pseudoscience and conspiracy theories database
25985	immune mediators
25986	inhibitory mechanisms
25987	COVID-19 protease inhibitors
25988	MolecularDynamics Simulation
25989	Shape-based ML
25990	nCorv-EMBS.
25991	Depreobesity
25992	Non-survivors
25993	Survivors
25994	Case-fatality rate
25995	Credible interval
25996	Intervention forecasting
25997	Computational approaches
25998	MERS-COV
25999	T-and B-cell epitopes
26000	Human impacts
26001	Protected areas
26002	physical and social distancing relaxation
26003	reopening
26004	Age-specific social contact patterns
26005	Retrospective and prospective analysis
26006	Underlying transmission patterns
26007	Mathematical biology
26008	Partial differential equations
26009	GHQ-28
26010	fungal natural products
26011	African-American
26012	Black
26013	colorectal cancer screening
26014	RNA replicons
26015	Interferon-β1b
26016	Statistical analysis plan
26017	Disease burden
26018	lower respiratory tract infection
26019	symptom duration
26020	symptom severity
26021	emulator
26022	individual‐based model
26023	mechanistic model
26024	Collaborative Cross
26025	RNA virus infection
26026	immune correlates of mortality
26027	Antioxidant compounds
26028	Biomarker patterns
26029	Calgranulin A
26030	Catalase
26031	Circulating leucocytes
26032	Comet assay
26033	Detoxification
26034	Ex vivo
26035	Genoprotection
26036	Impairments
26037	Individualised patient profile
26038	Liquid biopsy
26039	Liver malignancy
26040	Metalloproteinase
26041	Multi-level diagnostics
26042	Multi-omics
26043	Multiparametric modelling
26044	Palliative medicine
26045	Patient stratification
26046	Predictive preventive personalised medicine (PPPM/3 PM)
26047	Profilin
26048	ROS inhibition
26049	Redox-based therapy
26050	Rho A
26051	S100
26052	SOD-2
26053	Scavenger
26054	Selective internal radiation therapy (SIRT)
26055	Superoxide-dismutase 2
26056	Thioredoxin
26057	Trans-arterial chemo-embolisation (TACE)
26058	Unsupervised machine learning
26059	thermal scanning
26060	Travel risk assessment
26061	2019-nCoV, coronavirus, emerging infections, response, air-borne infections
26062	emerging or re-emerging diseases
26063	public health event
26064	ascertainment
26065	2019-nCoV infection
26066	Population movement
26067	Endemic MERS-CoV anxiety
26068	behavioral problem
26069	2019-nCoV, outbreak
26070	Dynamic modeling
26071	Second derivative
26072	Disease assessment
26073	Early detection
26074	epidemic control and prevention
26075	epidemic risk time series model
26076	incoming immigration population
26077	new diagnoses per day
26078	Fisher exact test
26079	analysis
26080	asymptomatic case
26081	Hyperbilirubinemia
26082	infectious disease epidemiology
26083	major outbreak
26084	Intolerance of uncertainty
26085	dynamic time warping
26086	lead-lag effects
26087	Help-seeking behavior
26088	Severe acute respiratory syndrome from coronavirus 2
26089	behavioral disorder
26090	psychiatric co-morbidity
26091	EID
26092	High consequence infectious disease
26093	Public health epidemiological surveillance
26094	food safety crisis
26095	game meat
26096	health/risk perception
26097	organic food
26098	PSS
26099	SARS-SOV-2
26100	heath care workers
26101	multicentric study
26102	Google
26103	Readability
26104	Oral nutritional supplements
26105	Pragmatic protocol
26106	Whey proteins
26107	post-acute/ long-term care
26108	Nurse and health care education
26109	Prevention of coronavirus disease (COVID-19)
26110	Virtual classrooms
26111	Reticular pattern
26112	follow up
26113	treatment response
26114	incident case
26115	projection
26116	Localized delivery
26117	Perceptions
26118	exemptions
26119	no visitor policy
26120	patient experience
26121	Anesthesiology
26122	oculoplastic surgery
26123	Fatalism
26124	Preventive behavior
26125	Community pharmacies
26126	Legislation
26127	Airports
26128	Schengen countries
26129	Republic of Kenya
26130	camels
26131	slaughterhouses
26132	World Health Organization research roadmap
26133	coronavirus research trends
26134	public health and disaster risk reduction
26135	public health preparedness
26136	response and recover
26137	social science research
26138	covid-19 forecasting
26139	Emerging disease
26140	Maladies émergentes
26141	Falls
26142	Angiotensin Converting Enzyme inhibitors
26143	Angiotensin Receptor Blockers
26144	cardiometabolic disease
26145	Disease modeling
26146	pre-symptomatic Transmission
26147	Factors
26148	teachers
26149	Case Report
26150	Activity tracker
26151	Diabetes type 1
26152	emotions
26153	social sentiments
26154	Stroke management
26155	ESRD
26156	Virtual medicine
26157	Blood urea nitrogen (BUN)
26158	D-dimer (DD)
26159	lymphocyte ratio
26160	third-generation infection
26161	Epidemiological scenarios
26162	numerical simulations
26163	pulses of release
26164	unique pulse of isolation/quarantine
26165	SEICR model
26166	effect of intervention
26167	pandemic spreading
26168	business economy
26169	sentiment
26170	Travel history report
26171	Withholding
26172	Oxygen therapy
26173	novel coronavirus pneumonia (COVID-19)
26174	digital data
26175	emerging outbreak
26176	hybrid model
26177	hybrid simulation
26178	acute disease
26179	Acute stroke care
26180	Stroke team
26181	subarachnoid hemorrhage
26182	rumor
26183	Confined settings
26184	official data
26185	standardize mortality rate
26186	prognoses
26187	eyewear
26188	goggles
26189	Baidu Index
26190	Internet surveillance
26191	Weibo Index
26192	Lysosomal storage disorders
26193	Digit ratio
26194	mouse infection model
26195	mass casualty
26196	novel COVID-19-infected pneumonia
26197	medical professionals
26198	opinion analysis
26199	Action
26200	Diaspora
26201	Racism
26202	Scleroderma
26203	cognitive impairment
26204	severe illness
26205	Emergency and disaster preparedness
26206	Racial and ethnic health disparities
26207	Reparations
26208	Structural and social determinants of health
26209	Sina Microblog
26210	public attention
26211	symptom cluster
26212	Disparities in access
26213	Disparities in quality
26214	Ethnic disparities
26215	Extrapulmonary complications
26216	Emergency departments
26217	Children's health
26218	Hospital closures
26219	Shelter in place
26220	Stay at home
26221	Government programs and policies
26222	Patient outcomes
26223	State issues
26224	Social network
26225	T lymphocyte subgroups
26226	service-learning
26227	Major depressive disorder
26228	Comparative analysis
26229	Epidemic characteristics
26230	COVID-19; geriatrics; long-term care
26231	Early convalescence
26232	Lung function
26233	Respiratory muscle strength
26234	information disclosure policy
26235	Runge-Kutta method
26236	SIRD Epidemiology model
26237	The basic reproduction number
26238	monkey
26239	zoo
26240	Soins cardiaques aigus ;Unité de soins intensifs
26241	Health behaviours
26242	Information-motivation-behaviour skills model
26243	Media use
26244	New media
26245	Alcohol use disorder
26246	longevity
26247	suicide
26248	Electronic medical records
26249	Organizational delivery
26250	Physician burnout
26251	Evidence based decision making
26252	Publish health
26253	Researchers
26254	State health policies
26255	State mandates
26256	Ambulatory care
26257	Communications
26258	Hospital medical staff
26259	Surge staffing
26260	Behavioral health care
26261	Grants
26262	Health philanthropy
26263	Cybercounseling
26264	LGBTQ
26265	LGBTQ youth
26266	Online programs
26267	Sexual and gender minority
26268	hospital medicine
26269	abuse
26270	intimate partner violence
26271	Pandemic H1N1
26272	national health policy
26273	the elderly
26274	Health inequities
26275	SARS-like strategy
26276	flu pandemic-like strategy
26277	curbside testing
26278	drive-through testing
26279	emergency center
26280	return to work
26281	Air purifier
26282	Call centers
26283	Occupational disease
26284	community and national resilience
26285	distress symptoms
26286	individual
26287	minority and majority groups
26288	sense of danger
26289	Stable
26290	Cluster outbreak
26291	ARS-CoV-2
26292	Negative pressure room
26293	health psychology
26294	mental health care
26295	psychological assistance
26296	Animal disease management
26297	Endemic and emerging diseases
26298	Veterinary services
26299	Aerosol-generating procedures (AGPs)
26300	Surgical triage
26301	Clinics
26302	Hospital systems
26303	Nursing staffing
26304	Staffing ratios
26305	middle-income
26306	SARS-CoV infection
26307	Lung CT scan
26308	Alcohol availability
26309	Heavy alcohol use
26310	Intentional injuries
26311	Suicidal behaviour
26312	VR
26313	VR Applications
26314	Virtual reality
26315	mental health intervention
26316	appendicitis
26317	Clinician hotline
26318	transmission dynamics
26319	labor-saving
26320	notification
26321	privacy protection
26322	GPS
26323	disease tracking
26324	mobile phones
26325	spatiotemporal data
26326	social welfare
26327	archetype
26328	knowledge modeling
26329	openEHR
26330	template
26331	cerebrospinal meningitis
26332	healthcare resources
26333	Students, Medical
26334	United Arab Emirates
26335	public sector
26336	geographic information system
26337	health service access
26338	Oxygen inhalation therapy
26339	internet search queries
26340	Propensity score–matching analysis
26341	Physicians, family
26342	healthcare system
26343	Active learning
26344	Cross-population train/test models
26345	Multitudinal and multimodal data
26346	large-scale monitoring system
26347	Doctors
26348	Helplessness
26349	Hopelessness
26350	Trainees
26351	akut stroke
26352	egészségügyi rendszer
26353	thrombolyticus terápia
26354	psychological stability
26355	Home health
26356	Hospitality quality
26357	Physician payment
26358	mood disorders
26359	perinatal mental health
26360	postpartum care
26361	Geographically weighted principal component analysis
26362	Index of multiple deprivations
26363	Negative binomial regression
26364	Hispanic, mortality, morbidity
26365	Minority
26366	remote patient management
26367	Health transformation
26368	Low income
26369	Organization of care
26370	Dromedary camels
26371	Prevalence of infection
26372	Professional Practice
26373	SMS
26374	health plans
26375	mobile fotonovelas
26376	text messaging
26377	Asylum-seekers
26378	Undocumented migrants
26379	Mitigating strategies
26380	Anxiety symptom
26381	Depression symptom
26382	ARIMA models
26383	WHO health systems framework building blocks
26384	emergency centres
26385	reductions
26386	restrictions
26387	Lung ultrasonography
26388	Mental health provider
26389	COVIDApp
26390	institutionalized individuals
26391	long-term
26392	Cluster transmission
26393	spatial−temporal analysis
26394	ACE2; Macrophage; Thrombotic
26395	Acute kidney Injury
26396	anxiety or depressive symptoms
26397	duration of therapy
26398	community health workers
26399	medication adherence
26400	community-orientated primary care
26401	foreigner
26402	health administration
26403	health apps
26404	Blood supply
26405	Chinese nurses
26406	a cross-sectional survey
26407	work stress
26408	Chest CT score
26409	Pandemic (H1N1) 2009
26410	Alcohol policy
26411	Communicable disease
26412	orthodontics
26413	patterns
26414	virtual care
26415	cancer prevention
26416	TyG index
26417	COVID-19 confinement
26418	emissions
26419	nitrogen dioxide
26420	Coronoavirus
26421	quality ratings
26422	strategic planning
26423	PETTICOAT
26424	acute complicated type B aortic dissection
26425	Cox regression
26426	Neutrophil-lymphocyte count ratio
26427	Prognostic biomarker
26428	Containment measure
26429	anaesthesiologist
26430	rapid response team
26431	Muscle pain
26432	Test and smell disorders
26433	cloud solution
26434	connected care
26435	telecare
26436	continuous RRT
26437	infectious disease control
26438	research exemption
26439	public health administration
26440	public health informatics
26441	Cornoavirus
26442	Mental disorders
26443	Mental health services
26444	medium term budgetary framework
26445	public financial management
26446	public opinion
26447	Psychiatry and mental health
26448	elderly subject
26449	firearm
26450	gun
26451	Random Forest
26452	machine-learning methods
26453	respiratory system diseases
26454	time series
26455	underreporting
26456	cancer networks
26457	Informadores clave
26458	Key informants
26459	Socioeconomic deprivation
26460	general medicine
26461	Urban clustering
26462	Chirurgie
26463	Urologie
26464	Calcul
26465	Crise sanitaire
26466	Heath crisis
26467	Lithiase
26468	Stone
26469	Urinaire
26470	Urinary
26471	basic psychological needs
26472	healthy eating
26473	sleep routines
26474	physician wellness
26475	surgical education
26476	surgical workforce
26477	Cluster of cases
26478	Prevention and control measures
26479	opioid crisis
26480	substance use
26481	Migrant workers
26482	Care fragmentation
26483	Empowerment
26484	Psychosocially complex
26485	System navigation
26486	Vulnerabilities
26487	global spread
26488	Anhui Province
26489	Spatiotemporal distribution
26490	Health Care Organization
26491	Stress disorder, post-traumatic
26492	orvos-beteg kapcsolat
26493	telemedicina
26494	triázs
26495	practices
26496	Belongingness
26497	Burdensomeness
26498	Public health insurance
26499	Optimism bias
26500	Prominence effect
26501	STAI
26502	Medical vulnerability for severe COVID-19 illness
26503	Post-traumatic stress symptoms
26504	screening program
26505	tailored treatment
26506	Viral vaccines
26507	Central venous catheters
26508	Vascular access devices
26509	China’s preparedness and responses
26510	Nipah
26511	contact list
26512	Asymptomatic cases
26513	Disease management.
26514	Mass screening
26515	confucianism
26516	palliative
26517	Delayed diagnosis
26518	Pediatric emergency
26519	Pandemic influenza preparedness framework
26520	OSA
26521	NCDs
26522	Sub Sahara Africa
26523	Age-structured
26524	Peak epidemic
26525	camel
26526	serological survey
26527	Middle East respiratory syndrome coronavirus (MERS-CoV)
26528	National health system
26529	Age group
26530	Comorbid
26531	MERS-CoV epidemiology
26532	Symptomatic
26533	residency decision making
26534	Assisted reproduction
26535	Economic policies
26536	Globalisation
26537	Water and soap
26538	Statistical computing
26539	Meningococal meningitis
26540	Geriatric patients
26541	Asociación Nacional de Cardiólogos de México
26542	Cardiología
26543	Hipertensión arterial pulmonar
26544	Insuficiencia cardiaca
26545	Mexican Society of Cardiology
26546	National Association of Cardiologists of Mexico
26547	Pulmonary arterial hypertension
26548	Sociedad Mexicana de Cardiología
26549	Convention on the Rights of Persons with Disabilities
26550	Disabled people
26551	Inclusiveness
26552	Music
26553	Addiction medicine
26554	Adolescent health services
26555	Adolescent medicine
26556	Feeding and eating disorders
26557	Reproductive health services
26558	Akutkrankenhaus
26559	Praxisentwicklung
26560	acute hospital
26561	interprofessional collaboration
26562	interprofessionelle Zusammenarbeit
26563	practice development
26564	military
26565	perianesthesia
26566	perioperative
26567	health behaviours
26568	social changes
26569	Camelus
26570	Qatar
26571	S1 protein
26572	camel handlers
26573	live animal market
26574	seropositive
26575	veterinary medicine
26576	treatment decision making
26577	uninsured and underinsured individuals
26578	Historical
26579	Vaccine safety regulation
26580	prevention and control measures
26581	Altruism
26582	Negative affect
26583	Problem-Based Learning Curriculum
26584	News
26585	Policy evaluation
26586	Health belief model
26587	Risk perception
26588	Consults
26589	Experience
26590	NYSGE
26591	Cardiological Society of India
26592	Cardiovascular evaluation
26593	nursing home residents
26594	hypoalbuminemia
26595	vascular diseases
26596	acute gastroenteritis
26597	acute respiratory tract infection
26598	influenza infection
26599	influenza transmission
26600	respiratory illness
26601	leisure
26602	preventative health behavior
26603	social health
26604	household dietary diversity score
26605	Enclosed wards
26606	Management strategies
26607	Psychiatric hospital
26608	sport participation
26609	leadership skills
26610	corticosteroid: hoax
26611	patient-centred care
26612	shared decision-making
26613	SEIR ward transmission model
26614	healthcare MERS-CoV outbreak
26615	Humanitarian crisis
26616	Internally displaced persons (IDPs)
26617	Northeastern Nigeria
26618	Cultural minorities
26619	Ramadan
26620	Ultra-orthodox Jews
26621	prediction of infected
26622	Observation
26623	Personnel
26624	Milan/Lombardia
26625	 SARS virus
26626	clinical research registration
26627	search design
26628	Infektionsschutz
26629	Versorgung
26630	Arbeitsbelastung
26631	Ethik
26632	Intensivpflege
26633	Pflegende
26634	Behaviour quarantine
26635	Tracheoesophageal puncture
26636	Voice prosthesis
26637	Spillover effects
26638	Underreporting
26639	Epidemiology modeling
26640	Medical liability
26641	Pandemic emergency
26642	Project ECHO
26643	interprofessional
26644	nurse educator
26645	subspecialty consultation
26646	cohorting
26647	trainee
26648	loss
26649	Home healthcare
26650	cardiac computer tomography
26651	nuclear cardiology
26652	Psychosocial problems
26653	impact psychosocial
26654	prévention
26655	tay at home order
26656	épidémie
26657	SAVR
26658	aortic valve replacement
26659	cancer ethics
26660	professional duty to treat
26661	nursing research
26662	 chile
26663	 resource allocation
26664	 social justice
26665	adipose
26666	human angiotensin converting enzyme 2
26667	Parotitis
26668	Acute stress
26669	Human Clinical factors
26670	Dispatch
26671	Help-lines
26672	Childhood well-being
26673	Costing
26674	New Zealand
26675	gross anatomy education
26676	online delivery
26677	online practical anatomy
26678	reflective practices
26679	student well-being
26680	Control effect
26681	antiphospholipid antibodies
26682	microorganisms
26683	outbreak preparedness
26684	Age Factors
26685	Chronic Disease/epidemiology
26686	Coronavirus Infections/ epidemiology
26687	Severity of Illness Index
26688	New York State
26689	PYLL
26690	Joint model
26691	Prognostic marker
26692	SpO2/FiO2
26693	Prediction system
26694	Internet analytics
26695	Disease control agency
26696	Professional competence
26697	IHDD
26698	internet hospital plus drug delivery
26699	Online learning
26700	Undergraduate nurse education
26701	Immunization catch-up programs
26702	Routine immunization
26703	High-risk susceptible people
26704	Digital healthcare
26705	surgical videos
26706	PEI
26707	Pandemic Efficiency Index
26708	Government discrepancies
26709	Low-income population
26710	early pandemic phase
26711	Asians
26712	Ukraine
26713	Rwanda
26714	insulin pumps
26715	telemedicine consultations
26716	uploading programs
26717	Role
26718	Intimate Partner Violence
26719	undocumented immigrants
26720	job crafting
26721	occupational satisfaction
26722	longitudinal study
26723	Methadone
26724	Opioid substitution therapy
26725	Kashmir
26726	Remote sensing
26727	SPSS-IBM
26728	Hemato- Oncology Care
26729	Cluster case
26730	Family clustering
26731	Mobile clinics
26732	Underserved
26733	Gross anatomy education
26734	undergraduate education
26735	Antiretroviral medicines
26736	International health
26737	airborne infection isolation
26738	hotel
26739	industrial hygienist
26740	ATP
26741	Immune dysfunction
26742	population data
26743	Enfermedad crítica
26744	Especialización
26745	Specialisation
26746	Unidades de cuidados intensivos
26747	hand hygiene compliance
26748	hospital-associated infections (HAIs)
26749	Influenza vaccines
26750	PPV23 vaccine
26751	Tamale
26752	newborn care
26753	aetiology
26754	transmission control measures
26755	traumatic dental injuries
26756	Ethanol
26757	Applikationsformen bei Medikamenten
26758	Chronische Erkrankung
26759	Drug administration routes
26760	Patientenpräferenz
26761	ambulante Kliniken
26762	outpatient clinics
26763	patient preference
26764	Belastungen
26765	Bewältigungsstrategien
26766	Herausforderungen
26767	burdens
26768	coping strategies
26769	Affordable Care Act
26770	COVID-19, Prescription drugs
26771	Health insurance exchanges
26772	Health insurance mandate
26773	Individual mandate
26774	Payment
26775	Preventive care
26776	Reinsurance
26777	State Medicaid
26778	altered fractionation
26779	chemoradiotherapy
26780	safe abortion
26781	Electronic cigarette
26782	Tobacco
26783	Respiratory Tract Infections
26784	Interval-censored data estimation method
26785	tele-oncology
26786	diabetic foot syndrome
26787	diabetic foot ulcer
26788	hospital-at-home
26789	Geriatric population
26790	expert committees
26791	support services
26792	“choosing wisely”
26793	genetic counseling
26794	remote delivery
26795	telegenetics
26796	primary care psychology
26797	postinfarction ventricular septal defect
26798	Human behaviour
26799	MOOC micro-video
26800	distance teaching
26801	camo
26802	surveys
26803	Computer modeling
26804	simulate
26805	Framework
26806	PDSA
26807	lifestyle behaviors
26808	subjective well-being
26809	Uncertainty quantification
26810	diabetes management
26811	acute cardiac dysfunction
26812	alfaisal university
26813	face-to-face-instruction
26814	online medical education
26815	distribution
26816	Cardiac arrest pandemic
26817	Cubrebocas
26818	Hemodinamia
26819	Mouthguards
26820	Paro cardiaco la pandemia
26821	Choroid
26822	Ciliary body
26823	Iris
26824	Macula
26825	Treatment lasers
26826	Treatment medical
26827	Vitreous
26828	Bayesian Regression
26829	Coronavirus Disease 19
26830	Newborn Care
26831	Health and Demographic Surveillance System
26832	Hospital Bed Capacity
26833	Length of Stay
26834	Mass Casualty Incidents
26835	Step Down Units
26836	Older workers
26837	employee benefits
26838	unions
26839	SIRD-model
26840	Conservative
26841	X-ray diffraction
26842	nanosensors
26843	point-of-care-technologies
26844	sewage sensors
26845	susceptible-exposed-infectious-removed
26846	Estimation
26847	PIBA
26848	Psychosocial
26849	commentary
26850	nCOVID
26851	geographic information systems
26852	FDG-PET
26853	NETest
26854	Neuroendocrine tumor
26855	PPQ
26856	PRRT
26857	Air pollutant
26858	Basic reproductive ratio
26859	Meteorological parameter
26860	healthcare services
26861	Face-masking
26862	Adjuvant therapies
26863	Atorvastatin
26864	ABALOPARATIDE
26865	BISPHOSPHONAT
26866	DENOSUMAB
26867	FRACTURES
26868	OSTEOPOROSIS
26869	ROMOSOZUMAB
26870	TERIPARATIDE
26871	on-line information
26872	readability
26873	allogenic
26874	autologous
26875	ClinicalTrials.gov
26876	Bifurcation
26877	Coupling
26878	Epidémiologie
26879	Plaies
26880	SOS-mains
26881	Urgences
26882	Wounds
26883	epidemic prediction
26884	secondary transmission
26885	Isfahan
26886	Isfahan Covid-19 registry
26887	patient care planning
26888	Covid Aspergillus
26889	Covid Pneumocystis
26890	Covid aspergillosis
26891	Covid fungal
26892	Covid mucorales
26893	Covid pneumocystosis
26894	emergency treatment
26895	global positioning system
26896	COVID - 19
26897	Epithelial permeability
26898	Inflammatory actions
26899	Air-emission reduction
26900	Car mobility behaviour
26901	Flexible lockdown strategy
26902	Spatial-temporal analysis
26903	TikTok
26904	medicalized hotel
26905	vulnerable groups
26906	diagnostic stewardship
26907	agricultural workers
26908	health behavior model
26909	structural vulnerability
26910	Racial/Ethnic disparities
26911	transcultural psychiatry
26912	Adverse pregnancy outcomes
26913	Low birth weight
26914	Containment measures
26915	Control effectiveness
26916	Epidemic trend
26917	Prevention policies
26918	Occupational population
26919	Pittsburgh sleep quality index
26920	Poor sleep quality
26921	chronic liver diseases
26922	liver injuries
26923	medical therapy
26924	partial least square discriminant analysis
26925	adaptive response
26926	low dose radiotherapy
26927	control and prevention
26928	clinical reasoning
26929	premature closure
26930	situativity theory
26931	Host recovery
26932	Viral persistence
26933	impact assessment
26934	inequity
26935	Chinese experience
26936	epidemic control comparison
26937	Clinical activity
26938	Italian surgical residents
26939	Research activity
26940	Surgical activity
26941	dyspnea relief
26942	tDCS
26943	adaptive model
26944	low-middle-income countries (LMIC)
26945	Population-based model
26946	Reconstruction
26947	Tipping point
26948	Under-detection
26949	WeChat
26950	Clinical Outcome
26951	Hypnotics
26952	Pandemic Preparedness
26953	Public Health Responses
26954	back calculation
26955	infection time
26956	Cellulitis
26957	Homeless persons
26958	Camels
26959	Jouf
26960	personal health record
26961	donors and donation: living
26962	registry/registry analysis
26963	Scientific Registry for Transplant Recipients (SRTR)
26964	Air quality index
26965	Drug therapies
26966	Hospital disinfection
26967	Meteorological conditions
26968	Sewage epidemiology
26969	Luciferase immunosorbent assay (LISA)
26970	Samples of humans and animals
26971	Serological IgG detection
26972	H1N1pdm
26973	influenza vaccine
26974	frist case
26975	dromedary
26976	healthcare-associated transmission
26977	Quantum physics
26978	individuals with obesity
26979	Microneutralization
26980	Biodiversity
26981	Angiotensin converting enzyme receptor 2
26982	I3 model
26983	perfect storm theory
26984	IgG Fc receptor
26985	MERS coronavirus
26986	antibody-dependent enhancement of viral entry
26987	fire-object
26988	infectious-disease
26989	data management
26990	dynamic causal modelling
26991	variational
26992	pediatric respiratory viruses
26993	plasma cell
26994	influenza season
26995	Seismology
26996	Space physics
26997	graph drawing
26998	graph visualisation
26999	Health savings accounts
27000	Income disparities
27001	Economic Appraisal
27002	Opportunity Cost
27003	Trade-Offs
27004	SARS, CT AI
27005	WHO, PCR
27006	betegbiztonság
27007	infekciókontroll
27008	légútbiztosítás
27009	nehéz légút
27010	leadership models
27011	professional issues
27012	pandemics < epidemiology
27013	respiratory tract < pathogenesis
27014	vertical transmission < epidemiology
27015	COVID-19 recruitment and retention
27016	Year of the Nurse and Midwife
27017	Study
27018	immune globulin < antiviral agents
27019	public policy < social science
27020	regulation < social science
27021	Lipidomics
27022	MPLEx
27023	Mass spectrometry (MS)
27024	Metabolomics
27025	epidemiological investigation
27026	adaptive immune system
27027	nephrology nurse
27028	Epidemiology of COVID-19 infection in children
27029	Management of COVID-19 infection in children
27030	Data-driven modeling
27031	Extreme diffusion
27032	Extreme growth
27033	Chest CT scan follow-up
27034	Clinical history
27035	Oxygen infrastructure
27036	district hospital
27037	oxygen concentrator
27038	prone patient
27039	National strategy/policy
27040	UK biobank
27041	Children's Hospital
27042	pediatric pulmonologist
27043	burden of disease
27044	user acceptability
27045	Critical healthcare capacity
27046	Spatial epidemiology
27047	Spatially-explicit mathematical model
27048	Transport connectivity
27049	Post-hospitalisation outcomes
27050	area under the curve
27051	systemic condition
27052	Spatiotemporal trend
27053	Bang-bang and singular control
27054	Short term prediction of COVID-19
27055	Theoretical epidemiology
27056	Transcritical bifurcation
27057	antipsychotics
27058	clozapine
27059	outcome studies
27060	service users
27061	stigma and discrimination
27062	Migrant worker
27063	Spatiotemporal cluster
27064	Time-dependent reproductive number
27065	hypnotics
27066	sleep problems
27067	clinical dermatology
27068	dermatologic diseases
27069	diagnostic distribution
27070	Family caregivers
27071	palliative and supportive care
27072	Colonoscopy
27073	Gastroscopy
27074	Aerosol Generating Procedures
27075	Percutaneous Endoscopic Gastrostomy tube
27076	Personal Protective equipment
27077	Tracheostomy tube
27078	negative mood
27079	Statistical inference
27080	New Delhi metallo-beta-lactamase
27081	health care related infections
27082	superinfections
27083	Endothelitis
27084	Hipercoagulability
27085	Alanine aminotransferase
27086	Aspartate aminotransferase
27087	Admissions
27088	Utilization
27089	Veterans Health Administration
27090	Attack rate
27091	Hidden population
27092	Diabetes drugs
27093	cultural competency
27094	psychoanalysis
27095	global alarm and anxiety
27096	impact on suicide rates
27097	psychological autopsy
27098	restricted movement and ability to work
27099	ProMED
27100	behavioral science
27101	ankylosing
27102	psoriatic
27103	spondylitis
27104	Long short-term memory
27105	Time series prediction
27106	Topological representations
27107	Lens and zonules
27108	Treatment Surgery
27109	Anti-angiogenic effect
27110	Cytostatic effect
27111	Cytotoxic effect
27112	Metastatic breast cancer
27113	Metronomic chemotherapy
27114	T- Regulatory cells
27115	Media information
27116	flow of information
27117	gum health
27118	oral health promotion
27119	health-care resources
27120	nonverbal cues
27121	patient–provider communication
27122	ARS
27123	AS
27124	Agence régionale de santé
27125	CME
27126	Clinical laboratory improvement amendements
27127	Cofrac
27128	Comité français d’accréditation
27129	Comité médical d’établissement
27130	DIV
27131	EBMD
27132	GHT
27133	Groupement hospitalier de territoire
27134	IDE
27135	ISO 22 870
27136	PBP
27137	RAQ
27138	SF
27139	TDR
27140	TROD
27141	aide-soignant
27142	contrôle de qualité
27143	diagnostic in vitro
27144	dispositifs médicaux
27145	examens de biologie médicale délocalisée
27146	infirmier diplômé d’Etat
27147	pôle de biologie et pathologie
27148	responsable assurance qualité
27149	sage-femme
27150	survey in France
27151	test de diagnostic rapide
27152	test rapide d’orientation diagnostique
27153	Paul Ricoeur
27154	gratitude
27155	Nurse education
27156	Nursing and Midwifery Council Emergency Standards
27157	Student nurses
27158	Decolonization
27159	adaptive clinical trial
27160	Cancer risk
27161	Low-dose
27162	Hospital resource utilisation
27163	Model evaluation
27164	clinical response
27165	Atazanavir/ritonavir
27166	Head and neck surgeon
27167	Mental wellness
27168	Psychiatric distress
27169	prevention practice
27170	Public health preparedness
27171	Public health students
27172	Public health workforce
27173	emergency service
27174	Laboratory values
27175	Meta-regression
27176	COVID-19: Education
27177	Housing
27178	Life expectancy
27179	echologic studies
27180	swab testing
27181	Criteria air pollutants
27182	NCore network
27183	Urban-rural contrast
27184	JAKi
27185	csDMARDs
27186	spondyloarthritis
27187	Bangladeshi people
27188	N/L ratio
27189	home-based telemental health
27190	Age interaction
27191	Epidemic dynamics
27192	Gender interaction
27193	Negative binomial distribution
27194	addiction care
27195	evidence-based policies and practices
27196	risk environment
27197	social capital
27198	Panic buying
27199	Sell-in
27200	Adult immunization
27201	CO-RADS classification
27202	Real-time reverse transcription polymerase chain reaction (RT-PCR)
27203	Global burden of disease
27204	Active case finding
27205	Paradigm
27206	KAP study
27207	fatigue
27208	gout flare
27209	pain
27210	k-mean
27211	unsupervised algorithms
27212	National lockdown
27213	commuting census data
27214	municipality-specific infection contact rate
27215	Case load rate
27216	Recovery rate
27217	COVID-19 TestNorm
27218	LOINC
27219	Testing name normalization
27220	Transmission dynamics model
27221	cancer centre preparedness
27222	acute stress reaction
27223	health professional students
27224	crises management
27225	decision makers
27226	reverse transcriptase ROC curve; tomography
27227	Metastatic
27228	Net reproductive number
27229	filtering face piece (FFP) mask
27230	respiratory protective equipment
27231	Middle Eastern Respiratory Syndrome (MERS)
27232	Standardized diagnosis and treatment
27233	underdetection
27234	simulation model
27235	Differentiated care
27236	Health - mental
27237	financial stressors
27238	Orientation and mobility
27239	assistive technology
27240	blind
27241	electronic travel aids
27242	low vision
27243	technology training
27244	long term care facility
27245	Allogeneic hematopoietic stem cell transplantation
27246	Cryopreservation
27247	ptCY
27248	commercial sex
27249	syphilis
27250	forum
27251	journals
27252	2019-nCoVs
27253	Case time distribution
27254	Fujian Province
27255	Imported epidemic area
27256	disease-modifying therapies
27257	service delivery
27258	Rural areas
27259	Contact Tracing
27260	genotyping
27261	immunofluorescence staining
27262	spike protein gene
27263	Neonatal calf diarrhea
27264	Rotavirus
27265	immunosuppressed patients
27266	patients with cancer
27267	staffing
27268	Enquête
27269	Internes
27270	Virus SARS-Cov2
27271	dying alone
27272	granular data
27273	virtual healthcare
27274	wounds and injuries
27275	Peer teaching
27276	Peer to peer teaching
27277	Asian continental ancestry group/genetics
27278	Clozapine, blood
27279	Clozapine/adverse effects
27280	Clozapine/metabolism
27281	Clozapine/toxicity
27282	Drug labeling
27283	Mortality/drug effects
27284	education, teaching
27285	performance improvement
27286	clinical audit
27287	colorectal neoplasms
27288	Healthcare communication
27289	Influencers
27290	Online medical community
27291	Physician networking
27292	Reddit
27293	channel mutations
27294	misdiagnosis
27295	seasonal incidence
27296	adolescent pregnancy
27297	Social contract; Intersectionality; Pandemic; SRHR/sexual and reproductive health and rights; Marginalized groups
27298	Mifepristone
27299	Misoprostol
27300	East and Southern Africa
27301	Polio eradication
27302	acute flaccid paralysis
27303	performance indicators
27304	persistent symptoms
27305	drug-drug interactions
27306	inhibition drug metabolism
27307	Ancillary workers
27308	cleaners
27309	high flow nasal canula
27310	undergraduate medical students
27311	meta‐analysis
27312	High and low-income Countries
27313	Hospital Terciario
27314	Servicio de Urgencias
27315	Tertiary Hospital
27316	naloxone
27317	alcohol use disorder
27318	Opportunistic screening
27319	mixed method
27320	thematic analysis
27321	common good
27322	ethical triage criteria
27323	JAK1/2
27324	SARS-Co-V2
27325	Combination treatment
27326	Heptad repeat
27327	Short hairpin RNA
27328	metropolitan
27329	stay-at-home directive
27330	cigarettes smoking
27331	waterpipe smoking
27332	Genetic
27333	circulatory disease
27334	low dose radiation therapy
27335	COVID-19. drug abuse
27336	infectious disease reporting
27337	international health regulations
27338	DNR
27339	emergency room
27340	goals of care
27341	ecosystem services
27342	endangered species
27343	population extinctions
27344	sixth mass extinction
27345	Nasal cannula
27346	Nasal high flow
27347	Positive airway pressure
27348	Mass vaccination
27349	Critical care nursing
27350	Nursing education
27351	Nursing faculty
27352	New medicine
27353	Disease prevention and control system
27354	Urban health
27355	adolescent health
27356	Collective action
27357	Complexity
27358	Decentralization
27359	Food sovereignty
27360	Transitions
27361	remote diabetes care
27362	inpatient management
27363	Public Finance
27364	Tax
27365	emerging spatiotemporal hot spots analysis
27366	local outlier analysis
27367	space-time cube
27368	Blended learning
27369	Pre-registration
27370	Satellite campus
27371	information ethics
27372	infosphere
27373	insulin infusion
27374	Editorial Policies
27375	Manuscripts as Topic
27376	clinical oncology care
27377	corona ambulance
27378	corona treatment
27379	primary care practice
27380	Cryopreserved graft
27381	Severe aplastic anemia
27382	bayesian
27383	pharmacodynamics
27384	Ecosystem
27385	Animal movements
27386	BCV
27387	BCoV
27388	BRD
27389	BRSV
27390	Bovine respiratory disease
27391	Bulk tank milk
27392	foot and ankle examination
27393	virtual physical examination
27394	psychometric
27395	substance-related disorder
27396	Accountability
27397	Aid effectiveness
27398	Harmonisation
27399	Interests
27400	Power
27401	Synergies
27402	Pre-symptomatic transmission
27403	correspondant en hygiène
27404	focus group
27405	focus groupe
27406	hygiene resource person
27407	hygiène hospitalière
27408	vécu au travail
27409	workplace experience
27410	Premature mortality
27411	Standard expected years of life
27412	gastroduodenal motility
27413	epidemiology (general)
27414	Adolescent Health
27415	Behcet syndrome
27416	child psychiatry
27417	anthropology
27418	outcome assessment, health care
27419	adolescent Health
27420	environment and public health
27421	pancreatitis
27422	Collaborative research
27423	Evidence ecosystem
27424	Repeatability
27425	Research waste
27426	Traceability
27427	Transparency
27428	theoretical model
27429	Equine coronavirus
27430	Spike S1 protein
27431	Epidemiology diagnosis
27432	Hospice
27433	hospice reauthorization
27434	Chlamydia trachomatis
27435	Neisseria gonorrhoeae
27436	pharyngeal
27437	hypothalamic pituitary adrenal axis
27438	parasympathetic system
27439	sympatho-vagal balance
27440	Chronic immune-mediated inflammatory rheumatic diseases
27441	Social environment
27442	Urban population
27443	immunization program
27444	family planning services
27445	health services accessibility
27446	induced
27447	long-acting reversible contraception
27448	reproductive health services
27449	business
27450	occupational travel
27451	pre-travel consult
27452	hospital records
27453	European-ancestry
27454	GRADE
27455	physical education
27456	heart arrest
27457	potassium channels
27458	Disease breakout prediction
27459	search queries
27460	Teleteaching
27461	Children’s Health
27462	Medical schools
27463	Myocardial Infarction
27464	cardiomypathy
27465	coronary circulation
27466	perinatal epidemiology
27467	emergency dentistry
27468	urgent care dentistry
27469	Critical care research
27470	bladder cancer
27471	Bioaerosol particles
27472	Biosafety level-3 laboratory
27473	Deposition rate
27474	Removal rate
27475	Profit-seeking
27476	Rebuild
27477	bovine respiratory disease
27478	multiplex RT-PCR
27479	swine enteric viruses
27480	Global virus network
27481	Globalization
27482	Contagious dynamics
27483	Outbreak analysis
27484	Stochastic models
27485	Virus transmissibility
27486	Korean native calves
27487	calf
27488	causative agents
27489	Bovine respiratory disease complex
27490	Calf diarrhoea
27491	Winter dysentery
27492	Barbados
27493	arbovirus
27494	genetic sequencing
27495	severe dengue
27496	acute respiratory tract infections (ARTIs)
27497	young children
27498	Respiratory Viruses
27499	Beef
27500	Bovine torovirus
27501	Dairy
27502	9-valent vaccine
27503	Delphi study
27504	HPV 6 and 11,elimination definition, Australia
27505	HPV vaccination programme
27506	HPV vaccine
27507	Keywords: human papillomavirus HPV
27508	elimination as a public health problem
27509	elimination target
27510	elimination threshold
27511	expert workshop
27512	genital warts
27513	group Delphi study
27514	modified Delphi study
27515	nonavalent HPV vaccine
27516	quadrivalent HPV
27517	Respiratory illness
27518	Severe acute respiratory illness
27519	Radiographs
27520	State
27521	HPV vaccination
27522	cervical cancer screening
27523	elimination of cervical cancer
27524	rotavirus
27525	viral pathogen indicator
27526	synchrony
27527	Avian Infectious bronchitis
27528	Backyard poultry
27529	Gilan Province
27530	Live bird market
27531	MXene
27532	adsorption
27533	dialysate
27534	uremic toxins
27535	CARV
27536	human influenza
27537	human respiratory syncytial virus
27538	Bayesian adaptive
27539	platform trial
27540	randomized clinical trial
27541	ambulance
27542	Arterial spin labeling
27543	cerebral perfusion
27544	microinfarct
27545	vascular cognitive impairment
27546	Pseudoscience
27547	capacity strain
27548	preparedness and response
27549	Responsibility
27550	deference
27551	testimony
27552	Epidemic intelligence
27553	Surveillance systems
27554	epidemiology/public health
27555	medical research
27556	research paradigm
27557	history of medicine
27558	PE
27559	aerography
27560	antimicrobial resistance (AMR)
27561	Bovine tuberculosis
27562	Evidence-based policy
27563	Veterinary epidemiology
27564	Infectious disease epidemiology
27565	Parameter inference
27566	children's rights
27567	costing
27568	anaesthetics / anesthesiology
27569	ILI
27570	medically attended respiratory infections
27571	population-based estimate of respiratory infections
27572	respiratory illness surveillance
27573	Respiratory infectious diseases prevention
27574	air ventilation
27575	protection from airborne droplets
27576	unannounced standardized patients
27577	E50
27578	E60
27579	I10
27580	Human microbiome
27581	Respiratory virome
27582	Human rhinovirus
27583	Klebsiella pneumoniae
27584	counterterrorism
27585	terrorism
27586	heat stress
27587	parasympathetic nervous system
27588	sympathetic nervous system
27589	WASH
27590	menstrual hygiene
27591	menstruation
27592	period poverty
27593	right to safe water
27594	urban slums
27595	water
27596	Literature screening
27597	PICO
27598	European Union
27599	civil-military intervention
27600	health security
27601	Acute Respiratory Infection
27602	Sodium hypochlorite
27603	VRE
27604	Shigellosis
27605	Deposition pollution
27606	Equipment layout
27607	data aggregation
27608	harmonic regression
27609	Internal conflict
27610	Moral injury
27611	hospital performance
27612	physician behavior
27613	real patients survey
27614	spread of respiratory infections
27615	Aspirin
27616	Peripheral artery disease
27617	Rivaroxaban
27618	antibiotic stewardship
27619	rapid PCR respiratory panel
27620	severe acute respiratory infections
27621	viral panel
27622	Distribution
27623	Influenza A virus
27624	2019 new coronavirus (2019-nCoV)
27625	Chinese Patent Medicines
27626	clinical application
27627	pharmacological action
27628	risk and perception
27629	Modern medicine
27630	Novel coronavirus pneumonia (COVID-19)
27631	joint administration
27632	policy participation
27633	epidemic prevention and control mechanism
27634	primary-level emergency
27635	Education level
27636	Partial differential equation
27637	Rumors
27638	Contamination fear
27639	Exposure with response prevention
27640	Obsessive-Compulsive Disorder
27641	COVID-19, COVID-19 related perceived risk
27642	Death distress
27643	Positivity
27644	Functional characteristics
27645	Qinwen Baidu Decoction
27646	Theoretical basis
27647	dyslipidemia
27648	lipoproteins
27649	oxidation
27650	epidemiological paradox
27651	animal models and immunotherapy
27652	entry mechanism
27653	possible vaccines
27654	PPAR-γ
27655	PPAR-γ agonists
27656	Glucose 6-phosphate dehydrogenase
27657	Mechanistic target of rapamycin
27658	Scotophilus bat coronavirus-512
27659	cell receptor
27660	severe acute respiratory syndrome-coronavirus
27661	Analytic Modeling
27662	Ensembles
27663	Nigeria NCDC
27664	Small Data
27665	Timeseries forecasting
27666	Adrenal hemorrhage
27667	Renal vein thrombosis
27668	q-metric
27669	ACE-2 receptors
27670	cardiac failure
27671	11 beta hydroxysteroid dehydrogenase
27672	angiotensin converrting enzyme
27673	glycyrrhizin
27674	mineralocorticoid receptor
27675	toll like receptor 4 (TLR4)
27676	Cellular proliferation
27677	Placental extract
27678	Tissue regeneration
27679	Motor vehicle accidents
27680	ectopic electron transfer chain
27681	34A12
27682	34A30
27683	37N25
27684	45J05
27685	Asymptotic
27686	Dynamic system model
27687	Predications
27688	ideological contracts
27689	perceived threat of COVID-19
27690	Viral suppression
27691	risk event involvement
27692	risk judgement
27693	Immunity system
27694	Potential challenges
27695	Immuno-enhancer
27696	Natural products.
27697	Integrated therapy
27698	Antiphospholipid antibody
27699	Factor VIII
27700	Biomedical
27701	Enzyme de conversion de l’angiotensine 2
27702	Récepteur aux androgènes
27703	Sérine protéase transmembranaire 2
27704	Type II Transmembrane Serine Protease
27705	Neuroleptic malignant syndrome
27706	Epidemic prevention
27707	Gathering epidemic
27708	thoracic medicine
27709	Coronavirus spread
27710	Indian context
27711	Indoor built environment
27712	Psychrometry
27713	Respiratory droplet drying
27714	chest pain center
27715	Costa Rica’s proposal
27716	patent pool
27717	Andrographis
27718	Defensins
27719	Repurposing strategy
27720	local
27721	nerve block
27722	DCP1A
27723	IFN-stimulated genes
27724	mRNA-decapping enzyme 1a
27725	nonstructural protein 5
27726	Rolling update mechanism
27727	CD4+ T cells
27728	MHV infection
27729	RSA59
27730	axonal blebbing
27731	demyelination
27732	host immunity
27733	m-CoV
27734	microglia
27735	poliomyelitis
27736	Inclusive leadership
27737	Job demands resources theory
27738	Psychological safety
27739	Public health emergencies
27740	acute bronchopneumonia
27741	aspiration pneumonia, COVID-19
27742	perivascular inflammation
27743	health consciousness
27744	health life goal
27745	perceived behavioral control
27746	High risk of death
27747	Simultaneous circulation
27748	Viral cooperation
27749	pandemic risk reduction
27750	use of PPE
27751	NLS
27752	Nup93
27753	SLN
27754	SRAS-CoV
27755	complexe des pores nucléaires
27756	nuclear pore complex
27757	Biogeopolitics
27758	asylum
27759	Electrochemical sensor
27760	Stem Cell Therapy
27761	medicinal mushrooms
27762	pneumococcal infection
27763	Obstetricians/gynecologists
27764	New Jersey
27765	SIR models
27766	PAK1
27767	pathogenic kinase
27768	APIM
27769	COVID-19 preventive behaviour
27770	Dyad
27771	Suicidal intention
27772	Angiotensin converting enzyme receptor
27773	studies
27774	Therapeutic option
27775	MDSC
27776	Consortium
27777	GEMM family study
27778	adipose tissue dysfunction
27779	ACE, ACE2
27780	cerebral microbleeds
27781	inclusive leadership
27782	self-sacrifice
27783	social exchange theory
27784	the COVID-19
27785	modernization
27786	emergency medical supplies
27787	reserve and supply
27788	nAChR α7
27789	humans health
27790	population-based
27791	winter dysentery
27792	NS7a
27793	uses
27794	epitope-specific vaccines (ESV)
27795	Qingwen Baidu Yin
27796	Markov chain Monte Carlo
27797	cellular automaton
27798	risk prediction
27799	spatio‐temporal model
27800	state‐space model
27801	AM, alveolar macrophages
27802	AR, androgen receptor
27803	CAS, Chemical abstracts service number
27804	CFDA, The China Food and Drug Administration
27805	COX, cyclooxygenases
27806	COX-2, cyclooxygenase
27807	DL, drug-likeness
27808	ESR1, estrogen receptor 1
27809	Flos Lonicerae
27810	Fructus Forsythiae
27811	GO, Gene Ontology
27812	HCV, human cytomegalovirus
27813	HPV, Human papillomavirus
27814	HQ, Huangqin, Radix Scutellariae
27815	JYH, Jinyinhua, Flos Lonicerae
27816	KEGG, Kyoto Encyclopedia of Genes and Genomes
27817	LQ, Lianqiao, Fructus Forsythiae
27818	MCP, monocyte chemoattractant protein
27819	NCOA1, nuclear receptor coactivator 1
27820	NCOA2, nuclear receptor coactivator 2
27821	NO, nitric oxide
27822	OB, oral bioavailability
27823	PG, prostaglandin
27824	ROS, reactive oxygen species
27825	RSV, respiratory syncytial virus
27826	Radix Scutellariae
27827	SHL oral liquid, Shuanghuanglian oral liquid
27828	SMILES, Simplified molecular input line entry specification
27829	TCMSP, Traditional Chinese Medicine Systems Pharmacology database
27830	Bio-power
27831	Governmentality
27832	connection and community
27833	Interleukins
27834	Phosphodiesterase type 5 inhibitors
27835	cathepsin B
27836	chikungunya virus
27837	macropinocytosis
27838	murine leukemia virus vector
27839	computational fluid dynamics (CFD)
27840	hospital general ward
27841	indoor air quality (IAQ)
27842	cell-to-cell fusion
27843	trypsin
27844	virus release
27845	Moxa smoke
27846	Cytokine expression
27847	Embryonated chicken eggs
27848	IBV replication
27849	TLR ligands
27850	Disadvantaged price inequality
27851	Disease threat
27852	Experimentation
27853	Pricing
27854	Risk aversion
27855	angiogenesis
27856	caveolae
27857	caveolin
27858	cavin
27859	incentives
27860	moral hazard
27861	NMD
27862	animal cells
27863	host-virus interactions
27864	plant cells
27865	Syndecan 1
27866	miR-10a-5p
27867	porcine hemagglutinating encephalomyelitis virus
27868	Crises
27869	Interacting
27870	People
27871	Lactobacillus
27872	glycerol monolaurate
27873	mumps virus
27874	reutericyclin
27875	yellow fever virus
27876	belief in a just world
27877	emerging adults
27878	feelings towards the future
27879	future expectation
27880	future planning
27881	social hardship
27882	APN
27883	enteroids
27884	interferon receptor
27885	actin
27886	clathrin
27887	dynamin 2
27888	TGF-β
27889	neonatal Fc receptor
27890	respiratory conditions
27891	computers in research and teaching
27892	enzymes and catalysis
27893	4-hydroxy-2-nonenal
27894	PGC-1α.
27895	calcium signaling
27896	free radical chain reaction
27897	hydroxyl radical
27898	mechanism; NFAT
27899	molecularhydrogen
27900	oxidized phospholipid
27901	2-methyl-6-nitroquinolin
27902	Bulk Scale Synthesis
27903	Fe3O4@SiO2
27904	Quinoline
27905	Silica functionalized Magnetic Nanoparticles (SMNP)
27906	connectivity
27907	food system
27908	shocks
27909	stakeholders
27910	TF
27911	chemotherapeutic enteritis
27912	Bm5 cell
27913	Silkworm
27914	Virus-like particle
27915	sialic acids
27916	virus glycoproteins
27917	virus receptors
27918	Anthrax toxin
27919	protecting antigen
27920	Anthroquine derivatives
27921	Immune boost
27922	Bactrian camel
27923	hybrid camel
27924	acute phase proteins
27925	oral hygiene
27926	periodontal diseases
27927	QX-like
27928	Human embryonic kidney (HEK)-293 mammalian cell expression system
27929	Indirect ELISA
27930	Porcine epidemic diarrhea (PED)
27931	Spike protein specific ELISA
27932	hemagglutination
27933	humoral response
27934	Ark
27935	recombinant Newcastle virus
27936	Neutralization assay
27937	Pseudotype viral particles
27938	Epitope region
27939	animal importation
27940	dog
27941	pantropic canine coronavirus
27942	Factor Xa
27943	Host proteases
27944	inactivated PDCoV vaccine
27945	piglets
27946	sows
27947	HSPA8
27948	attachment factor
27949	Pigs
27950	Middle-East GI-23 lineage
27951	broiler
27952	Angiotensin-converting enzyme-2 (ACE2)
27953	Middle-East Respiratory Syndrome (MERS)
27954	Novel Coronavirus (emerged late) 2019 (2019-nCoV Corona Virus Disease 2019 (COVID-19)
27955	transcription regulatory networks (TRNs) Corona virus (CoV)
27956	Epithelium, corneal
27957	Peptidyl-dipeptidase A
27958	Serine endopeptidases
27959	functional mechanisms
27960	structural feature
27961	Target protein
27962	Traditional Chinese medicine (TCM)
27963	Clinical character
27964	Sialadenitis
27965	SAR-CoV2
27966	SIRT1
27967	ACE2.
27968	Angiotensin Converting Enzyme Inhibitors
27969	Antihypertesives
27970	Excessive cytokine release
27971	Vascular thrombotic events
27972	ACE2 negative
27973	cell transplantation
27974	function recovery
27975	Enfermedad Coronavirus 2019
27976	Renin-inhibidores del sistema de angiotensina
27977	Acute axonal
27978	Acute respiratory distress (ARDS)
27979	Demyelinating neuropathy
27980	Huanggang
27981	Taian
27982	ACE-angiotensin-converting enzyme
27983	infection-immunology
27984	screening tools
27985	epithelial cell
27986	genetic regulation
27987	ARB'S
27988	Beta blockade
27989	Dilated Cardiomyopathy
27990	Bartter's syndrome
27991	Gitelman's syndrome
27992	Immune markers
27993	antiviral effects
27994	coronavirus main protease
27995	naringenin
27996	CDC, communicable diseases center
27997	MCV, mean corpuscular volume
27998	Brain imaging
27999	COVID-19, coronavirus
28000	CVAs, cerebrovascular accidents
28001	DM, diabetes mellitus
28002	MCA, middle cerebral artery
28003	Neurosurgical intervention
28004	UCTD, undifferentiated connective tissue disease
28005	pulmonary endothelium
28006	pulmonary vascular remodeling
28007	ANEC
28008	Oestrogens
28009	Acute stroke management
28010	Acute stroke thrombolysis
28011	ACE2, acute kidney injury
28012	catepsin
28013	Acciones inmunomoduladoras
28014	Anti-inflammatory effects
28015	Efectos antiinflamatorios
28016	Immuno-modulating actions
28017	Prevención
28018	VitaminD
28019	VitaminaD
28020	livedo
28021	purpura
28022	Ang 1-7
28023	Bartter’s syndrome
28024	Gitelman’s syndrome
28025	endosome pH
28026	gene mutations
28027	phenotype
28028	Adaptive
28029	Innate
28030	MasR
28031	Basigin CD147
28032	Exopeptidase CD26
28033	Peptidase Targeted Immunoregulation (PeTIr)
28034	Severe Acute Respiratory Syndrome Corona Virus2 (SARS-CoV2)
28035	cytokine synthesis inhibitory factor (IL10)
28036	platelet tissue factor CD142
28037	transferrin receptor CD71
28038	COVID-19 diagnostic
28039	forensic science
28040	Cardiac biomarkers
28041	Angiotensin Converting Enzyme 2 (ACE-2)
28042	Renin Angiotensin System (RAS)
28043	C57BL/6NKorl
28044	Human ACE2
28045	Transgenic mice
28046	α-MHC
28047	acetyl-carnosine
28048	lungs
28049	infectious Disease
28050	asthma ,COPD ,ACE2 ,TMPRSS2 ,Interleukin6
28051	clinical trials.
28052	Living systematic review
28053	AhR
28054	IDO1
28055	TiPARP
28056	AGE, Advanced Glycation End products
28057	AKT, Protein Kinase B
28058	Association rules
28059	CHM, Chinese Herbal medicine
28060	CNKI, China National Knowledge Infrastructure
28061	CRRT, continuous renal replacement therapy
28062	Chinese Herbal Medicine
28063	NCBI, National Coalition Building Institute
28064	NHC, National Health Commission
28065	NOS2, Nitric Oxide synthase
28066	PI3K, Phosphatidylinositol 3-kinase
28067	PPI, protein–protein interaction
28068	PTGS1, Prostaglandin G/H synthase 1
28069	PTGS2, Prostaglandin G/H synthase 2
28070	RAGE, Receptor of Advanced Glycation End products
28071	Renal/kidney injury
28072	TCMSP, Traditional Chinese Medicine Systems Pharmacology
28073	TNF, Tumor Necrosis Factor
28074	La Crosse virus
28075	bunyaviruses
28076	ionophores
28077	Griffithsin
28078	hamster
28079	HER2
28080	Poziotinib
28081	Trastuzumab
28082	Barrier integrity
28083	Lung dysfunction
28084	G protein coupled receptor (GPCR)
28085	GPCR kinases (GRKs)
28086	RAMP
28087	Two stage,
28088	closed-tube
28089	nested amplification
28090	Coronavirus Pandemic
28091	dental pulp stem cells
28092	regeneration
28093	KEYWORDS: MERS-CoV
28094	circRNA
28095	competing endogenous RNA
28096	Health Disparities
28097	Social Determinants of Health
28098	immune suppression
28099	home health monitoring
28100	sensor technology
28101	curcumin
28102	system biology
28103	acidified sodium chlorite solution
28104	chlorine dioxide solution
28105	chlorous acid solution
28106	Rebound effect
28107	European union fisheries policy
28108	Marine fisheries management
28109	Ocean harvest
28110	Water-energy-fisheries Nexus
28111	Lysosome
28112	TPC1
28113	TPC2
28114	TRPML1
28115	TRPML2
28116	TRPML3
28117	TPC
28118	Two-pore channel
28119	ESKAPE pathogens
28120	Pseudomonas aeruginosa
28121	mucosal barriers
28122	respiratory epithelial barrier
28123	theranostics
28124	vesicular drug delivery
28125	CRISPR-Cas
28126	MEMS devices
28127	personalized treatment
28128	Magnesium
28129	hypokalemia
28130	hypomagnesemia
28131	cure rate model
28132	restricted mean survival time
28133	sample size adjustment
28134	terminal event
28135	type I error rate
28136	Angiotensin‐converting enzyme 2
28137	anti‐hypertensive drugs
28138	CORD-19
28139	Drug-target-disease associations
28140	Knowledge Graph
28141	Web-server
28142	database mining
28143	behavioral health
28144	community mental health services
28145	Broad spectrum antivirals
28146	Endosomal pathway
28147	Lysosomotropism
28148	FLS
28149	circulating nucleic acids
28150	circulating tumor cells
28151	graphene
28152	dosing optimization
28153	dosing rationale
28154	modelling and simulations
28155	endpoint
28156	antimicrobial peptides
28157	bacterial and virus infections
28158	Clinical translation
28159	Healthtech
28160	Regulatory
28161	Proton Pump Inhibitors
28162	Turkey algorithm
28163	plasma treatment
28164	Qingfei Paidu decoction
28165	Metronidazole
28166	Epidemic Influenza A
28167	H7N9
28168	Stem cell therapeutics
28169	Visual analysis
28170	approach
28171	non-severe
28172	predictors 
28173	ADSC
28174	stromal cells
28175	WHO ordinal scale
28176	censoring
28177	endpoints
28178	log-rank test
28179	proportional odds model
28180	ACPS
28181	KDH
28182	Quantum chemical calculation
28183	COVID-19 treatment issues
28184	Treatment negligence
28185	ocular
28186	rapid meta-analysis
28187	toxic
28188	Multiple organ damage
28189	Post COVID-19
28190	Therapeutics treatment
28191	acellular therapy
28192	cybercrime
28193	fraud
28194	Ophthalmology.
28195	Pandemic 
28196	Hyperbaric oxygen therapy
28197	ISTH score
28198	Adverse reaction
28199	Hyperpigmentation
28200	adventitial cystic disease
28201	external iliac vein
28202	laparoscopic surgery
28203	ovarian tumor
28204	Interleukin-6 inhibitors
28205	ITK
28206	EV71
28207	cRNA
28208	vRNA
28209	cardiovascular adverse events
28210	pharmacovigilance analysis
28211	central vertigo
28212	covid-19 disease
28213	novel covid-19
28214	vestibular evaluations
28215	drug augmentation
28216	Pentoxil
28217	SARS (severe acute respiratory syndrome)
28218	anti-oxidant
28219	antifibrosis
28220	apoptosis-regulatory
28221	bronchodilator
28222	circulation, coronavirus
28223	PAP
28224	Whole lung lavage
28225	NSSI
28226	amygdala
28227	brain connectivity
28228	medial prefrontal cortex
28229	resting state
28230	intention formation
28231	intention translation
28232	multi-process action control framework
28233	lupus nephritis
28234	COV-SARS-2
28235	Disease-modifying antirheumatic drugs
28236	Acquired LQTS
28237	Drug toxicity
28238	Flow chart
28239	Proarrhythmia
28240	potential risk
28241	Humans
28242	Novel Coronavirus-2019
28243	nCOV-2019
28244	Cardiac adverse effects
28245	nonmaleficence
28246	extracorporeal therapy
28247	diazepam
28248	epinephrine
28249	COVID-19 main chain protease
28250	MD-Simulation
28251	Asian
28252	QTc interval
28253	cTp-e interval
28254	Action potential duration dispersion
28255	Experimental optical mapping
28256	T-wave alternans
28257	Coronavirus, malaria, antiviral
28258	dose
28259	dosage regimens
28260	drug monitoring
28261	population pharmacokinetic modelling
28262	Pre-exposure prophylaxis
28263	clinicaltrials.gov
28264	SARS-COV-1
28265	convalescent blood products
28266	corticosteroids convalescent sera
28267	novel virus
28268	qt prolongation
28269	history of health ethics/bioethics
28270	Glucose-6-phosphate dehydrogenase (G6PD) deficiency
28271	Haemolysis
28272	oseltamavir
28273	Mobile continuous telemetry
28274	Cardiac side effects
28275	Centrifugation
28276	Children magistral preparation
28277	Medicament manipulation
28278	Nasogastric tube
28279	BARDA, Biomedical Advanced Research and Development Authority
28280	EUA, Emergency Use Authorization
28281	OWSVI, Operation Warp Speed Vaccine Initiative
28282	accelerated approval
28283	emergency use
28284	operation warp speed
28285	vaccine approval
28286	Diagnostic kits
28287	Maternal fetal medicine
28288	cytokine-release syndrome
28289	lenzilumab
28290	severe acute respiratory distress syndrome
28291	Length of stay in hospitals (ALOS)
28292	operational
28293	drug toxicity
28294	heart (allograft) function/dysfunction
28295	psychiatric practitioner
28296	vulnerable population
28297	Steroid
28298	Hypoglycemia
28299	Analytical methods
28300	determination
28301	Adverse Events
28302	IL‐6 antagonist
28303	Financial impact
28304	dermatologic disorders
28305	melanin
28306	rheumatologic disorders
28307	Chemical descriptors
28308	Nonlinear optical application
28309	Optoelectronic devices
28310	Drug-induced arrhythmia
28311	Polymorphic ventricular tachycardia
28312	ethical challenges
28313	non-critical illness
28314	Twin pregnancy
28315	Surveys And Questionnaires
28316	antihistamines
28317	pruritis
28318	Demand
28319	Pharmacies
28320	Shortages
28321	Severe acute respiratory syndrome-related coronavirus
28322	Thrombotic thrombocytopenic purpura
28323	Severe infections
28324	doxycycline
28325	drug-interactions
28326	psychotropic drugs
28327	treatment COVID-19
28328	off label therapy
28329	propensity score matching
28330	access to medicines
28331	drug prices
28332	Aggregation
28333	Spearman's rank correlation
28334	patch tests
28335	anti-inflammatory agents, non-steroidal
28336	GLP-1RA
28337	SGLT-2
28338	Ritonavir/Lopinavir
28339	Dermatoethics
28340	Justice
28341	Nonmaleficence
28342	Sjogren's syndrome
28343	anticardiolipin
28344	imported lupus erythematosus
28345	systemic arthritis
28346	Bleomycin
28347	drug screening programs
28348	drug uptake transporters
28349	Fullerene
28350	Therapeutic effect
28351	Trial characteristics
28352	Trial registration
28353	Egyptian college of rheumatology
28354	chills
28355	Abakaliki
28356	Clinical trial reporting
28357	Drug information
28358	Retrospective studies
28359	COVi-2
28360	PARP-inhibitors
28361	geographical access
28362	glucose-6-phosphate dioxygenase deficiency
28363	upper east region
28364	Bioluminescence imaging
28365	multi-viral pneumonia
28366	LC–MS/MS
28367	improvement
28368	network meta-analysis
28369	cell-based reporter assay
28370	Glucocorticosteroid
28371	Pharmacotherapeutics
28372	Clinical deterioration
28373	Risk score
28374	M-type K+ current
28375	delayed-rectifier K+ current
28376	electroporation-induced current
28377	pituitary cell
28378	remdesivir (GS-5734)
28379	voltage hysteresis
28380	antiviral. 
28381	CoV2
28382	Sero-epidemiological study
28383	Competitive ELISA
28384	Monoclonal antibodies
28385	Malaria infection
28386	Protective factor
28387	immunochromatography
28388	Recombinant S1 subunit
28389	Convalescent plasma (CP)
28390	diagnostic methods
28391	respiratory viral infection
28392	heparin/ adverse effects
28393	thrombocytopenia/chemically induced
28394	Demyelinating event
28395	PCR negative
28396	defibrotide
28397	Challenge model
28398	Vaccine efficacy
28399	Acute myocardial infarction/STEMI
28400	Coronary Artery Disease
28401	bispecific
28402	polypeptides
28403	Autoantibody
28404	Immunofluorescence
28405	Molecular Mimicry
28406	AllerHunter
28407	FAO
28408	Federal Drug Administration
28409	Immuno epitope database
28410	adjuvant combination
28411	adjuvants
28412	aluminum
28413	functional antibody responses
28414	germinal center B cells
28415	rASP-1
28416	synergy
28417	Anti-β2-glycoprotein-I
28418	heparin induced thrombocytopenia
28419	SarsCov-2
28420	Transfusion Medicine
28421	hyperimmune plasma
28422	Antibodies, Anticardiolipin
28423	Antibodies, Antiphospholipid
28424	Microfiber
28425	Multiplex immunoassay
28426	Rapid
28427	thrombophilia
28428	IL6 blocking
28429	JAK-STAT inhibitors
28430	Severe respiratory syndrome
28431	Childhood immunization
28432	Immune fitness
28433	Mild symptom in children
28434	feline coronavirus (FCoV)
28435	feline enteric coronavirus (FECV)
28436	feline infectious peritonitis (FIP)
28437	multi-cat household
28438	Community screening
28439	Robots
28440	NMDA
28441	biogeocenosis
28442	cycles
28443	Teriflunomide
28444	Autopsies
28445	CAPS
28446	IgY antibody
28447	Infectious neonatal calf diarrhea
28448	Passive treatment
28449	Health law
28450	Identity theft
28451	(PEDV)
28452	Long-term preservation
28453	Neutralization test
28454	Pre-coated plate
28455	SARSCoV-2 antibodies
28456	Swab SARSCoV-2
28457	imaging cytometry
28458	antibody titer
28459	immunoglobulins A, M, and G
28460	vaccinations
28461	Adaptive management
28462	Sphenisciformes
28463	environmental stressors
28464	penguin
28465	seabird
28466	anti-Tumor Necrosis Factor (TNF) adalimumab
28467	fecal calprotectin
28468	inflammatory bowel disease (IBD)
28469	avian influenza virus H9N2
28470	commercial broilers
28471	specific pathogen free chickens
28472	Animal airway epithelial cell cultures
28473	Cell tropism
28474	Veterinary coronavirus
28475	Virus characterization
28476	AlphaLISA
28477	serum IgA
28478	serum IgG
28479	gut-mammary gland-secretory IgA axis
28480	lactogenic immunity
28481	lymphocyte trafficking
28482	age of vaccination
28483	Pathogenic enteric coronaviruses
28484	RT-PCR, detection methods
28485	Swine Diarrhea
28486	antigens
28487	chronic rejection
28488	graft rejection
28489	Airsacculitis
28490	Ammonia
28491	Broiler chickens
28492	QX-like type
28493	avian infectious bronchitis
28494	2019-nCoV-2
28495	Corona Virus Disease 2019(COVID-19)
28496	IPS-1
28497	Interferon beta
28498	iral infection
28499	Pneumonia. 
28500	Fuzzy inference system
28501	Healthcare supply chain disruption mitigation
28502	Germ aversion
28503	Perceived infectability
28504	Preventative behaviors
28505	Chinese preschoolers
28506	sleep disturbances
28507	sleep patterns
28508	food waste
28509	Immunity booster foods
28510	Vitamins rich Foods
28511	Stochastic model
28512	immuno-paralysis
28513	“cytokine storm”
28514	Conserved transcriptional response to adversity (CTRA)
28515	Social disruption stress
28516	Sociogenomics
28517	Stress hormones
28518	IPF
28519	bacterial pneumonia
28520	CF
28521	CFTR
28522	exacerbations
28523	CLR
28524	Mincle
28525	RLR
28526	proinflammatory response
28527	COVID-19 survivors
28528	respiratory muscle training
28529	Complement receptor 3
28530	immunology and inflammation
28531	health-seeking behavior
28532	Mortality risk
28533	Immunosuppressive therapy
28534	gut microbiome
28535	alcohol-associated liver disease
28536	contact dermatitis
28537	extracellular neutrophil traps
28538	neutrophil extracellular traps (NETs)
28539	vascular complications
28540	Interventional pain management
28541	Pain management
28542	Systemic analgesics
28543	low-resource countries
28544	maternity services
28545	islet transplantation
28546	coagulation pattern
28547	gender difference
28548	smoking habit
28549	essential micronutrients
28550	immune functions
28551	NAD+
28552	Botanical
28553	Coneflower
28554	Echinacea
28555	Tunisia
28556	Fear injury kidney
28557	COVID-19: Human health hazards: Environmental impact of hand rubs
28558	Hand sanitizers
28559	Interferons (IFNs)
28560	Warburg effect
28561	Insufficient vitamin D
28562	Proximity to the equator
28563	UV radiation
28564	PDE5 inhibitors
28565	oligodendrocyte
28566	virus-induced demyelination
28567	NCOVID-19
28568	SSA
28569	respiratory difficulties
28570	interleukin 1 receptor antagonist protein
28571	Coagulación
28572	Enfermedades autoinmunes
28573	Global food security
28574	crises
28575	earth system
28576	environmental footprint
28577	spatial scales
28578	system resilience
28579	time characteristics
28580	acute and chronic neurological diseases
28581	human respiratory virus
28582	Cardiometabolic risk
28583	Peyer's patches
28584	antiviral response
28585	coated Porcine enteric alphacoronavirus (PEAV)-loaded microspheres
28586	weaned piglets
28587	agent-based models
28588	immune system modeling
28589	cancer treatments
28590	death rates
28591	Climatic factors
28592	Low dose radon hyperthermia
28593	Creatine
28594	Function
28595	Metabolites
28596	attractor
28597	chaos
28598	contamination kinetics
28599	critical state
28600	dynamical systems
28601	reproductive rate
28602	stable cycle
28603	PVL-SA
28604	exotoxins
28605	toxic shock
28606	IL-6 cytokine
28607	Proteotronics
28608	topological analysis
28609	porcine encephalomyelitis virus
28610	vomiting and wasting disease
28611	Nanovaccines
28612	Carbonic anhydrase
28613	Kinetic model
28614	Thermoheliox
28615	Thermovaccination
28616	DDLT, Deceased Donor Liver Transplantation
28617	LDLT, Living Donor Liver Transplantation
28618	immunosuppressed
28619	nCoV, Novel Coronavirus
28620	recipient
28621	Chronic lymphocytic leukemia
28622	CoVId-19
28623	CoVid
28624	Lymphoid malignancies
28625	pediatric liver transplantation
28626	baseline characteristics
28627	rural US
28628	super-spreading events
28629	chronic glomerulonephritis
28630	nephrotic syndrome
28631	Dialysis membranes
28632	Hemoadsorption
28633	Medium cutoff dialyzer
28634	Kidney transplant
28635	telenursing
28636	Adult glioma
28637	Liver Transplantation
28638	cytokine-targeted therapy
28639	programmed cell death protein 1
28640	Cornelia de Lange syndrome
28641	guselkumab
28642	intellectual disability
28643	ANCA
28644	Glomerulonephritis
28645	Kidney biopsy
28646	biologics drugs
28647	patients perspective
28648	Continuous renal replacement therapies
28649	Cytokine removal
28650	Extracorporeal organ support
28651	Type III interferon
28652	etomidate
28653	propofol
28654	total intravenous anaesthesia
28655	Calcineurin inhibitor
28656	Lymphocytic bronchiolitis
28657	Surveillance bronchoscopy
28658	quarantine period
28659	China. 
28660	anti-coronavirus
28661	Lopinavir / ritonavir
28662	Adjunctive intervention
28663	Coronavirus pneumonia (CoV)
28664	nervous system symptoms
28665	2019 novel coronavirus (2019‐nCoV)
28666	prevention and treatment
28667	2019-nCoV protease
28668	Moleculardocking
28669	Therapeutic strategy
28670	comparative analysis
28671	differences between children and adults
28672	laboratory parameters
28673	Extracorporeal dialysis
28674	cell cultures
28675	therapeutic effect
28676	QTc interval prolongation
28677	length of hospitalization
28678	virus clearance time
28679	clinical diagnosis and treatment
28680	critical COVID-19 patient
28681	hepatitis flu
28682	human herpesvirus
28683	human papilloma virus infection
28684	Morus spp.
28685	crude extract
28686	picornaviruses
28687	Aliskiren
28688	Calcium channel antagonist
28689	2019 novel coronavirus-infection pneumonia (COVID-19-infection pneumonia
28690	COVID-19(SARS Cov2)
28691	biomaterial
28692	cell processing
28693	Terapia intensiva
28694	dehydroemetine
28695	emetine
28696	ipecac
28697	repurposing: antiviral
28698	MERS-CoV 3CLpro
28699	Blood glucose
28700	Interferon-lambda
28701	Middle east respiratory syndrome (MERS)
28702	Respiratory epithelium
28703	Shosaikoto
28704	Soshihotang
28705	Xiao Chai Hu Tang
28706	Attachment inhibition
28707	Caffeic acid
28708	Human coronavirus NL63
28709	Sambucus FormosanaNakai
28710	Virus yield
28711	Barotrauma
28712	Bleeding
28713	initial management
28714	antidiabetic drugs
28715	glycemic control
28716	severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2)
28717	Experimental research
28718	Korean Medicine
28719	Neuraminidase inhibitor
28720	investigational drugs
28721	LIGHT
28722	MAb
28723	TNFSF14
28724	bundle pharmacotherapy
28725	noninvasive-invasive sequential ventilation
28726	Alcohol poisoning
28727	Methanol
28728	pulmonary failure
28729	laboratory indexes
28730	post-admission complications
28731	Diagnostic method for COVID-19
28732	danoprevir
28733	time to achieve negative nucleic acid testing
28734	Ceftriaxone, Levofloxacin
28735	corona virus 19
28736	SSRIs
28737	MRC-5 human lung cell
28738	antiviral effect
28739	bis-benzylisoquinoline alkaloids
28740	cepharanthine
28741	fangchinoline
28742	human coronavirus strain OC43
28743	tetrandrine
28744	nutraceutical
28745	bioenergetics
28746	Reverse quarantine
28747	Kynurenine
28748	Eicosanoids
28749	Leukotrienes
28750	Thromboxane
28751	Lactobacillus plantarum
28752	Porcine IFN-λ3
28753	porcine enteric coronaviruses
28754	surface-displayed
28755	glycopeptide antibiotic
28756	vancomycin aglycone hexapeptide
28757	Antiviral response
28758	Duck enteritis virus
28759	IFN-β
28760	LGP2
28761	MDA5
28762	nucleocapsid N protein
28763	replication-transcription complexes
28764	viral mRNA synthesis
28765	Affinity purification
28766	Ascorbate peroxidase APEX2
28767	BioID
28768	Biotin ligase
28769	Mass spectrometry
28770	Proximity labeling
28771	Replicase microenvironment
28772	Replication transcription complex RTC
28773	TurboID
28774	glycopeptide
28775	perfluoroalkyl
28776	IFN-λ
28777	miR-30c-5p
28778	SCIT
28779	SLIT
28780	PK-PD
28781	Epidemic prevention measures
28782	Sustainable development
28783	Transmission of virus
28784	pyrazine
28785	ribonucleoside
28786	U18666A
28787	cationic amphiphilic drug
28788	PDCoV infection
28789	lncRNA
28790	metabolic pathway
28791	GSK2838232
28792	acyclovir
28793	antiviral API-ILs
28794	cocrystals
28795	ionic liquids of active pharmaceutical ingredients (API-ILs)
28796	pharmaceutical salts
28797	solubility
28798	late endosome
28799	inhibition assay
28800	virucidal assay
28801	Acetic acid
28802	Antifungal
28803	Antimicrobial
28804	Domestic hygiene
28805	Bacterial persister
28806	Cholesterol-based selectivity
28807	Membrane selectivity
28808	Membrane targeting
28809	Modelling and simulation
28810	Size-based selectivity
28811	Nucleocapsidgene
28812	Swine testicular cells
28813	C. parvum
28814	algae
28815	marine
28816	Camel cell line
28817	Column chromatography
28818	Gene walking
28819	Inclusion body
28820	Poxvirus
28821	Protein refolding
28822	RACE
28823	Rare codons
28824	Recombinant protein purification
28825	IRF3
28826	RNA degradation
28827	TBK1
28828	interferon signaling
28829	A77 1726
28830	Protein tyrosine kinases
28831	p70 S6 kinase
28832	ascorbate
28833	chicken embryo kidney cells
28834	hypericin
28835	2,6-DAPBPTSC, 2,6-diacetylpyridine bis-4-phenyl-3-thiosemicarbazone
28836	35-DTBP, 3,5-di-tert-butylphenol
28837	ATNR, Amine terminated liquid natural rubber
28838	ATT, 2-acetylthiophene thiosemicarbazone
28839	BBPT, Biacetyl bis(4-phenyl-3-thiosemicarbazone)
28840	BBTSC, Benzyloxybenzaldehyde thiosemicarbazone
28841	BCG, Bacillus calmette-guérine
28842	BDT, Benzyldithiosemicarbazone
28843	BGPT, Bipyridyl glyoxal bis(4-phenyl-3-thiosemicarbazone)
28844	BMTS, Biacetyl monothiosemicarbazone
28845	Biological/biomedical activities
28846	Bipy, 2,2-bipyridine
28847	CT DNA, Calf thymus deoxyribonucleic acid
28848	DAPY, 2,3-diamino-pyridine
28849	DTBP, 2,6-di-tert-butylphenol
28850	DTBQ, 2,6-di-tert-butyl-4,4′-benzoquinone
28851	EAC, Enrichlish Ascitices Cells
28852	HEK-293, Human Embryonic Kidney cells
28853	HL-60, Human leukemia-60 cell line
28854	HeLa, immortal cell lines
28855	HepG2, Hepatic cellular carcinoma cells (Human liver cancer cell line)
28856	IgG, Immunoglobin G
28857	K B HCT-8, Human colon cancer cell line
28858	M-IBDET, N-methylisatin-β-4′,4′-diethylthiosemicarbazone
28859	MCF-7, Michigan Cancer Foundation-7
28860	MCF7 cells, Michigan Cancer Foundation-7 (breast cancer cell line)
28861	MHV, Mouse hepatitis virus
28862	MLV, Moloney leukemia virus
28863	MSOPD, N,N-bis(3-methylsalicylidene)-ortho-phenylenediamine
28864	Metal complexes
28865	NQSC, Naphthoquinone semicarbazone
28866	NQTS, ortho-Naphthoquinone thiosemicarbazone
28867	OLED, Organic light emitting diode
28868	PAS, p-amino salicylic acid
28869	PPTS, Picolinealdehyde-4-phenyl-3-thiosemicarbazone
28870	Phen, 1,10-phenanthroline
28871	SARS CoV, Severe Acute Respiratory Syndrome coronavirus
28872	SB-HAG, Schiff bases of hydroxyamino guanidines
28873	SK-MEL-30, Human Melanoma Cell Line
28874	SK-OV-3 cells, Ovarian cancer cell line
28875	SSB-HAG, salicylaldehyde Schiff bases of HAG
28876	Schiff base
28877	Semicarbazone
28878	TCIDw, Tissue culture Infective Dose
28879	TTBDQ, 3,5,3′,5′-tetra-tert-butyl-4,4′-diphenoquinone
28880	VSV, vesicular stomatitis virus
28881	scCO2, Super-critical carbon dioxide
28882	NEDD4
28883	Na(+)/K(+)-ATPase
28884	Ouabain
28885	Proteolysis
28886	Nairovirus
28887	Viral pathogenesis
28888	TPEN
28889	ZIP
28890	labile zinc
28891	C−H activation
28892	alkenylation
28893	amidation
28894	indoles
28895	pharmaceuticals in the environment
28896	AVNP2
28897	C6 glioma
28898	Cognitive function
28899	COPD pathology
28900	COPD phenotypes
28901	Feline infectious peritonitis virus (FIPV)
28902	1-f8-D-Ribofuranosil-1,2,4-triazol-3-carboxamida
28903	1-f8-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
28904	Ribavirina
28905	Virazole
28906	Clearance ratio
28907	Coronaviruses (CoV)
28908	Patent Analysis
28909	Patents
28910	Research evaluation
28911	Technology assessment
28912	Home remedies
28913	Plasma
28914	Therapeutic compounds
28915	Chinese herbal
28916	Junior doctor
28917	consolidation
28918	crazy paving
28919	Shenfu injection
28920	arthritis, psoriatic
28921	Drug supply
28922	Pharmaceutical service
28923	repurposed
28924	Coronavirus2
28925	Islamic principles
28926	biologic drugs
28927	Chinese medical drug
28928	Core outcome set
28929	Meta analysis
28930	causes and management
28931	potential drugs
28932	buriti oil
28933	molecular dynamic
28934	Psychotropic Drugs
28935	HCV NS5b RdRp
28936	antihyperglycemic drugs
28937	clinical status
28938	Reported and unreported cases
28939	anti-viral agents
28940	Criminalisation
28941	training of doctors
28942	Antithyroid drugs
28943	Graves’ disease
28944	Graves’ orbitopathy
28945	advanced age
28946	adverse reactions
28947	progressive renal impairment
28948	vital target organs
28949	conservation strategies
28950	drug shortage
28951	therapeutic alternatives
28952	alternative care center
28953	drug distribution
28954	field hospital
28955	formulary
28956	pharmacy operations
28957	Darkweb
28958	Illicit drug market
28959	Market disruption
28960	pars plana vitrectomy
28961	phacoemulsification
28962	CARDS
28963	Anti-coagulation
28964	chronic insomnia
28965	Custom appliance
28966	Aerosol box
28967	Barrier enclosure
28968	Pharmacologic therapy
28969	Behavioral addiction
28970	Opioid
28971	ICU management
28972	Paracetamol
28973	SARS-nCoV-2 virus
28974	Dose
28975	VDR
28976	Huoxiang Zhengqi dropping pills
28977	Lianhua Qingwen granules
28978	Emergency shelter
28979	National state of disaster lockdown
28980	precipitant
28981	seizure exacerbation
28982	Non-specific effect
28983	SGLT2
28984	canagliflozin
28985	dapagliflozin
28986	empagliflozin
28987	1. COVID-19
28988	South indian medicinal plants
28989	COVID-19 (severe)
28990	drugs analysis
28991	therapeutic strategy
28992	deep vein thrombosis (DVT)
28993	analytic hierarchy process (AHP)
28994	epidemic dynamics model, nonlinear least squares
28995	technique for order preference by similarity to an ideal solution (TOPSIS)
28996	Anti-inflammatory agents, non-steroidal
28997	Pharmacoepidemiology
28998	Pharmacovigilance
28999	Civil society
29000	Marginalised people
29001	Vulnerable people
29002	CLI
29003	NPWT
29004	PRP
29005	non-healing ulcers
29006	3C-like protease (3CL(pro)) inhibitors
29007	Peptidomimetic inhibitors
29008	Proteolytic targeting chimaera (PROTAC)
29009	Drug compounding
29010	Intravenous infusions
29011	Patient satisfaction
29012	Airway epithelial cells
29013	CD13
29014	Long-acting muscarinic antagonist
29015	Long-acting β(2) agonist
29016	Antidiabetic drugs
29017	Ethical challenges
29018	Investigational off-label uses
29019	Off-label prescription
29020	Off-label uses
29021	Clinical Pharmacy Services
29022	Hospital Pharmacy Service
29023	crack cocaine, COVID-19, inhalation equipment, pipe sharing, respiratory risk
29024	Behçet's disease
29025	anti-TNF agents
29026	azathioprine
29027	Antiepileptic drugs
29028	Child neurology
29029	drug procurement
29030	pharmacy management (organisation, financial)
29031	NT-proBNP
29032	drugs withdrawal
29033	Controlled Substances Act
29034	Opioid use disorder
29035	War on drugs
29036	Death toll
29037	Forecast predictions
29038	Weibull distribution
29039	Salicyl-carnosine
29040	CID
29041	Immuno-thrombosis
29042	ARA2
29043	IECA
29044	Drug Use
29045	Harm Reduction
29046	Safe Supply
29047	Frontline health workers
29048	MENA region
29049	symptom control
29050	Medical device incident
29051	Abuse
29052	Addictovigilance
29053	Nitrous oxide
29054	Pregabalin
29055	Psychoactive substances
29056	DRAP
29057	Drug Regulatory Authority of Pakistan
29058	Drugs Act 1976
29059	Pharm-D
29060	Pharmacy proprietors
29061	Punjab Drug Rules 2007
29062	pharmacy administration
29063	Advertising as topic
29064	Drugs shortage
29065	Propofol
29066	Regional Anaesthesia
29067	Cardiac mass
29068	Coronavirus OC43
29069	cardiac tumour
29070	congestive heart failure
29071	inflammatory myofibroblastic tumour
29072	pericardial tamponade
29073	psychiatric medication
29074	GSK3b
29075	Glycogen Synthase Kinase
29076	laser precision manufacturing
29077	photothermal
29078	superhydrophobic
29079	epidemiologic studies
29080	nonsteroidal antiinflammatory drugs
29081	Mathematical programming
29082	Pharmaceutical shortage
29083	dasatinib
29084	fisetin
29085	senescent cell anti-apoptotic pathways
29086	unitary theory of fundamental aging processes
29087	Advanced Technology: Digital Era
29088	Incentive
29089	Intellectual Property
29090	Investments
29091	Law and Economics
29092	Patent
29093	Human metapneumovirus
29094	Cleidion javanicum
29095	Litsea cubeba
29096	Tinospora crispa
29097	bacterial
29098	ethnobotany
29099	ethnomedicinal plants
29100	fungal
29101	ASA, American Society of Anesthesiologist
29102	BMI, body mass index
29103	ETCO2, end-tidal CO2
29104	GA, general anaesthesia
29105	General anaesthesia
29106	LRA, locoregional anaesthesia
29107	NSAID, non-steroid anti-inflammatory drugs
29108	PONV, postoperative nausea and vomiting
29109	Postoperative pain
29110	Postoperative recovery
29111	SA, spinal anaesthesia
29112	Spinal anaesthesia
29113	VNRS, verbal numerical rating scale
29114	aerosol generation
29115	open reduction and internal fixation
29116	21st century cures act
29117	dipyridamole
29118	siblings
29119	Inflammatory indicators
29120	antimicrobial development
29121	chimeric antigen receptor T cells
29122	gyroslab
29123	millipore SMCxPro
29124	quanterix simoa
29125	multiple instance learning
29126	digital mental health
29127	evidence-based guidance
29128	Hand-rubs
29129	Hand-sanitisers
29130	Viscosity
29131	ursodeoxycholic acid
29132	Deprescribing
29133	Elderly population
29134	Hospital pharmacy
29135	Rational use of medicine
29136	Clinical trial design
29137	Occupational protection
29138	Pharmacy administration
29139	Wuchang Fangcang Shelter Hospital
29140	COVID‐19 pandemic
29141	Medical Device Design
29142	Respiratory Insufficiency
29143	Improvement
29144	neuraminidase
29145	cross protectivity
29146	inactivated vaccines
29147	next-generation vaccines
29148	synthetic vaccines
29149	reinforcement sensitivity theory
29150	6W63
29151	Flavonoid
29152	MVD
29153	X77
29154	apoptosis-inducing factor
29155	Il-6 inhibition
29156	cytokine/chemokine
29157	Heparanase
29158	aprotinin
29159	metalloproteinases
29160	Chaiyin Particles
29161	Ketoacidosis
29162	SGLT2 inhibitor
29163	Cytokine-Storm
29164	cardiovascular protection
29165	cytokine release Syndrome
29166	N-Acetyl-cysteine
29167	Cell Therapy and Immunotherapy
29168	Bentonite
29169	Dr Elsey
29170	FCoV infection
29171	Fuller’s earth
29172	cat litter
29173	reducing virus load
29174	virus inhibition
29175	ERK1/2
29176	Signal transduction
29177	climacostol
29178	human adenovirus (HAdV)
29179	natural compound
29180	viral inhibition
29181	Empirical free energy model
29182	Kinase inhibitors
29183	Lassbio chemical library
29184	PI4KIIIβ ligands
29185	CRM1
29186	Selinexor
29187	high content screening (HCS)
29188	leptomycin B
29189	natural products (NP)
29190	nuclear export
29191	bactericidal
29192	laser-induced graphene
29193	Hem agglutinin esterase (HE)
29194	Middle east respiratory syndrome coronavirus (MERS-CoV)
29195	New coronavirus (2019-nCoV)
29196	rRT-PCR tests
29197	Hormonal contraceptives
29198	condom
29199	intrauterine contraception
29200	Bitcoin
29201	Equity markets
29202	Financial markets
29203	Gold
29204	Volatility
29205	case-increase rate
29206	case-recovery rate
29207	COVID_19
29208	Consumer behaviour
29209	European power systems
29210	Populist Radical Right
29211	Political Determinants of Health
29212	Delphi
29213	Health literacy
29214	Hoarding
29215	Social dominance orientation
29216	Stockpiling
29217	outside China
29218	Insufficiency
29219	Cervical cancer screening
29220	Cervical excision
29221	Colposcopy
29222	university health services
29223	Cesarean Section
29224	Average wind speed
29225	Climatic conditions
29226	Climatology
29227	Environmental analysis
29228	Environmental economics
29229	Environmental health
29230	Environmental impact assessment
29231	Mean temperature
29232	curable tumors
29233	expert centers
29234	germ cell tumors
29235	pandemic testicular
29236	Job attitudes
29237	Work performance
29238	MeSH
29239	pediatric end of life
29240	pediatric hospice care
29241	telehospice
29242	CHIMERE
29243	Chemistry-transport modelling
29244	Emissions scenario
29245	Logistic growing
29246	Cross-national fear
29247	Fear assessment
29248	Fear of COVOD-19 Scale
29249	Psychological flexibility
29250	Preliminary clinical evaluation
29251	Radiograph
29252	goal
29253	economic segregation
29254	human mobility
29255	national lockdown
29256	Carbon emissions
29257	Climate policy
29258	Green recovery
29259	Stock returns
29260	Acute circulatory failure
29261	Lockdowns
29262	Exportation risk
29263	Importation risk
29264	Pandemic countermeasures
29265	Assistantship
29266	Students
29267	decision-making process
29268	surgery refusal
29269	health knowledge
29270	cord compression
29271	oncologic emergencies
29272	Appropriateness
29273	Endoscopic service
29274	Best evidence medical education
29275	psychological responses
29276	SRHR
29277	V/Q SPECT
29278	Minimally invasive
29279	Pancreas
29280	breast
29281	Hospital organization
29282	frontotemporal lobar dementia
29283	multidisciplinary care
29284	quality life
29285	Failure
29286	Irrigation and debridement
29287	Prosthetic joint infection
29288	Digital
29289	Safeguarding
29290	Quantification of adipose tissue
29291	Visceral adipose tissue
29292	UVA
29293	amotosalen
29294	pathogen inactivation
29295	ESMO
29296	GI cancers
29297	Air pollutant emissions
29298	Capital cities
29299	satellite NO2
29300	Antithrombin III
29301	Heparin resistance
29302	SARS-CoV critical illness
29303	Planetary science
29304	Social Policy
29305	iron deficiency
29306	oral iron
29307	Airline strategy
29308	Crisis response
29309	State aid
29310	Socioeconomic activities
29311	early trend
29312	SORT IT
29313	operational research
29314	People’s perceptions
29315	Public policies
29316	EU ETS
29317	Environmental policy
29318	MSR
29319	Progressive multiple sclerosis
29320	COVID-9
29321	Biochemical recurrence
29322	Oncologic outcomes
29323	Oil price
29324	assimilation
29325	weather forecast
29326	Environment-to-human pollution
29327	panel data
29328	stock market
29329	comprehensive cardiac rehabilitation
29330	COVID-19 response in Africa
29331	United Nations emergency appeal response to COVID-19
29332	efforts to mitigate and adapt to COVID-19
29333	gender matters in COVID-19 response
29334	impact of COVID-19 in Uganda
29335	impact of COVID-19 in children
29336	myths about COVID-19
29337	British
29338	Health Emergency
29339	Nursing Nursing Policy
29340	Pandemics Primary Care Nursing
29341	Roles and Responsibilities
29342	Fibroids
29343	Markov model
29344	Ulipristal acetate
29345	Uterine leiomyoma
29346	CE marking
29347	Face-shields
29348	International standards
29349	Visors
29350	active ageing
29351	people with disability
29352	promotion of health
29353	Global disparity
29354	Secondary cerebrovascular prevention - COVID-19
29355	Crisis unit
29356	PSYCOVID-19
29357	Psychological support
29358	iconography
29359	material culture
29360	museology
29361	plague mask
29362	protective clothing
29363	coronavirus (COVID-19)
29364	Response pattern
29365	Men who have sex with men
29366	canine infectious respiratory disease complex
29367	pathogen
29368	Aerosol Filtration Efficiency
29369	Particle Filtration Efficiency
29370	pre-screening
29371	approaches
29372	patient involvement
29373	public involvement
29374	Teleworking
29375	Wage inequality
29376	Instrument
29377	Self-assessed health
29378	Airlines' network
29379	Epidemics modelling
29380	European airports' security
29381	Infectious diseases spreading
29382	Helicopter money
29383	Household finance
29384	Monetary policy
29385	Survey data
29386	Health services administration & management
29387	community child health
29388	tropical medicine
29389	Public healthcare
29390	galenic plague
29391	justinianic plague
29392	medieval black Death
29393	plague of Athens
29394	E-cigarette vaping
29395	Endothelial function
29396	Shisha/waterpipe smoking
29397	Tobacco smoking
29398	Medical conference
29399	Digital work
29400	Locked-down digital work
29401	Misconceptions
29402	Childbed fever
29403	Puerperal fever 
29404	Rift Valley fever
29405	Daylight Photodynamic Therapy
29406	Dosimetry
29407	Live Dosimetry
29408	Photodynamic Therapy
29409	1918 influenza pandemic
29410	Prevention of infectious diseases
29411	Safe Village
29412	Spanish flu
29413	Doctor in training
29414	Resident doctor
29415	Cardiovascular magnetic resonance imaging
29416	Doppler ultrasound gating
29417	Fetal blood flow
29418	Metric optimized gating
29419	middle-income countries
29420	Severe acute respiratory infection
29421	bibliometric analysis
29422	Sexual Medicine
29423	Webinar
29424	Log-normal distribution
29425	operational strategies
29426	infection management
29427	kinetic analysis
29428	allergy and immunology
29429	chronic urticaria
29430	Contact tracing - COVID-19 - India - mobile apps - mobile health - privacy - telemedicine
29431	Buddhism
29432	Confucianism
29433	Eastern Philosophy
29434	Taoism
29435	2019 coronavirus
29436	affect heuristic
29437	risk perceptions
29438	societal norms
29439	global neurosurgery
29440	neurosurgery training
29441	Continuity of care
29442	Stroke units
29443	staff development
29444	outbreak phage
29445	Latin Countries
29446	Other
29447	Radionuclide Therapy
29448	SPECT
29449	Treatment Discontinuation
29450	health system capacity
29451	psychoanalytic responses to pandemic
29452	KHCC
29453	CMAQ
29454	Emissions reduction
29455	Shutdown
29456	Transboundary aerosol
29457	ark hospital
29458	Law enforcement
29459	Lock down period
29460	Psychological aspects
29461	understanding
29462	young people
29463	Emotional stage
29464	Peer support
29465	Smart phone
29466	sex life
29467	public health nurse
29468	refuge center
29469	Illness anxiety
29470	Panic
29471	Sports Medicine
29472	Elements
29473	Emission reduction
29474	Xianghe
29475	outdoor activity
29476	societies
29477	Daily new cases
29478	Dynamic prediction
29479	Governments’ interventions
29480	Segmentation
29481	Seven-day lag
29482	stationarity
29483	Lock-down
29484	Education Management
29485	Ex-pat Teacher
29486	International school
29487	Teacher engagement
29488	Teacher retention
29489	Disintegration
29490	Flushability
29491	Public toilet
29492	Restroom
29493	Sewer
29494	Classical machine learning
29495	Deep transfer learning
29496	Masked face
29497	Cancer centre
29498	SAR-C0V-2
29499	Community development
29500	Coproduction
29501	Volunteering
29502	civil society
29503	social mobilization
29504	Home sleep study
29505	In-lab testing
29506	Level-1 sleep study
29507	Positive airway pressure (PAP)
29508	Food system disruption
29509	Idiopathic central nervous system inflammatory diseases
29510	Neuromyelitis optica spectrum disorders
29511	Resource limited settings
29512	Cambodia
29513	Microfinance
29514	Over-indebtedness
29515	Social reproduction
29516	Age profiles
29517	Origin of infection
29518	Pandemic analysis
29519	Immigration rate
29520	Nonstandard finite difference scheme
29521	Novel coronavirus-19
29522	COVID in India
29523	COVID in South Asia
29524	WONCA
29525	World Organization of Family Doctors
29526	indigenous/Adivasi health
29527	subaltern populations
29528	ESKD Care
29529	Rice
29530	Stockpile
29531	Trade
29532	currency markets
29533	financial centres
29534	financial sector
29535	stock markets
29536	emergency stabilization policy
29537	publicly available face mask
29538	Education management
29539	Teacher satisfaction
29540	Diets
29541	Livelihoods
29542	Vegetables
29543	Turning point
29544	Asia Pacific
29545	Health EDRM
29546	tele-counseling
29547	Tor remadevii
29548	mahseer
29549	poaching
29550	Agri food system
29551	Molecular assay
29552	Panspecies
29553	Endangered species
29554	Wildlife trade
29555	Agricultural sustainability
29556	Crop residue burning
29557	NW India
29558	Rural-urban nexus
29559	anthropogenic land‐use change
29560	deforestation
29561	global change
29562	urbanisation
29563	zoonotic diseases
29564	Acute respiratory infection
29565	Mixed infection
29566	nanopillar
29567	photothermal effect
29568	point-of-care diagnosis
29569	computer
29570	immigrant Chinese
29571	interactive
29572	biopharmaceuticals
29573	emerging threat
29574	plant system
29575	villitis
29576	atypical coronavirus
29577	loss of taste
29578	keywords
29579	research hotspots
29580	caregiver protection
29581	imaging protocols
29582	patient protection
29583	nebulizer
29584	Public health systems
29585	heartEarth's oldest material is older than earthPandemic changes the course of human history-Anonymous Scientist and Philosopher
29586	deep extubation
29587	functional anatomy of the larynx
29588	laryngospasm
29589	partial airway obstruction
29590	stridor
29591	upper airway obstruction
29592	imaging utilization
29593	work relative value unit
29594	blood and urine tests
29595	severity detection
29596	Cost reduction
29597	Economic burden
29598	Hospital costs
29599	Value
29600	systemic capillary leak
29601	posttraumatic
29602	large vessel occlusion (LVO)
29603	stroke—diagnosis
29604	anesthesia practice
29605	lesson
29606	epilepsy surgery
29607	health information needs
29608	search trends
29609	Defense Mechanisms
29610	Therapeutic Alliance
29611	general neurology
29612	healthcare workflow
29613	Counties
29614	race factors
29615	Black children
29616	Latino children
29617	Native American children
29618	function
29619	marginalized population
29620	Announcement effect
29621	Realized volatility
29622	US financial market volatility
29623	COVID nephropathy
29624	acute renal failure (ARF)
29625	peritoneal dialysis (PD)
29626	resource shortage
29627	urgent-start PD
29628	Federally qualified health centers
29629	Fee for service
29630	competency
29631	procedure volume
29632	Cost sharing
29633	Healthcare.gov
29634	Medicaid patients
29635	Premiums
29636	Risk adjustment
29637	Risk sharing
29638	Special enrollment period
29639	Uninsured
29640	Crime rates
29641	Group-based offending
29642	Lockdown orders
29643	fellowship training
29644	procedural volume
29645	Criminal justice
29646	Police
29647	Preschool
29648	Best practices
29649	Nuclear Cardiology
29650	Crime
29651	Crime trends
29652	gender identity
29653	minority stress
29654	sexual orientation
29655	Search interest
29656	coronaphobia
29657	Power-law growth
29658	SEIR Model
29659	career construction theory
29660	counselors
29661	life design counseling
29662	self-construction theory
29663	Covid-19 and oncologic surgery
29664	meta-research
29665	publishing
29666	Vaso-Occlusive Crisis (VOC)
29667	clinical pain
29668	Posttraumatic Stress Disorder
29669	Stool PCR
29670	biologic therapy
29671	non-biologic systemic
29672	Asian American
29673	Hate crime
29674	inner city hospital
29675	Multi-hazards
29676	Coronavirus Aid
29677	Coronavirus Economic Stabilization Act
29678	Relief and Economic Security Act
29679	adult reconstructive surgery
29680	occupational therapy
29681	systems of care
29682	26A33
29683	62Q05
29684	92B05
29685	92C60
29686	Coronavirus dynamics
29687	Li Wenliang
29688	Metapopulation movement
29689	Obsession with COVID-19 scale
29690	natural disasters
29691	females
29692	housing insecurity
29693	hunger
29694	economic disadvantage
29695	Law Enforcement
29696	Policing
29697	Victimization
29698	intervening health behaviors
29699	preventive health behaviors
29700	Stay at home order
29701	Passenger perceptions
29702	Willingness to fly
29703	behavior, social
29704	Avoidance
29705	Distress
29706	BPM, Beats per minute
29707	FQHC, Federally Qualified Health Center
29708	patient prioritization
29709	proton therapy
29710	QMRA
29711	risk characterization
29712	Google Analytics
29713	progressive web application
29714	Mortality reduction
29715	Internet search
29716	mitigation measures
29717	survival-convolution model
29718	time-varying effective reproduction number
29719	geographic spillovers
29720	peer effects
29721	social spillovers
29722	cancer worry
29723	Spontaneous hemopneumothorax
29724	conservatism
29725	life history theory
29726	chronic neurological disease
29727	cocooning
29728	Personal Protective Equipment (PPE)
29729	Bias incident
29730	Racial discrimination
29731	Racialization
29732	ICU capacity
29733	Fractional grey model
29734	Exogenous variables
29735	Variational mode decomposition
29736	academic–community partnerships
29737	participatory action research
29738	ACGME
29739	Closed-loop systems
29740	Diabetes education
29741	Diabetes technology
29742	Virtual education
29743	Discrete cosine transform (DCT)
29744	Fourier decomposition method (FDM)
29745	Gaussian mixture model (GMM)
29746	Susceptible-infected-recovered (SIR) model
29747	Systemic racism
29748	Underserved minorities
29749	lifesaving
29750	Gross domestic product
29751	Unemployment insurance claim
29752	Vector auto regressive
29753	psychosocial health
29754	correctional health
29755	Child maltreatment
29756	Neglect
29757	Parental burnout
29758	reverse-surge
29759	virtual medicine
29760	Mortality Rate
29761	Water environment
29762	health information system
29763	health technology
29764	team-based medicine
29765	urothelial carcinoma
29766	Structural heart disease
29767	Transcatheter aortic valve repair
29768	Transcatheter mitral valve repair
29769	Chronic Liver Disease
29770	Calls for service
29771	Carbon dioxide (CO2)
29772	Cerebral hemodynamics
29773	Personal protection equipment (PPE)
29774	Powered air-purifying respirator (PAPR)
29775	Transcranial Doppler (TCD)
29776	natalizumab
29777	Consumer behavior
29778	Do-it-yourself
29779	ASD, Atrial septal defect
29780	COVID-19, Coronavirus disease 19
29781	POD, Post-operative day
29782	PPE, Personal protective equipment
29783	VSD, Ventricular septal defect
29784	immigration policy
29785	Portable CT
29786	Parkinson Disease
29787	Patient-Centered Care
29788	Benford’s law
29789	Epidemic growth model
29790	Sequential updating method
29791	child food security
29792	child nutrition
29793	parent feeding
29794	viral pandemic
29795	age segregation
29796	aged-care policies
29797	stereotyping
29798	CO(2) decrease
29799	Inventory
29800	Latinx/Hispanic
29801	Research methods
29802	Acute respiratory syndrome coronavirus
29803	Adult critical care
29804	Crisis Resource Management
29805	Perioperative care
29806	System Integration
29807	Internet-checking
29808	obsessive compulsive disorder
29809	suicidal ideation
29810	Cardiac Imaging
29811	Cardio‐Oncology
29812	Targeted Therapies
29813	Community Clinic
29814	Covid-19 Impact
29815	Immigrants
29816	Under Resourced
29817	GRECC
29818	video-to-home visits
29819	tele-exercise
29820	teletraining
29821	Biodefense strategy
29822	Liquidity
29823	Sentiment
29824	Erythema nodosum
29825	Rash
29826	Trust in information source
29827	Food allergy prevention
29828	Oral food challenges
29829	Oral immunotherapy
29830	Peanut allergy
29831	peer support
29832	Chief resident
29833	Radiology residency
29834	Fibrinolytics
29835	Primary percutaneous coronary intervention
29836	CT abdomen/pelvis
29837	Lung bases
29838	mental disorders
29839	Decision support app
29840	Participatory design
29841	GI Symptoms
29842	health and social inequalities
29843	Fatherhood premium
29844	Labor market inequality
29845	Motherhood penalty
29846	Economic Inequality
29847	Health Status Disparities
29848	Racial Disparity
29849	Socioeconomic Factors
29850	United States Population-Based Analysis.
29851	Mouse model
29852	Mouse-adapted virus
29853	Serial passage
29854	Virus clone isolation
29855	cluster analysis
29856	national scientific funds
29857	online didactics
29858	residency survey
29859	surgical residents
29860	Psychometric perception
29861	Middle ear
29862	Behavioral health
29863	Suicidal ideation
29864	technology use
29865	Affect
29866	Purchasing behavior
29867	Worry
29868	Ohio
29869	Approach
29870	Coaching
29871	USMLE examination preparation
29872	PERV
29873	xenotransplantation
29874	CNMT
29875	Nuclear Medicine
29876	Economic shutdowns
29877	Opening the economy
29878	Prosocial tendencies
29879	Reopening the economy
29880	Risk-taking tendencies
29881	Acute medical conditions
29882	Emergency department visits
29883	Medical emergencies
29884	Motor vehicle collisions
29885	Multi-sectoral efforts
29886	Public health surveillance
29887	Public health system
29888	Impending fracture
29889	Lombardy (Italy)
29890	infection fatality rate (IFR)
29891	reproduction ratio (R0)
29892	tobacco treamtent
29893	Bayesian influence
29894	disease hotspots
29895	geographic disparity
29896	urgent surgery
29897	benefits of volunteerism
29898	volunteerism
29899	critical care clinician
29900	intensive care unit clinician
29901	inducible epithelial resistance
29902	PANoptosis
29903	host defense
29904	Buprenorphine/naloxone
29905	MOUD
29906	OTPs
29907	SAMHSA
29908	medication for opioid use disorder
29909	opioid treatment programs
29910	detention
29911	refugee resettlement
29912	Bovine
29913	Coronavirus vaccines
29914	Domestic animal
29915	Pig
29916	Poultry
29917	Postgraduate medical education
29918	medical fellows
29919	medical residents
29920	SIR (Susceptible Infected-Recovered) model
29921	zones
29922	COVID-19 and vascular surgeon
29923	Vascular surgery and COVID-19
29924	Black health
29925	Structural inequities
29926	Rate
29927	health financing
29928	neoliberalism
29929	Grandparent kinship providers
29930	Material hardship
29931	Parenting stress
29932	Climate Crisis
29933	Collective Trauma
29934	Ethics of Care
29935	Health Inequity
29936	crisis climática
29937	determinantes sociales de la salud
29938	inequidad sanitaria
29939	trauma colectivo
29940	ética de asistencia
29941	健康不公平
29942	健康的社会决定性因素
29943	关怀的伦理
29944	气候危机
29945	集体创伤
29946	data politics
29947	narrative power
29948	poetry
29949	public health violence
29950	intensive care unit availability
29951	rural populations
29952	Community lockdown lifting
29953	Diagnostic testing and detection contact tracing
29954	Face mask compliance
29955	Mathematical model for COVID-19
29956	Artificial Neural Network
29957	Korean immigrants
29958	Anxiety disorder
29959	Prevention strategies
29960	Import cases
29961	Risk prediction
29962	Worldwide epidemic trends
29963	Economic anxiety
29964	Financial threat
29965	provider
29966	reprocessing
29967	shortage
29968	kidney replacement therapy
29969	Childhood Obesity
29970	covid-19 in cancer patients
29971	new york
29972	death rate
29973	government reaction
29974	lessons and experiences
29975	wildlife protection
29976	international organizations
29977	structural international relations theory
29978	Biological warfare
29979	Biosafety and biosecurity
29980	Global governance
29981	Origins of COVID-19
29982	P4 or BSL-4 lab
29983	racial inequality
29984	spatial clustering
29985	Applied behavior analysis
29986	California Department of Education
29987	Nonpublic agency
29988	Special education
29989	Co-benefits
29990	withdrawal of life-sustaining medical treatments
29991	Interleukin-6; cytokine
29992	Donation
29993	Plasma-derived
29994	Source Plasma
29995	Engagement
29996	Openness
29997	Pandemic adversity
29998	CASP-19
29999	COVID-19 new classes of occupation
30000	occupational calling
30001	medical populism
30002	Environmental attitudes
30003	Environmental regulations
30004	Food safety regulations
30005	practice guidelines
30006	Black Americans
30007	Syndemic theory
30008	Psychological inflexibility
30009	Online labour markets
30010	freelance work
30011	multi‐method study
30012	telework
30013	Infectious pandemic
30014	Resident well-being
30015	Surgical trainee
30016	Border
30017	Hispanic Health Dispaties
30018	Latino Population
30019	Sociology of Health
30020	Mood
30021	activity
30022	long-term care planning
30023	Online therapy
30024	conjoint therapy
30025	couple therapy
30026	family therapy
30027	organizational change
30028	race and racial disparities
30029	religionspirituality
30030	Atkins
30031	Ketogenic
30032	Traffic vehicle collisions
30033	Traffic vehicle injuries
30034	Teleneuropsychology
30035	Psychological stress, Loneliness
30036	University health services
30037	Job vacancies
30038	Labor demand
30039	Recessions
30040	Unemployment
30041	Mental health systems/hospitals
30042	Public policy issues
30043	Fossil fuels
30044	Renewables
30045	Social practices
30046	Sustainable energy transition
30047	Qualitative
30048	Sexual minority
30049	Fears
30050	Mitigation procedures
30051	Public health policy
30052	Employee adjustment
30053	Human resource management
30054	atrial natriuretic peptide
30055	brain natriuretic peptide
30056	cyclic guanosine 3' 5'‐monophosphate
30057	Press briefings
30058	cost-effectiveness analysis simulation model.
30059	hepatitis C
30060	viral hepatitis elimination
30061	Clinical trial, Chemotherapy
30062	Continuous negative pressure
30063	Operative field barrier
30064	Oral maxillofacial surgery
30065	Industrial workers
30066	Industrial zone
30067	Value Based Medicine
30068	career planning
30069	didactic education
30070	Correctional officers
30071	Jails
30072	Prisons
30073	Country-level analysis
30074	Public health policies
30075	Traffic
30076	Ultrafine particle (UFP)
30077	The Netherlands
30078	smoking behavior
30079	healthcare expenditure
30080	Mobile-health intervention
30081	Endovascular simulation
30082	Interventional radiology training
30083	Other-focus
30084	Self-disclosure
30085	Self-focus
30086	digital methodology
30087	podcast
30088	sonic geographies
30089	“Autopsy”
30090	“COVID-19″
30091	“Megakaryocyte”
30092	“Thrombosis”
30093	Microvascular disease
30094	Risk Communication
30095	Precarious work
30096	Unemployment interventions
30097	Work-family interface
30098	Youth unemployment
30099	tPA
30100	detention facilities
30101	COVID-19 Outcomes
30102	Supportive Care
30103	MDR-TB
30104	Service evaluation
30105	cerebrovascular accident
30106	General anesthesia
30107	Shortness of breath
30108	Adjuvant Chemotherapy
30109	COVID-19, Pandemics
30110	Pancreatic Cancer
30111	Rural health care
30112	community engagement participation
30113	social exclusion/inclusion
30114	aging network
30115	distanced connectivity
30116	social connectivity
30117	deconvolution
30118	interval censoring
30119	mixture distribution
30120	renewal process
30121	Cath lab
30122	Structural
30123	Health policy, planning and management
30124	I1
30125	J0
30126	J1
30127	Spanish flu pandemic
30128	health impacts
30129	long-run innovation
30130	renewables investment
30131	Fourth Amendment
30132	Population-Level Bioethics
30133	remyelination
30134	Buprenorphine
30135	Data monitoring committee
30136	Interim analyses
30137	ADA, American Dental Association
30138	ARI, Acute Respiratory Infections
30139	ASTM, American Society of Testing Materials
30140	COVID-19, Coronavirus Disease, first detected in 2019
30141	CRI, Confirmed respiratory infection
30142	DHCP, Dental Health Care Practitioner
30143	ER, Emergency Room
30144	Evidence-based review
30145	FFR, Filtering Facepiece Respirators
30146	H1N1, H1N1 Subtype of Influenza-A
30147	HCW, Healthcare Workers
30148	HVE, High-Volume Evacuation
30149	ICP, Infection Control Protocol
30150	ILI, Influenza-like Illness
30151	LCI, Laboratory-confirmed Influenza
30152	MERS, Middle East Respiratory Syndrome (a coronavirus formally identified in 2012)
30153	N95, Non-oil-resistant, filtering facepiece respirator filtering 95% of airborne particles
30154	NASIOM, National Academy of Sciences’ Institute of Medicine
30155	NIOSH, National Institute for Occupational Safety and Health
30156	OSHA, Occupational Safety and Health Administration
30157	RCT, Randomized Controlled Trial
30158	SARS, Severe Acute Respiratory Syndrome (a coronavirus formally identified in 2003
30159	Surgical facemask
30160	Affair Recovery
30161	Clinical Recommendations
30162	Infidelity
30163	Social work
30164	webside manner
30165	medical abortion
30166	clinical experiences
30167	disruption
30168	communication practices
30169	visitation policies
30170	Rural medicine
30171	Control of breathing
30172	Pulse oximetry
30173	FcγIIa receptor
30174	Heparin-induced thrombocytopenia and thrombosis
30175	Harm reduction service
30176	Medication assisted treatment
30177	Opioid treatment program
30178	Overdose prevention
30179	collective trauma
30180	health communication and technology
30181	pulmonary vasodilatation
30182	transcranial doppler
30183	Weight stigma
30184	intrapulmonary vasodilatation
30185	Internal medicine
30186	Remote Learning
30187	Ventilator sharing
30188	Intimacy
30189	Combat stress management
30190	Hospital preparedness/response
30191	Psychological impacts
30192	American Indian
30193	pulsus paradoxus
30194	respiratory effort
30195	additive manufacturing
30196	copper nanoparticles
30197	Myasthenia Gravis
30198	apps and smartphones
30199	mobile health (mHealth)
30200	psychological therapies
30201	public mental health
30202	Prepackaged medications
30203	Serious mental illness
30204	REMS
30205	Medication shortage
30206	inclusivity
30207	Hidradenitis suppurativa
30208	Support group
30209	Operations
30210	clinical distancing
30211	Colic
30212	Lethargy
30213	apps
30214	Alzheimer disease
30215	Athletic Trainer
30216	scope of Practice
30217	Scribe
30218	Epilepsy self-management
30219	Nursing research
30220	elections
30221	partisanship
30222	vote-by-mail
30223	Managed care
30224	Value-based payment
30225	Workforce issues
30226	N95 reuse
30227	Departments of Obstetrics and Gynecology
30228	Re-engineering
30229	crisis capacity
30230	respirator shortage
30231	sampling strategy
30232	challenging behavior
30233	function-based treatment
30234	functional assessment
30235	Child- abuse
30236	Lock-down in India
30237	Physical abuse
30238	Psycho-social impact of lock-down
30239	Sexual abuse
30240	Pediatric epilepsy
30241	Video communication
30242	CCP
30243	Hypogammaglobulinemia
30244	ED
30245	health-care utilization
30246	gout
30247	gestational diabetes screening
30248	Bocavirus
30249	Rhinovirus
30250	co-location
30251	direct procurement
30252	donation after brain death
30253	donation after circulatory death
30254	normothermic regional perfusion
30255	h1n1
30256	Communicable disease control/methods
30257	Disease outbreaks/prevention and control
30258	Emergency service,hospital
30259	Strategic insights
30260	Individual mobility
30261	Lockdown policies
30262	double- and triple-duty caregiving
30263	long-term care workers
30264	second jobs
30265	APRNs
30266	Access to Care
30267	Alex Azar
30268	Federal Health and Human Services
30269	Governors executive orders
30270	Restrictions
30271	Extracellular volume
30272	Phantom
30273	T1 mapping
30274	Coronavirus psychotherapy
30275	telepsychiatry for psychotherapy
30276	VLP vaccine
30277	avian flu
30278	pandemic influenza A
30279	Covid virus affecting vascular surgeons
30280	value-based care
30281	Energy justice
30282	Energy sovereignty
30283	Environmental justice
30284	pandemic-related pregnancy stress
30285	prenatal maternal stress
30286	disease threat
30287	feelings
30288	policy preference
30289	international/cross-cultural health
30290	minority health
30291	Social security
30292	California wildfire
30293	Slow violence
30294	Undocumented immigrants
30295	Police and pandemic
30296	Shelter-in-place order
30297	Stay-at-home order
30298	Carbon pricing
30299	Clean energy
30300	G20 economies
30301	Green New Deal
30302	Green economy
30303	home-based
30304	Advanced practice nursing
30305	Advanced practice nursing preparation
30306	Doctor of nursing practice
30307	Nursing doctoral education,
30308	Nursing doctorate
30309	Universal DNP
30310	Constitutional economics
30311	global health law
30312	advanced practice providers
30313	Foot-tapping
30314	Hand-tapping
30315	Relapsing-remitting multiple sclerosis
30316	Variability
30317	Emergency Supply Chain Management (SCM) reserve
30318	Intercontinental Pandemic Preparedness Organization (IPPO)
30319	cognitive behavioral therapy
30320	social connections
30321	Bereavement care
30322	Maternity care
30323	Pregnancy after loss
30324	THC e-Cigarettes
30325	NYHA functional class IV
30326	sacubitril/valsartan
30327	valsartan
30328	capecitabine
30329	etoposide
30330	oral therapy
30331	temozolomide
30332	topotecan
30333	vinorelbine
30334	allocation of resources
30335	diffusion-weighted imaging
30336	distortion-free
30337	near-silent MRI
30338	gme
30339	medicare
30340	physician shortage
30341	Bowman’s layer
30342	Optical coherence tomography
30343	corneal endothelium
30344	descemet’s membrane
30345	thickness maps
30346	T2*
30347	non-Cartesian
30348	rosette
30349	Characterization
30350	Protective efficacy
30351	AK-D cells
30352	Crispr/Cas gene editing
30353	FIPV
30354	Fcwf-4 CU cells
30355	IFNαR-deficient cells
30356	Interferon signaling-deficient cells
30357	TMPRSS2-expressing cells
30358	air quality index
30359	enrichment factors
30360	health risk assessment
30361	premedical
30362	socio-ecological
30363	epistemology
30364	explanation
30365	North Americans
30366	field methods
30367	focus groups
30368	qualitative methods
30369	research design
30370	research strategies
30371	use in research
30372	Remote work
30373	Telecommuting
30374	Work from home
30375	cooperativity
30376	fusion rosette
30377	membrane-mediated interaction
30378	theory of elasticity
30379	Intervention research
30380	Videoconferencing
30381	Venezuelan equine encephalitis virus
30382	alphavirus
30383	nanotrap particles
30384	Department of Defense
30385	Virus interference
30386	Neighborhoods
30387	creatine
30388	multi-ingredient supplement
30389	omega-3
30390	resistance exercise
30391	whey
30392	ADMA
30393	BH4
30394	L-arginine
30395	NADPH
30396	arginine
30397	arginine paradox
30398	eNOS uncoupling
30399	peripheral artery disease
30400	American Journal of Physiology - Lung Cellular and Molecular Physiology
30401	Journal of Applied Physiology
30402	World Lung Day
30403	diversity, equity, and inclusion
30404	harm
30405	blood-borne pathogens
30406	Female dermatologists
30407	Work-life balance
30408	COVID-19 [MeSH]
30409	Meta-analysis [MeSH]
30410	Pandemics [MeSH]
30411	Research design [MeSH]
30412	Clinical care delivery
30413	Data reporting
30414	Reopening
30415	Social trust
30416	medication treatment for opioid use disorder
30417	Prevalence Estimates
30418	Tuberculosis Screening
30419	Connection
30420	Healing
30421	Poetry
30422	Enhanced oil extraction
30423	Just transition
30424	accountability measures
30425	value demonstration
30426	biospecimens
30427	Quality Assurance
30428	global issues
30429	radiopharmaceuticals
30430	Hospitalizations
30431	Sino-nasal outcome test
30432	Sinusitis
30433	Therapeutic irrigation
30434	Interference
30435	Patient interaction
30436	Cramer-Rao bound
30437	arterial spin labeling
30438	brain hemodynamics
30439	magnetic resonance fingerprinting
30440	precision
30441	scan design
30442	SUV quantification
30443	continuous bed motion
30444	lesion detectability
30445	patient breathing repeatability
30446	respiratory motion correction
30447	Bronchiolitis
30448	Multiple respiratory viral
30449	DSS model
30450	and targeting
30451	liposomes
30452	αMSH
30453	COVID-19 or 2019-nCoV
30454	Confirmatory factor analysis
30455	Immune perception
30456	COVID-19 implications
30457	WHO MENA region
30458	Weak health systems
30459	conflict zones
30460	GPP-EP
30461	SAR-COV-2
30462	stakeholder engagement
30463	Energy policy
30464	Energy transition
30465	Potential
30466	Corona virus case
30467	responses
30468	Food policy
30469	Foodborne zoonotic pathogens
30470	Trade disruption
30471	FBOs
30472	NGOs
30473	food systems resilience
30474	Relevance
30475	Population densities
30476	Time–space geographies
30477	Communalistic resource-poor
30478	Ethical and practical challenges
30479	International best practice
30480	Systemic crisis
30481	Wild meat
30482	Covid-19 impacts
30483	Income distribution
30484	SAM multiplier Model
30485	Middle East North Africa (MENA)
30486	Research challenges
30487	Human rights violations
30488	Rule of law
30489	Social policy
30490	Stroke admissions
30491	Food markets
30492	Informal economy
30493	Small-scale retailers
30494	HIV continuum of care
30495	Mali
30496	NGO implication
30497	isolate
30498	Arab
30499	Chirurgie de la main
30500	Hand Surgery
30501	Energy governance
30502	Sustainability transitions
30503	Chronic cormobidity
30504	Obstetric practice
30505	Low-income country
30506	Pharmacy personnel
30507	mobile phone communication
30508	sales ban on tobacco products
30509	tobacco product use
30510	novel coronavirus disease-19
30511	self-testing
30512	Sub-Sahara Africa
30513	Welfare
30514	Communities
30515	Neglected Tropical Diseases
30516	Socio-Economics
30517	aerosol generating procedures (AGPs)
30518	global food security
30519	locust swarms in Africa
30520	health and well-being
30521	lessons from previous pandemics
30522	foreign body aspiration
30523	full-face snorkel masks
30524	pediatric bronchoscopy
30525	rigid bronchoscopy
30526	Health Occupations
30527	Colonialism
30528	Low-and-middle-income countries
30529	Guinea
30530	virus diversity
30531	Sub-saharan africa
30532	Humanitarian aid
30533	Market-led support
30534	Seed security
30535	Smallholders
30536	adult education
30537	adult learning
30538	health campaigns
30539	Family presence
30540	Family separation
30541	Medical isolation
30542	morphine
30543	body temperature
30544	forehead temperature
30545	infrared thermometer
30546	tympanic temperature
30547	Habitat degradation
30548	SDGs
30549	Climate Change
30550	Debt
30551	Development Studies
30552	Global Development
30553	Global Value Chains
30554	International Development
30555	Disease threshold
30556	Self-protection
30557	Fractal-fractional differential operators
30558	Numerical approximation
30559	Land investments
30560	Middle East and North Africa
30561	Safety nets
30562	Value chains
30563	Customer behavioural intentions
30564	Customer satisfaction
30565	Retail covid-19 readiness
30566	Retail social distancing
30567	Sanitised retail counters
30568	Sanitised retail entrances
30569	Sanitised retail shelves
30570	Senior citizens shopping hours
30571	COVID-19 model
30572	Estimation of the parameters
30573	Fractal-fractional model
30574	Numerical results
30575	Quarantine and isolation
30576	Adaptive predictor–corrector algorithm
30577	Fractional differential equations
30578	Stability analysis
30579	Commodity prices
30580	Global fear index
30581	Panel data forecasting
30582	Predictability
30583	evidence based review
30584	illness
30585	sports physician
30586	Agenda 2030
30587	Debt relief
30588	HIV treatment
30589	airway compression
30590	audiometry
30591	digits-in-noise
30592	speech recognition threshold
30593	speech-in-noise
30594	Future of education
30595	Learning sciences
30596	Aid
30597	Finance
30598	cross-country skiing
30599	cycling
30600	rowing
30601	running
30602	triathlon
30603	oximeter
30604	silent hypoxia
30605	Psychotrauma
30606	childhood abuse
30607	global mental health
30608	electronic health information system
30609	Entitlement approach
30610	Four pillars
30611	Household food security
30612	Burkina Faso
30613	Electro-chlorinator device
30614	Economic evaluations
30615	Future costs
30616	activism
30617	reproductive labour
30618	social movements
30619	Nasal tent; endoscopic sinus surgery
30620	HIV origins
30621	The WetNet
30622	experimentality
30623	Health Research
30624	Health Workers
30625	Indigenous population
30626	Internet of Things (IoT)
30627	future cities
30628	smart cities
30629	Family-centred nursing
30630	Rotational thromboelastometry
30631	Viscoelastic testing
30632	final epidemic size
30633	imitation game
30634	cardiovascular diseases (CVDs)
30635	clinical algorithm
30636	Working
30637	Working from home
30638	Basic sciences
30639	Education and training (see medical education & training)
30640	Hepatobiliary surgery
30641	Medical education and training
30642	Transplant surgery
30643	risk analysis
30644	unnatural epidemic
30645	rainfall
30646	Disruptive research
30647	Scientific publishing
30648	Kidney failure, chronic
30649	food choice
30650	grocery shopping
30651	heuristics
30652	Acceptance commitment therapy
30653	Optimism
30654	Pessimism
30655	infection control and management
30656	Acute Mental Health Care during COVID-19
30657	Faculty of pharmacy
30658	Pharmaceutical association
30659	Computable general equilibrium
30660	Periodicity
30661	Trade linkages
30662	outbreak management
30663	residential aged care facility
30664	endovascular clot retrieval
30665	‘Code Stroke’
30666	spinal cord injuries
30667	paediatric services
30668	Narrative review
30669	Stigmatization
30670	Gated recurrent units
30671	Variational autoencoder
30672	Gibrat’s law
30673	Mathematical modeling of epidemics
30674	Power law
30675	Tauberian theorem
30676	humanitarian crisis
30677	international health
30678	Interventional pneumology
30679	Radiation Therapy
30680	endometriosis
30681	lifestyle management
30682	mind-body therapies
30683	pelvic pain
30684	Information sources
30685	Kosovo
30686	Pharmacist attitudes
30687	data collection
30688	psychiatrist
30689	Equipment cleaning
30690	Transducer
30691	WFUMB
30692	Addictive disorders
30693	Metabolic associated fatty liver disease
30694	Nondiabetes
30695	Multidimensional Assessment of COVID-19_Related Fears
30696	psychopathology
30697	preventive behaviours
30698	elderly population
30699	risk cognition
30700	Resuming elective surgery
30701	G7
30702	mass gathering
30703	IFSO
30704	Digital sustainability
30705	Grand challenges
30706	Responsible IS research
30707	Sustainable development goals
30708	health vulnerabilities
30709	readymade garment workers
30710	starvation
30711	endemic
30712	Complex Adaptive Systems
30713	Design Thinking
30714	Health Policy Design
30715	Systems Thinking
30716	mental well-being online assessments
30717	well-being services
30718	COVID-19 associated pulmonary aspergillosis (CAPA)
30719	Fungal infection
30720	research personnel
30721	Dallas
30722	Partner abuse
30723	Stay-at-home
30724	positive mental health
30725	psychological measurement
30726	Chronic low-grade inflammation
30727	and oxygenation index
30728	respiratory rate
30729	behaviourism
30730	PFA
30731	health status
30732	Queensland
30733	finite element modelling
30734	silicone foam multi-layered prophylactic dressings
30735	Cryptomarket
30736	Darknet
30737	Drug market
30738	Routine Activities Theory
30739	Rabbits
30740	Tea
30741	Global Pandemic
30742	Kuhn-tucker
30743	Linear Regression
30744	Nonlinear
30745	Partial Derivative
30746	Progressive
30747	surgical outcome
30748	Immobility
30749	Material conditions
30750	Movement
30751	Social analysis
30752	Social suffering
30753	Clinical care
30754	Ethics framework
30755	New South Wales
30756	Remittances
30757	Social protection
30758	Tourism
30759	medical imaging
30760	mental well-being
30761	Avian coronavirus
30762	Eclectus parrot
30763	reappraisal
30764	stress appraisal
30765	stress mindset
30766	ventilation–perfusion imbalance
30767	work of breathing
30768	Bayesian structural time series
30769	COVID019
30770	Hydrocortisone
30771	Systematic Review
30772	infectious disease vulnerability index
30773	inform index
30774	mortality risk evaluation
30775	Economic activity and COVID-19
30776	History of pandemics
30777	Liberty and COVID-19
30778	Quality of life years (QALYS) and COVID-19
30779	Social choice and COVID-19
30780	Triage and COVID-19
30781	Value of human life and COVID-19
30782	Frameworks
30783	Biomedical publication
30784	Research governance
30785	Research integrity
30786	Systems theory
30787	Disablism
30788	Global health emergencies
30789	Airlines
30790	Business models
30791	Ultra long-haul
30792	Extended use and performance
30793	PPE/Mask supplies
30794	Thermal and surface disinfection
30795	respiratory hygiene
30796	health and mental health
30797	refugee
30798	Impacts
30799	Gender equity
30800	Human development
30801	Human environment
30802	Public health expenditure
30803	Public health outcomes
30804	Drones
30805	Foucault
30806	Panopticon
30807	Smartphones
30808	Hope
30809	Reason
30810	Spinoza
30811	Clinical ethics
30812	Dignity
30813	Resource rationing
30814	Digital destruction
30815	Digital disruption
30816	Infodemic
30817	Mental model
30818	Shared situational awareness
30819	Covid-19 fiscal response
30820	Debt management
30821	Deficit monetization
30822	Biomedical waste
30823	COVID-19 waste
30824	Food supply chain
30825	Food waste
30826	Solid waste management
30827	Climate action
30828	Climate change communication
30829	Framing
30830	Mitigation support
30831	Primary prevention
30832	Conspiracy theories
30833	Air transport
30834	High-speed rail
30835	Inter-city bus
30836	Spread pattern
30837	Spread speed
30838	Birth
30839	Constructs
30840	Peritraumatic distress
30841	Extraordinary event
30842	pet
30843	psychiatry training
30844	videoconference
30845	Portable
30846	Radiation safety
30847	particle counts
30848	Translational simulation
30849	Psychometrics
30850	cross‐cultural
30851	cultural diversity
30852	intergenerational trauma
30853	Education change
30854	Control strategies
30855	sir model
30856	Advanced care planning
30857	Allied health
30858	End of life
30859	Attitude and practice
30860	stress and depression
30861	financial contagion
30862	financial firms
30863	hedge ratios
30864	nonfinancial firms
30865	spillover index
30866	Financial uncertainty
30867	Global financial cycle
30868	Vector autoregressions
30869	World industrial production
30870	community nursing
30871	living wills/advance directives
30872	And psychological well-being
30873	Emotional regulation
30874	Family and work responsibilities
30875	Global health crisis
30876	Job security
30877	Exhalation
30878	HFNC
30879	HVNI
30880	High Flow Oxygen
30881	Low Flow Oxygen
30882	Particle Dispersion/Transmission
30883	Patient Simulation
30884	Prevention/Control
30885	Autoregressive model
30886	COVID-29
30887	Two pieces distributions based on the scale mixtures normal distribution
30888	industry
30889	mass casualty incidents
30890	Face Masks
30891	Health Beliefs
30892	Respiratory Disease
30893	antibiotic therapy
30894	Balanced diet
30895	Induction
30896	Paralysis
30897	Disease modelling
30898	R0-package
30899	adolescent and young adult
30900	psychological therapy
30901	psycho‐oncology
30902	remote health care
30903	Neutralising antibody
30904	psilocybin
30905	psychedelics
30906	selective serotonin reuptake inhibitors
30907	treatment-resistant depression
30908	gut-liver axis
30909	intestinal permeability
30910	online searches
30911	Male patients
30912	facial touching
30913	traditional clothing
30914	infographic
30915	pandemic containment
30916	Respiratory system compliance
30917	Behavioural change
30918	Conservation communication
30919	Conservation psychology
30920	Human-wildlife conflict
30921	Message framing
30922	Defensive
30923	EAFE
30924	ESG
30925	Emerging markets
30926	Return Spillover
30927	clinician-guided
30928	paediatric emergency medicine
30929	Cities
30930	Design institutes
30931	Smart City
30932	Urban economy
30933	Urban planning
30934	Cancer care workforce
30935	mental health legislation
30936	national emergency
30937	ARI
30938	IVC
30939	Intravenous vitamin C
30940	Mental health resources
30941	Mental health systems
30942	Policy making
30943	Microethics
30944	Reconciliation
30945	Song
30946	Emotional intelligence
30947	gastrointestinal cancer
30948	gastroscopy
30949	Diagnostic tests/Investigation
30950	Not applicable
30951	Physical therapy education
30952	Clinical Competence
30953	aerobic fitness
30954	sitting time
30955	elite performance
30956	exercise training
30957	thermoregulation
30958	hepatitis B
30959	home care services
30960	Tender equity
30961	critical care medicine
30962	Conversational Model
30963	metaphor
30964	Western Australia
30965	insectivorous bats
30966	viral diversity
30967	Patient care team
30968	Clinician
30969	Duties
30970	Duty
30971	Duty of care
30972	Duty to care
30973	Health professional
30974	International business
30975	Philanthropy
30976	Public relations
30977	Continuous medical education
30978	Mammography
30979	Mammography training
30980	Emotional and psychological support
30981	Maternity care providers
30982	Maternity services
30983	Human factor
30984	Risk analysis
30985	Airliner cabin
30986	Cough contaminants
30987	Cough-jets
30988	Local environment
30989	personalised medicine
30990	plasma medicine
30991	personal protective devices
30992	Obituary
30993	calicivirus
30994	mefloquine
30995	Tracheal
30996	polyvagal theory
30997	MRI phantoms
30998	MRI radiomics
30999	image features
31000	image texture
31001	Public mental health services
31002	commissioning
31003	purchaser/provider split
31004	youth mental health
31005	Contact tracing apps
31006	Freedom of movement
31007	Privacy paradox
31008	Technology of the self
31009	Vestibular neuritis
31010	Greenspace
31011	Australian mining history
31012	Restoring social licence
31013	Critical interpretative review
31014	Tissue fillers
31015	mimetic muscles
31016	orbicularis oculi
31017	orbicularis oris
31018	Adventure
31019	Protected area
31020	Haemophilus influenzae
31021	Conflict of interest
31022	Conscientious objection
31023	client-centred practice
31024	occupation
31025	Positioning
31026	Supraglottic airway device
31027	costs: labour vs. materials
31028	practice standards: definition
31029	Lung Cancer Nurse Specialist
31030	lung cancer stigma
31031	allocation of healthcare resources
31032	criminal law
31033	Mental health science
31034	intrusive memories of trauma
31035	psychological treatments
31036	bushmeat
31037	health risk
31038	markets
31039	bone marrow neoplasms
31040	hematologic diseases
31041	Food policies
31042	Food science and technology
31043	Humanitarian food aid
31044	Local food systems
31045	Clinical Placements
31046	Clinical Supervision
31047	Clinical Workforce Issues
31048	Global Crises
31049	Midwifery
31050	Nursing Education
31051	atrial deformation
31052	atrial strain
31053	feature tracking
31054	multi-vendor multi-modality
31055	speckle tracking
31056	Disease emergence
31057	Market biosecurity
31058	Risk reduction
31059	Epidemiological Monitoring
31060	Health information technology
31061	Hospital quality
31062	Medical informatics
31063	Patient experience
31064	Case-fatality
31065	Residential group homes
31066	Outcome assessment
31067	Special pathogens
31068	Reorganization
31069	ischemic strokes
31070	large vessel strokes
31071	reorganization
31072	NARDL
31073	Energy demand
31074	Home Energy Management System (HEMS)
31075	Social norms
31076	COVID-19/coronavirus
31077	American Miniature Horse
31078	horse
31079	employee engagement
31080	organizational culture
31081	relationships in health care
31082	appendectomy
31083	Prenatal
31084	resident recruitment
31085	virtual teaching
31086	organisational management
31087	radiology practice
31088	Luekocytosis
31089	White blood cell
31090	Adaptations
31091	CPT-coded examinations
31092	inpatient service
31093	aki
31094	prostacyclin
31095	right heart failure
31096	General surgery residency
31097	MANUSCRIPT
31098	Objective Structured Clinical Examination (OSCE)
31099	clinical skills assessment
31100	standardized patient
31101	Emergency Departments
31102	End of life care
31103	Hospital performance
31104	Psychiatric hospitals
31105	cerebrovascular disorders
31106	facial pressure ulcer
31107	pressure wound
31108	prone
31109	leukoencephalopathy
31110	Food and income security programs
31111	LVEF recovery
31112	posterior cerebral artery
31113	N-acetyl-cysteine
31114	ventricular failure
31115	Community-based learning
31116	Place-based education
31117	Virtual health
31118	health services administration
31119	health-care innovations
31120	computed tomography angiogram
31121	cardiac monitoring
31122	mobile telemetry
31123	telemetry
31124	AKI, acute kidney injury
31125	FS, fractional shortening
31126	PICU, pediatric intensive care unit
31127	TTE, transthoracic echocardiogram
31128	VIS, vasoactive ionotropic score
31129	hsTnT, high-sensitivity troponin T
31130	systemic acute respiratory syndrome
31131	Spiritual assessment
31132	chaplaincy
31133	Postoperative complications
31134	Wells DVT criteria
31135	Families and Environmental Crisis
31136	Families and Health Disparities
31137	Family Resilience
31138	Family and Couple Coping COVID-19 Pandemic and Quarantine
31139	Religious and Spiritual Factors
31140	afrontamiento familiar de la pandemia de la COVID-19
31141	afrontamiento familiar y de pareja
31142	factores religiosos y espirituales
31143	familias y desigualdad sanitaria
31144	las familias y la crisis ambiental
31145	resiliencia familiar
31146	宗教和精神因素
31147	家庭和伴侣应对
31148	家庭和健康差异性
31149	家庭和环境危机
31150	家庭复原力
31151	家庭应对COVID-19 大流行
31152	spine surgeons
31153	worldwide
31154	Arrhythmias, Dizziness
31155	Presyncope
31156	Syncope
31157	spine; surgeons
31158	physical therapy
31159	AEDP
31160	Accelerated experiential dynamic psychotherapy
31161	‘Shared traumatic reality’
31162	Nature
31163	5-FU, 5-fluorouracil 2% solution
31164	App, application
31165	BCC, basal cell carcinoma
31166	IMI, imiquimod 5% cream
31167	KCs, keratinocyte carcinomas
31168	SCC, squamous cell carcinoma
31169	TRET, tretinoin 0.1% cream
31170	imiquimod
31171	keratinocyte carcinomas
31172	tretinoin
31173	descriptive analysis
31174	severely affected communities
31175	calorimetry
31176	pulmonary disease
31177	congenital heart disease (CHD)
31178	congenital heart surgery
31179	morbidity)
31180	outcomes (includes mortality
31181	Calciphylaxis
31182	Panniculitis
31183	Brugada
31184	Crisis Standards of Care
31185	personal quarantine
31186	province-wide lockdown
31187	self-stigma
31188	saddle pulmonary embolism
31189	Essential medicines
31190	breathlessness
31191	Carotid thrombosis
31192	aging biomarkers
31193	geroprotectors
31194	Gaussian
31195	movies
31196	psychotherapist
31197	regulatory flexibility
31198	analytic frame
31199	online therapy
31200	Arrhythmia management
31201	brain edema
31202	cause of death
31203	decompressive craniectomy
31204	benchmarking
31205	Healthcare emergency management
31206	Acute myeloid leukemia
31207	Myelodysplatic Syndromes
31208	fulminant
31209	Medication safety
31210	residency application
31211	frame-shifting
31212	professional ethics in perinatal medicine
31213	ring-fencing
31214	Biopsychosocial
31215	Systems
31216	Asymmetric Fourier causality
31217	Economic activities
31218	PM2.5 emissions
31219	The USA
31220	paternalism
31221	patient rights
31222	Hospital-based violence interventions
31223	Street outreach
31224	Violence reduction
31225	Violence victimization
31226	Crow-AMSAA
31227	Deaths
31228	Infected cases
31229	NHPP
31230	political economy
31231	structural inequities
31232	Interprofessional collaboration
31233	partnership
31234	shared problem solving
31235	team effectiveness
31236	livedoid
31237	microvasculature
31238	reticular
31239	retiform
31240	Media trust
31241	Political polarization
31242	interorganizational coordination and collaboration
31243	public health emergency response
31244	Multisource data
31245	medical experts
31246	infusion
31247	pumps
31248	relocation
31249	virtual world
31250	COVD-19
31251	diffuse lung disease
31252	immunosuppressives
31253	involuntary civil commitment
31254	right to refuse treatment
31255	Doctoral students
31256	Emergency remote learning
31257	Graduate student roles
31258	Graduate students
31259	recreational athlete
31260	hyperinflammatory shock
31261	CT colonography
31262	Colorectal cancer screening
31263	intersectional
31264	women's health
31265	Dynamic clustering
31266	Website messaging
31267	Consultation-liaison psychiatry
31268	Nursing stress and depression
31269	Pulmonary vascular disease
31270	Quantitative CT metrics
31271	Essential health care
31272	Guatemala
31273	Indigenous health
31274	Mayan health
31275	Simulation training
31276	Women's health
31277	long-term effects
31278	novel therapies
31279	epicenter
31280	intensive critical care
31281	Predictions
31282	COVID-19 medical education
31283	Medical student exams
31284	Medical student grading
31285	NBME shelf
31286	Proctored exams
31287	Grace
31288	Language
31289	Philosophy
31290	grassroots
31291	legislative visit
31292	acute cardiac care
31293	Rituals
31294	Symbols
31295	Graduate medical education
31296	Residency application cycle
31297	Student advising
31298	Undergraduate medical education
31299	AGPs
31300	Deglutition disorders
31301	Retractions
31302	Harrison
31303	System Theory
31304	Public health messaging
31305	Non-COVID patient surgery
31306	acute sinusitis
31307	graves eye disease
31308	orbital abscess
31309	otolaryngologic emergency
31310	subperiosteal abscess
31311	Algorithmic fairness
31312	Clinical prediction models
31313	Healthcare rationing
31314	radiosurgery
31315	Government trust
31316	Rule compliance
31317	emergency medicine/teletrauma
31318	SDG4
31319	Billing
31320	Coding
31321	motor examination
31322	neurologic examination
31323	spine examination
31324	virtual spine evaluation
31325	Smart work
31326	Telework
31327	American Rhinologic Society
31328	Cor pulmonale
31329	Point of care echocardiography
31330	gender minority
31331	epoprostenol
31332	mucolytics
31333	nebulized antibiotics
31334	collaborative
31335	Application
31336	Competition
31337	ERAS
31338	NRMP match
31339	Clot in transit
31340	multisystem inflammatory syndrome
31341	Sudden Cardiac Arrest
31342	Caspase-1
31343	open science
31344	planetary public goods
31345	responsible innovation
31346	Urologic oncology
31347	spinal fusion
31348	law
31349	Intensivist coverage
31350	Hand-held ultrasound
31351	Bradycardia
31352	Dexmedetomidine
31353	Jewish
31354	Distance education
31355	Early childhood education
31356	Preservice teacher education
31357	Student teachers
31358	anoxic brain injury
31359	goals-of-care
31360	microvascular thrombosis and macrovascular thrombosis
31361	Human-animal interaction
31362	Rural community
31363	cannot intubate-cannot ventilate
31364	ageism or other discrimination
31365	health -
31366	anti-IL6 agents
31367	BIOMONITOR
31368	Implantable cardiac monitor
31369	Implantable loop recorder (ILR)
31370	dental insurance
31371	educational technology, < patient affairs, < professional interest
31372	finances, < health care access
31373	health care systems, < education
31374	institutional/organizational development, < professional interest
31375	licensure and certification, < professional interest
31376	patient demographics dental education
31377	Health Reform
31378	Obamacare
31379	Underinsured
31380	Anesthetic implications for covid
31381	Intubations
31382	helmet mask
31383	emergency preparedness and response
31384	hospital pharmacy service
31385	new practitioner
31386	pharmacy residency
31387	New York City—Economic development, Innovation district, Urban economy
31388	Tech economy
31389	Tech ecosystem
31390	artificial general intelligence
31391	cloud computing
31392	collaborative learning
31393	electronic commerce
31394	e‐learning
31395	human behavior
31396	human moral behavior
31397	human social behavior
31398	mobile banking
31399	mobile marketing
31400	mobile retailing
31401	online communities
31402	American Recovery and Reinvestment Act
31403	Distributional impacts
31404	Green stimulus
31405	Green subsides
31406	Heterogeneous effect
31407	Annual scientific meeting
31408	Medical toxicology
31409	Listeria monocytogenes
31410	cancer vaccines
31411	listeriosis
31412	Education in emergencies
31413	Inactivated
31414	Blood flow measurement
31415	Boundary conditions
31416	Cerebral aneurysms
31417	Computational fluid dynamics
31418	Intracranial aneurysms
31419	PC-MRI
31420	existential maturity
31421	presence
31422	psychic disconnection
31423	terror management
31424	ACP contemplation
31425	ACP discussion
31426	Immigrant status
31427	burial planning
31428	family relations
31429	physical exam
31430	remote exam
31431	spine
31432	Bion
31433	Winnicott
31434	climate crisis
31435	omnipotent fantasy
31436	the body
31437	cellulitis
31438	consult dermatology
31439	home-based care
31440	skin & soft tissue infections
31441	Invisibility
31442	Lives
31443	Relief measures
31444	Visibility
31445	coronary dilation
31446	systolic dysfunction
31447	Residency program management
31448	CUREs
31449	face-to-face instruction
31450	hybrid modality
31451	simulation labs
31452	being cool
31453	catharsis
31454	cinematherapy
31455	imitative learning
31456	doctor-patient communication
31457	mnemonics
31458	serious illness conversations
31459	Volunteer recruitment
31460	Workforce shortage
31461	Covid toes
31462	acral perniosis
31463	inspiratory pressure
31464	split ventilation
31465	Deforestation
31466	Land use
31467	Pathogen spillover
31468	Wildlife markets
31469	Content analysis
31470	Counseling journals
31471	TaqMan real-time PCR
31472	porcine
31473	Home quarantine
31474	Incidence analysis
31475	Travel history
31476	Numerical solutions
31477	Variational iteration method
31478	Treatment outcomeTrial Registration： Chinese Clinical Trial Registry， ChiCTR2000029865
31479	clinical analysis
31480	infection management and control
31481	travel restriction
31482	Contagiousness
31483	2019 novel Corona Virus
31484	Novel coronavirus (2019-nCov)
31485	inherited metabolic disorders (IMDs)
31486	newborn screening (NBS)
31487	Clinical condition
31488	Cuadro clínico
31489	Número de reproducción básico
31490	Transmisión
31491	Emergency Preparedness
31492	Emergency Service
31493	Epidemic transmission
31494	removal rate
31495	Cases of novel coronavirus
31496	Econometrics
31497	Environmental science
31498	Modelling COVID-19
31499	Phenomenological models
31500	Real-time forecasts
31501	Eye manifestations
31502	Online cognitive behavioral therapy (CBT)
31503	Sleep disorder
31504	Work schedule
31505	differentiating
31506	Commodity market
31507	Industries
31508	Emission Reduction
31509	Fine Particle
31510	Haze
31511	containment policy
31512	Epicenter
31513	The Novel Coronavirus
31514	lung imaging
31515	point of care ultrasound (POCUS)
31516	Control of infectious epidemic
31517	Experience and suggestion
31518	advice guideline
31519	radiological findings
31520	C23
31521	I12
31522	I18
31523	LOS
31524	monocyte-lymphocyte ratio
31525	Novel Coronavirus Pneumonia
31526	pediatric fever clinics
31527	Acute phase reaction protein
31528	Heart injuries
31529	Heart-lung transplantation
31530	over 70
31531	underlying diseases
31532	Fractional Caputo–Fabrizio derivative
31533	Novel coronavirus (nCoV-2019)
31534	Picard–Lindelöf technique
31535	public psychological states
31536	related factors
31537	ACS/NSTEMI
31538	health care outcomes
31539	Decision support
31540	Acute care
31541	BigBiGAN
31542	Coronavirus disease 2019 pneumonia
31543	Differentiation
31544	Semantic features
31545	universities
31546	neurology patients
31547	ecfmg
31548	physician burnout
31549	resident burnout
31550	re-vascularization
31551	tretment protocol
31552	Influencing factors
31553	Work hours
31554	GenBank
31555	genomic signal processing
31556	post-peak
31557	Acupressure therapy
31558	Liu Zi Jue Qigong
31559	Study protocol
31560	Traditional Chinese medicine rehabilitation
31561	control de infecciones
31562	neumonía por el nuevo coronavirus
31563	Arctic
31564	Kalaallit Nunaat (Greenland)
31565	coronavirus (COVID‐19)
31566	geopolitics
31567	islands
31568	Multi-systemic disease
31569	Therapeutical implication
31570	umifenovir
31571	Autoimmune bullous diseases
31572	cardiac complications
31573	inflammatory factors
31574	Health behavior change
31575	e-cigarette or vaping product use–associated lung injury
31576	swine-origin influenza A
31577	sonography
31578	Control measure
31579	severe coronavirus disease 2019
31580	predicting risk score
31581	Psychological intervention
31582	Chest computed tomography (chest CT)
31583	influenza A (H1N1) virus
31584	Correlation coefficient
31585	Multiple linear regression
31586	Odisha
31587	Fractional-order derivative
31588	SEIRD model
31589	SARS-nCoV 2
31590	laboratory network
31591	behavioral impact
31592	karachi
31593	 COVID‐19
31594	 acute anterior wall myocardial infarction
31595	 acute inferior wall myocardial infarction
31596	SEIR epidemic model
31597	Thoracic diseases
31598	Oropharyngeal Washings
31599	Energy research
31600	Energy sustainability
31601	Social behavior
31602	Time series modeling
31603	Two pieces scale mixtures of normal distributions
31604	Practice of surgery
31605	multiple indicators
31606	renal function
31607	urinary microprotein
31608	Tomography, X-ray computed ·
31609	Global stability
31610	Real data
31611	Stationary distribution
31612	Stochastic epidemic model
31613	Threshold value
31614	Health-Related Quality of Health
31615	Occupational Health
31616	Workplace Policies
31617	Agony
31618	ROC curve
31619	Dermatoscopy
31620	Melanoma
31621	Indian dentists
31622	fears
31623	statistical estimation
31624	Environmental gradients
31625	psychological status
31626	Nursing staff
31627	Willingness to work; Epidemic
31628	Safe medication use
31629	Macao
31630	RNA test
31631	Human coronaviruses (HCoV)
31632	news reporting
31633	psychosocial analysis
31634	stress management
31635	phenomenological models
31636	real-time forecasts
31637	sub-epidemic model
31638	Mediating effect
31639	capital asset pricing model
31640	dummy variable
31641	epidemic prediction model
31642	negative feedback
31643	complex emergencies
31644	lifestyle changes
31645	epidemics trend
31646	public primary care clinics
31647	triage and cohort
31648	Death investigation
31649	Forensic science
31650	adaptive neuro-fuzzy inference system (ANFIS)
31651	flower pollination algorithm (FPA)
31652	salp swarm algorithm (SSA)
31653	technical framework
31654	Frontline nurses
31655	Imported patient
31656	Hospital Anxiety and Depression Scale
31657	frontline medical workers
31658	Novel coronavirus disease patients
31659	Quarantine experience
31660	positive rate
31661	Psychological health
31662	mental health status
31663	paediatric medical workers
31664	Conjunctivitis,viral
31665	Hyperemia
31666	Tumor necrosis factor-α
31667	anesthesia nursing
31668	High-resolution CT
31669	Metapopulation
31670	social policy
31671	state
31672	Emission changes
31673	Primary emissions
31674	Secondary formation
31675	community pharmacy services
31676	hospital pharmacy services
31677	CO
31678	Emission reductions
31679	Hangzhou
31680	SO2
31681	day surgery
31682	surgery protocol
31683	epidemic spreading
31684	non linear fitting
31685	population model
31686	Severity of disease
31687	Biological specimens
31688	Forensic biology
31689	Researcher
31690	Expert statement
31691	Demand analysis
31692	Economic impacts
31693	Socio-economic analysis
31694	psychological phenomena
31695	Criterion
31696	Duration
31697	Hand drying
31698	Moment
31699	Procedure
31700	Hanshiyi Formula
31701	Mild COVID-19
31702	Moderate COVID-19
31703	The proportion to severe status
31704	Anxiety,depression
31705	Coping style
31706	shift work schedule
31707	tongue diagnosis
31708	early warning indicators
31709	moderate patients
31710	digestive
31711	liver damage
31712	depressive symptoms
31713	Fangcang Shelter Hospital
31714	emergency vascular case
31715	prevention and control strategy
31716	epidemiologic characteristic
31717	granulocyte count
31718	GAD-7
31719	PHQ-9
31720	Animal ethics
31721	Companion animals
31722	Urban resident
31723	psychology, clinical
31724	Kalman filtering
31725	Network-based model
31726	Non-Markovian process
31727	platelet value
31728	platelet-to-lymphocyte ratio
31729	blood collection
31730	donors
31731	quality management
31732	transfusion strategy
31733	General Surgery
31734	Prevention and control
31735	Epidemic cluster
31736	behavioral
31737	National Insurance Commission
31738	insurance industry
31739	body weight
31740	Burns, inhalation
31741	thin chest CT
31742	Progress
31743	pulmonary vascular enlargement sign (VES)
31744	Location-attention classification model
31745	Chaotic salp swarm algorithm
31746	Curvelet transform
31747	Arteriosclerosis obliterans
31748	Collective self-esteem
31749	Perceived social support
31750	One-class classification
31751	One-class support vector machine
31752	ESA
31753	NASA
31754	laboratory index
31755	Case fatality rates
31756	Mortality estimated model
31757	Moderate
31758	Neutrophil–lymphocyte ratio
31759	Predict
31760	colorectal surgery
31761	realworld data
31762	retrospective analysis
31763	Analysis
31764	Diffusion
31765	high-dose intravenous immunoglobulin
31766	Emergency operation
31767	Pneumonia;hernia
31768	dental medicine
31769	interleukin 6 (IL-6)
31770	mental health center
31771	prevention and control practice
31772	the 2019 novel coronavirus disease (COVID-19)
31773	shelter hospital
31774	cardiovascular comorbidities
31775	hospital infection
31776	Bundle pharmacotherapy
31777	Retail
31778	consumer behaviour
31779	crisis response
31780	Health care waste
31781	Incineration
31782	Urban transportation system
31783	dermatophytosis
31784	biostatistic
31785	Doubling rate
31786	Clustering analysis
31787	Herbal medicines
31788	Scaffold analysis
31789	Summer
31790	Computed tomography (CT) scan
31791	COVID-19, Pneumonia viral
31792	Convolutional Neural Network
31793	Pneumonia bacterial
31794	Low and middle income countries
31795	mental morbidities
31796	post-traumatic stress disorder symptom
31797	stigmatization
31798	Radiology nurses
31799	Policymaker
31800	Medical Intern
31801	Medical Student
31802	Psychiatric Nurse
31803	epidemic prediction, 3-staged model
31804	government’s control
31805	hospital system
31806	Deqi of moxibustion
31807	Heat-sensitive moxibustion
31808	Negative emotions
31809	infection protection rules
31810	nuclear medicine staff
31811	positron emission tomography/computerized tomography
31812	Non‐alcoholic fatty liver disease
31813	Chinese Materia Medica
31814	ISO/TC 249
31815	Quality standards
31816	Fasting blood glucose
31817	Initial symptoms
31818	COVID-19 pandemic confinement
31819	altered sleep duration and pattern
31820	crowdsourcing
31821	sleep as Android App
31822	wuhan China
31823	2019 pandemic
31824	age distribution
31825	crude death rates
31826	28-Day mortality
31827	Modified NUTRIC score
31828	Nutritional risk
31829	chronic hepatitis B
31830	AIT, allergen-specific immunotherapy
31831	AR, allergic rhinitis
31832	Allergen-specific immunotherapy
31833	EUFOREA, European Forum for Research and Education in Allergy and Airway Diseases
31834	INS, intranasal corticosteroids
31835	NSAID, non-steroidal anti-inflammatory drug
31836	Rhinitis
31837	SAR, seasonal allergic rhinitis
31838	Smell and taste
31839	anesthesia nurse
31840	medical rescue team
31841	Quantitative computed tomography (QCT)
31842	Severity stratification
31843	Holistic nursing
31844	Governance model
31845	Public health emergency governance
31846	PADI-web
31847	emerging disease
31848	epidemic intelligence
31849	one Health
31850	online news
31851	sanitizers
31852	image analysis using artificial intelligence
31853	treating COVID-19 patients
31854	medical robotics
31855	peripheral blood eosinophils
31856	chest CT manifestation
31857	Laboratories
31858	Multi-center
31859	alteration of hemostasis
31860	prothrombin time
31861	Complex network
31862	Evolutionary computation
31863	framework
31864	health content frames
31865	interactive features
31866	message style
31867	Least-squares fitting
31868	COVID-19 epidemic trend
31869	COVID-19 outbreak in India
31870	Epidemic diseases
31871	Global mortality benefit
31872	Value of a statistical life
31873	Tongue features
31874	Clubfoot
31875	Pediatric orthopaedics
31876	chronic obstructive pulmonary disease (COPD)
31877	Construction cost and time
31878	Isolation wards
31879	Prefabricated buildings
31880	severe acute respiratory coronavirus 2
31881	Patients′ rooms
31882	Wound
31883	Returning travelers
31884	Temperature screening
31885	Online mental health services
31886	Bacterial pneumonia
31887	serum iron
31888	Care delivery
31889	Dialysis unit
31890	Infection control precautions
31891	Image features
31892	first-line nurses
31893	work experience
31894	Segregation
31895	Lianhuaqingwen Capsule
31896	Symptom recovery
31897	conversion rate
31898	career choice
31899	SIRD Model
31900	Silent Carriers
31901	LIWC
31902	Psycholinguistics
31903	R language
31904	length of stay (LOS)
31905	cancer treatment
31906	disaster management framework
31907	disaster management strategy
31908	hotel industry
31909	Cytokine response syndrome
31910	Connections
31911	Fractional-order
31912	Inter-city networked coupling effects
31913	SEIHDR epidemic model
31914	GAD
31915	Latent profile
31916	Perceived threat
31917	Decline rate of daily confirmed-cases
31918	Growth rate of daily confirmed-cases
31919	Statistics of WHO
31920	Time-series
31921	Novel Coronavirus pneumonia
31922	clinical demand
31923	nurse training
31924	Fasting Blood Glucose
31925	Glycemic target
31926	propensity score
31927	survivors
31928	EUS
31929	postendemic
31930	Increased leukocyte count
31931	Makeshift hospitals
31932	Glucocorticoid therapy
31933	boosting
31934	healthcare analytics
31935	patient data
31936	random forest classification
31937	Age groups
31938	neurological procedure
31939	ICU transfer
31940	immune-inflammatory parameters
31941	neutrophil-lymphocyte ratio
31942	Benin
31943	Sanitary cordon
31944	COVID-19 information seeking
31945	worry
31946	Acute respiratory tract infection
31947	disease notification
31948	panic disorder
31949	psychological trauma
31950	COVID-19 outbreaks
31951	Padua Muscle Days
31952	Translational Mobility Medicine
31953	forewords of the editor
31954	Emerging outbreak
31955	Transmission model
31956	Critical type
31957	Surgical indications
31958	MMP3 concentrations
31959	quantitative analysis
31960	nasopharyngeal carcinoma
31961	Post-traumatic stress disorder (PTSD)
31962	Critical patients pneumonia
31963	Fungal infections
31964	Food choice
31965	Impact health
31966	Social aspect
31967	quantitative computed tomography assessment (quantitative CT assessment)
31968	chronic pulmonary disease
31969	Psychiatrists
31970	acute liver injury
31971	front-line workers
31972	Deep feature extraction
31973	Medical decision support system
31974	Dental education
31975	Dental student
31976	rheumatic heart disease
31977	Severe air pollution
31978	Time interrupted regression model
31979	endocrine surgery
31980	PUVA
31981	Anaesthesia management
31982	Tracheostomy tube change
31983	Public crisis
31984	Cluster region
31985	Generalized anxiety
31986	dead virus
31987	public Health Surveillance
31988	Susceptible-Exposed-Infectious-Recovered (SEIR)
31989	delay differential equation
31990	non-linear optimization
31991	quarantine states
31992	Lung ventilation function
31993	Restriction ventilation dysfunction
31994	Small airway dysfunction
31995	bacterial infection
31996	Protein extraction < Research and Analysis Methods
31997	Systemic immunity < Immune responses
31998	Market food environments
31999	System disruption
32000	Wild food environments
32001	disclosure
32002	information disclosure
32003	website
32004	Antibiotic agents
32005	Neutrophil-to-lymphocyte Ratio
32006	X-rays
32007	Fertility rate
32008	Knowledge spillover
32009	World aggregated data
32010	Pneumoni
32011	Predictive value of tests
32012	IgG and IgM antibody detection
32013	Inappropriate Antidiuretic Hormone Secretion Syndrome (SIADH)
32014	Diagnostic checks
32015	Ordinary least squares estimator
32016	fatty liver disease
32017	liver blood test
32018	Pattern identification
32019	Basic regeneration number
32020	General hospital
32021	Nursing management research
32022	Refined management
32023	Psychological needs
32024	The existence, relatedness and growth theory
32025	Spinal diseases
32026	acute cerebral infarction
32027	case
32028	General hospitals health manpower
32029	Hospital equipment and supplies
32030	Personnel management
32031	banti syndrome
32032	non-cirrhosis
32033	portal hypertension
32034	splenomegaly
32035	coping style
32036	00-01
32037	99-00
32038	FbProphet
32039	Logistic
32040	risk model
32041	signature
32042	adjuvant therapy
32043	Leukaemia inhibitory factor
32044	Synthetic stem cells
32045	chemical pathology
32046	D-dimer level
32047	recurrent viral activity
32048	maternal complications
32049	obstetric complications
32050	OMI
32051	TROPOMI
32052	Tropospheric NO(2)
32053	Spearman correlation
32054	Radiation center
32055	Traveller-derived cases
32056	Wuhan city travel ban
32057	perceived stress
32058	frontline medical staff
32059	O(3)
32060	Sentinel-5
32061	Epidemic spread
32062	Geodetector
32063	Spatial dependence
32064	Spatial-temporal differentiation
32065	hypoprealbuminemia
32066	liver impairment
32067	Immune parameters
32068	12-item General Health Questionnaire (GHQ-12)
32069	Oral medicine emergency
32070	Video conferencing
32071	Inflammatory biological markers
32072	Lung biopsy
32073	Morphological ultrastructure
32074	Agricultural production
32075	COVID-19 crisis
32076	Dynamic capabilities
32077	Firms in China
32078	Marketing innovation strategies
32079	Resource dependence
32080	Typology
32081	Prealbumin
32082	Chest CT features
32083	management algorithm
32084	Web-based
32085	Modified SEIR
32086	bronchoalveolar lavage
32087	electrical impedance tomography
32088	In-ICU mortality
32089	critical patients
32090	Pandemic surgery
32091	Sars-Cov2
32092	Surgery and Covid
32093	Spreading speed
32094	Cross-correlation
32095	Return
32096	Board utility
32097	Capital regulation
32098	Optimal guaranteed rate
32099	psychological interventions
32100	mild-moderate COVID-19
32101	refined risk management
32102	rehabilitation duration
32103	tailored clinical decisions-making
32104	Laboratory indicators
32105	Managing strategies
32106	Ward
32107	digital surveillance
32108	feminist
32109	Regional resilience
32110	economic geography
32111	kind of shocks
32112	pandemic crisis
32113	acute stress disorder
32114	Health standard
32115	myelosuppression
32116	CT image lesion
32117	virus nucleic acid
32118	Ground glass opacity
32119	early stage
32120	grid-form shadow
32121	proinflammatory
32122	College school students
32123	Primary school students
32124	Somatic symptoms
32125	Cloud Clinic
32126	progression
32127	Reverse-transcription polymerase chain reaction
32128	Knowledge, attitude and practice 
32129	Undergraduates
32130	Air Traffic Restriction
32131	Existing cases
32132	Megacity
32133	Recovery Rate
32134	Early warning, prevention and control
32135	Effective distance
32136	Population floating
32137	willingness
32138	Wuchang pattern
32139	three formulae and three medicines
32140	Caputo-Fabrizio fractional order derivative
32141	Numerical Simulation
32142	endodontic practice
32143	resuming
32144	Environmental
32145	Social and Governance (ESG)
32146	Alexithymia
32147	Infectious model
32148	Measure
32149	Pneumonias
32150	Partial and multiple wavelet coherence
32151	Medical resources
32152	Crisis Coordination
32153	and Medical Surge
32154	Patient arrangement
32155	classification of disease
32156	compiling textbooks
32157	disease diagnosis
32158	disease nomenclature
32159	economic and financial crisis
32160	Epidemic knowledge
32161	Governments' guidelines on epidemic prevention
32162	Modified behavioral framework
32163	Distancing measures
32164	emotion mining
32165	online education platform
32166	user satisfaction prediction
32167	MERS‐CoV aerosol infection
32168	animal nose‐only exposure device
32169	hDPP4 transgenic mice
32170	intranasal instillation
32171	perceived vulnerability
32172	Krebs von den Lungen-6 (KL-6)
32173	ICU, interface control unit
32174	MODS, multiple organ dysfunction syndrome
32175	OB, occult blood
32176	epidemiological factor
32177	provincial measures
32178	ST segment elevation myocardial infarction
32179	Infectious disease control
32180	Nursing administration research
32181	Quantitative easing
32182	Systemic risk
32183	Inter‐country Distancing
32184	inflammatory parameters
32185	oxygenation parameters
32186	therapeutic plasma exchange
32187	psychological problem
32188	ER stress response
32189	ion channel activity
32190	pro-inflammatory cytokine
32191	COVİD 19
32192	Smoking cessation
32193	COVID-19 diagnoses
32194	Future of PCR
32195	Microfluidics
32196	Miniaturization
32197	Experience and Practice
32198	Health Emergency Management
32199	Online forum
32200	CHM, Chinese herbal medicine
32201	ICD-11, The eleventh edition of the International Classification of Diseases
32202	TCM, Traditional Chinese Medicine
32203	Carbon dioxide
32204	Disposable plastic waste
32205	Hydrogen
32206	Pyrolysis
32207	Airborne spread
32208	Chain-binomial model
32209	Contact network model
32210	Small-world
32211	The basic reproductive number R0
32212	coronavirus-2019 pneumonia
32213	retroperitoneal hematoma
32214	elastic resistance training
32215	medical mode
32216	Emotional “inflection point”
32217	New coronavirus pneumonia (NCP)
32218	Self-regulation
32219	Clinical prediction model
32220	Diabetes inpatients
32221	Virtual consultation
32222	SAS
32223	mast cell
32224	Arabian Peninsula
32225	Coronavirus, Affected places
32226	Precautionary measures
32227	City lock-down
32228	Counterfactual analysis
32229	front-line nurses
32230	Gram-negative bacilli
32231	antibiotic prophylaxis
32232	critical ill
32233	LCOE cost
32234	Photovoltaic industry
32235	System dynamics analysis
32236	SARS coronavirus (virus classification)
32237	coronavirus (virus classification)
32238	shedding (pathogenesis)
32239	artificial intelligence technology
32240	medical staffs
32241	Decent society
32242	Whistle-blowing
32243	Food reserves scale
32244	Food stockpiling behavior
32245	WTP
32246	anti-epidemic
32247	legality
32248	Markov Chain Monte Carlo simulation
32249	mitigation effectiveness
32250	pandemic severity
32251	viral testing
32252	AI, Artificial intelligence
32253	AR, Autoregressive
32254	ARIMA, Autoregressive integrated moving average
32255	Bi-LSTM
32256	Bi-LSTM, Bidirectional long short term memory
32257	DL, Deep learning
32258	Deep learning models
32259	GRU
32260	GRU, Gated recurrent network
32261	LSTM, Long short term memory
32262	NN, Neural network
32263	RF, Random forest
32264	RNN, Recurrent neural network
32265	SARIMA, Seasonal autoregressive integrated moving average
32266	SIR, Susceptible-infective-removed
32267	SVR, Support vector machine
32268	Medical resources demand
32269	Transmission dynamics models
32270	Fatality curve
32271	Richards growth model
32272	temporary
32273	Airborne precaution
32274	Epidemic topics
32275	Spatiotemporal characteristics
32276	global impacts
32277	Combination of acupuncture and medication
32278	public behavior change
32279	Geopolitics
32280	International collaboration
32281	laboratory parameter
32282	Emergency treatment
32283	Radiotherapy center
32284	Nitrogen dioxide emissions
32285	Immunophenotype
32286	Severe/critical pneumonia
32287	Meta-population epidemic model
32288	Network dynamics
32289	FUO emergency department
32290	Lean management model
32291	internet + technology
32292	online mental health services
32293	facial masks
32294	self-quarantine
32295	Healthcare crisis
32296	Indifferent attitude
32297	Lack of facilities
32298	Synthetic control
32299	Non-invasive
32300	Confirmed cases
32301	Vector Autoregressive model, Time series
32302	Impulsive Epidemic Model
32303	Optimal Control
32304	SQEIAR Model
32305	multivariate logistic regression
32306	warning score
32307	cultural difference
32308	modern medicine
32309	laryngeal carcinoma
32310	CATFIN
32311	Financial institutions
32312	Operating Rooms
32313	clinical neuropsychology
32314	health care workforce
32315	Cardiopulmonary resuscitation.
32316	Emergency intubation
32317	Kaplan-meier
32318	Survival curve
32319	Infectious disease hospital
32320	Ignorance
32321	authoritarianism
32322	orientalism
32323	politics of knowledge
32324	sinophobia
32325	Lessons
32326	Long short term memory (LSTM) networks
32327	psychogenic issue
32328	Exponential growth method
32329	Incident cases
32330	Time dependent method
32331	Espagne
32332	Hand surgery
32333	Eastern Mediterranean Region
32334	First death
32335	diabetic foot
32336	ulcer
32337	34D05
32338	Mathematical modeling of COVID-19 pandemic
32339	Stability
32340	Wuhan case study
32341	Health Qigong
32342	proprioceptive neuromuscular facilitation
32343	Collaborative Governance
32344	CCPA
32345	OECD privacy principles
32346	privacy and data protection
32347	tracking app
32348	High flow oxygen therapy
32349	Urological emergencies
32350	ITU
32351	infectious diseases & infestations
32352	Spine surgeon
32353	opportunities and challenges
32354	technology enhanced learning
32355	Epidemic tracing
32356	Epidemic mathematical model
32357	Public closings
32358	policy learning
32359	family nurse practitioners
32360	Aerosol transmission
32361	information professionals
32362	burn-out
32363	laboratory personnel
32364	umbrella review
32365	Transmissionchain
32366	Dental care providers
32367	Primordial prevention
32368	food inflation
32369	food self-sufficiency
32370	food trade
32371	β-Coronavirus
32372	big data analysis
32373	major public health incidents
32374	predictive analysis
32375	cardio-cerebrovascular disease
32376	severity; mortality
32377	Gravity model
32378	Industrial information integration (III)
32379	Industrial sector
32380	Information integration networks (IIN)
32381	Economic forecast
32382	Fractional derivative with Mittag-Leffler kernel
32383	Fractional mathematical model
32384	Spectral method
32385	Professional identity
32386	Rescue experience
32387	bedside ultrasonography
32388	deep venous thrombosis
32389	facial rejuvenation
32390	word cloud
32391	intention to response
32392	Infection probability
32393	Wells-Riley model
32394	Contact rate
32395	Migration-in rate
32396	SEIAR
32397	Air cargo capacity
32398	Digital logistics
32399	Integrated supply chain
32400	e-commerce
32401	Covid-19 and Ebola model
32402	New fractional kernels
32403	New numerical scheme based on lagrange interpolation
32404	Mutile-scale convolutional neural network
32405	Environmental transmission
32406	Containment polices
32407	Transmission dynamic model
32408	Differential equation model
32409	Isolation measure
32410	Patients with mild symptoms
32411	The reproduction number
32412	Fear of academic year loss
32413	e-Learning crack-up
32414	acute abdomen
32415	human caring
32416	home-based TCM
32417	Nurses Role
32418	Nursing Leadership
32419	24-hour “SCI” supervision mode
32420	donning and doffing process
32421	International student
32422	MBBS
32423	Online distance education
32424	Modifiable areal unit problem
32425	Statistical bias
32426	Neutrophil/lymphocyte ratio
32427	older age
32428	stress response
32429	influenza pneumonia
32430	RAS blockers
32431	Myocardial injury biomarkers
32432	International Year of the Nurse and Midwife
32433	HDL
32434	Effective Education
32435	Misconception
32436	occupational injury
32437	skin injury
32438	Greater Mekong Subregion
32439	Rural households
32440	Border controls
32441	Global food system
32442	Trade barriers
32443	Benefiting kidney and strengthening anti-pathogenic qi
32444	Chinese herbal granules
32445	Oxiris
32446	hemodynamic
32447	Anthropogenic activities
32448	Concentrations and sources
32449	Heterogeneous conversion
32450	Nitrous acid
32451	Acute eosinophilic pneumonia
32452	Meropenem
32453	Postpartum exacerbation
32454	Cardiac insufficiency
32455	COVID-19 cases
32456	Diagnostic radiology examination
32457	Radiological protection
32458	CD4(+)T lymphocyte
32459	Dislipidemia
32460	Neurosensory dysfunction
32461	EOS
32462	MAGEC rod
32463	MCGR
32464	1918–19 influenza
32465	Multiple waves
32466	Years of life lost
32467	Función del órgano
32468	Organ function
32469	Hypocalcemia
32470	Reproducibility probability
32471	Shift in patient population
32472	clinical dynamics
32473	mild-moderate patients
32474	novel mobile cabin hospitals
32475	Pulmonary computed tomography
32476	cardiac damage
32477	coagulation activity
32478	inflammatory responses
32479	intravenous immunoglobulin (IVIG)
32480	instructional strategies
32481	Epidemiological characteristic
32482	Spatiotemporal analysis
32483	deep learning (DL)
32484	high resolution computed tomography (HRCT)
32485	Influencing factor
32486	ketoacidosis
32487	ketosis
32488	Epidemic pattern
32489	Evaluation of prevention effectiveness
32490	Lung epithelial cells
32491	xCELLigence
32492	Total body weight
32493	surveillance and monitoring
32494	Epidemic focus
32495	General belief in a just world (GBJW)
32496	Individual emotions
32497	stress disorders, traumatic
32498	trauma and stressor related disorders
32499	Labor exporting city
32500	RESPIRATORY MEDICINE (see Thoracic Medicine)
32501	citizen engagement
32502	dialogic communication theory
32503	emotional valence
32504	government social media
32505	media richness theory
32506	remote sensing technology
32507	teleassistance
32508	teleorthodontics
32509	SEIPS
32510	Gwet AC2
32511	oral disease
32512	tongue image
32513	Token economy
32514	fall prevention
32515	motor ability
32516	psychological outcomes
32517	Covid feet
32518	Digestive System
32519	Folic acid
32520	Omega‐3 fatty acids
32521	SDS
32522	fear of disease progression
32523	Anesthetic equipment
32524	cardiac involvement
32525	imported Italian cases
32526	resuming classes
32527	Local and global asymptotic stability
32528	New mathematical model for covid-19
32529	Stability analysis and reproductive number
32530	diabetes; pre-diabetes
32531	pre-diabetes
32532	Almajiri children
32533	Displacement
32534	Northern Nigeria
32535	early triage
32536	neurology practice
32537	Severe pneumonia in pregnant woman
32538	Suspected COVID-19 cases
32539	Biosafety protection
32540	Clinical microbiology laboratory
32541	Work flow
32542	metabolic (dysfunction)-associated fatty liver disease
32543	Deep brain stimulation
32544	Psychiatric neurosurgery
32545	ocular symptoms
32546	CRB-65
32547	Community-acquired pneumonia
32548	goggle-mask related skin disease
32549	health care work
32550	impetigo
32551	self-protection
32552	TLR5
32553	therapeutic development
32554	Safety management
32555	Specimen collection
32556	Porcine epidemic diarrhea virus (PEDV)
32557	aminopeptidase N
32558	enterocytes
32559	porcine coronavirus
32560	transmissible gastroenteritis virus (TGEV)
32561	African swine fever
32562	trade
32563	Comment
32564	Countermeasures
32565	managing chronic wounds
32566	Delay integral equations
32567	Dynamics and control of epidemics
32568	Generalized logistic function
32569	Density functional theory
32570	NO gas
32571	Caputo–Fabrizio derivative
32572	Fixed point
32573	Homotopy analysis method
32574	Acute stress disorder
32575	health promotion and prevention
32576	Angina
32577	Stethoscope
32578	frequency
32579	Lung stem/progenitor cells
32580	Huo-Gu formula
32581	Osteonecrosis of the femoral head
32582	Steroid-related osteonecrosis
32583	Dharmaśāstra
32584	Hindu law
32585	Manu
32586	Rigveda
32587	Secularization
32588	St. Louis IX
32589	Veda
32590	histology/cytology
32591	Droplet trajectory
32592	Indoor environment
32593	Numerical
32594	Comprehensive surveillance
32595	Critical, COVID-2019, hypercoagulation status
32596	Hikikomori
32597	Social Withdrawal behaviour
32598	hospital pharmacy competencies
32599	paediatric gastroenterology
32600	power of disclosure
32601	High Flow Nasal Cannula
32602	Noninvasive positive pressure ventilation
32603	Severe Acute Respiratory Infections
32604	Garch-midas
32605	Infectious disease pandemic
32606	Stock market volatility
32607	Emerging and re-emerging swine coronaviruses
32608	Microfluidic chip
32609	Ca(2+) channel blocker
32610	Ca(2+) influx
32611	big data sharing
32612	medical institutions
32613	megacities
32614	plasmonic
32615	face touching
32616	air distribution
32617	computational fluid flow
32618	discrete phase model
32619	Image segmentation problem
32620	Kapur’s entropy
32621	Slime mould algorithm (SMA)
32622	Whale optimization algorithm
32623	Bayes’ theorem
32624	causation
32625	Thromboelastometry
32626	Blood purifications
32627	Cytokine adsorption
32628	Evidence-based
32629	DCE MRI
32630	Quantitative metric
32631	Voxel Histogram
32632	APGARCH model
32633	Global Financial Crises
32634	Leverage effect
32635	graphenes
32636	kretschmann layout
32637	plasmonic bio‐sensing
32638	Under-reporting
32639	Deoxynivalenol
32640	Environmental Toxins
32641	MAPK p38 signaling
32642	Government efficacy
32643	Self-efficacy
32644	Tourism recovery
32645	Human-driven
32646	Smart cities
32647	Smart technologies
32648	Techno-driven
32649	Disequilibrium dynamics
32650	Multi market model
32651	Production network
32652	Food safety and nutrition
32653	attenuation
32654	live attenuated vaccine
32655	Data cleaning
32656	Disease prediction
32657	Dragonfly optimization
32658	Feature extraction
32659	Fitness basis
32660	Intelligent robotics
32661	Central corneal thickness
32662	Keratometry
32663	Paracentral corneal thickness
32664	Peripheral corneal thickness
32665	Precision
32666	Scheimpflug imaging
32667	Swept-source optical coherence tomography
32668	Feature tracking
32669	Fontan operation
32670	Strain
32671	Bacterial
32672	PDVAC
32673	Product development
32674	SAGE
32675	Airborne disease control
32676	Courtyard environment
32677	Design
32678	Behavior of wearing masks
32679	Global awareness
32680	internalized stigmatization
32681	mental health problems
32682	Algorithms
32683	Dilated cardiomyopathy
32684	Ventricular dysfunction, left
32685	Electrical impedance tomography
32686	High-frequency oscillatory ventilation
32687	Mean airway pressure
32688	Canine diarrhea
32689	Multiplex real-time PCR
32690	TaqMan probe
32691	Deformable registration algorithm
32692	right ventricular myocardial strain
32693	Cerebral blood flow
32694	Long-label pCASL
32695	Reproducibility
32696	Bioinorganic chemistry
32697	Mucosal vaccination
32698	Nanocarrier
32699	Vaccine delivery
32700	multiplex polymerase chain reaction
32701	virus.
32702	competitive advantage
32703	corporate political strategies
32704	internalization theory
32705	knowledge strategies
32706	Papain-like proteases
32707	Poly(C) binding protein 2
32708	Virus replication
32709	FGF pathway
32710	Wnt pathway
32711	alveolar epithelium
32712	alveolar organoid
32713	alveolar stem cell
32714	alveolar type II epithelial cell
32715	IRBs
32716	decellularization
32717	MALDI-TOF MS
32718	Sensititre YeastOne
32719	antifungal susceptibility testing
32720	non-Aspergillus molds
32721	external-beam partial breast irradiation
32722	interobserver variability
32723	supine position
32724	target volume delineation
32725	Airborne particle-bound metals
32726	Back propagation artificial neural network
32727	Health risk
32728	microbial function prediction
32729	neonatal piglets
32730	BVDV-1 aerosol
32731	Bovine viral diarrhea virus (BVDV)
32732	influenza virus A
32733	multiplex PCR
32734	Adenostemma lavenia
32735	NRF2
32736	antiaging
32737	ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic acid
32738	pap1+ transcription factor
32739	Business perspective
32740	Sharing economy
32741	Urban governance
32742	User perspective
32743	Immunoprecipitation
32744	Membrane (M) protein
32745	SPF chick
32746	short-chain fatty acids
32747	vascular integrity
32748	Differentiate
32749	ORF1
32750	internet addiction
32751	HD11
32752	USP47
32753	miR-gga-30d
32754	rural–urban
32755	Hydrogel patches
32756	long term
32757	skin injuries
32758	ORF3 protein
32759	cytoplasmic location
32760	location signal
32761	anti-fog
32762	hydrogel
32763	SAP
32764	Squama Manitis
32765	Agribusinesses
32766	Business agility
32767	Business value of IT
32768	E-commerce capability
32769	IT-enabled organizational capabilities perspective
32770	Economic development
32771	Heart risk factors, blood pressure
32772	Kuznets Curve
32773	Baculovirus
32774	Infection Simulation
32775	Infection kinetics
32776	Business travelers
32777	Convention
32778	Destination image
32779	Exhibition (MICE) stakeholders
32780	Incentive travel
32781	Meeting
32782	Political instability
32783	Thainess
32784	Medical plastic wastes
32785	Product distribution
32786	Py-GC/MS
32787	TG-FTIR
32788	L1,2-norm regularization
32789	group information
32790	multiexponential T2* relaxometry
32791	myelin water fraction
32792	nonnegative joint sparsity
32793	porcine sapelovirus
32794	porcine sapovirus
32795	triplex RT-PCR
32796	HEPIS
32797	MCF-7
32798	proliferation
32799	Inflation rate
32800	Information costs
32801	Regime switching
32802	Short selling costs
32803	respiratory care
32804	neuromuscular manifestations
32805	COVID – 19
32806	Externalities
32807	smell disorder
32808	taste disorder
32809	Intuitionistic fuzzy sets
32810	Relaxed measures
32811	Thrombolytic therapy
32812	Bowtie
32813	Integrated pandemics barrier model
32814	Lessons learned
32815	Safety zoo
32816	Scenario
32817	air-purifying
32818	aggressive testing
32819	severe-patients-targeted treatment
32820	COVID-19 · Coronavirus · Spine · Spinal practice
32821	public transport
32822	south korea
32823	data disclosure
32824	travel log
32825	large groups
32826	mass infection
32827	prevent
32828	sanitary glove
32829	Mass testing
32830	Workplace
32831	Early Detection of Disease
32832	Infectious Disease Outbreak
32833	healthcare-associated infections
32834	immigrant
32835	Regression tree
32836	Wavelet transforms
32837	Evidence-Based Health Policy
32838	Geographic Information System
32839	Health Facility Allocation
32840	Middle East Respiratory Syndrome (MERS), zoonosis
32841	MERS-CoV transmission dynamics
32842	branching process models
32843	COVID-19, Presymptomatic transmission, Outbreak investigation, Spa facility, Secondary attack rate, Close contact
32844	Blockchain
32845	HACCP
32846	Smart Factory
32847	Nationalism
32848	Tracking
32849	clinical clerkship
32850	AKI severity
32851	Distance awareness
32852	Distance unawareness
32853	Mass infection
32854	Public gatherings
32855	Post-traumatic stress symptom
32856	Medical observation
32857	Dental treatment
32858	Patients with disabilities
32859	Virus filter
32860	Oropharynx
32861	Tonsillectomy
32862	chest X-ray radiography
32863	4-Anilino-6-aminoquinazoline
32864	Surgical challenges
32865	Agricultural futures
32866	Cross-correlations
32867	Crude oil
32868	Multifractaity
32869	Learning Theory
32870	Pandemic risk
32871	Universal Recovery Curve
32872	Sedatives
32873	Experiment
32874	Marketing
32875	Ultimate broadening
32876	Anti-droplet
32877	Hexadecyltrimethoxysilane
32878	Polyurethane
32879	Silica sol
32880	Bovine group a rotavirus
32881	Bovine norovirus
32882	Calf diarrhea
32883	Li-ion batteries
32884	cobalt vanadates
32885	nanocomposites
32886	rate performance
32887	supercapatteries
32888	Physical Activity Promotion System
32889	fitness promotion
32890	high school students
32891	music beeps (MP)
32892	28B10
32893	34A07
32894	54C60
32895	58C06
32896	Diseases modeling
32897	Granular differentiability
32898	Matrix Mittag-Leffler function
32899	Hip-to-calcaneus radiograph
32900	Hip-to-talus radiograph
32901	Weight-bearing line
32902	Swine
32903	porcine epidemic diarrhea
32904	Nash
32905	chronic stroke
32906	home-based rehabilitation
32907	smartwatch
32908	wearable device
32909	lineage B
32910	plasma-derived therapy
32911	methylene blue
32912	platelet concentrates
32913	Radiologic findings
32914	Th1/Th2 cytokines
32915	Angiogenesis
32916	Angiopoietin-2
32917	E-selectin
32918	Endothelial
32919	Alpha-1 antitrypsin
32920	antiretroviral drug
32921	plasma cells
32922	smudged neutrophils
32923	SARS-CoV2 
32924	convalescent plasma transfusion
32925	thrombomodulin
32926	Blood coagulation tests
32927	Thrombelastography
32928	magnesium
32929	plasma cell neoplasms
32930	Antipsychotic
32931	Risperidone
32932	3D printing surgical tools
32933	Antibiofilm coatings
32934	Antimicrobial resistant strains
32935	Atmospheric-pressure cold plasma
32936	Hydration layer
32937	Plasma-polymerization
32938	infusions
32939	young plasma
32940	nonthermal plasma
32941	cold plasma
32942	virus inactivation
32943	endothelial cell
32944	F-Point
32945	Obstetric haemorrhage
32946	Von Clauss method
32947	convalescent care
32948	facilities
32949	ebola
32950	iso 31000
32951	olympics
32952	religious pilgrimage
32953	thermal scanners
32954	world health organization
32955	Biological trends
32956	Covid-2019
32957	operating theatre preparedness
32958	device-related pressure ulcer
32959	skin damage
32960	HWWS
32961	Interventions and challenges
32962	child and adolescent psychiatry
32963	mental health prevention
32964	neurodevelopment
32965	coronavirus guidelines
32966	health care worker safety
32967	prevention ophthalmology
32968	Urban environment
32969	Water consumption
32970	Fecal occult blood test
32971	capabilities
32972	healthcare facilities
32973	KAUH
32974	 Dentistry
32975	 MERS
32976	 Narrative Review
32977	monitored anaesthesia care
32978	stunting
32979	Demographic
32980	Najran
32981	Platelet donor
32982	Platelet inventory
32983	Plateletpheresis
32984	Gender impact
32985	Impact on women’s rights
32986	Minoritized women
32987	Violence risk
32988	pediatric palliative
32989	recurrent neural network
32990	text classification
32991	Psycho-social
32992	Toolkit
32993	equipment safety
32994	 research ethics
32995	payment
32996	undue influence
32997	Physical medicine and rehabilitation
32998	University hospital
32999	Behavioral change
33000	Contact rate reduction
33001	Disease dispersal
33002	open-source
33003	rapid prototyping
33004	Direct oral anticoagulant
33005	Stewardship
33006	personal protective equipment (ppe)
33007	ppe shortage
33008	ppe strategies
33009	Psychological Response
33010	Stressor
33011	clinical governance
33012	cardiovascular prevention
33013	COVID-19 prevention guidelines
33014	trust in science
33015	colorectal
33016	cdc coronavirus
33017	covid-19 mumbai
33018	who coronavirus
33019	optimal nutrition
33020	reprofiling
33021	analgesics opioid
33022	anesthetic techniques
33023	remifentanil
33024	Cognitive Internet of Medical Things (CIoMT)
33025	HEPOP flowchart
33026	frailty and sarcopenia
33027	home exercise program
33028	neuroanesthesia
33029	Kurdistan Region of Iraq
33030	non-therapeutic intervention
33031	Food loss waste (FLW)
33032	GHG emissions
33033	Life cycle assessment (LCA)
33034	Nutritional impact
33035	risk factors for suicide
33036	Peritoneal fluid
33037	Clinical best practices
33038	Incremental benefit cost ratio
33039	Psychological Distress
33040	cost effective
33041	non invasive
33042	safe
33043	epidemiological determinants
33044	Calcium
33045	Pituitary
33046	disease prevention
33047	device-related-pressure-ulcers
33048	occupational dermatoses
33049	wound care
33050	environmental maintenance
33051	standard precaution
33052	zoning
33053	Heatstroke
33054	inequities
33055	Collective narcissism
33056	Dark Triad
33057	breast imaging
33058	breast surgery
33059	cancer genetics
33060	Health and public health infrastructures
33061	Health behaviour
33062	Intergroup attitudes
33063	Lack of control
33064	dog bite
33065	Home care services
33066	New cases
33067	Sanitizers
33068	Amhara region
33069	Home ventilation
33070	SARS-co-V-2
33071	Arab countries
33072	Kingdom of Saudi Arabia
33073	polydatin
33074	resveratrol
33075	homemade masks
33076	medical masks
33077	COVID-19 lockdown
33078	Consumers’ behavior
33079	Household food waste
33080	Saving strategy
33081	nephrolithiasis
33082	urinary calculi
33083	post intensive care syndrome
33084	Antithrombotic
33085	lactic acid bacteria
33086	Cardiac telerehabilitation
33087	Alarming
33088	Analytics
33089	Reassurance
33090	Impact of Event Scale-Revised
33091	intrusive thoughts
33092	Peshawar
33093	Primary healthcare providers
33094	hospital pharmacists
33095	community-based palliative care
33096	home-based palliative care
33097	Cardiovascular surgical procedures
33098	Neural pathway
33099	home-based cardiac rehabilitation
33100	community-based epidemic prevention
33101	applied behavior analysis
33102	licensing
33103	forensic mental health services
33104	self-harm
33105	conspiracy mentality
33106	preventive health behaviours
33107	NTDs
33108	essential healthcare
33109	Self-stigma
33110	messaging
33111	SARS-Co-v2
33112	Compartmental epidemic model
33113	Logistic regression
33114	Preventive Knowledge
33115	Saudi males and females
33116	gender based
33117	face-touching
33118	habit reversal
33119	Patient triage
33120	Practical approach
33121	Video visits
33122	Web-based vision testing
33123	CDC, Centers for Disease Control and Prevention
33124	CMS, Centers for Medicare and Medicaid Services
33125	COVIR-19, coronavirus disease of 2019
33126	Surgical clothes
33127	Sociodemographic data
33128	environmental microbiology
33129	health care transmission
33130	phi 6 bacteriophage
33131	surface persistence
33132	under-reporting
33133	Alcohol Surrogates
33134	North-central Nigeria
33135	Competitiveness
33136	Data driven approach
33137	burial
33138	dignity
33139	Community infection
33140	N95 filtering facemask
33141	National survey in Japan
33142	Risk behaviors
33143	National Guard Health Affairs
33144	simulation-based training
33145	Secondary Attack rate
33146	Young adult
33147	Home Isolation
33148	Coronavirs pandemic
33149	Sleep apnea
33150	Sleep laboratory
33151	Sleep related breathing disorders
33152	T cell exhaustion (Tex) markers, programmed cell death marker 1 (CD279 - PD-1)
33153	T cell immunoglobulin and mucin domain-3 (CD366 - Tim-3)
33154	insufflation
33155	surgery procedure
33156	surgical team
33157	Postoperative
33158	healthy behavior
33159	COVID-19, hand eczema, hand hygiene, handwashing, healthcare workers, HECSI, moisturizing cream score, pandemic, risk factors
33160	Commercial drivers
33161	Syndemics
33162	Custodial settings
33163	family members
33164	Lifestyle intervention
33165	Prediabetes
33166	latent class analysis
33167	Indian Railway Health Services
33168	Indian Railway anaesthesiologists
33169	Railway Association of ISA
33170	railway coaches COVID care centers
33171	Breslow thickness
33172	Dashboard
33173	endonasal
33174	Health-care capacity constraints
33175	Value of statistical injury
33176	global action
33177	metabolic disease
33178	Lyapunov function
33179	Self-medication
33180	Reflections
33181	Sexual Assault Resistance Education
33182	Women’s Safety
33183	Multi-disciplinary team meetings
33184	Remote working
33185	stimulants
33186	hospital care
33187	Youth mental health
33188	Drive-thru pharmacy
33189	Value added services
33190	Mathematical analysis
33191	Congenital
33192	Advancement
33193	ethics of care
33194	feminism
33195	Behavioral health treatment delivery
33196	e-Mental health
33197	parental status
33198	safety behaviour
33199	professional roles
33200	atypical covid
33201	stemi
33202	Risk, Precautionary principle, Pandemic
33203	asymptomatic  transmission
33204	cattery management
33205	tom cat reproduction
33206	Child protection
33207	Child welfare
33208	W3C
33209	WCAG 2.1
33210	web accessibility
33211	Awake surgery
33212	Conservative surgery
33213	Cybercrime
33214	Cybervictimization
33215	Natural experiment
33216	Routine activity theory
33217	nonmedical opioid use
33218	Native American people
33219	Vision
33220	Big data integration and analytics
33221	Contact transmission
33222	face mask usage
33223	novel Coronavirus
33224	emerging virus
33225	Prevention of violence
33226	Exposure keratopathy
33227	Keratitis
33228	Keratopathy
33229	utilization of health services
33230	epidemic response
33231	family physician
33232	Healthcare associated infections
33233	Mobile phones
33234	UV-C device
33235	Nebulizer for delivery of photosensitizer into respiratory tract
33236	PDT for COVID 19 respiratory infection
33237	PDT for respiratory infection
33238	          Dietary Guidelines for Americans        
33239	Dietary Reference Intakes
33240	federal nutrition research
33241	Caloric intake
33242	Healthy lifestyle
33243	medium-chain fatty acid
33244	nursery
33245	pig
33246	Recurrent Neural Network
33247	Alcohol gel quality
33248	CoVID-19 prevention
33249	Ethanol volatilization rate
33250	Ethanol-based sanitizers
33251	Multivariate analysis
33252	Near-infrared spectroscopy
33253	Persian medicine
33254	Archetype
33255	Healthy aging
33256	Life-course
33257	Restrictive measures
33258	Vulnerable
33259	Homeless COVID-19
33260	psychiatric evaluation
33261	RNA vaccines
33262	RNA vectors
33263	protection against pathogens
33264	protection against tumor challenges
33265	Fundamental social causes
33266	Most-at-risk
33267	acute flaccid myelitis
33268	Ear protrusion
33269	External ear
33270	Surgical face mask
33271	aerosol generating medical procedures
33272	adjustment disorder
33273	cognitive-behavioral psychotherapy
33274	emotional contamination
33275	tranquilizers
33276	asymptomatic viral detection
33277	hematopoietic cell transplant
33278	Carbon prices
33279	Economic recovery
33280	Healthy diets
33281	Noncommunicable diseases
33282	Sustainable diets
33283	WHO European region
33284	African American people
33285	Knees
33286	Newspapers
33287	Television channels
33288	Serratia marcescens
33289	future of work
33290	industry 4.0
33291	psychosocial hazards
33292	robots
33293	technological unemployment
33294	Antarctic Cruise
33295	Antarctica
33296	Cruise Medicine
33297	Research Cruise
33298	Nursing Workforce
33299	newly diagnosed diabetes
33300	Twitter messaging
33301	Corona disease
33302	metaheuristics
33303	soft computing
33304	MPV
33305	physical functional performance
33306	General Practice
33307	Medical record systems, computerized
33308	Sentinel Surveillance
33309	all-cause
33310	reactive surveillance
33311	Community-acquired infection
33312	Hospital care
33313	Hospital stays
33314	Policy mandates
33315	Infarto de miocardio
33316	Scottish index for multiple deprivation (SIMD)
33317	socioeconomic deprivation
33318	OLS
33319	Tumour necrosis factor-alpha
33320	COVID-19 and SARS CoV2
33321	coagulation disorder
33322	Medical morbidity and mortality in psychiatric patients
33323	elective cardiovascular procedures
33324	emergency cardiovascular procedures
33325	vascular surgery
33326	Surgical complications
33327	Blood pressure
33328	Employment
33329	Health status
33330	Medical Expenditure Panel Survey
33331	Hip Fracture
33332	Pneumonia severity index
33333	Highly populated cities
33334	African-Americans
33335	socioeconomics factors
33336	Paediatricorthopaedic
33337	ICU Stay
33338	Non cancer
33339	couple infections
33340	domestic family infections
33341	imported family infections
33342	APGAR
33343	Advocacy
33344	Marginalization
33345	Old age
33346	Severe Acute Respiratory Syndrome-associated Coronavirus
33347	Diabetic nephropathy
33348	End-stage renal disease (ESRD)
33349	Intravenous immunoglobulin (IVIG)
33350	Adverse outcomes
33351	LCR
33352	Antagonistas del receptor de la angiotensina II
33353	Inhibidores de la enzima de conversión de la angiotensina
33354	metabolic encephalopathy
33355	multiorgan failure
33356	severe diabetic ketoacidosis
33357	ecmo
33358	Antipyretics
33359	mass testing
33360	centenarians
33361	oldest-old
33362	Transthoracic echocardiography
33363	Surgical outcome
33364	COVID–19-járvány
33365	EKG
33366	lélegeztetés hason fekvő helyzetben
33367	ventilation in prone position
33368	AMI, acute myocardial infarction
33369	IABP, intra-aortic balloon pump
33370	MR, mitral regurgitation
33371	TEE, transesophageal echocardiogram
33372	VA ECMO, venoarterial extra corporeal membrane oxygenation
33373	mitral regurgitation
33374	papillary muscle rupture
33375	transesophageal echocardiography
33376	Stem cell
33377	Viral hepatitis
33378	Speech
33379	Speech-language pathology
33380	Telepractice
33381	disease surveillance notification officers (DSNOs)
33382	poor-resource setting
33383	Cardiac catheterization
33384	Functional status
33385	system dynamics
33386	point-of-care lung ultrasound
33387	Adrecizumab
33388	HAM 8101
33389	adrenomedullin
33390	endothelial function
33391	Cardiac Surgery
33392	Etoposide
33393	Haemophagocytic lymphohistiocytosis
33394	Recurrent neural networks
33395	Basal insulin
33396	Basal-bolus insulin
33397	Continuous glucose monitoring system
33398	Correctional insulin
33399	In-hospital hyperglycaemia
33400	Prandial insulin
33401	public events ban
33402	cancer surgery
33403	perioperative outcomes
33404	CMV
33405	climate drivers
33406	hurricane
33407	sheltering
33408	Prosperity
33409	Public Health Emergencies
33410	Susceptible-infectious-removed (SIR) models
33411	Undersampling
33412	B-type natriuretic peptide
33413	Acute leukemia
33414	Chronic leukemia
33415	Myelodysplastic syndrome
33416	Treatment guidelines
33417	Anaesthesiologist
33418	Catheterisation laboratory
33419	Local analgesia
33420	Minimalist transcatheter aortic valve implantation
33421	Procedural complications
33422	Transfemoral transcatheter aortic valve implantation
33423	end of life decisions (geriatric medicine)
33424	restaurants
33425	Emergency during the peak of infection
33426	endotracheal intubation
33427	tracheostomy placement
33428	Health Services Accessibility
33429	Health Status Indicators
33430	Maternal Death
33431	Cardiac function
33432	Grieving
33433	Mourning
33434	Hepatitis A
33435	L-cysteine
33436	Emergency planning
33437	ICU beds prediction
33438	ICU patients
33439	Incremental learning
33440	infection control messages
33441	switchboard response times
33442	Policy analysis
33443	Orthopaedic services
33444	mortality monitoring
33445	public health action
33446	thrombosis (venous)
33447	Heart Failure
33448	S116 haplotype
33449	Calprotectin
33450	GDF-15
33451	DVT prophylaxis
33452	LMWH (low molecular weight heparin)
33453	Hyperglycemic hyperosmolar syndrome
33454	Subcutaneous insulin therapy
33455	ethnic minority groups
33456	COVID19 pneumonia
33457	Mechanical invasive ventilation
33458	geriatric population
33459	socioeconomics
33460	Barthel Index
33461	Nottingham extended activities of daily living
33462	Telephone interview for cognitive status
33463	personalized therapy
33464	cardiovascular cardiology
33465	meta-analysis statistics and study design
33466	systematic review statistics and study design
33467	Heat shock proteins
33468	Heme oxygenase
33469	Minority Aging (Race/ethnicity)
33470	physiotherapy
33471	Burden
33472	MERS-Coronavirus
33473	Predicción
33474	electrocautery
33475	smoke evacuation
33476	hypocaloric
33477	Hepatic steatosis
33478	Earth overshoot day
33479	Groundwater
33480	Vehicular traffic
33481	Informed consent
33482	Bone and muscle health
33483	Telematic survey
33484	low level laser therapy
33485	History of science
33486	Nature of science
33487	Philosophy of science
33488	Sociology
33489	intravenous ascorbate
33490	blood group
33491	factor VIIIc
33492	Benefit-cost analysis
33493	VSL
33494	value per statistical life
33495	H1N1 influenza
33496	Outbreak response
33497	Routine care
33498	politics
33499	Análisis de brotes de enfermedades
33500	Disease outbreaks analysis
33501	Disease outbreaks statistics and numerical data
33502	Estadísticas de brotes de enfermedades y datos numéricos
33503	Género
33504	Sexo
33505	culture change
33506	environments
33507	opportunity
33508	specific
33509	supportive
33510	CRRT
33511	CVVHD
33512	HCO
33513	Food Insecurity
33514	Medical Nutrition Therapy
33515	Nutrition Support
33516	Consent
33517	surgical capacity
33518	General medicine (see internal medicine)
33519	calcium & bone
33520	diabetes & endocrinology
33521	Comprehensive health strategies
33522	Estrategias integrales de salud
33523	Maternal and child health disparity
33524	Minority women
33525	Alternative stable states
33526	False detection
33527	Limited medical resources
33528	SIRS epidemic model
33529	CPAP; bilevel positive airway pressure
33530	NIPPV
33531	NIV helmet
33532	non-invasive positive pressure ventilation
33533	contrast echocardiography
33534	gastrointesinal endoscopy
33535	compensatory consumption
33536	heroes
33537	mortality salience
33538	congenital heart defects
33539	valvular heart diseases
33540	DEPRIVATION
33541	EMPLOYMENT
33542	GENDER
33543	GEOGRAPHY
33544	HEALTH INEQUALITIES
33545	symptoms and symptom management
33546	Renal cell carcinoma
33547	PLWH
33548	avian infectious bronchitis virus (IBV)
33549	interferon-inducible transmembrane (IFITM) proteins
33550	agriculture
33551	upstream causes
33552	Aging populations
33553	Sociable robots
33554	medical equipment
33555	Cardiotoxicity
33556	Interleukin-1β
33557	Interleukin-8
33558	Pro-inflammatory cytokines
33559	Tumor necrosis factor alpha
33560	Glycemic variability
33561	Immunostaining
33562	MERS-CoV infection
33563	Scoring
33564	Unlock
33565	Corona-phobia
33566	COVID survivors
33567	Emotional experiences
33568	binary logistic regression
33569	independent risk factors
33570	joint predictor
33571	arterial-to-alveolar oxygen tension ratio
33572	end-tidal carbon dioxide pressure
33573	physiologic dead-space ratio
33574	Hemostasis disorders
33575	transthoracic echocardiography
33576	Mustela putorius furo
33577	ferret coronavirus MSU-2
33578	resumption
33579	gamma interferon
33580	genetic risk factor
33581	pyrosequencing
33582	compassion fatigue
33583	organisational culture
33584	self care
33585	Acute exacerbation
33586	Pseudomonas
33587	polymicrobial infection
33588	Pandemic surge
33589	Supportive care
33590	Data Statistics
33591	Situation Prediction
33592	Spread Chain
33593	Global sensitivity analysis
33594	Hospitalization/self-isolation
33595	Optimal control theory
33596	Mental health care
33597	Mental health staff
33598	counselling
33599	stress and coping
33600	resident wellness
33601	emotional intelligence
33602	Computational simulations
33603	Model reduction
33604	Precautionary Behavior
33605	Risk Perceptions
33606	Electricity quantity
33607	Fixed-effect regression
33608	GDP
33609	High-frequency estimates
33610	Real-time monitoring
33611	Wholesale electricity markets
33612	Decisions
33613	Perceptions and behaviors
33614	Travel and tourism
33615	Work and study
33616	Emergency radiology
33617	surgical oncology practice
33618	2021 match
33619	otolaryngology applications
33620	virtual Interviews
33621	Orthodontic practice
33622	Perceived impact
33623	Survey research
33624	Treatment delays
33625	e-mental health
33626	Fellowship training
33627	epidemic models
33628	robust estimation
33629	assessment in health professions education
33630	failure modes effect analysis
33631	system engineering
33632	Premier healthcare database
33633	operating theatre utilisation
33634	surge planning
33635	psychological preparedness
33636	online communication
33637	Epidemic modelling
33638	online oktatás
33639	orvos-beteg kommunikáció
33640	orvosképzés
33641	simulated patient
33642	szimulált páciens
33643	Existence and uniqueness
33644	Ulam–Hyers stability
33645	Social crisis
33646	Peripheral arterial occlusive disease
33647	COVID‐19 pneumonia
33648	CO‐RADs
33649	computed tomography severity index
33650	hepatic steatosis
33651	Suicidality
33652	Emotion
33653	Community corrections
33654	Corrections
33655	Inmate
33656	Indonesian
33657	KAP survey
33658	Undergraduate students
33659	Connectedness
33660	epidemic risk management
33661	Age and Space Structured SIR Model
33662	Covid-19 Modeling
33663	Differential Equations in Epidemic Modeling
33664	Alzheimer’s disease (AD)
33665	Lockdown effect
33666	Outbreak containment policy
33667	Curve Estimation Statistical Models
33668	Estimators
33669	Forecast Values
33670	Quartic Linear Regression Model
33671	Confirmed Cases
33672	Learning loss
33673	Library use
33674	Register data
33675	Inverse problems
33676	changepoint
33677	interrupted time‐series
33678	Logistic population model
33679	Conformable calculus
33680	Dynamic system
33681	Fractional differential operator
33682	Fractional integral operator
33683	Intervention analysis
33684	Posterior probabilities
33685	Prediction intervals and forecast accuracy measures
33686	Arima model
33687	COVID-2019 pandemic
33688	Holt-winters’ method
33689	State space model
33690	Estrogens
33691	Gender discrimination
33692	Gender identity
33693	Health statistics
33694	Scientists
33695	Sex hormones
33696	Sexual identity
33697	CDC’s influenza-like illness report
33698	aggregated prescription data
33699	total case count
33700	undocumented infection
33701	non-verbal contact
33702	psychological care
33703	video-consults
33704	epidemiological methods
33705	BAME group
33706	BAME health workers
33707	Curriculum development
33708	Education technology
33709	Emerging technologies
33710	Instructional Design
33711	Online Learning
33712	Digital PET/CT
33713	Dose reduction
33714	Protocol optimization
33715	BSREM
33716	OSEM
33717	Penalized-likelihood reconstruction
33718	Q.Clear
33719	Demographic and health surveys
33720	Human geography
33721	Soap
33722	Social geography
33723	home monitoring
33724	lung function
33725	healthy immigrant effect
33726	immigrant category
33727	linked data
33728	Patient-reported outcomes
33729	patient experiences
33730	patient-reported outcome measures
33731	proms
33732	pros
33733	cytokine storm, monocytes
33734	Blood filtration devices
33735	hyper-inflammatory syndrome
33736	superantigen
33737	Glutamine
33738	Hyperinflammatory
33739	Sarcopenia
33740	Microvesicles
33741	Gestational trophoblastic diseases
33742	Hydatidiform mole
33743	Metabolic acidosis
33744	paracrine effect of cytokines
33745	calcitonin gene‐related peptide
33746	Gluten-free Diet
33747	Intestinal Permeability
33748	coronavirus disease 2019 deaths
33749	upregulated inflammation
33750	interleukin 6
33751	microvascular inflammation
33752	multi-system involvement
33753	new management strategy
33754	repurposed use of anti-interleukin
33755	point‐of‐care
33756	CRAC channel inhibitors
33757	Calcium release-activated calcium channel inhibitors
33758	Proinflammatory response
33759	Pulmonary endothelium
33760	corticosteroid therapy
33761	Circulating endothelial cells
33762	endothelial injury
33763	inflammation; IL-6
33764	Endothelial progenitor cells
33765	disproportionality
33766	complement C5
33767	leukotriene B4
33768	thrombin
33769	inflammatory cytokine response
33770	bioactive lipids
33771	immune check point inhibitory therapy
33772	Interstitial pulmonary edema
33773	COVID-19 related urticaria
33774	steroids and antihistamines
33775	CTG
33776	Cardiotocograph
33777	Physiological CTG interpretation
33778	ZigZag pattern
33779	tryptophan catabolism
33780	Coma
33781	Microbleeds
33782	chronic graft-versus-host disease (cGVHD)
33783	hematopoietic stem cell transplant (SCT)
33784	CCR5
33785	Host genetics
33786	Low-dose radiotherapy
33787	Fissured tongue
33788	Orofacial edema
33789	abdominal surgery
33790	Electrical storm
33791	lidocaine
33792	netosis
33793	Immunopharmacology
33794	Mood stabilizers
33795	anti-inflammatory agents
33796	non-steroidal
33797	familial Mediterranean fever
33798	chimeric antigen receptor-T-cell therapy
33799	inflammatory cytokine neutralization
33800	eosinophil-derived neurotoxin
33801	reactive
33802	cryopyrin-associated periodic syndromes
33803	hepatocytes
33804	systemic inflammatory response
33805	peptide nanofiber
33806	self-assembly
33807	Venous occlusive disease
33808	infections disease/AIDS
33809	neuro ophthalmology
33810	optic neuropathy
33811	retinal degenerations associated with systemic disease
33812	retinal pathology/research
33813	early intervention
33814	PLR
33815	Prognostic markers
33816	Linear regression (LR)
33817	Multilayer perceptron (MLP)
33818	Vector autoregression (VAR)
33819	pulmonary histopathology
33820	cytotoxicity, immunological
33821	Computed tomography angiography
33822	glucose homeostasis
33823	neuromuscular system
33824	sedentarism
33825	Immunoceutical
33826	COVID associated coagulopathy
33827	GDM
33828	arthritis, juvenile
33829	still's disease, adult-onset
33830	antithrombotic treatment
33831	Regression discontinuity
33832	Stroke activity
33833	neuropathology
33834	Multisystem inflammation syndrome in children
33835	catastrophic antiphospholipid antibody syndrome
33836	aerobic exercise
33837	calisthenics
33838	high-intensity interval training
33839	intermittent exercise
33840	haemoglobin oxygen
33841	antypsychotics
33842	barriers to treatment
33843	biological
33844	consultant-liaison
33845	extrapyramidal syndromes
33846	history of psychiatry
33847	Still's disease, adult-onset
33848	touch
33849	TAFI
33850	thrombin generation
33851	MUO
33852	feline
33853	lympho-histiocytic
33854	necropsy
33855	non-infectious
33856	LAMP assay
33857	Point of care diagnostics (PoC)
33858	Active random surveillance
33859	chronic hepatitis C
33860	sustained virologic response
33861	AFP
33862	Alpha-Fetoprotein
33863	Colonoscopy overuse
33864	Surveillance colonoscopy
33865	Public health practice
33866	Digital health technologies
33867	Pandemic disease surveillance
33868	Racial inequality
33869	Racialized subpopulations
33870	Solidarity COVID-19 apps
33871	syndromic surveillance system
33872	traditional surveillance system
33873	NGO
33874	Portal
33875	University
33876	Public Health Surveillance
33877	Trends
33878	Ducks
33879	avian viruses
33880	Brief psychotic disorder
33881	Brief reactive psychosis
33882	Biological disaster
33883	Hospital accreditation
33884	shelter
33885	Smartphone
33886	Digital health technology
33887	Program implementation
33888	CRE colonization
33889	carbapenem-resistant Klebsiella pneumoniae
33890	Disease forecasting
33891	Weighted overlay
33892	SMART
33893	psychological crisis intervention
33894	remote Psychological First Aid
33895	health care utilization
33896	serious illness
33897	DPP4 expression
33898	Natural
33899	Face detection
33900	Human skin detection
33901	Security
33902	YCbCr space color
33903	Idleb
33904	population-based and preventative services
33905	war
33906	new technology
33907	Coronavirus infectious disease 2019
33908	Knowledge gaps
33909	Research needs
33910	Surgeons role
33911	Civic technology
33912	Digital democracy platform
33913	Digital epidemic control
33914	Predictive preventive personalized medicine (3 PM / PPPM)
33915	Predictive, preventive and personalized digital healthcare
33916	Professional network
33917	Smartphone apps
33918	Social aspects
33919	Social machines
33920	emotional outbreak
33921	Disorder-lockdown-covid-19
33922	digital payments
33923	digital surge
33924	gig work
33925	internet governance
33926	clinic
33927	stone
33928	telephone
33929	non-specific immunity
33930	vaccine effectiveness
33931	time-varying Reproduction number
33932	sporting organisation
33933	CARES database
33934	CSC
33935	Cardiac arrest predictors
33936	Clinical decision rule
33937	Big tech
33938	Digital contact tracing
33939	Digital ethics
33940	digital innovation
33941	healthcare bottlenecks
33942	healthcare sustainable development
33943	internet of medical things
33944	public–private partnerships
33945	results-based-financing
33946	Bloodstream infection
33947	Multidrug-resistant bacteria
33948	Community-engaged health survey
33949	Police brutality
33950	SHUR data
33951	Social conditions and health
33952	injecting drug use
33953	needle and syringe programmes
33954	risk behaviours
33955	arterial spin labelling (ASL)
33956	cerebral blood flow (CBF)
33957	neurointensivism
33958	neuroradiology
33959	neurovascular
33960	Neuropsychiatry
33961	synucleinopathy
33962	respiratory centres
33963	vagus nerve
33964	paramedics
33965	Clinical profile
33966	Integrative protocol
33967	Bacillus stearothermophilus spores
33968	Vaporized hydrogen peroxide
33969	Peak day
33970	Period times
33971	Population Density
33972	Personalization
33973	Public transport planning
33974	Route guidance
33975	ASC
33976	Ambulatory surgery center
33977	Freestanding, laparoscopic-assisted myomectomy
33978	Ligation
33979	Minilaparotomy
33980	Morbidly
33981	Obese, occlusion
33982	Community relations
33983	Family relations
33984	Feelings
33985	fetal infection
33986	new coronavirus-19 infection
33987	pregnancy infection
33988	reproductive healthcare access
33989	EPDS
33990	beliefs
33991	estrogen therapy
33992	oral contraceptives
33993	Parenthood
33994	Type 1 diabetes mellitus
33995	severe acute respiratory syndrome novel coronavirus 2
33996	cardiotocograph
33997	obstetrical
33998	hydatidiform mole
33999	vesicular mole
34000	OB-GYN emergency department
34001	emergency services
34002	Abdominal pregnancy
34003	Decidual tissue
34004	Ectopic pregnancy
34005	Hemoperitoneum
34006	Polymorphic eruption of pregnancy
34007	Anestesia obstétrica
34008	Gestante
34009	Obstetric anesthesia
34010	postponement
34011	Breast feeding with Covid-19
34012	Neonatal Covid-19
34013	Vertical transmission of Covid-19
34014	parenthood
34015	newborn infant
34016	pregnant Women
34017	Obstetrics and gynaecology
34018	Amniocentesis
34019	Prenatal invasive diagnostic procedures
34020	self-managed abortion
34021	Epidemic influenza 1918
34022	Puerpal infection
34023	Serological diagnostics
34024	Postpartum
34025	Cryptosporidium spp.
34026	Eimeria spp.
34027	Nematodes
34028	Vulpes zerda
34029	canine adenovirus
34030	canine distemper virus
34031	fennec fox
34032	modified-live virus vaccine
34033	multiplex quantitative real-time RT-PCR
34034	Safety Management
34035	Hispanic/Latinx ethnicity
34036	autism spectrum disorder
34037	developmental delay
34038	operating theater
34039	COVID-19, Coronavirus. Novel Coronavirus-2019
34040	SINA, The Saudi Initiative for Asthma
34041	SPPA, Saudi Pediatric Pulmonology Association
34042	STS, The Saudi Thoracic Society
34043	Saudi Pediatric Pulmonology Association (SPPA)
34044	VHC, Valved holding chamber
34045	WAP, Written Action Plan
34046	autism spectrum disorders
34047	school attendance
34048	flank tenderness
34049	mesenteric adenitis
34050	Developmental delay
34051	Inequities
34052	Vulnerable children and families
34053	Kawasaki-like vasculitis
34054	mucocutaneous lymph node syndrome
34055	children with physical disabilities
34056	Parental Attitudes
34057	Psychological flexibility/inflexibility
34058	attention deficit hyperactivity disorder
34059	Family violence
34060	Maltreatment
34061	Telemental health
34062	Trauma treatment
34063	chronotype
34064	Otitis-prone
34065	eating pathology
34066	attention Deficit Hyperactivity Disorder
34067	trauma reaction
34068	Medicaid coverage
34069	Medicaid eligibility
34070	Private health insurance
34071	Disabilities
34072	Special educational needs
34073	affect
34074	day reconstruction method
34075	Health Anxiety
34076	Mental health and PTSD
34077	Social distancing and stay-at-home orders
34078	Caregiver burden
34079	Parent–child relationship
34080	ENT surgery
34081	cochlear implant
34082	disease containment
34083	Kidney replacement therapy
34084	Framework synthesis mental health services
34085	Service user experiences
34086	Clinical recommendations
34087	Pediatric age group
34088	infectious, disease
34089	alcohol-related problems
34090	Victim services
34091	Emergency services
34092	Infant and Young Child Feeding
34093	International Code of Marketing Breast-milk Substitutes
34094	Tele-neuropsychology
34095	tele-psychology
34096	Psychological First Aid
34097	obstetric protocol
34098	Vaccination coverage
34099	immunization programs
34100	Systems integration
34101	medical shelter
34102	protective personal equipment
34103	Multisystem
34104	maxillofacial
34105	Community Mobility
34106	Coronavirus/COVID-19
34107	Mental health care/service delivery systems
34108	Outpatient psychiatry
34109	secondary traumatization
34110	paediatric orthopaedics
34111	The Garda Síochána
34112	psychological support needs
34113	Child and adolescent mental health
34114	Croatia
34115	human coronavirus OC43
34116	children behavioral problems
34117	children emotional problems
34118	parent stress
34119	Caregiving
34120	family relationships
34121	home and community-based services
34122	long-term care; older adults
34123	Multisystem inflammatory syndrome in children (MIS-C)
34124	Pediatric multisystem inflammatory syndrome (PMIS)
34125	External fixation
34126	State of emergency
34127	Teachers
34128	brain biopsy
34129	Child abuse
34130	delayed attendance
34131	healthcare avoidance
34132	non-COVID illness
34133	incomplete Kawasaki disease
34134	Jewish community
34135	Purim
34136	digital screen time
34137	myopia
34138	motherhood
34139	productivity
34140	Maternal nutrition
34141	Nutrition security
34142	School feeding programs
34143	Neuropsychological assessment
34144	Social Stigma
34145	EBP implementation
34146	community mental health
34147	provider perspectives
34148	Motherhood
34149	Work
34150	Home treatment
34151	Acceptance and commitment training
34152	Kernels
34153	PAX Good Behavior Game
34154	Parenting
34155	Psychiatric facilities
34156	pediatric aerodigestive
34157	pediatric airway
34158	Science of learning
34159	Development policy
34160	Paediatric haematology and oncology
34161	Ansiedad
34162	Depresión
34163	Psychological effects
34164	surgical home
34165	team-based care
34166	preterm neonate
34167	Early identification or prediction
34168	Treatment response
34169	Rohingya refugees
34170	vulnerable situation
34171	neuropsychology trainees
34172	E-learning
34173	Undergraduate and postgraduate learners
34174	West Bengal
34175	Burnout syndrome
34176	Scale development
34177	Sonographic interstitial syndrome
34178	healthcare facilities liability
34179	medical malpractice claim
34180	Early Mobilization
34181	Practice Guidelines
34182	Respiratory Therapy
34183	Frame
34184	Phone
34185	Silence
34186	Transfer
34187	depressive disorders
34188	access to health care
34189	fertility services
34190	reproductive rights
34191	Acute bleeding
34192	Hysteroscopy
34193	emergency healthcare utilization
34194	ingestions
34195	education/programs
34196	acceptable delays
34197	elective paediatric orthopaedic conditions
34198	Anorexia Nervosa
34199	SIMPLE
34200	Standardised care
34201	Narrative in medicine
34202	clinician burnout
34203	compassionate care
34204	medical humanities
34205	Cleft palate
34206	Voice onset time
34207	Couinaud segments
34208	Magnetic resonance elastography
34209	Stiffness
34210	COIVD-19
34211	Mounier-Kuhn syndrome,Lung
34212	Diagnostic techniques
34213	clinical tests
34214	glaucomas (pediatric)
34215	lens/cataract
34216	neuro-ophthalmic disease
34217	optics/refraction/instruments
34218	Adolescent mental health
34219	deliberate self-harm
34220	psychoanalytic psychotherapy
34221	temporality in health care
34222	child neuropsychology
34223	Aortic root
34224	Bicuspid aortic valve
34225	Sinuses of valsalva
34226	Ambulatory Blood Pressure Monitoring (ABPM)
34227	Circadian Rhythm
34228	Cugini’s minimal–change hypertensive retinopathy
34229	Renin-angiotensin-aldosterone system (RAAS)
34230	Human bocavirus
34231	Postpandemic schools
34232	School after COVID-19
34233	Separation protests and anxiety
34234	incidental physical activity
34235	light physical activity
34236	moderate to vigorous physical activity
34237	steps
34238	Special Issue
34239	Body weight
34240	behavior reduction
34241	parent training
34242	parent well-being
34243	pediatric palliative care
34244	rescue ventilation
34245	Self-compassion
34246	Medical training
34247	Pediatric healthcare
34248	Videocollaboration
34249	Webconferences
34250	Aortic regurgitation
34251	Cardiac resynchronization therapy
34252	Hypertrophic cardiomyopathy
34253	Sinus venosus atrial septal defect
34254	Stress echocardiogram
34255	Tetralogy of fallot
34256	Pet ownership
34257	isolation hood
34258	positive pressure
34259	Active cases
34260	Pearson
34261	Polynomial regression
34262	Simple linear regression
34263	Support vector regression model
34264	angiotensin-converting enzyme 2 (ace-2)
34265	presymptomatic transmission
34266	symptom onset to hospitalisation
34267	WALANT
34268	34A08
34269	35R11
34270	Adams Bashforth method
34271	Attangana-Baleanu derivative
34272	Existence and stability theory
34273	Fixed point theorem
34274	Day of diagnosis
34275	Day of onset
34276	Ischgl
34277	Primary case
34278	Agent-based modeling (ABM)
34279	Geospatial information science (GIS)
34280	Existence and stability
34281	Health Care Facilities
34282	Manpower and Services
34283	COVID-19, percutaneous tracheostomy, open tracheostomy, bedside tracheostomy
34284	Healthcare associated transmission
34285	Household-associated transmission
34286	Olfaction Disorders
34287	Neuroaminidase
34288	SARS COVID-19
34289	Quarantined class
34290	public health dentistry
34291	Anestesia peridural
34292	Anestesia regional
34293	Epidural anesthesia
34294	Raquianestesia
34295	Regional anesthesia
34296	Spinal anesthesia
34297	Multisectoral response
34298	additive manufacturing/3D printing
34299	material biocompatibility
34300	technical considerations
34301	Surgical kits
34302	Surgical simulation
34303	Take-home simulation
34304	mobile radiography
34305	segregation
34306	Downsizing
34307	Prisoner health
34308	RNR model
34309	Digestive disorders
34310	Diabetic foot
34311	COVID-19, Infection control
34312	local transmission
34313	Confidentiality
34314	Diarrea
34315	Síntomas gastrointestinales
34316	Transmisión fecal-oral
34317	Activity Analysis
34318	Lockdown Coronavirus
34319	Occupational Science
34320	Occupational Therapy
34321	Occupations
34322	Hand injuries
34323	Mental health professionals
34324	prehospital/EMS
34325	substance misuse
34326	Care of patients
34327	Duhok
34328	Lockdown system
34329	Parameters
34330	Sustainable
34331	Neuraxial anesthesia
34332	Peripheral nerve block
34333	Knowledge, attitude and practice
34334	PPCI
34335	Tracheostomy care
34336	epidemiologists
34337	medical anthropologists
34338	second wave of infection
34339	intensivists
34340	social and electronic media
34341	special topics
34342	surgical quality
34343	n95
34344	appropriate use
34345	Ambient relative humidity
34346	COVID-19 droplets
34347	Droplet lifetime
34348	Social science
34349	dry powder-inhalers
34350	metered-dose inhalers
34351	nebulizers
34352	soft-mist inhalers
34353	Standard operating protocol
34354	FFP3
34355	costs and cost analysis
34356	Accident
34357	Air carrier's
34358	Carrier's liability
34359	Exoneration
34360	Period of liability
34361	Safety of passengers
34362	Transmission of COVID-19
34363	random forest model
34364	transmission wave
34365	chest compressions
34366	Response plans
34367	Strategic management
34368	Endoscopic Vessel Harvesting
34369	Bifurcation analysis
34370	Model-based control
34371	Nonlinear incidence rate
34372	Sliding mode control
34373	Dromedary camel
34374	Predictive modelling and simulation
34375	Time varying disease transmission rate
34376	LAMPOON
34377	structural heart interventions
34378	teleproctoring
34379	transcatheter mitral valve replacement (TMVR)
34380	Practice guidelines as topic
34381	Endoscopic endonasal skull base surgery
34382	Nose lid
34383	Transnasal surgery
34384	Service value chain
34385	Supply chain management
34386	Theory of constraints
34387	Climatic influence
34388	Geographical factors
34389	COM-B
34390	hygienic practices
34391	Hypochlorhydria
34392	pre-admission pathway
34393	restoration
34394	football
34395	clinical symptom
34396	naso‐pharyngeal discharge: sinusitis
34397	gloves use
34398	hands
34399	Aerosol-generating Procedure
34400	Endodontic Emergencies
34401	Long-term Calcium Hydroxide
34402	Instability
34403	Population safety
34404	oculoplastic training
34405	operating room safety
34406	Carers
34407	Independent living
34408	Medication review
34409	Medicines management
34410	Immunosupression
34411	Merocel
34412	surgicel
34413	Motilidad
34414	Neurogastroenterology
34415	Neurogastroenterología
34416	pH study
34417	pHmetría
34418	Sustainable waste management
34419	Aggression
34420	Farmworkers
34421	h-2A program
34422	Adjustment
34423	linear regression model
34424	perception-based questionnaire
34425	principal component analysis (PCA)
34426	social conflict
34427	safety checklist
34428	developing
34429	Covid-19 outbreak
34430	Dental professionals
34431	Impact on dentistry
34432	Acanthamoeba
34433	amoebae
34434	DPSIR
34435	Ecosystem services
34436	Regeneration
34437	Socio-Ecological systems
34438	Water security
34439	Health care worker-patient transmision
34440	Otorhinolaryngological surgical procedures
34441	SARS corona virus
34442	Internal migrants
34443	Worker
34444	nasolacrimal drainage
34445	routes of transmission
34446	Telemedicine distance learning
34447	Faecal virus shedding
34448	Feline coronavirus (FCoV)
34449	Itraconazole
34450	Mutian X pills
34451	Cost-effective intervention
34452	Discrete mathematical model
34453	Multi-regions
34454	drain removal
34455	home health
34456	infographics
34457	socio-economic development
34458	mask design
34459	A bit of fun
34460	Tongue in cheek submission
34461	Weed
34462	eucharist
34463	health public
34464	holly communion
34465	social science methods
34466	Academy of Family Physicians of India
34467	COVID 19 in India
34468	Heterogenous-mixing patterns
34469	Susceptible-infected-recovery model
34470	Cost-Benefit Analysis
34471	Demand for care
34472	Health financing
34473	Health sector reforms
34474	virucidal activity
34475	Crowd model
34476	Occupant exposure
34477	People movement
34478	bulk
34479	feed
34480	ingredient
34481	foodborne pathogens
34482	smart materials
34483	portability
34484	AV glove material properties
34485	Anti-vibration gloves
34486	manual dexterity
34487	vibration transmissibility
34488	hand disinfectants
34489	Finite elements
34490	Particle methods
34491	fuzzy logic systems
34492	healthcare robotics
34493	wall disinfection
34494	wall following
34495	Information systems
34496	Market networks
34497	Hcps
34498	Psychological parameters
34499	Work-safety
34500	Homeless person with mental illness
34501	Mental illness
34502	anatase single crystals
34503	competitive growth
34504	pp-MOCVD
34505	process-induced nanostructures
34506	General physician and Primary Health Center
34507	CIRDC
34508	Hospital association
34509	Neurotology
34510	Personal
34511	Protective
34512	Health Personnel
34513	Noise
34514	Protective Devices
34515	hot environment
34516	personal cooling garment
34517	gamified
34518	facemask shortage
34519	n-95 mask
34520	n95 mask
34521	COVID-19 negative
34522	Care escalation
34523	personal protective gears
34524	Head Covering
34525	Lung Sounds
34526	2019‐nCoV
34527	atopic eczema
34528	cross-sectional interventional radiology
34529	Teleradiology
34530	burial dead body
34531	severe acute respiratory syndrome CoV-2
34532	code blue
34533	residency programs
34534	Intensive Care Medicine
34535	Occupational Disease
34536	ADN, Associate Degree in Nursing
34537	BSN, Bachelor of Science in Nursing
34538	CAN, Certified Nursing Assistant
34539	GAD-7, Generalized Anxiety Disorder-7
34540	Guilan
34541	LPN, Licensed Practical Nurse
34542	MSN, Master of Science in Nursing
34543	OR, Odds Ratio
34544	PHQ-9, Patient Health Questionnaire-9
34545	RN, Registered Nurse
34546	SD, Standard Deviation
34547	FDA regulations
34548	local fabrication
34549	maker communities
34550	regulatory science
34551	gynaecology
34552	national health service
34553	women's health care
34554	Outpatient practice
34555	nutrition ECMO
34556	nutrition support teams
34557	facial protection
34558	Clinical Pharmacists
34559	Hospital Pharmacy Services
34560	Pediatric neuropsychology
34561	flexible
34562	in-office
34563	regional anaesthesia
34564	Aluminum
34565	Foreign body
34566	catheterization diagnostic
34567	coronary dissection
34568	endobronchial ultrasonography
34569	interventional bronchoscopy
34570	Video-based education
34571	Health Facilities
34572	interventional devices/innovation
34573	robot assisted
34574	Frontline healthcare workers
34575	Vapotherm
34576	nasal insufflation
34577	patient control
34578	Fuzzy Goal Programming
34579	Reverse supply chain
34580	Crisis resource managment
34581	System integration
34582	thoracic surgical procedures
34583	Breast care recommendations
34584	Priority categories
34585	Medical device innovation
34586	Filter paper mask
34587	Folium Plectranthii amboinicii
34588	mask shortage
34589	Visual acuity
34590	CKD (chronic kidney disease)
34591	Cross-sectional survey
34592	Enterprises
34593	Health and safety at work
34594	Health and safety service
34595	Surgical performance
34596	Surgical wellbeing
34597	administration and management
34598	disaster behavioral health
34599	stroke unit
34600	CBT
34601	Cognitive-behavioral interventions
34602	Frontline professionals
34603	Hospital preparedness
34604	In situ simulation
34605	Latent safety threats
34606	Multidisciplinary teams
34607	Safety I
34608	Safety II
34609	isolation rooms
34610	portable radiography
34611	elective surgical procedures
34612	JAMTT-HCC
34613	hepatocellular carcinoma liver dysfunction
34614	Robotics
34615	echocardiography services
34616	home dialysis
34617	Mobile Radiography
34618	IFCC recommendation
34619	laboratory professionals
34620	Face shields
34621	doffing
34622	donning
34623	COVID-19, personal protective equipment, middle ear, mastoid
34624	Corona Virus Disease 19, COVID-19
34625	Healthcare Personnel, HCP
34626	Personal Protective Equipment, PPE
34627	World Health Organization, WHO
34628	Diseases/processes
34629	Gated SPECT
34630	Modalities
34631	Myocardial blood flow
34632	Myocardial ischemia and infarction
34633	Physiology of myocardial/coronary perfusion
34634	Vasodilators
34635	Advanced cardiac life support
34636	Arrest, cardiopulmonary
34637	Heart arrest
34638	Health Systems
34639	Informatics
34640	minimal intervention dentistry
34641	Departments
34642	body fluids
34643	Covid – 19
34644	Dermatitis
34645	minimal access surgery
34646	consumer-directed services
34647	E. coli
34648	TiO2
34649	electron spin resonance
34650	nanowires
34651	photocatalysis
34652	Filtering Facepiece Respirator
34653	claims and litigation
34654	ethics in patient care
34655	legal
34656	          COVID-19        
34657	          nursing homes        
34658	          older people        
34659	          pandemic        
34660	health facility management
34661	orbit
34662	visor
34663	KN95 masks
34664	filtering face piece (FFP) respirator
34665	mask frames
34666	prototyping
34667	teleconsent
34668	communicable disease
34669	hazard control
34670	downside for the wearer – overheating
34671	safety measure
34672	biohazard containment
34673	particle count
34674	N95 mask respirator
34675	fit test
34676	FFP
34677	FPP
34678	Filtering facepiece respirator
34679	Reciclaje
34680	Brexit
34681	EU
34682	cross border healthcare
34683	FFP2/3
34684	Face scanning
34685	Reusable face mask
34686	Respiratory compliance
34687	Chronic myelogenous leukemia
34688	Febrile neutropenia
34689	Argatroban
34690	Heparin-induced thrombocytopenia
34691	Respiratory physiology
34692	Protective ventilation
34693	SARS-coV2
34694	DNAse 1
34695	Neutrophil extracellular trap
34696	dornase alfa
34697	Bordetella pertussis
34698	Hyperleukocytosis
34699	Leukapheresis
34700	Pulmonary hypertension
34701	Almitrine Bismesylate
34702	Inhaled nitric oxide
34703	Mthylene blue
34704	Reactive nitrogen species
34705	Necroptosis
34706	Receptor-interacting kinase 3
34707	immune modulation therapy
34708	dyspnoea
34709	Novel Coronavirus Disease 2019
34710	Pulmonary perfusion
34711	Thoracic Imaging
34712	knowledge management
34713	nursing methodology research
34714	standardized nursing terminology
34715	ST-segment elevation
34716	hematology-oncology
34717	limb ischemia
34718	multicentre clinical trial
34719	Depersonalization
34720	Exhaustion
34721	Postintubation dysphagia
34722	Narcolepsy
34723	Sleepiness
34724	sevoflurane
34725	volatile anaesthetic
34726	Acute Respiratory Distress Syndrome [ARDS]
34727	Bilevel positive airway pressure
34728	Continuous positive airways pressure [CPAP]
34729	vv ecmo
34730	warfarin
34731	aviation medicine
34732	hypocapnia
34733	hypocapnic hypoxia
34734	continuous airway pressure ventilation
34735	noninvasive mechanical ventilation
34736	COVID-19 associated invasive pulmonary aspergillosis
34737	invasive pulmonary aspergillosis
34738	multi-triazole resistance
34739	mechanical vent
34740	Massive pulmonary embolism
34741	major depressive disorder
34742	myalgic encephalomyelitis
34743	Canulation
34744	Criteria
34745	Driving pressure
34746	Tidal hyperinflation
34747	Transpulmonary pressure
34748	Popliteal
34749	Replacement
34750	Severe respiratory distress
34751	physiotherapy (rehabilitation)
34752	laryngo-tracheal stenosis
34753	tracheal surgery
34754	elderly patient population
34755	hospital patients
34756	nursing home patients
34757	symptom relief
34758	COVID-19, critical care, acute respiratory distress syndrome, mechanical ventilation
34759	Facial
34760	Pressure ulcers
34761	surgical tracheostomy
34762	medical devices and technologies
34763	nursing and nursing systems
34764	patient handling
34765	respiratory distress syndrome, adult
34766	systemic inflammatory response syndrome
34767	Prone Position
34768	disposition
34769	emergency medicine practice
34770	acute hypoxemic respiratory failure
34771	ipf
34772	dermatological findings
34773	Machine learning (ML)
34774	SOPA
34775	suspected COVID-19 symptoms
34776	Community mental health and covid-19
34777	Mental and physical comorbidities and covid-19
34778	Telehealth guidelines
34779	Dysphonia
34780	Findings
34781	orthopedic oncology
34782	preoperative assessment
34783	Gluten-free diet
34784	coronary thrombosis
34785	Clinical frailty scale
34786	digestive symptoms
34787	hepatic abnormalities
34788	Drive-up service
34789	Low resource setting
34790	thoracic
34791	implicit bias
34792	menopause
34793	perimenopause
34794	Eating behavior
34795	In-patient treatment
34796	psychiatric intensive care unit
34797	clinical psychology
34798	post-traumatic stress
34799	Bergamo
34800	Pre-gestational diabetes
34801	AIGkit application
34802	AIM
34803	advice from scientific societies
34804	neck circumference
34805	Anxiety disorders
34806	coexposures
34807	telemedicine COVID-19
34808	acute necrotizing encephalitis
34809	morphology
34810	Blindness
34811	Diabetic retinopathy
34812	Healthcare integration
34813	MERs
34814	occupational health nurses
34815	Camelus dromedarius
34816	natural infection
34817	Physical Function
34818	Chest diseases
34819	Inception-V3
34820	ResNet-152
34821	announcement duty
34822	compulsory secret
34823	medical confidentiality
34824	combined features
34825	Dyslipidemia
34826	Metabolic disease
34827	HAI
34828	Extracorporeal Life Support
34829	Indication
34830	Substance use disorder (SUD)
34831	Trauma-informed care
34832	Cachexia
34833	Medication-Assisted Treatment
34834	Respiratory Compromise
34835	underlying conditions
34836	vector-borne infections
34837	Dependence
34838	bereavement care
34839	cognitive behavior therapy
34840	COVID-19 airway management
34841	Coronavirus airway management
34842	Emergency airway management
34843	In-hospital airway management
34844	Academic Psychiatry
34845	Consultation-Liaison
34846	Inpatient Psychiatry
34847	Vasoconstriction
34848	Vasoplegia
34849	Ventilation-perfusion ratio
34850	Medical training/education
34851	Urologic practice
34852	Neuroendocrine tumour
34853	Parathyroid
34854	Pademia
34855	Resource
34856	radiology (diagnostics)
34857	Eating Disorders
34858	Suicide and Self-Harm
34859	Violence/Aggression
34860	Homeopathy
34861	Laws
34862	ClotPro®
34863	fibrinolysis “shut down”
34864	fibrinolysis „shut down”
34865	hypercoagulatio
34866	hypercoagulation
34867	thromboembolic complication
34868	thromboemboliás szövődmények
34869	Acute arterial thrombosis
34870	capillary leak
34871	systemic capillary leak syndrome
34872	Mining
34873	process assessment
34874	systems development
34875	Chronic pain
34876	service reconfiguration
34877	pharmacist consult
34878	countertransference
34879	dissociation
34880	frame
34881	teleanalysis
34882	transference
34883	Homeless Mentally Ill
34884	pain, postoperative
34885	egypt
34886	operating rooms
34887	pfa
34888	pfa efficacy
34889	pfa models
34890	pfa training
34891	psychological first aid
34892	rapid
34893	Novel coronavirus (COVID 19)
34894	preventive health care
34895	Artificial neural network
34896	Capsule networks
34897	Chest x-ray images
34898	Biopsy
34899	Head and Neck Neoplasms
34900	Mouth Neoplasms
34901	Registries
34902	Rheumatic Diseases
34903	Measles
34904	Acute respiratory insufficiency
34905	Controlled mechanical ventilation
34906	Insuficiencia respiratoria aguda
34907	Lung simulators
34908	Simuladores de pulmón
34909	Ventilación mecánica controlada
34910	Price of life
34911	Valuation
34912	negative pressure hood
34913	negative pressure rooms
34914	negative pressure tent
34915	stryker neptune
34916	vacuum assisted negative pressure isolation hood
34917	vanish system
34918	wall suction
34919	Convolutional Neural Networks
34920	Coronavirus Deep Learning
34921	Medical Image Analysis
34922	Pulmonary Imaging
34923	Middle eastern respiratory syndrome coronavirus (MERS-CoV)
34924	IR-UWB radar
34925	fall detection
34926	motion detection
34927	respiration rate
34928	sleep monitoring
34929	vital signs
34930	bovine viral diarrhea virus
34931	dual infection
34932	consultation
34933	drug eruption
34934	hospitalized patient
34935	Lima
34936	SOP
34937	caring
34938	Radiation protection
34939	orthopedic surgery
34940	Multivariate regression analysis
34941	fulminant myocarditis
34942	Environmental medicine
34943	Early release
34944	Mass incarceration
34945	Coronavirus detection
34946	Discovery
34947	Islamic Republic of Iran
34948	magnetic nanoparticles
34949	sensing
34950	Radical prostatectomy
34951	Same-day discharge
34952	Biofortification
34953	multiplex respiratory pathogen testing
34954	psychophysical olfactory evaluation
34955	Olfactory Dysfunction Recovery
34956	smart work
34957	individual lineage
34958	injuries
34959	Asymptomatic disease
34960	Cruise ship
34961	Early bronchiectasis
34962	PET-CT
34963	Pseudo-tumoral
34964	Spine trauma
34965	Vertebral fracture
34966	limbic system
34967	Erlang distribution
34968	Nasal
34969	Sudden olfactory loss
34970	Community participation
34971	Post-COVID-19
34972	Surgery cancellation
34973	Sars
34974	Endoscope
34975	Mannequin
34976	Rhinopharyngeal swab
34977	Neuroradiological lesions
34978	Swabbing
34979	Cellular automaton
34980	Contagious disease
34981	Genetic algorithm
34982	Epidemiological models
34983	resource distribution
34984	Medical journalism
34985	emotional response
34986	PJP
34987	Geospatial data
34988	HIV service
34989	South Carolina
34990	counties
34991	behavioural science
34992	socio-economic
34993	Transgender people
34994	Particulate matter (PM)
34995	Rohingya refugee
34996	Water, sanitation, and hygiene (WASH)
34997	PCP
34998	opportunistic infections
34999	social reproduction
35000	infection and infectious agents - viral: hepatitis C
35001	infection and infectious agents - viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
35002	Hepatitis B virus
35003	HIVAN
35004	Hantavirus
35005	Viral nephropathy
35006	microplastics
35007	musculoskeletal risks
35008	patents
35009	wastewater treatment
35010	Pneumocystis Carinii Pneumonia
35011	Chemo-radiotherapy
35012	Oral cavity
35013	Squamous cell carcinoma
35014	PD-L1 inhibitors
35015	Nmosd
35016	prostatic neoplasms
35017	acute chest pain
35018	diaphragmatic rupture
35019	gastric perforation
35020	COVID-19 related pneumonia
35021	Non-diabetic patients
35022	SGLT2-inhibitors
35023	Coronary
35024	Novel COVID-19-infected pneumonia
35025	Mesenchymal stem cells coronavirus
35026	adipose-derived stem cells coronavirus
35027	cellular therapy COVID-19
35028	mesenchymal stem cells COVID-19
35029	stem cell therapy COVID-19
35030	ct
35031	emphysema
35032	lung adenocarcinoma
35033	CTA neck
35034	Incidental lung disease
35035	LVEF, left ventricle ejection fraction calculated by Simpson’s biplane method
35036	left ventricle thrombus
35037	siadh
35038	Loculated pneumothorax
35039	CT and X-ray images
35040	Computer-aided diagnosis
35041	coronavirus automatic detection
35042	3D in Covid19
35043	3D lung reconstructions
35044	3D modeling in pneumonia
35045	3D parenchima reconstruction
35046	3D quantify in pneumonia
35047	3D rendering in pneumonia
35048	immunosuppressive regimens - maintenance
35049	COVID-19 Polymerase chain reaction testing
35050	COVID-19 gastrointestinal symptoms
35051	CT abdomen in COVID-19 patients
35052	Sensitivity of CT in COVID-19 patients' detection
35053	Patient outcome assessment
35054	Structured reporting
35055	InceptioNetV3
35056	NASNetlarge
35057	automatic detections
35058	chest X-ray images
35059	detection of COVID-19
35060	Radiography, thoracic
35061	point‐of‐care ultrasound
35062	cladribine
35063	duodenal perforation
35064	CO-RADS
35065	Renal infarct
35066	Spontaneous echo contrast
35067	ct-ss
35068	hrct chest
35069	Cutaneous Manifestations
35070	CT Abdomen
35071	neutrophil lymphocyte ratio
35072	peripheral blood
35073	platelet lymphocyte ratio
35074	systemic inflammatory index
35075	agranulocytosis
35076	Aspiration thrombectomy
35077	Catheter directed therapy
35078	Right heart strain
35079	Right ventricle dysfunction
35080	Trinidad & Tobago
35081	adult cardiac surgery
35082	acute limb ischemia (ALI)
35083	hypercoagulable states
35084	pneumonia/infections
35085	generalized additive model
35086	Iatrogenic pneumothorax
35087	Thoracoscopy
35088	Pulmonary abscess
35089	extrapulmonary
35090	intracerebral haemorrhage
35091	involvement
35092	Contrast-enhanced CT
35093	infiltrative shadow
35094	chronic myelomonocytic leukaemia
35095	Coated endotracheal tubes
35096	Endotracheal tube design
35097	VAP
35098	Pneumoniae
35099	Postmortem computed tomography
35100	Postmortem lung biopsy
35101	organizing pneumonia
35102	pulmonary infiltration
35103	subadventitial hematoma
35104	CoVID-19 pneumonia
35105	Italian epidemic
35106	Acutely altered mental status
35107	Multiple strokes
35108	Computed tomograpy
35109	Subarachnoidal hemorrhage
35110	LUS
35111	LUS score
35112	lung ultrasound score
35113	veno-venous ECMO
35114	Immunosuppressant
35115	Systemic treatment
35116	Human immunodeficiency virus
35117	Low dose radiation
35118	Radiation Physics
35119	Chronic lung diseases
35120	Calf pneumonia
35121	Multiplex qPCR
35122	Capsule network
35123	VDSNet
35124	VGG
35125	Vanilla NN
35126	COVID-19 Mpr°
35127	Cantharidin
35128	Medicinal chemistry
35129	Molecular docking studies
35130	Norcantharidin
35131	Norcantharimide
35132	SARS – CoV
35133	Olfactory cleft
35134	computed tomography scan
35135	Atypical
35136	Indian
35137	neuroepithelium
35138	facial pain
35139	headache disorders, secondary
35140	migraine disorders
35141	new daily persistent headache
35142	xerostomia
35143	Neuropsychiatric
35144	population prevalence
35145	Disfunción olfatoria posviral
35146	RAND/UCLA
35147	loss of sense of smell
35148	olfactory training
35149	letter
35150	dysosmia
35151	postviral olfactory dysfunction
35152	Reinfections
35153	KAP
35154	Antidiabetic agents
35155	Corona virus infectious disease
35156	Adolescent diabetes mellitus
35157	Nurse-led
35158	Dipeptidyl peptidase-4 enzyme
35159	Glucagon-like peptide analogues
35160	Sodium-glucose cotransporter 2 inhibitors
35161	Standalone continuous glucose monitoring
35162	Calcium-related disorders
35163	Cushing’s syndrome
35164	Endocrine disorders
35165	Pituitary tumors
35166	Primary adrenal insufficiency
35167	Coronavirus infectious Disease 2019 (COVID-19)
35168	pre-infection glycemic control
35169	Service development
35170	Endocrine disease
35171	Thyroid disease
35172	Electronic health record
35173	Fasting
35174	Flash glucose monitoring
35175	Paraclinical doctors
35176	Hormone bioassays < Research and Analysis Methods
35177	Respiratory tract < Pathogenesis
35178	cannabidiol
35179	food and drug administration
35180	cholestasis
35181	SARV-2 Cov
35182	Industry-4.0
35183	Retail industry
35184	Teledentistry
35185	Learning Behaviors
35186	Mental Wellbeing
35187	hyposalivation
35188	taste disturbances
35189	hemoglobin A1c testing
35190	Cognitive disorders
35191	Dysexecutive syndrome
35192	nutritional sciences
35193	A1c
35194	Self-monitoring of blood glucose
35195	closed-loop systems
35196	diabetes education
35197	virtual training
35198	angiotensin-converting enzyme inhibitors (ACE-I)
35199	dipeptidyl peptidase 4 inhibitors (DPP4i)
35200	Artery
35201	Occlusion
35202	Radial
35203	metabolic
35204	molecular imaging
35205	Body positioning
35206	Oxygen saturation
35207	Cardiovascular Outcomes
35208	Glucose Variability
35209	diabetic foot ulceration
35210	fast-track
35211	limb salvage
35212	Gut dysbiosis
35213	Country-wise analysis
35214	Life expectancy: Pandemic
35215	Diabetic
35216	Inflammatory skin conditions
35217	do-it-yourself artificial pancreas
35218	smart telemedicine
35219	ABCD scoring System
35220	Self assessment score
35221	Severity score
35222	Fatigue
35223	Post-viral
35224	Sratified analysis
35225	hyperlipidemia
35226	Myocardial ischaemia
35227	Stress T1
35228	quality indicators, healthcare
35229	patient-centered
35230	questionnaires
35231	Visual quantification
35232	interpretable artificial intelligence
35233	disease ecology
35234	epizootic
35235	Flow Cytometry
35236	stressor
35237	planetary
35238	social transformation
35239	clinical implications
35240	physical and mental pathologies
35241	Burn out
35242	DASS 21
35243	Decision making under uncertainty
35244	Diffusion models
35245	Scenario thinking
35246	pathology department
35247	myasthenia
35248	Electronic Health Record
35249	Health informatics
35250	Head neck cancer
35251	attentional bias
35252	cancer survivors
35253	catastrophic thinking about Covid-19 pandemic
35254	health anxiety
35255	adolescent cancer
35256	information needs
35257	young adult cancer
35258	OSCC
35259	urologic neoplasms
35260	urologic surgical procedures
35261	chemotherapy adherence
35262	cryptococcosis
35263	cryptococcus neoformans
35264	opportunistic infection
35265	Coping resources
35266	Health services utilization
35267	Perceived susceptibility
35268	minimal-access surgery
35269	endocrine therapy
35270	luminal
35271	neoadjuvant
35272	Head And Neck Neoplasms
35273	Laryngopharyngeal Reflux
35274	Retrospective Studies
35275	Adjuvant therapy
35276	Treatment of metastatic disease
35277	Gastric
35278	Hepato-Pancreato-Biliary
35279	Oesophageal
35280	Diagnostic Imaging
35281	Squamous Cell Carcinoma Of Head And Neck
35282	Thyroid Neoplasms
35283	Thyroid Nodule
35284	management.
35285	Vaginal cancer
35286	reconstruction
35287	Ground glass
35288	Peripheral distribution
35289	COVID‐19 lockdown
35290	Sri Lanka intervention
35291	mindfulness therapy
35292	oral cancer survivors
35293	over‐the‐phone
35294	patient online access
35295	double-lumen tube placement
35296	lung isolation
35297	Hematology tumor
35298	Solid tumor
35299	Obturator prosthesis
35300	Oesophageal Cancer
35301	Oesophagectomy
35302	neurological oncology
35303	Cancer management
35304	Gynecologic cancer
35305	Gynecologic neoplasms
35306	Away rotations
35307	Match
35308	Residency applications
35309	ethical considerations
35310	RTT
35311	Coping motives
35312	Psycho-Oncology
35313	survey methodology
35314	leukemia
35315	treatment guideline
35316	multidisciplinary treatment
35317	brachytherapy
35318	cervix
35319	HDR fractionation
35320	cervical cancer radiotherapy
35321	multi-disciplinary team
35322	patient's pathway
35323	smoke evacuation device
35324	smoke in surgery
35325	clinical decisions
35326	cultural issues
35327	Surgical priority
35328	Surgical scheduling
35329	cancer diagnosis
35330	cancer prognosis
35331	cancer screening
35332	Hi-tech
35333	Hypofractionated radiotherapy
35334	SBRT
35335	Cancer center collaboration
35336	Cancer management workflow
35337	Developing country
35338	Strategic action plan
35339	incidental cancer diagnosis
35340	missed cancer diagnosis
35341	Oncology research
35342	online training
35343	surgical learning
35344	Blood camp
35345	Blood drive
35346	Time to surgery
35347	psychooncology
35348	healthcare staff
35349	post-traumatic stress symptoms
35350	recovery phase
35351	axillary staging
35352	neo-adjuvant chemotherapy
35353	sentinel lymph node biopsy
35354	multigene assays
35355	neoadjuvant endocrine therapy
35356	remote working
35357	Clinical pathways
35358	Neoadjuvant chemotherapy
35359	Upfront surgery
35360	gynaecological cancers
35361	Image guided prostate biopsy
35362	Treatment delay
35363	Chronic myeloproliferative neoplasms
35364	SARS-CoV2 pandemic
35365	caregivers, COVID-19
35366	healthcare transformation
35367	gastrointestinal surgery
35368	gastrointestinal tumor
35369	Monoclonal Gammopathy of Undetermined Significance
35370	Multiple Myeloma
35371	disaster psychiatry
35372	Telephone triage
35373	Antiemetic
35374	Surgical volume
35375	Laser therapy
35376	Oral mucositis
35377	Photobiomodulation therapy
35378	Philippine General Hospital
35379	HRQoL
35380	sarcomas
35381	Coloproctology
35382	Coloproctología
35383	Cáncer colorrectal
35384	Pelvic floor, COVID-19
35385	Proctología
35386	Suelo pélvico
35387	clinics
35388	Oncology clinical trials
35389	Fractionation Index (FI)
35390	Análisis factorial
35391	Confiabilidad
35392	Factor analysis
35393	Preocupación por enfermar
35394	Sickness concern
35395	Unidimensionalidad
35396	Unidimensionality
35397	Operating room hazards
35398	Surgical diathermy
35399	Surgical plume
35400	Existential
35401	WhatsApp messenger
35402	action taken
35403	medical oncologists
35404	reactions
35405	sentimental analysis
35406	lipid droplets
35407	membrane subversion
35408	phosphatidic acid
35409	image processing, computer-assisted
35410	Breaking bad news
35411	HADS
35412	exhantem
35413	skin rash
35414	PCSM
35415	uroonc
35416	Caregiver
35417	Childhood cancer
35418	Childhood cancer survivors
35419	Pediatric Psycho-oncology
35420	immune checkpoint inhibitor
35421	immune-related colitis
35422	MeNTS
35423	surgical prioritization
35424	Intensive Care Unit (ICU)
35425	breast unit
35426	cancer-related distress
35427	belonging
35428	Integration
35429	MQSA compliance
35430	mammography
35431	sickle cell anemia
35432	vaso-occlusive crisis
35433	curve
35434	cardiothoracic surgery
35435	decision-making capacity
35436	serious mental illness
35437	Non-COVID
35438	Surgical emergency
35439	Breast radiotherapy
35440	cancer therapy
35441	dose adjustement
35442	drug-to-drug interaction
35443	telepathology
35444	MRD
35445	molecular genetics
35446	molecular haematology
35447	Endoscopy, Broncho-Esophagology, laryngology, computational modeling, simulation of surgery of the paranasal sinuses, clinical, allergy/rhinology
35448	Oncotype DX
35449	Recurrence Score result
35450	core needle biopsy
35451	Sitting
35452	Virtual Interviews
35453	Pancreatic tumors
35454	qualitative survey
35455	Peptide receptors radionuclide therapy
35456	phone
35457	IR/DR Residency
35458	cotinine
35459	cut-off value
35460	digital pathology
35461	(18)F-FDG PET/CT
35462	Combined compensation
35463	PSF
35464	Partial volume effect
35465	Quantification
35466	Reconstruction algorithm
35467	Respiratory motion
35468	TOF
35469	Cancer care facilities
35470	Air-liquid interface (ALI)
35471	Cell senescence
35472	Conditional reprogramming
35473	Functional models
35474	Normal cells
35475	Physiological conditions
35476	medical
35477	Chaplain
35478	Spiritual care
35479	Telechaplaincy
35480	localizer radiograph
35481	water equivalent diameter
35482	Live interactive
35483	Store and forward
35484	Survey methods
35485	Digital Microscopy
35486	Haematology PostGraduate Education
35487	Cavilon
35488	DuoDERM
35489	Mepitac
35490	fit testing
35491	hydrocolloid bandages
35492	skin protectants
35493	skin protective dressings
35494	Conventional PET
35495	Digital PET
35496	EARL-accreditation
35497	Myelodysplastic syndromes
35498	hemoglobin threshold
35499	education and training
35500	young adult
35501	Service utilisation
35502	biological disaster
35503	telecounseling
35504	Sense of coherence
35505	Education and training
35506	online psychological treatment
35507	practitioners' experiences
35508	teletherapy
35509	Pandemic Impact
35510	Right to mental health
35511	trauma-informed care
35512	Neural taxonomies
35513	Precision psychiatry
35514	Social connection
35515	trauma and stress-related disorders
35516	Alberta
35517	Text4Hope
35518	text messages
35519	Lockdonw
35520	Mental health & wellbeing
35521	Financial stress
35522	Gambling motives
35523	Online gambling
35524	Mental distress
35525	benefit system reform
35526	social disadvantage
35527	universal basic income
35528	threat
35529	funerals
35530	posttraumatic stress symptoms
35531	Intervenciones psicosociales
35532	Psychosocial interventions
35533	Salud mental
35534	general adult psychiatry
35535	service development
35536	coping response
35537	psychosocial response
35538	Depression, anxiety, stress symptoms
35539	Descriptive survey study
35540	Positive mental health
35541	Health Professionals
35542	Coronavirus Outbreak
35543	Psychological Crisis Intervention
35544	Psychosocial Aspects
35545	Public Mental Health Crisis
35546	Mental health ethical issues
35547	Digital therapy
35548	Psychological interventions
35549	acute stress
35550	digital psychiatry
35551	mhealth
35552	Mental health help line
35553	Tertiary care
35554	prescription drug misuse
35555	Services
35556	Young people
35557	Biopsychosocial model
35558	Evidence-based psychiatry
35559	COVID pandemic
35560	mental health concerns
35561	Chronic medical conditions
35562	Quality of health care
35563	call to action
35564	data insights
35565	due diligence
35566	quality of sleep
35567	Satellite clinic
35568	information technologies
35569	social deprivation
35570	social functioning
35571	medical student mental health
35572	medical student mental health supportive strategies
35573	Fear of COVID-19
35574	Mental wellbeing
35575	Rumination
35576	text
35577	COVID‐19 (coronavirus)
35578	counselling psychologist
35579	gendered impact
35580	graduate nursing education program planning and development
35581	Comportement
35582	Health locus of control
35583	Signal detection theory
35584	Administrative database
35585	Emergency service
35586	Person-centered care
35587	Community mental health services
35588	Learning organization
35589	Community mental health teams
35590	cost-effectiveness
35591	out-patient treatment
35592	gambling
35593	fear of coronavirus
35594	organisational support
35595	Interactive learning environments
35596	Low mood
35597	midwifery students
35598	economic hardship
35599	dermatologists
35600	nondermatologists
35601	Psychiatric repercussions
35602	clerkships
35603	COVID-19 pandemic outbreak
35604	Community-dwellers
35605	Health proffesionals
35606	Insomnio
35607	Psychological suffering
35608	Intellectual Disabilities
35609	Mental Health Care/Service Delivery Systems
35610	Neurodevelopmental Disorders
35611	IAPT
35612	cognitive behavioural therapy
35613	disaster response
35614	Incomplete grief
35615	psychological effect
35616	Posttraumatic stress
35617	obsessive–compulsive disorder
35618	Camus
35619	Existentialism
35620	The Plague
35621	suicide risk
35622	Bipolar Disorder
35623	and Adjunctive Therapies
35624	Battery exhaustion
35625	changes
35626	forensic mental health assessment
35627	Latent profile analysis
35628	War
35629	suicide rate
35630	Myomectomy
35631	organizations
35632	Community Mental Health
35633	Moral Injury
35634	Longitudinal Change
35635	Risk Perception
35636	Economic-anxiety
35637	Financial-anxiety
35638	Health-anxiety
35639	State-anxiety
35640	Racial and Ethnic Minorities
35641	Social Networks
35642	thoughts of suicide or self-harm
35643	symptoms worsening
35644	Confucian ethics
35645	environmental ethics
35646	food ethics
35647	personality
35648	Commentary
35649	Geropsychology
35650	Mattering
35651	Corona virus disease
35652	Interpersonal and Communication Skills
35653	Professionalism
35654	Resident wellness
35655	low and middle-income country
35656	COVID-19 stress
35657	Indian suicides
35658	Press media reporting suicide
35659	Psychological impact & pandemic
35660	modifiable risk factors
35661	career anxiety
35662	depression from COVID-19
35663	Psychiatric emergency centre
35664	Psychological crisis intervention
35665	remote communication
35666	adjustment disorders
35667	anxiety/anxiety disorders
35668	age differences
35669	veterans
35670	Afrontamiento
35671	Estereotipos
35672	Stereotypes
35673	vulnerability factors
35674	medical subspecialties
35675	guided meditation
35676	internet-based intervention
35677	relaxation
35678	Home spaces
35679	Mediterranean climate
35680	Mental and physical well-being
35681	Plant benefits
35682	Vegetable garden
35683	PANDEMIC
35684	PRESENCE
35685	PSYCHOANALYSIS
35686	PSYCHOTHERAPY
35687	REMOTE THERAPY
35688	SCREEN RELATIONS
35689	TECHNOLOGY
35690	Grantparenthood
35691	Social exclusion
35692	Successful ageing
35693	Personal hygiene
35694	Student engagement
35695	metabolic health
35696	psychological techniques
35697	sedentary behaviour
35698	Clinical staff
35699	Music therapy
35700	Support
35701	Accelerated intermittent theta burst stimulation
35702	elder
35703	M-health
35704	Mobile apps
35705	Mobile mental health
35706	Fine needle aspiration
35707	safety devices
35708	News report
35709	cost-sharing
35710	underinsured
35711	uninsured
35712	Stress management
35713	Tele-yoga
35714	Yoga
35715	Job satisfaction
35716	compulsion
35717	mental health law
35718	public health law
35719	virtual community
35720	Anaesthesiologists
35721	corona warriors
35722	front line warriors
35723	front line workers
35724	National economy
35725	Remittance
35726	Unemployment, Bangladesh
35727	topics in practice management
35728	COVID-related psychological distress
35729	Diet-related chronic diseases
35730	Life history theory
35731	Medical anthropology
35732	Comparative Study
35733	Presenteeism
35734	Psyco
35735	journey
35736	steer
35737	skin diseases
35738	aerob glycolysis
35739	mitochondrium
35740	biofortification
35741	jobs to be done theory
35742	potato
35743	sweetpotato
35744	data mining algorithm
35745	informatics system
35746	Social experiment
35747	care coordination
35748	documentation
35749	role of school nurse
35750	standards of practice
35751	elderly and terminally ill
35752	Data protection
35753	Online privacy
35754	Agent-Based Model
35755	Scenario Analysis
35756	Exploratory analysis
35757	diagnostic certainty
35758	report terminology
35759	reporting guidelines
35760	Case-Detection
35761	Face-Mask
35762	Model-Fitting
35763	bisexuality
35764	gonorrhea
35765	labeling
35766	partner notification
35767	self concept
35768	regional models
35769	spatially‐explicit infectious disease models
35770	Location privacy
35771	Searchable encryption
35772	metabolic syndrome (MES)
35773	non-alchoholic fatty liver disease
35774	telehepatology
35775	Hemorrhagic risk
35776	Oral anticoagulation
35777	Liver Failure
35778	Clinical Practice
35779	CVST
35780	Liver abnormality
35781	internal medicine residents
35782	protective gear
35783	Hospital admissions
35784	flare
35785	Faecal calprotectin
35786	Ultrasound bowel sonography
35787	Shielding
35788	Cholangitis
35789	protection procedures
35790	Department management
35791	Capsule endoscopy
35792	Panenteric
35793	HUS, Hemolytic Uremic Syndrome
35794	MMF, Mycophenolate Mofetil
35795	NLR, Neutrophil-Lymphocyte Ratio
35796	Pred, Prednisone
35797	SOT, Solid -Organ Transplant
35798	Tac, Tacrolimus
35799	Renal complications
35800	KRT
35801	COVID-19, pandemic, Coronavirus
35802	diabetic kidney disease
35803	renal damage
35804	neutropenic fever
35805	tumour necrosis factors
35806	Postkidney transplant recipient
35807	Advancing American Kidney Health Initiative
35808	legislation
35809	Renal MRI
35810	CrFK cells
35811	cellular metabolism
35812	glutamine
35813	metabolic profiling
35814	phenotype microarray
35815	canine parvovirus
35816	serotyping
35817	Broilers
35818	Nephropathogenicity
35819	virtual imaging trials
35820	diagnostic accuracy
35821	transthoracic ultrasound
35822	ultrasound artifacts
35823	illness management
35824	Metered Dse inhalers (MDI)
35825	Southwestern American Indian
35826	racial susceptibility
35827	miners
35828	Inception-V3.
35829	Microvessels
35830	Pathological correlation
35831	Perfusion
35832	Contrast-enhanced ultrasound
35833	Shred sign
35834	Lung Function 
35835	Psycho-emotional Stress
35836	lung ultrasonography
35837	Cerebral venous sinus thrombosis
35838	British Society of thoracic Imaging classification (BSTI)
35839	Chest X-rays (CXR)
35840	Convolutional neural network (CNN)
35841	X-Rays
35842	nCOVnet
35843	infected pneumatocele
35844	Physiological dead-space
35845	Ventilatory ratio
35846	Triage decision-making
35847	Trial methodology
35848	cardiopulmonary exercise testing
35849	diagnostic assessment
35850	endemic phase
35851	exhaled breath condensate
35852	one-lung ventilation
35853	pulmonary function tests
35854	pulmonary surgical procedures
35855	acute viral infection
35856	carbonic anhydrase
35857	kinetic model
35858	parametric analysis
35859	thermoheliox
35860	Agreement
35861	fSENC
35862	TGFbeta
35863	Exercise training
35864	Muscle force production
35865	Confidential Information
35866	Disaster Planning
35867	Information Diet
35868	Information Obesity
35869	striae rubrae
35870	fibreoptic intubation
35871	professional and training issues
35872	IFN-I, type I interferon
35873	BCGitis
35874	positive airway pressure
35875	sleep duration
35876	Canadian Thoracic Society
35877	asthma treatment
35878	IgE
35879	acute pulmonary thromboembolism
35880	Pre-screening
35881	Preliminary medical diagnosis
35882	update
35883	Podcast
35884	Study design
35885	medical psychology
35886	patient-doctor communication
35887	Educación médica
35888	Especialidades médicas
35889	Medical specialties
35890	Non-physiological reaction
35891	UV index
35892	References: 10
35893	Severe clinical forms
35894	Emergency Hospital Service
35895	H1N1 Influenza Pandemic
35896	diaspora
35897	sociocultural
35898	trigeminal
35899	Oceanic Ancestry Group
35900	immunisation programs
35901	Bio-invasion
35902	Bio-preparedness
35903	Common home
35904	Sheltering at home
35905	Sheltering in place
35906	War metaphor
35907	Smoking relapse
35908	electronic cigarette
35909	heated tobacco products
35910	vape shop
35911	Current smoking
35912	former smoking
35913	socio-economic status
35914	cessation policies
35915	COVID-19 pandemic measures
35916	Daily life praxis
35917	Sleeping habits
35918	Environmental conditions
35919	People customs
35920	perioperative radiotherapy
35921	rare cancers
35922	Antivirus
35923	Architecture
35924	Post-pandemic
35925	Urbanism
35926	Energy insecurity
35927	Primary healthcare
35928	SARS-Cov2-19
35929	Renewable energy sector
35930	eco-social crisis
35931	policy change
35932	Central pollution control board
35933	Pandemic situation
35934	resident clinic
35935	ugme
35936	Acute Coronary syndrome
35937	Primary PCI.
35938	academic learning in obstetrics and gynecology
35939	on-line learning
35940	sedentary behaviors
35941	Spatial regression
35942	Deglobalisation
35943	Economic shock
35944	Greenhouse gas emissions
35945	inpatient psychiatry
35946	COIVID19
35947	Travellers
35948	respiratory ailments
35949	ammonia
35950	Personal burden
35951	Armed groups
35952	Forest fires
35953	asynchronous
35954	collaborative practice
35955	Energy access
35956	Opportunities
35957	Bargaining
35958	Legitimacy
35959	Nonmarket strategy
35960	Cardiovascular magnetic resonance 
35961	Continuing operations
35962	Courts
35963	Operational continuity
35964	Lightning
35965	Thunderstorm
35966	Interprofessional education (IPE)
35967	Meaningful Discourse and Community of Inquiry
35968	Online Community of Learning
35969	online Education
35970	educational
35971	models
35972	information credibility
35973	mass communication
35974	negative emotions
35975	psychological response
35976	self-protective behaviors
35977	Atmospheric particles
35978	communities of practice
35979	professional identity formation
35980	single women
35981	virtual work
35982	Research impact
35983	Research opportunities
35984	Agility
35985	Lean
35986	Viable supply chain
35987	CHOGM
35988	Commonwealth
35989	Heads of government
35990	Landscape shocks
35991	Window of opportunity
35992	Global cooperation
35993	Psychological bias
35994	Public support
35995	Role of scientists
35996	Indigenous politics
35997	Behaviour change
35998	Deliberative governance
35999	Social mandate
36000	Tourist factors
36001	COVID-19 in Kuwait
36002	Infectious disease modeling
36003	Logistic growth models
36004	Model performance
36005	Parameter identification
36006	hospitalised isolation
36007	self-image
36008	Disposable plastics
36009	Microplastics pollution
36010	Plastic production
36011	Family Caregivers
36012	Memory Loss
36013	Climate finance
36014	Green central banking
36015	Green economic recovery
36016	Field-spectrometer
36017	Hyperspectral remote-sensing
36018	Online assessment
36019	Technology enhanced assessment
36020	Delhi
36021	Pollution reduction
36022	Social inclusion
36023	The Stirling Protocol
36024	Community resilience
36025	Disaster resilience
36026	Niger Delta
36027	Ogoni
36028	Oil
36029	Confinamiento
36030	Contingencia
36031	Contingency
36032	Rehabilitación
36033	Clinical environment
36034	IABP
36035	Pressure volume loop
36036	Software simulation
36037	Acronym
36038	New particle formation
36039	Sub-10 nm aerosol
36040	Urban aerosol
36041	system design
36042	user-centered design
36043	voting
36044	Human-robot interaction
36045	Multi-agent systems
36046	Patient monitoring
36047	Robots in Emergency Care for COVID-19
36048	Robots in therapy
36049	SMEs
36050	Small firms
36051	Acceptance and commitment therapy
36052	Committed action
36053	Mindful action plan
36054	Flu-like epidemics
36055	Pollen induced immune response
36056	Google mobility data
36057	Latent class regression
36058	Non-market valuation
36059	Recreation demand model
36060	health services needs and demand
36061	minority groups/education
36062	nursing faculty
36063	school of nursing
36064	training support/organization
36065	emerging technology
36066	medicine 4.0
36067	society 5.0
36068	Caenorhabditis elegans
36069	neurotoxicology
36070	serotonin
36071	tire wear
36072	clinician-patient relationship
36073	patient/relationship centered skills
36074	Interdisciplinary studies
36075	pandemic resources
36076	research practices
36077	scientific communication
36078	virtual tools
36079	hospital emergency management
36080	women in STEM
36081	Electrostatically charged PVDF nanofiber filter
36082	Facemask/Respirator
36083	Multimodule/multilayer
36084	Nano-aerosol
36085	100 nm
36086	Air filtration
36087	Charged fibers
36088	Electret
36089	Iso-quality factor
36090	Multilayering/multi-modules
36091	Nano-aerosols
36092	PVDF nanofiber filter
36093	Hospital waste
36094	Spatial spillovers
36095	solar energy
36096	AOD, Satellite data
36097	MODIS
36098	Mining, Indian territory
36099	Algae signature
36100	River health
36101	Stream ecological conditions
36102	Turbidity measurement
36103	Inner corruption
36104	Self
36105	Particle number concentration (PNC)
36106	Traffic-related air pollution
36107	Ultrafine particles
36108	Lockdown measures
36109	Traffic emission reduction
36110	Bacteria/virus inactivation
36111	Membrane filter
36112	Rose Bengal
36113	Singlet oxygen
36114	City
36115	Indoor air filtration
36116	Nano-and microparticles retention
36117	Energy transitions
36118	Just transitions
36119	Socio-economics
36120	T2 mapping
36121	J-point elevation
36122	ST elevation
36123	cardiovascular disorders
36124	speckle-tracking strain
36125	ST segment elevation
36126	QP/QS, pulmonic/systemic flow for shunt calculation
36127	STEMI, ST-segment myocardial infarction
36128	TIMI, Thrombolysis In Myocardial Infarction
36129	mechanical complications
36130	septal rupture
36131	ECG, Electrocardiogram
36132	EF, Ejection fraction
36133	RT-PCR, Real-time reverse transcription-polymerase chain reaction
36134	TTE, Transthoracic echocardiogram
36135	total ischemic time
36136	Global longitudinal strain
36137	left to right shunt
36138	post mi ventricular septum rupture
36139	delayed presentation
36140	door-to-balloon
36141	PA, pulmonary artery
36142	RCA, right coronary artery
36143	VSR, ventricular septal rupture
36144	ventricular septal rupture
36145	LVFWR
36146	LVFWR, left ventricular free wall rupture
36147	left ventricular aneurysm
36148	STEMI, ST-elevation myocardial infarction
36149	ST-elevation myocardial infarction (STEMI)
36150	STEMI networks
36151	brugada pattern
36152	st-segment elevation myocardial infarction (stemi)
36153	myocardial strain imaging
36154	CHF, Congestive Heart Failure
36155	COPD, Chronic Obstructive Pulmonary Disease
36156	EMS, Emergency Medical Systems
36157	PCI, Percutaneous Coronary Interventions
36158	PPCI, Primary Percutaneous Coronary Interventions
36159	STEMI, ST elevation Myocardial Infarction
36160	Respiratory failures
36161	Stent thrombosis
36162	abdominal aortic aneurysm
36163	Computed tomography angiography (CTA)
36164	MINOCA
36165	regional blood flow
36166	tomography, emission-computed, single-photon
36167	chest pain
36168	left-sided catheterization
36169	right-sided catheterization
36170	ventricular septal defect
36171	SENC
36172	Tagging
36173	delivery of care
36174	pericardial disease
36175	medical decision making
36176	Tissue tracking
36177	cardiovascular magnetic resonance
36178	myocardial blood flow
36179	myocardial perfusion
36180	phantom
36181	transmural gradients
36182	focused echocardiography
36183	rupture
36184	ventriculogram
36185	Cardiovascular magnetic resonance
36186	Right-ventricular function
36187	Speckle-tracking echocardiography
36188	Rubidium-82
36189	continuous quality improvement
36190	myocardial perfusion imaging
36191	motion compensation
36192	myocardial lipid metabolism
36193	proton magnetic resonance spectroscopy
36194	retrospective gating
36195	acute pyelonephritis
36196	direct renin inhibitor
36197	Association extraction
36198	Co-occurrence network embeddings
36199	Coronavirus infectious diseases
36200	case volume
36201	Air passengers data
36202	Walking
36203	COVID‐19 coronavirus
36204	institutional responses
36205	marketplaces
36206	public spaces
36207	representations
36208	the Netherlands
36209	retractions
36210	PACS
36211	teleradiology
36212	Japan 
36213	Black, Asian and minority ethnic (BAME)
36214	King Khalid University
36215	academic staff members
36216	Battle plan
36217	Case load
36218	doac
36219	unfractionated heparin
36220	cytological techniques
36221	Clinical laboratory tests
36222	Laser surgery
36223	health-care system organization
36224	Electricity demand reduction
36225	Energy conservation
36226	Smart city
36227	neurorehabilitation
36228	65+age group
36229	Ageing passengers
36230	Sudanese/British doctors
36231	experimental psychology
36232	neuroimaging
36233	preprint
36234	preregistration
36235	Access to Information
36236	Information Typology
36237	Financialisation
36238	debt
36239	financial chains
36240	audiologists
36241	speech-language pathologists
36242	intensive treatment unit
36243	care home
36244	caregiver
36245	containment and closure
36246	government policy responses
36247	international financial market
36248	stock market volatility
36249	behavioural responses
36250	conscientiousness
36251	neuroticism
36252	personality traits
36253	decompressive craniotomy
36254	lumbar puncture
36255	viral encephalitis
36256	COVID-19 situation
36257	Traumatic spine fracture
36258	Fellow
36259	TeleMedicine
36260	cold agglutinins
36261	haemolytic anaemia
36262	working from home
36263	disability studies
36264	disabled persons
36265	standards of care/ethics*
36266	Orthopedic trauma
36267	Human–wildlife interfaces
36268	Organizations
36269	disaster and crisis governance
36270	fever detection
36271	volunteering
36272	mainstream media
36273	prioritisation
36274	KAPs
36275	Makerere University Teaching Hospitals
36276	CT scans
36277	computed tomography imaging
36278	cumulative disadvantage
36279	strength-based perspective
36280	pandemic telehealth
36281	Capitalism
36282	COVID-19 and crime
36283	Google COVID-19 Community Mobility Reports
36284	Mobility and crime
36285	Mobility elasticity of crime
36286	Mobility theory of crime
36287	Movement and crime
36288	EACTA
36289	European Association of Cardiothoracic Anaesthesiology
36290	cardiothoracic and vascular anesthesia
36291	Analytical thinking
36292	Insight
36293	Doppler; diagnosis
36294	Elective surgery cancellation
36295	disaster recovery
36296	Foreign Bodies
36297	Nose
36298	Adult Congenital Heart Disease
36299	nervousness
36300	artificial intelligence markup language (AIML)
36301	chat bots
36302	functionalities
36303	geography of innovation
36304	global innovation systems
36305	calf diarrhoea
36306	mixed methods
36307	Educational planning
36308	Clergy
36309	Spirituality
36310	COVID hospital
36311	COVID-19 emergency
36312	lab organization
36313	panels for monitoring patients
36314	reagents
36315	staff management
36316	Hashtags
36317	Retweets
36318	Social Network Analysis
36319	COVID-19 Hospital relief act
36320	Revenue
36321	Visceral surgery
36322	Behavioral
36323	Loss aversion
36324	Prospect theory
36325	Medical student volunteer
36326	dental laser
36327	laser dentistry
36328	Antiseptics
36329	Antisépticos
36330	Persian Nowruz
36331	Mobile app
36332	Text messaging
36333	conspiracy beliefs
36334	mistrust
36335	vaccination hesitancy
36336	patient perceptions
36337	telemedicine perceptions
36338	healthy illusion
36339	threat and fear
36340	unrealistic optimism
36341	unrealistic pessimism
36342	Unorganized sectors
36343	census board
36344	hospital capacity
36345	real time data
36346	ventilator availability
36347	GISE
36348	Mitraclip
36349	Piedmont
36350	apnea
36351	Global media
36352	dermatology procedures
36353	risankizumab
36354	peer-review
36355	biobank
36356	biorepository
36357	translational research
36358	Academics
36359	Productivity
36360	Audiology
36361	critical care transport
36362	Surgical airway
36363	low and middle income countries (LMICs)
36364	In-hospital infection
36365	Upper Endoscopy
36366	delivery service
36367	pre-symptomatic
36368	maternity leave
36369	reflection
36370	Filipino adults
36371	coronavirus crisis
36372	national resilience
36373	scale validation
36374	Viral diagnostics
36375	portable point-of-care ultrasound
36376	remote supervision
36377	teleguidance
36378	ultrasound teleguidance
36379	PTSS
36380	outreach
36381	Lymph nodes
36382	C19P-S
36383	Relational Lockdown
36384	Relational Trauma
36385	confinamiento relacional
36386	trauma relacional
36387	关系创伤
36388	冠状病毒
36389	社会关系闭锁
36390	Telemedicine adoption
36391	Virtual software platforms
36392	online lecture
36393	Bone fracture
36394	Conservative treatment
36395	medical school application
36396	LMCA, left main coronary artery
36397	high-risk PCI
36398	Feminism
36399	flexible working
36400	Disease tracking
36401	Information distillation
36402	Real-time
36403	Social sensing
36404	home PACS
36405	stay home orders
36406	work safe orders
36407	ER
36408	Healthcare utilization
36409	Stock Market
36410	remote curriculum
36411	#Urology
36412	google search volume index (GSVI)
36413	public interest
36414	total joint arthroplasty (TJA)
36415	Federalism
36416	health reform
36417	state health policy
36418	Novel Coronavirus Disease (COVID-19)
36419	Social interventions
36420	Social networks
36421	3D Printing
36422	Orthopaedic cast
36423	Orthopaedic splint
36424	 Infectious disease incubation period
36425	Immunohistochemistory
36426	Self-injection-locked radar
36427	Vital sign sensing
36428	elderly.
36429	Patient numbers
36430	person-centered health care
36431	Bivalirudin
36432	Direct thrombin inhibitors
36433	Extracorporeal
36434	Ceasas
36435	Food marketing
36436	AHP
36437	Buprenorphine-naloxone
36438	opioid substitution therapy
36439	Personal Satisfaction
36440	Pharmaceutical Services
36441	Professional Role
36442	Qualitative Research
36443	Self Concept
36444	acgme
36445	usmle
36446	Group method of data handling
36447	Cross-country spillovers
36448	Global VAR
36449	Health shocks
36450	Unemployment indicators
36451	COVID-19 LIMS
36452	COVID-19 biobanks
36453	COVID-19 specimens
36454	intensive care unit/intensive care unit issues in palliative care
36455	palliative social work
36456	palliative team
36457	PDMS
36458	POC biosensors
36459	flexible materials
36460	paper
36461	eltrombopag
36462	e-dentistry
36463	video consultations
36464	COVID-19, Coronavirus Disease 2019)
36465	False Negative Rate
36466	Negative Predictive Value
36467	RT-PCR, Real Time Polymerase Chain Reaction)
36468	Moral appeal
36469	Moral suasion
36470	Public good contributions
36471	34D08
36472	34D23
36473	92D25
36474	Health care capacity
36475	Latent period
36476	Local and global stability analysis
36477	Flanders
36478	Personality characteristics
36479	Vulnerability to disease
36480	global health politics
36481	government responses
36482	Major Trauma
36483	Trauma; Orthopaedics; COVID-19
36484	nursing students
36485	perceived stress scale
36486	Operation table
36487	Pelvic-acetabulum
36488	Pulse oximeter
36489	Digital inequalities
36490	Vulnerable population
36491	Hypercapnia
36492	Hypothermia
36493	secondary care
36494	neutropaenia
36495	Medical negligence
36496	litigation
36497	dento-alveolar surgery
36498	qualitative content analysis
36499	Lutheran Confessions
36500	Martin Luther
36501	virtual communion
36502	Case management
36503	Elective surgical procedures
36504	Drug Shortage
36505	Drug Therapy
36506	Medication Systems
36507	Pharmacy Service
36508	OPD
36509	Internet of medical things
36510	IoMT applications
36511	COVID-19 psychological impacts
36512	Couple suicide
36513	Suicide pact
36514	AI applications
36515	Repurposed AI
36516	Team diversity
36517	CECT, contrast enhanced computed tomography
36518	H1N1, Hemagglutinin Type 1 and Neuraminidase Type 1
36519	RT-PCR, Reverse transcription polymerase chain reaction
36520	Botulinum Toxin
36521	intrathecal baclofen
36522	pandemic (COVID-19)
36523	spasticity
36524	University professors
36525	Voice disorders
36526	COVID-19; Coronavirus
36527	Prothrombotic state
36528	Vertebrobasilar disease
36529	Dental radiology
36530	Workplace safety
36531	dual‐earner couples
36532	gender equality
36533	unpaid labour
36534	share prices
36535	Spinal surgery
36536	neurobiology
36537	biological products/therapeutic use
36538	dermatologic agents/therapeutic use
36539	mobile health units
36540	Chatbot
36541	Employee Screening
36542	bush meat
36543	illness anxiety
36544	OECD
36545	Social disparities
36546	Social justice
36547	Structural injustice
36548	Home Care
36549	Health infrastructure systems
36550	Iran alumina company
36551	Global health security
36552	Turkish perspective
36553	occupational hazard
36554	preventiion
36555	SDM, shared decision making
36556	UNOS, United Network for Organ Sharing
36557	cardiac transplant
36558	chronic heart failure
36559	Extremity trauma
36560	Hand and upper-extremity emergencies
36561	Replantation
36562	Latency
36563	Replication number
36564	Forensic Medicine
36565	interprofessional research
36566	interprofessional scholarship
36567	remote data collection
36568	intrathecal pump
36569	daily stress
36570	Genital
36571	Sexual
36572	Loneliness, Social support
36573	candidate
36574	antiracism
36575	counterdata
36576	emergency physician
36577	Forex market
36578	High frequency
36579	MF-DFA
36580	Google Search Volume Index
36581	Pandemic Recovery
36582	Continuous traumatic stress
36583	Posttraumatic stress symptoms
36584	Trauma exposure
36585	lymphocyte transformation tests
36586	multiple drug hypersensitivity
36587	symmetrical drug-related intertriginous and flexural exanthema
36588	aorta and great vessels
36589	cardiacsurgical procedure
36590	Endoscopy outside regular working hours
36591	Patient reported outcomes
36592	Systemics
36593	changing clinical practice
36594	internet skills
36595	internet use
36596	literacy
36597	global crisis
36598	university
36599	hospice care service
36600	internship
36601	Big Five
36602	Situations
36603	critical care (ICU)
36604	screening criteria
36605	triggers
36606	Clinical neurology
36607	Neuroradiology
36608	Subarachnoid haemorrhage
36609	Advance Care Planning
36610	Virtual Workshops
36611	Discrete-time model
36612	Patients’ dynamics
36613	Adaptive neuro-fuzzy inference system
36614	COVID-19;Climatology
36615	Virus optimization algorithm
36616	educational intervention
36617	percutaneous coronary interventions
36618	Age-related differences
36619	urban–rural
36620	argatroban
36621	tissue-plasminogen activator
36622	Bone
36623	DXA
36624	Dual energy X-ray absorptiometry
36625	consumer spending
36626	shutdown
36627	ureteral stone
36628	          organisational delivery        
36629	          rehabilitation        
36630	          service design        
36631	World leaders
36632	Spatial effects
36633	Spatial panel data models
36634	fracture clinic
36635	virtual fracture clinic
36636	Chang Gung Memorial hospital
36637	Jenkins sleep scale
36638	Sleep difficulties
36639	Anti Xa activity
36640	Thrombosis prophylaxis management
36641	Viscoelastic coagulation tests
36642	EOL discussions
36643	Theory of Planned Behavior
36644	Acute ischaemic stroke
36645	Recanalization therapy
36646	Stroke activation
36647	Arterial embolization
36648	Lumbar artery bleeding
36649	Retroperitoneal hemorrhage
36650	carers
36651	Chest x-ray
36652	Patient attention
36653	Pelvic floor dysfunction
36654	Pelvic floor unit
36655	Urogynaecology
36656	Orthopedic practical examination
36657	Orthopedic residency
36658	Nox-2
36659	Nuclear Medicine Department
36660	CD95 (Fas)
36661	exhaustion
36662	stressors and resources
36663	aortic surgery
36664	intramural hematoma
36665	Adversity
36666	Ciencias para la familia
36667	Family Science
36668	adversidad
36669	estrés
36670	investigación
36671	大流行
36672	家庭科学
36673	研究
36674	紧张
36675	逆境
36676	Benchmarking
36677	MCDA
36678	Medical image
36679	Epidemic Response
36680	Unit-Based Consultation
36681	Sustainability challenge
36682	Wicked problem
36683	Complex systems
36684	Extreme events
36685	Bifactor
36686	COVID‐19 crisis
36687	experimentation
36688	federalism
36689	policy response
36690	transformative governance
36691	Early mobilisation
36692	COVID-19-related health worries
36693	anxiety symptoms
36694	evidence-based policy
36695	population medicine
36696	social-ecological system (SES)
36697	systemic approach
36698	women veterans
36699	alopecia areata
36700	hair diseases
36701	seborrheic dermatitis
36702	telogen effluvium
36703	fight
36704	second phase
36705	Public–Private-People partnership (4P)
36706	infrastructure
36707	patient behaviour
36708	Whole slide imaging
36709	laryngology
36710	speech-language pathology
36711	telepractice
36712	Imperative
36713	ABA
36714	Center-based services
36715	Essential services
36716	Health and safety
36717	Efficiency index
36718	Generalised Hurst exponent
36719	Herding behaviour
36720	Fontan
36721	univentricular circulation
36722	Osaka 
36723	trend analysis
36724	Mobile radiography
36725	neurourology
36726	Picotechnology
36727	Science
36728	Attacks
36729	Pandemic of COVID-19
36730	Sublimation
36731	Victim
36732	Evidence-Based Decisions
36733	Implementation Research
36734	Implementation Science
36735	Financial Resilience
36736	For-Profit Hospitals
36737	Ramadan fasting
36738	aesthetic center
36739	financial impact
36740	smartworking
36741	how to prepare
36742	Confidence
36743	Gambling
36744	Online casino gambling
36745	Online sports betting
36746	Issue Framing
36747	Pandemic Response
36748	Power Relations
36749	E-Health
36750	Healthcare Reform
36751	Low-Value Care
36752	Carcinoma de células escamosas cutáneo
36753	Cutaneous squamous cell carcinoma
36754	Diagnóstico precoz
36755	Laboratory test
36756	case detection
36757	epidemic in Italy
36758	statistical forecast
36759	Clinical simulation
36760	obstetric emergency
36761	suspected or confirmed COVID-19 cases
36762	mother-infant bonding
36763	one month after birth
36764	otolaryngology residents
36765	Coronavirus/COVID
36766	Pandemia de COVID-19
36767	Violencia de compañero íntimo
36768	Medication adherence
36769	Virtual learning
36770	Estimating
36771	Mapping
36772	catheterization laboratory reboot
36773	elective interventional procedures
36774	novel care model
36775	drive-through clinic
36776	Actigraphy
36777	Healthcare workers/medical staff
36778	measurement
36779	pulmonary embolism; Shock
36780	pulmonary embolism; TEE
36781	ventricular wall anatomy
36782	enteral access < nutrition
36783	nutrition assessment < nutrition
36784	parenteral nutrition < nutrition
36785	vitamins < nutrition
36786	social marketing/health communication
36787	Reperfusion
36788	speech language pathology
36789	cybersecurity
36790	Pseudocyst
36791	Treatment setting
36792	Medical gloves
36793	Medical residents
36794	woman
36795	Economic growth
36796	EpicCare
36797	SmartData
36798	SmartPhrases
36799	result
36800	surge staffing
36801	Clinical decision
36802	RT PCR
36803	advanced care planning
36804	disease-specific advanced care planning
36805	Functional movement disorders
36806	psychogenic movement disorders
36807	Prisoner
36808	Family medicine
36809	Identity
36810	biotechnology
36811	health care economics
36812	Purinergic signaling
36813	Carotid T occlusion
36814	Code stroke
36815	resilience engineering
36816	Addiction Psychiatry
36817	Substance-Related and Addictive Disorders
36818	Border zone infarcts
36819	CADASIL
36820	Vascular endothelial cell
36821	Door handle
36822	necrotizing periodontal disease
36823	scientific evidence
36824	Family Physician
36825	Entry to practice
36826	Time-to-Treatment
36827	adaptive behavioral
36828	COVID foot
36829	economic growth
36830	Dermatología
36831	Peru (Source: MeSH NLM)
36832	copd
36833	Commercial energy
36834	Energy consumption
36835	Industrial energy
36836	Residential energy
36837	Daubechies wavelet
36838	Tight frame
36839	license
36840	reimbursement
36841	Blood Management
36842	Blood Transfusion Services
36843	Voluntary Blood Donation
36844	Time use
36845	Home sleep apnea testing
36846	Football
36847	Soccer
36848	Divided community
36849	National emergency operation framework
36850	Religious cult
36851	Total community
36852	banding
36853	evl
36854	gi bleeding
36855	phg
36856	barbell
36857	dumbbell
36858	exercise is medicine
36859	human physical conditioning
36860	Social capital
36861	Impact, suspension, safety, liberty
36862	Administration
36863	Inactivation
36864	Thermal disinfection
36865	Consumer law enforcement
36866	Duty to trade fairly
36867	Online platforms
36868	Price gouging
36869	Principle-based approach
36870	Vulnerable consumers
36871	Astronomical instrumentation
36872	Physics
36873	basic sciences
36874	Ocean sciences
36875	Ophthalmic surgery
36876	Puromycin
36877	Puromycylation
36878	Ribopuromycylation
36879	Translation
36880	Medical school
36881	Undergraduate education
36882	surgical video capture
36883	virtual surgical education
36884	Self-assessment
36885	acting internship
36886	multimodal
36887	microbiom
36888	misfolded proteins
36889	Care delivery systems
36890	Cloud-based
36891	Workstation
36892	Behaviour
36893	POMS
36894	Long-term ventilation
36895	Risk of injury
36896	Cover-19
36897	Charles Rosenberg
36898	core curriculum
36899	emergency medicine resident
36900	ob-gyn
36901	Reconstructive surgical procedures
36902	Teaching Hospitals
36903	Mediastinal emphysema
36904	AIIMS
36905	Orthopaedic resident
36906	Subsidies
36907	awake
36908	hypoxaemia respiratory failure
36909	Food equity
36910	Food systems planning
36911	Local government policy
36912	CD50
36913	End-point dilution assay (EPDA)
36914	Plaque-forming units
36915	mathematics model
36916	Hypoxaemia
36917	Premature birth
36918	phage
36919	α-synuclein
36920	optic nerve
36921	optical coherence tomography
36922	Practice organisation
36923	accurate measurement
36924	immunodulators
36925	Action plan
36926	collaborative practice agreements
36927	rural pharmacy
36928	COV-19
36929	Moral
36930	lottery
36931	Noise spectra
36932	Seismic noise
36933	Shillong
36934	Education, professional
36935	Educational measurement
36936	Homeschooling
36937	Online education
36938	andemic
36939	eadership
36940	Burglary rates
36941	Crime pattern theory
36942	Disaster effects
36943	Routine activity
36944	Urban crime distribution
36945	Axillary nerve
36946	Pseudoparalytic shoulder
36947	Delusional topics
36948	General orthopaedics
36949	Prone-position ventilation
36950	Perspective
36951	Continuous positive airway pressure
36952	telesupervision
36953	airborne particulate mitigation
36954	endonasal surgery
36955	nasopharyngeal suctioning
36956	sinonasal cautery
36957	sinonasal drilling
36958	Telecare
36959	Ayushman Bharat program
36960	Health & wellness centres
36961	Universal health coverage
36962	Coronavirus response
36963	Rational choice
36964	Routine activities
36965	Disaster risk management
36966	Input–output model
36967	Cloud computing
36968	Fog computing
36969	Health monitoring
36970	Home hospitalization
36971	Coronavirus news
36972	Semantic networks
36973	Proof of work
36974	Trustless computing
36975	Assemblage
36976	Ecological crisis
36977	Anatomic pathology medical education
36978	Hand examination
36979	alone
36980	dying
36981	Remote Care
36982	Social Justice
36983	Orthopaedic surgeon
36984	human resources
36985	professional motivation
36986	qualification of medical personnel
36987	retraining of doctors
36988	human challenge
36989	sovereign immunity
36990	tort immunity
36991	smelling
36992	tasting
36993	DMV
36994	double-membrane spherule
36995	replication organelle
36996	spherule
36997	zippered ER
36998	race inequities
36999	systemic racism
37000	ESG investments
37001	European sovereign debt crisis
37002	Portfolio diversification
37003	country vaccine entry requirements
37004	health diplomacy
37005	yellow fever
37006	ACR
37007	ownership
37008	presidential address
37009	radiologist as physicians
37010	enzyme thermostability
37011	senior research project
37012	MNE geography
37013	MNE strategy
37014	city-regions
37015	global cities
37016	global value chains
37017	knowledge transfer
37018	off shoring
37019	attitudes to death
37020	bereavement support
37021	do not resuscitate
37022	verifying death
37023	Centrifugal microfluidics
37024	Lab-on-a-chip
37025	Paper
37026	cyclic olefin copolymer
37027	early-stage disease detection
37028	integrated heaters
37029	multiple displacement amplification
37030	on-chip DNA amplification
37031	polymer-based disposable microfluidic chips
37032	Central banks
37033	Coronavirus recovery plans
37034	Decarbonizing the economy
37035	Money creation
37036	Elder abuse
37037	Fraud
37038	Student
37039	itraconazole
37040	pleural fluid
37041	type I feline coronavirus
37042	Lacan
37043	passivity
37044	time
37045	waiting
37046	Nursing practice
37047	science communication
37048	teaching-learning
37049	Glaucoma
37050	Global ophthalmology
37051	Trachoma
37052	Parkinson
37053	Conspiracy beliefs
37054	Peritoneal Dialysis
37055	Codes of Ethics
37056	Ethics Committees
37057	Helsinki Declaration
37058	budget healthcare
37059	occupational burnout
37060	occupational safety of medical workers
37061	Bilateral panel
37062	Export diversification
37063	Export variety
37064	hypoglossal nerve stimulation
37065	overnight pulse oximetry
37066	Home telecare
37067	Sonic & EM signals from life forms
37068	 e-learning/computers
37069	best evidence medical education
37070	independent
37071	Digital biomarker
37072	Electronic health records
37073	Health applications
37074	Medical applications
37075	Mobile health
37076	problem-based learning
37077	Ganga
37078	Municipal sewage
37079	Continuous positive airway pressure helmet
37080	axillary vein
37081	Catastrophe Capitalism
37082	Consucrats
37083	Cosmedics
37084	Necropolitics
37085	Computer-assisted learning
37086	Serious games
37087	boot camp
37088	capstone course
37089	non-surgical
37090	residency preparation
37091	transition
37092	Cytology education
37093	Telecytology
37094	Virtual microscopy
37095	ILAE
37096	Policy advocacy
37097	nursing organizations
37098	nursing political influence
37099	British politics
37100	devolution
37101	intergovernmental relations
37102	territorial politics
37103	Aetiology of the disease
37104	Astrology
37105	Medical history
37106	Religious discourse
37107	Social discourse
37108	gaming
37109	longitudinal
37110	Public safety
37111	Infectious disease outbreak
37112	Blood gas
37113	Psychotherapy group
37114	therapeutic community
37115	Language learning
37116	Online applications
37117	Pedagogical innovation
37118	Web learning tools
37119	Digital pathology
37120	home reporting
37121	remote reporting
37122	technical specifications
37123	Epidemic preparedness
37124	Equitable Access
37125	ICC
37126	Cytomegalovirus
37127	Immunodeficiency virus
37128	Antibiotic
37129	C. difficile
37130	CDI
37131	Age discrimination
37132	Scarce resources
37133	Elderly patient
37134	skin signs
37135	Long-term care ethics
37136	Long-term care homes for the elderly
37137	Narrative
37138	Edadismo
37139	Mass media
37140	Medios de comunicación
37141	Thrombosis centres
37142	Vitamin K antagonists
37143	Hospital Palliative Care Team
37144	Symptom control
37145	Visiting restrictions
37146	Online multidisciplinary group therapy
37147	schema therapy
37148	Inadequate sleeping
37149	Media attention
37150	Socioeconomics
37151	teleneuropsychology
37152	validity study
37153	Chronological age
37154	Gait speed
37155	Physiological age
37156	disease activity
37157	autoethnography
37158	care and caring
37159	Bone strain index
37160	Dual-energy X-ray absorptiometry
37161	MolecuLight
37162	bacterial fluorescence imaging
37163	wound assessment
37164	wound documentation
37165	wound measurement
37166	Art-therapy
37167	Dance
37168	Imaginary
37169	Socialization
37170	principalism
37171	public health decision making
37172	Bolsonaro
37173	neoliberal authoritarianism
37174	strategic ignorance
37175	Sero-prevalence
37176	Socially vulnerable groups
37177	Societal safety
37178	health-protective behaviours
37179	Discourse
37180	Wet market
37181	Zoonotic disease
37182	Educational technology
37183	Interactive tutorial
37184	Public health informatics
37185	Video recording
37186	dead body
37187	mass fatality
37188	slums
37189	urban planning
37190	S. Korea
37191	safety management
37192	Disaster Management
37193	Emergency Preparedness and Response
37194	Pharmacy professionals
37195	Provider status
37196	Public Health Pharmacy
37197	Postpartum care
37198	thorax CT
37199	Market reaction
37200	elective care
37201	patient concerns
37202	public perceptions
37203	health education intervention
37204	pandemic reaction
37205	public adherence
37206	Dataset
37207	Portuguese
37208	Public and patient involvement
37209	Social philosophy
37210	economic interventions
37211	Health vulnerability
37212	Livelihood vulnerability
37213	Regional inequalities
37214	Rural economy
37215	Slovakia
37216	competitiveness
37217	public procurement
37218	emergency powers
37219	health law and policy
37220	justifiable authority allocation
37221	stressors
37222	Nursing policy
37223	Policy review
37224	recession
37225	nursing student
37226	pre-service nursing professional
37227	public health development
37228	inclusion
37229	comparative politics
37230	Counterpliance
37231	Relational frame theory
37232	Rule-following
37233	Rule-governed behavior
37234	political philosophy
37235	Fiscal stimulus
37236	Society 5.0
37237	Sustainable development goals (SDGs)
37238	European Court of Human Rights
37239	derogation
37240	liberal democracy
37241	lying for benevolent reasons
37242	republicanism
37243	social democracy
37244	teaching in medical schools
37245	Civil Liberties
37246	Constitutional Law
37247	Fourteenth Amendment
37248	Health Law
37249	Public Health Law
37250	Reproductive Rights
37251	Infodemic Response Checklist
37252	LMIC countries
37253	benefits and burdens of research
37254	equity in clinical research
37255	workforce education
37256	geriatric dentistry
37257	research methodology qualitative
37258	Hospital-Based Telehealth
37259	Intensive Outpatient Psychiatry
37260	Rapid Design
37261	Virtual Group Psychotherapy
37262	Disorders
37263	Psychosomatic
37264	Tension
37265	creativity
37266	problem solving
37267	Rapid Learning Systems
37268	Imaging volume
37269	Radiology operation
37270	Service locations
37271	Imaging Utilization
37272	Multimodality
37273	Administrative law
37274	Fiscal sociology
37275	Social funds
37276	COVID-19 crime
37277	De-carceration
37278	National research agenda
37279	Social ordinances
37280	Lisbon
37281	Urban social movements
37282	housing rights
37283	urban struggles
37284	clinical rotations
37285	licensing examinations
37286	facial expression
37287	mask wearing
37288	well being
37289	food availability
37290	contagion of emotions
37291	Catheter ablation
37292	Devices
37293	Cuidado informal
37294	Cuidados
37295	Informal care
37296	Administrative Performance
37297	Emergency Management
37298	Knowledge Management
37299	Learning Organization
37300	Editorial oversight
37301	Fake
37302	Integrity
37303	Post-publication peer review
37304	digital disinformation
37305	fact-checking
37306	third-person effect
37307	hotline
37308	spirituality
37309	support project
37310	health governance
37311	long-term care homes
37312	public discourse
37313	cause‐related marketing
37314	nonprofit
37315	virtual town hall
37316	humanitarian aid
37317	Medical Records Systems, Computerised
37318	Systematised Nomenclature of Medicine
37319	health equality
37320	Pharmaceutical services
37321	late implementation
37322	capitalist platforms
37323	community of rights
37324	open commons
37325	public good
37326	Shewhart control chart
37327	Statistical Process Control
37328	Statistical public reporting of healthcare data
37329	FQHC
37330	community health center
37331	Family Physicians in COVID care
37332	OB/GYN
37333	Physician
37334	General Population
37335	Healthcare Professionals
37336	Atención de crisis
37337	Crisis care
37338	Ética
37339	cooperative extension
37340	horse industry
37341	online resources
37342	XDR-TB
37343	low‐molecular‐weight heparin
37344	thrombin generation assay
37345	Cognitive diversity
37346	Epistemic justice
37347	Poverty-sensitive
37348	Public consultations
37349	online support
37350	remote support
37351	automated hand hygiene monitoring
37352	electronic compliance monitoring
37353	hand hygiene monitoring
37354	hand hygiene performance
37355	ACC20
37356	Virtual ACC Scientific Sessions
37357	impact of social media
37358	Healthcare providers
37359	landlord–tenant rights
37360	property law
37361	project ECHO
37362	government countermeasure
37363	Interpersonal distance
37364	Field-ICU
37365	Isolation Facility
37366	methamphetamine
37367	Sierologic tests
37368	Violence against women
37369	Women’s health
37370	Essential level of care
37371	Rehabilitation medicine
37372	Healthcare administration
37373	disease convergence
37374	health opportunity index
37375	public health exposome
37376	thematic mapping
37377	waiting times
37378	age stereotypes
37379	geronticide
37380	coping capacity
37381	pandemic control
37382	supply and distribution
37383	gold standard
37384	Assisted suicide
37385	Ethical history
37386	Religions
37387	Sober medicine
37388	manipulation
37389	massage
37390	gossip
37391	Social stigma
37392	Policy Making
37393	Public Policy
37394	administrative capacity
37395	public management
37396	biomedical reductionism
37397	determinants of health
37398	Arendt
37399	political world‐building
37400	UK Government
37401	World War II
37402	Anxiety symtoms
37403	Depressive symtoms
37404	Gaza Strip
37405	Siege
37406	Health security
37407	Securitization
37408	NHS long term plan
37409	future physician
37410	SPECT/CT
37411	radiomics
37412	personal health records
37413	Customer Service
37414	COVID-19 and virtual care
37415	surgical communication
37416	telehealth in surgery
37417	video care in surgery
37418	virtual care in surgery
37419	mobile health technology
37420	Ethical Capacity Building
37421	Ethical Digital Health
37422	Fourth industrial revolution
37423	Occupational health and safety
37424	Technology-enabled Human Resources for Health
37425	COVID19 corona virus
37426	Ergonomics Patient Safety
37427	behavioral economics
37428	durable goods
37429	intellectual property
37430	preventatives
37431	Dead space
37432	multi-risk
37433	natural hazard
37434	protest
37435	Central and peripheral cornea
37436	Corneal endothelium cell density
37437	Polymegethism and polymorphism
37438	Slit lamp biomicroscope
37439	Public perception
37440	Religious congregations
37441	medical insurance
37442	migrants
37443	undocumented
37444	unmet healthcare needs
37445	central corneal thickness
37446	corneal edema after cataract surgery
37447	trans-corneal oxygenation
37448	healthcare quality improvement
37449	Electromyogram
37450	Force variability
37451	Jaw elevators
37452	Masseter muscle
37453	Temporalis muscle
37454	Communication skills
37455	ethics/attitudes
37456	Esophagogastroduodenoscopy
37457	friends
37458	Lewes
37459	Sussex
37460	gravestone
37461	shooting
37462	Extra-pulmonary shunt
37463	Interatrial defects
37464	Intra-pulmonary shunt
37465	ciclosporine
37466	cyclophosphamide
37467	arenavirus
37468	mammarenavirus
37469	CovR-CovS
37470	RocA
37471	group A Streptococcus
37472	Scientific statement
37473	pharma industry
37474	Blood demand
37475	Blood supply management
37476	Hematochezia
37477	Melena
37478	Anaesthtetic consultation
37479	Surgical pathway
37480	Mass migration
37481	SARS-C0V-2 infection
37482	SAH
37483	Decision fatigue
37484	vicarious traumatization
37485	Moyamoya angiopathy
37486	Thalamus
37487	Herpes zoster
37488	Saliva ejector
37489	Border control
37490	Working-from-home
37491	Accelerometer
37492	Personalized Medicine
37493	eating concerns
37494	weight concerns
37495	weight gain
37496	34A34
37497	34C60
37498	92Bxx
37499	93A30
37500	Nonlinear differential systems
37501	Personal boundary
37502	Safe space
37503	First seizure
37504	attachment style
37505	childhood trauma
37506	COVID-19 causal beliefs
37507	Dysfunctional personality domains
37508	Emotional problems
37509	psychological inflexibility
37510	Cognitive impact
37511	Healthcare Worker
37512	In-Situ
37513	Personal Strengths
37514	Health service research
37515	Women’s Health
37516	particle counting
37517	staff safety
37518	coping abilities
37519	perceived impact on health
37520	psychosocial frailty
37521	competence
37522	medical negligence
37523	medical regulation
37524	MSK Radiology
37525	Academic radiology
37526	Acute care imaging
37527	General radiology
37528	Physician versatility
37529	Coping appraisal
37530	Treat appraisal
37531	Expectations
37532	Mental stress
37533	Global health ethics
37534	shared leadership
37535	Automation
37536	Future of work
37537	Intelligent Automation
37538	Filipino
37539	Radiologic technologists
37540	health care education
37541	trend of variation
37542	urologic surgery
37543	Hospital administration
37544	lidership
37545	bedtime
37546	time perception
37547	Surgical consent
37548	Trauma surgery
37549	hearing
37550	noise level
37551	speech recognition
37552	Pastoral care
37553	Pastoral visitation
37554	employment status
37555	labor force
37556	nursing personnel
37557	occupational status
37558	Guidelines for telemedicine
37559	Virtual visits
37560	Aerosol generating surgery
37561	Draping technique
37562	sleep duration and pattern
37563	somatic pain
37564	Clinical Deterioration
37565	Computed Tomography Angiography
37566	Embolism and Thrombosis
37567	Platelet Aggregation Inhibitors
37568	Paediatric: Clinical aspects
37569	ANTs
37570	FSL
37571	MRIStudio
37572	SPM
37573	Spatial normalization
37574	Warping
37575	chicken soup
37576	Postgraduate training
37577	Resource limited
37578	CO2
37579	Positive pressure
37580	Health Services Needs and Demand
37581	Practice Patterns, Physicians
37582	Specialization
37583	Hemothorax
37584	hemopneumothorax
37585	Nurses Unions
37586	Working conditions
37587	communication and decision-making
37588	Energy expenditure
37589	Indirect Calorimetry
37590	COVID-19; debriefing
37591	Organizational learning
37592	Pandemic preparation
37593	team segregation
37594	tertiary care
37595	Critical aortic stenosis
37596	E-consultation
37597	Intensive care Unit
37598	News Score
37599	airway obstruction
37600	awake tracheal intubation
37601	head & neck surgery
37602	SIR and integro-differential models
37603	Spatio-temporal meso-scale outbreak dynamics
37604	bonding
37605	separation
37606	End-of-life
37607	Family-centered care
37608	Withdrawal of life support
37609	oronavirus
37610	racture
37611	rauma
37612	Antenatal corticosteroids
37613	decision analysis
37614	rupture of membranes
37615	devices
37616	Halving time
37617	Suppression
37618	gender wage gap
37619	clinical pharmacists
37620	staff allocation
37621	anaesthetist
37622	neuromuscular blocking agent
37623	difficult conversations
37624	Intermediate Care
37625	Neurological examination
37626	5-Hydroxymethylfurfural
37627	Nutritional supplement
37628	heart failure with preserved ejection fraction
37629	hypertensive emergency
37630	preeclampsia
37631	feedback
37632	training support
37633	          design        
37634	          ergonomics        
37635	          mechanical ventilators        
37636	          safety        
37637	          standards        
37638	          usability        
37639	Healthcare simulation
37640	Pandemic planning and response
37641	Quality improvement and patient safety
37642	Almitrine
37643	Capillary shunt
37644	Peyton's approach
37645	Clinical skills
37646	communication skills
37647	atelectrauma
37648	hyperinflation
37649	optimal PEEP
37650	Exacerbated COPD
37651	Candidaemia
37652	neurological system
37653	paresthesia
37654	Anti-NMDA-R encephalitis
37655	NORSE
37656	Acute hemorrhagic encephalomyelitis
37657	Acute hemorrhagic leukoencephalitis
37658	frequently asked questions
37659	fiberoptic endoscopic evaluation of swallowing
37660	swallowing
37661	disaster preparation pandemic response
37662	ventilator distribution
37663	ventilator shortage
37664	Aortic arch
37665	Aortic disease
37666	Clog size
37667	Rapid response team
37668	Behavioral interventions
37669	Caregiver training
37670	Foster care
37671	Resources for caregivers
37672	brachial plexus
37673	upper extremity
37674	conduction anesthesia
37675	ARDS: prone position mech
37676	Hypoxaemia: ventilator management
37677	O2 del to tissues: factors impacting
37678	spinal cord stimulation
37679	assertive community treatment
37680	bipolar disorder
37681	aerodynamics
37682	impactor
37683	ECG-derived respiration
37684	LVET
37685	PEP
37686	digital stethoscope
37687	patch
37688	phonocardiogram-derived respiration
37689	wearable cardiorespiratory monitoring
37690	rehabilitation, COVID-19, health system, international civil society organization
37691	C19-YRS
37692	telephone screening tool
37693	citation network analysis
37694	co-citation network analysis
37695	knowledge base
37696	total laryngectomy
37697	voice prosthesis
37698	Post-resuscitation care
37699	Physical Medicine and Rehabilitation
37700	COVID—19
37701	Cerebral Palsy
37702	International Functional Classification
37703	tele-rehabilitation
37704	Radiological
37705	Status Epilepticus
37706	practice survey
37707	Decision Making
37708	Physical Therapy Department: Hospital
37709	Postdoctoral fellowship
37710	didactics
37711	in vivo histology using MRI
37712	multicenter study
37713	multiparameter mapping
37714	quantitative MRI
37715	Turbo-QUASAR
37716	cerebral blood flow
37717	cerebrovascular reserve
37718	pseudo-continuous arterial spin labeling
37719	pulsed arterial spin labeling
37720	Applicants
37721	Technology-based learning
37722	Coffee
37723	Fevers
37724	Milk
37725	Stomach
37726	Percutaneous dilatational tracheostomy
37727	key indicator cases
37728	otolaryngology surgical education
37729	virtual curriculum
37730	flatten the curve
37731	Ethical guidelines
37732	Ethnic minorities
37733	Pandemic ethics
37734	Social sciences and ethics
37735	Virtual geriatric clinics
37736	Priapism
37737	clinical otolaryngology
37738	Forensic examination
37739	Intimate partner violence (IPV)
37740	Sexual and gender-based violence
37741	Sexual violence
37742	patient generated data
37743	OMAG
37744	(MeSH): COVID-19
37745	Automobile Driving
37746	Public Awareness
37747	Face-to-face teaching
37748	Compassion
37749	Achilles tendon
37750	foot and ankle
37751	Allocation of resources
37752	Medical professionalism
37753	body bequests
37754	ethical framework
37755	Business ethics
37756	Consumer ethical decision making
37757	Corporate social responsibility
37758	Marketing philosophy
37759	Rhetoric
37760	Solidarity
37761	communities
37762	neighborhoods
37763	clinical training
37764	Information sharing
37765	Public interest
37766	doctrine of double effect.
37767	in-person appointments
37768	maximizing benefits
37769	health law
37770	Social ethics
37771	Decision support, clinical
37772	Healthcare quality improvement
37773	Medical homes
37774	policy guidelines/inst. review boards
37775	beneficence
37776	non-maleficence
37777	residency interview
37778	virtual interviews
37779	National Blood Transfusion Committee
37780	blood shortage
37781	massive bleeding
37782	ambiguity
37783	ignorance
37784	surgical teaching
37785	Panopto
37786	recording
37787	Phenomenological study
37788	postgraduate training
37789	communication education
37790	patient-centered communication
37791	video conference encounters
37792	Live-stream surgery
37793	Instant messaging applications
37794	Mobile learning
37795	Online medical education
37796	Telegram
37797	career Development
37798	medical Student
37799	specialty Choice
37800	academics
37801	away rotations
37802	residency match
37803	rotations
37804	Digital gift giving
37805	ethnography
37806	medical anthropology
37807	Anatomy education
37808	Body donation
37809	Virtual classes
37810	Training program
37811	Away Rotations
37812	Medical Students
37813	Residency Match
37814	Entrepreneurial hustle
37815	Social entrepreneurship
37816	Virtual idea blitz
37817	national meeting
37818	program director
37819	web conferencing
37820	Multiprofessional
37821	international medical education
37822	Perceived vulnerability
37823	Death experience
37824	e-Learning
37825	patient safety/quality improvement
37826	webinar
37827	autonomous referral request
37828	between-participants experiments
37829	employee referrals
37830	referral bonus
37831	referral likelihood
37832	referral quality
37833	KEYWORD
37834	African- and Hispanic Americans
37835	Clinical competency
37836	Clinical education
37837	Teaching strategies
37838	Barometer survey
37839	COVID-19 crises
37840	Information for policy
37841	Responsible science
37842	School situation
37843	Survey methodology
37844	Behavior analysis
37845	supervision
37846	Evidence-based assessment
37847	Psychological assessment
37848	Crisis communication
37849	Experimental studies
37850	Brunei
37851	Online Consultation
37852	Whatsapp
37853	testing rates
37854	plasmablasts
37855	post-traumatic stress disorder (PTSD)
37856	psychopathological symptomatology
37857	service transformation
37858	workforce deployment
37859	human–automation trust
37860	naïve automation users
37861	trust development
37862	Seizure recurrence
37863	Self-reported stress
37864	media effects
37865	rural America
37866	female leaders
37867	organizational rules
37868	poststructuralist
37869	sensemaking
37870	Insider trading
37871	Politics and trading
37872	US industries, Investor attention
37873	expressed emotion
37874	PASI
37875	educational level
37876	Influence measure
37877	Social Network
37878	Sustainable Computing
37879	Weighted Correlated Influence
37880	Composite leading indicator
37881	Financial market data
37882	News sentiment
37883	Mania
37884	Emergency neurology
37885	psychologist
37886	Facial plastic surgery
37887	family carers
37888	idiopathic thrombocytopenic purpura
37889	remote diagnosis
37890	Fenofibrate
37891	Serine
37892	Sphingolipids
37893	Sulfatide
37894	e-discussion
37895	webinars
37896	Pepcid
37897	Perception of Risk
37898	Rheumatology outpatient clinics
37899	Cricothyroidotomy
37900	Front-of-neck access
37901	Manikin
37902	Digital tablets
37903	Continuing medical education
37904	clinical education
37905	curriculum development/evaluation
37906	professional development
37907	﻿COVID-19
37908	outdoor
37909	oncological patients
37910	telehealth assistance
37911	Dizziness
37912	Academic Dermatology
37913	Remote Education
37914	Activity
37915	Calls
37916	EMS dispatch center
37917	aesthetics
37918	botox®
37919	botulinum
37920	cosmetic dermatology
37921	rhytides
37922	meta-regression
37923	Hearing aid
37924	Anti-inflammatory agents
37925	Nonsteroidal
37926	Social mobility
37927	Adalimumab
37928	Acne
37929	warts
37930	harmonization
37931	Cardiac surgery procedures
37932	subsets
37933	Disposable
37934	Electrical stimulation
37935	Nerve conduction study
37936	severe hyponatremia
37937	Patients’ preferences
37938	adult leukaemia
37939	clinical trials management
37940	risk-based assessment
37941	Cholecystecomy
37942	View
37943	opioid
37944	opioid misuse
37945	social determinant
37946	Conversion disorders
37947	Functional neurological disorders
37948	Psychogenic non-epileptic seizures
37949	COVID-19 infection, endoneurial edema, Guillain-Barré syndrome, MRI, spinal nerve, STIR
37950	cheilitis
37951	lip licking dermatitis
37952	Odontology
37953	Editorial policies
37954	Publishing trends
37955	Scientific evidence
37956	Scientific journals
37957	Research protocol
37958	Gamma knife
37959	Virtual Psychiatric Care
37960	Airwayscope®
37961	The aerosol box
37962	Chief residents
37963	Corona-virus
37964	Supraglottic airway
37965	Cognitive behavioural therapy
37966	Retraining therapy
37967	Smartphone applications
37968	Sound therapy
37969	Tinnitus
37970	laryngoscope
37971	scoring
37972	enanthema
37973	exanthema
37974	oral mucosa
37975	oral cavity ulcer
37976	oral manifestation
37977	bougie
37978	introducer
37979	tracheal trauma
37980	Hand
37981	Main
37982	Cardiovascular risk biomarkers
37983	Homocysteine
37984	Charts
37985	Application Limit
37986	Urology Match
37987	Secondary infections
37988	Syrian Camps
37989	Health worker
37990	Medicalized nursing home
37991	Emergency department operations
37992	Motor cortex
37993	factor X deficiency
37994	gastrointestinal bleeding
37995	dental treatment
37996	Endonasal endoscopy
37997	Burn
37998	Fall
37999	Gunshot wounds
38000	Coronary intervention
38001	giant cell arteritis
38002	polymyalgia rheumatica
38003	tumour necrosis factor inhibitors
38004	protocols and guidelines
38005	Adult otolaryngology
38006	Facial plastic & reconstructive surgery
38007	OTOLARYNGOLOGY
38008	Digital poverty
38009	gastrointestinal diseases
38010	analgesics, opioid
38011	opioid-related disorders
38012	injections
38013	spinal
38014	chondrocalcinosis
38015	crystal arthropathies
38016	injections, spinal
38017	occupational & industrial medicine
38018	sleep medicine
38019	analgesics
38020	acute promyelocytic leukaemia
38021	Speciality training
38022	prehospital care
38023	termination of resuscitation
38024	Human factors
38025	Button headband
38026	Patient security
38027	Prominent ear
38028	Antimicrobic phototherapy
38029	Germicidal UV
38030	UV safety
38031	erratum
38032	Endoscopic sinus surgery
38033	Online conference app
38034	Online lecture
38035	Injuries
38036	Chain of Survival
38037	Epic
38038	Medical Dermatology
38039	Store-and-forward
38040	Synchronous
38041	Burning Mouth Disorder
38042	Socially assistive robots
38043	dementia care
38044	Facial expressions
38045	Hand gestures
38046	Nonverbal communication
38047	Witnesses
38048	Shocks
38049	Corrective devices
38050	Home-based
38051	Osteoarthritis
38052	Total knee arthroplasty
38053	medical overuse
38054	Incarcerated
38055	Inguinal hernia
38056	Strangulated
38057	Teleconsulting
38058	Disconnection ban
38059	Energy assistance programme
38060	Energy poverty
38061	Fuel poverty
38062	Social tariff
38063	Buildings
38064	COVID-19 in lieu of medicine
38065	embryology
38066	facial trauma
38067	AWWA Policy Statements
38068	Emergency Planning
38069	Utilities
38070	Multimodal pain therapy
38071	Agri-food
38072	Disruptive technologies
38073	Green innovation
38074	bullae
38075	petechiae
38076	purpura fulminans
38077	Food and nutritional security
38078	Home gardens
38079	Undernourishment
38080	Urban agriculture
38081	psychological flexibility
38082	values
38083	CRISPR diagnostics
38084	orthopaedics and traumatology
38085	surgical priorities
38086	policy blunders
38087	hemocytometry
38088	white blood cells
38089	Conflicts
38090	Correlated shocks
38091	Brady-arrhythmia
38092	Leadless pacemakers
38093	Pacing strategies
38094	Temporary Pacing
38095	Contacto
38096	Epicutáneas
38097	Patch testing
38098	SCSEP
38099	cumulative advantage
38100	productive aging
38101	public scholarship
38102	Advanced practice
38103	BSTI
38104	Reporting radiographers
38105	Remote assessment
38106	Virtualised care
38107	acute stroke pathway
38108	healthcare planning
38109	stroke pathways
38110	COVID′19
38111	Malaysian perspective
38112	Policies
38113	Socio-economic
38114	virtual spine examination
38115	Criticality
38116	Material flow
38117	Craniocervical junction
38118	Craniocervical traumatic injury
38119	Glass fragment
38120	Interatlantooccipital penetration
38121	Nonmissile penetrating injury
38122	Spinal immobilization
38123	Aeropolitics
38124	Facilitation
38125	ICAO
38126	air service agreements
38127	telecommunication
38128	Delinquency
38129	Juvenile justice
38130	Juvenile justice reform
38131	Award
38132	pathology education
38133	whole slide imaging
38134	miscellaneous
38135	Anthropogenic gadolinium
38136	Drinking water
38137	Gadolinium anomaly
38138	Gadolinium-based contrast agents
38139	Micropollutants
38140	Palliative
38141	Financial well-being
38142	Great recession
38143	Circular economy
38144	Green Deal
38145	Industry transition
38146	Packaging
38147	Plastic recycling
38148	Bioreactor
38149	Microcarrier
38150	Process development
38151	Suspension culture
38152	Virus production
38153	electrochemical DNA sensor
38154	nucleic acid sensor
38155	pathogen sensing
38156	signal amplification
38157	age-related diseases
38158	bound water
38159	hydration
38160	stiffness
38161	cme
38162	Swivl
38163	telepresence robot
38164	bedside manners
38165	virtual visits headache toolbox
38166	webside manners
38167	Automated instruction
38168	Programmed instruction
38169	Teaching machine
38170	Airseal
38171	Laparoscopic and robotic-assisted surgery
38172	carbon dioxide
38173	transanal minimally invasive surgery
38174	Strengths
38175	generativity
38176	life reflection
38177	life story
38178	memory function
38179	eudaimonia
38180	personal growth
38181	personal strengths
38182	purpose in life
38183	Muslim women
38184	wifehood
38185	frontline healthcare professionals
38186	perceived severity
38187	psychosocial strengths
38188	Librarianship
38189	Library and information professionals
38190	health sciences
38191	Relationship banking
38192	economic and banking crisis
38193	enterprise finance
38194	regional banks
38195	Agrobiodiversity
38196	Informal food chain
38197	Seed systems
38198	UUK
38199	Bibliometric method
38200	Scientific production
38201	Scientific research
38202	distributional impact
38203	fiscal policy
38204	income distribution
38205	income generation model
38206	microsimulation
38207	nowcasting
38208	co‐production
38209	Algorithmic accountability
38210	Automated decision making
38211	Public sector innovation
38212	LoRA
38213	UAV
38214	packet reception rate
38215	topology control
38216	Universities
38217	human behaviour
38218	Cross correlation
38219	Data driven model
38220	End time
38221	Least square fitting
38222	Mean recovery time
38223	Peak infected cases
38224	Peak time
38225	Time-lag analysis
38226	COV
38227	CV
38228	Coefficient of variation
38229	Cornea endothelium
38230	Polymegethism
38231	Impact of COVID-19
38232	Consumer law
38233	Guiding principles
38234	Moratoria
38235	Refunds
38236	Gestión COVID-19
38237	Gestión caso
38238	Modified technique
38239	atypical manifestations
38240	Affect intensity
38241	Positive affect
38242	Trait emotional intelligence
38243	Anxiety and depression symptoms
38244	Bi-stability
38245	Testing activity
38246	Microbial keratitis
38247	Jordan universities
38248	TAM model
38249	e-learning system
38250	Retail investors
38251	Risk-taking
38252	Trading behavior
38253	Aglink-Cosimo
38254	Agricultural markets
38255	Biofuel markets
38256	GDP shock
38257	Green transition
38258	Commodity price shocks
38259	Macro-financial stimulus
38260	Virtuous growth cycles
38261	COVID-19 impact survey
38262	IPECP
38263	InterprofessionalResearch.Global
38264	Longitudinal survey
38265	interprofessional education and collaborative practice
38266	Positive perspective
38267	Summer season
38268	Trans-sphenoidal surgery
38269	Jakarta
38270	Meteorological factor
38271	Digital technologies
38272	Fuzzy decision making
38273	Hesitant fuzzy sets
38274	SWARA
38275	WASPAS
38276	Dynamic systems
38277	Forecasting of the epidemic
38278	The second wave
38279	Python
38280	Airline industry
38281	Business development
38282	Eco-friendly policies
38283	Environmental sustainability policies
38284	Sustainability practices
38285	Diversity and inclusion
38286	Entrepreneurial ecosystems
38287	Entrepreneurship
38288	Intersectionality
38289	Migrant status
38290	Equity index options
38291	Risk-neutral densities
38292	Financial crisis
38293	Safe-haven
38294	Business & management
38295	Co-word analysis
38296	Emerging research topics
38297	Positive Technology
38298	exergames
38299	m-Health
38300	Trauma and Orthopaedics
38301	Onsite appointment
38302	Oral Maxillofacial Surgery
38303	virtual consulting
38304	conceptual framework
38305	service
38306	psychological consultation
38307	NARNN
38308	Covid-19 model
38309	Lagrange polynomial
38310	Non-local operators
38311	Reproductivity numbers
38312	Retail strategy
38313	Retailing
38314	multi-residential buildings
38315	waste diversion
38316	Computer-Based Simulation
38317	High Fidelity Simulation Training
38318	Online Simulation
38319	Screen-Based Simulation
38320	Virtual Simulation
38321	Web-Based Simulation
38322	Durable solutions
38323	COVID-19 economic effects
38324	Climate change policy
38325	Excess demand
38326	Iraq Inquiry
38327	science policy
38328	Behavioral intention
38329	Female students
38330	Video conferencing tools
38331	60G25
38332	68T05
38333	68T37
38334	Bifurcation theory
38335	Eigenvalues
38336	Order parameters
38337	Synergetics
38338	Brent
38339	Gas
38340	Mutual information
38341	Renyi entropy
38342	S&P500
38343	Silver
38344	VIX
38345	WTI
38346	Complex adaptive systems
38347	Learning and Sensemaking processes
38348	Policy decision-making
38349	Natural climate solutions
38350	Food aid
38351	Food assistance
38352	Foreign aid
38353	ODA
38354	General trust
38355	Hoarding behaviors
38356	Optimism-pessimism
38357	Preventive behaviors
38358	elective procedure
38359	local anaesthetic
38360	standard operating procedure
38361	Advance Directives
38362	Electronic Health Records
38363	Resuscitation Orders
38364	Actors
38365	Artistic voice
38366	Singers
38367	theory-driven research
38368	Microvascular thrombosis
38369	Sublingual microcirculation
38370	Core surgical training
38371	competencies
38372	surgical skills
38373	health care utilisation
38374	symptom deterioration
38375	Geriatric psychiatry
38376	Household consumption
38377	Poverty rate
38378	Socio-economic impact
38379	Small island state
38380	Explosive process
38381	Recursive rolling window
38382	Time-varying Granger causality
38383	Embodiment
38384	Health Services
38385	Seemingly unrelated equations
38386	Business continuity
38387	Extreme disruptions
38388	citizen jury/assembly
38389	deliberative democracy
38390	Geography education
38391	geographical knowledge
38392	powerful knowledge
38393	COVID-19; testing
38394	arterial blood gas
38395	dyspnea descriptors
38396	Admisiones en el departamento de urgencias
38397	Brote pandémico
38398	Cirugía de cálculos
38399	Emergency department admissions
38400	Stone surgery
38401	Urolitiasis
38402	Aflibercept
38403	Anti-VEGF
38404	Macular
38405	Level of evidence
38406	hypogeusia
38407	incidence, ROC
38408	Human Biology Program
38409	face-to-face
38410	Journals
38411	Original article
38412	Females
38413	Anagen effluvium
38414	COVID-19 hair manifestations
38415	Downside risk
38416	Safe haven
38417	Principal components analysis
38418	health: COVID-19
38419	household dynamics
38420	Women’s empowerment
38421	US Embassies
38422	Employability
38423	E‑health
38424	CGE model
38425	Recovery plans
38426	Small open economy
38427	Sustainable investment
38428	Conservation policy
38429	Extinction
38430	Narratives
38431	Change
38432	Liquid modernity
38433	Order
38434	job vacancies
38435	labour demand
38436	labour market policy
38437	labour supply
38438	wage subsidies
38439	churches
38440	geography of religion
38441	infrasecular space
38442	intersacred space
38443	virtual services
38444	Penetrating
38445	Self-harm
38446	cervico-facial infection
38447	dental emergency
38448	dental facial infection
38449	incision and drainage
38450	post dental extraction infection
38451	urgent dental care centres
38452	3d printing
38453	engineering
38454	healthcare simulation
38455	healthcare technology
38456	simulation based medical education
38457	THR
38458	TKR
38459	Economic resilience
38460	Limb Salvage
38461	Wound Healing
38462	Backlog
38463	universal testing
38464	exclusion
38465	Trauma referrals
38466	Trauma workload
38467	Bank risk
38468	COVID-19 and finance
38469	Catastrophe insurance
38470	Financial market risk
38471	elective endoscopy
38472	emergency endoscopy
38473	endoscopy disinfection
38474	computer-assisted diagnoses
38475	Restarting
38476	Home-based learning
38477	Peer-tutoring
38478	SDG 4
38479	Social and emotional learning (SEL)
38480	Textbooks
38481	Academic profession
38482	Digitalisation of universities
38483	Online learning, teaching and assessment
38484	UK higher education
38485	ID training
38486	Metabolic features
38487	Climate emergency
38488	Trauma patients
38489	Michaelis-Menten
38490	enzyme kinetics
38491	hill equation
38492	ligand binding
38493	Door opener
38494	Couple Therapy
38495	Divorce
38496	Family Therapy
38497	COVID-19 time series
38498	ensembles
38499	fuzzy logic
38500	corruption
38501	out-of-pocket payments
38502	political economy of health
38503	structural adjustment
38504	structural violence
38505	posterior probability
38506	robust algorithm
38507	Limb salvage
38508	Margins
38509	Sarcomas
38510	Community containment
38511	Delay discounting
38512	Emotional reactivity
38513	Experiential avoidance
38514	Immigrant detention
38515	Immigration and Customs Enforcement (ICE)
38516	Conspiracy
38517	Individual differences
38518	Disease Diffusion
38519	Health Geography
38520	TPSN
38521	digitalisation
38522	e‐commerce
38523	e‐grocery
38524	food retail
38525	Network Governance
38526	Network of Networks
38527	Port Governance.
38528	Wicked Problem
38529	‘COVID-19 pandemic’
38530	‘Competency-based education’
38531	‘Educational technology’
38532	‘Online education’
38533	‘Optometry education’
38534	“Aprendizaje electrónico”
38535	“COVID-19”
38536	“Crisis pandémica”
38537	“Educación basada en la competencia”
38538	“Educación en línea”
38539	“Educación en optometría”
38540	“Tecnología educativa”
38541	dermatoporosis
38542	dissecting haematoma
38543	Management of service
38544	doctor-patient interaction
38545	mediatization
38546	International Continence Society
38547	urodynamics
38548	earthquake
38549	temporomandibular disorders
38550	gerontological social work
38551	Chest CT images
38552	dominated occupations
38553	Institutional Collective Action Framework
38554	local economic development
38555	fiscal responses
38556	public and nonprofit finance
38557	Psychiatric symptoms
38558	Subjective age
38559	solitude
38560	COVID-19 related anxiety
38561	somatic symptoms
38562	Clinical studies
38563	EMA
38564	Emergency use
38565	FDA
38566	Off-label use
38567	barium esophagogram
38568	flexible endoscopic evaluation of swallowing
38569	flexible nasopharyngolaryngoscopy
38570	modified barium swallow
38571	transnasal esophagoscopy
38572	upper aerodigestive tract endoscopy
38573	alcohol concentrations
38574	DISK
38575	IBD-DI
38576	Pulmonary disease detection
38577	Training from scratch
38578	Challenges of E-learning system
38579	E-learning system
38580	Success factors
38581	COVID-19 modelling
38582	COVID-19 prediction
38583	Inverse Artificial Neural Network model
38584	pericardiocentesis
38585	acute pericarditis
38586	cardiac tamponade
38587	text analytics
38588	Malignant arrhythmia
38589	COVID-19 neurological manifestations
38590	COVID-19 neuromuscular manifestations
38591	sport and exercise medicine
38592	Simple regression analysis
38593	Abusive behaviors
38594	Academic bullying
38595	healthy safety
38596	Palliatives
38597	Medical hardware
38598	information-seeking
38599	Carbon tax
38600	Macroeconomic modeling
38601	Neo-Keynesian CGE model
38602	Post-COVID economy
38603	Bias-variance dilemma
38604	Hyperparameters and chaos
38605	Statistical learning
38606	power meters
38607	reduced training
38608	road cycling
38609	ACO
38610	health care waste
38611	anticipatory
38612	frenetic
38613	Asylum seekers
38614	medico-legal evaluation
38615	dental care plan
38616	universal health insurance
38617	emergency care systems, emergency departments
38618	Diversification
38619	Impact of corona
38620	Sugar consumption
38621	Sugar export
38622	Sugar industry
38623	Sugar price
38624	m-health
38625	health care quality, access, and evaluation
38626	3-D Printing
38627	Additive Manufacturing
38628	Additive Supply Chain
38629	Supply Chain Management
38630	Pediatric airway surgery
38631	Surgical drape
38632	Neurosurgery training
38633	Alaska Natives
38634	American Indians
38635	Social Vulnerability Index
38636	community risk
38637	 dermatologists
38638	 impact
38639	 patients
38640	chronic inflammatory dermatoses
38641	clinical placement
38642	tomorrow’s doctors
38643	Burns unit
38644	OR protocols
38645	physical examination
38646	daily facemasks
38647	solid waste
38648	Charitable food
38649	Food banks
38650	Food poverty
38651	Precarious working
38652	Bystander CPR
38653	support group
38654	Tourette syndrome
38655	chronic tic disorder
38656	tic disorders
38657	new benzodiazepines
38658	new psychoactive substances
38659	substance abuse
38660	Pediatric urology
38661	Community response
38662	Orthopedic Procedures
38663	Wounds and Injuries
38664	Autoimmune hemolytic anemia
38665	Rheumatological Diseases
38666	Low cost
38667	left ventricle
38668	Phosphate, COVID-19, Respiratory Alkalosis
38669	electrolytes
38670	patient health engagement
38671	Chronic symptoms
38672	Dysautonomia
38673	Hematopoietic Stem Cell Transplant
38674	Barrier
38675	Religious cliché
38676	After effects
38677	Exacerbations
38678	Gynecological diseases
38679	cling film
38680	dermatology practice
38681	patient perspectives/narratives
38682	implantable cardiac devices
38683	Blood smears
38684	morphology cells
38685	nasopharyngoscopy
38686	negative pressure chamber
38687	stroboscopy
38688	Burn unit
38689	Embedded
38690	Embodied
38691	Meditation
38692	culture/diversity
38693	Humor
38694	logistic regression analysis
38695	aeromedical
38696	Larynx
38697	oculoplastic
38698	BSN
38699	Nursing leadership
38700	Student nurse
38701	Structural Inequities
38702	cardiac implantable electronic device
38703	defibrillator
38704	Referral systems
38705	Everolimus
38706	hyper-activation
38707	immune-regulation
38708	dental office
38709	social responsibility
38710	Job market
38711	Recruiting
38712	Specialty
38713	backup
38714	Inflammatory state
38715	Quarantines
38716	Telemonitoring, CoVID-19, Crisis
38717	Clinical adjustments
38718	Educational activity
38719	Radiation Oncology
38720	generation-Z
38721	millennials
38722	physician workforce
38723	high reliability organizing
38724	buprenorphine/naloxone
38725	Digitization
38726	Information intensity
38727	Product and services
38728	Science, technology and society
38729	COVID Pandemic
38730	Consumer habits
38731	Customer experience
38732	New regulations for shopping
38733	Aircraft Leasing
38734	Aviation
38735	Director General of Civil Aviation, Maintenance Training
38736	European Aviation Safety Agency
38737	MRO
38738	E-learning portal
38739	Higher education institution
38740	Information quality
38741	System quality
38742	Critical percolation
38743	Monte Carlo simulations
38744	Random graphs
38745	Telepsychology
38746	program development
38747	B corporations
38748	Latam
38749	community-centered
38750	social enterprise
38751	social purpose
38752	Disability studies
38753	Health legislation
38754	Age-friendly communities
38755	home- and community-based services
38756	participation
38757	Digital learning tools
38758	International cooperation
38759	Learning crisis
38760	social response
38761	Wikis
38762	blended/hybrid learning
38763	in‐service and professional development
38764	technologies: e‐mail, Facebook, podcasting, synchronous and asynchronous videoconferencing
38765	Affordances
38766	Corporeity
38767	Design research
38768	Dialectics
38769	Social interaction practices
38770	Transoral robotic surgery
38771	 Dermatology practice in shadow of COVID, Changing dermatology practice post COVID.
38772	MVPA
38773	CT angio
38774	CT ventilation
38775	Pulmunary embolism
38776	Surgical disparities
38777	electronic nicotine delivery devices
38778	Interprofessional practice
38779	health and social care
38780	sociological theory
38781	Food habits
38782	Life cycle assessment
38783	National dietary guidelines
38784	Planetary health diet
38785	golden standard
38786	Mal-union
38787	Non-union
38788	Virtual clinics
38789	Russian healthcare
38790	image
38791	reputation
38792	Utility Management
38793	Oregon
38794	Small Water Systems
38795	Water Systems
38796	Neuroophthalmology
38797	alcohol dehydration
38798	automated analysis
38799	automated kinetic measurements
38800	high-throughput experimentation
38801	micro-flow reactor
38802	packed bed reactors
38803	reactive gas chromatography
38804	Haematology
38805	radiology & imaging
38806	Cytogenetics and Molecular Genetics
38807	Granulocytes, Monocytes, Macrophages
38808	Immunodeficiencies
38809	health care management education
38810	health behaviour, health communication, haematology
38811	myeloma, multiple
38812	psychosocial support systems
38813	disaster and emergency preparedness
38814	Tele-pharmacy
38815	Evidence based surgery
38816	Allergy Practice
38817	COVID‐1
38818	LCIG
38819	human milk expression
38820	milk banking
38821	community care
38822	infectious illness
38823	Consultation skills
38824	Prescribing
38825	Religious Beliefs
38826	Latin-America
38827	Business and management
38828	General neurology
38829	Neurological practice
38830	eVisit
38831	patient/relationship-centered skills
38832	Bioaerosol
38833	Microdroplets
38834	68Ga-PSMA
38835	Feminist philosophy
38836	Lived experience
38837	Phenomenology
38838	Touch
38839	neoliberal governmentality
38840	parental practices
38841	story completion
38842	Hegemonic Masculinity
38843	Macho Masculinity
38844	COVID consent checklist
38845	Technocracy
38846	Time
38847	attenuate stochastic fluctuations
38848	control random gene regulation
38849	manipulate stochasticity
38850	noise buffering
38851	capnoperitoneum
38852	intra-abdominal pressure
38853	keyhole surgery
38854	minimal invasive surgery
38855	pressure–volume curve
38856	veterinary laparoscopic guidelines
38857	ANTERION
38858	corneal topography
38859	swept source Fourier domain
38860	Indigenous theories
38861	Postcolonialism
38862	Posthumanism
38863	High temperature 3-D printing
38864	Polycarbonate
38865	ULTEM
38866	Complex dynamics
38867	Pandemic spreading
38868	COVID-19 Epidemic
38869	Mathematical Modelling of Epidemics
38870	Samoa
38871	Technical assistance
38872	Volunteers
38873	Left-wing Authoritarianism
38874	Right-wing Authoritarianism
38875	Habits
38876	Food system
38877	Color reproduction
38878	Color-chart
38879	Remote diagnostic
38880	Normalisation
38881	Normalisation process theory
38882	Work practices
38883	Quality control
38884	Surgical masks
38885	Media commentary
38886	Environmental cleaning
38887	Patient room
38888	Surface cleaning
38889	UV marker
38890	Holistic approach
38891	Professional responsibility
38892	Modern(ism)
38893	Mystery
38894	Post-modern(ism)
38895	lumbar spine
38896	spine models
38897	three-dimensional (3d) printing
38898	vertebrae
38899	Aging research
38900	Aging science talks
38901	Electricity
38902	Seasonal adjustment
38903	Weather data
38904	practice models
38905	anterior segment
38906	Compressed-SENSE
38907	DCE-MRI
38908	Glioma grading
38909	T1-Perfusion MRI
38910	Cornea endothelial cells morphology
38911	Hydrogel
38912	Silicone hydrogel
38913	Soft contact lenses
38914	Finger tapping
38915	Spontaneous motor tempo
38916	Stepping
38917	Toe tapping
38918	Bayesian penalized likelihood
38919	Micro Hollow Sphere phantom
38920	NEMA image quality phantom
38921	image quality
38922	image reconstruction
38923	FTMH
38924	OCT measurements
38925	intraocular gas
38926	macular hole size
38927	Electroretinogram
38928	Photopic negative response
38929	AS-OCT
38930	corneal stroma
38931	topography
38932	Chronic Fatigue Syndrome
38933	Myalgic Encephalomyelitis
38934	Tests and measures
38935	exercise testing
38936	reliability
38937	Diffusion tensor imaging
38938	Diffusion-weighted imaging
38939	Inter-vendor reproducibility
38940	Neurite orientation dispersion and density imaging
38941	Scan–rescan reproducibility
38942	ADMIRE
38943	FBP
38944	MDCT
38945	SAFIRE
38946	abdomen phantom
38947	antibody–drug conjugates
38948	controlled-release
38949	Extended use respirators
38950	filtering face respirators
38951	fit test qualitative
38952	Adhesive tape
38953	Fogging
38954	biophysical methods
38955	learning outcomes
38956	career
38957	cell therapies
38958	mergers and acquisitions
38959	oligonucleotides
38960	product approvals
38961	rare diseases
38962	return to workplace
38963	Forecast feedback
38964	Reflexive prediction
38965	Prices versus quantities
38966	Weitzman
38967	handheld ultrasound
38968	Reduced order
38969	Inpatient psychiatry
38970	civil commitment
38971	mala beads
38972	nerolidol
38973	patch testing
38974	volatile
38975	Broadening
38976	Ear loop
38977	Handle
38978	Pressure injury
38979	Specs
38980	Adaptive capacity
38981	Destination development
38982	Overtourism
38983	Tourism area
38984	TPSN framework
38985	crisis definition
38986	geography of crisis
38987	media reports
38988	transboundary crisis
38989	Podiatry
38990	Business resilience
38991	IT management
38992	RMSE
38993	Regression analysis models
38994	Spread exposed
38995	Disruptions
38996	Mindfulness of the body
38997	Proprioception
38998	Somatics
38999	kāyagatāsati
39000	Multuple products
39001	Product substitution
39002	Stackelberg game
39003	cloud services
39004	humanoid robots
39005	pepper robot
39006	sensor networks
39007	smart infrastructure
39008	thermal imaging
39009	Avigan
39010	Density functional calculations
39011	Favilavir
39012	T-705
39013	Tautomerism
39014	ALSFRS-R
39015	Amyotrophic lateral sclerosis
39016	King’s staging system
39017	MiToS staging system
39018	Biomass
39019	Cogeneration
39020	Eco-indicator 99
39021	Exergoenvironmental analysis
39022	Sugarcane bagasse
39023	Analytic solution
39024	Approximant
39025	Asymptotic analysis
39026	House prices
39027	Housing expansions
39028	Housing supply
39029	Time-varying parameter VAR
39030	residency program
39031	urology residents
39032	frontliners
39033	4‐Adolescence
39034	Critical analysis < Digital/media literacies
39035	Digital/media literacies
39036	Information literacy < Digital/media literacies
39037	Informational text < Strategies
39038	Instructional strategies
39039	Instructional strategies; methods and materials
39040	New literacies < Digital/media literacies
39041	Specific media (hypertext
39042	and materials
39043	etc.) < Digital/media literacies
39044	film
39045	music
39046	teaching strategies < Strategies
39047	agape
39048	b/ordering
39049	Bacterial filtration efficiency
39050	Homemade masks
39051	Isolation masks
39052	Mask shortages
39053	Android forensics
39054	Dating app artifacts
39055	Dating apps
39056	Mobile forensics
39057	Online dating
39058	iOS forensics
39059	Containment policy
39060	Regime shift
39061	Banking crisis
39062	Capital control
39063	Exchange rate regime
39064	Loan-to-value (LTV) ratio
39065	Macroprudential policy
39066	Civil-rights tourism
39067	Commodification paradox
39068	Disney-fication
39069	Environmentalism
39070	Global tourism
39071	Lieux de mémoire
39072	Sites of nostalgia
39073	Time travel
39074	Utopian/dystopian imaginaries
39075	bundled payments
39076	costs
39077	assets
39078	finance
39079	CHT
39080	Fixation
39081	Gaze
39082	Saccade
39083	Visual search
39084	Voila Jones
39085	Fragile and challenging contexts
39086	Language teacher development
39087	dialogue
39088	public theology
39089	Art
39090	Cystic Fibrosis
39091	Zombie
39092	Cyber Supervision
39093	Live Supervision
39094	Online Therapy
39095	Outsider Witness Group
39096	Technology-Assisted Counseling
39097	cibersupervisión
39098	grupo de testigos externos
39099	supervisión en vivo
39100	terapia asistida por tecnología
39101	terapia en línea
39102	在线治疗
39103	外部人员见证组
39104	技术辅助咨询
39105	现场监督
39106	网络督导
39107	online lectures
39108	recording equipment
39109	remote instruction
39110	Fundamentals of bony fixation
39111	Medical Knowledge
39112	Rapid prototyping
39113	Simulation model design
39114	Live-interactive
39115	escape rooms
39116	team building
39117	biofilms
39118	Masculinities
39119	Single‐Parenting
39120	Argumentation
39121	Historical scientific controversies
39122	Puerperal fever
39123	Semmelweis
39124	University science education
39125	Reflection
39126	Strengths-based approach
39127	adaptable assignment
39128	elevator pitch
39129	teaching of gerontology
39130	Balance sheet
39131	Cash-days analysis
39132	Cash-flow tools
39133	Managing cash
39134	creeping crises
39135	transboundary crises
39136	Dawson, Trick, and Litzkow (DTL) electrodes
39137	Electroretinogram (ERG)
39138	Animal welfare
39139	Epidermal cup electrodes
39140	Non-invasive electrophysiology
39141	Retinocortical time
39142	Visual evoked potential
39143	Bio-impedance
39144	Hydration
39145	COVID9
39146	varicella zoster virus (VZV)
39147	Anterior segment diagnostic
39148	Corneal edema
39149	Pachymetry
39150	Flexible work arrangements
39151	Gig work
39152	Period effect
39153	Career development
39154	Generational differences
39155	healthcare utilization
39156	virtual clinics
39157	reflections
39158	breath analysis
39159	portable MS
39160	Veterans
39161	bioanalysis
39162	dismal science
39163	extracorporeal membrane oxygenation therapy
39164	study management
39165	Physical inactivity
39166	Sedentary behavior
39167	gene polymorphisms
39168	Dialysis staff
39169	epidemiologist
39170	care delivery model
39171	medical technology
39172	provider education
39173	Carbon and energy
39174	Climate-change impacts
39175	Energy and society
39176	bias identification
39177	brazil
39178	use of evidence in policy making
39179	Dialysis access
39180	Political legitimacy
39181	MEDICINE
39182	standardisation
39183	connected health
39184	NeglectedTropical Diseases
39185	New road map for neglected tropical diseases
39186	World chagas disease day
39187	Experiential learning
39188	Inter-professional
39189	ear nose throat
39190	larynx
39191	immune thrombocytopenia purpura
39192	Human cognition
39193	Human‐computer interaction
39194	Hybrid campus
39195	Multimodal learning
39196	Social networking
39197	Thoracoabdominal
39198	Disease fear
39199	Italian
39200	Bouchet nodules
39201	Hemorrhagic effusion
39202	Fundus camera flash
39203	Fundus photography
39204	Photic seizure
39205	Photosensitive epilepsy
39206	Wide-field fundus photography
39207	cognitive bias
39208	acute myeloid leukemia
39209	immunology and infectious diseases
39210	non-Hodgkin's lymphoma
39211	intermethod agreement
39212	laser ablation
39213	nail
39214	noninvasive imaging
